Citrus Sinensis ID: 005536
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 692 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RY67 | 708 | Wall-associated receptor | yes | no | 0.927 | 0.906 | 0.623 | 0.0 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.802 | 0.892 | 0.534 | 1e-161 | |
| Q9LZM4 | 657 | Wall-associated receptor | no | no | 0.796 | 0.838 | 0.339 | 8e-77 | |
| P0C5E2 | 654 | Probable serine/threonine | no | no | 0.591 | 0.625 | 0.387 | 7e-75 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.624 | 0.545 | 0.353 | 6e-74 | |
| Q9M342 | 639 | Wall-associated receptor | no | no | 0.573 | 0.621 | 0.405 | 8e-73 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.829 | 0.797 | 0.301 | 1e-70 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.593 | 0.547 | 0.355 | 4e-69 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.540 | 0.486 | 0.382 | 2e-67 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.609 | 0.564 | 0.351 | 2e-67 |
| >sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 814 bits (2102), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/661 (62%), Positives = 506/661 (76%), Gaps = 19/661 (2%)
Query: 38 VPYPFGFSPGCAIRLTCANATVK-IGEFEVQNVTADSIFVNLPTKCHRQITSLHPLFGPN 96
+PYPFGFS GC+IR C+ A IG+F VQNVT +SIFV L C R+I ++PLFG N
Sbjct: 57 LPYPFGFSNGCSIRFDCSAAEKPMIGDFSVQNVTENSIFVGLSHNCTRKIEDMNPLFGEN 116
Query: 97 YGMTRQNSLLLQNCTTHQNGCVIPTSLVEQRFNLKTCGVGSDNITCFSWPYNENKS--AS 154
+ T +NS L++NC +GC I +E LK+C + NI+CFS N + A
Sbjct: 117 FAPTSENSFLMENCNRTTDGCSIKQKFLENVLKLKSCD-ATGNISCFSLDSNSSSKNSAK 175
Query: 155 FMSFNDLSRTGCNYLFSSLAFNSGGNSAG-SLEFQLLELGWGLNGSCN---CSKNADCTR 210
F S L + C+ LFSS+AF S G +AG +LEF+ + LGW L G C C+ N DCT
Sbjct: 176 FFSMKTLRNSSCSLLFSSIAFESVGVNAGIALEFERVRLGWWLKGGCESGTCAANTDCT- 234
Query: 211 NFTFANGISGHRCRCQEGFEGDGFVAGDGCRRT-SDCNASKYLSGKCGGTRIGALVGGLI 269
+ +G +GHRC C +GF GDG+ + C+R +C SK + C I +VGG +
Sbjct: 235 DVETPHGYAGHRCSCLDGFHGDGYT--NPCQRALPECRGSKLVWRHCRSNLI-TIVGGTV 291
Query: 270 AGASIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEK 329
GA ++A +A +C R+RST LR+ LSAKRLL +AAGNSSV F+PYKEIEKAT FSEK
Sbjct: 292 GGAFLLAALAFFFFCKRRRSTPLRSHLSAKRLLSEAAGNSSVAFFPYKEIEKATDGFSEK 351
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+LG GAYGTVY GKL ND+WVAIKR R+RD++S+DQVMNEIKLLSSVSHPNL+RLLGCC
Sbjct: 352 QKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKLLSSVSHPNLVRLLGCC 411
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
IE+G+P+LVYE+MPNGTL +HLQR+RGSGLPWT+R+T+AT+TA+AIAYLHS+MNPPIYHR
Sbjct: 412 IEQGDPVLVYEYMPNGTLSEHLQRDRGSGLPWTLRLTVATQTAKAIAYLHSSMNPPIYHR 471
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
DIKS+NILLDY++ SKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ FHLSDKSDV
Sbjct: 472 DIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQCFHLSDKSDV 531
Query: 510 YSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSS 569
YSFGVVL EIIT LKVVDF+RPH+E+NLAALA+D+IG GC+DEIIDP L+ DAWTLSS
Sbjct: 532 YSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDEIIDPILDLDLDAWTLSS 591
Query: 570 IHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYMGSPAVSCCSLSECGSER 629
IH VAELAFRCLAFH DMRPTM EVA+ELE IR+S W ++ + SPA S S S+ GSER
Sbjct: 592 IHTVAELAFRCLAFHSDMRPTMTEVADELEQIRLSGWIPSMSLDSPAGSLRS-SDRGSER 650
Query: 630 SLSGLTVKKAGVKSQRLIVPPKSGDCLTTLDEVKDSSPVSVQDPWLSEQSSPSTNSLLGN 689
S VK++ + S+R+++P K DCL +++E+ DSSP+SVQDPWLS QSSPSTN+LLGN
Sbjct: 651 S-----VKQSSIGSRRVVIPQKQPDCLASVEEISDSSPISVQDPWLSAQSSPSTNTLLGN 705
Query: 690 V 690
+
Sbjct: 706 I 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 569 bits (1467), Expect = e-161, Method: Compositional matrix adjust.
Identities = 314/588 (53%), Positives = 392/588 (66%), Gaps = 33/588 (5%)
Query: 35 TKRVPYPFGFSPGCAIRLTCANATVK--IGEFEVQNVTADSIFVNLPTKCHRQITSLHPL 92
T + YPFGFS G IR C+ T + IGEF VQ VT +I+V +P C R I + L
Sbjct: 32 TSLLRYPFGFSDGYPIRFNCSEITGEAVIGEFAVQEVTNSNIYVEIPPVCKRNIRKIEQL 91
Query: 93 FGPNYGMTR-QNSLLLQNCTTHQ--NGCVIPTSLVEQRFNLKTCGVGSDNITCFSWPYNE 149
F N ++ QN +L+Q C + C+I VE R NL C ++C
Sbjct: 92 FRENLAPSKLQNIILVQGCKKQNKSSNCLIRNKFVENRLNLSKC---KSPVSCLDGA--T 146
Query: 150 NKSASFMSFNDL-SRTGCNYLFSSLAFNSGGNSAGSLEFQLLELGWGLNGSCN---CSKN 205
+A MS D+ + +GC Y FSS++ + + G L+ L W L GSC+ CS+N
Sbjct: 147 TTTADVMSLGDVVNGSGCKYWFSSISQSQVSVNLGRLK-----LDWWLKGSCSNTTCSEN 201
Query: 206 ADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSGKCGGTRIGALV 265
ADC + +G GHRC C+EGF G F GC R + + G ++ L
Sbjct: 202 ADCAK-VKLDDGGLGHRCTCREGFSGKAFTVPGGCHR--------LVYKRKGLHKLVVLG 252
Query: 266 GGLIAGASIVAVVALLCYCFR-KRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATS 324
I +V VV + Y FR K+S S A RLLC+ AGNSSVPFY YKEIEKAT
Sbjct: 253 TAGILVGVLVIVVLIATYFFRNKQSASSERASIANRLLCELAGNSSVPFYTYKEIEKATD 312
Query: 325 FFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
FS+K+ LGTGAYGTVYAG+ N VAIKR +++DT SIDQV+NEIKLLSSVSHPNL+R
Sbjct: 313 SFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKLLSSVSHPNLVR 372
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS-GLPWTIRITIATETAQAIAYLHSAMN 443
LLGCC +GEP LVYEFMPNGTL QHLQ ERG L W +R+ IA +TA AIA+LHS++N
Sbjct: 373 LLGCCFADGEPFLVYEFMPNGTLYQHLQHERGQPPLSWQLRLAIACQTANAIAHLHSSVN 432
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT---ESSHISTAPQGTPGYLDPQYHQY 500
PPIYHRDIKSSNILLD+ + SK++DFGLSRLGM+ E+SHISTAPQGTPGYLDPQYHQ
Sbjct: 433 PPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTAPQGTPGYLDPQYHQD 492
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
F LSDKSDVYSFGVVL+EII+ KV+DF+RP+SEVNLA+LA+DRIGRG V +IIDP L
Sbjct: 493 FQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIGRGRVVDIIDPCLNK 552
Query: 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608
+ +SIHN+AELAFRCL+FHR+MRPTM+E+ E+L I++ + +
Sbjct: 553 EINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIKLMHYGT 600
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 8e-77, Method: Compositional matrix adjust.
Identities = 207/609 (33%), Positives = 296/609 (48%), Gaps = 58/609 (9%)
Query: 38 VPYPFGFSPGC---AIRLTCANATVKIGEFEVQ-------NVTADSIFVNLP-------- 79
VPYP P C A R+ C + G N I + P
Sbjct: 51 VPYPLSTGPTCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLRPPGLASSVSC 110
Query: 80 --TKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVI---PTSLVEQ--RFNLKT 132
+Q L P + +T N++LL NC+ I PTSL + N
Sbjct: 111 ISADVSKQGLELDPHLP--FSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSYIKNNASP 168
Query: 133 CGVGSDNITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAFNSGGN---SAGSLEFQL 189
C S C ++ + +++A + N GC S + N
Sbjct: 169 C---SKAPLCCTFRTDGSQTAYTIRING---GGCLAYQSFVGLNPNKEVPPPGKKWPDTG 222
Query: 190 LELGWGLNGSCNCSKNADC------TRNFTFANGISGHRCRCQEGFEGDGFVAGDG-CRR 242
LEL W L C + DC ++ + RC C++G E D A G CR
Sbjct: 223 LELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAICGKCRH 282
Query: 243 TSDCNASKYLSGKCGGTRIGALVGGLIAGASIVAVVALLCYCFRKRSTSLRNQLSAKR-- 300
C K G V IA VAV+ + +K + + +R
Sbjct: 283 GKHCKKKKKTVVFAGAAVAVVGVTLAIA----VAVIGTK-HSHQKVKKDIHKNIVKEREE 337
Query: 301 LLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD 360
+L + S + +EI KAT+ FS+ + +GTG +G V+ L + AIKR + +
Sbjct: 338 MLSANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNN 397
Query: 361 TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ---RERGS 417
T DQ++NE+++L V+H +L+RLLGCC++ P+L+YEF+PNGTL +HL
Sbjct: 398 TKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWK 457
Query: 418 GLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL-GM 476
L W R+ IA +TA+ +AYLHSA PPIYHRD+KSSNILLD +KV+DFGLSRL +
Sbjct: 458 PLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDL 517
Query: 477 TES----SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPH 532
TE+ SHI T QGT GYLDP+Y++ F L+DKSDVYSFGVVL+E++T+ K +DF+R
Sbjct: 518 TETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREE 577
Query: 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM 592
+VNL + + + E IDP L+ + + +I + LA CL R RP+M
Sbjct: 578 EDVNLVMYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMK 637
Query: 593 EVAEELEHI 601
EVA+E+E+I
Sbjct: 638 EVADEIEYI 646
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|P0C5E2|Y1839_ARATH Probable serine/threonine-protein kinase At1g18390 OS=Arabidopsis thaliana GN=At1g18390 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 7e-75, Method: Compositional matrix adjust.
Identities = 174/449 (38%), Positives = 253/449 (56%), Gaps = 40/449 (8%)
Query: 183 GSLEFQLLELGWGLNGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVA--GDGC 240
G ++L+ G+ LN + N C R T SG RC G + FV DG
Sbjct: 199 GMTYVEILKRGFVLNWTANS-----CFRCIT-----SGGRC----GTDQQEFVCLCPDGP 244
Query: 241 RRTSDCNASKYLSGKCGGTRIGALVGGLIAGASIVAVVA--LLCYCFRKRST-SLRN--- 294
+ C K + +I + G A A++V ++A + Y + +R T S RN
Sbjct: 245 KLHDTCTNGKNDKRRRVIVKITKSISG--ASAAVVGLIAASIFWYVYHRRKTKSYRNSSA 302
Query: 295 --------QLSAKRLLCQAAGN--SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK 344
SAK + A V + Y+E+E+AT+ F LG G +GTVY GK
Sbjct: 303 LLPRNISSDPSAKSFDIEKAEELLVGVHIFSYEELEEATNNFDPSKELGDGGFGTVYYGK 362
Query: 345 LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-EPILVYEFMP 403
L + VA+KR + +Q NE+++L+ + HPNL+ L GC ++ + +LVYE++
Sbjct: 363 LKDGRSVAVKRLYDNNFKRAEQFRNEVEILTGLRHPNLVALFGCSSKQSRDLLLVYEYVA 422
Query: 404 NGTLCQHLQRERG--SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN 461
NGTL HL + S LPW+IR+ IA ETA A+ YLH++ I HRD+KS+NILLD N
Sbjct: 423 NGTLADHLHGPQANPSSLPWSIRLKIAVETASALKYLHASK---IIHRDVKSNNILLDQN 479
Query: 462 YRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ KVADFGLSRL + +H+STAPQGTPGY+DP YH + LS+KSDVYSF VVL+E+I+
Sbjct: 480 FNVKVADFGLSRLFPMDKTHVSTAPQGTPGYVDPDYHLCYQLSNKSDVYSFAVVLMELIS 539
Query: 522 ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCL 581
+L VD +RP E+NL+ +A+ +I + +++DP L D ++ VAELAF+CL
Sbjct: 540 SLPAVDITRPRQEINLSNMAVVKIQNHELRDMVDPSLGFDTDTRVRQTVIAVAELAFQCL 599
Query: 582 AFHRDMRPTMMEVAEELEHIRVSSWASNI 610
+D+RP M V + L I+ + + S +
Sbjct: 600 QSDKDLRPCMSHVQDTLTRIQNNGFGSEM 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 6e-74, Method: Compositional matrix adjust.
Identities = 171/484 (35%), Positives = 253/484 (52%), Gaps = 52/484 (10%)
Query: 199 SCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSGKCGG 258
SC C NA +S RC C GF+G+ + G GC+ ++C + ++ CG
Sbjct: 306 SCICDDNA----------YLSYARCSCTRGFQGNPYRLG-GCKDINECKEEEGMT-YCGT 353
Query: 259 TRIGALVG----------------GLIAGASIVAVVALLCYCFRKRSTSLRNQ------- 295
+ L G G G+ I V L Y F K+ L +
Sbjct: 354 NKCVNLQGHFKCVYNNHRPLAIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRN 413
Query: 296 ---LSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVA 352
L ++L+ + +E+EKAT FS LG G GTVY G L + VA
Sbjct: 414 GGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVA 473
Query: 353 IKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ 412
+K+ + D D +++ +NE+ +LS ++H N+++LLGCC+E P+LVYEF+PNG L +HL
Sbjct: 474 VKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLH 533
Query: 413 RERGSGL--PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470
E + W IR+ IA + A A++YLHS+ + PIYHRD+KS+NI+LD YR+KV+DFG
Sbjct: 534 DEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFG 593
Query: 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSR 530
SR + +H++T GT GY+DP+Y Q +DKSDVYSFGVVL+E+IT K + F R
Sbjct: 594 TSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLR 653
Query: 531 PHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT 590
LA I + + +IID + RD LS + A++A +CL RP+
Sbjct: 654 SQENRTLATYFILAMKENKLFDIIDARI---RDGCMLSQVTATAKVARKCLNLKGRKRPS 710
Query: 591 MMEVAEELEHIRVSSWASNIYMGSPAVSCCSLSECGSERSLSGLT--VKKAGVKSQRLIV 648
M EV+ EL+ IR+ + C S +E G E++ GL + +A +S+ +
Sbjct: 711 MREVSMELDSIRMPCGDMQLQ------ECVSENEEGEEQN-KGLVEDIMRAESRSKEFVT 763
Query: 649 PPKS 652
P S
Sbjct: 764 APAS 767
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 275 bits (703), Expect = 8e-73, Method: Compositional matrix adjust.
Identities = 168/414 (40%), Positives = 236/414 (57%), Gaps = 17/414 (4%)
Query: 198 GSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSGKCG 257
G C N+ C+ + T + RC C++GF+ D A R S + K S
Sbjct: 229 GDCRDLLNSVCSNDST---NLGQKRCFCKKGFQWDSVNAVCEVNRCSKRKSCKRWSNLPL 285
Query: 258 GTRIGALVGG-LIAGASIVAVVALLCYCFRKRSTSLRNQLSAKRL---LCQAAGNSSVPF 313
+ VG LIAG +V+ +R ++ S ++L L
Sbjct: 286 LGGLAGGVGAILIAGFITKTIVSKQ----NRRIAGNQSWASVRKLHRNLLSINSTGLDRI 341
Query: 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKL 373
+ KEI KAT F++ + LG G +G V+ G L + VA+KR + + SI Q++NE+++
Sbjct: 342 FTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEVQI 401
Query: 374 LSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG------LPWTIRITI 427
L VSH NL++LLGCCIE P+LVYEF+PNGTL +H+ G G LP R+ I
Sbjct: 402 LCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRLMI 461
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
A +TAQ + YLHS+ +PPIYHRD+KSSNILLD N KVADFGLSRLG+++ SH++T Q
Sbjct: 462 AHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTTCAQ 521
Query: 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547
GT GYLDP+Y+ F L+DKSDVYSFGVVL E++T K +DF+R +VNL +
Sbjct: 522 GTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKALKE 581
Query: 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
G + ++IDP + + S+ + LA C+ R RPTM A+E+E+I
Sbjct: 582 GRLMDVIDPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTMQVAAKEIENI 635
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 205/680 (30%), Positives = 313/680 (46%), Gaps = 106/680 (15%)
Query: 5 LSLSLLISICILYLANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANATVKIGEF 64
L + LL+ IC A+ L R C + VPYPFG GC K F
Sbjct: 9 LVVMLLLRICEYAAASTFPLALRNCSDHCGNVSVPYPFGIGKGC----------YKNKWF 58
Query: 65 EVQ-NVTADSIFVNLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTSL 123
E+ ++D + L + R +TS + G + ++ N +Q+ H +GC
Sbjct: 59 EIVCKSSSDQQPILLLPRIRRAVTSFN--LGDPFSISVYNKFYIQSPLKH-SGCPNRDGY 115
Query: 124 VEQRFNLKTCGVGSDNITCFSWPYNENKSASFMSFNDLSRTGC----------------- 166
NLK F+ NK+ FM+ L GC
Sbjct: 116 SSSSLNLKGSPFFISENNKFTAVGCNNKA--FMNVTGLQIVGCETTCGNEIRSYKGANTS 173
Query: 167 -----------------------------NYLFSSLAFNSGGNSAGSL----------EF 187
N +AF + +GSL E+
Sbjct: 174 CVGYKCCQMTIPPLLQLQVFDATVEKLEPNKQGCQVAFLTQFTLSGSLFTPPELMEYSEY 233
Query: 188 QLLELGWGLNGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCN 247
+EL W L+ S SK C N F + ++C C G+EG+ ++ G GC+ +C
Sbjct: 234 TTIELEWRLDLSYMTSKRVLCKGNTFFEDS---YQCSCHNGYEGNPYIPG-GCQDIDECR 289
Query: 248 ASKYLSGKCGGTRIGALVGGLIAGASIVAV---------------VALLCYCFRKRSTSL 292
KCG + ++G + A+ + LLC RKR +
Sbjct: 290 DPHL--NKCGKRKCVNVLGSYRCEKTWPAILSGTLSSGLLLLIFGMWLLCKANRKRKVAK 347
Query: 293 RNQLSAKR---LLCQAAGN------SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAG 343
+ + +R LL Q + + + ++E AT F+ LG G GTVY G
Sbjct: 348 QKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKG 407
Query: 344 KLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403
L + VA+K+ + +++++ +NEI LLS ++H N++++LGCC+E PILVYEF+P
Sbjct: 408 MLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIP 467
Query: 404 NGTLCQHLQR-ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462
N L HL + W +R+ IA E A A++YLHSA++ PIYHRD+KS+NILLD +
Sbjct: 468 NRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKH 527
Query: 463 RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA 522
R+KV+DFG+SR + +H++T QGT GY+DP+Y Q H + KSDVYSFGV+LIE++T
Sbjct: 528 RAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTG 587
Query: 523 LKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLA 582
K V R L A ++ + + EI+D ++ D + VA+LA RCL+
Sbjct: 588 EKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDR---EEVLAVAKLARRCLS 644
Query: 583 FHRDMRPTMMEVAEELEHIR 602
+ + RPTM +V EL+ ++
Sbjct: 645 LNSEHRPTMRDVFIELDRMQ 664
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 166/467 (35%), Positives = 245/467 (52%), Gaps = 56/467 (11%)
Query: 187 FQLLELGWGLN----------GSCNCSKNA------DCTRNFTFANGISGHRCRC-QEGF 229
F ++ELGW + G N ++ C + +G C C Q G+
Sbjct: 238 FTVIELGWYFDTSDSRLTNPVGCVNLTETGIYTSAPSCVCEYGNFSGFGYSNCYCNQIGY 297
Query: 230 EGDGFVAGDGCRRTSDCNASKYLSG-------------KC---GGTRIGALVGGLIAGAS 273
G+ ++ G GC +C K LS +C G +I L GL+ G
Sbjct: 298 RGNPYLPG-GCIDIDECEEGKGLSSCGELTCVNVPGSWRCELNGVGKIKPLFPGLVLGFP 356
Query: 274 IVAVV----ALLCYC-----------FRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKE 318
++ +V L+ + F KR+ L L ++L + S + KE
Sbjct: 357 LLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGL---LLKQQLTTRGGNVQSSKIFSSKE 413
Query: 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS 378
+EKAT F+ LG G GTVY G L + VA+KR + D D +++ +NE+ +LS ++
Sbjct: 414 LEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQIN 473
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS-GLPWTIRITIATETAQAIAY 437
H N+++L+GCC+E PILVYE +PNG L + L + + W +R+ I+ E A A+AY
Sbjct: 474 HRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAY 533
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
LHSA + P+YHRD+K++NILLD YR+KV+DFG SR + +H++T GT GYLDP+Y
Sbjct: 534 LHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEY 593
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557
Q +DKSDVYSFGVVL+E+IT K RP L + + + + V +I+D
Sbjct: 594 FQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSR 653
Query: 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
+ ++ TL + VA+LA RCL+ RP M EV+ ELE IR S
Sbjct: 654 I---KEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 157/410 (38%), Positives = 222/410 (54%), Gaps = 36/410 (8%)
Query: 223 CRCQEGFEGDGFVAGD-----GCRRTSD----CNASK---YLSG-KCGGTRIGALVGGLI 269
C C GFEG+ ++ G+ C R D C A K L G C T LV GL
Sbjct: 305 CSCASGFEGNPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNHRPLVIGLS 364
Query: 270 AGASIVAVVALL--CYCFRKRSTSLRNQLSAKRLLCQAAGN-------------SSVPFY 314
S + + + Y F +R L + K+ + G S +
Sbjct: 365 TSFSTLVFIGGIYWLYKFIRRQRRLNQK---KKFFKRNGGLLLQQQLTTTEGNVDSTRVF 421
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLL 374
+E+EKAT FS LG G GTVY G L + VA+K+ + D D +++ +NE+ +L
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 481
Query: 375 SSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG--SGLPWTIRITIATETA 432
S ++H N+++LLGCC+E PILVYEF+PNG L +HL + + W +R+ IA + A
Sbjct: 482 SQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIA 541
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGY 492
A++YLHSA + PIYHRDIKS+NI+LD +R+KV+DFG SR + +H++T GT GY
Sbjct: 542 GALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGY 601
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552
+DP+Y Q +DKSDVYSFGVVL E+IT K V F R LA + + +
Sbjct: 602 MDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSD 661
Query: 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
IID + RD L+ + A++A +CL RP+M +V+ ELE IR
Sbjct: 662 IIDARI---RDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 166/472 (35%), Positives = 256/472 (54%), Gaps = 50/472 (10%)
Query: 187 FQLLELGWGLNGS-------CNCSKNAD---------CTRNFTFANGISGHRCRCQE-GF 229
+ +ELGW + S +C +D C+ ++ + +G S C C G+
Sbjct: 233 YAAVELGWFFDTSDSRDTQPISCKNASDTTPYTSDTRCSCSYGYFSGFSYRDCYCNSPGY 292
Query: 230 EGDGFVAGDGCRRTSDC------NASK-----YLSG--KCGGTR---IGALVGGLIAGAS 273
+G+ F+ G GC +C N K L G C + + ++ G++ G++
Sbjct: 293 KGNPFLPG-GCVDVDECKLDIGRNQCKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSA 351
Query: 274 IV--AVVALLCYCF-RKRSTSLRNQ--------LSAKRLLCQAAGNSSVP-FYPYKEIEK 321
++ A Y F +KR +R + + K+ L + GN + + E+EK
Sbjct: 352 LLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEK 411
Query: 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
AT F++ LG G GTVY G L + VA+KR + D D +++ +NE+ +L+ ++H N
Sbjct: 412 ATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRN 471
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS-GLPWTIRITIATETAQAIAYLHS 440
+++LLGCC+E P+LVYEF+PNG LC+ L E + W +R+ IA E A A++YLHS
Sbjct: 472 IVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHS 531
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
A + PIYHRDIK++NILLD R+KV+DFG SR + +H++T GT GY+DP+Y Q
Sbjct: 532 AASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQS 591
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
++KSDVYSFGVVL+E++T K R LAA ++ + V +I+D +
Sbjct: 592 SKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRI-- 649
Query: 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYM 612
+D + + +VA LA RCL RP M EV+ ELE IR S + S I++
Sbjct: 650 -KDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHI 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 692 | ||||||
| 255562745 | 701 | kinase, putative [Ricinus communis] gi|2 | 0.965 | 0.952 | 0.716 | 0.0 | |
| 224094560 | 715 | predicted protein [Populus trichocarpa] | 0.960 | 0.930 | 0.664 | 0.0 | |
| 118489147 | 703 | unknown [Populus trichocarpa x Populus d | 0.962 | 0.947 | 0.671 | 0.0 | |
| 224084229 | 695 | predicted protein [Populus trichocarpa] | 0.976 | 0.972 | 0.646 | 0.0 | |
| 225468772 | 699 | PREDICTED: wall-associated receptor kina | 0.986 | 0.977 | 0.656 | 0.0 | |
| 356502214 | 699 | PREDICTED: wall-associated receptor kina | 0.992 | 0.982 | 0.612 | 0.0 | |
| 356559444 | 716 | PREDICTED: wall-associated receptor kina | 0.960 | 0.928 | 0.620 | 0.0 | |
| 42741727 | 703 | WAK-like kinase [Solanum lycopersicum] | 0.976 | 0.961 | 0.610 | 0.0 | |
| 356496836 | 694 | PREDICTED: wall-associated receptor kina | 0.969 | 0.966 | 0.62 | 0.0 | |
| 18400282 | 708 | wall-associated receptor kinase-like 14 | 0.927 | 0.906 | 0.623 | 0.0 |
| >gi|255562745|ref|XP_002522378.1| kinase, putative [Ricinus communis] gi|223538456|gb|EEF40062.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 975 bits (2521), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/681 (71%), Positives = 558/681 (81%), Gaps = 13/681 (1%)
Query: 20 NAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANAT--VKIGEFEVQNVTADSIFVN 77
N+ C +C +S K V YPFGFS GC I+L C T + IGEF VQN+T + I V+
Sbjct: 26 NSTIRCRNSCGVDESIKWVSYPFGFSDGCEIQLNCRQDTGDIGIGEFVVQNITPNGILVS 85
Query: 78 LPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTSLVEQRFNLKTCGVGS 137
LP KC+R + ++ PLFG +Y +N LLLQNCT + C IPTS + ++ +C S
Sbjct: 86 LPAKCNRSLEAISPLFGDHYAPAWRNGLLLQNCTRTLSSCYIPTSSFANQLHIPSCNPRS 145
Query: 138 DNITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAFNSGGNSAGSLEFQLLELGWGLN 197
DNITC+S E +S+N+L+ GC +LFSS A S N + SLEF+ +EL W L+
Sbjct: 146 DNITCYS---RERLGMDVLSYNNLNSAGCKFLFSSFAVGSN-NPSVSLEFERVELDWWLD 201
Query: 198 GSC-----NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYL 252
GSC NCSK+A+CT + +G G RC CQEGF GDGF GDGCR S CNASKY+
Sbjct: 202 GSCKLNRSNCSKHANCT-DIKLGDGKGGFRCWCQEGFTGDGFRNGDGCRSVSGCNASKYI 260
Query: 253 SGKCGGT-RIGALVGGLIAGASIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSV 311
+G+CGGT R+G LVGG+IAGAS++A +AL+ Y R+RSTSLRN+LSAKRLLC+AAGNSSV
Sbjct: 261 NGQCGGTTRVGVLVGGIIAGASLMAGLALIWYFVRQRSTSLRNRLSAKRLLCEAAGNSSV 320
Query: 312 PFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEI 371
PFYPY+EIEKAT+ FSEK RLG GAYGTVYAGKLHN++WVAIK+ R+RDTDSIDQVMNEI
Sbjct: 321 PFYPYREIEKATNGFSEKQRLGIGAYGTVYAGKLHNEEWVAIKKIRHRDTDSIDQVMNEI 380
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
KLLSSVSHPNL+RLLGCCIEEGEPILVYEFMP+GTLCQHLQRERG GLPWTIR+TIA ET
Sbjct: 381 KLLSSVSHPNLVRLLGCCIEEGEPILVYEFMPHGTLCQHLQRERGKGLPWTIRLTIAAET 440
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A AIAYLHSAMNPPIYHRDIKSSNILLDYNY+SKVADFGLSRLGMTESSHISTAPQGTPG
Sbjct: 441 ANAIAYLHSAMNPPIYHRDIKSSNILLDYNYKSKVADFGLSRLGMTESSHISTAPQGTPG 500
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551
YLDPQYHQYFHLSDKSDVYSFGVVL+EIIT LKVVDFSRPHSEVNLAALAIDRIGRGCVD
Sbjct: 501 YLDPQYHQYFHLSDKSDVYSFGVVLVEIITGLKVVDFSRPHSEVNLAALAIDRIGRGCVD 560
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611
EIIDPYL+P+RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR+S+W N+Y
Sbjct: 561 EIIDPYLDPNRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRLSAWVPNMY 620
Query: 612 MGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSGDCLTTLDEVKDSSPVSVQ 671
M SPA S CS + GSERSL ++KKAGV S+RL+VP + DCLT+L+E+KDSSPVSVQ
Sbjct: 621 MASPAASSCSSPDNGSERSLGVHSIKKAGVVSRRLLVPQRPADCLTSLEEIKDSSPVSVQ 680
Query: 672 DPWLSEQSSPSTNSLLGNVVQ 692
DPW SEQSSPS NSLLGN VQ
Sbjct: 681 DPWCSEQSSPSANSLLGNAVQ 701
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224094560|ref|XP_002310180.1| predicted protein [Populus trichocarpa] gi|222853083|gb|EEE90630.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/694 (66%), Positives = 543/694 (78%), Gaps = 29/694 (4%)
Query: 19 ANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANAT--VKIGEFEVQNVTADSIFV 76
+N++D C+ +C GKS K VPYPFGFS GC I L C + VKIGEF+VQN+T + I +
Sbjct: 31 SNSSD-CESSCGTGKSAKVVPYPFGFSRGCPIILQCNHTVGDVKIGEFQVQNITPNVIMI 89
Query: 77 NLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTSLVEQRFNLKTCGVG 136
N+ C+R I + PLFG N+G + NSLLLQNC N CVIPTS + + L C
Sbjct: 90 NILADCNRSIERIKPLFGKNFGPSSNNSLLLQNCDKPLNSCVIPTSSLRRDLKLTNCD-K 148
Query: 137 SDNITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAFNSGGNSAGSLEFQLLELGWGL 196
+DN+ C+S + + +++++ T C +FSSL G SA S +F +EL W L
Sbjct: 149 NDNLNCYS---QVPRDFDTLGYDNMTSTSCKSVFSSLFLGWEG-SAVSFQFGRVELEWWL 204
Query: 197 NGSCN--CSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSG 254
G N CS NA+ T+ NG G RC C +GF GDGF AG+GCR+ S C+ASKY+SG
Sbjct: 205 EGGYNNLCSNNANSTK-VKLWNGRVGFRCHCADGFAGDGFAAGNGCRKVSKCSASKYMSG 263
Query: 255 KCGGT-RIGALVG---------------GLIAGASIVAVVALLCYCFRKRSTSLRNQLSA 298
+CGGT R+G LVG GLIAGA ++A +A LCY R++STSLRN+LSA
Sbjct: 264 ECGGTTRVGVLVGVFAVTAPAFLAVHFSGLIAGALLMAGLAFLCYYVRRKSTSLRNRLSA 323
Query: 299 KRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRY 358
KRLLC+AAGNSSVPF+ YKEIEKAT+ FSEKHRLG GAYGTVYAGKL++DD VAIK+ R+
Sbjct: 324 KRLLCEAAGNSSVPFFQYKEIEKATNGFSEKHRLGIGAYGTVYAGKLNSDDLVAIKKLRH 383
Query: 359 RDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG 418
RDTDSIDQVMNEIKLLSSVSHPNL+RLLGCCIEEGEPILVYEFMPNGTLCQHLQ+ERG+G
Sbjct: 384 RDTDSIDQVMNEIKLLSSVSHPNLVRLLGCCIEEGEPILVYEFMPNGTLCQHLQQERGTG 443
Query: 419 LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478
LPWT+R+T+ATETA+AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM E
Sbjct: 444 LPWTVRLTVATETAKAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMVE 503
Query: 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538
SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL+EIITALK VDFSRPHSEVNLA
Sbjct: 504 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLVEIITALKAVDFSRPHSEVNLA 563
Query: 539 ALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
ALAIDRIGRGCVDEIIDPYL+P+RDAWTL+SI +VAELAFRCLAFHRDMRPTM+EVA EL
Sbjct: 564 ALAIDRIGRGCVDEIIDPYLDPNRDAWTLTSILSVAELAFRCLAFHRDMRPTMLEVAGEL 623
Query: 599 EHIRVSSWASNIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSGDCLTT 658
E I +S+W +YM S + S+ GS++SLS +KAG+ +L++P ++ D LT+
Sbjct: 624 EQIMLSAWIPTMYMAS-PSASSCSSQNGSQKSLSVSIGRKAGLARGKLLLPQRT-DSLTS 681
Query: 659 LDEVKDSSPVSVQDPWLSEQSSPSTNSLLGNVVQ 692
L+E KDSSPVS QD WLSEQSSPSTNSLLGNVV+
Sbjct: 682 LEETKDSSPVSEQDTWLSEQSSPSTNSLLGNVVR 715
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118489147|gb|ABK96380.1| unknown [Populus trichocarpa x Populus deltoides] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/681 (67%), Positives = 543/681 (79%), Gaps = 15/681 (2%)
Query: 19 ANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANAT--VKIGEFEVQNVTADSIFV 76
+N++D C+ +C +GKS K VPYPFGFS GC I L C + VKIGEF+VQN+T + I +
Sbjct: 31 SNSSD-CESSCGSGKSAKVVPYPFGFSIGCPIILQCNHTVGDVKIGEFQVQNITPNVIMI 89
Query: 77 NLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTSLVEQRFNLKTCGVG 136
N+ C+R I + PLFG N+ + +NSLLLQNC N CVI TS + + L CG
Sbjct: 90 NILADCNRSIERIKPLFGKNFCPSSKNSLLLQNCDKPLNSCVIRTSSLRRDLKLTNCGDK 149
Query: 137 SDNITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAFNSGGNSAGSLEFQLLELGWGL 196
+ ++ C+S + + +++++ T C +FSSL F SA S +F+ +EL W L
Sbjct: 150 NYDLNCYS---QVPRDFDTLGYDNMTSTRCKSVFSSL-FRGWEGSAVSFQFERVELEWWL 205
Query: 197 NGSCN--CSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSG 254
G N CS NA+ T+ NG G RC C +GF GDGF AG+GCR+ S C+ASKY+SG
Sbjct: 206 EGDSNNLCSNNANSTK-VKLWNGRGGFRCHCADGFAGDGFAAGNGCRKVSKCSASKYMSG 264
Query: 255 KCGGT-RIGALVGGLIAGASIVAVVALLCYCFRKRSTSL--RNQLSAKRLLCQAAGNSSV 311
+CGGT R+G LVGGLIAGA ++A +A LCY ++STS RN+LSAKRLLC+AAGNSSV
Sbjct: 265 ECGGTTRVGVLVGGLIAGALLMAGLAFLCYYVWRKSTSTSSRNRLSAKRLLCEAAGNSSV 324
Query: 312 PFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEI 371
PF+ YKEIEKAT+ FSEKHRLG GAYGTVYAGKL++DD VAIK+ R+RDTDSIDQVMNEI
Sbjct: 325 PFFQYKEIEKATNGFSEKHRLGIGAYGTVYAGKLNSDDLVAIKKLRHRDTDSIDQVMNEI 384
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
KLLSSVSHPNL+RLLGCCIEEGEPILVYEFMPNGTLCQHLQ+ERG+GLPWT+R+T+A ET
Sbjct: 385 KLLSSVSHPNLVRLLGCCIEEGEPILVYEFMPNGTLCQHLQQERGTGLPWTVRLTVAAET 444
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM ESSHISTAPQGTPG
Sbjct: 445 AKAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMVESSHISTAPQGTPG 504
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551
YLDPQYHQYFHLSDKSDVYSFGVVL+EIITALK VDFSRPHS+VNLAALAIDRIGRGCVD
Sbjct: 505 YLDPQYHQYFHLSDKSDVYSFGVVLVEIITALKAVDFSRPHSDVNLAALAIDRIGRGCVD 564
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611
EIIDPYL+P+RDAWTL+SI +VAELAFRCLAFHRDMRPTM+EVA ELE I +S+W +Y
Sbjct: 565 EIIDPYLDPNRDAWTLTSILSVAELAFRCLAFHRDMRPTMLEVAGELEQIMLSAWIPTMY 624
Query: 612 MGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSGDCLTTLDEVKDSSPVSVQ 671
M SP+ S S+ GS++SLS +KAG+ +LI+P ++ D LT+L+E KDSSPVS Q
Sbjct: 625 MASPSAS-SCSSQNGSQKSLSVSIGRKAGLARGKLILPQRT-DSLTSLEETKDSSPVSDQ 682
Query: 672 DPWLSEQSSPSTNSLLGNVVQ 692
D WLSEQSSPSTNSLLGNVV+
Sbjct: 683 DTWLSEQSSPSTNSLLGNVVR 703
|
Source: Populus trichocarpa x Populus deltoides Species: Populus trichocarpa x Populus deltoides Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084229|ref|XP_002307237.1| predicted protein [Populus trichocarpa] gi|222856686|gb|EEE94233.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/704 (64%), Positives = 533/704 (75%), Gaps = 28/704 (3%)
Query: 4 QLSLSLLISICILYLANAADL---------CDRTCRNGKSTKRVPYPFGFSPGCAIRLTC 54
Q SL L I+ +++A + C +C GKS + VPYPFGFS GC I+L C
Sbjct: 5 QESLLLFITFITIFIATTSPTTKAQKSGSNCASSCGIGKSARVVPYPFGFSNGCPIQLNC 64
Query: 55 --ANATVKIGEFEVQNVTADSIFVNLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTT 112
+KIGEF+VQN+T + I VNLP C+R I ++ PLFG NYG + QNSLLLQNC+
Sbjct: 65 ESTEGEIKIGEFQVQNITPNGILVNLPADCNRSIETIRPLFGLNYGPSWQNSLLLQNCSK 124
Query: 113 HQNGCVIPTSLVEQRFNLKTC-GVGSDNITCFSWPYNENKSASFMSFNDLSRTGCNYLFS 171
N CVI S + + K C +DN++C+S PY+ +S+ ++ T C+ +FS
Sbjct: 125 PSNSCVISRSPFQGELHSKNCEAAKNDNLSCYSLPYS---GIDTLSYEGVNSTQCSSVFS 181
Query: 172 SLAFNSGGNSAGSLEFQLLELGWGLNGSCN---CSKNADCTRNFTFANGISGHRCRCQEG 228
SLA S + S +++ +EL W L G C CSKNA+C+ NG G RC C +G
Sbjct: 182 SLALGSD-SPVVSFQYERIELEWWLEGHCRDTFCSKNANCSE-VKLQNGTVGFRCHCYDG 239
Query: 229 FEGDGFVAGDGCRRTSDCNASKYLSGKCGGTRIGALVGGLIAGASIVAVVALLCYCFRKR 288
F GDGF G+GCRR L + LIAGAS++AV ALLCY +K+
Sbjct: 240 FAGDGFTTGNGCRRGEPTWLYICLH------LFLLFIMRLIAGASLMAVFALLCYFVKKK 293
Query: 289 STSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHND 348
STS+RN+ SAKRLLC+AAGNSSVPF+ YKEIE+AT+ FSEK RLGTGAYGTVY+GKLHND
Sbjct: 294 STSMRNRSSAKRLLCEAAGNSSVPFFQYKEIERATNGFSEKQRLGTGAYGTVYSGKLHND 353
Query: 349 DWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLC 408
D VAIK+ + RDTDS+D VMNEIKLLSSVSHPNL+RLLGCC+EEGEPILVYEFMPNGTLC
Sbjct: 354 DLVAIKKIKQRDTDSLDLVMNEIKLLSSVSHPNLVRLLGCCLEEGEPILVYEFMPNGTLC 413
Query: 409 QHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVAD 468
QHLQRERG+GLPWT+R+T+A ETA AIAYLHS +NPPIYHRDIKSSNILLDYNYRSKVAD
Sbjct: 414 QHLQRERGNGLPWTVRLTVAAETANAIAYLHSVVNPPIYHRDIKSSNILLDYNYRSKVAD 473
Query: 469 FGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF 528
FGLSRLGM ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL+EIITA KVVDF
Sbjct: 474 FGLSRLGMEESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLVEIITAQKVVDF 533
Query: 529 SRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMR 588
SRPHSEVNLAALAIDRIGRGCVDEI+DPYL+P RDAWTLSSIH+VAELAFRCLAFHRDMR
Sbjct: 534 SRPHSEVNLAALAIDRIGRGCVDEIVDPYLDPDRDAWTLSSIHSVAELAFRCLAFHRDMR 593
Query: 589 PTMMEVAEELEHIRVSSWASNIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIV 648
PTMMEVAEELE IR+S+W ++M S S S+ GS++SL KKA V S+RL+V
Sbjct: 594 PTMMEVAEELEQIRLSAWVPTMHMAS-PSSSSHFSDHGSQKSLGVSVGKKAAVASRRLLV 652
Query: 649 PPKSGDCLTTLDEVKDSSPVSVQDPWLSEQSSPSTNSLLGNVVQ 692
P ++ D LT+L+EVKDSSPVSVQDPWLSEQSSPSTNSLL NVV
Sbjct: 653 PQRT-DSLTSLEEVKDSSPVSVQDPWLSEQSSPSTNSLLDNVVH 695
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225468772|ref|XP_002275295.1| PREDICTED: wall-associated receptor kinase-like 14-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/698 (65%), Positives = 545/698 (78%), Gaps = 15/698 (2%)
Query: 1 MIPQLSLSLLISICILYLANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCAN-ATV 59
M L ++L IC + L +A + + +C GKS KRV YPFGFS I+L C+ +
Sbjct: 11 MRKALQRTILALICTVTLVSA--IKNDSCGTGKSAKRVHYPFGFSSDSPIKLNCSKEGEI 68
Query: 60 KIGEFEVQNVTADSIFVNLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVI 119
+I F+VQNVT DSI +NLP +C R+I + PLFG NY ++ +NSLL QNC++ +GCVI
Sbjct: 69 EIQNFKVQNVTTDSIIINLPAQCQREIQKIEPLFGKNYALSSKNSLLFQNCSSSSSGCVI 128
Query: 120 PTSLVEQRFNLKTCGVGSDN-ITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAFNSG 178
PTS+ + L C SDN I+CF + + FMSF +++ TGC +L S+A
Sbjct: 129 PTSVFNGQNKLNNCNGKSDNNISCFPL----DSESEFMSFANVTGTGCKFLLLSMAVEWR 184
Query: 179 GNSAGSLEFQLLELGWGLNGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGD 238
NSA SLE +LGW L+ C+C+ NA T N T G G RC C+EGF+GDGF GD
Sbjct: 185 NNSAVSLELGTAQLGWWLDHPCHCAPNAKHT-NLTVPGGF-GCRCSCKEGFDGDGFKDGD 242
Query: 239 GCRRTSDCNASKYLSGKCGGT-RIGALVGGLIAGASIVAVVALLCYCFRKRSTSLRNQLS 297
GC+ +DCNASKY+SG CGGT R+ LVGG+I GAS+++ VAL+CYC R+RS R ++S
Sbjct: 243 GCQEVTDCNASKYMSGTCGGTTRVAVLVGGVIVGASLMSTVALICYCIRRRSYLRR-RMS 301
Query: 298 AKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFR 357
AKRL+C+AAGNSSVP YPYKE+E+AT+ FSEK RLGTGAYGTV+AGKLHND+WVAIK+ R
Sbjct: 302 AKRLICEAAGNSSVPLYPYKEVERATNGFSEKQRLGTGAYGTVFAGKLHNDEWVAIKKIR 361
Query: 358 YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS 417
RD DSI+QVMNEIKL+SSV+HPNL+RLLGCCIE GE ILVYEFM NGTL QHLQ+ERG
Sbjct: 362 NRDNDSIEQVMNEIKLISSVNHPNLVRLLGCCIENGEQILVYEFMANGTLSQHLQKERGK 421
Query: 418 GLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477
GLPWT R+ IATETA AIA+LHSA+ PPI+HRDIKSSNILLD N+ SKVADFGLSRLGMT
Sbjct: 422 GLPWTTRLNIATETANAIAHLHSAITPPIFHRDIKSSNILLDDNFNSKVADFGLSRLGMT 481
Query: 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNL 537
ESSHISTAPQGTPGYLDPQYHQ FHLSDKSDVYSFGVVL+EII+A+KVVDFSRPHSEVNL
Sbjct: 482 ESSHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIISAMKVVDFSRPHSEVNL 541
Query: 538 AALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597
AALAIDRIGRGCVDEIIDP+LEP RDAWTL SIH VAELAFRCLAFHRDMRP+MMEVA+E
Sbjct: 542 AALAIDRIGRGCVDEIIDPFLEPQRDAWTLCSIHKVAELAFRCLAFHRDMRPSMMEVADE 601
Query: 598 LEHIRVSSWA---SNIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSGD 654
LEH+R+S WA NI + S S CS GSE SL ++V+KAG+ S+RL VP + D
Sbjct: 602 LEHVRLSGWAPMEENICVASSVASSCSSPFNGSEMSLGCMSVRKAGIGSRRLFVPHRPTD 661
Query: 655 CLTTLDEVKDSSPVSVQDPWLSEQSSPSTNSLLGNVVQ 692
CL +++E+KDSSPVSV DPWLSEQSSPSTNSLLGNVVQ
Sbjct: 662 CLASMEEIKDSSPVSVHDPWLSEQSSPSTNSLLGNVVQ 699
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502214|ref|XP_003519915.1| PREDICTED: wall-associated receptor kinase-like 14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/700 (61%), Positives = 524/700 (74%), Gaps = 13/700 (1%)
Query: 5 LSLSLLISICILYLANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANAT-VKIGE 63
+ L++ I + L + +A C + YPFGFS C ++L C+ VKIG+
Sbjct: 1 MVLTIFIFMFCLRCSTSAKSNKNNCERSCGEHSLQYPFGFSSDCEVKLNCSKENKVKIGD 60
Query: 64 FEVQNVTADSIFVNLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTS- 122
EVQ+VT+D IFV+LP +C+R ++ L PLF N+ + N+ L+Q+C ++ +GCVIPTS
Sbjct: 61 LEVQSVTSDGIFVSLPVQCNRNVSFLDPLFRHNFAPSWSNTFLVQSCESNLSGCVIPTSS 120
Query: 123 LVEQRFNLKTCGVGSDNITCFSWPYNENKSAS-----FMSFNDLSRTGCNYLFSSLAFNS 177
R ++ C S+++ CF+ + S + D R GC +LFS+LAF+
Sbjct: 121 FAGGRNKVEGCDRESEDLHCFTQMRKSKSNGSREDDDVLMRLDWERVGCKFLFSALAFDR 180
Query: 178 GGNSAGSLEFQLLELGWGLNGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAG 237
SL+FQ++ELGW L G+C+CS NA CT G G RCRC EGF GDGF G
Sbjct: 181 SKVKELSLQFQMVELGWWLEGNCSCSNNASCTE-VNHGGGKLGFRCRCDEGFVGDGFKDG 239
Query: 238 DGCRRTSDCNASKYLSGKC-GGTRIGALVGGLIAGASIVAVVALLCYCFRKRSTSLRNQL 296
DGCRR S+C AS S C +IG VGG+I GA +VA ++L+CY R+RS+ LR Q+
Sbjct: 240 DGCRRVSECKASTLWSRGCRKAVKIGVFVGGIIVGAILVAALSLVCYFNRRRSSWLRKQV 299
Query: 297 SAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRF 356
+ KRLL +AAG+S+VP YPYKEIE+ATSFFSEKHRLGTGA+GTVYAG LHND+ VAIK+
Sbjct: 300 TVKRLLREAAGDSTVPLYPYKEIERATSFFSEKHRLGTGAFGTVYAGHLHNDECVAIKKI 359
Query: 357 RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG 416
+YRDT+S+DQVMNEIKLLSSVSHPNL+RLLGCCIE GE ILVYE+MPNGTL QHLQRERG
Sbjct: 360 KYRDTNSVDQVMNEIKLLSSVSHPNLVRLLGCCIEGGEQILVYEYMPNGTLSQHLQRERG 419
Query: 417 SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
LPWTIR+TIATETA AIAYLHS +NPPIYHRDIKSSNILLDY+++SKVADFGLSRLGM
Sbjct: 420 GVLPWTIRLTIATETANAIAYLHSEINPPIYHRDIKSSNILLDYSFQSKVADFGLSRLGM 479
Query: 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
+E+SHISTAPQGTPGY+DPQYHQ FHLSDKSDVYSFGVVL+EIITA+KVVDF+RP SE+N
Sbjct: 480 SETSHISTAPQGTPGYVDPQYHQNFHLSDKSDVYSFGVVLVEIITAMKVVDFARPQSEIN 539
Query: 537 LAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596
LAALA+DRI +GC+D+IIDP+LEPHRDAWTL SIH VAELAFRCLAFH DMRPTM+EVAE
Sbjct: 540 LAALAVDRIRKGCIDDIIDPFLEPHRDAWTLYSIHKVAELAFRCLAFHSDMRPTMIEVAE 599
Query: 597 ELEHIRVSSWAS---NIYMGSPAVSCCSLSECGSERSLSGLTVKK-AGVKSQRLIVPPKS 652
ELE IR S WA+ I S S CS GS SL G++ ++ AG+ S+ LIVP K+
Sbjct: 600 ELELIRRSGWATMEETICTASSVGSVCSSPRNGSVNSLRGVSFERAAGLGSETLIVPHKT 659
Query: 653 GDCLTTLDEVKDSSPVSVQDPWLSEQSSPSTNSLLGNVVQ 692
L +++EVKDSSPVSVQD WLS SSPSTNSLLG+VVQ
Sbjct: 660 DMFLQSIEEVKDSSPVSVQDTWLSGTSSPSTNSLLGHVVQ 699
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356559444|ref|XP_003548009.1| PREDICTED: wall-associated receptor kinase-like 14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/685 (62%), Positives = 523/685 (76%), Gaps = 20/685 (2%)
Query: 19 ANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANAT-VKIGEFEVQNVTADSIFVN 77
A + + C+R+C + YPFGFS C ++L C+ +IGE EVQ+VT+D IFV+
Sbjct: 41 ARSNNNCERSC----GEHSLQYPFGFSSDCEVKLNCSKENKAEIGELEVQSVTSDGIFVS 96
Query: 78 LPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTS-LVEQRFNLKTCGVG 136
LP +C+R ++ + PLF N+ T N+ L+Q+C +GCVIPTS R +++ C
Sbjct: 97 LPVQCNRSVSFIDPLFRDNFAPTWNNTFLVQSCKPKLDGCVIPTSSFAGGRKDVEGC--- 153
Query: 137 SDNITCFSW----PYNENKSASFMSFNDLSRTGCNYLFSSLAFNSGGNSAGSLEFQLLEL 192
++++CF+ N ++ ++ +D R GC +LFS+LAF+ SL+FQ++EL
Sbjct: 154 -EDLSCFTQLQKSKSNGSREDDVLTHSDWERVGCRFLFSALAFDRSKVKELSLQFQMVEL 212
Query: 193 GWGLNGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYL 252
GW L G+C+CS NA CT T G G RCRC EGF GDGF AGDGCRR S+C AS
Sbjct: 213 GWWLQGNCSCSNNASCTEVNT-DGGKRGFRCRCDEGFIGDGFRAGDGCRRVSECKASTLW 271
Query: 253 SGKC-GGTRIGALVGGLIAGASIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSV 311
SG C +IG LVGG+I G +VA + L+CY R++S+ LR Q++ KRLL +AAG+S+V
Sbjct: 272 SGGCRKAVKIGVLVGGIIFGGILVAALFLVCYFNRRQSSWLRKQVTVKRLLREAAGDSTV 331
Query: 312 PFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEI 371
P YPYKEIE+ATSFFSEKHRLGTGA+GTVYAG LHND+ VAIK+ +YRDT+S+DQVMNEI
Sbjct: 332 PLYPYKEIERATSFFSEKHRLGTGAFGTVYAGHLHNDECVAIKKIKYRDTNSVDQVMNEI 391
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
+LLSSVSHPNL+RLLGCCIE GE ILVYE+MPNGTL QHLQRERG LPWTIR+TIATET
Sbjct: 392 RLLSSVSHPNLVRLLGCCIEGGEQILVYEYMPNGTLSQHLQRERGGVLPWTIRLTIATET 451
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A AIAYLHSA + PIYHRDIKSSNILLDYN++SKVADFGLSRLGM+E+SHISTAPQGTPG
Sbjct: 452 ANAIAYLHSANDHPIYHRDIKSSNILLDYNFQSKVADFGLSRLGMSETSHISTAPQGTPG 511
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551
Y+DPQYHQ FHLSDKSDVYSFGVVL+EIITA+KVVDF+RP SE+NLAALA+DRI +GC+D
Sbjct: 512 YVDPQYHQNFHLSDKSDVYSFGVVLVEIITAMKVVDFARPQSEINLAALAVDRIKKGCID 571
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS--- 608
+IIDP+LEPHRDAWTL SI+ VAELAFRCLAFH DMRPTM+EVAEEL+ IR S WA+
Sbjct: 572 DIIDPFLEPHRDAWTLYSINKVAELAFRCLAFHSDMRPTMIEVAEELDLIRRSGWATMEE 631
Query: 609 NIYMGSPAVSCCSLSECGSERSLSGLTVKK-AGVKSQRLIVPPKSGDCLTTLDEVKDSSP 667
I M S S CS GS SL G++ ++ AG+ S+ LIVP K+ L +++EVKDSSP
Sbjct: 632 TICMASSVGSVCSSPRNGSVNSLRGVSFERAAGLGSETLIVPHKTDVFLQSIEEVKDSSP 691
Query: 668 VSVQDPWLSEQSSPSTNSLLGNVVQ 692
VSV D WLS SSPSTNSLLG+VVQ
Sbjct: 692 VSVHDSWLSGTSSPSTNSLLGHVVQ 716
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42741727|gb|AAS45124.1| WAK-like kinase [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2165), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/699 (61%), Positives = 526/699 (75%), Gaps = 23/699 (3%)
Query: 7 LSLLISICILYLANAADL-----CDRTC-RNGKSTKRVPYPFGFSPGCAIRLTCANAT-- 58
+ + SI + +L+++ + C++ C G + RV YPFGFS GC IRL C +T
Sbjct: 9 IRFVFSILLGWLSSSVEATNSTKCNQYCGAAGSYSPRVSYPFGFSEGCGIRLDCTESTGE 68
Query: 59 VKIGEFEVQNVTADSIFVNLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCV 118
++IGE+ +QNVT++++ VN C R I L N+GMT +N LLL NC ++ C
Sbjct: 69 IRIGEYIIQNVTSETLMVNFSMNCSRPIEDLQQFDRTNFGMTWRNGLLLHNCKVPKSECT 128
Query: 119 IPTSLVEQRFNLKTCGVGSDNITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAF--- 175
IP+ ++ R N+++C +N++C+S A ++ + L TGC + SS+
Sbjct: 129 IPSEILSTRLNIQSCDSKKENVSCYS-----EARADYLDYQKLKNTGCGTVISSILIGMD 183
Query: 176 -NSGGNSAGSLEFQLLELGWGLNGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGF 234
++ +SA +EFQ +EL WGL G C C +A+CT N + G RCRC++GF GDGF
Sbjct: 184 NDTMKSSAMFIEFQTMELAWGLEGDCACHNDANCT-NVSLPGNRKGFRCRCKDGFVGDGF 242
Query: 235 VAGDGCRRTSDCNASKYLSGKCGGT-RIGALVGGLIAGASIVAVVALLCYCFRKRSTSLR 293
GDGCR+ S CN S+YLSG+CGGT RIG LVGG+IAGA ++A +A+LCYC R+RS SL+
Sbjct: 243 SDGDGCRKVSRCNPSRYLSGRCGGTTRIGVLVGGIIAGAGLMAALAVLCYCIRRRSASLK 302
Query: 294 NQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAI 353
++SA+RLL +AAG++SV + YKEIE+AT+ FSEK RLG GAYGTVYAGKLH+D+WVAI
Sbjct: 303 KRMSARRLLSEAAGSNSVHVFQYKEIERATNSFSEKQRLGIGAYGTVYAGKLHSDEWVAI 362
Query: 354 KRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR 413
K+ R+RD D ++QVMNE+KLLSSVSHPNL+RLLGCCIE GE ILVYEFMPNGTL QHLQR
Sbjct: 363 KKLRHRDPDGVEQVMNEVKLLSSVSHPNLVRLLGCCIENGEQILVYEFMPNGTLAQHLQR 422
Query: 414 ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
ER SGLPWTIR+TIATETA AIA+LHSAMNPPIYHRDIKSSNILLDYN+ SKVADFGLSR
Sbjct: 423 ERSSGLPWTIRLTIATETAHAIAHLHSAMNPPIYHRDIKSSNILLDYNFNSKVADFGLSR 482
Query: 474 LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHS 533
GMT+ SHISTAPQGTPGY+DPQYHQ +HLSDKSDVYSFGVVL+EIITA+KVVDFSR HS
Sbjct: 483 FGMTDDSHISTAPQGTPGYVDPQYHQNYHLSDKSDVYSFGVVLVEIITAMKVVDFSRSHS 542
Query: 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMME 593
E+NLAALAIDRIG+G VDEIIDP+LEPHRDAWTLSS+H VAELAFRCLAFHRDMRP+M E
Sbjct: 543 EINLAALAIDRIGKGRVDEIIDPFLEPHRDAWTLSSVHRVAELAFRCLAFHRDMRPSMTE 602
Query: 594 VAEELEHIRVSSWAS---NIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPP 650
VA+ELE IR+SSWAS + M S S CS SE S T KK GV S+RLIVP
Sbjct: 603 VADELEQIRLSSWASLEDXVCMTSSVNSSCSSPRRRSETSFLCSTTKK-GVGSRRLIVPL 661
Query: 651 KSGDCLTTLDEVKDSSPVSVQDPWLSEQSSPSTNSLLGN 689
+ L ++E+K+SSPVSVQDP LSE+S PS N LLGN
Sbjct: 662 PLENSLALVEEIKNSSPVSVQDPGLSEESPPSPNRLLGN 700
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496836|ref|XP_003517271.1| PREDICTED: wall-associated receptor kinase-like 14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/700 (62%), Positives = 516/700 (73%), Gaps = 29/700 (4%)
Query: 6 SLSLLISICILYLANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANATVKI---- 61
+L+++++I I A +L TC + +PFGFS GC I+L C+N V++
Sbjct: 9 NLAIVLTIFIACTTRAQNLT--TCNGKCGEHTLQFPFGFSQGCPIQLDCSNDQVQLRSEF 66
Query: 62 GEFEVQNVTADSIFVNLPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPT 121
GEF VQNVT +IFVNLP KC+R + S+ P+F N+ T NS L+Q+C GCVIP
Sbjct: 67 GEFLVQNVTNSNIFVNLPAKCNRTMESIQPIFTENFAPTINNSFLVQDCREVFGGCVIPA 126
Query: 122 SLVEQRFNLKTCGVGSDNITCFSWPYNENKSASFMSFNDLSRTGCNYLFSSLAFNSGGNS 181
S V + +++ C S NI+CFS + F+++ DL+ T C YLFS+++F G +
Sbjct: 127 SFVSNQIDVENCSNKSANISCFS-----KQDEVFVTYADLNGTKCKYLFSAVSF--GQSK 179
Query: 182 AGSLEFQLLELGWGLNGSCN---CSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGD 238
L+FQ++ELGW L G C+ CS NA CT G RC+C EGF GDGF G
Sbjct: 180 EIPLQFQVVELGWWLPGQCDDHQCSNNATCT-----TVDRVGFRCQCIEGFTGDGFKNGI 234
Query: 239 GCRRTSDCNASK--YLSGKCG-GTRIGALVGGLIAGASIVAVVALLCYCFRKRSTSLRNQ 295
GCR+ S + S SG CG T+IG +VG + GA +VA + LLCYC R+RST LR
Sbjct: 235 GCRKASASSCSASTLTSGGCGKATKIGVVVGVITTGALVVAGLFLLCYCARRRSTWLRKH 294
Query: 296 LSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKR 355
KR L +AAGNSSVPFYPYKEIEKAT+FFSEKHRLGTGA+GTVYAGKLHND+WVAIK+
Sbjct: 295 TMVKRQLREAAGNSSVPFYPYKEIEKATNFFSEKHRLGTGAFGTVYAGKLHNDEWVAIKK 354
Query: 356 FRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER 415
R RDT+S DQVMNEI+LLSSVSHPNL+RLLGCCIE+GE ILVYEFM NGTL QHLQRER
Sbjct: 355 LRQRDTNSADQVMNEIRLLSSVSHPNLVRLLGCCIEKGEHILVYEFMQNGTLSQHLQRER 414
Query: 416 GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475
GLPWTIR+TIATETA AIAYLHSA++PPIYHRDIKS+NILLDY ++SK+ADFGLSRL
Sbjct: 415 SKGLPWTIRLTIATETANAIAYLHSAIHPPIYHRDIKSTNILLDYGFKSKIADFGLSRLA 474
Query: 476 MTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
+TE+SHISTAPQGTPGY+DPQYHQ F LSDKSDVYSFGVVL+EIITA+KVVDF+RP SE+
Sbjct: 475 LTETSHISTAPQGTPGYVDPQYHQNFQLSDKSDVYSFGVVLVEIITAMKVVDFARPRSEI 534
Query: 536 NLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595
NLAALA+DRI RG VDEIIDP+LEPHRDAWTL SIH VAELAFRCLAFH DMRPTMMEVA
Sbjct: 535 NLAALAVDRIRRGAVDEIIDPFLEPHRDAWTLYSIHKVAELAFRCLAFHSDMRPTMMEVA 594
Query: 596 EELEHIRVSSWAS--NIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSG 653
EELEHIR S WAS SP S S GSE+SL G+ + G S+RLIVP K+
Sbjct: 595 EELEHIRRSGWASMEETLTASPIGSTSSSPRHGSEKSLGGIKKARQGQGSERLIVPQKTE 654
Query: 654 DCLTTLDEVKDSSPVSVQD--PWLSEQSSPSTNSLLGNVV 691
L ++ EVKDSSPVSV D PW S SSPS+NSLLGNV+
Sbjct: 655 SFLQSM-EVKDSSPVSVHDPIPWSSGHSSPSSNSLLGNVI 693
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18400282|ref|NP_565552.1| wall-associated receptor kinase-like 14 [Arabidopsis thaliana] gi|30682087|ref|NP_850041.1| wall-associated receptor kinase-like 14 [Arabidopsis thaliana] gi|116256124|sp|Q8RY67.2|WAKLO_ARATH RecName: Full=Wall-associated receptor kinase-like 14; Flags: Precursor gi|20197000|gb|AAC23760.2| putative protein kinase [Arabidopsis thaliana] gi|330252362|gb|AEC07456.1| wall-associated receptor kinase-like 14 [Arabidopsis thaliana] gi|330252363|gb|AEC07457.1| wall-associated receptor kinase-like 14 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2102), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/661 (62%), Positives = 506/661 (76%), Gaps = 19/661 (2%)
Query: 38 VPYPFGFSPGCAIRLTCANATVK-IGEFEVQNVTADSIFVNLPTKCHRQITSLHPLFGPN 96
+PYPFGFS GC+IR C+ A IG+F VQNVT +SIFV L C R+I ++PLFG N
Sbjct: 57 LPYPFGFSNGCSIRFDCSAAEKPMIGDFSVQNVTENSIFVGLSHNCTRKIEDMNPLFGEN 116
Query: 97 YGMTRQNSLLLQNCTTHQNGCVIPTSLVEQRFNLKTCGVGSDNITCFSWPYNENKS--AS 154
+ T +NS L++NC +GC I +E LK+C + NI+CFS N + A
Sbjct: 117 FAPTSENSFLMENCNRTTDGCSIKQKFLENVLKLKSCD-ATGNISCFSLDSNSSSKNSAK 175
Query: 155 FMSFNDLSRTGCNYLFSSLAFNSGGNSAG-SLEFQLLELGWGLNGSCN---CSKNADCTR 210
F S L + C+ LFSS+AF S G +AG +LEF+ + LGW L G C C+ N DCT
Sbjct: 176 FFSMKTLRNSSCSLLFSSIAFESVGVNAGIALEFERVRLGWWLKGGCESGTCAANTDCT- 234
Query: 211 NFTFANGISGHRCRCQEGFEGDGFVAGDGCRRT-SDCNASKYLSGKCGGTRIGALVGGLI 269
+ +G +GHRC C +GF GDG+ + C+R +C SK + C I +VGG +
Sbjct: 235 DVETPHGYAGHRCSCLDGFHGDGYT--NPCQRALPECRGSKLVWRHCRSNLI-TIVGGTV 291
Query: 270 AGASIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEK 329
GA ++A +A +C R+RST LR+ LSAKRLL +AAGNSSV F+PYKEIEKAT FSEK
Sbjct: 292 GGAFLLAALAFFFFCKRRRSTPLRSHLSAKRLLSEAAGNSSVAFFPYKEIEKATDGFSEK 351
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+LG GAYGTVY GKL ND+WVAIKR R+RD++S+DQVMNEIKLLSSVSHPNL+RLLGCC
Sbjct: 352 QKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKLLSSVSHPNLVRLLGCC 411
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
IE+G+P+LVYE+MPNGTL +HLQR+RGSGLPWT+R+T+AT+TA+AIAYLHS+MNPPIYHR
Sbjct: 412 IEQGDPVLVYEYMPNGTLSEHLQRDRGSGLPWTLRLTVATQTAKAIAYLHSSMNPPIYHR 471
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
DIKS+NILLDY++ SKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ FHLSDKSDV
Sbjct: 472 DIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQCFHLSDKSDV 531
Query: 510 YSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSS 569
YSFGVVL EIIT LKVVDF+RPH+E+NLAALA+D+IG GC+DEIIDP L+ DAWTLSS
Sbjct: 532 YSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDEIIDPILDLDLDAWTLSS 591
Query: 570 IHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYMGSPAVSCCSLSECGSER 629
IH VAELAFRCLAFH DMRPTM EVA+ELE IR+S W ++ + SPA S S S+ GSER
Sbjct: 592 IHTVAELAFRCLAFHSDMRPTMTEVADELEQIRLSGWIPSMSLDSPAGSLRS-SDRGSER 650
Query: 630 SLSGLTVKKAGVKSQRLIVPPKSGDCLTTLDEVKDSSPVSVQDPWLSEQSSPSTNSLLGN 689
S VK++ + S+R+++P K DCL +++E+ DSSP+SVQDPWLS QSSPSTN+LLGN
Sbjct: 651 S-----VKQSSIGSRRVVIPQKQPDCLASVEEISDSSPISVQDPWLSAQSSPSTNTLLGN 705
Query: 690 V 690
+
Sbjct: 706 I 706
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 692 | ||||||
| TAIR|locus:2046728 | 708 | AT2G23450 [Arabidopsis thalian | 0.949 | 0.927 | 0.594 | 1e-210 | |
| TAIR|locus:2174994 | 622 | AT5G66790 [Arabidopsis thalian | 0.800 | 0.890 | 0.519 | 1.9e-147 | |
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.712 | 0.750 | 0.350 | 1.6e-71 | |
| TAIR|locus:2031230 | 629 | AT1G25390 [Arabidopsis thalian | 0.471 | 0.518 | 0.429 | 3.3e-69 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.462 | 0.444 | 0.384 | 3.6e-69 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.544 | 0.512 | 0.359 | 7.4e-69 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.472 | 0.441 | 0.388 | 3.5e-67 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.453 | 0.408 | 0.408 | 9.3e-67 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.527 | 0.464 | 0.360 | 2.3e-66 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.456 | 0.420 | 0.416 | 3.1e-66 |
| TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2037 (722.1 bits), Expect = 1.0e-210, P = 1.0e-210
Identities = 404/680 (59%), Positives = 492/680 (72%)
Query: 19 ANAADLCDRTCRNGKSTKRVPYPFGFSPGCAIRLTCANATVK-IGEFEVQNVTADSIFVN 77
AN C+ C G T +PYPFGFS GC+IR C+ A IG+F VQNVT +SIFV
Sbjct: 42 ANFTVPCNGRC--GGLT--LPYPFGFSNGCSIRFDCSAAEKPMIGDFSVQNVTENSIFVG 97
Query: 78 LPTKCHRQITSLHPLFGPNYGMTRQNSLLLQNCTTHQNGCVIPTSLVEQRFNLKTCGVGS 137
L C R+I ++PLFG N+ T +NS L++NC +GC I +E LK+C +
Sbjct: 98 LSHNCTRKIEDMNPLFGENFAPTSENSFLMENCNRTTDGCSIKQKFLENVLKLKSCDA-T 156
Query: 138 DNITCFSWPYNENK--SASFMSFNDLSRTGCNYLFSSLAFNSGGNSAG-SLEFQLLELGW 194
NI+CFS N + SA F S L + C+ LFSS+AF S G +AG +LEF+ + LGW
Sbjct: 157 GNISCFSLDSNSSSKNSAKFFSMKTLRNSSCSLLFSSIAFESVGVNAGIALEFERVRLGW 216
Query: 195 GLNGSCN---CSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRT-SDCNASK 250
L G C C+ N DCT T +G +GHRC C +GF GDG+ + C+R +C SK
Sbjct: 217 WLKGGCESGTCAANTDCTDVET-PHGYAGHRCSCLDGFHGDGYT--NPCQRALPECRGSK 273
Query: 251 YLSGKCGGTRXXXXXXXXXXXXSIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSS 310
+ C + ++A +A +C R+RST LR+ LSAKRLL +AAGNSS
Sbjct: 274 LVWRHCR-SNLITIVGGTVGGAFLLAALAFFFFCKRRRSTPLRSHLSAKRLLSEAAGNSS 332
Query: 311 VPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNE 370
V F+PYKEIEKAT FSEK +LG GAYGTVY GKL ND+WVAIKR R+RD++S+DQVMNE
Sbjct: 333 VAFFPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNE 392
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWXXXXXXXXX 430
IKLLSSVSHPNL+RLLGCCIE+G+P+LVYE+MPNGTL +HLQR+RGSGLPW
Sbjct: 393 IKLLSSVSHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGSGLPWTLRLTVATQ 452
Query: 431 XXXXXXYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
YLHS+MNPPIYHRDIKS+NILLDY++ SKVADFGLSRLGMTESSHISTAPQGTP
Sbjct: 453 TAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTP 512
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550
GYLDPQYHQ FHLSDKSDVYSFGVVL EIIT LKVVDF+RPH+E+NLAALA+D+IG GC+
Sbjct: 513 GYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCI 572
Query: 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610
DEIIDP L+ DAWTLSSIH VAELAFRCLAFH DMRPTM EVA+ELE IR+S W ++
Sbjct: 573 DEIIDPILDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQIRLSGWIPSM 632
Query: 611 YMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSGDCLTTLDEVKDSSPVSV 670
+ SPA S S S+ GSERS VK++ + S+R+++P K DCL +++E+ DSSP+SV
Sbjct: 633 SLDSPAGSLRS-SDRGSERS-----VKQSSIGSRRVVIPQKQPDCLASVEEISDSSPISV 686
Query: 671 QDPWLSEQSSPSTNSLLGNV 690
QDPWLS QSSPSTN+LLGN+
Sbjct: 687 QDPWLSAQSSPSTNTLLGNI 706
|
|
| TAIR|locus:2174994 AT5G66790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
Identities = 306/589 (51%), Positives = 378/589 (64%)
Query: 35 TKRVPYPFGFSPGCAIRLTCANATVK--IGEFEVQNVTADSIFVNLPTKCHRQITSLHPL 92
T + YPFGFS G IR C+ T + IGEF VQ VT +I+V +P C R I + L
Sbjct: 32 TSLLRYPFGFSDGYPIRFNCSEITGEAVIGEFAVQEVTNSNIYVEIPPVCKRNIRKIEQL 91
Query: 93 FGPNYGMTR-QNSLLLQNCTTHQ--NGCVIPTSLVEQRFNLKTCGVGSDNITCFSWPYNE 149
F N ++ QN +L+Q C + C+I VE R NL C ++C
Sbjct: 92 FRENLAPSKLQNIILVQGCKKQNKSSNCLIRNKFVENRLNLSKC---KSPVSCLDGA--T 146
Query: 150 NKSASFMSFNDL-SRTGCNYLFSSLAFNSGGNSAGSLEFQLLELGWGLNGSCN---CSKN 205
+A MS D+ + +GC Y FSS++ S S+ L+L W L GSC+ CS+N
Sbjct: 147 TTTADVMSLGDVVNGSGCKYWFSSIS-----QSQVSVNLGRLKLDWWLKGSCSNTTCSEN 201
Query: 206 ADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSGKCGGTRXXXXX 265
ADC + +G GHRC C+EGF G F GC R L K G
Sbjct: 202 ADCAK-VKLDDGGLGHRCTCREGFSGKAFTVPGGCHR---------LVYKRKGLHKLVVL 251
Query: 266 XXXXXXXSIVAVVALLC-YCFR-KRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKAT 323
++ +V L+ Y FR K+S S A RLLC+ AGNSSVPFY YKEIEKAT
Sbjct: 252 GTAGILVGVLVIVVLIATYFFRNKQSASSERASIANRLLCELAGNSSVPFYTYKEIEKAT 311
Query: 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLL 383
FS+K+ LGTGAYGTVYAG+ N VAIKR +++DT SIDQV+NEIKLLSSVSHPNL+
Sbjct: 312 DSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKLLSSVSHPNLV 371
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG-LPWXXXXXXXXXXXXXXXYLHSAM 442
RLLGCC +GEP LVYEFMPNGTL QHLQ ERG L W +LHS++
Sbjct: 372 RLLGCCFADGEPFLVYEFMPNGTLYQHLQHERGQPPLSWQLRLAIACQTANAIAHLHSSV 431
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT---ESSHISTAPQGTPGYLDPQYHQ 499
NPPIYHRDIKSSNILLD+ + SK++DFGLSRLGM+ E+SHISTAPQGTPGYLDPQYHQ
Sbjct: 432 NPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTAPQGTPGYLDPQYHQ 491
Query: 500 YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
F LSDKSDVYSFGVVL+EII+ KV+DF+RP+SEVNLA+LA+DRIGRG V +IIDP L
Sbjct: 492 DFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIGRGRVVDIIDPCLN 551
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608
+ +SIHN+AELAFRCL+FHR+MRPTM+E+ E+L I++ + +
Sbjct: 552 KEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIKLMHYGT 600
|
|
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 1.6e-71, Sum P(2) = 1.6e-71
Identities = 186/531 (35%), Positives = 267/531 (50%)
Query: 97 YGMTRQNSLLLQNCTTHQNGCVI---PTSLVEQ--RFNLKTCGVGSDNITCFSWPYNENK 151
+ +T N++LL NC+ I PTSL + N C S C ++ + ++
Sbjct: 128 FSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSYIKNNASPC---SKAPLCCTFRTDGSQ 184
Query: 152 SASFMSFNDLSRTGCNYLFSSLAFNSGGN--SAGSLEFQL-LELGWGLNGSCNCSKNADC 208
+A + N GC S + N G LEL W L C + DC
Sbjct: 185 TAYTIRING---GGCLAYQSFVGLNPNKEVPPPGKKWPDTGLELQWALPKEPVCKTDVDC 241
Query: 209 ------TRNFTFANGISGHRCRCQEGFEGDGFVAGDG-CRRTSDCNASKYLSGKCGGTRX 261
++ + RC C++G E D A G CR C K G
Sbjct: 242 NLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAICGKCRHGKHCKKKKKTVVFAGAAVA 301
Query: 262 XXXXXXXXXXXSIVAVVALLCYCFRKRSTSLRNQLSAKR---LLCQAAGNSSVPFYPYKE 318
VAV+ + +K + + +R L + G SS + +E
Sbjct: 302 VVGVTLAIA----VAVIGTK-HSHQKVKKDIHKNIVKEREEMLSANSTGKSS-RIFTGRE 355
Query: 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS 378
I KAT+ FS+ + +GTG +G V+ L + AIKR + +T DQ++NE+++L V+
Sbjct: 356 ITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEVRILCQVN 415
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ--RERG-SGLPWXXXXXXXXXXXXXX 435
H +L+RLLGCC++ P+L+YEF+PNGTL +HL +R L W
Sbjct: 416 HRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWKPLTWRRRLQIAYQTAEGL 475
Query: 436 XYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL-GMTES----SHISTAPQGTP 490
YLHSA PPIYHRD+KSSNILLD +KV+DFGLSRL +TE+ SHI T QGT
Sbjct: 476 AYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNESHIFTGAQGTL 535
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550
GYLDP+Y++ F L+DKSDVYSFGVVL+E++T+ K +DF+R +VNL + + +
Sbjct: 536 GYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLVMYINKMMDQERL 595
Query: 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
E IDP L+ + + +I + LA CL R RP+M EVA+E+E+I
Sbjct: 596 TECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVADEIEYI 646
|
|
| TAIR|locus:2031230 AT1G25390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 3.3e-69, Sum P(2) = 3.3e-69
Identities = 143/333 (42%), Positives = 206/333 (61%)
Query: 274 IVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLG 333
+VA+ A++ +R++ S ++ ++K + + +P + YKE++ AT FS+ LG
Sbjct: 239 LVALFAVIHRNYRRKDGSELSRDNSKSDVEFSQVFFKIPIFSYKELQAATDNFSKDRLLG 298
Query: 334 TGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG 393
G +GTVY GK+ + VA+KR + ++Q MNEI++L+ + H NL+ L GC
Sbjct: 299 DGGFGTVYYGKVRDGREVAVKRLYEHNYRRLEQFMNEIEILTRLHHKNLVSLYGCTSRRS 358
Query: 394 -EPILVYEFMPNGTLCQHLQRERG--SG-LPWXXXXXXXXXXXXXXXYLHSAMNPPIYHR 449
E +LVYEF+PNGT+ HL E G L W YLH++ I HR
Sbjct: 359 RELLLVYEFIPNGTVADHLYGENTPHQGFLTWSMRLSIAIETASALAYLHAS---DIIHR 415
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
D+K++NILLD N+ KVADFGLSRL ++ +H+STAPQGTPGY+DP+YH+ +HL+DKSDV
Sbjct: 416 DVKTTNILLDRNFGVKVADFGLSRLLPSDVTHVSTAPQGTPGYVDPEYHRCYHLTDKSDV 475
Query: 510 YSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSS 569
YSFGVVL+E+I++ VD SR SE+NL++LAI++I E+ID L +
Sbjct: 476 YSFGVVLVELISSKPAVDISRCKSEINLSSLAINKIQNHATHELIDQNLGYATNEGVRKM 535
Query: 570 IHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
VAELAF+CL MRPTM +V EL+ I+
Sbjct: 536 TTMVAELAFQCLQQDNTMRPTMEQVVHELKGIQ 568
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 3.6e-69, Sum P(3) = 3.6e-69
Identities = 128/333 (38%), Positives = 190/333 (57%)
Query: 280 LLCYCFRKRSTSLRNQLSAKR----LLCQAAG--NSSV---PFYPYKEIEKATSFFSEKH 330
LLC RKR + + + +R LL Q + SV + ++E AT F+
Sbjct: 335 LLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASR 394
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
LG G GTVY G L + VA+K+ + +++++ +NEI LLS ++H N++++LGCC+
Sbjct: 395 ILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCL 454
Query: 391 EEGEPILVYEFMPNGTLCQHLQR-ERGSGLPWXXXXXXXXXXXXXXXYLHSAMNPPIYHR 449
E PILVYEF+PN L HL + W YLHSA++ PIYHR
Sbjct: 455 ETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHR 514
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
D+KS+NILLD +R+KV+DFG+SR + +H++T QGT GY+DP+Y Q H + KSDV
Sbjct: 515 DVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDV 574
Query: 510 YSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSS 569
YSFGV+LIE++T K V R L A ++ + + EI+D ++ D
Sbjct: 575 YSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDR---EE 631
Query: 570 IHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
+ VA+LA RCL+ + + RPTM +V EL+ ++
Sbjct: 632 VLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQ 664
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 7.4e-69, Sum P(3) = 7.4e-69
Identities = 147/409 (35%), Positives = 210/409 (51%)
Query: 207 DCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRTSDCNASKYLSGKCGGTRXXXXXX 266
+C+ T N + G C+CQ G+ D T C ++
Sbjct: 296 NCSDPKTCRNKVGGFYCKCQSGYRLD--------TTTMSCKRKEF---------AWTTIL 338
Query: 267 XXXXXXSIVAVVALLCYCFRKR---STSLRNQLSAKR---LLCQ---AAGNSSVPFYPYK 317
+V ++ + C R + T LR Q + +L Q AG S+V +
Sbjct: 339 LVTTIGFLVILLGVACIQQRMKHLKDTKLREQFFEQNGGGMLTQRLSGAGPSNVDVKIFT 398
Query: 318 E--IEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLS 375
E ++KAT+ ++E LG G GTVY G L ++ VAIK+ R D+ ++Q +NE+ +LS
Sbjct: 399 EDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLS 458
Query: 376 SVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER-GSGLPWXXXXXXXXXXXXX 434
++H N+++LLGCC+E P+LVYEF+ NGTL HL S L W
Sbjct: 459 QINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGT 518
Query: 435 XXYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
YLHS+ + PI HRDIK++NILLD N +KVADFG SRL + + T QGT GYLD
Sbjct: 519 LAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLD 578
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554
P+Y+ L++KSDVYSFGVVL+E+++ K + F RP S +L + +DEII
Sbjct: 579 PEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEII 638
Query: 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603
+ + D L I A +A C + RP M EVA +LE +RV
Sbjct: 639 GGEVM-NED--NLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRV 684
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 568 (205.0 bits), Expect = 3.5e-67, Sum P(3) = 3.5e-67
Identities = 133/342 (38%), Positives = 197/342 (57%)
Query: 274 IVAVVALLC--YCFRKRS-TSLRNQLSAKR---LLCQ---AAGNSSVPFYPYKE--IEKA 322
+V ++A +C + ++R T LR Q + +L Q AG S++ F + E +++A
Sbjct: 352 LVLLLAAICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEA 411
Query: 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
T+ + E LG G GTVY G L ++ VAIK+ R D+ +DQ ++E+ +LS ++H N+
Sbjct: 412 TNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNV 471
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER-GSGLPWXXXXXXXXXXXXXXXYLHSA 441
+++LGCC+E P+LVYEF+ NGTL HL S L W YLHS+
Sbjct: 472 VKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYLHSS 531
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
+ PI HRDIK++NILLD N +KVADFG S+L + ++T QGT GYLDP+Y+
Sbjct: 532 ASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTG 591
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561
L++KSDVYSFGVVL+E+++ K + F RP + +L + + + EIID + +
Sbjct: 592 LLNEKSDVYSFGVVLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQVL-N 650
Query: 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603
D L I A +A C + RP M EVA +LE +RV
Sbjct: 651 ED--NLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRV 690
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 9.3e-67, Sum P(3) = 9.3e-67
Identities = 131/321 (40%), Positives = 184/321 (57%)
Query: 286 RKRSTSLRNQ-LSAKRLLCQAAGN-SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAG 343
+K+ RN L ++ L GN S + +E+EKAT FS LG G GTVY G
Sbjct: 391 QKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKG 450
Query: 344 KLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403
L + VA+K+ + D D +++ +NE+ +LS ++H N+++LLGCC+E PILVYEF+P
Sbjct: 451 MLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIP 510
Query: 404 NGTLCQHLQRERG--SGLPWXXXXXXXXXXXXXXXYLHSAMNPPIYHRDIKSSNILLDYN 461
NG L +HL + + W YLHSA + PIYHRDIKS+NI+LD
Sbjct: 511 NGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEK 570
Query: 462 YRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+R+KV+DFG SR + +H++T GT GY+DP+Y Q +DKSDVYSFGVVL E+IT
Sbjct: 571 HRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELIT 630
Query: 522 ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCL 581
K V F R LA + + +IID + RD L+ + A++A +CL
Sbjct: 631 GEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARI---RDGCKLNQVTAAAKIARKCL 687
Query: 582 AFHRDMRPTMMEVAEELEHIR 602
RP+M +V+ ELE IR
Sbjct: 688 NMKGRKRPSMRQVSMELEKIR 708
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 2.3e-66, Sum P(4) = 2.3e-66
Identities = 140/388 (36%), Positives = 201/388 (51%)
Query: 240 CRRTSDCNASKYLSG-KCGGTRXXXXXXXXXXXXSIVAVVALLCYCFR---KRSTSLRNQ 295
C+ T C + G +C G + ++ +V + + + KR + R +
Sbjct: 347 CKETDTC--VNFEGGYRCVGDKTKAIMIGAGTGFGVLVLVGGVWWLRKFLVKRRMAKRKK 404
Query: 296 LSAKR---LLCQAAGNS------SVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLH 346
KR LL Q N+ + KE+EKAT FSE LG G GTVY G L
Sbjct: 405 KFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLV 464
Query: 347 NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGT 406
+ VA+K+ + D D + + +NE+ +LS ++H ++++LLGCC+E PILVYEF+ NG
Sbjct: 465 DGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGN 524
Query: 407 LCQHLQRERGSG--LPWXXXXXXXXXXXXXXXYLHSAMNPPIYHRDIKSSNILLDYNYRS 464
L +H+ E + W YLHSA + PIYHRDIKS+NILLD YR+
Sbjct: 525 LFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRA 584
Query: 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALK 524
KVADFG SR + +H +T GT GY+DP+Y++ ++KSDVYSFGV+L E+IT K
Sbjct: 585 KVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDK 644
Query: 525 VVDFSRPHSEVNLAALAIDRIG--RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLA 582
V + E+ +A R+ + +I+D + RD + VA LA +CL+
Sbjct: 645 PVIMVQNTQEI-IALAEHFRVAMKERRLSDIMDARI---RDDSKPEQVMAVANLAMKCLS 700
Query: 583 FHRDMRPTMMEVAEELEHIRVSSWASNI 610
RP M EV ELE I S S +
Sbjct: 701 SRGRNRPNMREVFTELERICTSPEDSQV 728
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 3.1e-66, Sum P(3) = 3.1e-66
Identities = 134/322 (41%), Positives = 186/322 (57%)
Query: 286 RKRSTSLRNQ-LSAKRLLCQAAGN-SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAG 343
RKR RN L K+ L GN S + KE+EKAT F+ LG G GTVY G
Sbjct: 379 RKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKG 438
Query: 344 KLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403
L + VA+KR + D D +++ +NE+ +LS ++H N+++L+GCC+E PILVYE +P
Sbjct: 439 MLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIP 498
Query: 404 NGTLCQHLQRERGS-GLPWXXXXXXXXXXXXXXXYLHSAMNPPIYHRDIKSSNILLDYNY 462
NG L + L + + W YLHSA + P+YHRD+K++NILLD Y
Sbjct: 499 NGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKY 558
Query: 463 RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA 522
R+KV+DFG SR + +H++T GT GYLDP+Y Q +DKSDVYSFGVVL+E+IT
Sbjct: 559 RAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITG 618
Query: 523 LKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLA 582
K RP L + + + + V +I+D + ++ TL + VA+LA RCL+
Sbjct: 619 EKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRI---KEGCTLEQVLAVAKLARRCLS 675
Query: 583 FHRDMRPTMMEVAEELEHIRVS 604
RP M EV+ ELE IR S
Sbjct: 676 LKGKKRPNMREVSVELERIRSS 697
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RY67 | WAKLO_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6232 | 0.9277 | 0.9067 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 692 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-38 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| pfam12947 | 36 | pfam12947, EGF_3, EGF domain | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-52
Identities = 88/281 (31%), Positives = 128/281 (45%), Gaps = 30/281 (10%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHND-DWVAIKRFRYRDTDSIDQVM--NEIKLLSSVSHPNL 382
+ +LG+G++GTVY K VA+K + R S EI++L +SHPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+RL+ ++ LV E+ G L +L R L IA + + + YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN- 117
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQ 499
I HRD+K NILLD N K+ADFGL++ + +SS T GTP Y+ P
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKK-LLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 500 YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
+ K DV+S GV+L E++T E L L + + I+ P LE
Sbjct: 175 GY--GPKVDVWSLGVILYELLT-----GKPPFSGENILDQLQL-------IRRILGPPLE 220
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
W+ S +L +CL RPT E+ L+H
Sbjct: 221 FDEPKWSSGSE-EAKDLIKKCLNKDPSKRPTAEEI---LQH 257
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 68/200 (34%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 332 LGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSI-DQVMNEIKLLSSVSHPNLLRLLGCC 389
LG G +GTVY + VAIK + D+ S+ ++++ EI++L ++HPN+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+E LV E+ G+L L+ G L + I + + + YLHS I HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 450 DIKSSNILLDYNYRS-KVADFGLSRLGMTESSHISTAPQGTPGYLDP-QYHQYFHLSDKS 507
D+K NILLD + K+ADFGLS+L +T + GTP Y+ P + S+KS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 508 DVYSFGVVLIEIITALKVVD 527
D++S GV+L E+ ++
Sbjct: 176 DIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 34/274 (12%)
Query: 332 LGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSI-DQVMNEIKLLSSVSHPNLLRLLGCC 389
LG G++G VY + VAIK + + ++++ EIK+L + HPN++RL
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+E + LV E+ G L L ++RG R + A+ YLHS I HR
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEAR-FYLRQILSALEYLHS-KG--IVHR 121
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLSDK 506
D+K NILLD + K+ADFGL+R + ++T GTP Y+ P Y
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTT-FVGTPEYMAPEVLLGKGY---GKA 176
Query: 507 SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWT 566
D++S GV+L E++T P + +IG+ P W
Sbjct: 177 VDIWSLGVILYELLTG------KPPFPGDDQLLELFKKIGK--------PKPPFPPPEWD 222
Query: 567 LSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+S +L + L + R T E L+H
Sbjct: 223 ISP--EAKDLIRKLLVKDPEKRLT---AEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 81/289 (28%), Positives = 129/289 (44%), Gaps = 50/289 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPNLLRLL 386
LG GA+G VY GKL D VA+K + ++ + E +++ + HPN++RLL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRER-------GSGLPWTIRITIATETAQAIAYLH 439
G C EE LV E+M G L +L++ R S L ++ A + A+ + YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYH 498
S HRD+ + N L+ + K++DFGLSR + + P ++ P+
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CV 550
+ + KSDV+SFGV+L EI T + P+ ++ + ++ + +G C
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT-----LGATPYPGLSNEEV-LEYLRKGYRLPKPEYCP 233
Query: 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599
DE+ EL C + RPT E+ E LE
Sbjct: 234 DEL--------------------YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 51/285 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTDSIDQV--MNEIKLLSSVSHPNLLR 384
LG GA+G VY G L D VA+K + ++ + E ++ +SHPN++R
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
LLG C + +V E+MP G L L R+ G L + +A + A+ + YL S N
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES-KN- 122
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGYLD 494
HRD+ + N L+ N K++DFGLSR + + AP+
Sbjct: 123 -FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL----- 176
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSR-PHSEVNLAALAIDRIGRGCVDEI 553
+ + KSDV+SFGV+L EI T P+ ++ ++ + G
Sbjct: 177 ----KDGKFTSKSDVWSFGVLLWEIFT------LGEQPYPGMS-NEEVLELLEDGY---- 221
Query: 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
L + + EL +C A+ + RPT E+ E+L
Sbjct: 222 ---RLPRPENCPD-----ELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 49/284 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDW-----VAIKRFR-YRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG GA+G VY G L VA+K + I++ + E +++ + HPN+++L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
LG C EE ++V E+MP G L +L++ R L + ++ A + A+ + YL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG---YLDPQYHQYFH 502
HRD+ + N L+ N K++DFGLSR +G ++ P+ +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDL---YDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CVDEII 554
+ KSDV+SFGV+L EI T P+ ++ A + ++ + +G C E+
Sbjct: 181 FTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAEV-LEYLKKGYRLPKPPNCPPEL- 233
Query: 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
+L +C A + RPT E+ E L
Sbjct: 234 -------------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 50/284 (17%)
Query: 332 LGTGAYGTVYAGKL-----HNDDWVAIKRFR-YRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG GA+G VY GKL VA+K + I++ + E +++ + HPN+++L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
LG C EE +V E+M G L +L++ R L + ++ A + A+ + YL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLESK---N 122
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG---YLDPQYHQYFH 502
HRD+ + N L+ N K++DFGLSR +G ++ P+ +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDL---YDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CVDEII 554
+ KSDV+SFGV+L EI T +P+ ++ + ++ + G C E+
Sbjct: 180 FTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEEV-LEYLKNGYRLPQPPNCPPEL- 232
Query: 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
+L +C A + RPT E+ E L
Sbjct: 233 -------------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 41/282 (14%)
Query: 330 HRLGTGAYGTVYAGKLHND-DWVAIK--RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G++G+VY + + +A+K + ++ + EI++LSS+ HPN++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 387 GCCI-EEGEPILVY-EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
G EE + ++ E++ G+L L ++ LP + + + +AYLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTPGYLDP-----QYH 498
I HRDIK +NIL+D + K+ADFG ++ LG E+ + + +GTP ++ P + +
Sbjct: 122 -IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
+D++S G +IE+ T P SE+ A+ +IG E P +
Sbjct: 181 GR-----AADIWSLGCTVIEMATG------KPPWSELGNPMAALYKIGSS--GEP--PEI 225
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
H LS + +CL RPT E L+H
Sbjct: 226 PEH-----LSE--EAKDFLRKCLRRDPKKRPT---ADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 74/209 (35%), Positives = 114/209 (54%), Gaps = 15/209 (7%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAG--KLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLS 375
E+E+ + + KH+LG G YG VY G K ++ VA+K + DT +++ + E ++
Sbjct: 2 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLK-EDTMEVEEFLKEAAVMK 57
Query: 376 SVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAI 435
+ HPNL++LLG C E ++ EFM G L +L+ + + + +AT+ + A+
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 436 AYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GY 492
YL HRD+ + N L+ N+ KVADFGLSRL MT ++ TA G +
Sbjct: 118 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTY--TAHAGAKFPIKW 171
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ Y S KSDV++FGV+L EI T
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 31/278 (11%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDW-VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
F ++G G +G VY + VAIK + + ++++NEI++L HPN+++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
G +++ E +V EF G+L L + L + + E + + YLHS
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG-- 118
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
I HRDIK++NILL + K+ DFGLS +L + GTP ++ P+
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 504 SDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563
K+D++S G ITA+++ + P+SE+ A+ +I P + +
Sbjct: 175 DYKADIWSLG------ITAIELAEGKPPYSELP-PMKALFKIAT------NGPPGLRNPE 221
Query: 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL-EH 600
W+ + +CL + + RPT AE+L +H
Sbjct: 222 KWSDEFKDFLK----KCLQKNPEKRPT----AEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 2e-31
Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKR--FRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G G++G VY + + +K + +NE+K+L ++HPN+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLP--------WTIRITIATETAQAIAYLHS 440
E+G+ +V E+ G L Q +++++ G P W +++ +A + YLHS
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYLHS 121
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QY 497
I HRDIK NI L N K+ DFG+S++ + T GTP YL P Q
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQN 177
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557
Y + KSD++S G VL E+ T LK P NL L +I +G I Y
Sbjct: 178 KPY---NYKSDIWSLGCVLYELCT-LK-----HPFEGENLLEL-ALKILKGQYPPIPSQY 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 59/193 (30%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 332 LGTGAYGTVYAG-KLHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G GA+G VY G L D+VAIK+ +++ +M EI LL ++ HPN+++ +G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
++ E+ NG+L Q +++ P ++ + Q +AYLH + H
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIH 122
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSD 508
RDIK++NIL + K+ADFG++ + + S + GTP ++ P+ + S SD
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASD 181
Query: 509 VYSFGVVLIEIIT 521
++S G +IE++T
Sbjct: 182 IWSLGCTVIELLT 194
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ G + VA+K + T S + + E +++ + H L++L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC- 70
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
E EPI +V E+M G+L L+ G L + +A + A+ +AYL S N HR
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RN--YIHR 127
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGT--P-GYLDPQYHQYFHLSDK 506
D+ + NIL+ N K+ADFGL+RL + TA +G P + P+ Y + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 507 SDVYSFGVVLIEIIT 521
SDV+SFG++L EI+T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 24/283 (8%)
Query: 320 EKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH 379
E+ F+ + +LG+G +G V+ G N VAIK + D E++ L + H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 380 PNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
+L+ L C GEP+ ++ E M G+L L+ G LP I +A + A+ +AYL
Sbjct: 62 KHLISLFAVC-SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
HRD+ + NIL+ + KVADFGL+RL + E ++S+ + + P+
Sbjct: 121 EEQN---SIHRDLAARNILVGEDLVCKVADFGLARL-IKEDVYLSSDKKIPYKWTAPEAA 176
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
+ S KSDV+SFG++L E+ T +V P+ +N D+I G
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQV-----PYPGMNNHE-VYDQITAG---------- 220
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+R + ++ C A + RP+ + EEL++I
Sbjct: 221 --YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-30
Identities = 73/283 (25%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHP-NLLRLLG 387
LG G++G VY + VA+K + +++ + EI++L+S++HP N+++L
Sbjct: 8 LGEGSFGEVYLARDRKL--VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 388 CCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+EG LV E++ G+L L + R L + + I + A+ YLHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 447 YHRDIKSSNILLDYNY-RSKVADFGLSRL-----GMTESSHISTAPQGTPGYLDPQYHQY 500
HRDIK NILLD + K+ DFGL++L + + + GTPGY+ P+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 501 F---HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557
+ S SD++S G+ L E++T L + + S + I + + + P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ + LA R + + +L H
Sbjct: 243 NPELISKAASDLLK-------KLLAKDPKNRLSS---SSDLSH 275
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/208 (34%), Positives = 108/208 (51%), Gaps = 14/208 (6%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV 377
EI++ + +LG G +G V+ G +N VA+K + T + E +++ +
Sbjct: 2 EIDRTSIQL--LRKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKL 58
Query: 378 SHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
HP L++L C E EPI +V E M G+L ++LQ G L I +A + A +A
Sbjct: 59 RHPKLIQLYAVCTLE-EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYL 493
YL A N HRD+ + N+L+ N KVADFGL+R+ + I A +G +
Sbjct: 118 YLE-AQN--YIHRDLAARNVLVGENNICKVADFGLARVIKED---IYEAREGAKFPIKWT 171
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ Y S KSDV+SFG++L EI+T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 5/204 (2%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391
+G+G +G V+ G VAIK R S + + E +++ +SHP L++L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDI 451
LV+EFM +G L +L+ +RG T+ + + + + +AYL S+ + HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 452 KSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYS 511
+ N L+ N KV+DFG++R + + ST + + P+ + S KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 512 FGVVLIEIITALKVVDFSRPHSEV 535
FGV++ E+ + K +R +SEV
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 34/271 (12%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWV-AIKRFRYRDTDSIDQ--VMNEIKLLSSVSHPNL 382
F +++G G++G V+ D V A+K+ + ++ ++E ++L+ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLP----WTIRITIATETAQAIAYL 438
+R +++G+ +V E+ NG L + L+ +RG LP W I I +A+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHL 117
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
HS I HRDIKS N+ LD K+ D G+++L ++++++ + GTP YL P+
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELC 173
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
+ ++KSDV++ GVVL E T P N AL I +I RG + Y
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCT------GKHPFDANNQGAL-ILKIIRGVFPPVSQMYS 226
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589
+ +A+L +CL RP
Sbjct: 227 Q------------QLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 29/270 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391
LG+G +G V+ GK VAIK R S D + E K++ +SHPNL++L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDI 451
+ +V E+M NG L +L+ +G + + + ++ +A+ YL S HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-LDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 452 KSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQYHQYFHLSDKSD 508
+ N L+ + KV+DFGL+R + + T+ QGT + P+ Y S KSD
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 509 VYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLS 568
V+SFGV++ E+ + K+ +SEV ++ + G P L+
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAGYRLY------RPK-----LA 226
Query: 569 SIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
V + + C + RP ++ +L
Sbjct: 227 PTE-VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/195 (33%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ G + VAIK + + + S + + E L+ + HP L+RL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+E PI ++ E+M NG+L L+ G L I +A + A+ +A++ N HR
Sbjct: 72 QE--PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-RKN--YIHR 126
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQYHQYFHLSDK 506
D++++NIL+ K+ADFGL+RL E + TA +G + P+ Y + K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL--IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 507 SDVYSFGVVLIEIIT 521
SDV+SFG++L EI+T
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
+ ++G GA G VY VAIK+ R R + + ++NEI ++ HPN
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLC----QHLQRERGSGLPWTIRITIATETAQAIAY 437
++ + E +V E+M G+L Q+ R + + E Q + Y
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-----MNEPQIAYVCREVLQGLEY 131
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
LHS + HRDIKS NILL + K+ADFG + E S ++ GTP ++ P+
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEV 187
Query: 498 ---HQYFHLSDKSDVYSFGVVLIEII 520
Y K D++S G++ IE+
Sbjct: 188 IKRKDY---GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 71/286 (24%), Positives = 133/286 (46%), Gaps = 54/286 (18%)
Query: 332 LGTGAYGTVYAGKLHNDDW----------VAIKRFRYRDTD--SIDQVMNEIKLLSSVSH 379
LG+GA+GTVY G W VAIK R +T + ++++E +++SV H
Sbjct: 15 LGSGAFGTVYKGV-----WIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDH 68
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG-----SGLPWTIRITIATETAQA 434
P+++RLLG C+ + L+ + MP G L +++ + L W ++I A+
Sbjct: 69 PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYL 493
++YL + HRD+ + N+L+ K+ DFGL++L + P ++
Sbjct: 122 MSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLAALAIDRIGRGCVDE 552
+ + + KSDV+S+GV + E++T F ++P+ + + D + +G +
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMT------FGAKPYEGIPAVEIP-DLLEKG--ER 229
Query: 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
+ P + +I +V + +C + RPT E+ E
Sbjct: 230 LPQPP---------ICTI-DVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDWV----AIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G++G V + + + +K+ + ++ + E +LS ++HP +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLP-WTIRITIATETAQAIAYLHSAMNPPI 446
E + LV E+ P G L HL +E R A E A+ YLHS I
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAA-EIVLALEYLHSL---GI 114
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ---YFHL 503
+RD+K NILLD + K+ DFGL++ +E S +T GTP YL P+ Y
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY--- 170
Query: 504 SDKS-DVYSFGVVLIEIIT 521
K+ D +S GV+L E++T
Sbjct: 171 -GKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLL 374
KE++ +G G +G V G VA+K + D+ + + E ++
Sbjct: 4 NSKELKL-------GATIGKGEFGDVMLGDYRGQK-VAVKCLK-DDSTAAQAFLAEASVM 54
Query: 375 SSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG-SGLPWTIRITIATETAQ 433
+++ HPNL++LLG ++ +V E+M G+L +L R RG + + ++ A + +
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCE 113
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS-------TAP 486
+ YL HRD+ + N+L+ + +KV+DFGL++ S TAP
Sbjct: 114 GMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTAP 168
Query: 487 QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSR-PHSEVNLAALAIDRI 545
+ + F S KSDV+SFG++L EI + F R P+ + L + +
Sbjct: 169 EALR-------EKKF--STKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVV-PHV 212
Query: 546 GRG----CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+G + + +D W L RPT ++ E+L I
Sbjct: 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPA----------------KRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 69/231 (29%), Positives = 122/231 (52%), Gaps = 14/231 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ G +N VA+K + T S+ + E L+ ++ H L+RL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+E EPI ++ E+M G+L L+ + G + I + + A+ +AY+ HR
Sbjct: 72 KE-EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQYHQYFHLSDK 506
D++++N+L+ + K+ADFGL+R+ + ++ + TA +G + P+ + + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV-IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 507 SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR--GCVDEIID 555
SDV+SFG++L EI+T K+ +S+V A R+ R C DE+ D
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 62/190 (32%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391
LGTG +G V GK VAIK + + S D+ + E K++ +SH L++L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDI 451
+ +V E+M NG L +L RE G + + + + + +AYL S HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDL 126
Query: 452 KSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYS 511
+ N L+D KV+DFGLSR + + S + + P+ Y S KSDV++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 512 FGVVLIEIIT 521
FGV++ E+ +
Sbjct: 187 FGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 332 LGTGAYG--TVYAGKLHNDDWVAIKRFRYRDTDS--IDQVMNEIKLLSSVSHPNLLRLLG 387
LG GA+G T+Y + +D V K +NEI +LS + HPN++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+++ ++ E+ GTL + R++G + + + A++Y+H A I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GIL 123
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
HRDIK+ NI L K+ DFG+S++ +E S T GTP Y+ P+ Q + KS
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKS 182
Query: 508 DVYSFGVVLIEIITALKVVDFSRP 531
D+++ G VL E++T + D + P
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 30/205 (14%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMN--EIKLLSSVSHPNLLRLLG 387
++G G YG VY + + VAIK+ + R EIKLL ++HPN+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+G+ LV+EFM + L + ++ R GLP ++ + + Q +A+ HS I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHIST----APQ---GTPGYLDPQ 496
HRD+K N+L++ K+ADFGL+R + ++ T AP+ G GY
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY---- 176
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIIT 521
S D++S G + E+++
Sbjct: 177 -------STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+G GA VYA L N++ VAIKR S+D++ E++ +S +HPN+++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ E LV ++ G+ + + GL I T+ E + + YLHS N I
Sbjct: 69 VVGDELWLVMPYLSGGS-LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQI- 124
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRL---GMTESSHISTAPQGTPGYLDP----QYHQY 500
HRDIK+ NILL + K+ADFG+S G + + GTP ++ P Q H Y
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 501 FHLSDKSDVYSFGVVLIEIIT 521
K+D++SFG+ IE+ T
Sbjct: 185 DF---KADIWSFGITAIELAT 202
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 79/272 (29%), Positives = 126/272 (46%), Gaps = 29/272 (10%)
Query: 328 EKHRL-GTGAYGTVYAGKLHNDD-WVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLL 383
EK R+ G GA+G V+ + D V IK+ D NE ++L +SHPN++
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
+E+ ++V E+ P GTL +++Q+ S L TI Q + LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD---EDTILHFFVQILLALHHVHT 119
Query: 444 PPIYHRDIKSSNILLD-YNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
I HRD+K+ NILLD + K+ DFG+S++ ++S + GTP Y+ P+ +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEGKP 177
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562
+ KSD+++ G VL E + +LK R NL AL + +I G I D Y
Sbjct: 178 YNQKSDIWALGCVLYE-LASLK-----RAFEAANLPALVL-KIMSGTFAPISDRYSP--- 227
Query: 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594
++ +L L RP + ++
Sbjct: 228 ---------DLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 86/282 (30%), Positives = 134/282 (47%), Gaps = 47/282 (16%)
Query: 332 LGTGAYGTVYAG-KLHNDDWVAIKRFRYRDTDS-----IDQVMNEIKLLSSVSHPNLLRL 385
LG+G++G+VY G L + D+ A+K D + Q+ EI LLS + HPN+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ---AIAYLHSAM 442
LG EE + E +P G+L + L++ GS P + I T Q + YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKK-YGS-FPEPV---IRLYTRQILLGLEYLH--- 119
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP----QYH 498
+ HRDIK +NIL+D N K+ADFG+++ + S S +G+P ++ P Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF--KGSPYWMAPEVIAQQG 177
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
Y +D++S G ++E+ T P S++ A A+ +IGR I +L
Sbjct: 178 GYGL---AADIWSLGCTVLEMATG------KPPWSQLEGVA-AVFKIGRSKELPPIPDHL 227
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+A + +CL +RPT AE LEH
Sbjct: 228 SD--EA---------KDFILKCLQRDPSLRPT---AAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391
LG+G +G V+ GK VAIK S + + E K++ +SHP L++L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDI 451
+ +V EFM NG L +L++ +G L + +++ + + + YL HRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SFIHRDL 126
Query: 452 KSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYS 511
+ N L+ KV+DFG++R + + S+ + + P+ + S KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 512 FGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIH 571
FGV++ E+ T K+ + + EV ++ I RG + P L
Sbjct: 187 FGVLMWEVFTEGKMPFEKKSNYEV------VEMISRG--FRLYRPKLAS----------M 228
Query: 572 NVAELAFRCLAFHRDMRPTMMEVAEEL 598
V E+ + C + RPT E+ +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRF---RYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G++ TV A + + AIK + + V E ++L+ ++ HP +++L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+E V E+ PNG L Q++++ GS L A E A+ YLHS I
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRK-YGS-LDEKCTRFYAAEILLALEYLHS-KG--I 123
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ------------------- 487
HRD+K NILLD + K+ DFG +++ SS S
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
GT Y+ P+ SD+++ G ++ +++T
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 54/288 (18%)
Query: 332 LGTGAYGTVYAGKLH----NDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+G G +G V G+L + VAIK + D +D + E ++ HPN++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 386 LGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
G + + P++ + E+M NG+L + L+ G + + A + YL S MN
Sbjct: 71 EGV-VTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYL-SEMN- 126
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHIS---------TAPQGTPGYLD 494
HRD+ + NIL++ N KV+DFGLSR L +E+++ + TAP+
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI----- 180
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLAALAIDRIGRGCVDEI 553
Y + SDV+SFG+V+ E+++ + RP+ +++ + + +
Sbjct: 181 ----AYRKFTSASDVWSFGIVMWEVMS------YGERPYWDMS---------NQDVIKAV 221
Query: 554 IDPY-LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
D Y L P D S+++ +L C R+ RPT ++ L+
Sbjct: 222 EDGYRLPPPMDC--PSALY---QLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 27/204 (13%)
Query: 330 HRLGTGAYGTVY------AGKLHNDDWVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNL 382
LG G+ G VY GK+ A+K+ D + Q++ E+K L S P +
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKI-----YALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
++ G +EGE +V E+M G+L L++ +P + IA + + + YLH+
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKR 119
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSR-----LGMTESSHISTAPQGTPGYLDPQY 497
+ I HRDIK SN+L++ K+ADFG+S+ L ++ + T +P + +
Sbjct: 120 H--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFVGTVTYMSPERIQGES 176
Query: 498 HQYFHLSDKSDVYSFGVVLIEIIT 521
+ Y +D++S G+ L+E
Sbjct: 177 YSY-----AADIWSLGLTLLECAL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQ-VMNEIKLLSSVSHPNLLRLLGCC 389
++G G +G VY G L + VA+K R + + + E ++L HPN+++L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 390 IEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
+++ +PI V E +P G+L L R++ + L + ++ + A + YL S H
Sbjct: 62 VQK-QPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP----GYLDPQYHQYFHLS 504
RD+ + N L+ N K++DFG+SR E I T G + P+ Y +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 505 DKSDVYSFGVVLIEIIT 521
+SDV+S+G++L E +
Sbjct: 174 SESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSI--DQVMNEIKLLSSVSHPNLLRLL 386
+G GAYG V + + VAIK+F+ + D + E+K+L + H N++ L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+G LV+E++ TL + L+ G P +R I + QAIAY HS N I
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHS-HN--I 121
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTES------SHIST----APQGTPGYLDPQ 496
HRDIK NIL+ + K+ DFG +R + +++T AP+ G D
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYVATRWYRAPELLVG--DTN 178
Query: 497 YHQYFHLSDKS-DVYSFGVVLIEIIT 521
Y K DV++ G ++ E++
Sbjct: 179 Y-------GKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 332 LGTGAYGTVYAGKLHNDD----WVAIKRF-RYRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G G +G VY G L + D A+K R D + ++Q + E ++ SHPN+L LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 387 GCCI-EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--ITIATETAQAIAYLHSAMN 443
G C+ EG P++V +M +G L ++ E + P T++ I + A+ + YL S
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--P-TVKDLIGFGLQVAKGMEYLASK-- 117
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE---SSHISTAPQGTPGYLDPQYHQY 500
HRD+ + N +LD ++ KVADFGL+R + S H T + ++ + Q
Sbjct: 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 501 FHLSDKSDVYSFGVVLIEIIT 521
+ KSDV+SFGV+L E++T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 332 LGTGAYGTVYAGKLHNDD-----WVAIKRFRYRDTDSIDQVMN----EIKLLSSVSHPNL 382
LG G +G V + VA+K +Q + EI++L ++ H N+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLDHENI 68
Query: 383 LRLLGCCIEEGEPI--LVYEFMPNGTLCQHLQRERGS-GLPWTIRITIATETAQAIAYLH 439
++ G C + G L+ E++P+G+L +LQR R L + +++ + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLG 126
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA--PQGTPG-YLDPQ 496
S HRD+ + NIL++ K++DFGL+++ + E P +P + P+
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIFWYAPE 182
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIIT 521
+ S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 330 HRLGTGAYGTVYAG-KLHNDDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVSHPNLLRLL 386
+++G G +G VY L + +A+K R +D D +I ++ +E+K+L + HPNL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ---AIAYLHSAMN 443
G + + + E+ GTL + L E G L + I T Q +AYLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHV---IRVYTLQLLEGLAYLHSHG- 119
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFG----LSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
I HRDIK +NI LD+N K+ DFG L T + + GTP Y+ P+
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL-AGTPAYMAPEVIT 176
Query: 500 YFHLSDK---SDVYSFGVVLIEIITALKVVDFSRPHSE 534
+D++S G V++E+ T RP SE
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG------KRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 83/290 (28%), Positives = 139/290 (47%), Gaps = 43/290 (14%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
LG GA+G VY K A K + + ++ M EI++L++ +HP +++LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 391 EEGEPILVYEFMPNGTL-CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+G+ ++ EF P G + L+ +RG P I+ I + +A+ YLHS I HR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQ-VICRQMLEALQYLHSM---KIIHR 134
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-----GTPGYLDPQYHQYFHLS 504
D+K+ N+LL + K+ADFG+S + ++ T + GTP ++ P+ +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 505 D-----KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
D K+D++S G+ LIE+ PH E+N + + +I + +P
Sbjct: 189 DTPYDYKADIWSLGITLIEM------AQIEPPHHELNPMRVLL-KIAKS------EPPTL 235
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609
W++ + + A L H + RP+ A+ LEH VSS SN
Sbjct: 236 SQPSKWSM-EFRDFLKTA---LDKHPETRPS---AAQLLEHPFVSSVTSN 278
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
+ R+G+G YG VY + + + VAIK + D + + EI +L HPN++
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
G + + +V E+ G+L Q RG L + ET + +AYLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHETG-- 121
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTES---SHISTAPQGTPGYLDPQYHQY 500
HRDIK +NILL + K+ADFG+S +L T + S I GTP ++ P+
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAV 175
Query: 501 FHLSD---KSDVYSFGVVLIE 518
K D+++ G+ IE
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 86/287 (29%), Positives = 132/287 (45%), Gaps = 37/287 (12%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
LG GA+G VY A + A K + + ++ M EI +LS HPN++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 391 EEGEPILVYEFMPNGTLCQ-HLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
E + ++ EF G L L+ ERG P IR + + +A+ +LHS + HR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQ-IRY-VCRQMLEALNFLHSHK---VIHR 127
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD---- 505
D+K+ NILL + K+ADFG+S + T GTP ++ P+ D
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYD 186
Query: 506 -KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP--YLEPHR 562
K+D++S G+ LIE+ PH E+N + + +I + +P +P +
Sbjct: 187 YKADIWSLGITLIEL------AQMEPPHHELNPMRVLL-KILKS------EPPTLDQPSK 233
Query: 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609
W+ SS ++ L CL D RPT AE L+H VS + N
Sbjct: 234 --WS-SSFNDF--LK-SCLVKDPDDRPT---AAELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 30/163 (18%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPN 381
+ + ++G G YG VY A + VA+K+ R ++ I + EIKLL + HPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPI-TAIREIKLLQKLRHPN 59
Query: 382 LLRLLGCCIEEGEP--ILVYEFMP---NGTLCQHLQRERGSGLPWTIRIT------IATE 430
++RL +G+ +V+E+M G L ++ T +
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE-----------VKFTESQIKCYMKQ 108
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ + YLHS I HRDIK SNIL++ + K+ADFGL+R
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ G + VAIK + T S + + E +++ + H L++L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
EE PI +V E+M G+L L+ E G L + +A + A +AY+ MN HR
Sbjct: 72 EE--PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MN--YVHR 126
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQYHQYFHLSDK 506
D++++NIL+ N KVADFGL+RL + ++ + TA QG + P+ Y + K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL-IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 507 SDVYSFGVVLIEIITALKV 525
SDV+SFG++L E+ T +V
Sbjct: 184 SDVWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 54/193 (27%), Positives = 105/193 (54%), Gaps = 9/193 (4%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ + VA+K + + S++ + E ++ ++ H L++L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+E PI ++ EFM G+L L+ + GS P I + + A+ +A++ HR
Sbjct: 72 KE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLSDKSD 508
D++++NIL+ + K+ADFGL+R+ + ++ + + P + P+ + + KSD
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 509 VYSFGVVLIEIIT 521
V+SFG++L+EI+T
Sbjct: 186 VWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 1e-21
Identities = 50/151 (33%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR-YRDTDSI-DQVMNEIKLLSSVSHPNL 382
+ + +LG G YG VY + + VA+K+ R + + I + EI LL + HPN+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
++LL E + LV+E+ L ++L + G P I+ +I + + +AY HS
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-SIMYQLLRGLAYCHSHR 118
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
I HRD+K NIL++ + K+ADFGL+R
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 67/199 (33%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 335 GAYGTVY-AGKLHNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
GAYG V+ A K D AIK + D + +DQV+ E +LS P +++L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 391 EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTI-RITIATETAQAIAYLHSAMNPPIYHR 449
+ LV E++P G L GS L + RI IA E A+ YLHS I HR
Sbjct: 64 GKKNLYLVMEYLPGGD-LASLLENVGS-LDEDVARIYIA-EIVLALEYLHSN---GIIHR 117
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-------GTPGYLDPQYHQYFH 502
D+K NIL+D N K+ DFGLS++G+ + GTP Y+ P+
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 503 LSDKSDVYSFGVVLIEIIT 521
S D +S G +L E +
Sbjct: 178 HSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ G + + VA+K + T S + + E +++ + H L++L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
EE PI +V E+M G+L L+ G L + +A + A +AY+ MN HR
Sbjct: 72 EE--PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MN--YIHR 126
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQYHQYFHLSDK 506
D++S+NIL+ K+ADFGL+RL E + TA QG + P+ Y + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 507 SDVYSFGVVLIEIITALKV 525
SDV+SFG++L E++T +V
Sbjct: 184 SDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 43/211 (20%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFRYRDTDSIDQ-----VMNEIKLLSSVSHPNLLR- 384
LG G+YG+VY K +D+ A+K D S+ Q +NEI++L+SV+HPN++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEV---DLGSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 385 ----LLGC--CIEEGEPILVYEFMPNGTLCQHLQRERGSGLP------WTIRITIATETA 432
L G CI V E+ P G L + + + + W I I +
Sbjct: 65 KEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL-RGL 116
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTP 490
QA LH I HRD+KS+NILL N K+ D G+S++ + I GTP
Sbjct: 117 QA---LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTP 165
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
Y+ P+ + S KSD++S G +L E+ T
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 40/282 (14%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSID-------QVMNEIKLLSSVSHPNLLR 384
LG GAYGTVY G + +A+K+ DT ++ ++ E+ LL S+ H N+++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
LG C+++ + EF+P G++ L R LP + + +AYLH N
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLH---NN 121
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSR----LGMTES-SHISTAPQGTPGYLDPQYHQ 499
+ HRDIK +N++L N K+ DFG +R +G+ + S++ + GTP ++ P+
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 500 YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN-LAALAIDRIGRGCVDEIIDPYL 558
KSD++S G + E+ T P + ++ LAA+ RG + P L
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATG------KPPLASMDRLAAMFYIGAHRGLM-----PRL 230
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
A + CL + RP+ +++ L H
Sbjct: 231 PDSFSA-------AAIDFVTSCLTRDQHERPSALQL---LRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+LG G +G V+ G + VAIK + T + + E +++ + H L+ L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 391 EEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
EE PI +V EFM G+L L+ G L + +A + A +AY+ MN HR
Sbjct: 72 EE--PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MN--YIHR 126
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQYHQYFHLSDK 506
D++++NIL+ N K+ADFGL+RL + ++ + TA QG + P+ Y + K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL-IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 507 SDVYSFGVVLIEIITALKV 525
SDV+SFG++L E++T +V
Sbjct: 184 SDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 23/227 (10%)
Query: 329 KHRLGTGAYGTVYAGKLHN----DDW--VAIKRFR-YRDTDSIDQVMNEIKLLSSVSHPN 381
K LG GA+G V+ G+ ++ +D VA+K + D+ E +LL++ H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR----------ERGSGLPWTIR--ITIAT 429
+++ G C E PI+V+E+M +G L + L+ T+ + IA
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQG 488
+ A + YL S HRD+ + N L+ Y+ K+ DFG+SR + T+ +
Sbjct: 130 QIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 489 TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
++ P+ Y + +SDV+SFGVVL EI T K + + EV
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 332 LGTGAYGTVYAGKLHNDDW---VAIKRFRYRDTDS-----IDQVMNEIKLLSSVSHPNLL 383
LG GA+G VY ++ D +A+K+ + ++ + EI+LL ++ H ++
Sbjct: 10 LGQGAFGRVYL--CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
+ GC ++ + E+MP G++ L + G+ L T+ + + + YLHS M
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGA-LTETVTRKYTRQILEGVEYLHSNM- 124
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ--GTPGYLDPQY---H 498
I HRDIK +NIL D K+ DFG S+ T S + GTP ++ P+
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 499 QYFHLSDKSDVYSFGVVLIEIITA 522
Y K+DV+S G ++E++T
Sbjct: 183 GY---GRKADVWSVGCTVVEMLTE 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 23/164 (14%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMN--EIK 372
YK I+ +LG G +G+VY A + VAIK+ + + S ++ MN E+K
Sbjct: 1 YKVIK----------QLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVK 49
Query: 373 LLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGL--PWTIRITIAT 429
L + HPN+++L E E V+E+M G L Q L ++R IR +I
Sbjct: 50 SLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIR-SIIY 106
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ Q +A++H +HRD+K N+L+ K+ADFGL+R
Sbjct: 107 QILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 74/278 (26%), Positives = 124/278 (44%), Gaps = 32/278 (11%)
Query: 332 LGTGAYGTVYAG--KLHNDDW--VAIKRFRYRDTDSIDQ-VMNEIKLLSSVSHPNLLRLL 386
+G G +G VY G ++ VA+K + + S+ + + E ++ HP++++L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 387 GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
G E P+ +V E P G L +LQ + S L I + + + A+AYL S
Sbjct: 74 GVITEN--PVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLES-KR-- 127
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLS 504
HRDI + N+L+ K+ DFGLSR + + S+ + P ++ P+ + +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 505 DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564
SDV+ FGV + EI+ +++V I RI G + + P P
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENG--ERLPMPPNCPP--- 235
Query: 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
TL S L +C A+ RP E+ +L I
Sbjct: 236 -TLYS------LMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 332 LGTGAYGTVY------AGKLHNDDWVAIKRFRYRDTDS--IDQVMNEIKLLSSVSHPNLL 383
LG G G V GK+ +A+K R + + Q++ E+ +L + P ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKI-----MAVKTIR-LEINEAIQKQILRELDILHKCNSPYIV 62
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
G G+ + E+M G+L + L+ +G +P I IA + + YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
I HRD+K SNIL++ + K+ DFG+S + S ++ GT Y+ P+ Q
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNS--LAKTFVGTSSYMAPERIQGNDY 176
Query: 504 SDKSDVYSFGVVLIEIIT 521
S KSD++S G+ LIE+ T
Sbjct: 177 SVKSDIWSLGLSLIELAT 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 70/223 (31%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSS 376
E E E+ LG G YG VYA + L +AIK RD+ + + EI L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 377 VSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR-ITIATETAQ-- 433
+ H N+++ LG E G + E +P G+L L+ + G P TI T Q
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQIL 118
Query: 434 -AIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKVADFGLS-RLG----MTESSHISTAP 486
+ YLH + I HRDIK N+L++ Y+ K++DFG S RL TE+
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------ 169
Query: 487 QGTPGYLDPQYHQYFHLSDK--------SDVYSFGVVLIEIIT 521
GT Y+ P+ + DK +D++S G ++E+ T
Sbjct: 170 TGTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMAT 206
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 332 LGTGAYGTVYAGKL-HNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LGTG++G V + + + A+K ++ V+NE ++L S+ HP L+ L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ LV E++P G L HL++ P R A + A+ YLHS ++ I
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA-QVVLALEYLHS-LD--IV 123
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
+RD+K N+LLD + K+ DFG ++ T GTP YL P Y
Sbjct: 124 YRDLKPENLLLDSDGYIKITDFGFAKR---VKGRTYTL-CGTPEYLAPEIILSKGY---- 175
Query: 505 DKS-DVYSFGVVLIEII 520
K+ D ++ G+++ E++
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDW----VAIKRFR-----YRDTDSIDQVMNEIKLLSSVSHPNL 382
LG G +G+V G+L DD VA+K + Y + I++ ++E + HPN+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPNV 63
Query: 383 LRLLGCCIEEGE------PILVYEFMPNGTLCQHLQRERGSGLPWTIR----ITIATETA 432
++L+G C E P+++ FM +G L L R GLP + + + A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES----SHISTAP-- 486
+ YL N HRD+ + N +L + VADFGLS+ + I+ P
Sbjct: 124 LGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 487 -QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
D Y + KSDV++FGV + EI T
Sbjct: 181 WIAIESLADRVY------TSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 11/194 (5%)
Query: 332 LGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G++G V +L D+ A+K + D ++ M E ++L+ L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 388 CCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C + + + V E++ G L H+QR P A E + +LH I
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR--FYAAEIVLGLQFLHER---GI 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K N+LLD K+ADFG+ + G+ ST GTP Y+ P+ Y
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYGPA 176
Query: 507 SDVYSFGVVLIEII 520
D ++ GV+L E++
Sbjct: 177 VDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 71/254 (27%), Positives = 114/254 (44%), Gaps = 57/254 (22%)
Query: 320 EKATSFFSEKHRLGTGAYGTVYAGKLHN-----------DDW------VAIKRFRYRDTD 362
E + +LG G +G V+ + +D VA+K R +D
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 363 S--IDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR------- 413
+ D + E+K+LS +S PN+ RLLG C + ++ E+M NG L Q LQ+
Sbjct: 61 NAREDF-LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 414 --ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471
L ++ + +AT+ A + YL S +N HRD+ + N L+ NY K+ADFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLES-LN--FVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 472 SR-LGMTESSHISTAPQGTP----------GYLDPQYHQYFHLSDKSDVYSFGVVLIEII 520
SR L ++ + QG L ++ + KSDV++FGV L EI+
Sbjct: 177 SRNLYSSDYYRV----QGRAPLPIRWMAWESVLLGKF------TTKSDVWAFGVTLWEIL 226
Query: 521 TALKVVDFSRPHSE 534
T + +P+
Sbjct: 227 TLCR----EQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW------VAIKRFR-YRDTDSIDQVMNE 370
EI + F E+ LG GA+G VY G+L + VAIK + + + E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL--------------QRERG 416
+L+S + HPN++ LLG C +E +++E++ +G L + L
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 417 SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
S L + + IA + A + YL S HRD+ + N L+ K++DFGLSR
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 477 TESSHISTAPQGTP-GYLDPQYHQYFHLSDKSDVYSFGVVLIEI 519
+ + + P ++ P+ Y + +SD++SFGVVL EI
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 34/229 (14%)
Query: 332 LGTGAYGTVYAGKLHN--DDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSH---PNLLR 384
+G GAYG VY GK H VA+K DT D + E+ LLS + PN+ +
Sbjct: 9 IGRGAYGAVYRGK-HVPTGRVVALKIINL-DTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQR-----ERGSGLPWTIRITIATETAQAIAYLH 439
G ++ ++ E+ G++ + L + E+ + I E A+ Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-------IIREVLVALKYIH 118
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
+ HRDIK++NIL+ K+ DFG++ L SS ST GTP ++ P+
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVIT 174
Query: 500 YFHLSD-KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547
D K+D++S G+ + E+ T + P+S+V+ A A+ I +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG------NPPYSDVD-AFRAMMLIPK 216
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDW----VAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+LG G++G V G+ VA+K + + +D +D + E ++ S+ H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 386 LGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
G + P+ +V E P G+L L+++ + A + A + YL S
Sbjct: 62 YGVVLTH--PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTP-GYLDPQYHQYFH 502
HRD+ + NILL + + K+ DFGL R L E ++ P + P+ +
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 503 LSDKSDVYSFGVVLIEIIT 521
S SDV+ FGV L E+ T
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 60/306 (19%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSID--QV 367
Y+ +E +G G++GTV GK+ + K Y + + Q+
Sbjct: 2 YEVLET----------IGKGSFGTVRKVRRKSDGKI-----LVWKEIDYGNMTEKEKQQL 46
Query: 368 MNEIKLLSSVSHPNLLRLLGCCI-EEGEPI-LVYEFMPNG---TLCQHLQRERGSGLPWT 422
++E+ +L + HPN++R I + + +V E+ G L Q ++ER +
Sbjct: 47 VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEE 105
Query: 423 IRITIATETAQAIAYLH--SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480
I T+ A+ H S + HRD+K +NI LD N K+ DFGL+++ + S
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDS 164
Query: 481 HISTAPQGTPGYLDPQY--HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538
+ GTP Y+ P+ H + +KSD++S G ++ E+ S P + N
Sbjct: 165 SFAKTYVGTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYELCA------LSPPFTARNQL 216
Query: 539 ALAIDRIGRGCVDEIIDPYLEPHRDAWTLSS-IHNVAELAFRCLAFHRDMRPTMMEVAEE 597
LA +I G I P+R + L+ I + L D RP+ E+
Sbjct: 217 QLAS-KIKEGKFRRI------PYRYSSELNEVIKS-------MLNVDPDKRPSTEEL--- 259
Query: 598 LEHIRV 603
L+ +
Sbjct: 260 LQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 332 LGTGAYGTVYAGKLHND-DWVAIKR--FRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G G++G +Y K +D + IK + E+ LL+ + HPN++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERG------SGLPWTIRITIATETAQAIAYLHSAM 442
E G +V E+ G L + + R+RG L W ++I++ + ++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH--- 118
Query: 443 NPPIYHRDIKSSNILLDYNYR-SKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
+ I HRDIKS NI L N +K+ DFG++R + +S ++ GTP YL P+ Q
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
++K+D++S G VL E+ T
Sbjct: 178 PYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCC 389
+G G YG VY + VAIK + D +++ E +L S HPN+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 390 IEEGEPI------LVYEFMPNGT---LCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
I++ P LV E G+ L + L R++G L I ET + +AYLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-RKKGKRLKEEWIAYILRETLRGLAYLH- 130
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP----- 495
+ HRDIK NILL N K+ DFG+S + + GTP ++ P
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-LDSTLGRRNTFIGTPYWMAPEVIAC 187
Query: 496 -QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554
+ +SDV+S G ITA+++ D P +++ A+ +I R
Sbjct: 188 DEQPDA-SYDARSDVWSLG------ITAIELADGKPPLCDMH-PMRALFKIPRN-----P 234
Query: 555 DPYL-EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
P L P W+ ++E CL + + RP M E+ LEH
Sbjct: 235 PPTLKSPEN--WSKKFNDFISE----CLIKNYEQRPFMEEL---LEH 272
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 43/280 (15%)
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQV-MNEIKLLSSVSHPNLLRLLGC 388
+G G +G V G + + VA+K + D+ Q + E +++ + H NL++LLG
Sbjct: 12 QTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 389 CIEE-GEPILVYEFMPNGTLCQHLQRERG-SGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+EE G +V E+M G+L +L R RG S L + + + +A+ YL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
HRD+ + N+L+ + +KV+DFGL++ E+S + + P+ + S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 507 SDVYSFGVVLIEIITALKVVDFSR-PHSEVNLAALAIDRIGRG----CVDEIIDPYLEPH 561
SDV+SFG++L EI + F R P+ + L + + R+ +G D +
Sbjct: 180 SDVWSFGILLWEIYS------FGRVPYPRIPLKDV-VPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ W L + RP+ +++ E+LEHI
Sbjct: 233 KQCWHLDAA----------------TRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-19
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 61/306 (19%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNLLRLLGC 388
+G+GAYG V + VAIK+ D ID +++ EIKLL + H N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 389 CI-----EEGEPILVYEFMPNGT-LCQHLQRERGSGLPWTIRITIATETAQ---AIAYLH 439
+ + +V E M T L + ++ S P T I Q + YLH
Sbjct: 68 LRPPSPEDFNDVYIVTELME--TDLHKVIK----SPQPLTDDH-IQYFLYQILRGLKYLH 120
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG--TPGYLDP-- 495
SA N + HRD+K SNIL++ N K+ DFGL+R + + T Y P
Sbjct: 121 SA-N--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177
Query: 496 --QYHQYFHLSDKS-DVYSFGVVLIEIITALKVVDFSRP----HSEVNLAALAIDRIGRG 548
+Y K+ D++S G + E++T +P ++ L ++ +G
Sbjct: 178 LLSSSRY----TKAIDIWSVGCIFAELLT-------RKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 549 CVDEIIDP-------YLE--PHRDAWTLSSIH-NVAELA----FRCLAFHRDMRPTMMEV 594
+++ YL+ P + LS + + A + L F R T
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---A 283
Query: 595 AEELEH 600
E L H
Sbjct: 284 DEALAH 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 331 RLGTGAYGTVY-AGKLHNDDWVAIKR---FRYRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
++G G + VY A L + VA+K+ F D + + EI LL + HPN+++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQ--RERGSGLP----WTIRITIATETAQAIAYLHS 440
IE E +V E G L + ++ +++ +P W + + + A+ ++HS
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS----ALEHMHS 124
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ--GTPGYLDPQYH 498
I HRDIK +N+ + K+ D GL R SS + A GTP Y+ P+
Sbjct: 125 KR---IMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSPERI 178
Query: 499 QYFHLSDKSDVYSFGVVLIEI 519
+ KSD++S G +L E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 42/226 (18%)
Query: 335 GAYGTVYAGKLHNDDW-----VAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPNLLRLL 386
G +G ++ G L ++ V +K + D S QV + E LL +SH N+L +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVK--DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 387 GCCIEEGE-PILVYEFMPNGTLCQHLQ--RERGSGLPWTIR----ITIATETAQAIAYLH 439
CIE+GE P ++Y +M G L LQ R + P + + +A + A ++YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR---------LGMTESSHISTAPQGTP 490
+ H+DI + N ++D + K+ D LSR LG E+ +
Sbjct: 135 KR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------- 184
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
++ + S SDV+SFGV+L E++T + P+ E++
Sbjct: 185 -WMALESLVNKEYSSASDVWSFGVLLWELMTLGQT-----PYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 18/215 (8%)
Query: 325 FFSEKHRLGTGAYGTVYAGKLHNDD--WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
F +LG G+YG+VY +H + VAIK + + +++ EI +L P +
Sbjct: 4 VFDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYI 60
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
++ G + + +V E+ G++ + + L I +T + + YLHS
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHS-N 118
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQYHQYF 501
HRDIK+ NILL+ ++K+ADFG+S +L T + + GTP ++ P+ Q
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
++K+D++S G ITA+++ + P+S+++
Sbjct: 175 GYNNKADIWSLG------ITAIEMAEGKPPYSDIH 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 38/282 (13%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQ------VMNEIKLLSSVSHPNLLR 384
LGTGA+ + Y + + +A+K+ Y S +Q + EI+L++ ++HP+++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIA--TETAQAIAYLHSAM 442
+LG E+ L E+M G++ HL + G + + I + + ++YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSV-SHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 443 NPPIYHRDIKSSNILLDYN-YRSKVADFGLS-RLG--MTESSHISTAPQGTPGYLDPQYH 498
I HRD+K +N+L+D R ++ADFG + RL T + GT ++ P+
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
+ DV+S G V+IE+ TA K + HS N AL I +I I +L
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA-KPPWNAEKHS--NHLAL-IFKIASATTAPSIPEHL 236
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
P + ++ RCL + RP E+ L+H
Sbjct: 237 SP-----------GLRDVTLRCLELQPEDRPPSREL---LKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 332 LGTGAYGTVYAGKLHNDD-WVAIKRF----RYRDTDSIDQV-MNEIKLLSSVSHPNLLRL 385
LG G Y VY + VAIK+ R D I+ + EIKLL + HPN++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT------IATETAQAIAYLH 439
L + LV+EFM T + + +++ +I +T T + + YLH
Sbjct: 68 LDVFGHKSNINLVFEFME--TDLEKVIKDK------SIVLTPADIKSYMLMTLRGLEYLH 119
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
S I HRD+K +N+L+ + K+ADFGL+R
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 57/193 (29%), Positives = 85/193 (44%), Gaps = 11/193 (5%)
Query: 333 GTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
G GA+G V K A+K + S+ V+NE ++L ++HP L+ L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
+E LV + + G L HL + + ++ I E A+ YLHS I H
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWIC-EIVLALEYLHS-KG--IIH 123
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSD 508
RDIK NILLD + DF ++ ++T+ GTPGY+ P+ S D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181
Query: 509 VYSFGVVLIEIIT 521
+S GV E +
Sbjct: 182 WWSLGVTAYECLR 194
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 330 HRLGTGAYGTVYAG--KLHNDDW--VAIKRFRYRDTDSI-DQVMNEIKLLSSVSHPNLLR 384
LG G +G+V G + + VA+K + + + + E +++ + HP ++R
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 385 LLGCCIEEGEP-ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
L+G C +GEP +LV E P G L ++L++ R +P + +A + A +AYL S
Sbjct: 61 LIGVC--KGEPLMLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESKH- 115
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTP-GYLDPQYHQYF 501
HRD+ + N+LL +++K++DFG+SR LG + +T P + P+ Y
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
S KSDV+S+GV L E +
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 25/198 (12%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQV-MNEIKLLSSVSHPNLLRLLGCC 389
+G G +G V G+ + VA+K + D Q + E +++ + H NL+RLLG
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRI-TIATETAQAIAYLHSAMNPPIYH 448
+ G I V E M G L L R RG L I++ + + A+ + YL S + H
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGM--TESSHIS---TAPQGTPGYLDPQYHQYFHL 503
RD+ + NIL+ + +KV+DFGL+R+G ++S + TAP+ H+ F
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALK-------HKKF-- 174
Query: 504 SDKSDVYSFGVVLIEIIT 521
S KSDV+S+GV+L E+ +
Sbjct: 175 SSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 332 LGTGAYGTVYAGKL----HNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+G G +G V+ G L + VAIK + Y + D ++E ++ SH N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
G + +++ E+M NG L ++L+ G + + + + A + YL S MN
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL-SDMN-- 127
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTPGYLDPQYHQYFHL 503
HRD+ + NIL++ N KV+DFGLSR+ E ++ ++ + + P+ Y
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 504 SDKSDVYSFGVVLIEIIT 521
+ SDV+SFG+V+ E+++
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 41/301 (13%)
Query: 326 FSEKH-----RLGTGAYGTV----Y------AGKLHNDDWVAIKRFRYRDTDSIDQVMNE 370
F E+H +LG G +G+V Y G++ VA+K+ ++ + + E
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEV-----VAVKKLQHSTAEHLRDFERE 55
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEP--ILVYEFMPNGTLCQHLQRERG-----SGLPWTI 423
I++L S+ H N+++ G C G LV E++P G+L +LQ+ R L +
Sbjct: 56 IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS 115
Query: 424 RITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHI 482
+I E + Y+H RD+ + NIL++ R K+ DFGL++ L + +
Sbjct: 116 QICKGMEYLGSKRYVH---------RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK 166
Query: 483 STAPQGTPGY-LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALA 541
P +P + P+ S SDV+SFGVVL E+ T D S + +
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMG 223
Query: 542 IDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
D+ G+ V +I+ R + + C RP+ E+A ++E I
Sbjct: 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
Query: 602 R 602
R
Sbjct: 284 R 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 59/192 (30%), Positives = 83/192 (43%), Gaps = 15/192 (7%)
Query: 335 GAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMN----EIKLLSSVSHPNLLRLLGCC 389
GA+G+VY A K D+ AIK + D + +QV N ++ P + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+ LV E++ G C L + G GLP E + LH I HR
Sbjct: 67 QSKDYLYLVMEYLNGGD-CASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIHR 121
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
DIK N+L+D K+ DFGLSR G+ + GTP YL P+ SD
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGDDKMSDW 176
Query: 510 YSFGVVLIEIIT 521
+S G V+ E +
Sbjct: 177 WSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 35/210 (16%)
Query: 332 LGTGAYGTVYAG-KLHNDDWVAIK----------RFRYRDTDSIDQVMNEIKLLSSVSHP 380
+G G YG VY + + +A+K R R D + + +EI+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 381 NLLRLLGCCIEEGEPIL--VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
N+++ LG E E L E++P G++ L R G +R + + +AYL
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVR-FFTEQVLEGLAYL 124
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI-----STAPQGTPGYL 493
HS I HRD+K+ N+L+D + K++DFG+S+ +S I + + QG+ ++
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDNDQNMSMQGSVFWM 177
Query: 494 DPQ----YHQYFHLSDKSDVYSFGVVLIEI 519
P+ Y Q + S K D++S G V++E+
Sbjct: 178 APEVIHSYSQGY--SAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLGCCI 390
LG G +G V+ G L + VA+K + + + ++E ++L HPN+++L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 391 EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRD 450
+ +V E +P G L++++ L + A + A +AYL S HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 451 IKSSNILLDYNYRSKVADFGLSRL---GMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
+ + N L+ N K++DFG+SR G+ SS + P + P+ Y S +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP---IKWTAPEALNYGRYSSES 175
Query: 508 DVYSFGVVLIEIIT 521
DV+S+G++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPNLLRLLGC 388
LG GA+G VY K N + + + DT S +++ M EI +L+S HPN+++LL
Sbjct: 13 LGDGAFGKVY--KAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 389 CIEEGEPILVYEFMPNGTL-CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
E ++ EF G + L+ ER P IR+ + +T +A+ YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEP-QIRV-VCKQTLEALNYLHEN---KII 125
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD-- 505
HRD+K+ NIL + K+ADFG+S T + + GTP ++ P+ D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKN-TRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 506 ---KSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
K+DV+S G+ LIE+ PH E+N
Sbjct: 185 YDYKADVWSLGITLIEM------AQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 45/290 (15%)
Query: 332 LGTGAYGTVYAGKLHNDDW---VAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G +G+V G+L+ DD VA+K + ++ ++E + HPN++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 387 GCCIEEGE------PILVYEFMPNGTLCQHLQRERGSG----LPWTIRITIATETAQAIA 436
G C++ E P+++ FM +G L L R LP + + T+ A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
YL S HRD+ + N +L+ N VADFGLS+ + QG + +
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY----RQGRIAKMPVK 179
Query: 497 YHQYFHLSD-----KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551
+ L+D KSDV+SFGV + EI T + P+ V +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT-----PYPGVENS------------- 221
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
EI D + +R + + L C + RP+ + ELE
Sbjct: 222 EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 68/284 (23%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 332 LGTGAYGTVYAGKLHND--DWVAIK---------RFRYRDTD-SIDQVMNEIKLL-SSVS 378
LG+GA+G VY + N+ + +A+K R+ D SI +++E+ ++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ--RERGSGLP----WTIRITIATETA 432
HPN++R +E +V + + L +H +E+ W I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGY 492
A+ YLH I HRD+ +NI+L + + + DFGL++ ES S GT Y
Sbjct: 125 -ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILY 179
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552
P+ + +K+DV++FG +L ++ T P N+ +LA +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLAT---------K 224
Query: 553 IIDPYLEPHRDA-WTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595
I++ EP + ++ +V ++ CL + RP +++V+
Sbjct: 225 IVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 330 HRLGTGAYGTVYAG------KLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSV-SHP 380
LG GA+G V + VA+K + + D D V +E++++ + H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKHK 76
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG------LPWTIRITI------- 427
N++ LLG C +EG +V E+ +G L L+ R G P T+
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 428 -ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAP 486
A + A+ + +L S HRD+ + N+L+ ++ K+ADFGL+R + HI
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYR 189
Query: 487 QGTPGYLDPQYHQYFHLSDK-----SDVYSFGVVLIEIIT 521
+ T G L ++ L D+ SDV+SFGV+L EI T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 79/319 (24%), Positives = 135/319 (42%), Gaps = 81/319 (25%)
Query: 332 LGTGAYGTVYAGK------LHNDDWVAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPNLLR 384
LG G +G V VA+K + + S + +++E LL V+HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRER-------GSGL-------------PWTIR 424
L G C ++G +L+ E+ G+L L+ R GS T+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 425 --ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482
I+ A + ++ + YL + M + HRD+ + N+L+ + K++DFGLSR E S++
Sbjct: 128 DLISFAWQISRGMQYL-AEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 483 STAPQGTP-GYLDPQY---HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538
+ P ++ + H Y + +SDV+SFGV+L EI+T L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVT---------------LG 226
Query: 539 ALAIDRIGRGCVDEIIDPY--LEPHR------DAWTLSSIHNVAE----LAFRCLAFHRD 586
+PY + P R + + N +E L C D
Sbjct: 227 G---------------NPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPD 271
Query: 587 MRPTMMEVAEELEHIRVSS 605
RPT ++++ELE + V S
Sbjct: 272 KRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 26/229 (11%)
Query: 329 KHRLGTGAYGTVYAGKLHN----DD--WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
K LG GA+G V+ + +N D VA+K + + E +LL+++ H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 383 LRLLGCCIEEGEP-ILVYEFMPNGTLCQHLQ--------------RERGSGLPWTIRITI 427
++ G C + G+P I+V+E+M +G L + L+ R+ L + + I
Sbjct: 70 VKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAP 486
A++ A + YL S HRD+ + N L+ N K+ DFG+SR + T+ +
Sbjct: 129 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 487 QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
++ P+ Y + +SDV+SFGV+L EI T K F ++EV
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 17/196 (8%)
Query: 331 RLGTGAYGTVYAGKLHNDDW-VAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLL 386
R+G G +G V++G+L D+ VA+K R +T D + + E ++L SHPN++RL+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
G C ++ +V E + G L+ E G L I + A + YL S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP----GYLDPQYHQYFH 502
HRD+ + N L+ K++DFG+SR E + + G + P+ Y
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 503 LSDKSDVYSFGVVLIE 518
S +SDV+SFG++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLSSVSHPN 381
F++ +G G++G VY A + ++ VAIK+ Y S ++ ++ E++ L + HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+ GC + E LV E+ G+ L+ + L I Q +AYLHS
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH 134
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY---- 497
HRDIK+ NILL K+ADFG + L +S + GTP ++ P+
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 498 --HQYFHLSDKSDVYSFGVVLIEI 519
QY K DV+S G+ IE+
Sbjct: 187 DEGQY---DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 83/348 (23%), Positives = 136/348 (39%), Gaps = 44/348 (12%)
Query: 268 LIAGASIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYK-----EIEKA 322
++ A + L F RN L KR+ G + F+ K I
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE-NEDGTWELQFFDSKVSKSITINDI 688
Query: 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
S E++ + G G Y GK + + + D +SI +EI + + HPN+
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVK-EINDVNSIPS--SEIADMGKLQHPNI 745
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
++L+G C E L++E++ L + L L W R IA A+A+ +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRC 800
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
+P + ++ I++D + RL + T + Y+ P+ +
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKD 854
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562
+++KSD+Y FG++LIE++T D V+ +I R C Y + H
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPAD---AEFGVH---GSIVEWARYC-------YSDCHL 901
Query: 563 DAWTLSSIH-----------NVAELAFRCLAFHRDMRPTMMEVAEELE 599
D W SI V LA C A RP +V + LE
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 325 FFSEKHRLGTGAYGTVYAG-KLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNL 382
F++ R+G G++G VY G + VAIK + D I+ + EI +LS P +
Sbjct: 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
R G ++ + ++ E++ G+ L + L T TI E + + YLHS
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSER 121
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
HRDIK++N+LL K+ADFG++ +T++ GTP ++ P+ +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 503 LSDKSDVYSFGVVLIEI 519
K+D++S G+ IE+
Sbjct: 178 YDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 320 EKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLS 375
E F++ +G G++G VY A + ++ VAIK+ Y S ++ ++ E+K L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 376 SVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA-QA 434
+ HPN + GC + E LV E+ G+ L+ + + I T A Q
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQG 137
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
+AYLHS + HRDIK+ NILL + K+ADFG + + +S + GTP ++
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMA 189
Query: 495 PQY------HQYFHLSDKSDVYSFGVVLIEI 519
P+ QY K DV+S G+ IE+
Sbjct: 190 PEVILAMDEGQY---DGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDS---IDQVMNEIKLLSSVSHPN 381
F + ++G G YG VY + + VA+K+ R DT++ + EI LL ++HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPN 60
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+++LL E + LV+EF+ + L + + SG+P + + + Q +A+ HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTPGYLDPQY--- 497
+ HRD+K N+L++ K+ADFGL+R G+ ++ T T Y P+
Sbjct: 120 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 174
Query: 498 HQYFHLSDKSDVYSFGVVLIEIIT 521
+Y+ S D++S G + E++T
Sbjct: 175 CKYY--STAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 74/261 (28%), Positives = 123/261 (47%), Gaps = 34/261 (13%)
Query: 329 KHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
K LG GA+G V+ + +N VA+K + ++ E +LL+++ H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 383 LRLLGCCIEEGEP-ILVYEFMPNGTLCQHLQRERG------------SGLPWTIRITIAT 429
++ G C+E G+P I+V+E+M +G L + L R G + L + + IA
Sbjct: 70 VKFYGVCVE-GDPLIMVFEYMKHGDLNKFL-RAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQG 488
+ A + YL S HRD+ + N L+ N K+ DFG+SR + T+ +
Sbjct: 128 QIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 489 TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI--- 545
++ P+ Y + +SDV+S GVVL EI T K + ++EV + + R+
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IECITQGRVLQR 243
Query: 546 GRGCVDEIIDPYL-----EPH 561
R C E+ D L EPH
Sbjct: 244 PRTCPKEVYDLMLGCWQREPH 264
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 329 KHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
K LG GA+G V+ + HN VA+K + + E +LL+ + H ++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 383 LRLLGCCIEEGEP-ILVYEFMPNGTLCQHLQR--------ERGSGLP-----WTIRITIA 428
+R G C E G P ++V+E+M +G L + L+ G + + IA
Sbjct: 70 VRFYGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQ 487
++ A + YL S HRD+ + N L+ K+ DFG+SR + T+ +
Sbjct: 129 SQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ P+ Y + +SD++SFGVVL EI T
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 320 EKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLS 375
+ F H +G G++G VY A H ++ VA+K+ Y + ++ ++ E+K L
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 376 SVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA-QA 434
+ HPN + GC ++E LV E+ G+ L+ + + I T A Q
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQG 133
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
+AYLHS + HRDIK+ NILL + K+ADFG + +S + GTP ++
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMA 185
Query: 495 PQY------HQYFHLSDKSDVYSFGVVLIEI 519
P+ QY K DV+S G+ IE+
Sbjct: 186 PEVILAMDEGQY---DGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 61/234 (26%), Positives = 116/234 (49%), Gaps = 35/234 (14%)
Query: 332 LGTGAYGTVYAGKLH--NDDWVAIKRFRY---------RDTDSIDQVMNEIKLLSSVSHP 380
+G+G++G+VY G ++ + + +A+K+ R +D + EI LL + H
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
N+++ LG ++ + E++P G++ L G+ T+ + + + YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGA-FEETLVRNFVRQILKGLNYLH- 123
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAP-------QGTPGYL 493
N I HRDIK +NIL+D K++DFG+S+ E++ +ST QG+ ++
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWM 179
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL-AIDRIG 546
P+ + + K+D++S G +++E++T H + L AI +IG
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG--------KHPFPDCTQLQAIFKIG 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
++ ++G GA GTVY A + VAIK+ + + ++NEI ++ HPN++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQ---HLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
L + E +V E++ G+L + G + E QA+ +LHS
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN 134
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
+ HRDIKS NILL + K+ DFG E S ST GTP ++ P+
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRK 190
Query: 502 HLSDKSDVYSFGVVLIEII 520
K D++S G++ IE++
Sbjct: 191 AYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 332 LGTGAYGTVYA----GKLHNDD--WVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLL 383
LG GA+G V G +D VA+K + + + +M+E+K++S + +H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
LLG C G +++ E+ G L L+R+R S L ++ + + A+ +A+L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-- 160
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFH 502
HRD+ + N+LL + K+ DFGL+R M +S+++ P ++ P+
Sbjct: 161 -NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 503 LSDKSDVYSFGVVLIEIIT 521
+ +SDV+S+G++L EI +
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 46/232 (19%)
Query: 305 AAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVY------AGKLHNDDWVAIKR-FR 357
A+G++ E+E+ +R+G+GA GTVY G+L+ A+K +
Sbjct: 62 ASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLY-----ALKVIYG 109
Query: 358 YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL-CQHLQRERG 416
+ Q+ EI++L V+HPN+++ GE ++ EFM G+L H+ E+
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169
Query: 417 SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
+A + IAYLH I HRDIK SN+L++ K+ADFG+SR+ +
Sbjct: 170 LA-------DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI-L 218
Query: 477 TESSHISTAPQGTPGYLDPQ----------YHQYFHLSDKSDVYSFGVVLIE 518
++ + GT Y+ P+ Y Y D++S GV ++E
Sbjct: 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY-----AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 332 LGTGAYGTVYAGKL----HNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+G G +G V G+L + +VAIK + Y + D ++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
G + +++ EFM NG L L++ G + + + A + YL S MN
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGIAAGMKYL-SEMN-- 126
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRL---GMTESSHISTAPQGTP-GYLDPQYHQYF 501
HRD+ + NIL++ N KV+DFGLSR ++ ++ S+ P + P+ Y
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
+ SDV+S+G+V+ E+++
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQ-VMNEI 371
I K T F K LG+GA+GTVY G L + VAIK R + ++ +++E
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER---GSG--LPWTIRIT 426
+++SV +P++ RLLG C+ L+ + MP G L +++ + GS L W ++I
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI- 118
Query: 427 IATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTA 485
A+ + YL + HRD+ + N+L+ K+ DFGL++ LG E + +
Sbjct: 119 -----AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ ++ + + + +SDV+S+GV + E++T
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 331 RLGTGAYGTVY-AGKLHNDDWVAIKRFRYRD-TDSI-DQVMNEIKLLSSVSHPNLLRLLG 387
R+G GA+G V+ A + VA+K+ R I +Q + EIK L + HP +++LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT--IATETAQAIAYLHSAMNPP 445
+LV E+MP L + L+ E P + +AY+H+
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ--YHQYFHL 503
I HRD+K +N+L+ + K+ADFGL+RL E + + T Y P+ Y +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY- 178
Query: 504 SDKSDVYSFGVVLIEII 520
D+++ G + E++
Sbjct: 179 DPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 329 KHRLGTGAYGTVY---AGKL------------HNDDWVAIKRFRYRDTDSI-DQVMNEIK 372
K +LG G +G V+ A L VA+K R T + + + EIK
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL-QRE------RGSGLPWTIR- 424
++S + +PN++RLLG C+ + ++ E+M NG L Q L QRE + +P
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 425 --ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSH 481
+ +A + A + YL S +N HRD+ + N L+ +Y K+ADFG+SR L +
Sbjct: 130 NLLYMAVQIASGMKYLAS-LN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFS 529
I ++ + + SDV++FGV L E+ T K +S
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 332 LGTGAYG-TVYAGKLHNDDWVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+G G++G + +++D A+K R + + +++ E LL+ + HPN++
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+G +V E+ G L Q ++ +RG P + + + ++H + HR
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHR 124
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
DIKS NI L N + K+ DFG +RL + ++ T GTP Y+ P+ + ++KSD+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNNKSDI 183
Query: 510 YSFGVVLIEIIT 521
+S G +L E+ T
Sbjct: 184 WSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 325 FFSEKHRLGTGAYGTV--YAGKLHNDD---WVAIKRFRYRDTDSIDQV-MNEIKLLSSVS 378
+ + LG G +G V Y ND VA+K + EI +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 379 HPNLLRLLGCCIEEGEPI--LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
H N+++ GCC E+G L+ E++P G+L +L + + L + A + + +A
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMA 121
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG-TPGY-LD 494
YLHS HRD+ + N+LLD + K+ DFGL++ + G +P +
Sbjct: 122 YLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ + S SDV+SFGV L E++T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 32/274 (11%)
Query: 325 FFSEKHRLGTGAYGTVYAG-KLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNL 382
F++ ++G G++G V+ G VAIK + D I+ + EI +LS P +
Sbjct: 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ G +++ + ++ E++ G+ L E G L T TI E + + YLHS
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
HRDIK++N+LL + K+ADFG++ +T++ GTP ++ P+ +
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562
K+D++S G ITA+++ PHSE++ + +L P
Sbjct: 178 YDSKADIWSLG------ITAIELAKGEPPHSELHPMKVL---------------FLIPKN 216
Query: 563 DAWTLSSIHN--VAELAFRCLAFHRDMRPTMMEV 594
+ TL ++ + E CL RPT E+
Sbjct: 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 332 LGTGAYGTVYAGKLHNDDW-------VAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPNLL 383
LG+GA+G VY G + VA+K R TD + + E L+S+ +HPN++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 384 RLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRER-----GSGLPWTIRITIATETAQAIAY 437
+LLG C+ EP ++ E M G L +L+ R L + I + A+ Y
Sbjct: 63 KLLGVCLLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 438 LHSAMNPPIYHRDIKSSNILL---DYNYRS--KVADFGLSRLGMTESSHISTAPQG--TP 490
L HRD+ + N L+ Y+ K+ DFGL+R + +S + +G
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPV 177
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ P+ + +SDV+SFGV++ EI+T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDT----DSIDQVMNEIKLLS-SVSHPNLLRLL 386
LG G++G V +L + + +D D ++ M E ++LS + +HP L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 387 GCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITI-ATETAQAIAYLHSAMNP 444
CC + + + V EF+ G L H+Q+ R R A E A+ +LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEITSALMFLHDK--- 115
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
I +RD+K N+LLD+ K+ADFG+ + G+ ST GTP Y+ P+ Q
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYG 174
Query: 505 DKSDVYSFGVVLIEII 520
D ++ GV+L E++
Sbjct: 175 PSVDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 35/235 (14%)
Query: 329 KHRLGTGAYGTVY------AGKLHNDDW-----------VAIKRFRY-RDTDSIDQVMNE 370
K +LG G +G V+ K + D+ VA+K R + ++ + + E
Sbjct: 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLP---------W 421
IK++S + PN++RLL CI ++ E+M NG L Q L R +
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESS 480
+ I +AT+ A + YL S++N HRD+ + N L+ NY K+ADFG+SR L +
Sbjct: 130 STLIFMATQIASGMKYL-SSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
I ++ + + SDV++FGV L EI+T K +P+S++
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK----EQPYSQL 237
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 50/293 (17%)
Query: 332 LGTGAYGTVYAGKLH---NDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G G +G V G+ H + V +K R T D + E++ ++HPN+L+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERG--SGLPWT-IRITIATETAQAIAYLHSAMNP 444
CIE +LV EF P G L +L+ RG + + + +A E A + +LH A
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFH- 502
H D+ N L + K+ D+GL+ E +I+ P +L P+ +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 503 ------LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN----LAALAIDRIGRGCVDE 552
+ KS+++S GV + E+ TA +P+ +++ L + ++ D
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQ------DI 228
Query: 553 IID-PYLE-PHRDAWTLSSIHNVAELAFRCLAF---HRDMRPTMMEVAEELEH 600
+ P L+ + D W + + F + RPT EV E L +
Sbjct: 229 KLPKPQLDLKYSDRW------------YEVMQFCWLDPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 332 LGTGAYGTVYAGKLHNDDW---VAIKRFR-YRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G +G V ++ D AIKR + Y D E+++L + HPN++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETA 432
G C G L E+ P+G L L++ R S L + A + A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-G 491
+ + YL HRD+ + NIL+ NY +K+ADFGLSR + ++ P
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 188
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ + Y + SDV+S+GV+L EI++
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 332 LGTGAYGTVYAGKLH----NDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+G G +G V +G+L + VAIK + Y + D ++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTI--RITIATETAQAIAYLHSAMN 443
G + ++V E+M NG+L L++ G +T+ + + A + YL S M
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FTVIQLVGMLRGIASGMKYL-SDMG 126
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTPGYLDPQYHQYF 501
HRD+ + NIL++ N KV+DFGLSR+ E+++ + + + P+ Y
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
+ SDV+S+G+V+ E+++
Sbjct: 185 KFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 17/156 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYR-DTDSIDQVM-NEIKLLSSV---SHPNLLR 384
+G GAYGTVY + L+ +VA+K+ R + I EI LL + HPN++R
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 385 LLGCC----IEEGEPI-LVYEFMPNGTLCQHLQRERGSGL-PWTIRITIATETAQAIAYL 438
LL C + + LV+E + + L +L + GL P TI+ + + + + +L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFL 123
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474
HS I HRD+K NIL+ + + K+ADFGL+R+
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 332 LGTGAYGTVYAGKL-HNDDWVAIKRFRYRDT---DSIDQVMNEIKLL---SSVSHPNLLR 384
LG G +G V + + AIK + D D ++ +M E ++ +S HP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI-ATETAQAIAYLHSAMN 443
L C E V E+ G L H+ + S R A + YLH N
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVVLGLQYLHE--N 120
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
+Y RD+K N+LLD K+ADFGL + GM ST GTP +L P+ L
Sbjct: 121 KIVY-RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV-----L 173
Query: 504 SDKS-----DVYSFGVVLIEII 520
++ S D + GV++ E++
Sbjct: 174 TETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 36/209 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDWV----------AIKRFRYRDTDSID-QVMNEIKLLSSVSHP 380
LG+GA+GTVY G WV AIK + + M+E +++S+ HP
Sbjct: 15 LGSGAFGTVYKGI-----WVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 381 NLLRLLGCCIEEGEPI--LVYEFMPNGTLCQHLQRER---GSG--LPWTIRITIATETAQ 433
+L+RLLG C+ P LV + MP+G L ++ + GS L W ++I A+
Sbjct: 70 HLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GY 492
+ YL + HRD+ + N+L+ K+ DFGL+RL + + P +
Sbjct: 121 GMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ + Y + +SDV+S+GV + E++T
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 325 FFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLSSVSHP 380
FS+ +G G++G VY A + N + VAIK+ Y S ++ ++ E++ L + HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA-QAIAYLH 439
N ++ GC + E LV E+ G+ L+ + + I T A Q +AYLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH 132
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY-- 497
+ + HRD+K+ NILL K+ DFG + + + + GTP ++ P+
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 498 ----HQYFHLSDKSDVYSFGVVLIEI 519
QY K DV+S G+ IE+
Sbjct: 185 AMDEGQY---DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQV----MNE 370
Y+++EK +G G YG VY + + VA+K+ R D + V + E
Sbjct: 1 YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIRE 48
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE 430
I LL ++HPN++RLL E + LV+EF+ + L +++ +GL + + +
Sbjct: 49 ISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
Q IAY HS + HRD+K N+L+D K+ADFGL+R
Sbjct: 108 LLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 37/235 (15%)
Query: 332 LGTGAYGTVYA----GKLHNDDW--VAIKRFRYRDTDSIDQVMN---EIKLLSSVSHPNL 382
+G GA+G V+ G L + + VA+K + + S D + E L++ HPN+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHPNI 70
Query: 383 LRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQR--------------------ERGSGLPW 421
++LLG C G+P+ L++E+M G L + L+ L
Sbjct: 71 VKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481
T ++ IA + A +AYL HRD+ + N L+ N K+ADFGLSR + +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 482 ISTAPQGTP-GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
++ P ++ P+ Y + +SDV+++GVVL EI + + H EV
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 59/226 (26%)
Query: 332 LGTGAYGTVYAGKLHN------DDWVAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPNLLR 384
LG G++G VY G + VAIK + + +NE ++ + +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRER-------GSGLPWTIR-ITIATETAQAIA 436
LLG ++V E M G L +L+ R G G P + I +A E A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
YL + HRD+ + N ++ + K+ DFG++R D
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--------------------DIY 170
Query: 497 YHQYFH----------------LSD-----KSDVYSFGVVLIEIIT 521
Y+ L D KSDV+SFGVVL E+ T
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 332 LGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRL 385
LG+GA+GTVY G D VAIK R + + ++++E +++ V P + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERG-----SGLPWTIRITIATETAQAIAYLHS 440
LG C+ LV + MP G L +++ + L W ++I A+ ++YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---GYLDPQY 497
+ HRD+ + N+L+ K+ DFGL+RL + + P L+
Sbjct: 128 VR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 498 HQYFHLSDKSDVYSFGVVLIEIIT 521
H+ F + +SDV+S+GV + E++T
Sbjct: 185 HRRF--THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 14/194 (7%)
Query: 332 LGTGAYGTVYAGKLHNDDW--VAIKRF---RYRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
LGTG++G V N+D+ VAIKRF + +D V +E K+L+ ++HP + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
G +E LV EF+ G L+R + P + A + YL S +N I
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS-LN--I 152
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K N+LLD + K+ DFG +++ T + + GTP Y+ P+
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLNVGHGKA 208
Query: 507 SDVYSFGVVLIEII 520
+D ++ G+ + EI+
Sbjct: 209 ADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWV-AIKRFRYRDTDSI-DQVMNEIKLLSSVSHPNLL 383
E RLG GA G+V +L N + A+K + Q++ E+++ S P ++
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 384 RLLGCCIEEGEPIL--VYEFMPNGTLCQHLQ--RERGSGLPWTIRITIATETAQAIAYLH 439
+ G ++E + E+ G+L + ++RG + + IA + ++YLH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
S I HRDIK SNILL + K+ DFG+S G +S T GT Y+ P+ Q
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLAGTF-TGTSFYMAPERIQ 176
Query: 500 YFHLSDKSDVYSFGVVLIEI 519
S SDV+S G+ L+E+
Sbjct: 177 GKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 69/213 (32%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFR---YRDTDSIDQVMNEIK-LLSSVSHPNLLRLL 386
+G G++G V K D A+K + +M E LL +V HP L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ V +++ G L HLQRER P A E A A+ YLHS I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSL---NI 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY---HQYFHL 503
+RD+K NILLD + DFGL + G+ S ST GTP YL P+ Y
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPY--- 173
Query: 504 SDKS-DVYSFGVVLIEIITALKVVDFSRPHSEV 535
D++ D + G VL E++ L +SR +E+
Sbjct: 174 -DRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKR---FRYRDTDSIDQVMNEIKLLSSVS 378
+F EK ++G G + VY + VA+K+ F D + + EI LL ++
Sbjct: 2 ANFQIEK-KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ--RERGSGLPWTIRITIATETAQAIA 436
HPN+++ L IE+ E +V E G L Q ++ +++ +P + A+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
++HS + HRDIK +N+ + K+ D GL R ++++ + + GTP Y+ P+
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPE 176
Query: 497 YHQYFHLSDKSDVYSFGVVLIEI 519
+ KSD++S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
++ ++G GA GTV+ A + VAIK+ + + ++NEI ++ + +PN++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
L + E +V E++ G+L + + + + E QA+ +LH+
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ-- 135
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
+ HRDIKS N+LL + K+ DFG E S ST GTP ++ P+
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193
Query: 505 DKSDVYSFGVVLIEII 520
K D++S G++ IE++
Sbjct: 194 PKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 56/307 (18%)
Query: 332 LGTGAYGTVYAGKLHNDDW--------VAIKRFRYRDTDS-IDQVMNEIKLLSSV-SHPN 381
LG G +G V + D VA+K + T+ + +++E++++ + H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------ITI 427
++ LLG C ++G ++ E+ G L ++L+ R G+ + ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
A + A+ + YL S HRD+ + N+L+ + K+ADFGL+R + HI +
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 488 GTPGYLDPQYHQYFHLSDK-----SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
T G L ++ L D+ SDV+SFGV+L EI T P+ V
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL-----GGSPYPGVP------ 247
Query: 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
V+E+ E HR + + + + C RPT ++ E+L+ R
Sbjct: 248 -------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD--R 298
Query: 603 VSSWASN 609
+ + SN
Sbjct: 299 ILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 70/288 (24%), Positives = 130/288 (45%), Gaps = 58/288 (20%)
Query: 332 LGTGAYGTVYAGKLHNDDW----------VAIKRFRYRDT-DSIDQVMNEIKLLSSVSHP 380
LG+G +GTV+ G W VAIK + R + ++ + + + S+ H
Sbjct: 15 LGSGVFGTVHKGI-----WIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 381 NLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLP-----WTIRITIATETAQA 434
++RLLG C G + LV + P G+L H+++ R S P W ++I A+
Sbjct: 70 YIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKG 121
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP---- 490
+ YL + HR++ + NILL + ++ADFG++ L + + TP
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550
+ +Y H +SDV+S+GV + E+++ + P++ + + D + +G
Sbjct: 179 ALESILFGRYTH---QSDVWSYGVTVWEMMSY-----GAEPYAGMRPHEVP-DLLEKG-- 227
Query: 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
+ +P + +I +V + +C ++RPT E+A E
Sbjct: 228 ----ERLAQPQ-----ICTI-DVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 331 RLGTGAYGTVYAGKLHND------DWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
++G G++G K D + I + ++ + + E+ +LS++ HPN+++
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLP------WTIRITIATETAQAIAYL 438
E G +V ++ G L + + +RG P W ++I +A + ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHV 117
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
H + I HRDIKS NI L + K+ DFG++R+ + + ++ GTP YL P+
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEIC 173
Query: 499 QYFHLSDKSDVYSFGVVLIEIIT 521
+ ++KSD+++ G VL E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 324 SFFSEKHRLGTGAYGTVYAG-KLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPN 381
F+ +G G++G VY + VAIK + D I+ + EI+ LS P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+ + G ++ + ++ E+ G+ C L + L T I E + YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGS-CLDLLKP--GKLDETYIAFILREVLLGLEYLHE- 116
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQYHQY 500
I HRDIK++NILL K+ADFG+S +L T S + GTP ++ P+ +
Sbjct: 117 -EGKI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQ 172
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
+K+D++S G ITA+++ P S++
Sbjct: 173 SGYDEKADIWSLG------ITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
++ ++G GA GTVY A + VAIK+ + + ++NEI ++ +PN++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
L + E +V E++ G+L + + + + E QA+ +LHS
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ-- 135
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
+ HRDIKS NILL + K+ DFG E S ST GTP ++ P+
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193
Query: 505 DKSDVYSFGVVLIEII 520
K D++S G++ IE++
Sbjct: 194 PKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 19/197 (9%)
Query: 332 LGTGAYGTVYAGKLH---NDDWVAIKRFRYRDTDSI--DQVMNEIKLLSSVSHPNLLRLL 386
LG+G +GTV G ++ VA+K + + D D+++ E ++ + +P ++R++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 387 GCCIEEGEP-ILVYEFMPNGTLCQHLQRERGSGLPWTIR--ITIATETAQAIAYLHSAMN 443
G C E E +LV E G L + LQ+ + T + + + + + YL
Sbjct: 63 GIC--EAESWMLVMELAELGPLNKFLQKNKHV----TEKNITELVHQVSMGMKYLEET-- 114
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTP-GYLDPQYHQYF 501
HRD+ + N+LL + +K++DFGLS+ LG E+ + + P + P+ Y+
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 502 HLSDKSDVYSFGVVLIE 518
S KSDV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFRYRDT----DSIDQVMNEIKLLS-SVSHPNLLRL 385
LG G++G V +L D V AIK + +D D +D M E ++L+ + HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK-KDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
C + V E++ G L +QR R P + R A E A+ +LH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-RF-YAAEVTLALMFLHR--HGV 117
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
IY RD+K NILLD K+ADFG+ + G+ +T GTP Y+ P+ Q
Sbjct: 118 IY-RDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEYGP 175
Query: 506 KSDVYSFGVVLIEII 520
D ++ GV++ E++
Sbjct: 176 SVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 332 LGTGAYGTVYAGKLHNDDW---VAIKRFR-YRDTDSIDQVMNEIKLLSSVSH-PNLLRLL 386
+G G +G V ++ D AIKR + Y D E+++L + H PN++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQ------------RERGSGLPWTIR--ITIATETA 432
G C G L E+ P+G L L+ + + + + A + A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-G 491
+ + YL HRD+ + NIL+ NY +K+ADFGLSR + ++ P
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ + Y + SDV+S+GV+L EI++
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 65/197 (32%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 332 LGTGAYGTVYAGKLHNDD-WVAIKRFRYR---DTDSIDQVMNEIK-LLSSVSHPNLLRLL 386
+G G++G V K +D + A+K + + + +M E LL ++ HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ V +++ G L HLQRER P R A E A AI YLHS +N I
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-RARF-YAAEVASAIGYLHS-LN--I 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K NILLD + DFGL + G+ ST GTP YL P+ +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYDRT 176
Query: 507 SDVYSFGVVLIEIITAL 523
D + G VL E++ L
Sbjct: 177 VDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 325 FFSEKHRLGTGAYGTVYAG-KLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNL 382
F++ R+G G++G V+ G VAIK + D I+ + EI +LS P +
Sbjct: 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ G ++ + ++ E++ G+ L R T+ E + + YLHS
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
HRDIK++N+LL K+ADFG++ +T++ GTP ++ P+ Q
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 503 LSDKSDVYSFGVVLIEI 519
K+D++S G+ IE+
Sbjct: 178 YDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLSSVSHPNLLRLLG 387
+GTG +G V+ ++ + A+K + + Q V NE ++L VSHP ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ ++ E++P G L +L R G T A+E A+ YLHS I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLF-YASEIVCALEYLHSK---EIV 123
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
+RD+K NILLD K+ DFG ++ + + GTP YL P+ Q +
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAV 179
Query: 508 DVYSFGVVLIEII 520
D ++ G+++ E++
Sbjct: 180 DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 77/292 (26%), Positives = 140/292 (47%), Gaps = 53/292 (18%)
Query: 332 LGTGAYGTVYAG------KLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLSSVSHPNL 382
LG G++G VY G K + VA+K ++ S+ + +NE ++ + ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71
Query: 383 LRLLGCCIEEGEPILV-YEFMPNGTLCQHLQRER-------GSGLPWTIR--ITIATETA 432
+RLLG + +G+P LV E M +G L +L+ R G P T++ I +A E A
Sbjct: 72 VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP-TLQEMIQMAAEIA 129
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGY 492
+AYL++ HRD+ + N ++ +++ K+ DFG++R + E+ + +G G
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYR---KGGKGL 182
Query: 493 LDPQYHQYFHLSD-----KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547
L ++ L D SD++SFGVVL EI + + +P+ ++ + +
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQGLSNEQVLKFVMDG 237
Query: 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599
G +D+ P P R + ++ + C F+ MRPT +E+ L+
Sbjct: 238 GYLDQ---PDNCPER-------VTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKR---FRYRDTDSIDQVMNEIKLLSSVSHPN 381
F + ++G G + VY A L + VA+K+ F D + + EI LL ++HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQ---HLQRERGSGLPWTIRITIATETAQAIAYL 438
+++ IE+ E +V E G L + H ++++ +P + A+ ++
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSALEHM 122
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
HS + HRDIK +N+ + K+ D GL R + + + + GTP Y+ P+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPERI 178
Query: 499 QYFHLSDKSDVYSFGVVLIEI 519
+ KSD++S G +L E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 332 LGTGAYGTVYAGKLHNDDWV----AIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G+Y V +L +D + +K+ D + ID V E + S +P L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C LV E++ G L H+QR+R LP A E A+ +LH I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHER---GI 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K N+LLD + K+ D+G+ + G+ ST GTP Y+ P+ +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGFS 176
Query: 507 SDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
D ++ GV++ E++ D + ++N
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDS------IDQVMNEIKLLSSVSHPNLLR 384
LG GA+G VY + +A K+ ++ D +S + + EI+LL ++ H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQF-DPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 385 LLGCCIEEGEPILV--YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
GC + E L E+MP G++ L+ L ++ + + ++YLHS M
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM 126
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSR----LGMTESSHISTAPQGTPGYLDPQYH 498
I HRDIK +NIL D K+ DFG S+ + M+ + S GTP ++ P+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--GTPYWMSPEVI 181
Query: 499 QYFHLSDKSDVYSFGVVLIEIIT 521
K+DV+S G ++E++T
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 332 LGTGAYGTVYAGKLHND-DWVAIKRFRYRDTDSIDQ--VMNEIKLLSSVSHPNLLRLLGC 388
+G G+YG V + D IK+ R+ ++ E +LLS + HPN++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 389 CIEEGEPILVY---EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
EGE L+Y F G L L+ ++G LP + + A A+ YLH
Sbjct: 68 W--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--- 122
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
I HRD+K+ N+ L KV D G++R+ + ST GTP Y+ P+ +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNY 181
Query: 506 KSDVYSFGVVLIEIIT 521
KSDV++ G + E+ T
Sbjct: 182 KSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 332 LGTGAYGTVYAGKLHNDDWV----AIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G+Y V +L + IK+ D + ID V E + + S HP L+ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C E V EF+ G L H+QR+R LP + E + A+ +LH I
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GI 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P+ +
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILRGEDYGFS 176
Query: 507 SDVYSFGVVLIEIITALKVVDF--SRPHSEVN 536
D ++ GV++ E++ D + + N
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHND-DWVAIKRFRYRDTDS--IDQVMNEIK 372
Y+++EK +G G YGTV+ K + VA+KR R D D + EI
Sbjct: 2 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC 51
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
LL + H N++RL + + LV+E+ + L ++ G P ++ + +
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVK-SFMFQLL 109
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ +A+ HS + HRD+K N+L++ N K+ADFGL+R
Sbjct: 110 KGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSID----------QVMNEIKLLSSVS 378
+ RLG G++GTVY K D A+ R + I Q E +LLS +
Sbjct: 5 QQRLGKGSFGTVYLVK----DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG--------LPWTIRITIATE 430
HP +++ +E ++ E+ L L+ + +G W I++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG-- 118
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
+ Y+H I HRD+K+ NI L N K+ DFG+SRL M S ++T GTP
Sbjct: 119 ----VHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTP 169
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEI 519
Y+ P+ ++ KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
++ ++G GA GTVY A + VAI++ + + ++NEI ++ +PN++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
L + E +V E++ G+L + + + + E QA+ +LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
+ HRDIKS NILL + K+ DFG E S ST GTP ++ P+
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 194
Query: 505 DKSDVYSFGVVLIEII 520
K D++S G++ IE+I
Sbjct: 195 PKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 332 LGTGAYGTVYAGKLH--NDDWVAIKRFRYR-DTDSIDQVMNEIKL-LSSVSHPNLLRLLG 387
LG GAYG V + H +A+KR R ++ +++ ++ + + SV P + G
Sbjct: 9 LGRGAYGVVDKMR-HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQR---ERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
EG+ + E M T + ++G +P I IA +A+ YLHS ++
Sbjct: 68 ALFREGDVWICMEVM--DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS- 124
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLS-RL--GMTESSHISTAPQGTPGYLDPQYHQYF 501
+ HRD+K SN+L++ N + K+ DFG+S L + ++ P P ++P+ +Q
Sbjct: 125 -VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK- 182
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
KSDV+S G+ +IE+ T
Sbjct: 183 GYDVKSDVWSLGITMIELAT 202
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDS--IDQVMNEIKLLSSVSHPNL 382
+++ ++G G YG VY G+ VA+K+ R + + EI LL + HPN+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIAYLHSA 441
+ L ++E L++EF+ + L ++L +G + + + + Q I + HS
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ HRD+K N+L+D K+ADFGL+R
Sbjct: 121 R---VLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 332 LGTGAYGTVYAGKLHNDDWV----AIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G+Y V +L + + +K+ D + ID V E + S HP L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C E V E++ G L H+QR+R LP + E + A+ YLH I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GI 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P+ +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFS 176
Query: 507 SDVYSFGVVLIEIITALKVVD 527
D ++ GV++ E++ D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 20/197 (10%)
Query: 331 RLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
++G G+ G V A VA+K+ R + + NE+ ++ HPN++ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+ E +V EF+ G L + R + T+ +A+++LH+ + HR
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQ---GVIHR 139
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST-APQ-----GTPGYLDPQYHQYFHL 503
DIKS +ILL + R K++DFG + +S P+ GTP ++ P+
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGF-------CAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 504 SDKSDVYSFGVVLIEII 520
+ D++S G+++IE++
Sbjct: 193 GTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
F R+G+G YG VY A ++ + AIK + + V EI ++ H N++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
G + + + EF G+L Q + G L + ++ ET Q + YLHS
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGP-LSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQ------- 496
HRDIK +NILL N K+ADFG+S ++ T + S GTP ++ P+
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERK 183
Query: 497 --YHQYFHLSDKSDVYSFGVVLIEI 519
Y+Q D+++ G+ IE+
Sbjct: 184 GGYNQL------CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPN 381
F LGTG++G V K ++ AIK + R+ + V E +L +SHP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG-LPWTIRITIATETAQAIAYLHS 440
++ ++ +E + EF+ G L HL R +G P + E A YLHS
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
I +RD+K N+LLD KV DFG ++ + + + GTP YL P+ Q
Sbjct: 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC---GTPEYLAPEVIQS 189
Query: 501 FHLSDKSDVYSFGVVLIEII 520
D ++ GV+L E I
Sbjct: 190 KGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 332 LGTGAYGTVYAGKLHNDDW---VAIKRFR-YRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G +G V + D AIK + + + E+++L + HPN++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQ------------RERGSGLPWTIR--ITIATETA 432
G C G + E+ P G L L+ +E G+ T + + A++ A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-G 491
+ YL HRD+ + N+L+ N SK+ADFGLSR E ++ P
Sbjct: 130 TGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ + Y + KSDV+SFGV+L EI++
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT----DSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G++G V +L ++ A+K + +D D ++ M E ++L+ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALK-KDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 387 GCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITI-ATETAQAIAYLHSAMNP 444
C + E + V EF+ G L H+Q + L R T A E + +LHS
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL---YRATFYAAEIVCGLQFLHSKG-- 116
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
I +RD+K N++LD + K+ADFG+ + + + ST GTP Y+ P+ Q +
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYT 174
Query: 505 DKSDVYSFGVVLIEII 520
D +SFGV+L E++
Sbjct: 175 FSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 322 ATSFFSEKHRLGTGAYGTVYAGKLH-----NDDWVAIKRFR-YRDTDSIDQVMNEIKLLS 375
A F E LG A+G +Y G L+ + VAIK + + + E L++
Sbjct: 6 AVRFMEE---LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA 62
Query: 376 SVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL------------QRERG---SGLP 420
+ HPN++ LLG +E +++E++ G L + L E G S L
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 421 WTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480
+ IA + A + YL S H+D+ + NIL+ K++D GLSR +
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
Query: 481 HISTAPQGTP-GYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ P ++ P+ Y S SD++SFGVVL EI +
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 49/227 (21%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVMNEIKL 373
+K++EK LG G Y TVY G+ + VA+K + + + EI L
Sbjct: 2 FKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 374 LSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR------ERGSGLPWTIRITI 427
+ + H N++RL E + +LV+E+M + L++ RG+ P T++ +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMD-----KDLKKYMDTHGVRGALDPNTVK-SF 105
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGM---TESSHIS 483
+ + IA+ H + HRD+K N+L++ K+ADFGL+R G+ T S+ +
Sbjct: 106 TYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 484 T----APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITAL 523
T AP G+ Y S D++S G ++ E+IT
Sbjct: 163 TLWYRAPDVLLGSRTY-----------STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT----DSIDQVMNEIKLLS-SVSHPNLLRL 385
LG G++G V+ +L + + AIK + +D D ++ M E ++LS + HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 386 LGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITI-ATETAQAIAYLHSAMN 443
C + E + V E++ G L H+Q LP R T A E + +LHS
Sbjct: 62 Y-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP---RATFYAAEIICGLQFLHSK-- 115
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY---HQY 500
I +RD+K NILLD + K+ADFG+ + M + T GTP Y+ P+ +Y
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 501 FHLSDKSDVYSFGVVLIEII 520
D +SFGV+L E++
Sbjct: 174 NT---SVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/197 (32%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 332 LGTGAYGTVYAGKLHND-DWVAIKRFRYR---DTDSIDQVMNEIK-LLSSVSHPNLLRLL 386
+G G++G V K D A+K + + + +M E LL +V HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ V +F+ G L HLQRER P R A E A A+ YLHS I
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLHSI---NI 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K NILLD + DFGL + G+ +S +T GTP YL P+ + +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 507 SDVYSFGVVLIEIITAL 523
D + G VL E++ L
Sbjct: 177 VDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 38/180 (21%)
Query: 329 KHRLGTGAYGTVYAGKLHNDD-----------------WVAIKRFRYRDT-DSIDQVMNE 370
K +LG G +G V+ ++ N VA+K R ++ + + E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQ-----HLQRERGSGLP----- 420
+K+LS + PN++RLLG C++E ++ E+M NG L Q HL + +G
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 421 -------WTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
++ + +A + A + YL S++N HRD+ + N L+ N K+ADFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL-SSLN--FVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 332 LGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT----DSIDQVMNEIKLLS-SVSHPNLLRL 385
LG G++G V +L +++ AIK + +D D ++ M E ++L+ + HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK-KDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 386 LGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITI-ATETAQAIAYLHSAMN 443
C + E + V E++ G L H+Q SG R A E + +LH
Sbjct: 62 F-CTFQTKEHLFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK--K 115
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
IY RD+K N+LLD + K+ADFG+ + M ST GTP Y+ P+ +
Sbjct: 116 GIIY-RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKY 173
Query: 504 SDKSDVYSFGVVLIEII 520
++ D +SFGV+L E++
Sbjct: 174 NESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 332 LGTGAYGTVYAGKLH--NDDW------VAIKRFRYRDTDS-IDQVMNEIKLLSSVS-HPN 381
LG G +G V + + + VA+K + TD + +++E++L+ + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT--------------I 427
++ LLG C +EG ++ E+ G L + L+ R G +T IT
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
A + A+ + YL S HRD+ + N+L+ + K+ADFGL+R I +
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 488 GTPGYLDPQYHQYFHLSDK-----SDVYSFGVVLIEIIT 521
+ G L ++ L D+ SDV+SFG+++ EI T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 53/194 (27%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 332 LGTGAYGTVYAG--KLHNDDW-VAIKRFRYRDTDSI-DQVMNEIKLLSSVSHPNLLRLLG 387
LG+G +G V G K+ VAIK + + S+ D++M E +++ + +P ++R++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 388 CCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C E E + LV E G L + L ++ + + + + + + + YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTP-GYLDPQYHQYFHLS 504
HRD+ + N+LL + +K++DFGLS+ LG +S + + + P + P+ + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 505 DKSDVYSFGVVLIE 518
+SDV+S+G+ + E
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 330 HRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
R+G+G YG VY A LH + A+K + D + EI ++ H N++ G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
+ + + E+ G+L Q + G I + ET Q +AYLHS H
Sbjct: 75 YLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK---MH 129
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ------YFH 502
RDIK +NILL N K+ADFG++ +T + + GTP ++ P+ Y
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 503 LSDKSDVYSFGVVLIEI 519
L D+++ G+ IE+
Sbjct: 189 L---CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 332 LGTGAYGTVYAGKLHND--DWVAIKRFRYRDTDSIDQ--VMNEIKLLSSVSHPNLLRLLG 387
+G G+YG V K H + VAIK+F + D + + M EI++L + H NL+ L+
Sbjct: 9 VGEGSYGMVMKCK-HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ LV+EF+ + T+ L++ GL + + + I + HS I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHIST----APQGTPGYLDPQYHQ 499
HRDIK NIL+ + K+ DFG +R G + +++T AP+ G D +Y +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYGR 180
Query: 500 YFHLSDKSDVYSFGVVLIEIITA 522
D+++ G ++ E++T
Sbjct: 181 ------AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 332 LGTGAYGTVYAGKLHNDD--------WVAIKRFRYRDTDS-IDQVMNEIKLLSSVS-HPN 381
LG G +G V + D VA+K + T+ + +++E++++ + H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE----------- 430
++ LLG C ++G ++ E+ G L ++L+ R G+ ++ I +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 431 ---TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
A+ + YL S HRD+ + N+L+ N K+ADFGL+R + ++I +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKK 195
Query: 488 GTPGYLDPQYHQYFHLSDK-----SDVYSFGVVLIEIIT 521
T G L ++ L D+ SDV+SFGV++ EI T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 49/190 (25%), Positives = 91/190 (47%), Gaps = 16/190 (8%)
Query: 340 VYAGKLHNDDWVAIKRFRYRDTDS---IDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEP- 395
+Y G +N + V I+ F+ ID NEIK L + N+L++ G I+ +
Sbjct: 36 IYKGIFNNKE-VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 396 ---ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIK 452
L+ E+ G L + L +E+ L + ++ +A + + + L+ N P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 453 SSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYS 511
S + L+ NY+ K+ GL + L +++ + L+ + +Y + K D+YS
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY---TIKDDIYS 207
Query: 512 FGVVLIEIIT 521
GVVL EI T
Sbjct: 208 LGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 27/210 (12%)
Query: 332 LGTGAYGTVYAG------KLHNDDWVAIKRFRYRDTDSIDQ---VMNEIKLLSSVSHPNL 382
LG G++G VY G K + VAIK + S+ + +NE ++ + ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHV 71
Query: 383 LRLLGCCIEEGEPILV-YEFMPNGTLCQHLQRER-------GSGLPWTIR-ITIATETAQ 433
+RLLG + +G+P LV E M G L +L+ R P + I +A E A
Sbjct: 72 VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG--TPG 491
+AYL++ HRD+ + N ++ ++ K+ DFG++R + E+ + +G
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVR 186
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ P+ + + SDV+SFGVVL EI T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDS------IDQVMNEIKLLSSVSHPNLLR 384
LG GA+G VY +A+K+ + D DS ++ + EI+LL ++ H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPF-DPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 385 LLGCC--IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
GC EE + + E+MP G++ L+ T R T + Q ++YLHS M
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT--RQILQGVSYLHSNM 126
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT---ESSHISTAPQGTPGYLDPQYHQ 499
I HRDIK +NIL D K+ DFG S+ T + I + GTP ++ P+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPYWMSPEVIS 182
Query: 500 YFHLSDKSDVYSFGVVLIEIIT 521
K+DV+S ++E++T
Sbjct: 183 GEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 40/285 (14%)
Query: 332 LGTGAYGTVYAGKLHNDD------WVAIKRFRYRDTDSIDQVMN-EIKLLSSVSHPNLLR 384
LG G +G V+ K + V +K + +++ E+ + +SH N++R
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 385 LLGCCIEEGEP-ILVYEFMPNGTLCQHLQRERGSGLPWTI-------RITIATETAQAIA 436
LLG C E EP ++ E+ G L Q L+ + ++ + T+ A +
Sbjct: 73 LLGLC-REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
+L +A HRD+ + N L+ KV+ LS+ + +L P+
Sbjct: 132 HLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556
Q S KSDV+SFGV++ E+ T ++ P ++ DE +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGEL-----PFYGLS--------------DEEVLN 229
Query: 557 YLEPHRDAWTLSS--IHNVAELAFRCLAFHRDMRPTMMEVAEELE 599
L+ + + + +L RC A + RP+ E+ L
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 331 RLGTGAYGTVYAGKLHNDD---WVAIKRFRYRDTDSIDQ--VMNEIKLLSSVSHPNLLRL 385
++G G+YG V+ K N + VAIK+F + D + + + EI++L + HPNL+ L
Sbjct: 8 KIGEGSYGVVF--KCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
+ + + LV+E+ + T+ L++ G+P + I +T QA+ + H
Sbjct: 66 IEVFRRKRKLHLVFEYCDH-TVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKH---N 120
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHIST----APQGTPGYLDPQY 497
HRD+K NIL+ + K+ DFG +R+ G + +++T AP+ G D QY
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG--DTQY 178
Query: 498 HQYFHLSDKSDVYSFGVVLIEIIT 521
DV++ G V E++T
Sbjct: 179 ------GPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDT----DSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G++G V A + D+ AIK + +D D ++ M E ++L+ P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK-KDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 387 GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
C + + + V E++ G L H+Q+ P + A E A + +LHS
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP--HAVFYAAEIAIGLFFLHSK---G 121
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ---YHQYFH 502
I +RD+K N++LD K+ADFG+ + + T GTP Y+ P+ Y Y
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPY-- 178
Query: 503 LSDKS-DVYSFGVVLIEII 520
KS D ++FGV+L E++
Sbjct: 179 --GKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 72/299 (24%), Positives = 130/299 (43%), Gaps = 54/299 (18%)
Query: 332 LGTGAYGTVYAG--------KLHNDDWVAIKRFRYRDTDS-IDQVMNEIKLLSSV-SHPN 381
LG G +G V K + VA+K + TD + +++E++++ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------ITI 427
++ LLG C ++G ++ E+ G L ++L+ R G+ ++ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
A + A+ + YL S HRD+ + N+L+ + K+ADFGL+R + +I +
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKK 192
Query: 488 GTPGYLDPQYHQYFHLSDK-----SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
T G L ++ L D+ SDV+SFGV+L EI T P+ +
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL-----GGSPYPGIP------ 241
Query: 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
V+E+ E HR + H + + C RPT ++ E+L+ +
Sbjct: 242 -------VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 7/155 (4%)
Query: 365 DQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR 424
+Q++ E+++L + P ++ G +GE + E M G+L Q L+ + +P I
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEIL 105
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484
++ + +AYL I HRD+K SNIL++ K+ DFG+S G S ++
Sbjct: 106 GKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS-MAN 160
Query: 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEI 519
+ GT Y+ P+ Q H S +SD++S G+ L+E+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 78/291 (26%), Positives = 121/291 (41%), Gaps = 55/291 (18%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRY---RDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G G YG VY A + VA+K+ R ++ I + EIK+L ++H N++ L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHRNIVNLKE 73
Query: 388 CCIEEGEPI----------LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAY 437
++ + + LV+E+M + L L+ SGL I + Q +
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLE----SGLVHFSEDHIKSFMKQLLEG 128
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
L+ HRDIK SNILL+ + K+ADFGL+RL +E S T T Y P+
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 498 ----HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553
+Y DV+S G +L E+ T +P + N ++ I R C
Sbjct: 189 LLGEERY---GPAIDVWSCGCILGELFT-------KKPIFQANQELAQLELISRLCG--- 235
Query: 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM---EVAEELEHI 601
P W +V +L + F+ M+P + EE I
Sbjct: 236 -----SPCPAVWP-----DVIKLPY----FN-TMKPKKQYRRRLREEFSFI 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 332 LGTGAYGTV-----------YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP 380
LG G +G V YA K+ + + K D + + E ++L + HP
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAK-------DEVAHTLTESRVLKNTRHP 55
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L L + V E++ G L HL RER T R E A+ YLHS
Sbjct: 56 FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-RF-YGAEIVSALDYLHS 113
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
I +RD+K N++LD + K+ DFGL + G+T+++ + T GTP YL P+ +
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLED 169
Query: 501 FHLSDKSDVYSFGVVLIEII 520
D + GVV+ E++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 8/191 (4%)
Query: 331 RLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
++G G+ G V A + H VA+K+ R + + NE+ ++ H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+ E +V EF+ G L + R + T+ +A++YLH N + HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLH---NQGVIHR 142
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
DIKS +ILL + R K++DFG +++ + GTP ++ P+ + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 510 YSFGVVLIEII 520
+S G+++IE+I
Sbjct: 202 WSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDS------IDQVMNEIKLLSSVSHPNLLR 384
LG GA+G VY +A+K+ ++ D +S ++ + EI+LL ++ H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQF-DPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 385 LLGCCIEEGEPIL--VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
GC + E L E MP G++ L+ L + + + ++YLHS M
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM 126
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT--ESSHISTAPQGTPGYLDPQYHQY 500
I HRDIK +NIL D K+ DFG S+ T S + GTP ++ P+
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 501 FHLSDKSDVYSFGVVLIEIIT 521
K+D++S G ++E++T
Sbjct: 184 EGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/178 (28%), Positives = 74/178 (41%), Gaps = 44/178 (24%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDD--WVAIKRF---RYRDTDSIDQVMNE 370
Y+ + K LG G +G VY VA+K+ +D I + E
Sbjct: 10 YEILGK----------LGEGTFGEVYKA-RQIKTGRVVALKKILMHNEKDGFPI-TALRE 57
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPIL-----VYEFMPNGTLCQHLQRERGSGLPWTIRI 425
IK+L + HPN++ L+ +E + VY P + L SGL +
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDL-----SGLLENPSV 110
Query: 426 TIATETAQA----------IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ +Q I YLH I HRDIK++NIL+D K+ADFGL+R
Sbjct: 111 KL--TESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 26/161 (16%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY---RDTDSIDQVMNEIKLLSSVSHPN 381
F + +R+G G YG VY + + + VA+K+ R RD I + EI LL ++ HPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPN 67
Query: 382 LLRLLGCCI-EEGEPI-LVYEFMPNGTLCQHLQRERGSGL-----PWTIRIT--IATETA 432
++ L + + + I LV E+ C+ + S L P++ + +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEY------CEQ---DLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ + YLH I HRD+K SN+LL K+ADFGL+R
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 10/196 (5%)
Query: 332 LGTGAYGTVYAGKLHNDDWV----AIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G G++G V + + + I++ + + E +L+ V+ P ++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ LV F+ G L HLQRE G R A E A+ LH N +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTA-ELLCALENLHK-FN--VI 115
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
+RD+K NILLDY + DFGL +L M + +T GTP YL P+ +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAV 174
Query: 508 DVYSFGVVLIEIITAL 523
D ++ GV+L E++T L
Sbjct: 175 DWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V K+ + + A+K + R +T + + +E ++L +HP +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ ++ E+ G L L R+RG +T R IA A YLH+ IY
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIACVV-LAFEYLHN--RGIIY 116
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
RD+K N+LLD N K+ DFG ++ L + + GTP Y+ P+
Sbjct: 117 -RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGYDFS 172
Query: 507 SDVYSFGVVLIEIIT 521
D +S G++L E++T
Sbjct: 173 VDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSI--DQVMNEIKLLSSVSHPNLLRLLGCC 389
LG G G+V K V K+ + S Q++ E++++ P ++ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+ E + EFM G+L + ++ G +P I IA + + YL++ I HR
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIYKKGGP-IPVEILGKIAVAVVEGLTYLYNVHR--IMHR 128
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLSDK 506
DIK SNIL++ + K+ DFG+S G +S I+ GT Y+ P Q +Y + K
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS--GELINS-IADTFVGTSTYMSPERIQGGKY---TVK 182
Query: 507 SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
SDV+S G+ +IE+ FS + + I
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 332 LGTGAYGTVYAGKLHNDD--WVAIKRFRYRDTDSIDQ---VMNEIKLLSSVSHPNLLRLL 386
+G GA+GTV LH +A+KR R D +Q +M+ ++ S P +++
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 387 GCCIEEGEPILVYEFMPNG-TLCQHLQRERGSG-LPWTIRITIATETAQAIAYLHSAMNP 444
G EG+ + E M E +P I IA T +A+ YL +
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK- 128
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG-----TPGYLDPQYHQ 499
I HRD+K SNILLD N K+ DFG+S G S T G P +DP
Sbjct: 129 -IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERIDPSARD 185
Query: 500 YFHLSDKSDVYSFGVVLIEIIT 521
+ + +SDV+S G+ L E+ T
Sbjct: 186 GYDV--RSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 48/293 (16%)
Query: 332 LGTGAYGTVYAGKLHNDD----WVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLLR 384
LG G +G+V +L ++D VA+K + + +D I++ + E + HPN+++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIK 65
Query: 385 LLGCCIEEGE------PILVYEFMPNGTLCQHLQRERGSGLPWTIRITI----ATETAQA 434
L+G + P+++ FM +G L L R P+T+ + + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
+ YL S+ N HRD+ + N +L+ N VADFGLS+ + + QG L
Sbjct: 126 MEYL-SSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY----RQGCASKLP 178
Query: 495 PQYHQYFHLSD-----KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549
++ L+D SDV++FGV + EI+T + P++ V +
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT-----PYAGVENS----------- 222
Query: 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
EI + ++ +R + +V EL +C + RP+ + ++LE I
Sbjct: 223 --EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTD-----SIDQVMNEIKLLSSVSHPNLLRL 385
+G GAYGTVY A H+ +VA+K R + + S + + +K L + HPN++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 386 LGCCI-----EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
+ C E + LV+E + + L +L + GLP + + + + +LH+
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAP-QGTPGYLDPQYHQ 499
I HRD+K NIL+ + K+ADFGL+R+ S ++ P T Y P+
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVLL 180
Query: 500 YFHLSDKSDVYSFGVVLIEI 519
+ D++S G + E+
Sbjct: 181 QSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 325 FFSEKHRLGTGAYGTV----YAGKLHND-DWVAIKRFRYRDTDS-IDQVMNEIKLLSSVS 378
F LG G +G V Y + N + VA+K + + I + EI++L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 379 HPNLLRLLGCCIEEGEP--ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
H N+++ G C E+G L+ EF+P+G+L ++L R + + ++ A + + +
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMD 123
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGY-LD 494
YL S HRD+ + N+L++ ++ K+ DFGL++ T+ + + +P +
Sbjct: 124 YLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 495 PQ--YHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ F+++ SDV+SFGV L E++T
Sbjct: 181 PECLIQSKFYIA--SDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 331 RLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
++G G+ G V A + H+ VA+K R + + NE+ ++ H N++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+ E ++ EF+ G L + + R L T+ QA+ YLHS + HR
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQ---GVIHR 141
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST-APQ-----GTPGYLDPQYHQYFHL 503
DIKS +ILL + R K++DFG + IS P+ GTP ++ P+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGF-------CAQISKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 504 SDKSDVYSFGVVLIEII 520
+ D++S G+++IE++
Sbjct: 195 GTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 36/209 (17%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMN--EIKLLSSVS-HPNLLRL 385
++G G + V + + AIK + + S++QV N EI+ L +S HPN+LRL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 386 LGCCIEE--GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
+ + G LV+E M + L + ++ + ++ + + +++ ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVK-SYMYQLLKSLDHMHRN-- 119
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFG-----LSRLGMTESSHIST----APQG--TPGY 492
I+HRDIK NIL+ + K+ADFG S+ TE +IST AP+ T GY
Sbjct: 120 -GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--YISTRWYRAPECLLTDGY 175
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P K D+++ G V EI++
Sbjct: 176 YGP----------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 365 DQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR 424
+Q++ E+++L + P ++ G +GE + E M G+L Q L++ +P I
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQIL 105
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484
++ + + YL I HRD+K SNIL++ K+ DFG+S G S ++
Sbjct: 106 GKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS-MAN 160
Query: 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEI 519
+ GT Y+ P+ Q H S +SD++S G+ L+E+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 332 LGTGAYGTVYAGKLHNDD-WVAIKRFRYR---DTDSIDQVMNEIK-LLSSVSHPNLLRLL 386
+G G++G V + ++ + A+K + + +M+E LL +V HP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ V +++ G L HLQRER P R A E A A+ YLHS +N I
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-RARF-YAAEIASALGYLHS-LN--I 117
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K NILLD + DFGL + + + ST GTP YL P+
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYDRT 176
Query: 507 SDVYSFGVVLIEIITALKVVDFSRPHSEV 535
D + G VL E++ L +SR +E+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 332 LGTGAYGTV-YAGKLHNDDWVAIKRFRYRDT----DSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G++G V A + D+ AIK + +D D ++ M E ++L+ P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 387 GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
C + + + V E++ G L +Q+ P + A E A + +LHS
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAV--FYAAEIAIGLFFLHSK---G 121
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
I +RD+K N++LD K+ADFG+ + M + T GTP Y+ P+ Y
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPYGK 180
Query: 506 KSDVYSFGVVLIEII 520
D ++FGV+L E++
Sbjct: 181 SVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 24/200 (12%)
Query: 332 LGTGAYGTV-----------YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP 380
LG G +G V YA K+ + V I + D + + E ++L + HP
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKE-VIIAK------DEVAHTLTESRVLQNTRHP 55
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L L V E+ G L HL RER R A E A+ YLHS
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGA-EIVSALGYLHS 113
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
+ +RD+K N++LD + K+ DFGL + G+++ + + T GTP YL P+ +
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 169
Query: 501 FHLSDKSDVYSFGVVLIEII 520
D + GVV+ E++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 18/196 (9%)
Query: 331 RLGTGAYGTV------YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
++G G+ G V +GKL VA+K+ R + + NE+ ++ H N++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKL-----VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
+ + E +V EF+ G L + R + + +A++ LH+
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQ--- 135
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
+ HRDIKS +ILL ++ R K++DFG E + GTP ++ P+
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLPYG 194
Query: 505 DKSDVYSFGVVLIEII 520
+ D++S G+++IE++
Sbjct: 195 PEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 35/162 (21%)
Query: 329 KHRLGTGAYGTVY-AGKLHNDDWVAIKR----FRYRDTDSIDQVMNEIKLLSSVS-HPNL 382
+LG GAYG V+ A + VA+K+ FR TD+ + EI L + HPN+
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDA-QRTFREIMFLQELGDHPNI 69
Query: 383 LRLLGCC-IEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE------TAQ- 433
++LL E + I LV+E+M + L IR I + Q
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYME-------------TDLHAVIRANILEDVHKRYIMYQL 116
Query: 434 --AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
A+ Y+HS + HRD+K SNILL+ + R K+ADFGL+R
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVS 378
KA S+ + +LG G+Y TVY GK N VA+K R ++ + + E LL +
Sbjct: 3 KADSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 379 HPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAY 437
H N++ LL I E + LV+E++ + LCQ++ + G P +++ + + + ++Y
Sbjct: 62 HANIV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSY 118
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
+H I HRD+K N+L+ K+ADFGL+R + SH + T Y P
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 498 ----HQYFHLSDKSDVYSFGVVLIEIITAL 523
+Y S D++ G + +E+I +
Sbjct: 175 LLGSTEY---STCLDMWGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDT----DSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G++G V A + D+ AIK + +D D ++ M E ++L+ P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 387 GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
C + + + V E++ G L H+Q+ P + A E + + +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV--FYAAEISVGLFFLHRR---G 121
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
I +RD+K N++LD K+ADFG+ + M + T GTP Y+ P+ Y
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQPYGK 180
Query: 506 KSDVYSFGVVLIEII 520
D +++GV+L E++
Sbjct: 181 SVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 5e-12
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCI 390
+G G YG VY G+ +A + D +++ EI +L SH N+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 391 EEGEP------ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
++ P LV EF G++ ++ +G+ L I E + +++LH
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--- 130
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
+ HRDIK N+LL N K+ DFG+S +L T + GTP ++ P+
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDEN 188
Query: 504 SD-----KSDVYSFGVVLIEI 519
D KSD++S G+ IE+
Sbjct: 189 PDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 366 QVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTI-- 423
Q++ E+K+L + P ++ G +GE + E M G+L Q L++ +P I
Sbjct: 45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENILG 102
Query: 424 RITIATETAQAIAYL---HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480
+I+IA + + YL H M HRD+K SNIL++ K+ DFG+S G S
Sbjct: 103 KISIAV--LRGLTYLREKHKIM-----HRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS 153
Query: 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
++ + GT Y+ P+ Q H + +SD++S G+ L+E+
Sbjct: 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 28/194 (14%)
Query: 351 VAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLLRLL--GCCIEEGEPILVYEFMPNG 405
VAIK R + + E L + + HPN++ LL G G V+E++P
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64
Query: 406 TLCQHLQRERGSGLPWTIRITIATET----AQAIAYLHSAMNPPIYHRDIKSSNILL--- 458
TL + L + LP A ET Q + L A N I HRD+K NI++
Sbjct: 65 TLREVLAAD--GALP-------AGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 459 DYNYRSKVADFGLSRLGM-TESSHISTAPQ-----GTPGYLDPQYHQYFHLSDKSDVYSF 512
+KV DFG+ L + ++T + GTP Y P+ + ++ SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 513 GVVLIEIITALKVV 526
G++ +E +T +VV
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFRYRDT-DSIDQVMNEIKLLSSVSH--PNLLRLLG 387
+G+G G VY + V A+K+ R + +++ ++ ++ SH P +++ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYG 81
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL---HSAMNP 444
I + + + E M T L + +P I + +A+ YL H +
Sbjct: 82 YFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI-- 137
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
HRD+K SNILLD + K+ DFG+S G S T G Y+ P+ +
Sbjct: 138 ---HRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 505 DK----SDVYSFGVVLIEIITAL 523
K +DV+S G+ L+E+ T
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 63/306 (20%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQ-VMNEIKLLSSVSHPNLLRLLGC- 388
+G GAYG V + VAIK+ + + Q + EIK+L H N++ +L
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDII 72
Query: 389 ---CIEEGEPI-LVYEFMPNGTLCQHLQRERGSG------LPWTIRITIATETAQAIAYL 438
E + +V E M L + ++ + S L +R + Y+
Sbjct: 73 RPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR---------GLKYI 122
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS--TAPQGTPGYLDPQ 496
HSA + HRD+K SN+LL+ N K+ DFGL+R+ E H T T Y P+
Sbjct: 123 HSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 497 YHQYFHLSDKS-DVYSFGVVLIEIITALKVVDFSRP-------HSEVNLAALAIDRIGRG 548
K+ D++S G +L E+++ RP ++N L + +G
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSN-------RPLFPGKDYLHQLN---LILGVLGTP 229
Query: 549 CVDE---IIDP----YLE--PHRDAWTLSSI---HNVAELAF--RCLAFHRDMRPTMMEV 594
++ II Y++ P + + + + L + L F+ R T V
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---V 286
Query: 595 AEELEH 600
E L H
Sbjct: 287 EEALAH 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 332 LGTGAYGTVYAG-KLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G+GA G V A VAIK+ +++ + E+ L+ V+H N++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 389 -----CIEEGEPI-LVYEFMPNGTLCQHLQR----ERGSGLPWTIRITIATETAQAIAYL 438
+EE + + LV E M + LCQ +Q ER S L + + I +L
Sbjct: 84 FTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLY--------QMLCGIKHL 134
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGYLDPQY 497
HSA I HRD+K SNI++ + K+ DFGL+R T + P T Y P+
Sbjct: 135 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 188
Query: 498 HQYFHLSDKSDVYSFGVVLIEII 520
+ D++S G ++ E+I
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 332 LGTGAYGTVY---------AGKLHNDDWVAIKRFRYRDTDSIDQV--MNEIKLLSSVSHP 380
LG G++G V+ AG+L+ A+K + D+V E +L+ V+HP
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLY-----AMKVLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWT---IRITIATETAQAIAY 437
+++L EG+ L+ +F+ G L L +E + +T ++ +A E A A+ +
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLA-ELALALDH 113
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES-SHISTAPQ--GTPGYLD 494
LHS I +RD+K NILLD K+ DFGLS+ ES H A GT Y+
Sbjct: 114 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMA 166
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ + +D +SFGV++ E++T
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 16/155 (10%)
Query: 332 LGTGAYGTVYAGK-LHNDD-WVAIKRFRYRDTD-----SIDQVMNEIKLLSSVSHPNLLR 384
+G GAYG V+ + L N +VA+KR R + + S + + ++ L + HPN++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 385 LLGCCI-----EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
L C E + LV+E + + L +L + G+P + + + + +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474
S + HRD+K NIL+ + + K+ADFGL+R+
Sbjct: 128 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 33/206 (16%)
Query: 332 LGTGAYGTV---YAGKLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G+GAYG V + K VAIK+ ++ + E++LL + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK--VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 387 GC-----CIEEGEPI-LVYEFMP---NGTL-CQHLQRERGSGLPWTIRITIATETAQAIA 436
+E+ + + LV M N + CQ L + I+ + + + +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH-------IQF-LVYQILRGLK 132
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
Y+HSA I HRD+K SNI ++ + K+ DFGL+R T+ T T Y P+
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDE--MTGYVATRWYRAPE 185
Query: 497 -YHQYFHLSDKSDVYSFGVVLIEIIT 521
+ H + D++S G ++ E++T
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDW------VAIK--RFRYRDTDSIDQVMNEIKLLSSVSHPNLL 383
LG GA+G VY G D VA+K + D D + E ++S +H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSKFNHQNIV 72
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG-----SGLPWTIRITIATETAQAIAYL 438
RL+G E ++ E M G L L+ R S L + A + A+ YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 439 HSAMNPPIYHRDIKSSNILLDY---NYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLD 494
HRDI + N LL +K+ADFG++R S + P ++
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEI 519
P+ + K+DV+SFGV+L EI
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 26/201 (12%)
Query: 332 LGTGAYGTV-----------YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP 380
LG G +G V YA K+ + + K D + + E ++L + HP
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-------DEVAHTVTESRVLQNTRHP 55
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI-ATETAQAIAYLH 439
L L V E+ G L HL RER + R E A+ YLH
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH 112
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
S + +RDIK N++LD + K+ DFGL + G+++ + + T GTP YL P+ +
Sbjct: 113 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 500 YFHLSDKSDVYSFGVVLIEII 520
D + GVV+ E++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 13/197 (6%)
Query: 332 LGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG G +G V A GK++ + KR + R + + +NE K+L VS ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM--ALNEKKILEKVSSRFIVSL 58
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
+ + LV M G L H+ G P I A + + +LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRR 115
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
I +RD+K N+LLD + +++D GL+ + + I GTPGY+ P+ Q
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI-KGRAGTPGYMAPEVLQGEVYDF 173
Query: 506 KSDVYSFGVVLIEIITA 522
D ++ G L E+I
Sbjct: 174 SVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDS--IDQVMNEIKLLSSVSHPNLLRLLG 387
++G G YG VY + ++ +A+K+ R D + EI LL + H N++RL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
E LV+E++ + L +H+ + T + + IAY HS +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VL 124
Query: 448 HRDIKSSNILLDYNYRS-KVADFGLSR 473
HRD+K N+L+D + K+ADFGL+R
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 333 GTGAYGTVYAGKLHNDD---WVAIKRFR--YRDTDSIDQ-VMNEIKLLSSVSHPNLLRLL 386
G G YG VY K N AIK+F+ I Q EI LL + H N++ L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 387 GCCIE--EGEPILVYEFMPN--GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+E + L++++ + + + ++ + +P ++ ++ + + YLHS
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 443 NPPIYHRDIKSSNILL----DYNYRSKVADFGLSRL 474
+ HRD+K +NIL+ K+ D GL+RL
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLGCC 389
+G G YG VY G+ + AIK + D +++ EI +L SH N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 390 IEEGEP------ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
I++ P LV EF G++ ++ +G+ L I E + +A+LH+
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
+ HRDIK N+LL N K+ DFG+S +L T + GTP ++ P+
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDE 197
Query: 503 LSD-----KSDVYSFGVVLIEI 519
D +SD++S G+ IE+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 332 LGTGAYGTV-----------YAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP 380
LG G +G V YA K+ + + K D + + E ++L + HP
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHP 55
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L L V E+ G L HL RER R A E A+ YLHS
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSALDYLHS 113
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
N + +RD+K N++LD + K+ DFGL + G+ + + + T GTP YL P+ +
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 170
Query: 501 FHLSDKSDVYSFGVVLIEII 520
D + GVV+ E++
Sbjct: 171 NDYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 19/202 (9%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
F E + A G +YA K+ +K+ +++ E +LS + P + +L
Sbjct: 14 FGEVQVVREKATGDIYAMKV-------MKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
++ LV E+ P G L L R + +A E AI +H M
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQ-MG-- 122
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI-STAPQGTPGYLDPQYHQYFHLS 504
HRDIK N+L+D K+ADFG S +T + + S P GTP Y+ P+ +
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 505 DKS------DVYSFGVVLIEII 520
K D +S GV+ E+I
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 70/272 (25%), Positives = 105/272 (38%), Gaps = 59/272 (21%)
Query: 331 RLGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G GA+G V+ A+K R D + I V E +L+ P +++L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 387 GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
++ E + LV E+MP G L L R + T R IA E A+ +H +
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIA-ELVLALDSVHK-LG-- 121
Query: 446 IY-HRDIKSSNILLDYNYRSKVADFGLS--------RLGMTESSHISTAPQ--------- 487
+ HRDIK NIL+D + K+ADFGL R SH
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 488 -----------GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEII-------------TAL 523
GTP Y+ P+ + + D +S GV+L E++ T
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240
Query: 524 KVV----DFSRPHSEVNLAALAIDRIGRGCVD 551
K++ P + ++ AID I R D
Sbjct: 241 KIINWKESLRFPP-DPPVSPEAIDLICRLLCD 271
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDWV--AIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
LG G YG+VY LH V A+K R D +Q++ E+ +L P ++ G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 389 CIEEGEPILVYEFMPNGTLCQ-HLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
EG + E+M G+L + + G+P + I + + +L N I
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD-- 505
HRD+K +N+L++ N + K+ DFG+S G +S ++ G Y+ P+ + +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS--GNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 506 ----KSDVYSFGVVLIEI 519
+SDV+S G+ ++E+
Sbjct: 183 TYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSH 379
ATS+ + + +LG G+Y TVY G N VA+K + + + + E LL + H
Sbjct: 4 ATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 380 PNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
N++ LL I E + V+E+M + L Q++ + G P+ +R+ + + + +AY+
Sbjct: 63 ANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYI 119
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHIST----APQGTP 490
H I HRD+K N+L+ Y K+ADFGL+R T SS + T P
Sbjct: 120 HGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEII 520
G D S D++ G + IE++
Sbjct: 177 GATD--------YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 332 LGTGAYGTVY---------AGKLHNDDWVAIKRFR----YRDTDSIDQVMNEIKLLSSV- 377
LGTGAYG V+ AGKL+ A+K + + + + E ++L +V
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLY-----AMKVLKKATIVQKAKTAEHTRTERQVLEAVR 62
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIA 436
P L+ L + + L+ +++ G L HL QRE + +R+ IA E A+
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLALD 119
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
+LH I +RDIK NILLD + DFGLS+ + E + + GT Y+ P+
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 497 Y-------HQYFHLSDKSDVYSFGVVLIEIIT 521
H D +S GV+ E++T
Sbjct: 177 VIRGGSGGH-----DKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 28/223 (12%)
Query: 347 NDDWVAIKRF--RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404
+ VA+K+ + + + EI + HPN+L + I + E +V M
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464
G+ L+ GLP I + A+ Y+HS HR +K+S+ILL + +
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKV 140
Query: 465 KVADFGLSRLGMTES------------SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSF 512
++ S M + S + P +P L Y ++KSD+YS
Sbjct: 141 VLSGLRYSV-SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY---NEKSDIYSV 196
Query: 513 GVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555
G ITA ++ + P ++ + ++++ RG V ++D
Sbjct: 197 G------ITACELANGHVPFKDMPATQMLLEKV-RGTVPCLLD 232
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYR-DTDSI-DQVMNEIK 372
Y+++EK +G G YG VY A + VA+K+ R D + I + EI
Sbjct: 3 YEKLEK----------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREIS 52
Query: 373 LLSSVSH-PNLLRLLGCCIE-----EGEPIL--VYEFMPNGTLCQHLQRERGS---GLPW 421
LL +S ++RLL +E G+P L V+E++ + L + + LP
Sbjct: 53 LLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPA 109
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSR 473
+ + + +A+ H + HRD+K N+L+D K+AD GL R
Sbjct: 110 KTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 68/241 (28%), Positives = 109/241 (45%), Gaps = 24/241 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDD---WVAIKRFR----YRDTDSIDQVMNEIKLLSSVSHPNLL 383
LG G YG V+ K+ D A+K + R+ E +L +V HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
L+ G+ L+ E++ G L HL+RE G + T ++ E + A+ +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLS-EISLALEHLHQQ-- 119
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
I +RD+K NILLD K+ DFGL + + E + T GT Y+ P+
Sbjct: 120 -GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRSGH 177
Query: 504 SDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH-R 562
D +S G ++ +++T + P + N ID+I +G + + PYL P R
Sbjct: 178 GKAVDWWSLGALMYDMLTG------APPFTAENRKK-TIDKILKGKL--NLPPYLTPEAR 228
Query: 563 D 563
D
Sbjct: 229 D 229
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 332 LGTGAYGTVYAGKLH----NDDWVAIKRFRYRDTDSIDQ-VMNEIKLLSSVSHPNLLRLL 386
LGTG +G + G L + VAI R +D + + E L H N++RL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
G ++V E+M NG L L++ G L + + A + YL S M
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL-SEMG--Y 128
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL--DPQYHQYFHLS 504
H+ + + +L++ + K++ F RL +S I T G L P+ QY H S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 505 DKSDVYSFGVVLIEIIT 521
SDV+SFG+V+ E+++
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 44/197 (22%)
Query: 314 YPYKEIEKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTD---SIDQVMN 369
+P+ + S + + ++G G +G V+ A VA+K+ + I +
Sbjct: 5 FPFCDE---VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPI-TALR 60
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEP--------ILVYEFMPNGTLCQH-LQRERGSGLP 420
EIK+L + H N++ L+ C + P LV+EF C+H L +GL
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF------CEHDL-----AGLL 109
Query: 421 WTIRITIATETAQAIA--------YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472
+ + + Y+H I HRD+K++NIL+ + K+ADFGL+
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166
Query: 473 RLGMTESSHISTAPQGT 489
R + +S +
Sbjct: 167 R-----AFSLSKNSKPN 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 14/190 (7%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLGCC 389
LG G GTVY A L +A+K T + Q+M+E+++L P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
E + EFM G+L + + +P + IA + + YL S I HR
Sbjct: 69 FVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVAVVKGLTYLWSL---KILHR 119
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
D+K SN+L++ + K+ DFG+S + S I+ GT Y+ P+ SDV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVST-QLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 510 YSFGVVLIEI 519
+S G+ +E+
Sbjct: 177 WSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 331 RLGTGAYGTVY-AGKLHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLL 386
++G G YG V+ A K + VA+KR + + + V+ E +L++ L++LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 387 GCCIEEGEPILVYEFMPNG---TLCQHLQ--RERGSGLPWTIRITIATETAQAIAYLHSA 441
++ L E++P G TL +L E + R +A E +A+ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA------RFYMA-EMFEAVDALHEL 120
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
HRD+K N L+D + K+ DFGLS+ +T ++ + G+P Y+ P+ +
Sbjct: 121 ---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGK 173
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
D +S G +L E +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 332 LGTGAYGTVYAGKLHND--DWVAIKRFRYRDTDSIDQV----MNEIKLLSSVSHPNLLRL 385
+G GAYG V + H + + VAIK+F+ D++ ++V + E+K+L ++ N++ L
Sbjct: 9 VGEGAYGVVLKCR-HKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
G+ LV+E++ L + L+ P +R I Q I +H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKND 120
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS-TAPQGTPGYLDPQYHQYFHLS 504
I HRDIK N+L+ +N K+ DFG +R ++E S+ + T T Y P+
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 505 DKSDVYSFGVVLIEI 519
D++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 332 LGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG G +G V A GKL+ + KR + R + M E ++L+ V H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK--GYEGAMVEKRILAKV-HSRFIVS 57
Query: 386 LGCCIE-EGEPILVYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATETAQAIAYLHSAM 442
L + + + LV M G L H+ E G P + + +LH
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
I +RD+K N+LLD + +++D GL+ + + + + GTPG++ P+ Q
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 503 LSDKSDVYSFGVVLIEIITA 522
D ++ GV L E+I A
Sbjct: 174 YDFSVDYFALGVTLYEMIAA 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 27/160 (16%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKR--------FRYRDTDSIDQV------MNEIKLLSS 376
LG G YG V A VAIK+ +D + + E+K+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 377 VSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA---Q 433
+ H N++ L+ +E LV + M L + + R+ IR+T + Q
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ L+ HRD+ +NI ++ K+ADFGL+R
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 1/90 (1%)
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL-GMTESSHISTAPQGTPG 491
Q + +H + + HRDIKS+NILL N K+ DFG S++ T S + GTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
Y+ P+ + S K+D++S GV+L E++T
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 335 GAYGTVYAGKLHND--DWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
GAYG VY + H + A+K+ ++ + I QV E +L+ +P ++ + C
Sbjct: 12 GAYGAVYLVR-HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CS 69
Query: 390 IEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPW-TIRITIATETAQAIAYLHSAMNPPIY 447
E + +V E++ G C L + G+ LP R+ A ET A+ YLH N I
Sbjct: 70 FETKRHLCMVMEYVEGGD-CATLLKNIGA-LPVDMARMYFA-ETVLALEYLH---NYGIV 123
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESS------HISTAPQ--------GTPGYL 493
HRD+K N+L+ K+ DFGLS++G+ + HI + GTP Y+
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEII 520
P+ D ++ G++L E +
Sbjct: 184 APEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 54/176 (30%), Positives = 78/176 (44%), Gaps = 50/176 (28%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNLLRLLGC 388
+G GAYG V + K ++ VAIK+ + ID + + EIKLL + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 389 ----CIEEGEPI-LVYEFM---------PNGTL----CQHL--QRERGSGLPWTIRITIA 428
E + +VYE M + TL CQ+ Q RG
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG------------ 120
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG------MTE 478
+ Y+HSA + HRD+K SN+LL+ N K+ DFGL+R MTE
Sbjct: 121 ------LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSH 379
T+ + + +G GA+G V + + VAIK+ + + E+KLL + H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 380 PNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
N++ L I E I V E + GT L R L + + + Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYV 124
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
HSA + HRD+K SNIL++ N K+ DFGL+R+ PQ T GY+ +Y+
Sbjct: 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLARI---------QDPQMT-GYVSTRYY 171
Query: 499 Q-------YFHLSDKSDVYSFGVVLIEII 520
+ + + D++S G + E++
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 31/204 (15%)
Query: 332 LGTGAYGTV---YAGKLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G+GA G V Y L D VAIK+ +++ + E+ L+ V+H N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 387 GC-----CIEEGEPI-LVYEFMPNGTLCQHLQ----RERGSGLPWTIRITIATETAQAIA 436
+EE + + LV E M + LCQ +Q ER S L + + I
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIK 133
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
+LHSA I HRD+K SNI++ + K+ DFGL+R T S + T T Y P+
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPE 188
Query: 497 YHQYFHLSDKSDVYSFGVVLIEII 520
+ D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
L+S VSH +L + G C+ E I+V EF+ +G L L++E+G +P +IT+A + A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAWKITVAQQLA 127
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-------KVADFGLSRLGMTESSHISTA 485
A++YL + + H ++ + NILL + K++D G+S ++ +
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI 184
Query: 486 PQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEI 519
P ++ P+ LS +D +SFG L+EI
Sbjct: 185 P-----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 32/159 (20%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDS---IDQVMNEIKLLSSVSHPNLLRLL 386
R+ G YG VY + + VA+K+ + I + EI +L + HPN++
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVT-- 68
Query: 387 GCCIEE---GEPI----LVYEFMPNGTLCQH-----LQRERGSGLPWTIRITIATETAQA 434
++E G + +V E++ +H ++ + L ++ + +
Sbjct: 69 ---VKEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVK-CLMLQLLSG 118
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+A+LH I HRD+K+SN+LL+ K+ DFGL+R
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCI 390
+G G YG VY D +A + +D +++ E +L S+ HPN+++ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 391 EE-----GEPILVYEFMPNGTLCQHLQ--RERGSGLPWTIRITIATETAQAIAYLHSAMN 443
+ G+ LV E G++ + ++ G L + I + +LH N
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---N 146
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY----HQ 499
I HRD+K +NILL K+ DFG+S +T + GTP ++ P+ Q
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTPFWMAPEVIACEQQ 205
Query: 500 YFHLSD-KSDVYSFGVVLIEI 519
Y + D + DV+S G+ IE+
Sbjct: 206 YDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 314 YPYKEIEKATSFFSEKHR----LGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDS---ID 365
Y +E+ K +++R +G+GAYGTV A VAIK+ YR S
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAK 59
Query: 366 QVMNEIKLLSSVSHPNLLRLLGCCIEE------GEPILVYEFMPN--GTLCQH--LQRER 415
+ E++LL + H N++ LL + + LV FM G L +H L +R
Sbjct: 60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR 119
Query: 416 GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475
L + + + + Y+H+A I HRD+K N+ ++ + K+ DFGL+R
Sbjct: 120 IQFLVYQM--------LKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQT 168
Query: 476 MTESSHISTAPQGTPGYLDPQY-HQYFHLSDKSDVYSFGVVLIEIIT 521
+E T T Y P+ + H + D++S G ++ E++T
Sbjct: 169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 332 LGTGAYGTVYAGKLHND---DWVAIKRFRYRDTDSIDQV--MNEIKLLSSVSHPNLLRLL 386
+G G +G V G++++ V +K R +Q+ + E + S+ H NLL+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGL----PWTIRITIATETAQAIAYLHSAM 442
G C E +LV EF P G L +L+ R + L P T++ +A E A + +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLLHLHKN- 119
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYF 501
H D+ N LL + K+ D+GLS E +++ P ++ P+
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 502 H-------LSDKSDVYSFGVVLIEI 519
H + +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 71/308 (23%), Positives = 117/308 (37%), Gaps = 84/308 (27%)
Query: 332 LGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSID------QVMNEIKLLSSVSHPN 381
+G G G VY L D VA+K+ R D + + + E K+ + + HP
Sbjct: 10 IGKGGMGEVY---LAYDPVCSRRVALKKIR---EDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 382 LLRLLGCCIEEGEPILVYEFMP--NGTLCQHLQR------------ERGSGLPWTIRITI 427
++ + C +G+P VY MP G + L + + + + I
Sbjct: 64 IVPVYSIC-SDGDP--VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL-------------SRL 474
+ I Y+HS + HRD+K NILL + D+G +
Sbjct: 121 --KICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 475 GMTESSHIS-TAPQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT--------- 521
+ S T P GTP Y+ P+ S+ +D+Y+ GV+L +++T
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 522 ALKVVDFSR--------PH-------SEVNLAALAIDRIGR-GCVDEIIDPYLEPH---R 562
K+ P+ S++ + ALA+D R V E+ LEPH
Sbjct: 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD-LEPHLQGS 294
Query: 563 DAWTLSSI 570
WT+ +
Sbjct: 295 PEWTVKAT 302
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 40/214 (18%)
Query: 332 LGTGAYGTVY---------AGKLHNDDWVAIKRFR----YRDTDSIDQVMNEIKLLSSVS 378
LGTGAYG V+ +GKL+ A+K + + + + E ++L +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLY-----AMKVLKKATIVQKAKTTEHTRTERQVLEHIR 62
Query: 379 H-PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIA 436
P L+ L + + L+ +++ G L HL QRER I E A+
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG---EIVLALE 119
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
+LH I +RDIK NILLD N + DFGLS+ + + + GT Y+ P
Sbjct: 120 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 497 Y-------HQYFHLSDKS-DVYSFGVVLIEIITA 522
H DK+ D +S GV++ E++T
Sbjct: 177 IVRGGDGGH------DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKL------HNDDWVAIKRFRYRDTDSI-DQVMNE 370
EI +T F E+ LG +G VY G L VAIK + + + ++ +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL--------------QRERG 416
+ S + HPN++ LLG +E +++ + + L + L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 417 SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
S L + I T+ A + +L S + H+D+ + N+L+ K++D GL R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 477 TESSHISTAPQGTP-GYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ P ++ P+ Y S SD++S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 28/183 (15%)
Query: 351 VAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC-----CIEEGEPI-LVYEFM 402
VA+K+ +++ + E+ LL V+H N++ LL +EE + + LV E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 403 PNGTLCQ----HLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL 458
+ LCQ L ER S L + + I +LHSA I HRD+K SNI++
Sbjct: 109 -DANLCQVIHMELDHERMSYLLYQMLC--------GIKHLHSA---GIIHRDLKPSNIVV 156
Query: 459 DYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGYLDPQYHQYFHLSDKSDVYSFGVVLI 517
+ K+ DFGL+R T ++ P T Y P+ + D++S G ++
Sbjct: 157 KSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 518 EII 520
E++
Sbjct: 214 ELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 332 LGTGAYGTV---YAGKLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G+GA G V Y L + VAIK+ +++ + E+ L+ V+H N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 387 GC-----CIEEGEPILVYEFMPNGTLCQHLQ----RERGSGLPWTIRITIATETAQAIAY 437
+EE + + + + + LCQ +Q ER S L + + I +
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC--------GIKH 141
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
LHSA I HRD+K SNI++ + K+ DFGL+R T S + T T Y P+
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 498 HQYFHLSDKSDVYSFGVVLIEII 520
+ D++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 46/211 (21%)
Query: 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456
+V E+MP G L +L W T E A+ +HS M HRD+K N+
Sbjct: 120 MVMEYMPGGDLV-NLMSNYDIPEKWARFYT--AEVVLALDAIHS-MG--FIHRDVKPDNM 173
Query: 457 LLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQ------YHQYFHLSDKSDV 509
LLD + K+ADFG ++ TA GTP Y+ P+ Y+ + D
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYY--GRECDW 230
Query: 510 YSFGVVLIEII-------------TALKVVD------------FSRPHSEVNLAAL--AI 542
+S GV L E++ T K++D S+ ++ A L
Sbjct: 231 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDRE 290
Query: 543 DRIGRGCVDEI-IDPYLEPHRDAWTLSSIHN 572
R+GR VDEI P+ + D WT +I
Sbjct: 291 VRLGRNGVDEIKSHPFFK--NDQWTFDNIRE 319
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 8e-09
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 40/241 (16%)
Query: 331 RLGTGAYGTVYAGKLHNDD----WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
++G G +G V+ K W AI +R Q++ E+ ++ + H N++R +
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 387 GCCIEEGEPIL--VYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ + L + EF G L +++Q+ + + + I + A+AY H+
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138
Query: 443 NPP----IYHRDIKSSNILLDYNYR-----------------SKVADFGLSR-LGMTESS 480
+ P + HRD+K NI L R +K+ DFGLS+ +G+ +
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA 198
Query: 481 HISTAPQGTPGYLDPQ--YHQYFHLSDKSDVYSFGVVLIEIITAL----KVVDFSRPHSE 534
H GTP Y P+ H+ DKSD+++ G ++ E+ + K +FS+ SE
Sbjct: 199 HSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255
Query: 535 V 535
+
Sbjct: 256 L 256
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLG 387
+LG G+Y TVY G+ VA+K R + + E LL + H N++ L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGL-PWTIRITIATETAQAIAYLHSAMNPPI 446
+ LV+E++ + L Q++ G GL +R+ + + + +AY H +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDC-GGGLSMHNVRLFL-FQLLRGLAYCHQRR---V 124
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSR 473
HRD+K N+L+ K+ADFGL+R
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G G+YG V + H + VAIK+ + +++ EIKLL + HP+++ +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 389 CI-----EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT--IATETAQ-------- 433
+ E + +V+E M S L I+ + E Q
Sbjct: 68 MLPPSRREFKDIYVVFELM-------------ESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM--TESSHISTAPQGTPG 491
A+ Y+H+A ++HRD+K NIL + + + K+ DFGL+R+ T ++ T T
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 492 YLDPQ-----YHQYFHLSDKSDVYSFGVVLIEIIT 521
Y P+ + +Y + D++S G + E++T
Sbjct: 172 YRAPELCGSFFSKY---TPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 332 LGTGAYGTVYAGKLHND---DWVAIKRFR-YRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+G G YG V+ K+ N A+K D D +++ E +L ++S HPN+++
Sbjct: 26 IGKGTYGKVF--KVLNKKNGSKAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFY 81
Query: 387 GCC----IEEGEPI-LVYEFMPNGTLCQHLQ--RERGSGLPWTIRITIATETAQAIAYLH 439
G ++ G+ + LV E G++ ++ +RG + I I E + +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY-- 497
N I HRD+K +NILL K+ DFG+S +T + GTP ++ P+
Sbjct: 142 V--NKTI-HRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 498 -HQYFHLS--DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554
Q + + DV+S G ITA+++ D P ++++ A+ +I R +
Sbjct: 198 CEQQLDSTYDARCDVWSLG------ITAIELGDGDPPLADLH-PMRALFKIPRNPPPTLH 250
Query: 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
P L W+ + + +CL + RPT V++ L+H+
Sbjct: 251 QPEL------WS----NEFNDFIRKCLTKDYEKRPT---VSDLLQHV 284
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 326 FSEKHRLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSI--DQVMNEIKLLSSVSHPNL 382
++ ++G+GAYG+V A + VAIK+ I + E+ LL + H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 383 LRLLGCCIEEGEPIL-----VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAY 437
+ LL + Y MP + LQ+ G L + + + Y
Sbjct: 77 IGLLD--VFTSAVSGDEFQDFYLVMP--YMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
+HSA I HRD+K N+ ++ + K+ DFGL+R E + GY+ ++
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRW 179
Query: 498 HQ-------YFHLSDKSDVYSFGVVLIEIIT 521
++ + H + D++S G ++ E++T
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G GA+G V++ + VA+K+ +++ S +V E+K+L H N+L L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL-- 65
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTI----RIT---IATETAQ---AIAYL 438
+ +P + F + + +Q S L I ++ + Q + YL
Sbjct: 66 --DILQPPHIDPFEEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ-Y 497
HSA I HRDIK N+L++ N K+ DFGL+R+ + S T T Y P+
Sbjct: 120 HSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 498 HQYFHLSDKSDVYSFGVVLIEII 520
H + D++S G + E++
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 331 RLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLGC 388
+LG G Y TVY G+ D+ VA+K R + + E+ LL + H N++ L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
E LV+E++ + L Q+L + G+ + + + + Y H + H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLD-DCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLH 127
Query: 449 RDIKSSNILLDYNYRSKVADFGLSR 473
RD+K N+L++ K+ADFGL+R
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 4/155 (2%)
Query: 369 NEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIA 428
+E+ L++ H +++ + + +L+ E+ G L + +++ LP+ +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ- 487
Q + L + + HRD+KS+NI L K+ DFG S+ ++S + A
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSF 231
Query: 488 -GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
GTP YL P+ + S K+D++S GV+L E++T
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
LG G+ G V+ A D VA+K+ D S+ + EIK++ + H N++++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 391 EEGEPI--------------LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
G + +V E+M L L E+G R+ + + +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARL-FMYQLLRGLK 128
Query: 437 YLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRLGMTESSHISTAPQG--TPGYL 493
Y+HSA + HRD+K +N+ ++ + K+ DFGL+R+ SH +G T Y
Sbjct: 129 YIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 494 DPQ-YHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ + + D+++ G + E++T
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 31/206 (15%)
Query: 332 LGTGAYGTVYAG-KLHNDDWVAIKRFRYRDTDSI---DQVMNEIKLLSSVSHPNLLRLL- 386
+G+GAYG+V A VA+K+ R SI + E++LL + H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 387 ----GCCIEEGEPI-LVYEFM----PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAY 437
+EE + LV M N CQ L + L + I + + Y
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKY 135
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY 497
+HSA I HRD+K SN+ ++ + K+ DFGL+R E T T Y P+
Sbjct: 136 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 188
Query: 498 H-QYFHLSDKSDVYSFGVVLIEIITA 522
+ H + D++S G ++ E++T
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 44/128 (34%), Positives = 64/128 (50%), Gaps = 15/128 (11%)
Query: 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456
LV ++M G L HLQ+E G + IA E A+ +LH I +RD+K NI
Sbjct: 73 LVTDYMSGGELFWHLQKE-GRFSEDRAKFYIA-ELVLALEHLHKY---DIVYRDLKPENI 127
Query: 457 LLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS-----DVYS 511
LLD + DFGLS+ +T++ +T GT YL P+ L +K D +S
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPE----VLLDEKGYTKHVDFWS 182
Query: 512 FGVVLIEI 519
GV++ E+
Sbjct: 183 LGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 52/237 (21%), Positives = 92/237 (38%), Gaps = 67/237 (28%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMN---- 369
YK IE +G+GAYG V A + VAIK+ + D
Sbjct: 6 RYKPIEN----------IGSGAYGVVCSAIDTRSGKKVAIKKI----PHAFDVPTLAKRT 51
Query: 370 --EIKLLSSVSHPN---LLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTI 423
E+K+L H N + +L + + + +V + M + L S P T
Sbjct: 52 LRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-----DLHHIIHSDQPLT- 105
Query: 424 RITIATETAQA--------IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475
E + + Y+HSA + HRD+K SN+L++ + ++ DFG++R
Sbjct: 106 -----EEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 476 MTES--------SHISTAPQGTPGYLDPQ----YHQYFHLSDKSDVYSFGVVLIEII 520
+ +++T Y P+ +Y + D++S G + E++
Sbjct: 158 SSSPTEHKYFMTEYVATRW-----YRAPELLLSLPEY---TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 332 LGTGAYGTV---YAGKLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G+GAYG+V Y +L VA+K+ ++ + E++LL + H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 387 -----GCCIEE-GEPILVYEFM----PNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
IE E LV M N CQ L E L + + + +
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--------LRGLK 132
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
Y+HSA I HRD+K SN+ ++ + ++ DFGL+R ++ T T Y P+
Sbjct: 133 YIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPE 185
Query: 497 YH-QYFHLSDKSDVYSFGVVLIEII 520
+ H + D++S G ++ E++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 331 RLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLGC 388
+LG G Y TV+ G+ ++ VA+K R + + E+ LL + H N++ L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
+ LV+E++ + L Q++ + G+ + + + +AY H + H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLH 127
Query: 449 RDIKSSNILLDYNYRSKVADFGLSR 473
RD+K N+L++ K+ADFGL+R
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 326 FSEKHRLGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH 379
F + LG G +G V A GK++ + KR + R +S+ +NE ++L V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--ALNEKQILEKVNS 59
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
++ L + LV M G L H+ +G + A E + LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
I +RD+K NILLD + +++D GL+ + + E I GT GY+ P+ +
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIK-GRVGTVGYMAPEVVK 174
Query: 500 YFHLSDKSDVYSFGVVLIEII 520
+ D ++ G +L E+I
Sbjct: 175 NERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP--NGTLCQHLQRERGSGLPWTIRITI 427
E LL +V+HP+++R+ + +V +P + L +L + LP + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRP-LPIDQALII 162
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
+ + + YLH+ I HRD+K+ NI ++ + + D G ++ + + + A
Sbjct: 163 EKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA-- 217
Query: 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEII 520
GT P+ + K+D++S G+VL E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 332 LGTGAYGTVY---------AGKLHNDDWVAIKRFR----YRDTDSIDQVMNEIKLLSSVS 378
LGTGAYG V+ GKL+ A+K + + +++ E +L V
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLY-----AMKVLQKAALVQKAKTVEHTRTERNVLEHVR 62
Query: 379 H-PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIA 436
P L+ L E + L+ +++ G + HL QR+ S +R E A+
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--EDEVRFYSG-EIILALE 119
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
+LH I +RDIK NILLD + DFGLS+ ++E + + GT Y+ P+
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 497 YHQYFHLSDKS-DVYSFGVVLIEIIT 521
+ K+ D +S G+++ E++T
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 331 RLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLGC 388
+LG G Y TV+ G+ ++ VA+K R + + E+ LL ++ H N++ L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
E LV+E++ + L Q+L ++I + + + ++Y H I H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCHKR---KILH 126
Query: 449 RDIKSSNILLDYNYRSKVADFGLSR 473
RD+K N+L++ K+ADFGL+R
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 332 LGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG G +G V A GK++ + KR + + + + + E ++L V+ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM--ALLEKEILEKVNSPFIVNL 58
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
+ LV M G L H+ GL I + + I +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---D 115
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
I +RD+K N+LLD +++D GL+ + + + I T GT GY+ P+ + S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI-TQRAGTNGYMAPEILKEEPYSY 173
Query: 506 KSDVYSFGVVLIEII 520
D ++ G + E++
Sbjct: 174 PVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 22/172 (12%)
Query: 332 LGTGAYGTVY------AGKLHN----DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
LG G G V+ GKL D IKR + + +V+ E ++L+++ HP
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR------NKVKRVLTEQEILATLDHPF 62
Query: 382 LLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L L + + LV ++ P G L + LQR+ G L + A E A+ YLH
Sbjct: 63 LPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH- 120
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS-TAPQGTPG 491
+ +Y RD+K NILL + ++DF LS+ E +S +G+
Sbjct: 121 -LLGIVY-RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
++S +SH +L+ G C+ E I+V E++ G+L +L++ + I I+ E A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVA 106
Query: 433 QAIAY-LHSAMNPPIYHRDIKSSNILL----DYNYRS----KVADFGLSRLGMTESSHIS 483
+ +A+ LH + + H ++ + N+LL D + K++D G+S + + +
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE 166
Query: 484 TAPQGTPGYL-DPQYHQYFHLSDKSDVYSFGVVLIEI 519
P P + +PQ +LS +D +SFG L EI
Sbjct: 167 RIPWVPPECIENPQ-----NLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 64/289 (22%)
Query: 332 LGTGAYG-----------TVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP 380
+G GA+G VYA KL + + IKR +DS E +++ + P
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSK-FEMIKR-----SDSA-FFWEERDIMAFANSP 103
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
+++L ++ +V E+MP G L +L W T E A+ +HS
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYT--AEVVLALDAIHS 160
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDPQYHQ 499
+ HRD+K N+LLD + K+ADFG ++ T TA GTP Y+ P+ +
Sbjct: 161 M---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLK 216
Query: 500 ------YFHLSDKSDVYSFGVVLIEII-------------TALKVVDFSRP--------- 531
Y+ + D +S GV L E++ T K++D
Sbjct: 217 SQGGDGYY--GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274
Query: 532 --HSEVNLAALAID---RIGRGCVDEIID-PYLEPHRDAWTLSSIHNVA 574
H++ + A D R+GR V+EI P+ + D W +I A
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK--NDQWNWDNIRETA 321
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 332 LGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH---PNL 382
+G G +G VY GK++ + KR + + +++ +NE +LS VS P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDCPFI 59
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ + + + + M G L HL + G +R ATE + ++H
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLEHMH--- 114
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
N + +RD+K +NILLD + +++D GL+ + H S GT GY+ P+ Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 503 LSDKS-DVYSFGVVLIEII 520
D S D +S G +L +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 85/296 (28%)
Query: 332 LGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMN---EIKLLSSVSHPNLLRLLG 387
+G GA+G V K A+K+ R + +QV + E +L+ +P +++L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQR-----ERGSGLPWTIRITIATETAQAIAYLHSAM 442
+E L+ E++P G + L + E + R IA ET AI +H +
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET------RFYIA-ETILAIDSIHK-L 120
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLS-------------RLGMTESSHISTAPQ-- 487
HRDIK N+LLD K++DFGL L S+
Sbjct: 121 G--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 488 ----------------------GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEII----- 520
GTP Y+ P+ + + D +S GV++ E++
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 521 --------TALKVVDFSR----PHSEVNLAALAID-----------RIGRGCVDEI 553
T K++++ P EV L+ A D R+G V+EI
Sbjct: 239 FCSDNPQETYRKIINWKETLQFP-DEVPLSPEAKDLIKRLCCEAERRLGNNGVNEI 293
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI-STAPQGTP 490
A+ + +HS HRDIK N+LLD N ++ADFG S L M + + S+ GTP
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 491 GYLDPQYHQYFH-----LSDKSDVYSFGVVLIEII 520
Y+ P+ Q + D +S GV + E++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTI-RITIAT 429
L+S +SH +L++L G C+ + E I+V E++ G L L RE+ + ++ +A
Sbjct: 52 ASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNN--VSLHWKLDVAK 108
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILL-------DYNYRSKVADFGLSRLGMTESSHI 482
+ A A+ YL + + H ++ NIL+ Y K++D G+ ++ +
Sbjct: 109 QLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEI 519
P P + L+ +D +SFG L+EI
Sbjct: 166 ERIPWIAPECIRNGQAS---LTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 81/297 (27%)
Query: 324 SFFSEKHRLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMN---EIKLLSSVSH 379
S F + LG GA+G V A K+ A+K R +D + +QV + E +L+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-----ERGSGLPWTIRITIATETAQA 434
+++L ++ V +++P G + L R E + + +T+A E+
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF-YIAELTLAIESVHK 119
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL--------SRLGMTESSHI---S 483
+ ++H RDIK NIL+D + K+ DFGL + + SHI S
Sbjct: 120 MGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 484 TAPQ-----------------------------------GTPGYLDPQYHQYFHLSDKSD 508
P GTP Y+ P+ + D
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 509 VYSFGVVLIEII-------------TALKVVDFSRP---HSEVNLAALAIDRIGRGC 549
+S GV+L E++ T LKV+++ +V L+ A+D I + C
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 13/201 (6%)
Query: 326 FSEKHRLGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH 379
F + LG G +G V A GK++ + KR + R +S+ +NE ++L V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM--ALNEKQILEKVNS 59
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
++ L + LV M G L H+ G + A E + LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
+RD+K NILLD +++D GL+ + + E I GT GY+ P+
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIR-GRVGTVGYMAPEVLN 174
Query: 500 YFHLSDKSDVYSFGVVLIEII 520
+ D + G ++ E+I
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 35/165 (21%)
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR---------ERGSGLP 420
EI +L ++SH ++ L ++ + T+C + + +R LP
Sbjct: 136 EIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLP 183
Query: 421 WTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTES 479
ITI +A+AYLH I HRD+K+ NI LD + + DFG + +L
Sbjct: 184 LEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA--- 237
Query: 480 SHISTAPQ--GTPGYLDPQYHQYFHLSD---KSDVYSFGVVLIEI 519
H T PQ G G L+ + L K+D++S G+VL E+
Sbjct: 238 -HPDT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 40/209 (19%)
Query: 332 LGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+G G +G VY GK++ + KR + + +++ +NE +LS VS
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVS------- 52
Query: 386 LGCCIEEGEPILV---YEFMPNGTLCQHLQRERGSGLPWTIR----------ITIATETA 432
G C P +V Y F L L G L + + A E
Sbjct: 53 TGDC-----PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGY 492
+ ++H N + +RD+K +NILLD + +++D GL+ + H S GT GY
Sbjct: 108 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGY 161
Query: 493 LDPQYHQYFHLSDKS-DVYSFGVVLIEII 520
+ P+ Q D S D +S G +L +++
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 27/78 (34%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH----- 502
HRDIK NIL+D N ++ADFG M + + S+ GTP Y+ P+ Q
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 503 LSDKSDVYSFGVVLIEII 520
+ D +S GV + E++
Sbjct: 185 YGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 41/225 (18%)
Query: 325 FFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMN---EIKLLSSVSHPN 381
F E ++G G YG VY K D K + + + M+ EI LL + HPN
Sbjct: 2 FEYEGCKVGRGTYGHVY--KAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 382 LLRLLGCCIEEGEP--ILVYEFMPNGTLCQHLQRERGSG-------LPWTIRITIATETA 432
++ L + + L++++ + L ++ R S LP ++ ++ +
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMTESSHISTAPQG 488
I YLH+ + HRD+K +NIL+ R K+AD G +RL +P
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--------FNSPLK 167
Query: 489 TPGYLDPQYHQYF-----------HLSDKSDVYSFGVVLIEIITA 522
LDP ++ H + D+++ G + E++T+
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 332 LGTGAYGTVYAGKLHNDDWVA---IKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G G +G V +++ D VA +K + + ++ + + + HPN+L+ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 388 CCIEEGEPILVYEFMPNGTL----CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
C+E +LV+E+ G L Q R S L R +A E A + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMHKHN- 119
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFH 502
H D+ N L + KV D+G+ E + + P +L P+ FH
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 503 -------LSDKSDVYSFGVVLIEI 519
+ S+V++ GV L E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 45/227 (19%)
Query: 325 FFSEKHRLGTGAYGTVYAGKLHN--DDWVAIKRFRYRDTDSIDQVMN---EIKLLSSVSH 379
F E ++G G YG VY K + DD + + + + M+ EI LL + H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDD----RDYALKQIEGTGISMSACREIALLRELKH 57
Query: 380 PNLLRLLGCCIEEGEP--ILVYEFMPNGTLCQHLQRERGSG-------LPWTIRITIATE 430
PN++ L + + L++++ + L ++ R S LP + ++ +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMTESSHISTAP 486
I YLH+ + HRD+K +NIL+ R K+AD G +RL +P
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--------FNSP 165
Query: 487 QGTPGYLDPQYHQYF-----------HLSDKSDVYSFGVVLIEIITA 522
LDP ++ H + D+++ G + E++T+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 39/221 (17%)
Query: 317 KEIEKATSFFSE-----KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVM-NE 370
K + + F K +L G +G V K K F + I N
Sbjct: 4 KSLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ----KLFVQK---IIKAKNFNA 56
Query: 371 IKLLSSV---SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI 427
I+ + +PN ++L +L+ +++ +G L L++E +I
Sbjct: 57 IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKVADFGLSRLGMTESSHISTAP 486
+ +A+ LH I H DIK N+L D R + D+GL ++ T S +
Sbjct: 117 --QLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY----- 166
Query: 487 QGTPGYLDPQ------YHQYFHLSDKSDVYSFGVVLIEIIT 521
GT Y P+ Y F D ++ GV+ E++T
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSF------DWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF-----H 502
HRDIK N+LLD N ++ADFG + + + S GTP Y+ P+ Q
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 503 LSDKSDVYSFGVVLIEII 520
+ D +S GV + E++
Sbjct: 185 YGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 27/77 (35%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQ--YHQYFHLS 504
HRD+ + N+L+ K+ DFGL+R M +S++IS P ++ P+ ++ + +
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY--T 319
Query: 505 DKSDVYSFGVVLIEIIT 521
SDV+SFG++L EI T
Sbjct: 320 TLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 21/158 (13%)
Query: 324 SFFSEKHRLGTGAYGTV-YAGKLHNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSH 379
S F + LG GA+G V A K+ A+K R +D + + V E +L+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET------AQ 433
++RL ++ V +++P G + L IR+ I E A+
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL-----------IRMGIFPEDLARFYIAE 109
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471
+ S HRDIK NIL+D + K+ DFGL
Sbjct: 110 LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 32/124 (25%), Positives = 60/124 (48%), Gaps = 4/124 (3%)
Query: 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL 458
Y+ + + L + GL ++ + A+ + +L S HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270
Query: 459 DYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLSDKSDVYSFGVVLI 517
K+ DFGL+R M +S+++S P ++ P+ + SDV+S+G++L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 518 EIIT 521
EI +
Sbjct: 331 EIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 58/257 (22%), Positives = 98/257 (38%), Gaps = 67/257 (26%)
Query: 332 LGTGAYGTVYAG------KLHNDDWVAIKRFRYRDTDSIDQ-VMNEIKLLSSV-SHPNLL 383
LG GA+G V K + + VA+K + T S + +M+E+K+L + +H N++
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 384 RLLGCCIEEGEPILV-YEFMPNGTLCQHLQRERGSGLPW-------TIRITIATETAQAI 435
LLG C + P++V EF G L L+ +R P+ R E ++
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 436 AYLHSAMNPPIYHRDIKSS----------------------------------------- 454
+ + ++ R S+
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK 194
Query: 455 ---------NILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLS 504
NILL N K+ DFGL+R + ++ P ++ P+ +
Sbjct: 195 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYT 254
Query: 505 DKSDVYSFGVVLIEIIT 521
+SDV+SFGV+L EI +
Sbjct: 255 TQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 35/208 (16%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRF----RYRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G G++G VY A + + VAIK+ +Y++ E+ ++ +++H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--------RELLIMKNLNHINIIFLK 125
Query: 387 GC----CIEEGEPIL----VYEFMPNGT--LCQHLQRERGSGLPWTIRITIATETAQAIA 436
C ++ E + V EF+P +H R + LP + + + +A+A
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA-LPLFLVKLYSYQLCRALA 184
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSR---LGMTESSHISTAPQGTPGY 492
Y+HS I HRD+K N+L+D N + K+ DFG ++ G S+I + P
Sbjct: 185 YIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL 241
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEII 520
+ + H+ D++S G ++ E+I
Sbjct: 242 MLGATNYTTHI----DLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIK------------------- 372
LG G +YAG L+ D D D EIK
Sbjct: 3 LGRGTRTQIYAGILNYKD---------DDEDDGYSYEKEIKVILKVLDPSHRDISLAFFE 53
Query: 373 ---LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS-GLPWTIRITIA 428
++ VSH +++ L G C+ + E I+V EF+ G L + R+ PW + +A
Sbjct: 54 TASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVA 111
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILL-------DYNYRSKVADFGLSRLGMTESSH 481
+ A A++YL + + H ++ + NILL + K++D G+ ++
Sbjct: 112 KQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC 168
Query: 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEI 519
+ P P ++ +LS +D +SFG L EI
Sbjct: 169 VERIPWIAPECVEDSK----NLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 28/93 (30%), Positives = 53/93 (56%), Gaps = 4/93 (4%)
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGT 489
+ AQ + +L ++ N HRD+ + N+LL +K+ DFGL+R M +S+++
Sbjct: 220 QVAQGMDFL-ASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 490 P-GYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P ++ P+ + +SDV+S+G++L EI +
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 13/195 (6%)
Query: 332 LGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG G +G V A GK++ + KR + R +++ +NE ++L V+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNSRFVVSL 65
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
+ LV M G L H+ G + A E + LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--- 122
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
I +RD+K NILLD +++D GL+ + + E I GT GY+ P+ + +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIR-GRVGTVGYMAPEVVKNERYTF 180
Query: 506 KSDVYSFGVVLIEII 520
D + G ++ E+I
Sbjct: 181 SPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 13/201 (6%)
Query: 326 FSEKHRLGTGAYGTVYA------GKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH 379
F LG G +G V A GK++ + KR + R +++ +NE ++L V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKRILEKVNS 59
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
++ L + LV M G L H+ G I A E + L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499
I +RD+K NILLD +++D GL+ + + E + GT GY+ P+
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVR-GRVGTVGYMAPEVIN 174
Query: 500 YFHLSDKSDVYSFGVVLIEII 520
+ D + G ++ E+I
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 332 LGTGAYGTVY---AGKLHNDD---WVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLL 383
LG GA+G V A L +D VA+K + TD + +M+E+K+LS + H N++
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 384 RLLGCCIEEGEPILVY-EFMPNGTLCQHLQRE 414
LLG C G P+LV E+ G L L+++
Sbjct: 106 NLLGACTHGG-PVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 35/152 (23%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
E +L +++HP++++L G L+ C + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN---IAICDILAIER 189
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGT 489
+AI YLH I HRDIK+ NI +++ + DFG + + +++ GT
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 490 PGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ D++S G+VL E+ T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 22/136 (16%)
Query: 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456
+V E+MP G L + W T E A+ +HS HRD+K N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-KWARFYT--AEVVLALDAIHSM---GFIHRDVKPDNM 173
Query: 457 LLDYNYRSKVADFG----LSRLGMTESSHISTAPQGTPGYLDPQYHQ------YFHLSDK 506
LLD + K+ADFG +++ GM GTP Y+ P+ + Y+ +
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVRCD----TAVGTPDYISPEVLKSQGGDGYY--GRE 227
Query: 507 SDVYSFGVVLIEIITA 522
D +S GV L E++
Sbjct: 228 CDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 19/157 (12%)
Query: 324 SFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMN---EIKLLSSVSH 379
S F + +G GA+G V K+ + A+K R D +Q + E +L+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-----ERGSGLPWTIRITIATETAQA 434
+++L ++ V +++P G + L R E + R IA E A
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIA-ELTCA 113
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471
I +H HRDIK NIL+D + K+ DFGL
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 5/77 (6%)
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQ--YHQYFHLS 504
HRD+ + NILL N K+ DFGL+R + ++ P ++ P+ + + + +
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY--T 253
Query: 505 DKSDVYSFGVVLIEIIT 521
+SDV+SFGV+L EI +
Sbjct: 254 TQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 332 LGTGAYGTVYAGK---LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSV-SHPNLLRL 385
LG GAYG V + + ++ VAIK+ + + + E+KLL H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 386 LGCCIEEGEP---ILVYEFMPNGTLCQHLQRERGSGLPWT---IRITIATETAQAIAYLH 439
I + +YE + L Q ++ SG P T + I + + Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIR----SGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR---LGMTESSHISTAPQGTPGYLDPQ 496
SA + HRD+K N+L++ + K+ DFGL+R E++ T T Y P+
Sbjct: 123 SA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 497 YHQYFHLSDKS-DVYSFGVVLIEII 520
F K+ DV+S G +L E++
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 332 LGTGAYGTVYAGKLHNDD------WVAIKRFRYRDTDSIDQ-VMNEIKLLSSVSHP-NLL 383
LG GA+G V D VA+K + T S + +M+E+K+L + H N++
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 384 RLLGCCIEEGEPILV-YEFMPNGTLCQHLQRERGSGLPW 421
LLG C + G P++V EF G L +L+ +RG +P+
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPY 113
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 8/100 (8%)
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484
++ + + A+ +++L S HRD+ + NILL + +K+ DFGL+R +S+++
Sbjct: 217 LSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 485 APQGTP-GYLDPQYHQYFH--LSDKSDVYSFGVVLIEIIT 521
P ++ P+ F+ + +SDV+S+G++L EI +
Sbjct: 274 GNARLPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|205157 pfam12947, EGF_3, EGF domain | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 4e-04
Identities = 12/35 (34%), Positives = 14/35 (40%), Gaps = 6/35 (17%)
Query: 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFV 235
C NA CT N C C+ G+ GDG
Sbjct: 7 GCHPNATCT------NTGGSFTCTCKSGYTGDGVT 35
|
This family includes a variety of EGF-like domain homologues. This family includes the C-terminal domain of the malaria parasite MSP1 protein. Length = 36 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLSDK 506
HRD+ + NILL N K+ DFGL+R + ++ P ++ P+ + +
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261
Query: 507 SDVYSFGVVLIEIIT 521
SDV+SFGV+L EI +
Sbjct: 262 SDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 34/146 (23%), Positives = 59/146 (40%), Gaps = 12/146 (8%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVA-IKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
L G VY ++D+V I R + D +V ++LL+ P + ++L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAI-LQLLARKGLP-VPKVLASG 62
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+G L+ E++ TL + S IA + A+ +A LH + H
Sbjct: 63 ESDGWSYLLMEWIEGETL------DEVSEEEKED---IAEQLAELLAKLHQLPLLVLCHG 113
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLG 475
D+ NIL+D + D+ + G
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 28/82 (34%), Positives = 37/82 (45%), Gaps = 17/82 (20%)
Query: 397 LVYEFMPNGTLCQHLQRERGSGLPWTI------RITIATETAQAIAYLHSAMNPPIYHRD 450
L+ EF+P G L L + + R +A E AI +H HRD
Sbjct: 78 LIMEFLPGGDLMTMLIK-------YDTFSEDVTRFYMA-ECVLAIEAVHKL---GFIHRD 126
Query: 451 IKSSNILLDYNYRSKVADFGLS 472
IK NIL+D K++DFGLS
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 366 QVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV--------YEFMPNGTLCQHLQRERGS 417
Q+ NEI L ++H N+L++ E ++ Y FM + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDR 263
Query: 418 GLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477
L R I + A+ Y+H + HRDIK NI L+ + + + DFG +
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
E GT P+ + +D++S G++L+++++
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQ-VMNEIKLLSSVS-HPNLL 383
LG+GA+G V H VA+K + S Q +M+E+K++S + H N++
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRER 415
LLG C + G ++ E+ G L +L R +
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 65/274 (23%), Positives = 104/274 (37%), Gaps = 59/274 (21%)
Query: 332 LGTGAYGTV-YAGKLHNDDWVAIKRFRYRDTDSIDQVMN---EIKLLSSVSHPNLLRLLG 387
+G GA+G V K A+K R D +QV + E +L ++++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ L+ EF+P G + L ++ T + IA ET AI +H
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT-QFYIA-ETVLAIDAIHQL---GFI 123
Query: 448 HRDIKSSNILLDYNYRSKVADF----GLSRLGMTE------------------------- 478
HRDIK N+LLD K++DF GL + TE
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 479 -----SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEII------------- 520
++ + GTP Y+ P+ + D +S GV++ E++
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 521 TALKVVDFSRP---HSEVNLAALAIDRIGRGCVD 551
T KV+++ EV ++ A D I R C D
Sbjct: 244 TYRKVMNWKETLVFPPEVPISEKAKDLILRFCTD 277
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 43/146 (29%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 335 GAYGTVYAG-KLHNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
GA+G VY G K +N A+K + D + + QV E L+ P ++ L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 391 EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRD 450
LV E++ G + + L G I+ E A A+ YLH I HRD
Sbjct: 75 SANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYIS-EVALALDYLHRH---GIIHRD 129
Query: 451 IKSSNILLDYNYRSKVADFGLSRLGM 476
+K N+L+ K+ DFGLS++ +
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQ-VMNEIKLLSSV-SHPNLL 383
LG+GA+G V G + VA+K + S Q +M+E+K+++ + H N++
Sbjct: 45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIV 104
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS 417
LLG C + G ++ E+ G L +L + R +
Sbjct: 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDN 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 692 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.0 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.85 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.78 | |
| PLN02236 | 344 | choline kinase | 96.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.63 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 96.5 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 96.35 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.15 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.13 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.61 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.59 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.45 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.43 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.97 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.96 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.59 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.32 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-60 Score=505.05 Aligned_cols=293 Identities=45% Similarity=0.766 Sum_probs=260.9
Q ss_pred CCCCCChHHHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEE
Q 005536 310 SVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389 (692)
Q Consensus 310 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~ 389 (692)
..+.|+++|++++|++|+..++||+|+||+||+|.+.+++.||||++........++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57789999999999999999999999999999999999999999988765433156699999999999999999999999
Q ss_pred EeCC-eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEee
Q 005536 390 IEEG-EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVAD 468 (692)
Q Consensus 390 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 468 (692)
.+.+ +++||||||++|+|.++|+......|+|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 599999999999999999986543799999999999999999999999888999999999999999999999999
Q ss_pred ecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC
Q 005536 469 FGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 469 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
||+|+.......+..+...||.+|+||||+..+.++.|+|||||||+|+||+||+++.+...+..+..+..|+...+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99998755412222222289999999999999999999999999999999999999999877777778999999999999
Q ss_pred cccccccccCCcCCCccCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 549 CVDEIIDPYLEPHRDAWTL-SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~-~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.+.+++|+.+.. ..... +.+.++.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 301 ~~~eiiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999863 22222 6788899999999999999999999999999776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=408.71 Aligned_cols=258 Identities=35% Similarity=0.530 Sum_probs=214.1
Q ss_pred ccceeecccccEEEEEEEEeCCCEEEEEEeecCCch--hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-eeEEEEEeCC
Q 005536 327 SEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-EPILVYEFMP 403 (692)
Q Consensus 327 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-~~~lV~E~~~ 403 (692)
...+.||+|+||+||+|.+.....||||++...+.. ..++|.+|+.+|++++|||||+++|+|.+.. ...|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345569999999999999976666999999865422 2569999999999999999999999999987 7999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceEEcCCC-ceEEeeecCCccCCCCCCc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP-IYHRDIKSSNILLDYNY-RSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~-iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~~ 481 (692)
+|+|.++|+......+++..+++||.|||+||.|||+. + ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999986556799999999999999999999995 5 99999999999999997 99999999998633211 3
Q ss_pred ccccCCCCCCCCCccccc--cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 482 ISTAPQGTPGYLDPQYHQ--YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~--~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
..+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+ .+.+......+...++
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~------ 267 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPI------ 267 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCC------
Confidence 344578999999999999 56999999999999999999999999974432 2222222223222222
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
+..+...+..|+.+||+.||.+||++.|++..|+.+..+.-
T Consensus 268 ------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 268 ------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 12245678899999999999999999999999999987543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=397.93 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=220.4
Q ss_pred CccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+...+.||+|.||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3446789999999999999988889999999865 455678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
+|.++|+...+..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+||||||...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999998666779999999999999999999999 499999999999999999999999999999654555545555
Q ss_pred CCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
..-...|.|||.+..+.++.|||||||||+||||+| |+.|+.... ...+.+.+.+|. +-.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~le~Gy------------Rlp 424 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELLERGY------------RLP 424 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHHhccC------------cCC
Confidence 566789999999999999999999999999999999 666654221 123455555542 223
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.+..++.++.+|+..||..+|++|||++.+...|+++...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 3456778999999999999999999999999999988653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=365.49 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=209.8
Q ss_pred CChHHHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005536 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391 (692)
Q Consensus 314 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~ 391 (692)
.+..++++ .+.||+|..|+|||+++. +++.+|+|.+... +....++..+|++++++.+||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44556655 568999999999999975 4788999999544 45567889999999999999999999999999
Q ss_pred CC-eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 392 EG-EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 392 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
.. ...|+||||.+|+|.+.+... +.+++...-+||.++++||.|||+. .+||||||||+|||++..|++||+|||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 98 599999999999999998765 4599999999999999999999974 599999999999999999999999999
Q ss_pred CCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
.++..... ......||..|||||.+++..|+.++||||||+.|+|+.+|+.|+....+.. .. ....+..|-.+..
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~-~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LD-IFELLCAIVDEPP 299 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CC-HHHHHHHHhcCCC
Confidence 99864322 4456789999999999999999999999999999999999999987541111 11 1122333333322
Q ss_pred cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..+.+. ....++..++..||+.||.+||+++|++
T Consensus 300 P~lP~~-----------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 300 PRLPEG-----------EFSPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred CCCCcc-----------cCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 222111 2456899999999999999999988887
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=380.29 Aligned_cols=246 Identities=23% Similarity=0.347 Sum_probs=211.1
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
..|...+.||+|||+++|.++. ..|+.||+|++.+. .....+...+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999996 78999999999764 3456778899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
|+|++++|..++++ ...+++.++..+..||+.||.|||+. +|||||||..|+||+++.++||+|||||.....+
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 99999999998873 46799999999999999999999995 9999999999999999999999999999875433
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.+......|||.|+|||++....++..+||||+||++|.||.|++||+... ......+++.....
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y~-------- 236 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEYS-------- 236 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCcc--------
Confidence 234456789999999999999999999999999999999999999997432 23334555432111
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.....+..+||.++|+.+|.+|||+++|+
T Consensus 237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred -----cccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 1112335678999999999999999988887
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=369.00 Aligned_cols=202 Identities=29% Similarity=0.512 Sum_probs=180.8
Q ss_pred hccCccceeecccccEEEEEEEEeC-CCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
..+|...++||+|+||+||+|++.. +..||||.+... .....+.+..|+++|+.++|||||.|++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3568888889999999999999654 789999999766 5566778899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC------CceEEeeecCCc
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN------YRSKVADFGLSR 473 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~------~~~kl~DFGla~ 473 (692)
|||.+|+|.+||+..+ .+++.....++.|+|.||++||+ ++||||||||+||||+.. -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999763 59999999999999999999999 599999999999999765 468999999999
Q ss_pred cCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCC
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP 531 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~ 531 (692)
... .........|++-|||||+++..+|+.|+|+||+|++|||+++|+.||+...+
T Consensus 164 ~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 164 FLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 754 33344567899999999999999999999999999999999999999985443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=367.19 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=213.1
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCc-------hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDT-------DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG 393 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~ 393 (692)
..+.|...+.||+|+||.|-+|. ..+++.||||+++.+.. .......+|++||++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678888999999999999998 45689999999986521 12334579999999999999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CceEEeeec
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN---YRSKVADFG 470 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFG 470 (692)
..|+||||++||.|.+.+..+. .+.+..-..++.|++.|+.|||+ +||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999998764 37777778899999999999999 599999999999999765 789999999
Q ss_pred CCccCCCCCCcccccCCCCCCCCCccccccCC---CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQYFH---LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
+|+... ....+....||+.|.|||++.+.. +..|.|+||+||+||-+++|.+||...... ....+++.+
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~------~sl~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD------PSLKEQILK 396 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC------ccHHHHHhc
Confidence 999743 344556778999999999987653 234789999999999999999999643221 123556666
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccccc
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~~ 611 (692)
|+.... .....+..++..+|+.+||..||++|||+.|++ .++|.....
T Consensus 397 G~y~f~---------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL-------~hpW~~~~~ 444 (475)
T KOG0615|consen 397 GRYAFG---------PLQWDRISEEALDLINWMLVVDPENRPSADEAL-------NHPWFKDAP 444 (475)
T ss_pred Cccccc---------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh-------cChhhhccc
Confidence 655322 111235667899999999999999999999988 788876443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=396.33 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=221.6
Q ss_pred hhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE 394 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~ 394 (692)
.+.+....+.||+|+||+||+|+..+ .+.||||.++..... ..++|++|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34455667789999999999998543 457999999987655 78899999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcc--------CCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 395 PILVYEFMPNGTLCQHLQRER--------GSG----LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
.++|+|||..|+|.++|.... +.+ |+..+.+.||.|||.|+.||-++ .++||||..+|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 999999999999999998532 123 88899999999999999999995 999999999999999999
Q ss_pred ceEEeeecCCccCCCCCCcc-cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHH
Q 005536 463 RSKVADFGLSRLGMTESSHI-STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 463 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~ 540 (692)
.|||+||||+|.....+.+. .....-..+||+||.+..+++|.+||||||||+|||+++ |+.|+..... +.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~E 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QE 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HH
Confidence 99999999999755544443 334556789999999999999999999999999999998 8888763321 34
Q ss_pred HHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
+++.+++|.+.+ .+..++.++.+|+..||+.+|.+||+++||-..|+.....
T Consensus 714 VIe~i~~g~lL~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 VIECIRAGQLLS------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHcCCccc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 567777765532 3446778999999999999999999999999999987654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.07 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=209.4
Q ss_pred cCccceeecccccEEEEEEE-EeCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEE-EEEeCC-eeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLG-CCIEEG-EPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g-~~~~~~-~~~lV~ 399 (692)
.|.+.++||.|.||+|||+. +.+|..||.|.++.. +....+....|+.+|++|+|||||++++ .+.++. .++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46678899999999999998 678999999999855 4456678899999999999999999999 444444 489999
Q ss_pred EeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 400 EFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNP-PIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
||+..|+|.+.++..+ .+.+++..++++..|++.||.++|+...+ -|+||||||.||+|+.+|.+||+||||+++..
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999997543 35599999999999999999999994322 38999999999999999999999999999854
Q ss_pred CCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
... ......+|||.||+||.+...+|+.||||||+|+++|||..-+.||... ++. ...++|.+|....+.|
T Consensus 180 s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~~p~- 250 (375)
T KOG0591|consen 180 SKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPPLPD- 250 (375)
T ss_pred chh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCCCcH-
Confidence 433 3335568999999999999999999999999999999999999999754 222 2355676664443322
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
.-...++.+|+..|+..||+.||+...+++.+
T Consensus 251 ----------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 251 ----------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ----------HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 23456789999999999999999854444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.62 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=214.4
Q ss_pred hccCccceeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.+.|+..+.||+|+||+||.++..+ ++.+|+|.+++. ...+.+...+|..||.+++||.||+++..|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999998554 789999999865 234567889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
+||+.||.|..+|+++ ..+++..+.-.+.+|+.||.|||+ .+||||||||+|||||++|+++|+||||++....+
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999876 458999888999999999999999 49999999999999999999999999999964333
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
........||+.|||||++.+..|+..+|.||+|+++|||++|.+||..... ....+.+.+++....
T Consensus 179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~~~I~~~k~~~~----- 245 (357)
T KOG0598|consen 179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMYDKILKGKLPLP----- 245 (357)
T ss_pred -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHHHHHhcCcCCCC-----
Confidence 2334457899999999999999999999999999999999999999974432 233455555442111
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccccc
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~~ 611 (692)
+.-...+..+|+.+.|+.+|++|.- ...-.+.|+.+++...+-
T Consensus 246 -------p~~ls~~ardll~~LL~rdp~~RLg---~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 246 -------PGYLSEEARDLLKKLLKRDPRQRLG---GPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred -------CccCCHHHHHHHHHHhccCHHHhcC---CCCChHHhhcCcccccCC
Confidence 0112246789999999999999964 112234477777665443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=374.24 Aligned_cols=267 Identities=28% Similarity=0.487 Sum_probs=218.2
Q ss_pred ChHHHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005536 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE 392 (692)
Q Consensus 315 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~ 392 (692)
+.++++...+.+....+||+|.||+||+|+++.+ ||||+++... .+..+.|.+|+.++++.+|.||+-++|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3466666666777788999999999999998754 9999998763 45788999999999999999999999999988
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
.. .||+.++++-+|+.|||-.+ ..++..+.++||.|||+|+.|||. ++|||||||+.||+|++++.|||+||||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccce
Confidence 87 99999999999999999764 569999999999999999999999 59999999999999999999999999998
Q ss_pred ccCCC-CCCcccccCCCCCCCCCcccccc---CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC
Q 005536 473 RLGMT-ESSHISTAPQGTPGYLDPQYHQY---FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 473 ~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
..... ..........|...|||||+++. .+|+..|||||||+|+|||+||..|+.....+. .+-++++|
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccc
Confidence 65222 22233345568899999998753 479999999999999999999999987333222 22234444
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
.+.. |.. .....+.++|.+|+..||..++++||.+.+|+..|+.+..
T Consensus 609 ~l~p--d~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 YLMP--DLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccCc--cch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2211 111 1112456789999999999999999999999998888765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=377.55 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=216.0
Q ss_pred CccceeecccccEEEEEEEEeC----CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
..+.+.||.|.||.||+|+++- ...||||.++..- +....+|+.|..||.+++||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3456789999999999999754 3479999999764 4566789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
||+||+|+.+|+.+.+ .+++.+..-+..+||.|++||.++ ++|||||.++|||++.+..+||+||||+|...++..
T Consensus 711 yMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999998764 499999999999999999999996 999999999999999999999999999997555442
Q ss_pred cccccCCC--CCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 481 HISTAPQG--TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 481 ~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
...+...| ..+|.|||.+...++|.+||||||||++||.++ |.+|+-.... +.+++.+++|
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------QdVIkaIe~g--------- 850 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QDVIKAIEQG--------- 850 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-------HHHHHHHHhc---------
Confidence 33333333 569999999999999999999999999999998 8777632211 2234445443
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.+-+.+++++..+.+|++.||++|..+||++.+|+..|+++-..
T Consensus 851 ---yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 851 ---YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ---cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22344678889999999999999999999999999999996543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=388.85 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=215.3
Q ss_pred ccCccceeecccccEEEEEEEEeC--CC----EEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN--DD----WVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
.+.+..+.||+|.||.||.|...+ +. .||||.++.. +.+...+|.+|..+|+.++|||||+++|+|.+...++
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344557789999999999999765 32 4999999865 4667889999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 397 LVYEFMPNGTLCQHLQRERG-----SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
|++|||++|+|..||++.+. ..|+....+.++.|||+|+.|||+ +++|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999998642 458999999999999999999999 5999999999999999999999999999
Q ss_pred CccCCCCCCcccccC-CCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 472 SRLGMTESSHISTAP-QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 472 a~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
||.+........... .-..+|||||.++.+.++.|||||||||+||||+| |..|+..... .+......+.|+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------FEVLLDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch------HHHHHHHHhCCc
Confidence 995444333332222 34569999999999999999999999999999999 6666653322 222222333332
Q ss_pred ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
+ +.+..+++.+.+|+..||+.+|++||++..++++++.|.....
T Consensus 923 L-------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 923 L-------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred c-------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 2 2234567789999999999999999999999999999876544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=360.45 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=206.7
Q ss_pred hhccCccceeecccccEEEEEEEE------eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL------HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE- 392 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~- 392 (692)
..++|...++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999974 224679999997543 33456799999999999 899999999998765
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcc---------------------------------------------------------
Q 005536 393 GEPILVYEFMPNGTLCQHLQRER--------------------------------------------------------- 415 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 415 (692)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45789999999999999997532
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc-ccccCCCCCC
Q 005536 416 ---GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPG 491 (692)
Q Consensus 416 ---~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~ 491 (692)
...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1247888999999999999999999 59999999999999999999999999999864322221 1223456789
Q ss_pred CCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHH
Q 005536 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSI 570 (692)
Q Consensus 492 Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~ 570 (692)
|+|||++.+..++.++||||||++||||++ |..||....... .....+..+..... +....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~------------~~~~~ 303 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA------------PENAT 303 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC------------CCCCC
Confidence 999999998899999999999999999997 999986433211 12233333221111 11223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 571 HNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 571 ~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
..+.+|+.+||+.+|++|||+.||+++|+.+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=348.27 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=203.6
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--eeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG--EPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~--~~~lV~E 400 (692)
.++...+.||+|+||+||++...+ |+..|||.+...+....+.+.+|+.+|++++|||||+.+|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456667899999999999999765 8899999998764444777999999999999999999999855444 6899999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeecCCccCCC--
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRLGMT-- 477 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~-- 477 (692)
|+++|+|.+++.+..+ .|++..+.+.+.||++||+|||+ ++|+|+||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998866 79999999999999999999998 59999999999999999 79999999999986432
Q ss_pred CCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.........+||+.|||||++..+ ....++|||||||+++||+||+.||... .....+......++...+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~---- 243 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE---- 243 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC----
Confidence 222334457899999999999854 3345999999999999999999998632 111222222222221221
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+.....+..+++.+|++.+|++|||+.|+++
T Consensus 244 --------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 244 --------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred --------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12234467889999999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.43 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=210.9
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHH--HHHHHHHHhCC-CCCeeeeEEEEEeCC-eeE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQV--MNEIKLLSSVS-HPNLLRLLGCCIEEG-EPI 396 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~--~~E~~il~~l~-H~niv~l~g~~~~~~-~~~ 396 (692)
..++|...++||.|.||.||+|+ ...+..||||+++..-.. .++. ++|++.|++|+ ||||++|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45678889999999999999998 456889999999866333 3333 58999999999 999999999999988 999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||| ..+|+++++.. ++.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+||..
T Consensus 87 fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev- 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV- 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc-
Confidence 999999 57999999876 67899999999999999999999995 9999999999999999999999999999963
Q ss_pred CCCCcccccCCCCCCCCCcccc-ccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc---
Q 005536 477 TESSHISTAPQGTPGYLDPQYH-QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE--- 552 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e--- 552 (692)
......+..+.|..|.|||++ +.+-|+.+.|+||+|+|++||.+-++.|......+++...-.++..-.+....+
T Consensus 161 -~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 161 -RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred -ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 344556778899999999975 667899999999999999999999999986655444333322221111111111
Q ss_pred ---ccc---ccCC-cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 553 ---IID---PYLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 553 ---i~d---~~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+. |... ......-.....+.++|+.+|++.||++|||+.|.++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 000 0000 0011111234568899999999999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=399.89 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=216.9
Q ss_pred HhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
.....|...+.||+|+||.||+|+. .++..||||+++..... ..+|++++++++|||||+++|+|.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3445678888999999999999986 56889999998654322 234688999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.++++. ++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999999953 8999999999999999999997666899999999999999999988876 776543211
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....+|+.|+|||++.+..++.|+|||||||++|||+||+.|++.... .......+...........+++|+.+.
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 1233688999999999999999999999999999999999999864322 223344555444444555666777664
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
... ....+...++.+++.+||+.+|++||+|+||+++|+++...
T Consensus 911 ~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 911 GDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 322 23345677889999999999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.84 Aligned_cols=266 Identities=25% Similarity=0.324 Sum_probs=207.9
Q ss_pred cCccceeecccccEEEEEEE-EeCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~lV~ 399 (692)
.|+..++||+|.||.|||++ +.+|+.||+|+++... +....-..+||.||++|+||||++|.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 45556789999999999998 5678999999998764 34456678999999999999999999999877 6899999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
|||+. +|.-++... +-.++..++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 198 eYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99964 887777653 3469999999999999999999999 599999999999999999999999999999876666
Q ss_pred CcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc-------
Q 005536 480 SHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD------- 551 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 551 (692)
....+..+-|..|.|||++.+. .|+.+.|+||.||||.||++|++.+......++............+....
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 6667888889999999988765 89999999999999999999999998665544433322211111111111
Q ss_pred ccccccCCc--CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 552 EIIDPYLEP--HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 552 ei~d~~l~~--~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..+.+.... ...+.........++|+..+|..||++|.|+.+++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 111110000 00001112335678999999999999999999887
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=345.13 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=208.3
Q ss_pred CCCCCChHHHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchh---HHHHHHHHHHHHhCCCCCeeeeE
Q 005536 310 SVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDS---IDQVMNEIKLLSSVSHPNLLRLL 386 (692)
Q Consensus 310 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~H~niv~l~ 386 (692)
.++.++.++++. .....||+|++|.||+|++ +++.||||+++...... .+.|.+|+.+|++++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 345556666633 2235799999999999987 68899999997653332 57788999999999999999999
Q ss_pred EEEEe----CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 387 GCCIE----EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 387 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
|++.+ ....++||||+++|+|.+++... ..++|..+++++.+++.||+|||+. .+++||||||+|||+++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCC
Confidence 99977 34678999999999999999764 4589999999999999999999974 3788999999999999999
Q ss_pred ceEEeeecCCccCCCCCCcccccCCCCCCCCCcccccc--CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH
Q 005536 463 RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY--FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~ 540 (692)
.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 161 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~- 229 (283)
T PHA02988 161 KLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------E- 229 (283)
T ss_pred cEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------H-
Confidence 9999999999753221 123468899999999876 68999999999999999999999999743221 1
Q ss_pred HHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
....+..+..... .+......+.+|+.+||+.||++|||++||++.|+.++.
T Consensus 230 ~~~~i~~~~~~~~-----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 230 IYDLIINKNNSLK-----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHhcCCCCC-----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1222211111100 011234578999999999999999999999999998763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=346.25 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=200.3
Q ss_pred ccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHh--CCCCCeeeeEEEEEeCC----eeEEEEE
Q 005536 327 SEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSS--VSHPNLLRLLGCCIEEG----EPILVYE 400 (692)
Q Consensus 327 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~H~niv~l~g~~~~~~----~~~lV~E 400 (692)
+..+.||+|.||.||||++.+ +.||||++. .++.+.|++|-.|.+. |+|+||+++++.-.... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 345679999999999999865 889999997 4566788999888875 57999999999876555 8999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM------NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~------~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
|.++|+|.+||..+ .++|....+||..+++||+|||+.. +++|+|||||++||||..|++..|+|||+|..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999875 4999999999999999999999854 57899999999999999999999999999976
Q ss_pred CCCCCC-cccccCCCCCCCCCccccccC-CCC-----CccceeehhHHHHHHHhCCcccCC-CCCcccccHH--------
Q 005536 475 GMTESS-HISTAPQGTPGYLDPQYHQYF-HLS-----DKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLA-------- 538 (692)
Q Consensus 475 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s-----~ksDV~SfGvll~eLltg~~p~~~-~~~~~~~~~~-------- 538 (692)
...... ......+||.+|||||++.+. .+. .+.||||+|.|||||+++-..++. ..+.-+..+.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 443221 122336899999999998654 233 368999999999999998665532 1111111000
Q ss_pred -HHHHHH-hccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 539 -ALAIDR-IGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 539 -~~~~~~-~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
+...+. +++.....+.|.-.. ..-+..+.+.+..||..|++.|.|+.=|.+++.++...
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~-------h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK-------HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc-------CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111111 111111222222111 13456788999999999999999999999999887653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=360.80 Aligned_cols=266 Identities=27% Similarity=0.391 Sum_probs=215.8
Q ss_pred hHHHHHhhccCccceeecccccEEEEEEEEeCC----CE-EEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEE
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHND----DW-VAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLG 387 (692)
Q Consensus 316 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~----~~-vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g 387 (692)
...++...++....++||+|+||.||+|++... .. ||||..+.. ......+|++|.+++++++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 344555556666678999999999999997543 23 899999853 3667889999999999999999999999
Q ss_pred EEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEe
Q 005536 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVA 467 (692)
Q Consensus 388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 467 (692)
++.....++||||+++||+|.+||++... .++..++++++.+.|.||+|||+ +++|||||.++|+|++.+..+||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999998753 69999999999999999999999 499999999999999999999999
Q ss_pred eecCCccCCCCCCcccc-cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHh
Q 005536 468 DFGLSRLGMTESSHIST-APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRI 545 (692)
Q Consensus 468 DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~ 545 (692)
||||++.... ..... ...-..+|+|||.+..+.++.++|||||||++||+++ |..|+.... .. .+..++
T Consensus 305 DFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~------~~-~v~~kI 375 (474)
T KOG0194|consen 305 DFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK------NY-EVKAKI 375 (474)
T ss_pred ccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC------HH-HHHHHH
Confidence 9999986431 11111 2235679999999999999999999999999999999 666765322 12 233334
Q ss_pred -ccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 546 -GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 546 -~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
..+.... .+...+.++..+..+||..+|++||+|.++.+.|+.+....-
T Consensus 376 ~~~~~r~~------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 VKNGYRMP------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HhcCccCC------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 3222111 112345677888999999999999999999999999876543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.22 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=213.5
Q ss_pred ccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
..|...++||+|+.|.||.++ ..+++.||||++........+-.++|+.+|+..+|+|||.+++.+...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456677789999999999997 5568899999999887777788899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++|+|.|.+.... +++.++..|+.++++||+|||. ++|+|||||.+||||+.++.+||+|||++..+..+.. .
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999887643 9999999999999999999999 5999999999999999999999999999987554443 4
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....+|||.|||||+.....|..|.||||||++++||+-|++||-...+.. ++.++......++-.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~P~lk~~------ 492 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPKLKNP------ 492 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCCCCcCCc------
Confidence 466789999999999999999999999999999999999999997544322 2334443333333222
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
......+.+++.+||+.|+++||++.|+++
T Consensus 493 ----~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 ----EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ----cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 234467899999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.16 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=205.6
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
+.|+...++|+|+||+|||.+.++ |+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 356777889999999999999765 89999999986533 334557899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++. ++.+-|... ...++......++.|++.|+.|+|+. ++|||||||+||||+.++.+||+|||+|+.... ..
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9965 444555544 34589999999999999999999994 999999999999999999999999999997543 45
Q ss_pred cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHh--------ccC-cc
Q 005536 481 HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI--------GRG-CV 550 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~-~~ 550 (692)
...+..+.|..|.|||.+.+ .+|....||||+||++.||++|.+.|......++..+....+..+ ..+ ..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 55677889999999999877 689999999999999999999999887654444433332222111 111 01
Q ss_pred cccccccC---CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 551 DEIIDPYL---EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 551 ~ei~d~~l---~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.-+.-|.. .+....+ .....-+++++..||+.||++|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111110 0111111 133446889999999999999999998873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=341.97 Aligned_cols=262 Identities=19% Similarity=0.217 Sum_probs=204.9
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999985 468899999987542 2334568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++|+|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 9999999988876544569999999999999999999999 49999999999999999999999999999763222
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......||..|+|||++.+..++.++|||||||++|||++|+.||........ .......+.....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~---------- 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE---------- 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc----------
Confidence 122345789999999999999999999999999999999999999975432211 1111111211100
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
..+.....++.+|+.+||+.+|++||++.+. ..+++..++|...
T Consensus 223 ---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~--~~~~~~~h~~~~~ 266 (285)
T cd05631 223 ---EYSEKFSEDAKSICRMLLTKNPKERLGCRGN--GAAGVKQHPIFKN 266 (285)
T ss_pred ---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCC--CHHHHhcCHhhcC
Confidence 1111233578899999999999999973221 1223335666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.07 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=210.7
Q ss_pred hccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.+.|+....||.|..++||+|+ ...++.||||++.... ....+.+.+|+..++.++||||++++..|..++.+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578889999999999999998 5567999999998664 3346899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
||.+|++.+.+...-...+++..+..|..++++||.|||+ +|.||||||+.|||||.+|.+||+|||.+........
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999988766779999999999999999999999 5999999999999999999999999998765333221
Q ss_pred c---ccccCCCCCCCCCccccc--cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 481 H---ISTAPQGTPGYLDPQYHQ--YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 481 ~---~~~~~~gt~~Y~aPE~~~--~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
. .....+||+.|||||++. -..|+.|+||||||++..||.+|..||....| ....+..+. +.......
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLq-n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQ-NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc-CCCCCccc
Confidence 1 115568999999999843 33699999999999999999999999974433 122223333 22221111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+. .+........+.+++..||+.||++|||++++++
T Consensus 255 ~~~~---~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLD---KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCC---hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111 1122334457899999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.45 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=210.5
Q ss_pred hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.++|+..++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3568889999999999999999888889999998754 334678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.++++......+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999987666679999999999999999999999 499999999999999999999999999998643322222
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||++....++.++||||||+++|||+| |+.||..... ......+.++.... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--------~ 225 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-------SDVMSALQRGYRMP--------R 225 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCC--------C
Confidence 233456778999999988899999999999999999998 8888853221 11222232221110 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
. .....++.+++.+||+.+|++||+++++.+.|+.+
T Consensus 226 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 M----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 11235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.37 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=204.0
Q ss_pred HhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCee
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~ 395 (692)
+-.++|...+.||+|+|++|++++. ..++.||||++.+. .+...+-...|-.+|.+| .||.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446788899999999999999984 45889999999754 223344566799999999 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
|+|+||++||+|.++|++. +.+++.-....|.||+.||+|||+. |||||||||+|||||+|+++||+|||.|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999886 4589888999999999999999994 9999999999999999999999999999874
Q ss_pred CCCCC----------ccc--ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHH
Q 005536 476 MTESS----------HIS--TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 476 ~~~~~----------~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~ 543 (692)
..... ... ...+||..|.+||++.....+..+|+|+|||+||+|+.|++||...++.. ..+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-------iFq 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-------IFQ 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-------HHH
Confidence 43111 111 34689999999999999999999999999999999999999997554321 122
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eV 594 (692)
+|.. +|- +++....+.+.+|+.+.|..||.+|+|.+||
T Consensus 298 kI~~------l~y-------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 298 KIQA------LDY-------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred HHHH------hcc-------cCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence 2221 011 1223344678899999999999999997444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.49 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=206.2
Q ss_pred hccCccceeecccccEEEEEEEEe----CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH----NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
.++|+..+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999864 35689999998653 2345679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997653 468999999999999999999998 4999999999999999999999999998765322
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+.+.++....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~~~---- 228 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGFRLP---- 228 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCCC----
Confidence 21111122345678999999999999999999999999999875 99988643221 1233333331111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.+...+..+.+++.+||+.+|++||+++||.+.|+++
T Consensus 229 --------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=339.19 Aligned_cols=262 Identities=25% Similarity=0.362 Sum_probs=201.4
Q ss_pred ccCccceeecccccEEEEEEEEeC-----------------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-----------------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRL 385 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l 385 (692)
++|...++||+|+||.||++.+.+ +..||+|.++... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997543 2369999987653 3345679999999999999999999
Q ss_pred EEEEEeCCeeEEEEEeCCCCCHHHHHhhcc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 005536 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRER-----------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448 (692)
Q Consensus 386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiH 448 (692)
++++.+.+..++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999986532 12478899999999999999999994 9999
Q ss_pred cCCCCCceEEcCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhC--Ccc
Q 005536 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA--LKV 525 (692)
Q Consensus 449 rDik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg--~~p 525 (692)
|||||+|||+++++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975322211 122334568899999999888999999999999999999975 445
Q ss_pred cCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 526 VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
+...... .........+......... ..+...+..+.+|+.+||+.+|++||||.||.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVYL---------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccccccc---------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5422211 1111111111111100000 0011234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.20 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=204.9
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
+.|+..+.||+|+||.||++.+.++..+|+|.++.. ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999888888999998643 3345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+|+|.++++... ..+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999997643 358999999999999999999998 4999999999999999999999999999876433222222
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.+.++... ..+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~--~~~~----- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRL--YRPK----- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCC--CCCC-----
Confidence 23345678999999988889999999999999999999 8888853321 1122333333211 1111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
.....+.+|+.+||+.+|++||+|.|+++.|
T Consensus 225 -----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=323.04 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=213.6
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||.|+||+|.+.+.+ ++..+|+|++.+.. ..+.+...+|..+|+.+.||.++++.+.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34666889999999999999854 57889999998653 345567789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|-|+.+|++. +++++....-+|.||+.||+|||+. +|++|||||+|||||.+|.+||.|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999875 4599999999999999999999994 999999999999999999999999999986322
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
..-...|||.|+|||.++...+..++|.|||||++|||+.|.+||...++ ....++|-++.+.
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~-------- 259 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVK-------- 259 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCccc--------
Confidence 23556899999999999999999999999999999999999999986654 2345555554332
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhccccccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMR-PTMMEVAEELEHIRVSSWASNIYM 612 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~R-Psm~eVl~~L~~i~~~~~~~~~~~ 612 (692)
.+.-...++.+|+.+.|+.|-.+| -.+. .=-+.|+.++|...+.+
T Consensus 260 -----fP~~fs~~~kdLl~~LL~vD~t~R~gnlk---nG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 260 -----FPSYFSSDAKDLLKKLLQVDLTKRFGNLK---NGVEDIKNHPWFKGVDW 305 (355)
T ss_pred -----CCcccCHHHHHHHHHHHhhhhHhhhcCcC---CCccccccCcccccccH
Confidence 111222467899999999999999 2222 12357788999876654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.49 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=209.5
Q ss_pred hhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..++|+..+.||+|++|.||+|...+++.||+|.++... ...++|.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788899999999999999998788889999987543 3457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++....+..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999999987655679999999999999999999998 49999999999999999999999999999864322211
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+..... ......+.++....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~-------- 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQGYRMP-------- 224 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCC--------
Confidence 1122233468999999998899999999999999999999 8888853221 11122222211100
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 ----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=337.22 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=214.2
Q ss_pred HhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
....+|+..++||+|+||+||+|+..++..+++|.+.........++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45567888999999999999999988899999999987766567789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.+++....+..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++...... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-V 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc-c
Confidence 9999999999987666679999999999999999999998 59999999999999999999999999999764322 2
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......++..|++||.+....++.++||||||+++|||++ |+.|+...... .....+..+....
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~------- 224 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------EVYDQITAGYRMP------- 224 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHHhCCcCC-------
Confidence 22223456778999999988899999999999999999998 78888643211 1112222211100
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 -----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.47 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=208.1
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
..|+..++||+|+||.||+|...+ ++.||+|.++.. ....+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788899999999999998654 788999998754 445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999999987655679999999999999999999998 599999999999999999999999999997643322222
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||++.+..++.++||||||+++|||++ |..|+..... ....+.+..+...+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--------- 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKGYRME--------- 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCCC---------
Confidence 222345678999999998999999999999999999998 8888763321 11122232221111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.+...+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.47 Aligned_cols=256 Identities=26% Similarity=0.351 Sum_probs=209.5
Q ss_pred HhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC----Cc-hhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCC
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR----DT-DSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEG 393 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~ 393 (692)
...++|...+.||+|+||+|+.|.. .+++.||||.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4557899999999999999999974 45799999976653 11 23455668999999999 999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CceEEeeecCC
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLS 472 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla 472 (692)
..++||||+.+|+|.+++.. ...+.+.....++.|++.|++|+|+ ++|+||||||+|||||.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999988 3558889999999999999999999 499999999999999999 99999999999
Q ss_pred ccCCCCCCcccccCCCCCCCCCccccccCC-CC-CccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYFH-LS-DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ... ....+.++..
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~-l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPN-LYRKIRKGEF 240 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHH-HHHHHhcCCc
Confidence 8743 2334456778999999999999877 76 68999999999999999999998522 122 2222444322
Q ss_pred cccccccCCcCCCccCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 551 DEIIDPYLEPHRDAWTLSS-IHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~-~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.- +... ..++..|+.+||+.+|.+|+++.||+ .++|...
T Consensus 241 ~~-------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-------~h~w~~~ 280 (370)
T KOG0583|consen 241 KI-------------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL-------EHPWFQK 280 (370)
T ss_pred cC-------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-------hChhhcc
Confidence 10 0011 45788999999999999999977776 5677654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.03 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=205.2
Q ss_pred hhccCccceeecccccEEEEEEEE------eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL------HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEG 393 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~ 393 (692)
..++|+..+.||+|+||+||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788899999999999999974 235579999997543 34456789999999999 8999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccC---------------------------------------------------------
Q 005536 394 EPILVYEFMPNGTLCQHLQRERG--------------------------------------------------------- 416 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 416 (692)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999975321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 417 ----------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 417 ----------------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
..++|..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 247899999999999999999999 4999999999999999999999999999976433221
Q ss_pred c-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 481 H-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 481 ~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
. ......++..|+|||++.+..++.++||||||+++|||++ |..||...... ....+.+.++.... .+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~--~~-- 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRML--SP-- 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCC--CC--
Confidence 1 1223345678999999999999999999999999999998 77787533211 11222233221111 00
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.....++.+|+.+||+.+|++||+|.||+++|++.
T Consensus 340 --------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 --------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.83 Aligned_cols=249 Identities=32% Similarity=0.497 Sum_probs=196.8
Q ss_pred cceeecccccEEEEEEEEe-----CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 328 EKHRLGTGAYGTVYAGKLH-----NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++++++++||||++++|++.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 24679999997543 34578999999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC-CCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT-ESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~-~~~ 480 (692)
+++|+|.++|.......+++..++.|+.|+|+||+|||+ .+|+|+||+++|||+++++.+||+|||+++.... ...
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999998755679999999999999999999999 4899999999999999999999999999986422 122
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
...........|+|||.+....++.++||||||+++|||++ |+.|+.... .......+.++......
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~----- 227 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQRLPIP----- 227 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEETTSB-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccceec-----
Confidence 22334457789999999999999999999999999999999 677764321 12223344433322211
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
......+.+++.+||..+|++||+|.+++++|
T Consensus 228 -------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 -------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11235688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.40 Aligned_cols=264 Identities=30% Similarity=0.461 Sum_probs=225.6
Q ss_pred hHHHHHhhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE 394 (692)
Q Consensus 316 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~ 394 (692)
++++|--.......++||-|.||.||.|.+.. .-.||||.++. +....++|++|..+|+.++|||+|+|+|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 36666666777788999999999999999876 45799999975 46778999999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
+|||+|||.+|+|.+||.+.....++--..+.+|.||+.|+.||.. +.+|||||.++|.|+.++..+||+||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999998877778888999999999999999998 5999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
...+.........-...|.|||-+....++.|||||+|||+||||.| |..|+. .+++.+ +.+.+++|-
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP------GidlSq-VY~LLEkgy---- 483 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYGLLEKGY---- 483 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC------CccHHH-HHHHHhccc----
Confidence 66665555555556789999999999999999999999999999998 766664 233332 344444431
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
+-+.+..++..+.+|++.||+.+|.+||++.|+-+.+|.+-
T Consensus 484 --------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 --------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 11234467789999999999999999999999999998754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.98 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=214.2
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
-.+.|+..+.||+|+||.||+++.. .|..+|+|++++.. ..+.+....|-.+|...++|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999855 48999999999764 4456778899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||++||++..+|... ..|++......+.+++.|+.-||+. |+|||||||+|+|||..|++||+||||+.-...
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999875 5699999999999999999999996 999999999999999999999999999842110
Q ss_pred ----C-------------------CC----cc-------------------cccCCCCCCCCCccccccCCCCCccceee
Q 005536 478 ----E-------------------SS----HI-------------------STAPQGTPGYLDPQYHQYFHLSDKSDVYS 511 (692)
Q Consensus 478 ----~-------------------~~----~~-------------------~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S 511 (692)
+ .. .. ....+|||.|||||++.+..|+...|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 00 00 01135999999999999999999999999
Q ss_pred hhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005536 512 FGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTM 591 (692)
Q Consensus 512 fGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm 591 (692)
||+|+||||.|.+||....+.+- +.++...+..-. - +... ....+..+||.+|+. ||++|.-.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~~l~-f----P~~~----~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRETLK-F----PEEV----DLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhhhcc-C----CCcC----cccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999986665332 222222211000 0 0001 122678899999999 99999762
Q ss_pred HHHHHHHHhhhhcccccccccCC
Q 005536 592 MEVAEELEHIRVSSWASNIYMGS 614 (692)
Q Consensus 592 ~eVl~~L~~i~~~~~~~~~~~~s 614 (692)
.-+++|+.++|+..+.|..
T Consensus 437 ----~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 437 ----KGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred ----ccHHHHhcCCccccCCcch
Confidence 3356788999998776533
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.71 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=205.8
Q ss_pred HHhhccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIE 391 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~ 391 (692)
.-..++|+..+.||+|+||.||+++.. ++..||||+++... ....+.+.+|+.+++.+ +|+||+++++++.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 334567888999999999999998742 23579999997543 33456788999999999 89999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcc--------------------------------------------------------
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRER-------------------------------------------------------- 415 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 415 (692)
.+..++||||+++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999986431
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc-c
Q 005536 416 ------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH-I 482 (692)
Q Consensus 416 ------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~ 482 (692)
...+++..+++|+.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1247888999999999999999999 59999999999999999999999999999754332211 1
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .....+..+.... .+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~~--~~----- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQMS--RP----- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCcc--CC-----
Confidence 223345678999999998899999999999999999997 999986432211 1112222111000 00
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.....++.+++.+||+.+|++||++.+|+++|+++
T Consensus 338 -----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 -----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01235788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=342.10 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=194.6
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+.||+|+||.||+++.. +++.||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999999754 2345567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 999988764 458999999999999999999999 499999999999999999999999999987532221 22234
Q ss_pred CCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCcc
Q 005536 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~ 565 (692)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+.+..+... .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~~~-------------~ 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIR-------------F 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCC-------------C
Confidence 56999999999999999999999999999999999999998643221 111112111110 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 005536 566 TLSSIHNVAELAFRCLAFHRDMRP-----TMMEVA 595 (692)
Q Consensus 566 ~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl 595 (692)
+.....++.+|+.+||+.+|++|| ++.+++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l 249 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 249 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHH
Confidence 112335678999999999999998 666665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=340.21 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=204.4
Q ss_pred ccCccceeecccccEEEEEEEEeC-CC----EEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DD----WVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
..|+..+.||+|+||+||+|++.. ++ .||+|.++... ....++|.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 458889999999999999998643 33 38999987543 34567899999999999999999999999765 5789
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998653 458999999999999999999999 4999999999999999999999999999986443
Q ss_pred CCCcc-cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ESSHI-STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.|++..... .....+..+.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERLP--Q 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCCCCC--C
Confidence 22221 122335678999999999999999999999999999998 88888632211 1112222211100 0
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~ 605 (692)
+......+.+++.+||+.+|.+||++.+++..|.++...+
T Consensus 233 ----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 233 ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0112346789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.66 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=209.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|...+.||+|.||.||||+.+ +.+.||+|.+.+.. +.+.+.+.+|++|+++++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888889999999999999854 46889999997653 4457789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+.+ +|..+|... ..++++....|+.++..||.|||+. +|+|||+||+||||+.++.+|++|||+|+. +....
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~-m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARA-MSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhh-cccCc
Confidence 9965 999999864 4599999999999999999999995 999999999999999999999999999997 44456
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
...+...|||-|||||+..+.+|+..+|.||+||+|||+++|++||.... .....+.|... +
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d-------~---- 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKD-------P---- 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcC-------C----
Confidence 67788899999999999999999999999999999999999999996211 11122233221 1
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..++......+..++...|..||.+|.+..+++.
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1223355667889999999999999999888763
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.08 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=207.1
Q ss_pred ccCccceeecccccEEEEEEEEeC----CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
++|+..+.||+|+||+||+|++.. ...||||.++... ....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998743 3579999987543 33456799999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC-
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT- 477 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~- 477 (692)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999997654 368999999999999999999999 5999999999999999999999999999986432
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
..........++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ....+.+.++...+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~--- 229 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRLPP--- 229 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCCC---
Confidence 11112223345678999999998899999999999999999998 8888753211 112233332211110
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+......+.+|+.+||+.+|++||++.||++.|+++
T Consensus 230 ---------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ---------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=334.56 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=207.7
Q ss_pred ccCccceeecccccEEEEEEEEeCC------CEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHND------DWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
+.|+..+.||+|+||.||+|..... ..|++|.++... ....++|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 3577788999999999999986442 479999987543 334567899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 397 LVYEFMPNGTLCQHLQRERG--------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
++|||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999976422 348899999999999999999999 4999999999999999999
Q ss_pred ceEEeeecCCccCCCCC-CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHH
Q 005536 463 RSKVADFGLSRLGMTES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 463 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~ 540 (692)
.+||+|||+++...... ........+++.|+|||++.+..++.++||||||+++|||++ |..||....+ ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 99999999997543222 122234456889999999988899999999999999999998 9888864322 11
Q ss_pred HHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
..+.+..+..... +...+.++.+|+.+||+.+|.+||++.||++.|+.+
T Consensus 235 ~~~~i~~~~~~~~------------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQLLPC------------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCCcCCC------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2333333322211 123446889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.07 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=204.5
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
+.|...+.||+|+||+||+|+..++..+|+|.++.. ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 356778899999999999999877778999998754 3345779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+|+|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999997653 368999999999999999999998 4999999999999999999999999999876433222222
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....++..|++||++.+..++.++||||||+++|||++ |+.|+..... ......+.++.....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~--------- 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRLYR--------- 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCCCC---------
Confidence 23346678999999998889999999999999999999 8888753321 112223322211110
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 ---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112357899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.15 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=213.2
Q ss_pred hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.+.....++||+|.||.|.+.....+..||||+++.... ....+|.+|+++|.+++||||+.|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345566789999999999999998889999999997754 4458999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC-C
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES-S 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~-~ 480 (692)
|++|+|.++|..+....+.-..-++|+.|||.||+||.+. +++||||.++|+|+|.++++||+|||++|-..... .
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999987655556667788999999999999996 99999999999999999999999999999644433 3
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh--CCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT--ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
+.....+-..+|||||.+..++++.+||||+|||+|||+++ ..+|+....... ..+.. .++++..-
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~---------~~~~~~~~ 761 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENA---------GEFFRDQG 761 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhh---------hhhcCCCC
Confidence 34445556789999999999999999999999999999986 666765222111 01111 11111111
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.......+.-++..+.+|+.+||+.+-++||+++++...|.+.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111123345677899999999999999999999999888764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.52 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=202.4
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||.||+++..+ ++.||||+++... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468889999999999999999764 7899999997542 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999754 458999999999999999999999 4999999999999999999999999999975322
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.... +.+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~--~~~~~--- 219 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------TWENLKYWK--ETLQR--- 219 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-------HHHHHHhcc--ccccC---
Confidence 2244579999999999998899999999999999999999999997443211 111111110 00000
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+...........++.+|+.+||+.+|++||++.|++
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 000000012345788999999999999999988776
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=343.25 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=202.3
Q ss_pred CCCChHHHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005536 312 PFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391 (692)
Q Consensus 312 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~ 391 (692)
...|++++.. .+-||.|+.|.||+|++++ +.||||+++.-. ..+|+-|++|+|+||+.|.|+|..
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 3456666543 5679999999999999964 569999986321 257888999999999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
...++|||||++.|-|...|+.. ..++......|..+||.|+.|||.+ .|||||||+-||||..+..+||+|||-
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999764 5688889999999999999999995 999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
++...+. .......||..|||||++++.+.++|.|||||||||||||||..|+..-.....+ --++.+.+
T Consensus 259 S~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------wGVGsNsL- 328 (904)
T KOG4721|consen 259 SKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------WGVGSNSL- 328 (904)
T ss_pred hHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------EeccCCcc-
Confidence 9863332 2234557999999999999999999999999999999999999988532221111 01111111
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
. -..+..+++.+.-|+++||+..|..||++++++..|+
T Consensus 329 -------~---LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 329 -------H---LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred -------c---ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1 1223456678888999999999999999999998875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=334.16 Aligned_cols=267 Identities=21% Similarity=0.241 Sum_probs=201.0
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..+.||+|+||+||+++.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 47889999997542 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++++.|..+.. . ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~-~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEE-M-PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHh-c-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999877755443 2 3458999999999999999999998 4999999999999999999999999999986433222
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHH--------HHHh-ccCccc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALA--------IDRI-GRGCVD 551 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~~~ 551 (692)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...+ ......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2333456899999999999888999999999999999999999999743321111100000 0000 000000
Q ss_pred ccccccCCcCC---CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 552 EIIDPYLEPHR---DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 552 ei~d~~l~~~~---~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
....+...... ..........+.+|+.+||+.||++|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000000 000112345789999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.85 Aligned_cols=199 Identities=27% Similarity=0.387 Sum_probs=175.4
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.++|+..+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467899999999999999999865 47789999987653 3345679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999999764 3589999999999999999999984 36999999999999999999999999998753221
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF 528 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~ 528 (692)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345689999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=311.48 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=206.5
Q ss_pred ccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCch--hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.+|...++||+|.||.||+|+ ...|+.||||+++..+.. -.....+|++.|+.++|+||+.|++++.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778899999999999998 456899999999876432 23467899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
||+ -+|+..++.+ ...++...+..++.++++||+|||+ +.|+||||||+|+|++.++.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 995 5898888765 4568999999999999999999999 499999999999999999999999999999855433
Q ss_pred cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC-
Q 005536 481 HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL- 558 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l- 558 (692)
...+..+-|..|.|||.+.+ .+|+...|+||.||++.||+-|.+-|..... ++........++.-..+++.+-.-
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCcccccc
Confidence 33344478999999998765 4799999999999999999999877765433 333333444444322222211100
Q ss_pred ----------CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 559 ----------EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 559 ----------~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+..+..-....+++.+|+.+++.+||.+|.+++|+++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 00011111234456799999999999999999999873
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.30 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+.||+|+||+||+++.. +++.||||+++.. ......++.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999999754 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 999999764 4589999999999999999999994 9999999999999999999999999998753221 122234
Q ss_pred CCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCcc
Q 005536 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~ 565 (692)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+.. . .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~------~-------~ 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI------R-------F 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCC------C-------C
Confidence 5699999999999999999999999999999999999999863221 111222222111 0 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhhhccccccc
Q 005536 566 TLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 566 ~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl~~L~~i~~~~~~~~~ 610 (692)
+.....++.+|+.+||+.||++|| ++.+++ .++|....
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll-------~h~~f~~~ 257 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM-------EHRFFASI 257 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH-------cCCCcCCC
Confidence 112335688999999999999999 666665 56666543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.84 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=206.0
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||+||+++.. +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 47899999997542 234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999999764 458899999999999999999999 49999999999999999999999999999763222
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....+ ....+.+.++... +
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~-~------ 234 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLK-F------ 234 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcC-C------
Confidence 1234689999999999999999999999999999999999999864321 1123333333211 0
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
+.....++.+|+.+||+.||.+||+. +...+++|..++|...
T Consensus 235 ------p~~~~~~~~~li~~~L~~dP~~R~~~--~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 235 ------PNWFDGRARDLVKGLLQTDHTKRLGT--LKGGVADVKNHPYFHG 276 (329)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHcCCC--CCCCHHHHhcCCccCC
Confidence 00122467899999999999999972 1122455557777654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.13 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=204.4
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||.||+++.. +++.||||.++.. .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 5789999999854 233456788999999998 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 9999988754 459999999999999999999999 49999999999999999999999999998742221 12233
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcc--cccHHHHHHHHhccCcccccccccCCcCC
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHS--EVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||+...... ......+..+.+.++... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I---- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C----
Confidence 4579999999999999999999999999999999999999997432221 111222223333322111 0
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
+.....++.+++.+||+.+|.+||++... ..++++..++|....
T Consensus 225 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i~~hp~~~~~ 268 (329)
T cd05588 225 ---PRSLSVKASSVLKGFLNKDPKERLGCHPQ-TGFRDIKSHPFFRNI 268 (329)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHHhcCCCCCCC
Confidence 11123467899999999999999984322 224555678887644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.03 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=197.1
Q ss_pred ccCccceeecccccEEEEEEEEe--CCCEEEEEEeecCC--chhHHHHHHHHHHHHhC---CCCCeeeeEEEEEe-----
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH--NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSV---SHPNLLRLLGCCIE----- 391 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~H~niv~l~g~~~~----- 391 (692)
++|+..+.||+|+||+||+++.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999987543 22334566788777766 69999999999863
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
....++||||++ ++|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999995 699999987655669999999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ......+........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 9753222 22344568999999999988899999999999999999999999987543322 111122211100000
Q ss_pred ----------ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 552 ----------EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 552 ----------ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..+.+................+.+|+.+||+.+|++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 00000000000000112335678999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.76 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=205.3
Q ss_pred hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.++|+..++||+|+||.||++...++..||+|.++.... ..+.|.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356788899999999999999988888899999976433 4567999999999999999999999875 45689999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.++++......+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999999987655668999999999999999999999 499999999999999999999999999997643322222
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.+..+...+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~--------- 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERGYRMP--------- 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCC---------
Confidence 222345678999999988899999999999999999999 8888853221 11222232221110
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.+......+.+|+.+||+.+|++|||+.++.+.|++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 ---CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.03 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=208.8
Q ss_pred hhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..+.|+..++||+|+||.||++...+++.||+|.+.... ...++|.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 456788899999999999999998889999999987543 3457899999999999999999999986 45678999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++....+..+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999999987666679999999999999999999998 49999999999999999999999999999764322222
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
......++..|+|||++....++.++||||||+++|||++ |+.||...... ...+.+.++...+.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~------- 224 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGYRMPR------- 224 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCCCCCC-------
Confidence 2233456789999999998899999999999999999999 99988633211 11222322211111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
+.....++.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.65 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=206.1
Q ss_pred hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.++|...++||+|+||+||+|+..+...||+|+++... ...++|.+|++++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 45688999999999999999998777789999997543 34567999999999999999999999874 45689999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++|+|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999987655568999999999999999999999 599999999999999999999999999997643322222
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|++||+..+..++.++||||||+++|||++ |+.||...... .....+..+...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~---------- 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRM---------- 222 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCCC----------
Confidence 223456778999999988899999999999999999999 77777533211 112222221100
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.........+.+|+.+|++.+|++||++.++++.|+..
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123446788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=346.04 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=208.1
Q ss_pred HHhhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEe
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIE 391 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~ 391 (692)
+...++|...++||+|+||.||+|+... ...||||+++... ....+.|.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3445678889999999999999998532 2369999997543 334567999999999996 9999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcc--------------------------------------------------------
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRER-------------------------------------------------------- 415 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 415 (692)
.+..+|||||+++|+|.++|+...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999999987532
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 005536 416 --------------------------------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNIL 457 (692)
Q Consensus 416 --------------------------------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NIL 457 (692)
...+++..++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEE
Confidence 1247888999999999999999999 49999999999999
Q ss_pred EcCCCceEEeeecCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccc
Q 005536 458 LDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEV 535 (692)
Q Consensus 458 ld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~ 535 (692)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--- 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--- 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence 999999999999999864332221 1223457789999999998899999999999999999997 88887633211
Q ss_pred cHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 536 NLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 536 ~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
......+..+.... .+.....++.+++.+||+.+|++||++.+|+++|+++.
T Consensus 347 ---~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 ---STFYNKIKSGYRMA------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHHHHhcCCCCC------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11222232221110 01123457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.50 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=210.8
Q ss_pred ccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
.+|...+.||+|+||.||+++.. ++..+++|.++.......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999743 245689999876655666789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 005536 398 VYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR 463 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~ 463 (692)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999997542 1348999999999999999999998 59999999999999999999
Q ss_pred eEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHH
Q 005536 464 SKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALA 541 (692)
Q Consensus 464 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~ 541 (692)
+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.|+...... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EV 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence 99999999975332221 22234456889999999998899999999999999999999 98887543221 12
Q ss_pred HHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 542 IDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 542 ~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.+.+..+...+.. ...+..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus 235 ~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLERP------------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCCC------------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 3333333222211 12335788999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.79 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=210.6
Q ss_pred ccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
++|...+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999742 235689999876655667789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEE
Q 005536 398 VYEFMPNGTLCQHLQRER-----------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV 466 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl 466 (692)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 1248999999999999999999998 49999999999999999999999
Q ss_pred eeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHH
Q 005536 467 ADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDR 544 (692)
Q Consensus 467 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~ 544 (692)
+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence 99999975432221 11223346788999999998899999999999999999998 8888753321 112333
Q ss_pred hccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 545 IGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 545 ~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
+..+...... ......+.+|+.+||+.+|.+|||+.||++.|+++...
T Consensus 235 i~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRP------------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCC------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 4433322110 11234689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.28 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|...++||+|+||+||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999865 57899999987543 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
++ ++|.+++... +..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TK 158 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-Cc
Confidence 96 5999988754 3458899999999999999999999 49999999999999999999999999999753221 12
Q ss_pred ccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC---cccc-----
Q 005536 482 ISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG---CVDE----- 552 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~e----- 552 (692)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ....+... ...+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccch
Confidence 2234568999999998765 5689999999999999999999999975433222111 11111100 0000
Q ss_pred ----cccccCCcC-CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 553 ----IIDPYLEPH-RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 553 ----i~d~~l~~~-~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
...+..... ..........+..+|+.+||+.||.+|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 000000000 0000011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=335.48 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=203.9
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999865 57899999997542 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999764 458999999999999999999999 49999999999999999999999999999763221
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.+..+...
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~-------- 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGKLE-------- 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcC--------
Confidence 1234689999999999988999999999999999999999999864322 1122333322211
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhhhcccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPT-MMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPs-m~eVl~~L~~i~~~~~~~~ 609 (692)
.+......+.+|+.+||+.||.+||+ |.+ .++++..++|...
T Consensus 217 -----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~---~~~~~l~h~~~~~ 259 (291)
T cd05612 217 -----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKN---GADDVKNHRWFKS 259 (291)
T ss_pred -----CCccCCHHHHHHHHHHcCCCHHHccCCccC---CHHHHhcCccccC
Confidence 01112346789999999999999995 111 1233347777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.00 Aligned_cols=250 Identities=27% Similarity=0.413 Sum_probs=202.6
Q ss_pred cCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
.|+..+.||+|+||.||+++..++..+|+|.+.... ...++|.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467788999999999999998777789999986442 3446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999997653 368999999999999999999999 49999999999999999999999999999764332222222
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
...++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+....
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~----------- 221 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSAGYRLY----------- 221 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHcCCcCC-----------
Confidence 2334568999999998899999999999999999999 78888643221 1122222221100
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 564 ~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
.+.....++.+|+.+||+.+|++||||.||++.|
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=335.90 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=195.3
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+.||+|+||.||+++.. +++.||+|+++.. ......++.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 5889999999754 2345667889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 999988764 458999999999999999999999 499999999999999999999999999987532221 22234
Q ss_pred CCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCcc
Q 005536 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~ 565 (692)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+.. . .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~~~~------~-------~ 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEDI------K-------F 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhccCCc------c-------C
Confidence 57999999999999889999999999999999999999998643211 11122211111 0 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 005536 566 TLSSIHNVAELAFRCLAFHRDMRP-----TMMEVA 595 (692)
Q Consensus 566 ~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl 595 (692)
+.....++.+|+.+||+.+|++|| ++.|++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 112335678999999999999997 777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.38 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=198.9
Q ss_pred eeecccccEEEEEEEE-eCCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+.||+|+||+||+++. .+++.||+|.++.. ......++.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 45789999999754 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
+|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 999988754 4589999999999999999999973 489999999999999999999999999987532222 22234
Q ss_pred CCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCcc
Q 005536 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~ 565 (692)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+... +
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~~~~------~------- 215 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEIR------F------- 215 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcCCCC------C-------
Confidence 56999999999999989999999999999999999999998643211 111222111110 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhhhccccccc
Q 005536 566 TLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 566 ~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl~~L~~i~~~~~~~~~ 610 (692)
+.....++.+|+.+||+.||++|+ ++.+++ .++|....
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il-------~h~~~~~~ 258 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM-------QHKFFAGI 258 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh-------cCCCcCCC
Confidence 111234678999999999999997 777776 45665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.67 Aligned_cols=262 Identities=23% Similarity=0.274 Sum_probs=202.0
Q ss_pred cCccceeecccccEEEEEEEE----eCCCEEEEEEeecC----CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCee
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL----HNDDWVAIKRFRYR----DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~ 395 (692)
+|+..+.||+|+||+||+++. .+++.||+|.++.. .....+.+.+|+.++.++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 35788999999743 223456788999999999 499999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999764 458999999999999999999999 49999999999999999999999999999864
Q ss_pred CCCCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 476 MTESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 476 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
............||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ...+...+.+.
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC------
Confidence 33333333345799999999998765 478899999999999999999999964332211 11222222211
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
++.+. ......+.+++.+||+.||++||++... ..+++..++|...
T Consensus 227 ~~~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~--~~~~~l~h~~~~~ 272 (332)
T cd05614 227 DPPFP-------SFIGPEAQDLLHKLLRKDPKKRLGAGPQ--GASEIKEHPFFKG 272 (332)
T ss_pred CCCCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCC--CHHHHHcCCCcCC
Confidence 11111 1223467899999999999999943311 1233336677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.80 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=207.2
Q ss_pred ccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
+.|...+.||+|+||.||+|+..+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 478999999765444 4678999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 397 LVYEFMPNGTLCQHLQRER------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 1348899999999999999999998 499999999999999999999
Q ss_pred EEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHH
Q 005536 465 KVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAI 542 (692)
Q Consensus 465 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~ 542 (692)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence 9999999975322211 12233456789999999999999999999999999999999 99888543221 122
Q ss_pred HHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 543 ~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
+.+..+...... ......+.+++.+||+.+|++||++.||+++|++
T Consensus 235 ~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRLLQRP------------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCcCCCC------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 333333322111 1233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.74 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=204.9
Q ss_pred HhhccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG 393 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~ 393 (692)
..+++|+..+.||+|+||.||+|... .+..||||+++... .....+|.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999998753 24579999986432 234567899999999999999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceE
Q 005536 394 EPILVYEFMPNGTLCQHLQRERG--------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSK 465 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~k 465 (692)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 99999999999999999976431 236888999999999999999999 4999999999999999999999
Q ss_pred EeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHH
Q 005536 466 VADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 466 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~ 543 (692)
|+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..|+..... ....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 999999875332221 11223356788999999998899999999999999999999 6777753321 11222
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.+..+...+. +......+.+++.+||+.+|++||++.|+++.|++
T Consensus 233 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLLDK------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2222221111 11233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.70 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=198.1
Q ss_pred ecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||+|+||+||+++.. +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 4788999998753 234566788999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 487 (692)
.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccccc
Confidence 9999764 458999999999999999999999 49999999999999999999999999999853222 22234457
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+..+... .+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~-~~~~~~~~~~~-------------~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NE-MYRKILQEPLR-------------FPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HH-HHHHHHcCCCC-------------CCC
Confidence 99999999999999999999999999999999999999863321 11 12222222110 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
....++.+++.+||+.+|++||++..+.+ +..++|...
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e----~l~hp~~~~ 252 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQE----IKNHPFFSQ 252 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHH----HHcCCCcCC
Confidence 23356789999999999999986544332 335566543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.05 Aligned_cols=261 Identities=24% Similarity=0.346 Sum_probs=206.2
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 4688999999854 234456788999999988 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 9999988754 459999999999999999999999 49999999999999999999999999998752221 12223
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||++||||++|+.||+...............+.+......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------- 221 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------------- 221 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-------------
Confidence 4579999999999999999999999999999999999999997543333323333333333322111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.+......+.+++.+||+.||++||++.+. ..++++..++|...+
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i~~h~~f~~~ 266 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDIKSHTFFRSI 266 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHHHcCCCCCCC
Confidence 011123467899999999999999996542 234566778887644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.51 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=209.1
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||.||+|+.. +++.||||.++.. +......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999854 6889999988643 2344567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 400 EFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2458899999999999999999998 4999999999999999999999999999876432
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... . ....+.+.........
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~-~~~~~~~~~~~~~~~~--- 229 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L-FSLCQKIEQCDYPPLP--- 229 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----H-HHHHHHHhcCCCCCCC---
Confidence 22 1123346889999999998888999999999999999999999998532211 1 1122223222111110
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.......+.+++.+||+.+|++||++.||++.|++++
T Consensus 230 --------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 --------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1123457899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.38 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=194.1
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIK-LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||+|.+.... .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 57889999987532 223345556654 67889999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence 9999888754 458888899999999999999998 49999999999999999999999999998753221 22234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~------------- 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHKPLQ------------- 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcCCCC-------------
Confidence 45689999999999988999999999999999999999999864321 1112222221110
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.+......+.+++.+||+.+|.+||+...- +.++..++|..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~---~~~~~~~~~~~ 255 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAKAD---FLEIKNHVFFS 255 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCCCC---HHHHhCCCCcC
Confidence 011223468899999999999999986422 23445666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=324.55 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=204.5
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
++|...++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999886543 34567899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++.......+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 9999999987655568999999999999999999998 4999999999999999999999999999976432222222
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+....+. .....+..+....
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---------- 223 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGYRMP---------- 223 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC----------
Confidence 23346778999999988899999999999999999999 88887632211 1122222221100
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.+......+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 --CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.20 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=209.1
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEE
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCC 389 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~ 389 (692)
+++...++|+..+.||+|+||.||++...+ ...+|+|.++... .....++.+|++++.++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344455678889999999999999998643 3579999987542 33456789999999999 799999999999
Q ss_pred EeCCeeEEEEEeCCCCCHHHHHhhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 005536 390 IEEGEPILVYEFMPNGTLCQHLQRE--------------RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSN 455 (692)
Q Consensus 390 ~~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~N 455 (692)
.+.+..+++|||+++|+|.++++.. ....+++..++.++.|++.||+|||+ ++|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceee
Confidence 9999999999999999999999753 23458999999999999999999998 499999999999
Q ss_pred eEEcCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcc
Q 005536 456 ILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHS 533 (692)
Q Consensus 456 ILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~ 533 (692)
||+++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 9999999999999999986433221 11223345678999999988899999999999999999998 8888753221
Q ss_pred cccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
....+.+..+...+ .+......+.+|+.+||+.+|++|||+.|+++.|+.+.
T Consensus 241 -----~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -----EELFKLLKEGYRME------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHHHHHcCCcCC------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11122222221111 11123457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.14 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=200.3
Q ss_pred eeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
++||+|+||.||+|+..+ ++.||||.++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998654 789999999753 234456788899999876 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 9999998764 4589999999999999999999994 99999999999999999999999999987532222 2234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+.. ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~~---~~p-------- 216 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDDV---LYP-------- 216 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC---CCC--------
Confidence 45699999999999998999999999999999999999999974332 112222222211 001
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.....++.+|+.+||+.+|++||+..+.....+++..++|...
T Consensus 217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 1123567899999999999999954433333444456777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.94 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=175.3
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.++|+..++||+|+||.||+++.. ++..+|+|.++... ....+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 47789999887542 3345679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.+++... ..+++.....++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999764 3589999999999999999999973 47999999999999999999999999998753221
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFS 529 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~ 529 (692)
......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123456899999999999889999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.50 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=197.6
Q ss_pred eeecccccEEEEEEEE----eCCCEEEEEEeecC----CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 330 HRLGTGAYGTVYAGKL----HNDDWVAIKRFRYR----DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++||+|+||.||+++. .+++.||||.++.. .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 34788999999753 223345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 9999999999764 457888899999999999999999 499999999999999999999999999987532222 2
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+... +
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~~~------~--- 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGKLN------L--- 219 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC------C---
Confidence 22345799999999999988899999999999999999999999864322 1122333332211 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhhhcccccc
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl~~L~~i~~~~~~~~ 609 (692)
+......+.+++.+||+.+|++|| ++.+++ .++|...
T Consensus 220 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~-------~h~~~~~ 261 (323)
T cd05584 220 ----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ-------SHPFFRH 261 (323)
T ss_pred ----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh-------cCCCcCC
Confidence 111234678999999999999999 555554 5666543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=326.27 Aligned_cols=267 Identities=23% Similarity=0.345 Sum_probs=202.2
Q ss_pred CccceeecccccEEEEEEEE-----eCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEE
Q 005536 326 FSEKHRLGTGAYGTVYAGKL-----HNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPIL 397 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~l 397 (692)
|...+.||+|+||+||++.. .+++.||+|.++.... ...+.|.+|++++++++||||+++++++.+. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3567899999976532 3457789999999999999999999998764 35789
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||+++++|.+++... .+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999753 49999999999999999999999 4999999999999999999999999999986433
Q ss_pred CCCc--ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ESSH--ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.... ......++..|+|||.+....++.++||||||+++|||++|+.|+........ ................+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence 2211 11223456779999999888999999999999999999999998754321100 00000000000001111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.... ...+.....++.+++.+||+.+|++|||+++|+++|+++.
T Consensus 239 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111 0111234468899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.04 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=205.2
Q ss_pred hhccCccceeecccccEEEEEEEEeCC--CEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHND--DWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
..++|+..+.||+|+||.||+|+..+. ..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 345688899999999999999986543 58999998643 2344567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999999764 458999999999999999999999 499999999999999999999999999997632
Q ss_pred CCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ....+.+.++... +.
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~p- 248 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIYQKILEGIIY--FP- 248 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCC--CC-
Confidence 21 2345799999999999988899999999999999999999999974322 1122333332210 01
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhhhcccccccc
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl~~L~~i~~~~~~~~~~ 611 (692)
......+.+++.+||+.+|++|+ +++|+ ..++|..+..
T Consensus 249 ----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~-------~~hp~f~~~~ 291 (340)
T PTZ00426 249 ----------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV-------KEHPWFGNID 291 (340)
T ss_pred ----------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH-------HcCCCcCCCC
Confidence 11224578999999999999996 55554 4778876543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.86 Aligned_cols=275 Identities=24% Similarity=0.359 Sum_probs=207.0
Q ss_pred CCCChHHHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHH--hCCCCCeeeeEEEE
Q 005536 312 PFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLS--SVSHPNLLRLLGCC 389 (692)
Q Consensus 312 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~--~l~H~niv~l~g~~ 389 (692)
.-.|+--...+.++....+.||+|.||.||+|+++ |+.||||++...+ .+.+.+|.+|.. .|+|+||+.+++.-
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 44555556667778888999999999999999985 6679999998543 345667777776 45999999999986
Q ss_pred EeC----CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceEEcC
Q 005536 390 IEE----GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM-----NPPIYHRDIKSSNILLDY 460 (692)
Q Consensus 390 ~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~-----~~~iiHrDik~~NILld~ 460 (692)
..+ .+++||++|.++|+|+|||.+. .++....++++..+|.||+|||-+. +|.|.|||||+.|||+..
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 543 3789999999999999999873 5999999999999999999999753 688999999999999999
Q ss_pred CCceEEeeecCCccCCCCCCcc---cccCCCCCCCCCccccccC----CC--CCccceeehhHHHHHHHhC---------
Q 005536 461 NYRSKVADFGLSRLGMTESSHI---STAPQGTPGYLDPQYHQYF----HL--SDKSDVYSFGVVLIEIITA--------- 522 (692)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~----~~--s~ksDV~SfGvll~eLltg--------- 522 (692)
++...|+|+|||.....+.... ....+||.+|||||++... .+ -..+||||||.|+||+..+
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 9999999999997644433222 3456799999999987543 11 2369999999999999863
Q ss_pred -CcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC-c-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 523 -LKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD-A-WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 523 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~-~-~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
+.||..-.+ .+.+. +.+++- +..+.+.+..+ . .+.+.+..+.+|++.||..+|.-|.|+-.+-+.|.
T Consensus 432 y~~Pyyd~Vp-~DPs~-----eeMrkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 432 YQLPYYDVVP-SDPSF-----EEMRKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred hcCCcccCCC-CCCCH-----HHHhcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 233322111 11111 111111 11112222111 1 13467788999999999999999999999999998
Q ss_pred hhhh
Q 005536 600 HIRV 603 (692)
Q Consensus 600 ~i~~ 603 (692)
++..
T Consensus 502 ~l~~ 505 (513)
T KOG2052|consen 502 KLSN 505 (513)
T ss_pred HHhc
Confidence 8864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=327.34 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=203.7
Q ss_pred ccCccceeecccccEEEEEEEEe-----CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-----NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~ 396 (692)
+.|+..+.||+|+||+||++... ++..||+|+++.......++|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999753 4778999999877666778899999999999999999999987543 4688
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997653 458999999999999999999998 499999999999999999999999999998643
Q ss_pred CCCCc--ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc----
Q 005536 477 TESSH--ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV---- 550 (692)
Q Consensus 477 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 550 (692)
..... ......++..|+|||++.+..++.++||||||+++|||++|..++..... .+.+.+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 231 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--------EFMRMMGNDKQGQMI 231 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--------hhhhhcccccccccc
Confidence 32221 11122344569999999988999999999999999999998766532110 01111111100
Q ss_pred ----cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 551 ----DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 551 ----~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.+++.... ..........++.+|+.+||+.+|++||||.||+++|+.++
T Consensus 232 ~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 232 VYHLIELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hHHHHHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000000 00011123457899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.43 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=210.2
Q ss_pred HhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
...++|...++||+|+||+||++...+++.||||.+... ....+++.+|+.++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 345788999999999999999999888888999998754 3445789999999999999999999999998899999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.+++....+..+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999987655679999999999999999999998 4999999999999999999999999999876433222
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+.+..+....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~------- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERGYRMP------- 224 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC-------
Confidence 22223335678999999998899999999999999999999 8888853221 11222222221100
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.+.....++.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 -----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.46 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=206.3
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|++|.||+++.. +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999865 5789999998754 345677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.......+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-c
Confidence 999999999987655679999999999999999999998 599999999999999999999999999987643322 2
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.++....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-------- 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPPV-------- 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCC--------
Confidence 22344688999999999998999999999999999999999999864331 112223332222111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||+.+|++||++.++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1123357899999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.59 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=210.7
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||.||+|... +++.||+|.++.. +....+++.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7889999988643 2334678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 400 EFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 400 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||+++++|.+++... ....+++..++.++.+++.||+|||+ .+|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998653 23458999999999999999999999 4999999999999999999999999999875332
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.. .......+++.|+|||++.+..++.++||||||+++|||++|+.|+.... ..... ..+.+..+....+..
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~-~~~~~~~~~~~~~~~-- 230 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYS-LCKKIEKCDYPPLPA-- 230 (267)
T ss_pred CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHH-HHhhhhcCCCCCCCh--
Confidence 21 12233468899999999988889999999999999999999999985332 11111 122222222111110
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
......+.+++.+||..+|++||++.+|+++|++++
T Consensus 231 ---------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 ---------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 123457889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=336.93 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=205.9
Q ss_pred hhccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE- 392 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~- 392 (692)
..++|+..+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457888999999999999999642 24689999987543 33456788999999999 899999999988754
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccC--------------------------------------------------------
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERG-------------------------------------------------------- 416 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 416 (692)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 568899999999999999864321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc-cccCCCCCCC
Q 005536 417 ---SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI-STAPQGTPGY 492 (692)
Q Consensus 417 ---~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y 492 (692)
..++|..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 258999999999999999999998 499999999999999999999999999998643322222 2234567889
Q ss_pred CCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHH
Q 005536 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIH 571 (692)
Q Consensus 493 ~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~ 571 (692)
+|||++.+..++.++|||||||+||||++ |+.||......+ .....+..+..... +.....
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~------------~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMRA------------PEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCCC------------CccCCH
Confidence 99999999999999999999999999998 988886432211 12222332211110 012235
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 572 NVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 572 ~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
++.+++.+||+.+|++||++.||++.|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 78899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=352.81 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=203.3
Q ss_pred cCccceeecccccEEEEEEEEeC--CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN--DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.|...+.||+|+||.||++.... ++.||+|.+...+......+.+|+.+++.++||||+++++++.+.+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48889999999999999997543 5678888876665556667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 403 PNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 403 ~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
++|+|.++|... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653 23458899999999999999999999 4999999999999999999999999999986432211
Q ss_pred -cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 481 -HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~~------ 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYDPF------ 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCC------
Confidence 223445699999999999999999999999999999999999999863221 112222222222111
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+.....++.+|+.+||+.+|++||++.++++
T Consensus 292 ------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122356889999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.71 Aligned_cols=258 Identities=22% Similarity=0.249 Sum_probs=205.3
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999864 57899999998542 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997652 459999999999999999999999 499999999999999999999999999998644333
Q ss_pred CcccccCCCCCCCCCccccc------cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC-cccc
Q 005536 480 SHISTAPQGTPGYLDPQYHQ------YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG-CVDE 552 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~e 552 (692)
........||+.|+|||++. ...++.++||||||+++|||++|+.||...... .. ...+... ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~-~~~i~~~~~~~~ 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KT-YNNIMNFQRFLK 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HH-HHHHHcCCCccC
Confidence 33334457999999999986 456788999999999999999999998643321 11 1222111 1111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
..+ .......+.+|+.+||+ +|++||++.+++ .++|....
T Consensus 230 ~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~-------~h~~~~~~ 269 (330)
T cd05601 230 FPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLC-------CHPFFSKI 269 (330)
T ss_pred CCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHh-------CCCCcCCC
Confidence 000 01223567889999998 999999987765 67776543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=341.07 Aligned_cols=268 Identities=22% Similarity=0.244 Sum_probs=201.6
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|+..++||+|+||.||++... .++.||+|... .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999854 57889999753 24578999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+ .++|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 165 ~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 Y-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9 47898888654 4589999999999999999999994 9999999999999999999999999999753322222
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCccc----ccHHHHHHHHhccCc--------
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSE----VNLAALAIDRIGRGC-------- 549 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~-------- 549 (692)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ...............
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 33445799999999999998999999999999999999999987643221110 001111111111000
Q ss_pred --ccccc-----cccCC-cCCCcc--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 550 --VDEII-----DPYLE-PHRDAW--TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 550 --~~ei~-----d~~l~-~~~~~~--~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
..++. ..... .....+ ......++.+|+.+||+.||.+|||++|++ .++|...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL-------~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL-------DFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh-------cChhhcc
Confidence 00000 00000 000001 012345788999999999999999999988 4677653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=335.80 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=198.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.|...+.||+|+||+||+++.. +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999854 47899999997542 3445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999764 358899999999999999999999 4999999999999999999999999999753210000
Q ss_pred ----------------------------------------------cccccCCCCCCCCCccccccCCCCCccceeehhH
Q 005536 481 ----------------------------------------------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGV 514 (692)
Q Consensus 481 ----------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGv 514 (692)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012346999999999999889999999999999
Q ss_pred HHHHHHhCCcccCCCCCcccccHHHHHHHHhccC-cccccccccCCcCCCccCHHHHHHHHHHHHHh--cccCCCCCCCH
Q 005536 515 VLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG-CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRC--LAFHRDMRPTM 591 (692)
Q Consensus 515 ll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~C--l~~~p~~RPsm 591 (692)
++|||++|+.||....+... ...+... ....+ +.. .....++.+|+.++ +..++..||++
T Consensus 237 il~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~------~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET-------QLKVINWENTLHI------PPQ----VKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH-------HHHHHccccccCC------CCC----CCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999974432111 1111110 00000 000 01234677888884 45566669998
Q ss_pred HHHHHHHHhhhhccccccc
Q 005536 592 MEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 592 ~eVl~~L~~i~~~~~~~~~ 610 (692)
.|++ .++|....
T Consensus 300 ~~~l-------~hp~f~~~ 311 (381)
T cd05626 300 DDIK-------AHPFFSEV 311 (381)
T ss_pred HHHh-------cCcccCCC
Confidence 8886 56776543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.64 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=202.2
Q ss_pred CccceeecccccEEEEEEEEeC----CCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe-----
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE----- 394 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~----- 394 (692)
|...+.||+|+||.||+|++.. +..||||+++... ....+++.+|+++++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998653 3579999987542 3446789999999999999999999999876554
Q ss_pred -eEEEEEeCCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeee
Q 005536 395 -PILVYEFMPNGTLCQHLQRER----GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 395 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 469 (692)
.++|+||+++|+|.+++.... ...+++...+.++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999986542 2358999999999999999999999 49999999999999999999999999
Q ss_pred cCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhcc
Q 005536 470 GLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 470 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
|+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|+...... ...+.+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHc
Confidence 999864332221 1122345678999999988899999999999999999999 88887533211 12233333
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+..... +.....++.+++.+||+.+|++||++.||++.|+++
T Consensus 231 ~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQ------------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC------------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 221111 112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.11 Aligned_cols=272 Identities=24% Similarity=0.318 Sum_probs=202.4
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.++|+..++||+|+||+||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999965 578999999875432 234567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 994 7888888754 3458899999999999999999999 49999999999999999999999999998753221 2
Q ss_pred cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc-------
Q 005536 481 HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE------- 552 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e------- 552 (692)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......+ ........+.......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhc
Confidence 22234568999999998765 4588899999999999999999999974322111 1111111111100000
Q ss_pred -cccccCCcCCCccC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 553 -IIDPYLEPHRDAWT-------LSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 553 -i~d~~l~~~~~~~~-------~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
..++.......... ......+.+|+.+||+.||++|||++|++ .++|...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l-------~h~~f~~ 293 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL-------SHEYFSD 293 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh-------cCccccc
Confidence 00000000000000 01124678999999999999999998887 5677653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=327.59 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=203.5
Q ss_pred ccCccceeecccccEEEEEEEE-----eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-----HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
+.|+..++||+|+||+||+|+. .++..|++|.++... .....+|.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999985 245789999997543 3345789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 398 VYEFMPNGTLCQHLQRER---------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
||||+++++|.+++.... ...+++...+.++.|++.||+|||+ ++|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999986432 1247899999999999999999999 4999999999999999999
Q ss_pred ceEEeeecCCccCCCC-CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHH
Q 005536 463 RSKVADFGLSRLGMTE-SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 463 ~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~ 540 (692)
.+||+|||+++..... .........++..|+|||++.+..++.++||||||+++|||++ |..||....+ ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 9999999999753322 1122233446778999999988889999999999999999998 8888753221 11
Q ss_pred HHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
..+.+..+.... .+.....++.+++.+||+.+|.+||++.+|+++|+.
T Consensus 235 ~~~~~~~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 223333222111 011223578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=345.60 Aligned_cols=266 Identities=22% Similarity=0.330 Sum_probs=215.8
Q ss_pred HHhhccCccceeecccccEEEEEEEEeCC-CEEEEEEeecCCchhHHHHHHHHHHHHhCC-CCCeeeeEEE-EEe-----
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHND-DWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGC-CIE----- 391 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~g~-~~~----- 391 (692)
+....++++.+.|.+|||+.||.+....+ ..||+|++-..++...+...+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456677889999999999999998776 999999999888899999999999999997 9999999993 321
Q ss_pred -CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 392 -EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 392 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
.-+.+|.||||++|.|-|+|.......|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..||+|||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 13688999999999999999876556699999999999999999999984 6889999999999999999999999999
Q ss_pred CCccCCCCC--Ccc------cccCCCCCCCCCcccc---ccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHH
Q 005536 471 LSRLGMTES--SHI------STAPQGTPGYLDPQYH---QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA 539 (692)
Q Consensus 471 la~~~~~~~--~~~------~~~~~gt~~Y~aPE~~---~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~ 539 (692)
.+.-..... ... .-...-|+-|.+||.+ .+..+++|+|||+|||+||-|.....||+......
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 986422111 110 0112369999999964 67789999999999999999999999998543221
Q ss_pred HHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc-cccc
Q 005536 540 LAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS-SWAS 608 (692)
Q Consensus 540 ~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~-~~~~ 608 (692)
|++-... ... .....+.+.+||..||+.||++||++.+|++.+-+|+.. .|.+
T Consensus 266 -------------Ilng~Y~--~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 266 -------------ILNGNYS--FPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred -------------EEecccc--CCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 1111111 011 135677899999999999999999999999999988754 3443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.65 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=208.5
Q ss_pred hhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..+.|+..++||+|+||.||++...++..+++|.++.. ....+.|.+|++++++++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45678899999999999999999877888999988754 3456789999999999999999999999887 778999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999987655678999999999999999999998 49999999999999999999999999998754332222
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ......+..+...+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~------- 224 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYRMPR------- 224 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCCCCC-------
Confidence 2233456778999999998889999999999999999999 8888853221 112223332211111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
......++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 225 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 225 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 012335688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.91 Aligned_cols=256 Identities=22% Similarity=0.249 Sum_probs=202.5
Q ss_pred ecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||+|+||+||+++.. +++.||+|.+.... ....+.+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58899999986432 22344566799999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 487 (692)
.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 999876655569999999999999999999999 59999999999999999999999999998753322 2223456
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
|+..|+|||++.+..++.++|||||||++|||++|+.||...... ... ............. . ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~-~~~~~~~~~~~~~----~----~~~---- 220 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAK-EELKRRTLEDEVK----F----EHQ---- 220 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhH-HHHHHHhhccccc----c----ccc----
Confidence 899999999999888999999999999999999999998643221 111 1111111111110 0 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
....++.+|+.+||+.+|++||+++|++ +++..++|....
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~---~~~~~h~~f~~~ 260 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKN---DDPRKHEFFKTI 260 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccch---hhhhcChhhcCC
Confidence 1234678999999999999999998875 666678887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.75 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=201.8
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 4788999999854 234456688899998877 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence 9999988754 458999999999999999999999 49999999999999999999999999999753221 12223
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcc--cccHHHHHHHHhccCcccccccccCCcCC
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHS--EVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||+...... ......+..+.+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----------- 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----------- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-----------
Confidence 4578999999999999999999999999999999999999996422211 111222233333222111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.+.....++.+|+.+||+.||++||+.... ..++++..++|....
T Consensus 224 --~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~-~~~~~i~~hp~f~~~ 268 (329)
T cd05618 224 --IPRSLSVKAASVLKSFLNKDPKERLGCHPQ-TGFADIQGHPFFRNV 268 (329)
T ss_pred --CCCCCCHHHHHHHHHHhcCCHHHcCCCCCC-CCHHHHhcCCCCCCC
Confidence 111223467899999999999999984211 112344567777543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.69 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=206.8
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||+||+++.. +++.||||+++... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 58899999997542 245667899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999865 458999999999999999999999 599999999999999999999999999997643322
Q ss_pred ----------------------------CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCC
Q 005536 480 ----------------------------SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP 531 (692)
Q Consensus 480 ----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~ 531 (692)
........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345699999999999999999999999999999999999999874432
Q ss_pred cccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhhhccccccc
Q 005536 532 HSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT-MMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPs-m~eVl~~L~~i~~~~~~~~~ 610 (692)
. .....+.... ....-+ ... ....++.+|+.+||+ +|.+||+ ++|++ .++|....
T Consensus 236 ~-------~~~~~i~~~~-~~~~~p----~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll-------~hp~~~~~ 291 (350)
T cd05573 236 Q-------ETYNKIINWK-ESLRFP----PDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIK-------SHPFFKGI 291 (350)
T ss_pred H-------HHHHHHhccC-CcccCC----CCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHh-------cCCCcCCC
Confidence 1 1112222100 000000 000 123568899999998 9999999 88887 45665543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=336.43 Aligned_cols=273 Identities=22% Similarity=0.339 Sum_probs=200.2
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----eeE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-----EPI 396 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-----~~~ 396 (692)
+|+..++||+|+||.||+|+.. +++.||||+++.. ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999854 5789999998743 2334567899999999999999999999986432 479
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999994 7899988754 458999999999999999999999 499999999999999999999999999997533
Q ss_pred CCCC--cccccCCCCCCCCCcccccc--CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHH--------HHHHH
Q 005536 477 TESS--HISTAPQGTPGYLDPQYHQY--FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA--------LAIDR 544 (692)
Q Consensus 477 ~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~--------~~~~~ 544 (692)
.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............. .....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 12234579999999999865 578999999999999999999999986433211110000 00111
Q ss_pred hccCcccccccccCCcC---CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 545 IGRGCVDEIIDPYLEPH---RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 545 ~~~~~~~ei~d~~l~~~---~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
+......+.+....... ...........+.+++.+||+.+|++||+++|++ .++|....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l-------~hp~f~~~ 296 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL-------ADPYFKGL 296 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh-------cCchhhhc
Confidence 11111111110000000 0000001234678999999999999999999887 56776543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.17 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=200.2
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHH
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLC 408 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 408 (692)
++||+|+||.||+|...+++.||+|.++.... .....|.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876533 33457899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCC
Q 005536 409 QHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG 488 (692)
Q Consensus 409 ~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 488 (692)
+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++..............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9987643 458999999999999999999998 599999999999999999999999999987532222222223345
Q ss_pred CCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 489 TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 489 t~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
+..|+|||++.+..++.++||||||+++|||++ |..||...... .....+..+..... +.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~------------~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYRMSC------------PQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCCCCC------------CC
Confidence 678999999998899999999999999999998 88888533211 11222222211110 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
.....+.+++.+||+.+|++||++.|++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.36 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=201.7
Q ss_pred cCccceeecccccEEEEEEEEe-CCC----EEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDD----WVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.|+..+.||+|+||+||+|++. +++ .+++|.+.... ....+++..|+.++++++||||+++++++. ....+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 4666789999999999999864 344 47788875432 234567888999999999999999999875 4557899
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
+||+++|+|.+++.... ..++|..++.|+.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999997653 468999999999999999999998 59999999999999999999999999999864332
Q ss_pred CC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 479 SS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 479 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.. .......++..|++||++.+..++.++||||||+++|||++ |+.|+....+. ...+.+.++.... .+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA--QP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC--CC
Confidence 21 22234557789999999998899999999999999999998 98888643221 1122223222111 11
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
. .....+.+++.+||..+|.+|||+.|+++.|+.+...
T Consensus 234 ~----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 Q----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1 1224578899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.33 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=206.9
Q ss_pred hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.++|+..+.||+|+||.||++... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999864 78899999976543 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999999987655579999999999999999999999 499999999999999999999999999998642211
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....+..|+|||++....++.++||||||+++|||++ |+.|+..... ......+.++...+.
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-------- 220 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEKGYRMEA-------- 220 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCCCC--------
Confidence 13345678999999988899999999999999999997 8888753321 112222222211111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112235788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.96 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=204.2
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 4789999999753 234556788899999877 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence 9999998764 458999999999999999999999 49999999999999999999999999998753222 22234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~---~~-------- 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEVV---YP-------- 216 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCCC---CC--------
Confidence 45799999999999998999999999999999999999999974322 1122233222110 00
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~~ 611 (692)
.....++.+++.+||+.||++||++.++ ...+++..++|.....
T Consensus 217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 217 --TWLSQDAVDILKAFMTKNPTMRLGSLTL-GGEEAILRHPFFKELD 260 (320)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCCCCC-CCHHHHHcCCCcCCCC
Confidence 1123567899999999999999998663 3456667888876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.94 Aligned_cols=251 Identities=28% Similarity=0.372 Sum_probs=197.0
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIK-LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||||++.... .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 58899999997532 223345556655 56789999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCccc
Confidence 9999999764 458999999999999999999999 4999999999999999999999999999875322 122234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~------~~----- 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKPLR------LK----- 216 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCC------CC-----
Confidence 45699999999999999999999999999999999999999864321 1112222222110 11
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
......+.+++.+||+.+|.+||++.+ .++++..++|...
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~~---~~~~il~~~~~~~ 256 (323)
T cd05575 217 --PNISVSARHLLEGLLQKDRTKRLGAKD---DFLEIKNHVFFSS 256 (323)
T ss_pred --CCCCHHHHHHHHHHhhcCHHhCCCCCC---CHHHHHcCCCcCC
Confidence 112356889999999999999999863 3344456777653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.69 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=203.5
Q ss_pred ccCccceeecccccEEEEEEEEeC-C--CEEEEEEeecC-CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-D--DWVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV 398 (692)
++|+..+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998754 3 24788888743 334556799999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 399 YEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
+||+++++|.+++.... ...+++..++.|+.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999997542 1248899999999999999999998 599999999999999999999
Q ss_pred EEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHH
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~ 543 (692)
||+|||++..... .........+..|+|||++.+..++.++||||||+++|||++ |..||...... ...+
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELYE 229 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence 9999999864211 111112233567999999998899999999999999999998 98888643221 1122
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.+..+...+ .+......+.+|+.+||+.+|.+||++.+++++|+.+...
T Consensus 230 ~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 230 KLPQGYRME------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHhcCCCCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 222221110 0112335688999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.75 Aligned_cols=261 Identities=23% Similarity=0.252 Sum_probs=200.2
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..++||+|+||+||+++... ++.||+|.+... .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999998754 678999998642 2233456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997642 458999999999999999999999 499999999999999999999999999987543333
Q ss_pred CcccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 480 SHISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
........||+.|+|||++. ...++.++|||||||++|||++|+.||..... .. ....+........+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~-~~~~i~~~~~~~~~ 229 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VE-TYGKIMNHKERFQF 229 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HH-HHHHHhCCCccccC
Confidence 33334457999999999986 34688999999999999999999999864321 11 12222211100000
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhhhhccccccc
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDM--RPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~--RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
. ........++.+|+.+|+..++++ |+++.|++ .++|..+.
T Consensus 230 p--------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~-------~h~~f~~~ 272 (332)
T cd05623 230 P--------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK-------QHPFFTGI 272 (332)
T ss_pred C--------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHh-------CCCCcCCC
Confidence 0 001123456788999988654444 67876665 66666544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.69 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=203.7
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
...++|+..++||+|+||+||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999865 4789999999643 2234456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||+++|+|.+++... .++...+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998653 47888889999999999999999 499999999999999999999999999997643
Q ss_pred CCCCcccccCCCCCCCCCccccccC----CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYF----HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e 552 (692)
...........||+.|+|||++.+. .++.++|||||||+||||++|+.||...... . ....+..+.. .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~-~ 265 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKN-S 265 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCC-c
Confidence 3222223445799999999988653 4788999999999999999999999743321 1 1222222110 0
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhhhhcccccc
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDM--RPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~--RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
+..+ . ......++.+|+.+||+.+|++ ||++.|++ .++|...
T Consensus 266 ~~~~----~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell-------~h~~~~~ 309 (370)
T cd05596 266 LTFP----D----DIEISKQAKDLICAFLTDREVRLGRNGVDEIK-------SHPFFKN 309 (370)
T ss_pred CCCC----C----cCCCCHHHHHHHHHHccChhhccCCCCHHHHh-------cCcccCC
Confidence 0000 0 0123357789999999999988 99988876 5566543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=336.49 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=211.7
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
-|...+.||.|+-|.|-.|+. ..|+.+|||++.+.. ........+|+.||+.+.||||+++++++++..++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356678899999999999985 569999999997652 2234557789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++|-|+++|... ++|++.+..+.+.||+.|+.|+|.. +|+||||||+|+|||.++++||+|||+|.+- ...
T Consensus 93 yv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE--VPG 165 (786)
T ss_pred ecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc--cCC
Confidence 99999999999875 4599999999999999999999996 9999999999999999999999999999862 233
Q ss_pred cccccCCCCCCCCCccccccCCCC-CccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLS-DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......|.+.|.+||++.+.+|. .++||||.|||||.||||+.||+.++ ....+.++++|..+ +
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f~-M------ 231 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVFE-M------ 231 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCccc-C------
Confidence 445667899999999999999886 58999999999999999999998322 23345666666432 1
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
+.....+..+|+.+||..||.+|.|++||+ +++|....
T Consensus 232 ------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~-------kHP~l~g~ 269 (786)
T KOG0588|consen 232 ------PSNISSEAQDLLRRMLDVDPSTRITTEEIL-------KHPFLSGY 269 (786)
T ss_pred ------CCcCCHHHHHHHHHHhccCccccccHHHHh-------hCchhhcC
Confidence 123345788999999999999999988776 67776543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.27 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=207.7
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||.||+++. .+++.++||.+.... ....+++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999985 578899999886532 334568899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 400 EFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987432 3458999999999999999999998 4999999999999999999999999999876432
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.. .......++..|+|||++.+..++.++||||||+++|||++|..|+...... . ....+.+..... +.
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~-~~~~~~~~~~~~-----~~ 227 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L-YSLCKKIEQCDY-----PP 227 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----H-HHHhhhhhcCCC-----CC
Confidence 22 1223346889999999998888999999999999999999999998532211 0 111122221111 10
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+. .......+.+++.+||+.+|++||||.+|++.++++
T Consensus 228 ~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LP------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 10 112345788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.78 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=204.1
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
+|+..+.||+|+||+||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 57899999997532 2234567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++|+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999998876544569999999999999999999999 499999999999999999999999999997632221
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ........+..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------- 221 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------- 221 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc-----------
Confidence 1233468999999999998899999999999999999999999997433211 1111122222111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
...+......+.+|+.+||+.||++||++.+ +..+++..++|..
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~--~~~~~l~~~~~~~ 265 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRG--EGAEEVKAHPFFR 265 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCC--CCHHHHhcCcCcc
Confidence 0111123456889999999999999994332 1233344666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.60 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=206.9
Q ss_pred cceeecccccEEEEEEEE-eCC----CEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 328 EKHRLGTGAYGTVYAGKL-HND----DWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..++||+|+||+||||.+ .++ -+||||.+... ..+..++|+.|+.+|.+|+|||+++|+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 356899999999999985 333 46899998755 3456789999999999999999999999998876 8899999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
|+.|+|.+|++.++ ..+.-+..+.|..|||+||.|||. ++++||||.++|||+..-..+||.|||++++...+...
T Consensus 779 mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred cccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999875 568889999999999999999998 59999999999999999999999999999986554433
Q ss_pred cc-ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 482 IS-TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 482 ~~-~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.. ....-.+.|||-|.+....|+.+||||||||++|||+| |.+|++.-... .+-+.++.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dlle~------------ 915 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDLLEK------------ 915 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHHHhc------------
Confidence 32 22334678999999999999999999999999999999 77777532211 11222222
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
+++-..+..+..++..++.+||..|++.||+++++..++.+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2233345567778999999999999999999999998887654
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.87 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=205.8
Q ss_pred hccCccceeecccccEEEEEEEEeC-C---CEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-D---DWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
.++|+..+.||+|+||.||+|++.. + ..+++|.++... ....+++.+|++++++++|+|++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578889999999999999998753 3 269999987542 3446789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 468999999999999999999998 4999999999999999999999999999875432
Q ss_pred CCCccc--ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 478 ESSHIS--TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 478 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
...... .....+..|+|||++....++.++||||||+++|||++ |+.|+..... ......+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCCCC---
Confidence 221111 12223567999999988889999999999999999998 9999853321 1122223222100
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+ .......++.+++.+||+.+|++||+|.+|++.|+++
T Consensus 230 -~--------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -P--------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -C--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.86 Aligned_cols=238 Identities=24% Similarity=0.350 Sum_probs=190.3
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||||.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 4778999999753 233455666777777654 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999998764 358999999999999999999999 499999999999999999999999999997532222 2234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.... +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~------~~~------ 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDR------PHF------ 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC------CCC------
Confidence 45799999999999988999999999999999999999999864321 11122222111 000
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMME 593 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~e 593 (692)
+.....++.+|+.+||+.+|++||++.+
T Consensus 216 -~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 -PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 1112346789999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=334.28 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=198.8
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHH---HhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLL---SSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
|+..+.||+|+||.||++... +++.||||+++... ....+.+.+|++++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 57899999997542 23445666776665 566899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+++++|..+++. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988864 359999999999999999999999 49999999999999999999999999998753222
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+...
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~~~------- 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDEVR------- 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-------
Confidence 1 2223457999999999999989999999999999999999999998643221 112222222110
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.+......+.+++.+||+.+|.+||++.+. .++++..++|...
T Consensus 220 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~--~~~~l~~~~~f~~ 262 (324)
T cd05589 220 ------YPRFLSREAISIMRRLLRRNPERRLGSGEK--DAEDVKKQPFFRD 262 (324)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCC--CHHHHhhCCCcCC
Confidence 011223567899999999999999965442 1334445666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.69 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=204.7
Q ss_pred ccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
++|...++||+|+||.||++... ++..+++|.++.......+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999643 345799999887666667889999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 398 VYEFMPNGTLCQHLQRERG-------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
+|||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999976432 348999999999999999999998 499999999999999999999
Q ss_pred EEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHH
Q 005536 465 KVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAI 542 (692)
Q Consensus 465 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~ 542 (692)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HH
Confidence 9999999875332211 11223345788999999998999999999999999999998 888875322111 12
Q ss_pred HHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 543 ~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
+.+..+...+. +......+.+|+.+||+.+|.+||++.||++.|++
T Consensus 235 ~~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELER------------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCCC------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 22222211111 01223568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.51 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=200.5
Q ss_pred eeecccccEEEEEEEE----eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 330 HRLGTGAYGTVYAGKL----HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
+.||+|+||+||+++. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCce
Confidence 99999999754 458999999999999999999999 49999999999999999999999999999763322 1222
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.+....
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~~~~------------ 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKAKLG------------ 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcCCCC------------
Confidence 345789999999999988899999999999999999999999864321 1112222222110
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 564 ~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.+......+.+|+.+||+.||++||++.+.. ++++..++|...
T Consensus 217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~--~~~~~~~~~~~~ 259 (318)
T cd05582 217 -MPQFLSPEAQSLLRALFKRNPANRLGAGPDG--VEEIKRHPFFST 259 (318)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC--HHHHhCCCCcCC
Confidence 0111235678999999999999999977632 344456666543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.45 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=202.2
Q ss_pred ccCccceeecccccEEEEEEEEeC-CC--EEEEEEeecC-CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DD--WVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV 398 (692)
++|+..+.||+|+||.||+|...+ +. .+++|.++.. .....++|.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999998643 43 4678877643 234556889999999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 399 YEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
|||+++++|.++++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999997542 1358899999999999999999998 599999999999999999999
Q ss_pred EEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHH
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~ 543 (692)
||+|||+++... .........++..|+|||++.+..++.++||||||+++|||+| |..||...... ...+
T Consensus 164 kl~dfg~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQE--VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE 234 (303)
T ss_pred EeCccccCcccc--hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHHH
Confidence 999999986321 1111122234678999999988889999999999999999998 98888533211 1122
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
.+..+...+ .+......+.+|+.+||+.+|++||++.++++.|+++..
T Consensus 235 ~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 KLPQGYRLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHhcCCcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222211100 011123468899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=352.04 Aligned_cols=258 Identities=23% Similarity=0.277 Sum_probs=207.0
Q ss_pred HHHHHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005536 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG 393 (692)
Q Consensus 317 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~ 393 (692)
.+.+...++|...+.||+|+||+||+++. .+++.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 44455668999999999999999999984 46899999998754 3345667889999999999999999988775432
Q ss_pred --------eeEEEEEeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 005536 394 --------EPILVYEFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR 463 (692)
Q Consensus 394 --------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~ 463 (692)
..++||||+++|+|.++|.... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCC
Confidence 3679999999999999997532 3468999999999999999999999 59999999999999999999
Q ss_pred eEEeeecCCccCCCC-CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHH
Q 005536 464 SKVADFGLSRLGMTE-SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542 (692)
Q Consensus 464 ~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~ 542 (692)
+||+|||+++..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~ 254 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVM 254 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHH
Confidence 999999999864322 12223445799999999999999999999999999999999999999864321 1122
Q ss_pred HHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 543 ~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+..+.... .+.....++.+|+.+||+.+|++||++.++++
T Consensus 255 ~~~~~~~~~~------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 255 HKTLAGRYDP------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHHhcCCCCC------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 2232222211 11123457889999999999999999999875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.07 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=205.0
Q ss_pred cCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
+|+..+.||+|+||+||+|+... ...+++|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998532 2568898887543 3345789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 005536 398 VYEFMPNGTLCQHLQRER----------------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSN 455 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~N 455 (692)
|+||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999986431 1348899999999999999999998 499999999999
Q ss_pred eEEcCCCceEEeeecCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcc
Q 005536 456 ILLDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHS 533 (692)
Q Consensus 456 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~ 533 (692)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999754332221 1223346778999999988889999999999999999999 8888853321
Q ss_pred cccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
....+.+.++..... +.....++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 -----~~~~~~~~~~~~~~~------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -----ERLFNLLKTGYRMER------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHHHhCCCCCCC------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112222322211100 11223578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.83 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=194.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.|+..++||+|+||+||+++.. +++.||||.+.... ....+++.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455678999999999999865 57899999997543 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 155 ~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 224 (353)
T PLN00034 155 DGGSLEGT------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDP 224 (353)
T ss_pred CCCccccc------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccc-ccc
Confidence 99998643 235677788999999999999999 49999999999999999999999999999864321 122
Q ss_pred cccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 483 STAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||....... ... ....+......+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~-~~~~~~~~~~~~----- 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WAS-LMCAICMSQPPE----- 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHH-HHHHHhccCCCC-----
Confidence 234579999999998743 234568999999999999999999997332211 111 111111111110
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.......++.+|+.+||+.+|++||++.||+ .++|...
T Consensus 296 -------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell-------~hp~~~~ 333 (353)
T PLN00034 296 -------APATASREFRHFISCCLQREPAKRWSAMQLL-------QHPFILR 333 (353)
T ss_pred -------CCCccCHHHHHHHHHHccCChhhCcCHHHHh-------cCccccc
Confidence 0112345788999999999999999999988 4677653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.59 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=196.9
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
++||+|+||+||+|+.. +++.||+|.+.... .+....|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999864 68889999876443 34456799999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc-cccC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI-STAP 486 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~ 486 (692)
.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999754 3458999999999999999999998 499999999999999999999999999987532211110 1111
Q ss_pred CCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCcc
Q 005536 487 QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565 (692)
Q Consensus 487 ~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~ 565 (692)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......+..+.... .
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~~~~~~------------~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQGVRLP------------C 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHcCCCCC------------C
Confidence 23467999999998899999999999999999998 8777753221 11122222111110 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 566 ~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
+......+.+|+.+||+.+|++||++.||+++|+.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 11234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.54 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=205.4
Q ss_pred HHhhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE 392 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~ 392 (692)
+...++|+..++||+|+||.||+|...+ +..||+|.++... .....++.+|+.++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3456789999999999999999997542 3479999886543 23445688999999999999999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 393 GEPILVYEFMPNGTLCQHLQRER--------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999997532 1335778889999999999999998 599999999999999999999
Q ss_pred EEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHH
Q 005536 465 KVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAI 542 (692)
Q Consensus 465 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~ 542 (692)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~ 231 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVL 231 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH
Confidence 9999999985332221 11222345778999999998899999999999999999998 6777753211 1122
Q ss_pred HHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 543 ~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
+.+..+...+. +......+.+++.+||+.+|++|||+.++++.|+...
T Consensus 232 ~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVMDGGYLDQ------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHcCCCCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 22222211110 1122357899999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.46 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=208.9
Q ss_pred hccCccceeecccccEEEEEEEEeC-----CCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCee
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-----DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE-EGEP 395 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~-~~~~ 395 (692)
.++|...+.||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999766 678999998754 23456778999999999999999999999876 4678
Q ss_pred EEEEEeCCCCCHHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeee
Q 005536 396 ILVYEFMPNGTLCQHLQRERG------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 469 (692)
++++||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999976432 458999999999999999999998 49999999999999999999999999
Q ss_pred cCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhcc
Q 005536 470 GLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 470 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
|+++.......+ ......++..|+|||++.+..++.++||||||+++||+++ |+.||....+.. ....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHc
Confidence 999854332222 2233456778999999988889999999999999999999 999886432211 1222222
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
+.... .......++.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 235 ~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLA------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 21000 011223578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.01 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=207.2
Q ss_pred hccCccceeecccccEEEEEEEEeC--------CCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN--------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE 392 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~ 392 (692)
.++|...+.||+|+||.||+++..+ ...+|+|.++... ....+++.+|+.++.++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678999999999999999997532 3469999997542 34556788999999999 799999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERG--------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL 458 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILl 458 (692)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 999999999999999999976432 248999999999999999999998 499999999999999
Q ss_pred cCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCccccc
Q 005536 459 DYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVN 536 (692)
Q Consensus 459 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~ 536 (692)
++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999875432111 11122234578999999988889999999999999999998 7777753221
Q ss_pred HHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 537 LAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 537 ~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
....+.+..+...+. +.....++.+|+.+||+.+|++||+|.||++.|+++...
T Consensus 249 --~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 --EELFKLLKEGHRMDK------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHHHcCCCCCC------------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 112222332211111 112345788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.71 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=199.4
Q ss_pred CccceeecccccEEEEEEEEeCCC---EEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------Ce
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHNDD---WVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE------GE 394 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~------~~ 394 (692)
|...++||+|+||.||+|++.+.. .||+|.++.. .....+.|.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 345678999999999999976532 5899988754 244567899999999999999999999987542 25
Q ss_pred eEEEEEeCCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 395 PILVYEFMPNGTLCQHLQRER----GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
.++++||+++|+|.+++...+ ...+++...+.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885432 2348999999999999999999999 599999999999999999999999999
Q ss_pred CCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccC
Q 005536 471 LSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 471 la~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
+++....... .......+++.|++||++.+..++.++||||||+++|||++ |+.||..... ....+.+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence 9986432221 11223346778999999999999999999999999999999 7788753221 1123333333
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
..... +......+.+++.+||+.+|++|||+.||++.|+++
T Consensus 231 ~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQ------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22111 012335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.14 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=201.2
Q ss_pred HHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-----
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE----- 392 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~----- 392 (692)
+.+++.|+..+.||+|+||.||+|... +++.||+|.+.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456778899999999999999999865 47889999987543 4456788999999999 699999999998753
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 393 -GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 457899999999999999987655679999999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~ 546 (692)
++.... .........|++.|+|||++. ...++.++||||||+++|||++|+.|+....+... .....
T Consensus 158 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~~~~ 229 (272)
T cd06637 158 SAQLDR-TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIP 229 (272)
T ss_pred ceeccc-ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HHHHh
Confidence 975322 122234457899999999875 34688899999999999999999999863321110 11111
Q ss_pred cCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 547 ~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
........+ ......+.+|+.+||+.+|.+||++.|++
T Consensus 230 ~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 230 RNPAPRLKS-----------KKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred cCCCCCCCC-----------CCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111111111 12235688999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.99 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=201.7
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H-~niv~l~g~~~~~~~~~lV~ 399 (692)
+|+..+.||+|+||.||+|+..+ ++.||||+++.. .....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999998654 678999999753 23456678899999999976 56888999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 999999999998764 458999999999999999999999 49999999999999999999999999998742211
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~-------- 219 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNVS-------- 219 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC--------
Confidence 1222345699999999999999999999999999999999999999864321 1112222222110
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.+.....++.+++.+||+.+|.+|++..+ ...++++.++|...
T Consensus 220 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~--~~~~~~~~hp~~~~ 262 (324)
T cd05587 220 -----YPKSLSKEAVSICKGLLTKHPAKRLGCGP--TGERDIREHAFFRR 262 (324)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHHcCCCCC--CCHHHHhcCCCcCC
Confidence 01122346789999999999999998632 12334556666543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.40 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=202.5
Q ss_pred hhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE 394 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~ 394 (692)
.+++|...+.||+|+||.||+|...+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999998754 4678999886543 3345679999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---ceEE
Q 005536 395 PILVYEFMPNGTLCQHLQRERG-----SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY---RSKV 466 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl 466 (692)
.++||||+++++|.+++...+. ..++|..+++++.|++.||+|||+ ++++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976542 258999999999999999999999 4999999999999998754 6999
Q ss_pred eeecCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHH
Q 005536 467 ADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDR 544 (692)
Q Consensus 467 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~ 544 (692)
+|||+++........ .......+..|+|||++.+..++.++||||||+++|||++ |+.||+...... ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 999999864221111 1112234568999999998899999999999999999997 888886432211 1222
Q ss_pred hccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 545 IGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 545 ~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
+......+ .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~~------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRLD------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22111110 11123457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.05 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=212.3
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe-eEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE-PILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~-~~lV~ 399 (692)
++|...+.+|+|+||.++..+. .++..+++|++.... ....+..++|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688889999999999998874 356789999998653 3345578899999999999999999999999988 99999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
+|++||+|.+.+.+.++..++++.+..++.|++.|+.|||+ +.|+|||||++|||++.+..+||+|||+|+....+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999999887789999999999999999999997 599999999999999999999999999999854443
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......||+.||.||.+.+.+|..|+||||||+++|||.+-+++|...+. .... .++-++.
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li-~ki~~~~---------- 222 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELI-LKINRGL---------- 222 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHH-HHHhhcc----------
Confidence 234556899999999999999999999999999999999999999874432 2221 2222221
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
....+.....++..|+..||+.+|+.||++.+++.+-
T Consensus 223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1222234456889999999999999999999998763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=319.02 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=208.9
Q ss_pred hccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
..+|+..+.||+|.||.|-++.. ..|+.||||.+++. ++++.-.+.+|++||+.|+||||++++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34677778899999999999984 66999999999765 455566778999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||..+|.|+||+... ..|++.+...++.||..|+.|+|. ++++|||||.+|||||+|+++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 9999999999999875 459999999999999999999999 4999999999999999999999999999987433
Q ss_pred CCcccccCCCCCCCCCccccccCCCC-CccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLS-DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
....+...|.+.|.+||...+.+|. +..|-|||||+||.|+.|..||+... ......++.+|...|--.
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------hk~lvrQIs~GaYrEP~~-- 275 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------HKRLVRQISRGAYREPET-- 275 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-------HHHHHHHhhcccccCCCC--
Confidence 2344667899999999999998885 57999999999999999999998432 123455666665544322
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+....-||+|||..||++|.|+.+|+.
T Consensus 276 ------------PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 276 ------------PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ------------CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 224567999999999999999888764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.33 Aligned_cols=260 Identities=22% Similarity=0.241 Sum_probs=199.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||+|.+... .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 4789999999742 2334566889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999754 3458999999999999999999999 499999999999999999999999999987543333
Q ss_pred CcccccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC-ccccc
Q 005536 480 SHISTAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG-CVDEI 553 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ei 553 (692)
........||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ... ...+... ....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~-~~~i~~~~~~~~~ 229 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VET-YGKIMNHKEHFQF 229 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHH-HHHHHcCCCcccC
Confidence 222334569999999999863 4578899999999999999999999864321 111 1112111 10110
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHHhhhhccccccc
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRD--MRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~--~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
... .......+.+++.+||..+++ .||++.+++ .++|....
T Consensus 230 -----~~~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l-------~hp~~~~~ 272 (331)
T cd05597 230 -----PPD----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFK-------DHPFFEGI 272 (331)
T ss_pred -----CCc----cCCCCHHHHHHHHHHccCcccccCCCCHHHHh-------cCCCCCCC
Confidence 000 011335678888888765333 377876665 67776543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.53 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=207.8
Q ss_pred HHHhhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCC-CCCeeeeEEEEE
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCI 390 (692)
Q Consensus 319 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~g~~~ 390 (692)
++...++|...++||+|+||.||+|++.+ +..||||+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44555678888999999999999998642 3579999997543 233457899999999997 999999999999
Q ss_pred eCCeeEEEEEeCCCCCHHHHHhhccC------------------------------------------------------
Q 005536 391 EEGEPILVYEFMPNGTLCQHLQRERG------------------------------------------------------ 416 (692)
Q Consensus 391 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 416 (692)
..+..++||||+++|+|.++++..+.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 005536 417 ------------------------------------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSS 454 (692)
Q Consensus 417 ------------------------------------------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~ 454 (692)
..+++...+.++.|++.||+|||+ ++|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence 236788889999999999999998 59999999999
Q ss_pred ceEEcCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCc
Q 005536 455 NILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPH 532 (692)
Q Consensus 455 NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~ 532 (692)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986432221 11223357889999999998889999999999999999998 88887533211
Q ss_pred ccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
......+..+.... . +.....++.+|+.+||+.+|.+||+++||++.|+++.
T Consensus 349 ------~~~~~~~~~~~~~~--~----------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ------EQFYNAIKRGYRMA--K----------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------HHHHHHHHcCCCCC--C----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11222222221110 0 1112357899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.11 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=207.8
Q ss_pred HhhccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE 392 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~ 392 (692)
...++|...+.||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467889999999999999999742 23479999987553 33456789999999999 799999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
+..++||||+++|+|.++++......+++..++.++.|++.||+|||+ ++|+|+||||+|||+++++.+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999987655558999999999999999999998 49999999999999999999999999999
Q ss_pred ccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 473 RLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 473 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
+........ ......++..|+|||.+....++.++||||||+++|||++ |+.|+...... ..+...+..+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcCCc
Confidence 864332211 1223346788999999998899999999999999999998 88887633221 111222222211
Q ss_pred cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.. . +.....++.+++.+||+.+|++||++.||++.|+++
T Consensus 263 ~~-----~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MA-----Q-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-----C-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 0 011235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.34 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=201.2
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
++|+..+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999996 467889999998665556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.++++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 999999998754 458999999999999999999998 499999999999999999999999999997532211 11
Q ss_pred cccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 483 STAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....|+..|+|||.+. ...++.++||||||+++|||++|+.|+....+.... ..+.... ...+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~---~~~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSN---FQPPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCC---CCCCCCc
Confidence 23346889999999874 445788999999999999999999988533221110 0011110 0011110
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~ 597 (692)
. .......+.+++.+||+.+|++||+++++++.
T Consensus 233 -~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 233 -D----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -c----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0 01223578899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=339.69 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=203.8
Q ss_pred hhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~ 396 (692)
..++|...+.||+|.||+|+++.+.. ++.+|||.+++.. .++.+..+.|..|+...+ ||.++.|+.+|.+.++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 44689999999999999999998654 7889999999763 567788899999998885 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||+.||++..+.+ ...+++..+.-+|.+|+.||+|||+ ++||+||||.+|||||.+|.+||+||||++..+
T Consensus 446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999543333 3459999999999999999999999 499999999999999999999999999999755
Q ss_pred CCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.... ......|||.|||||++.+..|+...|.|||||+|||||.|..||...+..+ ..+.|..
T Consensus 520 ~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------~FdsI~~--------- 582 (694)
T KOG0694|consen 520 GQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------VFDSIVN--------- 582 (694)
T ss_pred CCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHhc---------
Confidence 3333 4466789999999999999999999999999999999999999997543321 1122211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTM 591 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm 591 (692)
+...++.-...+.+.|+.++|..+|++|.-+
T Consensus 583 ----d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ----DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122344556788999999999999999876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.14 Aligned_cols=247 Identities=29% Similarity=0.353 Sum_probs=208.7
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.++|+..+.||+|.||.||.|+.+ ++-.||+|++.+.. ....+++.+|++|-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356888999999999999999854 46789999997652 33457899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
+||.++|.|...|+..+...+++.....+..|+|.||.|+|. ++||||||||+|+|++.++..||+|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999997777779999999999999999999999 699999999999999999999999999986522
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
........||..|++||...+..++.+.|+|++|++.||++.|.+||+... .....+++.+- ++.+|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~---~~~~p-- 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKV---DLKFP-- 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHc---cccCC--
Confidence 334456689999999999999999999999999999999999999997433 12233444332 22222
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
......+.+|+.+|+..+|.+|.+..||+
T Consensus 243 --------~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 243 --------STISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred --------cccChhHHHHHHHHhccCccccccHHHHh
Confidence 12345788999999999999999976665
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.77 Aligned_cols=261 Identities=21% Similarity=0.229 Sum_probs=199.6
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||+||+++.. +++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 4788999998743 2234456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997642 458999999999999999999999 599999999999999999999999999997643333
Q ss_pred CcccccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 480 SHISTAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
........||+.|+|||++.+ ..++.++||||||++||||++|+.||...... . ....+......--+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~~~~ 229 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNHEERFQF 229 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------H-HHHHHHcCCCcccC
Confidence 222334569999999999875 46788999999999999999999999643221 1 11222111100000
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhhhhccccccc
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDM--RPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~--RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.+.. .....++.+++.+||...+++ |++++++ ..++|....
T Consensus 230 p~~~--------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~-------~~h~~f~~~ 272 (331)
T cd05624 230 PSHI--------TDVSEEAKDLIQRLICSRERRLGQNGIEDF-------KKHAFFEGI 272 (331)
T ss_pred CCcc--------ccCCHHHHHHHHHHccCchhhcCCCCHHHH-------hcCCCcCCC
Confidence 1100 122357888999999865543 3455444 466666543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.28 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=200.4
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~ 399 (692)
+|+..+.||+|+||+||+++.. +++.||||.++... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 46789999997542 23445677888888877 5899999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999998764 358999999999999999999999 499999999999999999999999999997532221
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.+....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~~~-------- 219 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVA-------- 219 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--------
Confidence 222345799999999999999999999999999999999999999964322 1112222222110
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.+.....++.+|+.+||+.+|++|++...- ..+++..++|..
T Consensus 220 -----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~--~~~~i~~h~~~~ 261 (323)
T cd05616 220 -----YPKSMSKEAVAICKGLMTKHPGKRLGCGPE--GERDIKEHAFFR 261 (323)
T ss_pred -----CCCcCCHHHHHHHHHHcccCHHhcCCCCCC--CHHHHhcCCCcC
Confidence 111233567899999999999999985211 123344555544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=332.77 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=199.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||||+++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999864 47899999997532 234467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999764 458999999999999999999999 499999999999999999999999999987532110
Q ss_pred C----------------------------------cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcc
Q 005536 480 S----------------------------------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKV 525 (692)
Q Consensus 480 ~----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p 525 (692)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234699999999999998999999999999999999999999
Q ss_pred cCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHhhhh
Q 005536 526 VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLA--FHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~--~~p~~RPsm~eVl~~L~~i~~ 603 (692)
|....+. .....+......-.+.+.. ....++.+++.+++. .++..||+++||+ .
T Consensus 236 f~~~~~~-------~~~~~i~~~~~~~~~p~~~---------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~-------~ 292 (363)
T cd05628 236 FCSETPQ-------ETYKKVMNWKETLIFPPEV---------PISEKAKDLILRFCCEWEHRIGAPGVEEIK-------T 292 (363)
T ss_pred CCCCCHH-------HHHHHHHcCcCcccCCCcC---------CCCHHHHHHHHHHcCChhhcCCCCCHHHHh-------C
Confidence 9643321 1122222211110111100 122356677777554 2334568877775 6
Q ss_pred cccccccc
Q 005536 604 SSWASNIY 611 (692)
Q Consensus 604 ~~~~~~~~ 611 (692)
++|.....
T Consensus 293 hp~f~~~~ 300 (363)
T cd05628 293 NPFFEGVD 300 (363)
T ss_pred CCCCCCCC
Confidence 77776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.08 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=205.7
Q ss_pred hccCccceeecccccEEEEEEEEeC------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCee
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~ 395 (692)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998643 3579999987543 34456789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEe
Q 005536 396 ILVYEFMPNGTLCQHLQRERG--------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVA 467 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 467 (692)
++||||+++|+|.+++..... ..++|..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 999999999999999975321 247899999999999999999998 599999999999999999999999
Q ss_pred eecCCccCCCCC-CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHh
Q 005536 468 DFGLSRLGMTES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRI 545 (692)
Q Consensus 468 DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~ 545 (692)
|||+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...+.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHHHHH
Confidence 999987533222 122234457889999999988889999999999999999998 88887533221 112222
Q ss_pred ccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 546 GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 546 ~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
..+...... ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDLP------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCCC------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 222211111 1124578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.96 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=200.6
Q ss_pred eeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++... ++.||||.++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 678999999854 234556778899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9999988764 359999999999999999999999 499999999999999999999999999987522221 2223
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~~~------------- 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDEVR------------- 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCC-------------
Confidence 44689999999999999999999999999999999999999864321 1112222221110
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.+......+.+|+.+||+.+|++||++.+ ..+.++..++|...
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~--~~~~~ll~~~~~~~ 257 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLP--TGEQDIKGHPFFRE 257 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCC--CCHHHHhcCCCcCC
Confidence 01122356889999999999999999844 33444556677654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.30 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=204.9
Q ss_pred ccCccceeecccccEEEEEEEEeC----CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.+|+..+.||+|+||.||+|+... +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467888999999999999998642 3379999987543 33456899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997653 458999999999999999999999 49999999999999999999999999999864332
Q ss_pred CCcccc--cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 479 SSHIST--APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 479 ~~~~~~--~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
...... ...++..|++||++.+..++.++||||||+++||+++ |+.||...... .....+.++...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~~---- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGYRL---- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCCCcC----
Confidence 222211 2234568999999998899999999999999999887 99888533221 122233322110
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+ .+...+..+.+++.+||+.+|.+||+|.++++.|+++
T Consensus 229 ~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 P--------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C--------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.03 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=196.7
Q ss_pred eecccccEEEEEEEEe---CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCC
Q 005536 331 RLGTGAYGTVYAGKLH---NDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGT 406 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 406 (692)
.||+|+||.||+|++. ++..||+|.+..... ...++|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 345699999876533 34567999999999999999999999875 457899999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc--cc
Q 005536 407 LCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI--ST 484 (692)
Q Consensus 407 L~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~--~~ 484 (692)
|.+++... ...+++..+++++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998754 3468999999999999999999998 499999999999999999999999999997543322211 12
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+..+...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~----------- 218 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQGKRLD----------- 218 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCCCCC-----------
Confidence 2234678999999988889999999999999999996 9888863321 11223333332111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 564 ~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.+.....++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 219 -~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 -CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.76 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=203.1
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG 393 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~ 393 (692)
++....++|+..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999975 4788999998642 2234456889999999999999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999998653 48889999999999999999999 499999999999999999999999999998
Q ss_pred cCCCCCCcccccCCCCCCCCCccccccC----CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYF----HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
..............||+.|+|||.+.+. .++.++||||||++||||++|+.||..... .. ....+....
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~-~~~~i~~~~ 263 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VG-TYSKIMDHK 263 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HH-HHHHHHhCC
Confidence 6432222222455799999999998654 378899999999999999999999964321 11 112222111
Q ss_pred -ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhhhhcccccc
Q 005536 550 -VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDM--RPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 550 -~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~--RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
...+.+ .......+.+++.+||+.++.+ ||++.|++ .++|...
T Consensus 264 ~~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l-------~hp~~~~ 309 (370)
T cd05621 264 NSLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIK-------QHPFFKN 309 (370)
T ss_pred cccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHh-------cCcccCC
Confidence 011000 0123456778999999855543 88987776 4677654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.68 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=202.5
Q ss_pred cCccceeecccccEEEEEEEEeC------CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
.|...++||+|+||+||+|+..+ +..||+|+++..... ..+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35667789999999999998643 467999999755332 34678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 005536 398 VYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR 463 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~ 463 (692)
++||+++++|.+++.... ...+++..+++++.|++.||+|||+ .+|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999986321 1348899999999999999999998 49999999999999999999
Q ss_pred eEEeeecCCccCCCCC-CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHH
Q 005536 464 SKVADFGLSRLGMTES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALA 541 (692)
Q Consensus 464 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~ 541 (692)
+||+|||+++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 9999999987533221 122233456789999999988889999999999999999998 7777653211 122
Q ss_pred HHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 542 IDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 542 ~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.+.+.++....+ +......+.+|+.+||+.+|++||+++||+..|+.
T Consensus 236 ~~~i~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVLPC------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcCCC------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 333333322111 11234568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.71 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=203.7
Q ss_pred ccCccceeecccccEEEEEEEE-----eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--Cee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-----HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEP 395 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~ 395 (692)
+.|...+.||+|+||.||+++. .++..||+|.++... ....+.+.+|++++++++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567888999999999999974 346789999987553 34456799999999999999999999998875 568
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999997542 358999999999999999999998 59999999999999999999999999999864
Q ss_pred CCCCCc--ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCC--------cccccHHHHHHHHh
Q 005536 476 MTESSH--ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP--------HSEVNLAALAIDRI 545 (692)
Q Consensus 476 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~--------~~~~~~~~~~~~~~ 545 (692)
...... ......++..|+|||++.+..++.++||||||+++|||++++.|...... .............+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 332211 12234567789999999888899999999999999999998765432110 00000011112222
Q ss_pred ccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 546 GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 546 ~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
..+..... .......+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 240 ~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPR------------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCC------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 22211110 112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.24 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=208.3
Q ss_pred HhhccCccceeecccccEEEEEEEEe--------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEE
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH--------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCI 390 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~ 390 (692)
....+|...+.||+|+||.||+++.. ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888899999999999999742 23479999987542 34567899999999999 8999999999999
Q ss_pred eCCeeEEEEEeCCCCCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 005536 391 EEGEPILVYEFMPNGTLCQHLQRERG--------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456 (692)
Q Consensus 391 ~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NI 456 (692)
..+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 99999999999999999999986421 347889999999999999999999 4999999999999
Q ss_pred EEcCCCceEEeeecCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCccc
Q 005536 457 LLDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSE 534 (692)
Q Consensus 457 Lld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~ 534 (692)
|+++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 9999999999999999864332221 1223456788999999988889999999999999999998 677764321
Q ss_pred ccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 535 VNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 535 ~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.....+.+..+..... +......+.+|+.+||+.+|++||+|.||++.|++|...
T Consensus 245 ---~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ---VEELFKLLKEGHRMDK------------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHHHHHcCCcCCC------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1122333332211110 112345788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.87 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=201.9
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999865 57899999997542 334566889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999764 4589999999999999999999994 99999999999999999999999999986432110
Q ss_pred Cc-------------------------------------ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhC
Q 005536 480 SH-------------------------------------ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA 522 (692)
Q Consensus 480 ~~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg 522 (692)
.. ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124599999999999988999999999999999999999
Q ss_pred CcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 005536 523 LKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT---MMEVAEELE 599 (692)
Q Consensus 523 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPs---m~eVl~~L~ 599 (692)
+.||....+.. ....+......-.+ + .. ......+.+|+.+|+. +|.+|++ +.|++
T Consensus 236 ~~Pf~~~~~~~-------~~~~i~~~~~~~~~-~----~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll---- 294 (364)
T cd05599 236 YPPFCSDNPQE-------TYRKIINWKETLQF-P----DE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK---- 294 (364)
T ss_pred CCCCCCCCHHH-------HHHHHHcCCCccCC-C----CC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh----
Confidence 99997433211 11122111100000 0 00 0123467789999997 8999997 66665
Q ss_pred hhhhccccccc
Q 005536 600 HIRVSSWASNI 610 (692)
Q Consensus 600 ~i~~~~~~~~~ 610 (692)
.++|....
T Consensus 295 ---~h~~~~~~ 302 (364)
T cd05599 295 ---SHPFFKGV 302 (364)
T ss_pred ---cCCCcCCC
Confidence 56666543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.17 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=197.3
Q ss_pred eecccccEEEEEEEEe---CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 331 RLGTGAYGTVYAGKLH---NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+||+|+||+||+|.+. ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 46789999987543 334678999999999999999999999875 45678999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc--c
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI--S 483 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~--~ 483 (692)
+|.+++... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999754 458999999999999999999998 599999999999999999999999999997643322211 1
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ....+.+.++...+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~~~~~~--------- 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESGERMEC--------- 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCCCC---------
Confidence 22234679999999988889999999999999999998 8888864321 112333443322111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+.....++.+|+.+||+.+|++||++.+|.+.|+..
T Consensus 220 ---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112335788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.24 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=200.1
Q ss_pred hccCccceeecccccEEEEEEEEeC---------------CCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN---------------DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLL 386 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~ 386 (692)
.++|+..++||+|+||.||+++..+ ...||+|.++.. .....+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987542 124899998754 234456799999999999999999999
Q ss_pred EEEEeCCeeEEEEEeCCCCCHHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 005536 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERG----------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456 (692)
Q Consensus 387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NI 456 (692)
+++...+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 999999999999999999999999965321 237899999999999999999999 4999999999999
Q ss_pred EEcCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhC--CcccCCCCCcc
Q 005536 457 LLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA--LKVVDFSRPHS 533 (692)
Q Consensus 457 Lld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg--~~p~~~~~~~~ 533 (692)
|+++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+++ ..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999975332221 122334457799999999888999999999999999999984 4455422111
Q ss_pred cccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.......+............ .+......+.+|+.+||+.+|++||+|.+|++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 --QVIENTGEFFRNQGRQIYLS---------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHhhhhccccccCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111100000000 011123578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.35 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=206.6
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..|...+.||+|.||.||||.. ..++.||+|++... ..+++++.++|+.+|.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566678899999999999985 44788999999865 456678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+.+|++.+.|... ..+.+..+.-|.+++..||.|||+. +.+|||||+.|||+..+|.+||+|||++-........
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999753 3457888888999999999999995 9999999999999999999999999999765444333
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
. ...+||+.|||||+++...|+.|+||||||++.+||.+|.+|+..-.|..-..+ | .+-.-|.+.+
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------I-----pk~~PP~L~~- 233 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------I-----PKSAPPRLDG- 233 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------c-----cCCCCCcccc-
Confidence 3 667899999999999988999999999999999999999999875544221111 1 1111222221
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.....+.+++..||+.||+.||++.++++
T Consensus 234 ------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ------DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33456889999999999999999999874
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.48 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=205.0
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
+|+..++||+|+||.||+++.. +++.+|+|.++.. .....+++.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999854 5788999998653 2345678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.......+++...+.++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||+++..... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc-ccc
Confidence 99999999977656668999999999999999999999 49999999999999999999999999998753322 222
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+..+....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhcCCCCCC---------
Confidence 2345689999999999988999999999999999999999999864321 111222323222211
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~ 597 (692)
+......+.+|+.+||+.+|++||++.||+..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223467899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=317.28 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=201.9
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCeeEEEEEeC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE-EGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 402 (692)
++|...+.||+|+||.||++... +..|++|.++.. ...+.|.+|+.++++++|+|++++++++.+ .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999764 778999998643 345679999999999999999999998654 46789999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.......+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 99999999987655568999999999999999999998 49999999999999999999999999998753221
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+.... +. .....+.++...+.
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~-~~~~~~~~~~~~~~-------- 220 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LK-DVVPRVEKGYKMDA-------- 220 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HH-HHHHHHhcCCCCCC--------
Confidence 123345678999999998899999999999999999998 888875321 11 12222322211111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.......+.+++.+||+.+|++|||+.++++.|++|
T Consensus 221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.42 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=190.7
Q ss_pred eeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+|+..+ ++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999654 6889999997541 23455677788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9999999754 458999999999999999999999 499999999999999999999999999987522211 1223
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+. +...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~------~~~~----- 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDN------PCYP----- 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC------CCCC-----
Confidence 45689999999999988999999999999999999999999864321 11122222211 1010
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMM 592 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~ 592 (692)
.....++.+++.+||+.+|++||++.
T Consensus 217 --~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 217 --RWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred --ccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 11224678999999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.20 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=204.1
Q ss_pred ccCccceeecccccEEEEEEEEe-CCC----EEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDD----WVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
+.|+..++||+|+||+||+|++. +++ .||+|.++... ....+++.+|+.++..++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 46778899999999999999853 444 48999987543 34466789999999999999999999998754 5789
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999997643 458999999999999999999999 5999999999999999999999999999986432
Q ss_pred CCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.... ......+++.|++||.+.+..++.++||||||+++|||++ |..|++.... ......+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~-- 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLLEKGERLPQ-- 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcCCC--
Confidence 2221 1122345678999999988899999999999999999998 8888763321 111222222211110
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~ 605 (692)
+......+.+++.+||+.+|++||++.|+++.|+.+...+
T Consensus 233 ----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0122356889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.15 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=196.6
Q ss_pred eeecccccEEEEEEEEeC-CC--EEEEEEeecC-CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN-DD--WVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||.||+|++.+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999755 33 4788888743 344567899999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 405 GTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 405 gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997542 1248899999999999999999998 599999999999999999999999999
Q ss_pred CCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
+++.... .........+..|+|||++....++.++||||||+++|||++ |..||..... . ...+.+..+.
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~-~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------A-ELYEKLPQGY 228 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------H-HHHHHHhCCC
Confidence 9863111 111112234668999999988899999999999999999997 9888853211 1 1122222211
Q ss_pred ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
..+. +......+.+|+.+||+.+|.+||++.|+++.|+++-
T Consensus 229 ~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC------------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1110 1122356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.11 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=203.7
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
|++.+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45667788888889999999999999854 46789999988776667788999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeecCCc
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGL--PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSR 473 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~ 473 (692)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999998643 234 888889999999999999998 59999999999999986 6799999999987
Q ss_pred cCCCCCCcccccCCCCCCCCCccccccCC--CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYFH--LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
...... .......|++.|+|||++.... ++.++||||||+++|||++|+.|+......... .+ .......
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~---~~~~~~~- 229 (268)
T cd06624 158 RLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MF---KVGMFKI- 229 (268)
T ss_pred ecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hh---hhhhhcc-
Confidence 533221 2223345899999999986643 788999999999999999999998632211110 00 0000000
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+ ..+.....++.+++.+||+.+|++||++.|+++
T Consensus 230 ---~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 ---HP-------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---CC-------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 111123356889999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.42 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=204.1
Q ss_pred hccCccceeecccccEEEEEEEEeC-----------------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeee
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-----------------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLR 384 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~ 384 (692)
.++|+..+.||+|+||.||+++..+ +..||+|.+.... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987643 2458999987553 345678999999999999999999
Q ss_pred eEEEEEeCCeeEEEEEeCCCCCHHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 005536 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERG---------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSN 455 (692)
Q Consensus 385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~N 455 (692)
+++++..++..++|+||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976531 2589999999999999999999984 99999999999
Q ss_pred eEEcCCCceEEeeecCCccCCCCC-CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh--CCcccCCCCCc
Q 005536 456 ILLDYNYRSKVADFGLSRLGMTES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT--ALKVVDFSRPH 532 (692)
Q Consensus 456 ILld~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt--g~~p~~~~~~~ 532 (692)
|+++.++.+||+|||+++...... ........+++.|+|||++.+..++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 999999999999999987533221 122334557889999999988899999999999999999998 5556542211
Q ss_pred ccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
..................... .+...+.++.+|+.+||+.+|++|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP---------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccCC---------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111111100 011223578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=320.29 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=198.1
Q ss_pred ecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||+|+||+||++... +++.||+|.+.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 57899999987542 22346778999999999999999999999999999999999999999
Q ss_pred HHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 408 CQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 408 ~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence 9888543 23458999999999999999999999 499999999999999999999999999997533222 22234
Q ss_pred CCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCcc
Q 005536 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~ 565 (692)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......+..+.. ..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~-------------~~ 220 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRILNDSV-------------TY 220 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhhcccCC-------------CC
Confidence 5789999999999999999999999999999999999999964322111 1111111111100 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 566 ~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
+......+.+++.+||+.+|++||++++. ..+++..++|...
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~--~~~~~l~h~~~~~ 262 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDG--NCDGLRTHPLFRD 262 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCC--CHHHHhcChhhhc
Confidence 11234578899999999999999954332 1333345677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.37 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=203.3
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
..|+..+.||+|+||.||++...+++.+|+|.++.. ....++|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 357778899999999999999877889999998754 3345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999997653 4589999999999999999999984 999999999999999999999999999875433222222
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....++.+|+|||++.+..++.++||||||+++|||++ |+.|+..... ....+.+.++. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCC--CCCCCCC----
Confidence 23345678999999998899999999999999999998 8888863221 11222232221 1111111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
....+.+|+.+||+.+|++||++.||+++|
T Consensus 226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 235789999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.49 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=200.3
Q ss_pred eeecccccEEEEEEEEeC--C--CEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN--D--DWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|++|+||+|.+.+ + ..||||.+..... ...++|.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998654 2 2699999987655 567789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc--c
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH--I 482 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~--~ 482 (692)
++|.+++.......++|...+.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999987543568999999999999999999999 59999999999999999999999999999864332211 1
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... . ....+... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~~~~~-~~~~-------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------Q-ILKKIDKE-GERL-------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHhc-CCcC--------
Confidence 223457889999999998899999999999999999999 99988533211 1 11111110 0000
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
..+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001123457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.66 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=217.3
Q ss_pred ccCccceeecccccEEEEEEEEeCC-----CEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHND-----DWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
+.....++||.|.||.||+|.+.+- -.||||..+.. +.+..+.|+.|..++++++||||++|+|+|.+. ..+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 3444567899999999999986543 25999999874 466788999999999999999999999999865 5799
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
|||.++-|.|..||+.++ ..|+.......+.||..||+|||+ ..++||||..+|||+....-+||+|||++|....
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999999874 459999999999999999999999 4999999999999999999999999999998766
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
+.....+...-...|||||.+...+++.+||||-|||.+||++. |.+||..-...+ ++-.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------------VI~~ 604 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------------VIGH 604 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------------eEEE
Confidence 66655555566789999999999999999999999999999997 899997433211 1111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
.-.+++.+.+..++..+..|..+||.++|.+||.+.|+...|..+..
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 22344555667788899999999999999999999999999988765
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.08 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=196.9
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
+|+..+.||+|+||.||+++. .+++.||+|.+... .....++|.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999985 46788999998754 2344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 999996542 37888899999999999999999 49999999999999999999999999999753221 2
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
.....||..|+|||++.+..++.++||||||+++|||++|+.||................+.+..... +.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PVLPV-- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CCCCC--
Confidence 23457899999999999889999999999999999999999998643222111111111111111111 11100
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.....++.+++.+||+.+|++||+++|+++
T Consensus 223 ----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 223 ----GQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred ----CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 012346789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.35 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=202.3
Q ss_pred cCccceeecccccEEEEEEEEeC-C---CEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-D---DWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
.|+..+.||+|+||.||+|+... + ..||||.++.. .....++|..|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998654 2 36999998754 3445678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997653 458999999999999999999998 499999999999999999999999999987543221
Q ss_pred Cc-cccc-CC--CCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 480 SH-ISTA-PQ--GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 480 ~~-~~~~-~~--gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
.. .... .. .+..|+|||++.+..++.++||||||+++|||++ |..||..... ....+.+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-------~~~~~~i~~~~~~--- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QDVINAIEQDYRL--- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-------HHHHHHHHcCCcC---
Confidence 11 1111 11 2457999999999999999999999999999887 8888853321 1122222221100
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
..+.+.+..+.+++.+||+.+|++||+|.+|+..|+++
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=325.84 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=206.7
Q ss_pred hhccCccceeecccccEEEEEEEEe--------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH--------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIE 391 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~ 391 (692)
..++|...++||+|+||.||+++.. ....||+|.++... ....+++.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3457888899999999999999742 23469999987542 34567789999999999 69999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNIL 457 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NIL 457 (692)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence 999999999999999999997642 1348999999999999999999998 49999999999999
Q ss_pred EcCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccc
Q 005536 458 LDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEV 535 (692)
Q Consensus 458 ld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~ 535 (692)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---- 242 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---- 242 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999976432211 11122234568999999988899999999999999999999 7888753221
Q ss_pred cHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 536 NLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 536 ~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
....+.+..+...+. +.....++.+|+.+||+.+|++||++.|+++.|+++...
T Consensus 243 ---~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 ---EELFKLLREGHRMDK------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ---HHHHHHHHcCCCCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 122233333221111 112234688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.80 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=201.0
Q ss_pred HHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC--------------chhHHHHHHHHHHHHhCCCCCeee
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD--------------TDSIDQVMNEIKLLSSVSHPNLLR 384 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~il~~l~H~niv~ 384 (692)
.+..++|...+.||+|.||.|-+|+. .+++.||||++.+.. ....++..+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44567899999999999999999984 458899999996431 112468899999999999999999
Q ss_pred eEEEEEe--CCeeEEEEEeCCCCCHHHHHhhccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 005536 385 LLGCCIE--EGEPILVYEFMPNGTLCQHLQRERGSG-LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN 461 (692)
Q Consensus 385 l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~ 461 (692)
|+.+..+ .+..|||+||+..|.+... ....+ |+..+.++++.++..||+|||. ++||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 9999865 4689999999998887432 12234 8999999999999999999999 599999999999999999
Q ss_pred CceEEeeecCCccCCC----CCCcccccCCCCCCCCCccccccCC----CCCccceeehhHHHHHHHhCCcccCCCCCcc
Q 005536 462 YRSKVADFGLSRLGMT----ESSHISTAPQGTPGYLDPQYHQYFH----LSDKSDVYSFGVVLIEIITALKVVDFSRPHS 533 (692)
Q Consensus 462 ~~~kl~DFGla~~~~~----~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SfGvll~eLltg~~p~~~~~~~~ 533 (692)
+++||+|||.+..... +.........|||.|+|||...++. .+.+-||||+||+||-|+.|+.||-...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 9999999999875421 1112223468999999999876632 3457899999999999999999996321
Q ss_pred cccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.....++|....+. -+.. .+..+++.+|++++|++||++|.+ |..|+.++|....
T Consensus 324 ----~~~l~~KIvn~pL~-------fP~~----pe~~e~~kDli~~lL~KdP~~Ri~-------l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ----ELELFDKIVNDPLE-------FPEN----PEINEDLKDLIKRLLEKDPEQRIT-------LPDIKLHPWVTRD 378 (576)
T ss_pred ----HHHHHHHHhcCccc-------CCCc----ccccHHHHHHHHHHhhcChhheee-------hhhheecceeccC
Confidence 11223333332111 1111 134567889999999999999999 4555688997644
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.96 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=200.9
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-----chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-----TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
++|...+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 57899999987542 1234578899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998764 458899999999999999999999 4999999999999999999999999999875332
Q ss_pred CCCccc--ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ESSHIS--TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~---- 226 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTNP---- 226 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCCC----
Confidence 211111 3346788999999999989999999999999999999999998633211 1111111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+......+.+++.+||+.+|++||++.|+++
T Consensus 227 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 --------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred --------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 011123356889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.46 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=204.4
Q ss_pred hccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCee
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~ 395 (692)
.++|+..+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 45789999987553 33456799999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 005536 396 ILVYEFMPNGTLCQHLQRER--------------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSN 455 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~N 455 (692)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999997532 1247889999999999999999998 599999999999
Q ss_pred eEEcCCCceEEeeecCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcc
Q 005536 456 ILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHS 533 (692)
Q Consensus 456 ILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~ 533 (692)
||+++++.+||+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999875322211 11222345678999999998899999999999999999998 7777642211
Q ss_pred cccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
......+..+..... +.....++.+|+.+||+.+|++||++.|+++.|++
T Consensus 239 -----~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -----EEVIYYVRDGNVLSC------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112233333322111 11233578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.61 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=205.9
Q ss_pred ccCccceeecccccEEEEEEEEeCC----CEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHND----DWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
++|...+.||+|+||.||+|...+. ..|+||...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577888999999999999986543 468999887654 4456789999999999999999999998865 557899
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 358999999999999999999998 49999999999999999999999999999764433
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.........++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~---- 229 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGRIENGERLPM---- 229 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCcCCC----
Confidence 2222233345678999999988889999999999999999996 99998643221 11122222211110
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
+......+.+++.+|+..+|++|||+.++++.|+.++..
T Consensus 230 --------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 230 --------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 112335788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.76 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=210.1
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----ee
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-----EP 395 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-----~~ 395 (692)
-.++|.+.++||+|||+-||.++ +.++..+|+|++.....++.+..++|++..++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999998 6778899999999888888899999999999999999999999876443 58
Q ss_pred EEEEEeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 396 ILVYEFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
||+++|...|+|.+++.... +..+++.+.++|+.++++||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999998653 346999999999999999999999963 569999999999999999999999999987
Q ss_pred cCCCC--CCcc------cccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHH
Q 005536 474 LGMTE--SSHI------STAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542 (692)
Q Consensus 474 ~~~~~--~~~~------~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~ 542 (692)
..... ..+. .....-|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------- 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------- 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence 53221 1110 11234689999999874 456889999999999999999999999732211
Q ss_pred HHhccCcc-cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 543 DRIGRGCV-DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 543 ~~~~~~~~-~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
.|.+ ..+....+.-.. .....+.+.+|+.+||+.||.+||++.+++..++.+
T Consensus 248 ----GgSlaLAv~n~q~s~P~---~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPN---SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----CCeEEEeeeccccccCC---CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 111121111100 112557889999999999999999999999988875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=335.57 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=198.3
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----eeE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-----EPI 396 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-----~~~ 396 (692)
+|+..++||+|+||+||+++. .+++.||||++... +....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 46889999998653 2345567899999999999999999999998776 789
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+|+||+. ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888887653 458999999999999999999999 499999999999999999999999999998643
Q ss_pred CCCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc---
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE--- 552 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e--- 552 (692)
...........+|+.|+|||++.+. .++.++||||||+++|||++|+.||....+..... ...+.++.....+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD---LITDLLGTPSLEAMRS 231 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCHHHHHH
Confidence 3333333445689999999998764 57899999999999999999999997544322111 1111111000000
Q ss_pred --------cccccC-Cc---CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 553 --------IIDPYL-EP---HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 553 --------i~d~~l-~~---~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+..... .+ ..........+++.+|+.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 000000 00 00000112245788999999999999999999887
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=314.69 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=204.1
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..++||+|+||+||+++.. +++.||+|++... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999854 5789999998753 234556899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.......+++..++.++.|++.||+|||+ .+++|+||+|+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 999999999987655568999999999999999999998 499999999999999999999999999997533221 1
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......|++.|+|||++.+..++.++||||||++++||++|+.|+..... ... ...+..+.....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~-~~~~~~~~~~~~-------- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNL-VLKIIRGSYPPV-------- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHH-HHHHhcCCCCCC--------
Confidence 22334588999999999988999999999999999999999999863321 111 222222221111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||+.+|++||+|.||++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.64 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=198.5
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||||.+.... ....+.+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999854 47899999986432 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC-
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE- 478 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~- 478 (692)
||+++|+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999999764 458889999999999999999999 49999999999999999999999999997421100
Q ss_pred -----------------------------------------CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHH
Q 005536 479 -----------------------------------------SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLI 517 (692)
Q Consensus 479 -----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~ 517 (692)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000012346999999999999999999999999999999
Q ss_pred HHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCC---CHHHH
Q 005536 518 EIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP---TMMEV 594 (692)
Q Consensus 518 eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP---sm~eV 594 (692)
||++|+.||....+... ...+...... ...+ .. .....++.+++.+|+ .+|.+|+ ++.|+
T Consensus 236 ell~G~~Pf~~~~~~~~-------~~~i~~~~~~-~~~~----~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTPAET-------QLKVINWETT-LHIP----SQ----AKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCHHHH-------HHHHhccCcc-ccCC----CC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999975432111 1111111100 0000 00 112345677888876 4999999 76666
Q ss_pred HHHHHhhhhcccccc
Q 005536 595 AEELEHIRVSSWASN 609 (692)
Q Consensus 595 l~~L~~i~~~~~~~~ 609 (692)
+ .++|...
T Consensus 299 l-------~h~~~~~ 306 (376)
T cd05598 299 K-------AHPFFKG 306 (376)
T ss_pred h-------CCCCcCC
Confidence 5 6677654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=314.72 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=197.9
Q ss_pred eeecccccEEEEEEEEeC-C---CEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN-D---DWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
++||+|+||.||+|+... + ..+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997533 2 5799999876543 35678999999999999999999999875 4568999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc--
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI-- 482 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~-- 482 (692)
++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998653 68999999999999999999998 499999999999999999999999999998643322211
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+...+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~~~--------- 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------AEVIAMLESGERLP--------- 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCcCC---------
Confidence 112234568999999998899999999999999999998 8998864321 11222232221111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.+......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11123357889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.83 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=194.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhC---CCCCeeeeEEEEEeC-----C
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSV---SHPNLLRLLGCCIEE-----G 393 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~H~niv~l~g~~~~~-----~ 393 (692)
+|+..+.||+|+||+||+++.. +++.||+|.++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 578999999875422 2234566777777665 699999999988642 4
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999996 5899998876555699999999999999999999994 99999999999999999999999999997
Q ss_pred cCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc-
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE- 552 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e- 552 (692)
..... .......||..|+|||++.+..++.++||||||+++|||++|++||........ .......+......+
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChhhC
Confidence 63221 222345689999999999888999999999999999999999999864322111 111111111000000
Q ss_pred ---------cccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 553 ---------IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 553 ---------i~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.+..............+++.+|+.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 0000000000011112345678999999999999999998887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.49 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=203.4
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~ 399 (692)
+|+..+.||+|+||+||+++.. +++.||+|+++.. .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999864 5789999999753 2334567888999998886 577888999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998764 458999999999999999999999 499999999999999999999999999987532221
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....+ ....+.+.++...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~-------- 219 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNVS-------- 219 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--------
Confidence 222345689999999999988999999999999999999999999864322 1112222222110
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.+.....++.+++.+||+.+|.+|++..+. ..++++.++|....
T Consensus 220 -----~p~~~~~~~~~li~~~l~~~p~~R~~~~~~--~~~~i~~h~~f~~~ 263 (323)
T cd05615 220 -----YPKSLSKEAVSICKGLMTKHPSKRLGCGPE--GERDIREHAFFRRI 263 (323)
T ss_pred -----CCccCCHHHHHHHHHHcccCHhhCCCCCCC--CHHHHhcCcccCCC
Confidence 011223467899999999999999986432 23456677776544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.25 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=199.1
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...++||+|+||+||+++. .+++.||||++... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 45789999998653 2334567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999764 458899999999999999999999 499999999999999999999999999986321100
Q ss_pred C------------c----------------------------------ccccCCCCCCCCCccccccCCCCCccceeehh
Q 005536 480 S------------H----------------------------------ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFG 513 (692)
Q Consensus 480 ~------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfG 513 (692)
. . ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999988999999999999
Q ss_pred HHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCC---CC
Q 005536 514 VVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMR---PT 590 (692)
Q Consensus 514 vll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~R---Ps 590 (692)
|+||||++|+.||....+.. ....+..... .+.-+ .. .....++.+|+.+||+ +|.+| ++
T Consensus 236 vil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~~~~p----~~----~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE-------TYRKIINWRE-TLYFP----DD----IHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH-------HHHHHHccCC-ccCCC----CC----CCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999996433211 1112211100 00000 00 0123467899999998 66665 58
Q ss_pred HHHHHHHHHhhhhcccccc
Q 005536 591 MMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 591 m~eVl~~L~~i~~~~~~~~ 609 (692)
+.|++ .++|..+
T Consensus 299 ~~~~l-------~hp~~~~ 310 (377)
T cd05629 299 AHEIK-------SHPFFRG 310 (377)
T ss_pred HHHHh-------cCCCcCC
Confidence 77776 5666553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.25 Aligned_cols=251 Identities=28% Similarity=0.370 Sum_probs=196.9
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIK-LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||+|++... .....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 5889999999754 2234455666665 46779999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 9999988754 458999999999999999999999 49999999999999999999999999998753221 22234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+.+..+... +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~~~~--~~~-------- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHKPLV--LRP-------- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcCCcc--CCC--------
Confidence 457999999999999999999999999999999999999998643211 112222222110 011
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.....+.+++.+||+.+|.+||++.+. ++++..++|...
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~---~~~i~~h~~f~~ 256 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKED---FLEIQEHPFFES 256 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCC---HHHHhcCCCcCC
Confidence 123467899999999999999998644 344556666653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=313.88 Aligned_cols=248 Identities=31% Similarity=0.473 Sum_probs=203.8
Q ss_pred eeecccccEEEEEEEEeC----CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||.||++.... +..|++|.++..... ..+++.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 778999999866433 378899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 405 GTLCQHLQRER-------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 405 gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
++|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 3569999999999999999999999 5999999999999999999999999999986443
Q ss_pred CC-CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.. ........++..|+|||.+....++.++||||||+++|||++ |+.|+..... ....+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCC---
Confidence 22 122344567899999999988899999999999999999999 5888864421 11233333221111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
.+.....++.+++.+||+.+|++||++.|+++.|+
T Consensus 228 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ---------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=333.76 Aligned_cols=257 Identities=22% Similarity=0.302 Sum_probs=197.1
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.|...++||+|+||+||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 57889999997542 2345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC-
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES- 479 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~- 479 (692)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999764 4588899999999999999999994 99999999999999999999999999975311000
Q ss_pred ---------------------------------------------CcccccCCCCCCCCCccccccCCCCCccceeehhH
Q 005536 480 ---------------------------------------------SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGV 514 (692)
Q Consensus 480 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGv 514 (692)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCC---H
Q 005536 515 VLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT---M 591 (692)
Q Consensus 515 ll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPs---m 591 (692)
+||||++|+.||....+.. . ...+..... ....+ .. .....++.+++.+++ .+|++|++ +
T Consensus 237 il~elltG~~Pf~~~~~~~------~-~~~i~~~~~-~~~~p----~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE------T-QMKVINWQT-SLHIP----PQ----AKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH------H-HHHHHccCC-CcCCC----Cc----ccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999997543211 1 111111000 00000 00 112345677777776 49999987 5
Q ss_pred HHHHHHHHhhhhccccccc
Q 005536 592 MEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 592 ~eVl~~L~~i~~~~~~~~~ 610 (692)
.|++ .++|....
T Consensus 300 ~ei~-------~hp~f~~~ 311 (382)
T cd05625 300 DEIK-------AHPFFKTI 311 (382)
T ss_pred HHHh-------cCCCcCCc
Confidence 5443 56676543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.69 Aligned_cols=269 Identities=21% Similarity=0.300 Sum_probs=202.0
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|...++||+|+||+||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999865 57789999997543 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
++ ++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...... .
T Consensus 86 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 86 LD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 96 5888888654 3458999999999999999999999 599999999999999999999999999997532221 2
Q ss_pred ccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc---cc------
Q 005536 482 ISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC---VD------ 551 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~------ 551 (692)
......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||......+.... ....+.... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSND 236 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchh
Confidence 2233467999999998764 4688999999999999999999999975443222111 111111000 00
Q ss_pred ccccccCCcCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 552 EIIDPYLEPHRD----AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 552 ei~d~~l~~~~~----~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
+..+........ ........++.+|+.+||+.||.+|||+.|++ .++|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l-------~h~~~~ 290 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM-------KHAYFR 290 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh-------cChhhh
Confidence 000000000000 00012335678999999999999999998887 466765
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.92 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=195.8
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||.||+++.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 47899999997542 23455677888888765 899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 9999998764 458999999999999999999999 49999999999999999999999999998742211 12234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+. +.+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~------~~~~----- 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDT------PHYP----- 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC------CCCC-----
Confidence 45799999999999999999999999999999999999999964321 11122222211 1010
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.....++.+|+.+||+.||++||++.+ .++.++|...
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~~~~~------~~~~h~~f~~ 253 (316)
T cd05620 217 --RWITKESKDILEKLFERDPTRRLGVVG------NIRGHPFFKT 253 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChH------HHHcCCCcCC
Confidence 112346789999999999999999742 2345666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.35 Aligned_cols=263 Identities=26% Similarity=0.367 Sum_probs=200.9
Q ss_pred hccCccceeecccccEEEEEEEEe-----------------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeee
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-----------------NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLR 384 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~ 384 (692)
.++|+..++||+|+||+||++... +...||+|.++... ....++|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 23468999997543 344578999999999999999999
Q ss_pred eEEEEEeCCeeEEEEEeCCCCCHHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 005536 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERG---------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSN 455 (692)
Q Consensus 385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~N 455 (692)
+++++.+.+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999976431 2377889999999999999999994 99999999999
Q ss_pred eEEcCCCceEEeeecCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh--CCcccCCCCCc
Q 005536 456 ILLDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT--ALKVVDFSRPH 532 (692)
Q Consensus 456 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt--g~~p~~~~~~~ 532 (692)
||+++++.+||+|||+++........ ......++..|++||......++.++||||||+++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999754322211 1222345678999999888899999999999999999998 55666432221
Q ss_pred ccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
.. .............. ...+ .+......+.+|+.+||+.+|++||+|.||++.|++
T Consensus 241 ~~---~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QV---IENTGEFFRDQGRQ-VYLP--------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHHhhcccc-ccCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111111110000 0000 011233578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.87 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=200.2
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|+..++||+|+||.||+++.. ++..+|+|.++... ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999864 47788999887543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... ..+++..+..++.|+++||+|||+. .+++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999765 4589999999999999999999973 48999999999999999999999999998753221
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc----------
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD---------- 551 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 551 (692)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...............
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 1234468999999999988889999999999999999999999986432111 000000000000000
Q ss_pred ----------ccccccCCcCCCcc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 552 ----------EIIDPYLEPHRDAW-TLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 552 ----------ei~d~~l~~~~~~~-~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
++.+.......... ......++.+++.+||+.+|++||++.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000000 0012346889999999999999999988873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.99 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=192.7
Q ss_pred eeecccccEEEEEEEEeC---CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN---DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+.||+|+||.||+|+..+ +..+|+|.++... .....+|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998654 3569999987653 234457899999999999999999999999999999999999999
Q ss_pred CHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc-
Q 005536 406 TLCQHLQRERG---SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH- 481 (692)
Q Consensus 406 sL~~~l~~~~~---~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~- 481 (692)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 246788888999999999999999 49999999999999999999999999999753322211
Q ss_pred ccccCCCCCCCCCccccccC-------CCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYF-------HLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
......++..|+|||++... .++.++||||||+++|||++ |+.||........ ....+ .+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV------LTYTV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHh-hcccCCC
Confidence 12234578899999987642 35789999999999999996 9989864332111 01111 1111122
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
.++.+. ....+.+.+|+.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~-------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK-------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC-------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222211 112345778999998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.17 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=206.3
Q ss_pred ccCccceeecccccEEEEEEEEe-----CCCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-----NDDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIE--EGEP 395 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~--~~~~ 395 (692)
+.|...+.||+|+||.||++++. ++..||||.++..... ..++|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34666789999999999999864 2578999999865443 56789999999999999999999999887 5578
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999998653 359999999999999999999998 49999999999999999999999999999864
Q ss_pred CCCCC--cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccc--------cHHHHHHHHh
Q 005536 476 MTESS--HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV--------NLAALAIDRI 545 (692)
Q Consensus 476 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~--------~~~~~~~~~~ 545 (692)
..... .......++..|++||.+.+..++.++||||||+++|||++|+.|+......... .......+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 42211 1112234567799999998889999999999999999999999887532211100 0011112222
Q ss_pred ccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 546 GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 546 ~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
..+... ..+.....++.+|+.+||+.+|++||+|.||+++|+.|+
T Consensus 240 ~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGERL------------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCCcC------------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 211100 001123367899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.85 Aligned_cols=255 Identities=21% Similarity=0.258 Sum_probs=201.7
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
|+..+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999864 57899999987542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.......+++..++.++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999999999976555569999999999999999999998 599999999999999999999999999987533222
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.................... ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~--------- 223 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----EE--------- 223 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----hh---------
Confidence 12334789999999999998999999999999999999999999974332111111111111000 00
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHhhhhccccc
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPT-----MMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPs-----m~eVl~~L~~i~~~~~~~ 608 (692)
........+.+|+.+||+.+|++||| ++|++ .++|..
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~-------~h~~~~ 265 (285)
T cd05630 224 ---YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK-------EHPLFK 265 (285)
T ss_pred ---cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH-------cChhhh
Confidence 01112346789999999999999999 55555 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.25 Aligned_cols=257 Identities=20% Similarity=0.244 Sum_probs=200.0
Q ss_pred hHHHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391 (692)
Q Consensus 316 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~ 391 (692)
..+++...++|+..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556666789999999999999999999865 4788999998642 22344567899999999999999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
.+..++||||+++|+|.+++... .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998653 37888899999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccC----CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYF----HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
++..............||+.|+|||++... .++.++|||||||+||||++|+.||..... .. ....+..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~-~~~~i~~ 261 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VG-TYSKIMN 261 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HH-HHHHHHc
Confidence 986433322233456799999999998654 378899999999999999999999974322 11 1222221
Q ss_pred C-cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHH
Q 005536 548 G-CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDM--RPTMMEVA 595 (692)
Q Consensus 548 ~-~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~--RPsm~eVl 595 (692)
. ....+.+ .......+.+|+.+||+.++.+ ||++.|++
T Consensus 262 ~~~~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~ 302 (371)
T cd05622 262 HKNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIK 302 (371)
T ss_pred CCCcccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHh
Confidence 1 1111111 0123356788999999844433 67766665
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.81 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=203.9
Q ss_pred hccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..+|+..+.||+|+||.||+|+. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999985 45789999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++....... .
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred cCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 9999999998643 48999999999999999999999 499999999999999999999999999987532221 1
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......+++.|+|||++.+..++.++||||||+++|||++|+.||....+... .......+ ...+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~~~~~------ 238 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TPELQN------ 238 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC-CCCCCC------
Confidence 22334688999999999888899999999999999999999999964432111 11111111 111100
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||+.+|++||++.||++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ----ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1123356889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.01 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=206.1
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|+||.||.++. .+++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999998884 45788999998754 345567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876556689999999999999999999984 999999999999999999999999999986433322
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......+++.|+|||++.+..++.++||||||+++|||++|+.||+..... .....+..+......
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~------- 222 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKIVQGNYTPVV------- 222 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCCCc-------
Confidence 234456899999999998888999999999999999999999998643221 112222223222111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~ 597 (692)
.....++.+++.+||+.+|++||++.|+++.
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 -----SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.38 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=200.1
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG---- 393 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~---- 393 (692)
...++|+..+.||+|+||.||+++.. ++..||||++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999864 4789999999643 3345667889999999999999999999986543
Q ss_pred --eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 394 --EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 394 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
..++||||++ ++|.+.++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 4799999996 567676643 37889999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc-----
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG----- 546 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~----- 546 (692)
++.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....+.+.
T Consensus 170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSAE 244 (359)
T ss_pred cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcHH
Confidence 975322 2223445789999999999999999999999999999999999999974432110 000111100
Q ss_pred -------------cC-------cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 547 -------------RG-------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 547 -------------~~-------~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
.. ...+.......+...........++.+|+.+||+.||++|||+.|++ .++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l-------~hp~ 317 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL-------RHPY 317 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh-------cCch
Confidence 00 00000000000000001111235678999999999999999999987 4666
Q ss_pred cc
Q 005536 607 AS 608 (692)
Q Consensus 607 ~~ 608 (692)
..
T Consensus 318 ~~ 319 (359)
T cd07876 318 IT 319 (359)
T ss_pred hh
Confidence 54
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=326.83 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=208.1
Q ss_pred HHHhhccCccceeecccccEEEEEEEEeC--------CCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEE
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHN--------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGC 388 (692)
Q Consensus 319 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~ 388 (692)
++....+|...+.||+|+||.||+++... ...||+|.++... ....+++.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 33344578889999999999999997422 2368999887542 34567899999999999 79999999999
Q ss_pred EEeCCeeEEEEEeCCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 005536 389 CIEEGEPILVYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSS 454 (692)
Q Consensus 389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~ 454 (692)
+.+.+..+++|||+++|+|.+++.... ...++|..++.++.|++.||+|||+ ++|+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence 999999999999999999999997542 2348899999999999999999999 49999999999
Q ss_pred ceEEcCCCceEEeeecCCccCCCCCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCc
Q 005536 455 NILLDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPH 532 (692)
Q Consensus 455 NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~ 532 (692)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999753322111 1222345678999999999899999999999999999998 7777753221
Q ss_pred ccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
......+..+...+. +.....++.+|+.+||+.+|++||+|.|+++.|+++...
T Consensus 243 ------~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 ------EELFKLLKEGHRMDK------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ------HHHHHHHHcCCCCCC------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 112223322211111 112235788999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.71 Aligned_cols=239 Identities=23% Similarity=0.357 Sum_probs=189.2
Q ss_pred eeecccccEEEEEEEEeCC-------------CEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 330 HRLGTGAYGTVYAGKLHND-------------DWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~-------------~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
+.||+|+||.||+|++.+. ..|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999985432 258999887665556668899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc-------eEEeee
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR-------SKVADF 469 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~-------~kl~DF 469 (692)
+||||+++++|..++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998887543 458999999999999999999998 59999999999999987664 899999
Q ss_pred cCCccCCCCCCcccccCCCCCCCCCccccc-cCCCCCccceeehhHHHHHHH-hCCcccCCCCCcccccHHHHHHHHhcc
Q 005536 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQ-YFHLSDKSDVYSFGVVLIEII-TALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 470 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SfGvll~eLl-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
|++...... ....++..|+|||++. +..++.++||||||+++|||+ +|+.|+......+ ...+..
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~~ 223 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERFYE 223 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HHHHHh
Confidence 998753221 2345788999999886 467899999999999999998 5777765322111 011111
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
+... .. .....++.+|+.+||+.+|++||++.+|++.|
T Consensus 224 ~~~~-~~------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCM-LV------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCcc-CC------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1100 00 01235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=319.34 Aligned_cols=260 Identities=19% Similarity=0.231 Sum_probs=204.4
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
|+..+.||+|+||+||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++.+++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 57899999987542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 999999999876555569999999999999999999998 49999999999999999999999999998753221 1
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ .......+.++.. .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~--~-------- 223 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE--V-------- 223 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc--c--------
Confidence 12344789999999999988999999999999999999999999864322111 1111122221110 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
........+.+|+.+||+.+|++||++.|.. .+++..++|..
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~--~~~l~~~~~~~ 265 (285)
T cd05632 224 ---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEG--AGEVKRHPFFR 265 (285)
T ss_pred ---cCccCCHHHHHHHHHHccCCHhHcCCCcccC--hHHHHcChhhh
Confidence 1112234678999999999999999965442 44555566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.23 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=194.5
Q ss_pred eeecccccEEEEEEEEeC----CCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCeeEEEEEeCC
Q 005536 330 HRLGTGAYGTVYAGKLHN----DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE-EGEPILVYEFMP 403 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 403 (692)
+.||+|+||.||+|.+.+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 347999998643 33456789999999999999999999998764 556899999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC---
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS--- 480 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~--- 480 (692)
+|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997643 347888889999999999999998 4999999999999999999999999999975332111
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCC-cccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITAL-KVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......++..|+|||++.+..++.++||||||+++|||++|. .|+..... .. ....+..+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~----~~~~~~~~~~~~------- 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FD----ITVYLLQGRRLL------- 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHhcCCCCC-------
Confidence 1112334677899999998889999999999999999999964 44532211 11 112222221110
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.+...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 223 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 -----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00112356889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.96 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=199.5
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHH
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLC 408 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 408 (692)
++||+|+||.||++...+++.|++|.+...... ..++|.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 5678999999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc-ccCC
Q 005536 409 QHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS-TAPQ 487 (692)
Q Consensus 409 ~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 487 (692)
+++.... ..+++..++.++.+++.||+|||+ ++++||||||+|||++.++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9997643 458999999999999999999998 5999999999999999999999999999975332111111 1223
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccC
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWT 566 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~ 566 (692)
++..|+|||.+.+..++.++||||||+++|||+| |..|+...... .....+..+.. . ..+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~~~--~----------~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESGYR--M----------PAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcCCC--C----------CCC
Confidence 4667999999988899999999999999999999 77777533221 11122221110 0 001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 567 LSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 567 ~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
.....++.+++.+||+.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.48 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=198.4
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5567789999999999998754 677899998766666678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... .....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-ccccc
Confidence 9999888754 34699999999999999999999994 9999999999999999999999999998753222 22223
Q ss_pred cCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 485 APQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
...++..|+|||++. +..++.++|||||||++|||++|+.|+....+ ...... +.......+..+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~~--- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLK-IAKSEPPTLAQP--- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHH-HhhcCCCCCCCc---
Confidence 456899999999874 44577899999999999999999999863321 111111 111111111111
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.....++.+++.+||+.+|.+||++.+++
T Consensus 232 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 232 -------SRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred -------cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11235788999999999999999998876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.55 Aligned_cols=260 Identities=26% Similarity=0.350 Sum_probs=203.2
Q ss_pred hccCccceeecccccEEEEEEEE------eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-C
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL------HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE-G 393 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~-~ 393 (692)
.++|+..+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999973 346789999997543 33456788999999999 689999999988654 4
Q ss_pred eeEEEEEeCCCCCHHHHHhhccC---------------------------------------------------------
Q 005536 394 EPILVYEFMPNGTLCQHLQRERG--------------------------------------------------------- 416 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 416 (692)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999875321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc-ccccCC
Q 005536 417 --------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH-ISTAPQ 487 (692)
Q Consensus 417 --------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 487 (692)
..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 237888899999999999999999 49999999999999999999999999999764322111 112334
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccC
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWT 566 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~ 566 (692)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ......+.++..... +
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~---------- 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMRA--P---------- 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCCC--C----------
Confidence 6678999999988899999999999999999997 88887543221 112222332221111 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 567 LSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 567 ~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
.....++.+++.+||+.+|++||++.||++.|+.+..
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0112468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.40 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=200.4
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE------ 392 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~------ 392 (692)
..++|...+.||+|+||.||++... .++.||||++... +....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999854 4788999999753 234456788999999999999999999987543
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 577777753 38899999999999999999999 59999999999999999999999999999
Q ss_pred ccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc-----
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR----- 547 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 547 (692)
+.... ........||..|+|||++.+..++.++||||||+++|||++|+.||........ .......+..
T Consensus 174 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 248 (364)
T cd07875 174 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPEF 248 (364)
T ss_pred cccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHH
Confidence 85322 2222445789999999999999999999999999999999999999964432111 1111111110
Q ss_pred -------------Cc-------ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 005536 548 -------------GC-------VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWA 607 (692)
Q Consensus 548 -------------~~-------~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~ 607 (692)
.. ..++....+.+............+.+|+.+||+.||++|||+.|++ .++|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L-------~hp~~ 321 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL-------QHPYI 321 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh-------cCccc
Confidence 00 0000000000000011111235678999999999999999998886 56666
Q ss_pred c
Q 005536 608 S 608 (692)
Q Consensus 608 ~ 608 (692)
.
T Consensus 322 ~ 322 (364)
T cd07875 322 N 322 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.69 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=203.3
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
++|+..+.||+|+||.||+++..+ ++.|++|.+..... .+++.+|++++++++|+||+++++++.+.+..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999765 78999999875432 778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AK 155 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc-cc
Confidence 999999998754 35689999999999999999999984 99999999999999999999999999987643222 12
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+....+... ...+..... +.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~-----~~~---- 219 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPNKPP-----PTL---- 219 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhccCCC-----CCC----
Confidence 2344588999999999988999999999999999999999999874322111 111111000 000
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+......+.+++.+||+.+|++||++.||++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011123357889999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.38 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=203.7
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCch--hHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCC------
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVSHPN-LLRLLGCCIEEG------ 393 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~n-iv~l~g~~~~~~------ 393 (692)
..|...++||+|.||+||+|+. .+|+.||+|+++....+ .-....+|+.+|++++|+| |+.|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3456667799999999999984 56889999999876442 2345689999999999999 999999998877
Q ss_pred eeEEEEEeCCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 394 EPILVYEFMPNGTLCQHLQRERG--SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
..++|+||+ .-+|.+++..... ..++...+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 6799999987653 3577788999999999999999995 999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC--
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG-- 548 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 548 (692)
|+.... .....+..++|..|.|||++.+. .|+...||||+|++++||++++.-|..... ........+.++.-
T Consensus 167 Ara~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCc
Confidence 985332 22334666789999999998776 799999999999999999999988876544 22233333333321
Q ss_pred -cccccc-cccCCcCCCccC------H---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 549 -CVDEII-DPYLEPHRDAWT------L---SSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 549 -~~~ei~-d~~l~~~~~~~~------~---~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
....+. -+........+. . .......+++.+||+.+|.+|.|++.+++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 111111 001110111111 1 11136789999999999999999998874
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.55 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=188.3
Q ss_pred eecccccEEEEEEEEeC-------------------------CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeee
Q 005536 331 RLGTGAYGTVYAGKLHN-------------------------DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l 385 (692)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998531 13589999876555556788999999999999999999
Q ss_pred EEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---
Q 005536 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY--- 462 (692)
Q Consensus 386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~--- 462 (692)
++++.+....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999988754 3468999999999999999999998 5999999999999997643
Q ss_pred ----ceEEeeecCCccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHH-hCCcccCCCCCccccc
Q 005536 463 ----RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEII-TALKVVDFSRPHSEVN 536 (692)
Q Consensus 463 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLl-tg~~p~~~~~~~~~~~ 536 (692)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 4899999988642221 22357888999998865 56899999999999999995 68888864332111
Q ss_pred HHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 537 LAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 537 ~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
. . .+.... ... . .....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 231 -~-~---~~~~~~-------~~~---~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 -E-R---FYEKKH-------RLP---E----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -H-H---HHHhcc-------CCC---C----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 1 111000 000 0 11236889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.97 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=202.0
Q ss_pred hccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|+..++||+|+||.||+|+... ++.|++|.+...+....+++.+|+++++.++|+||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3568888999999999999998754 788999999877667778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|..++.... ..+++..++.++.|++.+|+|||+ .+|+||||||+||+++.++.+||+|||++..... ...
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~-~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-TLQ 165 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc-ccc
Confidence 99999988876543 458999999999999999999998 4999999999999999999999999999875222 122
Q ss_pred ccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
......+++.|+|||++. ...++.++||||||+++|||++|+.|+....+ ... ...+..........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~-~~~~~~~~~~~~~~- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRV-LLKIAKSEPPTLSQ- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHH-HHHHhcCCCccCCC-
Confidence 223456889999999874 44578899999999999999999999864322 111 11222211111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+.....++.+++.+||+.+|++||++.|++
T Consensus 238 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 238 ---------PSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred ---------CcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 112234678999999999999999998886
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.78 Aligned_cols=268 Identities=24% Similarity=0.295 Sum_probs=200.9
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE----- 392 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~----- 392 (692)
...++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999854 4788999999754 234456788999999999999999999988643
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 393 -GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 35799999995 577777653 38899999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc----
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR---- 547 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 547 (692)
++.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....+.+..
T Consensus 166 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW---NKVIEQLGTPCPE 240 (355)
T ss_pred cccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHH
Confidence 975322 22234457899999999999989999999999999999999999998643321110 111111100
Q ss_pred --------------C--ccc-----ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 548 --------------G--CVD-----EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 548 --------------~--~~~-----ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
. ... ......+.+...........++.+|+.+||+.||++|||+.|++ .++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell-------~hp~ 313 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL-------QHPY 313 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh-------cCcc
Confidence 0 000 00000000000111112345788999999999999999999987 5666
Q ss_pred cc
Q 005536 607 AS 608 (692)
Q Consensus 607 ~~ 608 (692)
..
T Consensus 314 ~~ 315 (355)
T cd07874 314 IN 315 (355)
T ss_pred hh
Confidence 54
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=310.51 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=202.8
Q ss_pred cCccceeecccccEEEEEEEEeC--CCEEEEEEeecC----------CchhHHHHHHHHHHHHh-CCCCCeeeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN--DDWVAIKRFRYR----------DTDSIDQVMNEIKLLSS-VSHPNLLRLLGCCIE 391 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~il~~-l~H~niv~l~g~~~~ 391 (692)
+|+..+.||+|+||.||+|+... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999765 678999988643 12345567889998875 799999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeee
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 469 (692)
.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. .+++|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988642 234689999999999999999999963 48999999999999999999999999
Q ss_pred cCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 470 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
|++....... ......|+..|++||++.+..++.++||||||+++|||++|+.|+...... .....+.++.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SLATKIVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HHHHHHhhcc
Confidence 9997643322 334556899999999999888999999999999999999999998633211 1122222221
Q ss_pred ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
...... ......+.+++.+||+.+|++||++.||..+|+
T Consensus 230 ~~~~~~-----------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLPE-----------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCCc-----------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111100 012356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.93 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=204.1
Q ss_pred hccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|+..+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46788999999999999999985 46889999999876666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 999999999864 3489999999999999999999994 99999999999999999999999999987532221 2
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||....+..... .+..+......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~~~~~~~~------- 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPELQ------- 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eeccCCCCCCC-------
Confidence 2234468899999999998889999999999999999999999996443321110 00000000000
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+......+.+++.+||+.+|++||++.+|++
T Consensus 237 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123356789999999999999999998883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.78 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=204.0
Q ss_pred ccCccceeecccccEEEEEEEEe------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
++|+..+.||+|+||+||+++.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 2457999988754433 4678999999999999999999999999989999
Q ss_pred EEEEeCCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeee
Q 005536 397 LVYEFMPNGTLCQHLQRERG-------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 469 (692)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999986542 258999999999999999999998 49999999999999999999999999
Q ss_pred cCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccC
Q 005536 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 470 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
|+++..............++..|++||.+.+..++.++||||||+++|||++ |..||..... ......+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHcC
Confidence 9987533222222233456778999999988889999999999999999999 7777742211 1122223222
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
...... .......+.+++.+||+.+|++||++.|++++|.
T Consensus 235 ~~~~~~-----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPV-----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCC-----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 221110 0123357889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.67 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=203.1
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||+++.. +++.||+|+++.. .....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 4789999999753 2334567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999764 458999999999999999999999 599999999999999999999999999986432110
Q ss_pred C----------------------------------cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcc
Q 005536 480 S----------------------------------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKV 525 (692)
Q Consensus 480 ~----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p 525 (692)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred cCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 005536 526 VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~ 605 (692)
|....+.. ....+........+.+. .....++.+|+.+++. +|.+|++... ++++..++
T Consensus 236 f~~~~~~~-------~~~~i~~~~~~~~~p~~---------~~~s~~~~~li~~l~~-~p~~R~~~~~----~~ei~~hp 294 (360)
T cd05627 236 FCSETPQE-------TYRKVMNWKETLVFPPE---------VPISEKAKDLILRFCT-DSENRIGSNG----VEEIKSHP 294 (360)
T ss_pred CCCCCHHH-------HHHHHHcCCCceecCCC---------CCCCHHHHHHHHHhcc-ChhhcCCCCC----HHHHhcCC
Confidence 97443311 12222211100001110 0123467788888764 9999987432 34555788
Q ss_pred cccccc
Q 005536 606 WASNIY 611 (692)
Q Consensus 606 ~~~~~~ 611 (692)
|.....
T Consensus 295 ~f~~~~ 300 (360)
T cd05627 295 FFEGVD 300 (360)
T ss_pred CCCCCC
Confidence 877554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.75 Aligned_cols=257 Identities=24% Similarity=0.395 Sum_probs=205.0
Q ss_pred ccCccceeecccccEEEEEEEEeC-CC----EEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DD----WVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
..|+..+.||+|+||+||+|...+ +. .||+|.++... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778899999999999998643 32 58999887553 3455789999999999999999999999987 78899
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999998653 348999999999999999999999 5999999999999999999999999999986433
Q ss_pred CCCcc-cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ESSHI-STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
..... .....++..|++||.+....++.++||||||+++|||++ |+.|++.... ....+.+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-- 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGERLPQ-- 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCCCCCC--
Confidence 22211 112234678999999988899999999999999999999 9999864322 112223332211100
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
+......+.+++.+||..+|.+||++.++++.|+++...
T Consensus 233 ----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 233 ----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 011224678999999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.96 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=202.0
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+.|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999865 57889999987543 33345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
++ ++|.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+|||+++++.+||+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 96 6999988764 3458999999999999999999999 499999999999999999999999999987532221 2
Q ss_pred ccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc---cCcccccccc-
Q 005536 482 ISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG---RGCVDEIIDP- 556 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ei~d~- 556 (692)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ......+. ......+++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhccc
Confidence 2233457899999998765 35788999999999999999999998754322111 11111111 0000111000
Q ss_pred -----cCCcCC----CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 557 -----YLEPHR----DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 557 -----~l~~~~----~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
...... ..........+.+|+.+||+.||.+|||++|++ .++|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil-------~h~~f~ 290 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM-------KHPYFH 290 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh-------cCcccc
Confidence 000000 001112345678999999999999999998887 566654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.55 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=197.4
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999865 58899999987542 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERG-SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
++ ++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-V 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-c
Confidence 96 689998876433 568999999999999999999999 49999999999999999999999999998753222 1
Q ss_pred cccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC---c-------
Q 005536 481 HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG---C------- 549 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~------- 549 (692)
.......+++.|+|||.+.+. .++.++||||||+++|||+||+.||......... ......+... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL---FRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHhCCCChhhhhcchhh
Confidence 222334678999999987654 5788999999999999999999998643221110 0001111000 0
Q ss_pred --ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 --VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 --~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
....++................++.+++.+||+.||++|||+.+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0000000000000000112345678999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.08 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=197.5
Q ss_pred eeecccccEEEEEEEEeC-------CCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 330 HRLGTGAYGTVYAGKLHN-------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+.||+|+||.||+|+..+ +..+|||.+.... .....+|.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2479999886543 24567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-----ceEEeeecC
Q 005536 402 MPNGTLCQHLQRER-----GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-----RSKVADFGL 471 (692)
Q Consensus 402 ~~~gsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-----~~kl~DFGl 471 (692)
+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++|+||||+|||++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997542 2348899999999999999999998 4899999999999999877 899999999
Q ss_pred CccCCCCC-CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 472 SRLGMTES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 472 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
++...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||..... . . ....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~---~-~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---Q---E-VLQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---H---H-HHHHHhcCC
Confidence 87533221 112223356789999999999999999999999999999998 9888853221 1 1 112222211
Q ss_pred ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
... .+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 231 ~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQ------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccC------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 110 011234578899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.74 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=201.8
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-CeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-GEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~-~~~~lV~E 400 (692)
+|+..+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999864 46789999987542 34556789999999999999999999987644 46789999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.+++.......+++..++.++.+++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999987655679999999999999999999999 499999999999999999999999999997643222
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......+++.|+|||++.+..++.++||||||++++||++|+.|++.... .. ....+..+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~-~~~~~~~~~~~~~------- 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NS-LVYRIIEGKLPPM------- 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HH-HHHHHHhcCCCCC-------
Confidence 223345689999999999999999999999999999999999999863221 11 1122222222111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||+.+|++||++.|+++
T Consensus 223 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 -----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=310.85 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=203.3
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999865 57899999987553 34556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... .+++..++.++.|++.||.|||+ ++++||||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998754 68999999999999999999998 499999999999999999999999999997643321 2
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......+++.|+|||++.+..++.++||||||+++|||+||+.||....+. .....+..+...++.+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~----- 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKNNPPSLEGN----- 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhcCCCCCccc-----
Confidence 233456889999999999888999999999999999999999998643321 11222222211111110
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.....+.+++.+||..+|++||+++++++
T Consensus 222 ------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ------KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ------ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.86 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=190.3
Q ss_pred eeecccccEEEEEEEEeCC---CEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKLHND---DWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
++||+|+||+||+|...++ ..+++|.+.... .....+|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999986543 468888876443 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC-c
Q 005536 406 TLCQHLQRERG---SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS-H 481 (692)
Q Consensus 406 sL~~~l~~~~~---~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~-~ 481 (692)
+|.+++..... ...++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999977543 235788889999999999999999 4999999999999999999999999999875322221 1
Q ss_pred ccccCCCCCCCCCcccccc-------CCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQY-------FHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+....+. ......+..+ ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 1233356778999998643 356889999999999999999 67777533211 1111222222 1222
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
.++.+. ......+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~-------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD-------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc-------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 123345677888888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.54 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=200.2
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
++|...+.||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 57899999998765556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ...
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 999999998754 4589999999999999999999994 9999999999999999999999999998753321 222
Q ss_pred cccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 483 STAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....|+..|+|||++. ...++.++||||||+++|||++|+.|+....+.... . ........ .+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~-~~~~~~~~---~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMTKSNFQ---PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------H-hhhccCCC---CCccc
Confidence 23456899999999874 456889999999999999999999988543321111 0 11111110 00000
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
... .....+.+++.+||+.+|++||++++|++
T Consensus 233 -~~~----~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 -DKM----KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -ccC----CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 12346789999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.32 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=199.8
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHH--HHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
|+..+.||+|+||+||+++... ++.||+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999766 458999999877543332 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++... ..+++..++.++.|+++||+|||+. +|+|+||||+|||+++++.++|+|||.+... ......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999833 4589999999999999999999994 9999999999999999999999999998753 222334
Q ss_pred cccCCCCCCCCCccccc-cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 483 STAPQGTPGYLDPQYHQ-YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....++..|+|||.+. +..++.++||||+|+++|+|++|..|+........ .....+.... .........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~- 226 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKR----PLPSSSQQS- 226 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHT----HHHHHTTSH-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhcccc----ccccccccc-
Confidence 45567899999999998 88899999999999999999999999874411111 1111111110 000000000
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.....++.+++.+||+.+|++||++.+++
T Consensus 227 -----~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 227 -----REKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp -----TTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred -----chhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01126889999999999999999999887
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.15 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=193.9
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIK-LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||+||+++.. +++.||+|++.... .....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 46789999997532 222334445544 56889999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence 9999999764 3478888889999999999999994 9999999999999999999999999999753222 22234
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+.+...... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~~--~~--------- 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPLQ--LK--------- 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCCcC--CC---------
Confidence 457999999999999999999999999999999999999998643211 112222221110 01
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
......+.+++.+||+.+|.+||++.+.+ .++..+.|..
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~---~~i~~~~~~~ 255 (325)
T cd05602 217 --PNITNSARHLLEGLLQKDRTKRLGAKDDF---MEIKNHIFFS 255 (325)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCCCCCH---HHHhcCcccC
Confidence 12234678999999999999999987543 3444555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=314.27 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=206.2
Q ss_pred CCChHHHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEE
Q 005536 313 FYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCI 390 (692)
Q Consensus 313 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~ 390 (692)
.++..++..++++|+..+.||+|+||.||++... +++.+|+|.+... ....+++.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3566788888999999999999999999999864 5788999998654 23346778899999999 7999999999987
Q ss_pred eC-----CeeEEEEEeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 005536 391 EE-----GEPILVYEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR 463 (692)
Q Consensus 391 ~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~ 463 (692)
+. +..++||||+++++|.++++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence 54 3589999999999999988642 23568999999999999999999998 49999999999999999999
Q ss_pred eEEeeecCCccCCCCCCcccccCCCCCCCCCccccccC-----CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHH
Q 005536 464 SKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF-----HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538 (692)
Q Consensus 464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~ 538 (692)
+||+|||+++...... .......|+..|+|||++... .++.++||||||+++|||++|+.|+....+..
T Consensus 167 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----- 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----- 240 (291)
T ss_pred EEEeecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence 9999999987533221 122345689999999987543 36889999999999999999999986432211
Q ss_pred HHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 539 ALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 539 ~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. ...+.++....+.++ ......+.+|+.+||+.+|++||++.|+++
T Consensus 241 -~-~~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 -T-LFKIPRNPPPTLLHP----------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -H-HHHHhcCCCCCCCcc----------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 112222222211111 122346889999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.99 Aligned_cols=238 Identities=23% Similarity=0.393 Sum_probs=189.9
Q ss_pred eeecccccEEEEEEEEeCCC-----------EEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 330 HRLGTGAYGTVYAGKLHNDD-----------WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999976543 4788877654333 6789999999999999999999999988 778999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-------ceEEeeecC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-------RSKVADFGL 471 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-------~~kl~DFGl 471 (692)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999998753 368999999999999999999998 5999999999999999888 799999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccC--CCCCccceeehhHHHHHHHhC-CcccCCCCCcccccHHHHHHHHhccC
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYF--HLSDKSDVYSFGVVLIEIITA-LKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SfGvll~eLltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
+..... .....++..|+|||++... .++.++||||||+++|||++| ..|+........ ...+...
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHhcC
Confidence 975322 2234567789999998776 789999999999999999994 666643321110 1111110
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
... + ......+.+++.+||..+|++||++.||++.|+
T Consensus 223 --~~~------~------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 --HRL------P------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CCC------C------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 001157889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.25 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=205.6
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|+..+.||+|+||.||+++.. +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999864 4678999999877666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++...... ..
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IA 156 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhh-hh
Confidence 99999999987652 458999999999999999999998 49999999999999999999999999998753321 11
Q ss_pred ccccCCCCCCCCCccccccC---CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 482 ISTAPQGTPGYLDPQYHQYF---HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
......++..|+|||.+... .++.++||||||+++|||++|+.|+....+... ...+...... .+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~~~---~~~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSNFP---PPKL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCC---Cccc
Confidence 22345688899999998776 889999999999999999999999864322111 1111111000 0000
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. .......++.+++.+||+.+|.+||++.+|+.
T Consensus 227 ~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 K-----DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c-----chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 11234467899999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.65 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=203.8
Q ss_pred CChHHHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005536 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIE 391 (692)
Q Consensus 314 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~ 391 (692)
+.++.+..+.++|+..+.||+|+||.||+++.. +++.+|+|.++.. ....+++.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 345667788899999999999999999999864 4788999987643 23346788999999999 69999999998853
Q ss_pred -----CCeeEEEEEeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 392 -----EGEPILVYEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 392 -----~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
.+..++||||+++++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 35689999999999999988642 23458999999999999999999999 499999999999999999999
Q ss_pred EEeeecCCccCCCCCCcccccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHH
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA 539 (692)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~ 539 (692)
||+|||+++..... ........|++.|+|||++.. ..++.++||||||+++|||++|+.|+....+...
T Consensus 164 kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 164 KLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EEccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 99999998764322 122234468999999998753 4578899999999999999999999864322111
Q ss_pred HHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005536 540 LAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597 (692)
Q Consensus 540 ~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~ 597 (692)
...+..+......++. ....++.+|+.+||+.+|++||++.||++.
T Consensus 238 --~~~~~~~~~~~~~~~~----------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 --LFKIPRNPPPTLHQPE----------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --HhhccccCCCcccCCC----------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111111111111 122468899999999999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.36 Aligned_cols=278 Identities=19% Similarity=0.283 Sum_probs=201.1
Q ss_pred hHHHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCC------CCeeeeEEE
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH------PNLLRLLGC 388 (692)
Q Consensus 316 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H------~niv~l~g~ 388 (692)
.+++...+++|...++||+|+||+||++... .++.||||+++.. ....+++..|+++++.++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3455566789999999999999999999864 4778999999643 2233456677777777654 458899998
Q ss_pred EEeC-CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-----
Q 005536 389 CIEE-GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY----- 462 (692)
Q Consensus 389 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~----- 462 (692)
+... ...++|||++ +++|.+++.+. ..+++..+..|+.|++.||+|||+. .+|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 8764 5788999988 78899988764 4599999999999999999999973 3899999999999998765
Q ss_pred -----------ceEEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCC
Q 005536 463 -----------RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP 531 (692)
Q Consensus 463 -----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~ 531 (692)
.+||+|||++... ........||+.|+|||++.+..++.++|||||||+||||++|+.||+....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4999999987642 1223456799999999999999999999999999999999999999975443
Q ss_pred cccccHHHHHHHHh----c----cCccccccc------ccCCc--------CCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 005536 532 HSEVNLAALAIDRI----G----RGCVDEIID------PYLEP--------HRDAWTLSSIHNVAELAFRCLAFHRDMRP 589 (692)
Q Consensus 532 ~~~~~~~~~~~~~~----~----~~~~~ei~d------~~l~~--------~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP 589 (692)
.+...+.......+ . .....++++ +...+ ............+.+|+.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 22211111110000 0 000000000 00000 00000001124578999999999999999
Q ss_pred CHHHHHHHHHhhhhccccccc
Q 005536 590 TMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 590 sm~eVl~~L~~i~~~~~~~~~ 610 (692)
|++|++ .++|....
T Consensus 431 ta~e~L-------~Hp~~~~~ 444 (467)
T PTZ00284 431 NARQMT-------THPYVLKY 444 (467)
T ss_pred CHHHHh-------cCcccccc
Confidence 999988 67887543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.80 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=207.1
Q ss_pred hccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..+|+..+.||.|+||+||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35688999999999999999985 56889999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... .
T Consensus 98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 170 (296)
T cd06655 98 LAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-S 170 (296)
T ss_pred cCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc-c
Confidence 9999999988643 489999999999999999999994 99999999999999999999999999987533222 1
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.... ..+.......+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-------~~~~~~~~~~~~~------ 237 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGTPELQN------ 237 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCCcccCC------
Confidence 223446899999999999888999999999999999999999998654332111 1111111111101
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
+......+.+++.+||+.+|++||++.+|+ .++|..
T Consensus 238 ----~~~~~~~~~~li~~~l~~dp~~Rpt~~~il-------~~~~~~ 273 (296)
T cd06655 238 ----PEKLSPIFRDFLNRCLEMDVEKRGSAKELL-------QHPFLK 273 (296)
T ss_pred ----cccCCHHHHHHHHHHhhcChhhCCCHHHHh-------hChHhh
Confidence 112234678899999999999999999887 566654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.41 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=204.9
Q ss_pred CChHHHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005536 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIE 391 (692)
Q Consensus 314 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~ 391 (692)
.++.++....+.|+..+.||+|+||.||+|+.. +++.||+|.+... .....++..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 356677778889999999999999999999864 5788999998654 34456788999999999 69999999999863
Q ss_pred ------CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceE
Q 005536 392 ------EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSK 465 (692)
Q Consensus 392 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~k 465 (692)
.+..+++|||+++|+|.+++.......+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4578999999999999999987666668999999999999999999999 4999999999999999999999
Q ss_pred EeeecCCccCCCCCCcccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH
Q 005536 466 VADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 466 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~ 540 (692)
|+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||....+....
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 99999987532211 1223456899999999875 346888999999999999999999998643221111
Q ss_pred HHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..+.+..... .. .......+.+|+.+||+.+|.+||++.|++
T Consensus 236 --~~~~~~~~~~-----~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 236 --FLIPRNPPPK-----LK------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred --hhHhhCCCCC-----Cc------ccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 0111111100 00 012335789999999999999999999887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=314.97 Aligned_cols=240 Identities=20% Similarity=0.353 Sum_probs=189.8
Q ss_pred eeecccccEEEEEEEEeC--------CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 330 HRLGTGAYGTVYAGKLHN--------DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+.||+|+||+||+|.... ...|++|.+........+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998533 234888888765555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc--------eEEeeecCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR--------SKVADFGLSR 473 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~--------~kl~DFGla~ 473 (692)
+++|+|.++++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999998653 368999999999999999999999 59999999999999987765 6999999886
Q ss_pred cCCCCCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCC-cccCCCCCcccccHHHHHHHHhccCccc
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITAL-KVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
.... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+....+... ...... . .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~~-~-~ 222 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFYED-R-H 222 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHHHc-c-c
Confidence 4221 1234678899999998764 5899999999999999999985 44432211110 111110 0 0
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
.+ +.....++.+|+.+||+.+|++|||+++++++|+
T Consensus 223 ~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 QL------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cC------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0112246889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.42 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=189.9
Q ss_pred eeecccccEEEEEEEEeCCC---EEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 330 HRLGTGAYGTVYAGKLHNDD---WVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
++||+|+||+||+|+..++. .+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999865543 45677665443 345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC-Ccc
Q 005536 406 TLCQHLQRERG--SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES-SHI 482 (692)
Q Consensus 406 sL~~~l~~~~~--~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~-~~~ 482 (692)
+|.+++..... ..+++...+.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986432 346777888999999999999998 499999999999999999999999999986422111 112
Q ss_pred cccCCCCCCCCCcccccc-------CCCCCccceeehhHHHHHHHhC-CcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 483 STAPQGTPGYLDPQYHQY-------FHLSDKSDVYSFGVVLIEIITA-LKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SfGvll~eLltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....+ .......+ .+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-hhcccccC
Confidence 234467899999998743 2457899999999999999974 556643221 11111112 22223333
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
++.+... ....+.+++..|| .+|++||+++||+++|.
T Consensus 231 ~~~~~~~-------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP-------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC-------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333211 2246778999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.11 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=202.8
Q ss_pred CccceeecccccEEEEEEEEeC-----CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-----DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
|+..+.||+|+||.||+++..+ +..||+|.++..... ..+.+.+|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999998754 378999999765433 6778999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999875443489999999999999999999994 99999999999999999999999999998644332
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
........+++.|+|||.+.+..++.++||||||++++||++ |+.|+..... ....+.+..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~----- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYRLPK----- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCCCC-----
Confidence 222222347889999999988889999999999999999998 7777653211 112222332221111
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
......++.+++.+||+.+|++|||+.|+++.|
T Consensus 226 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011345788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.02 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=203.6
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|+..+.||+|+||+||++... +++.||+|.+.... ....+++.+|+++++.++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999865 57889999887543 34467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... ..+++.....++.+++.||.|||+. .+|+||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999988764 4589999999999999999999974 48999999999999999999999999998643221
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccc-----cHHHHHHHHhccCcccccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV-----NLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~ei~d~ 556 (692)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......+. ..... ...+..... +
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-LQQIVQEPP-----P 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-HHHHhhccC-----C
Confidence 122456899999999998889999999999999999999999999754332111 11111 111111100 0
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
.+. ......++.+|+.+||+.+|++||++.||++..
T Consensus 232 ~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 012345788999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.78 Aligned_cols=263 Identities=22% Similarity=0.260 Sum_probs=198.2
Q ss_pred hccCccceeecccccEEEEEEEEeC---CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN---DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
..+|...+.||+|+||.||++...+ +..||+|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997543 467999987643 34568999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
|++. ++|.+++.. ...+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9994 789898843 3569999999999999999999999 499999999999999999999999999997533222
Q ss_pred -CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc-----
Q 005536 480 -SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI----- 553 (692)
Q Consensus 480 -~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei----- 553 (692)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..................++.....-.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 12223457999999999999999999999999999999999999998654433221111112222211110000
Q ss_pred -----ccccCCcCCCccC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 554 -----IDPYLEPHRDAWT-------LSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 554 -----~d~~l~~~~~~~~-------~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+..........+. .....++.+++.+||+.+|++||++.|++.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000000 012346788999999999999999999983
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.09 Aligned_cols=268 Identities=22% Similarity=0.254 Sum_probs=205.2
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCch-h-HHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTD-S-IDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~-~-~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~lV 398 (692)
+.|+..++|++|.||.||+|+. .+++.||+|+++..... . --.-++|+.+|.+.+|||||.+-.+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3466688999999999999985 45789999999865321 1 12457999999999999999999887643 579999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||++ -+|...|+... .++...+..-+..|+++||+|||.. .|+|||||++|+|+.+.|.+||+|||+||.+...
T Consensus 156 Me~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99996 48988888764 6788999999999999999999994 9999999999999999999999999999975433
Q ss_pred CCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc--
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID-- 555 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d-- 555 (692)
....+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++.|......++.+ ...+.++...-..+..
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccccCCCcc
Confidence 3445667789999999987665 79999999999999999999999887654443333 3333333211100000
Q ss_pred ---------------ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 556 ---------------PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 556 ---------------~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
..+...+... ...+.-.+|+...|.+||.+|.|++|.+ .+.|+.+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~--~lse~g~~Lln~llt~dP~kR~tA~~~L-------~h~~F~e 366 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGAL--SLSEQGFDLLNKLLTYDPGKRITAEDGL-------KHEYFRE 366 (419)
T ss_pred ccchhhccccCCCCchhhhhhcccc--ccchhHHHHHHHHhccCccccccHHHhh-------ccccccc
Confidence 0011111111 1235678999999999999999999887 5666653
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.34 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=199.9
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
+.|...+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 6778999998643 2446789999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~ 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence 9999999987655568999999999999999999998 59999999999999999999999999998753221 1
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ...+.+.++...+.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~--------- 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVKECVEKGYRMEP--------- 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhCCCCCCC---------
Confidence 22234678999999988899999999999999999998 88888633221 12223332211111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=347.11 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=204.3
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..++||+|+||+||+|+.. +++.||||+++... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999865 47899999997532 233567999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 400 EFMPNGTLCQHLQRER---------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999987421 1236778889999999999999999 499999999999999999999999999
Q ss_pred CCccCCCCCC-----------------cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcc
Q 005536 471 LSRLGMTESS-----------------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHS 533 (692)
Q Consensus 471 la~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~ 533 (692)
+++....... .......||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976411100 01122469999999999999999999999999999999999999986422110
Q ss_pred cccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 005536 534 EVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP-TMMEVAEELEHIRV 603 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP-sm~eVl~~L~~i~~ 603 (692)
. .....+ .++..... ..+.+..+.+++.+||+.+|++|| +++++.+.|+....
T Consensus 239 -i----~~~~~i--------~~P~~~~p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 -I----SYRDVI--------LSPIEVAP----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred -h----hhhhhc--------cChhhccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 000000 11100000 012335688999999999999995 77888888887643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.27 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=216.8
Q ss_pred HHhhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc---hhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCe
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGE 394 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~ 394 (692)
+.....|+..++||+|.||.||+++... |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3455678888999999999999999665 89999999986643 34568999999999998 9999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC----CceEEeeec
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN----YRSKVADFG 470 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~DFG 470 (692)
.++|||++.+|.|.+.+... .+++.....++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999999876 39999999999999999999999 499999999999999543 579999999
Q ss_pred CCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
++..... ........||+.|+|||++....|+...||||+||++|.|++|..||........ ...+.++..
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------~~~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------FLAILRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------HHHHHcCCC
Confidence 9987443 4456777999999999999999999999999999999999999999975443222 113444433
Q ss_pred cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
......| ......+.+++.+++..||.+|+|+.++++ ++|...
T Consensus 256 --------~f~~~~w-~~is~~akd~i~~ll~~dp~~R~ta~~~L~-------HpWi~~ 298 (382)
T KOG0032|consen 256 --------DFTSEPW-DDISESAKDFIRKLLEFDPRKRLTAAQALQ-------HPWIKS 298 (382)
T ss_pred --------CCCCCCc-cccCHHHHHHHHHhcccCcccCCCHHHHhc-------CccccC
Confidence 1111222 234667889999999999999999999986 788653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.48 Aligned_cols=263 Identities=24% Similarity=0.273 Sum_probs=197.0
Q ss_pred hhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
...+|...+.||+|+||.||++.... ++.||||... ...+.+|+++|++++|+||+++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34579999999999999999998754 6789999643 2346789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC-
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES- 479 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~- 479 (692)
++ .++|.+++.... ..++|..++.|+.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 241 ~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99 579999887542 469999999999999999999999 499999999999999999999999999997643221
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCC-CcccccHHHHHHHHhccCcc--ccccc-
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSR-PHSEVNLAALAIDRIGRGCV--DEIID- 555 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~--~ei~d- 555 (692)
........||+.|+|||++.+..++.++|||||||+||||++|..++.... ............+.+..... .+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 112234569999999999999999999999999999999999876553221 11111111122222222111 00000
Q ss_pred --c--------------cCCcCCCccC--HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 556 --P--------------YLEPHRDAWT--LSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 556 --~--------------~l~~~~~~~~--~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
. ........|. ......+.+|+.+||+.||.+|||+.|++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL 453 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence 0 0000000010 01123678999999999999999999998
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=311.21 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=202.8
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|+..+.||+|+||+||+++.. ++..||+|.+........+.|.+|++++++++|+||+++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888889999999999999864 5789999999877667778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 9999999998764 3469999999999999999999999 499999999999999999999999999987532221 1
Q ss_pred ccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
......+++.|++||.+. ...++.++||||||+++|||++|+.|+...... . ....+..+....+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~~- 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------R-VLLKILKSEPPTLDQ- 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------H-HHHHHhcCCCCCcCC-
Confidence 223456899999999874 345778999999999999999999998643221 1 112222221111100
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+.....++.+++.+||+.+|++||++.+|+
T Consensus 231 ---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 231 ---------PSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred ---------cccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 112234678999999999999999998886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.54 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=198.8
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 47899999987542 2234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|..++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998887776543 358999999999999999999999 4999999999999999999999999999986433221
Q ss_pred cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc-----------C
Q 005536 481 HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR-----------G 548 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~ 548 (692)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ....... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL---IRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChHHhhhcccc
Confidence 2233457889999999865 4678999999999999999999999864432221111 1111100 0
Q ss_pred cc-cccccccCCc--CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 549 CV-DEIIDPYLEP--HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 549 ~~-~ei~d~~l~~--~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.. .....+.... ............+.+|+.+||+.+|++||++.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 00 0000000000 00000012245788999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.61 Aligned_cols=271 Identities=23% Similarity=0.311 Sum_probs=207.1
Q ss_pred HHHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEee--cCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe----
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE---- 391 (692)
Q Consensus 319 l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~---- 391 (692)
...+...|...+.||+|+||.|..++. .+++.||||++. ..+....++-.+|+++|+.++|+||+.+++.+..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 334556677678999999999999985 458899999997 4456677888999999999999999999999865
Q ss_pred -CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 392 -EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 392 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
-...|+|+|+| .-+|.+.++.. ..|+.....-+..|+++||.|+|+. +|+||||||+|+|++.+..+||+|||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 35789999999 66888888764 4499999999999999999999996 99999999999999999999999999
Q ss_pred CCccCCCC-CCcccccCCCCCCCCCccccc-cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH--------
Q 005536 471 LSRLGMTE-SSHISTAPQGTPGYLDPQYHQ-YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL-------- 540 (692)
Q Consensus 471 la~~~~~~-~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~-------- 540 (692)
+||..... .....+..+-|..|.|||.+. ...|+...||||.|||+.||++|++.|.......+..+...
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99974332 223346677899999999864 45899999999999999999999999987665554443322
Q ss_pred HHHHhccCcccccccccCCcCCCc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDA---WTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~---~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
....+........+...-...... .-........+|+.+||..||.+|+|++|.+
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 122222111111111000000000 0012234678999999999999999988876
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.60 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=191.8
Q ss_pred ecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhC---CCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSV---SHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
||+|+||+||+++.. +++.||||++.... .....++..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 47899999986432 22344566777777665 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCcc
Confidence 9999998754 458999999999999999999999 49999999999999999999999999998753222 12234
Q ss_pred cCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC
Q 005536 485 APQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+..+... +...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~------- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVR-FPKN------- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCCC-CCCc-------
Confidence 45699999999998654 488999999999999999999999864321 1122333322211 1000
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 564 ~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
....++.+++.+||+.+|++||++.+. ++++..++|..
T Consensus 220 ----~~~~~~~~li~~~L~~~P~~R~~~~~~---~~~ll~h~~~~ 257 (330)
T cd05586 220 ----VLSDEGRQFVKGLLNRNPQHRLGAHRD---AVELKEHPFFA 257 (330)
T ss_pred ----cCCHHHHHHHHHHcCCCHHHCCCCCCC---HHHHhcCcccc
Confidence 123467899999999999999965432 22334566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.16 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=199.4
Q ss_pred cCccceeecccccEEEEEEEEeCCCEEEEEEeecCC------chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD------TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
+|...+.||+|+||+||+|...+++.+|||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999998889999999987542 12345688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999764 358899999999999999999998 48999999999999999999999999998753211
Q ss_pred -----CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 479 -----SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 479 -----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
.........|+..|+|||++.+..++.++||||||+++|||++|+.||........ ........+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~- 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHRGLMPR- 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhccCCCCC-
Confidence 11122334689999999999988999999999999999999999999864321111 0000000111111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+. .....++.+++.+||+.+|++||++.|++
T Consensus 230 ----~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 230 ----LP-------DSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred ----CC-------CCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 11 12335678999999999999999999887
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=335.31 Aligned_cols=268 Identities=21% Similarity=0.303 Sum_probs=195.1
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--------
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-------- 392 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~-------- 392 (692)
..++|...++||+|+||+||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 57899999886432 2345799999999999999999987532
Q ss_pred CeeEEEEEeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-ceEEeee
Q 005536 393 GEPILVYEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADF 469 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DF 469 (692)
..+++||||++ ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 24678999996 5787777542 23569999999999999999999999 4999999999999999664 7999999
Q ss_pred cCCccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC
Q 005536 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 470 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
|+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ .....+.+...
T Consensus 216 Gla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVRIIQVLGTP 290 (440)
T ss_pred ccchhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 999864322 12234568999999998765 4689999999999999999999999875433221 11111111110
Q ss_pred cc----------cccccccCCc--CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 549 CV----------DEIIDPYLEP--HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 549 ~~----------~ei~d~~l~~--~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.. .++.-+.... .....+.....++.+|+.+||+.+|.+|||+.|++ .++|...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l-------~hp~f~~ 356 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL-------ADPFFDD 356 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh-------CChhHHh
Confidence 00 0000000000 00001112345788999999999999999998887 5566543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.31 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=199.7
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556678999999999999864 46789999987543 345567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.. ..+++..+..++.|++.||+|||+ ++++|+||+|+||++++++.+||+|||++....... ..
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 99999998864 358999999999999999999998 599999999999999999999999999997533221 22
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+....+.. ....+..+.. +.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~~-----~~~---- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKNSP-----PTL---- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcCCC-----CCC----
Confidence 233468899999999998899999999999999999999999986332211 1111111111 111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.......+.+++.+||+.+|++||+|.+|++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1123456889999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.56 Aligned_cols=258 Identities=18% Similarity=0.276 Sum_probs=193.9
Q ss_pred ceeeccc--ccEEEEEEEE-eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 329 KHRLGTG--AYGTVYAGKL-HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 329 ~~~LG~G--~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
.++||+| +|++||+++. .+++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7899999985 468899999997542 2334567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC---
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS--- 480 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~--- 480 (692)
+|+|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999976555569999999999999999999998 4999999999999999999999999986543211110
Q ss_pred ---cccccCCCCCCCCCcccccc--CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 481 ---HISTAPQGTPGYLDPQYHQY--FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 481 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ..... ..+.....++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEK-LNGTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHH-hcCCcccccc
Confidence 01122356788999999875 468899999999999999999999986422111 01111 1111111110
Q ss_pred c-------------------cC--------------CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 P-------------------YL--------------EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~-------------------~l--------------~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. .. ..............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 00 00000111223457889999999999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=306.34 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=202.1
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 5788999998754 234567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~~~~ 480 (692)
+++++|.+++.......+++..++.++.+++.+|+|||+ .+|+|+||||+||+++++ ..+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 999999999987655668999999999999999999999 499999999999999865 46899999999764322
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|++..... .. ...+..+....+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~------ 222 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------AL-VLKIMSGTFAPIS------ 222 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HH-HHHHHhcCCCCCC------
Confidence 1223356899999999999888999999999999999999999998643221 11 1122222111111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
......+.+++.+||+.+|++|||+.|+++
T Consensus 223 ------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 ------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=311.40 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=199.3
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
+|+..+.||+|+||.||+++.. ++..||+|.++.. .....+++.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999875 5889999998754 3344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 403 PNGTLCQHLQRER-GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 403 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
++++|.+++.... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~ 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---S 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---C
Confidence 9999999887642 23589999999999999999999973 4899999999999999999999999999875322 1
Q ss_pred ccccCCCCCCCCCccccccC------CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYF------HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~------~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... .......+..+....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~-- 230 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAIVDGDPPTL-- 230 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHHHhhcCCCCC--
Confidence 22334688899999988544 35889999999999999999999986432111 1111122222211111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+.....++.+++.+||+.+|++||++.+++
T Consensus 231 ----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 231 ----------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred ----------CcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 112445788999999999999999998877
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.35 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=202.1
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..|+..++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999865 47889999987543 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.. ..+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-c
Confidence 999999999864 348899999999999999999998 499999999999999999999999999997643222 2
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....+... ...+..+..
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~----------- 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPKNNP----------- 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhcCCC-----------
Confidence 22344688899999999888899999999999999999999999864332111 111111111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..........+.+++.+||+.+|++||++.++++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 1112345567899999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.97 Aligned_cols=191 Identities=22% Similarity=0.337 Sum_probs=164.6
Q ss_pred hccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
..+|...+.||+|+||.||+|+... ++.||+|..... ....|+.++++++|+||+++++++.+.+..++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4579999999999999999998754 578999975432 235699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+ .++|.+++... ...+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 139 ~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 139 Y-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred c-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 9 57898988754 3569999999999999999999999 49999999999999999999999999999752221 1
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVV 526 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~ 526 (692)
......||+.|+|||++.+..++.++||||||+++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456899999999999999999999999999999999976655
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.49 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=200.0
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-----chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-----TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
+|+..+.||+|+||+||+|... +++.|++|.+.... .+..+++.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 68899999987543 23557899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999764 358999999999999999999998 49999999999999999999999999998763322
Q ss_pred CCcccccCCCCCCCCCccccccCC-CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFH-LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
. ......|+..|++||.+.... ++.++|+||||+++|||++|+.||....+. ..............+
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~---- 223 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPPI---- 223 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCCc----
Confidence 2 224456899999999987766 899999999999999999999998643211 111111111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||+.+|++||++.++++
T Consensus 224 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 --------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122356789999999999999999999873
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.90 Aligned_cols=195 Identities=25% Similarity=0.379 Sum_probs=160.0
Q ss_pred ceeecccccEEEEEEEEe---CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCeeEEEEEeCC
Q 005536 329 KHRLGTGAYGTVYAGKLH---NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE--EGEPILVYEFMP 403 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 403 (692)
.++||+|+||+||+|+.. +++.||+|.++.. .....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 458999999999999864 4578999998643 223567899999999999999999999865 356889999985
Q ss_pred CCCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCceEEeeecCC
Q 005536 404 NGTLCQHLQRER-------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLS 472 (692)
Q Consensus 404 ~gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla 472 (692)
++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68888875432 1248899999999999999999999 499999999999999 45679999999999
Q ss_pred ccCCCCCC--cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCC
Q 005536 473 RLGMTESS--HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFS 529 (692)
Q Consensus 473 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~ 529 (692)
+....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 86432211 12234578999999999876 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.80 Aligned_cols=248 Identities=24% Similarity=0.422 Sum_probs=198.4
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCch---------hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTD---------SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE 394 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~ 394 (692)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5788999988654221 23568899999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999764 458899999999999999999998 4999999999999999999999999999876
Q ss_pred CCCCCCc-----ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 475 GMTESSH-----ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 475 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~ 228 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------Q-AIFKIGENA 228 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------H-HHHHHhccC
Confidence 4321111 112345889999999999888999999999999999999999998643211 1 111111111
Q ss_pred ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+ + +......+.+++.+||+.+|.+||++.||++
T Consensus 229 ~~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPE-----I-------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCc-----C-------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111 1 1123457889999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=344.22 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=201.6
Q ss_pred HHHHHhhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-
Q 005536 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE- 392 (692)
Q Consensus 317 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~- 392 (692)
.+.+...++|.+.++||+|+||+||+++... +..||+|.+... .......|..|+.++++|+|||||++++++.+.
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 3445566789999999999999999998654 678899988754 234567799999999999999999999998654
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCceEEcCC----
Q 005536 393 -GEPILVYEFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAM----NPPIYHRDIKSSNILLDYN---- 461 (692)
Q Consensus 393 -~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~----~~~iiHrDik~~NILld~~---- 461 (692)
..++|||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.. .++||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 56899999999999999997632 246999999999999999999999842 1359999999999999642
Q ss_pred -------------CceEEeeecCCccCCCCCCcccccCCCCCCCCCcccccc--CCCCCccceeehhHHHHHHHhCCccc
Q 005536 462 -------------YRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY--FHLSDKSDVYSFGVVLIEIITALKVV 526 (692)
Q Consensus 462 -------------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SfGvll~eLltg~~p~ 526 (692)
..+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 35899999999763222 12234579999999998854 45889999999999999999999999
Q ss_pred CCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 527 DFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
...... ......+..+.... + . ....++.+|+.+||+.+|.+||++.|+++
T Consensus 244 ~~~~~~------~qli~~lk~~p~lp-----i----~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNF------SQLISELKRGPDLP-----I----K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcH------HHHHHHHhcCCCCC-----c----C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 643221 11222232221100 0 0 12356889999999999999999999983
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=316.15 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=200.9
Q ss_pred ccCccceeecccccEEEEEEEEe-CCC----EEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDD----WVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
+.|+..+.||+|+||.||+|+.. ++. .||+|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45667789999999999999864 343 47888887543 23345789999999999999999999998754 4679
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999998764 3458999999999999999999999 4999999999999999999999999999986432
Q ss_pred CCCc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 478 ESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ....+.+..+.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--~ 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERLP--Q 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCCC--C
Confidence 2211 1223346779999999998899999999999999999998 8888753211 11122222221110 0
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
+ ......+.+++.+||..+|++||+|.++++.|+.+...
T Consensus 233 ~----------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 P----------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 11224678999999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.28 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=204.7
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|+..+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999854 57889999987543 33567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERG-SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
+++++|.+++..... ..+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986543 568999999999999999999998 4999999999999999999999999999876433222
Q ss_pred c---ccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 481 H---ISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 481 ~---~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
. ......|+..|++||++... .++.++||||||+++|||++|+.|+....+.. ...+..... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~----- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND-PP----- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC-CC-----
Confidence 1 22344689999999998776 78999999999999999999999986433211 111212111 11
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+.... ........+.+++.+||+.+|++||++.||++
T Consensus 226 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGA--DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCcc--ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111000 01133467889999999999999999998873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=309.49 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=198.6
Q ss_pred CccceeecccccEEEEEEEEe----CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC------
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH----NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG------ 393 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~------ 393 (692)
|...+.||+|+||+||+|.+. .++.||||+++.. .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999854 2578999998754 3345678999999999999999999999886542
Q ss_pred eeEEEEEeCCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeee
Q 005536 394 EPILVYEFMPNGTLCQHLQRER----GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 469 (692)
..++++||+++|+|.+++.... ...+++...+.++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998876432 1248899999999999999999998 49999999999999999999999999
Q ss_pred cCCccCCCCCC-cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhcc
Q 005536 470 GLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 470 Gla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
|+++....... .......+++.|++||.+....++.++||||||+++|||++ |+.|+..... . .....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~-~~~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------S-EIYNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------H-HHHHHHHc
Confidence 99986432221 12223345678999999988889999999999999999999 7787753221 1 11222222
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+.... .+......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 231 ~~~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100 0012335789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.38 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=206.4
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc---hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||+||++...+ ++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999998764 88999999976532 25567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999986655679999999999999999999998 499999999999999999999999999986532211
Q ss_pred Cc----------------------------ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCC
Q 005536 480 SH----------------------------ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP 531 (692)
Q Consensus 480 ~~----------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~ 531 (692)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 11123588999999999988899999999999999999999999864332
Q ss_pred cccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 532 HSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
. ..... +...... .. . .......+.+++.+||+.+|++||++...+++| ..++|....
T Consensus 238 ~------~~~~~-~~~~~~~------~~-~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l---l~~~~~~~~ 295 (316)
T cd05574 238 D------ETFSN-ILKKEVT------FP-G----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI---KQHPFFRGV 295 (316)
T ss_pred H------HHHHH-HhcCCcc------CC-C----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHH---HcCchhhcC
Confidence 1 11111 1111100 00 0 011346789999999999999999955544332 245666543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=311.26 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=197.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||.|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 57899999987542 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+. ++|.+++.......+++..++.++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 95 689999987666679999999999999999999998 499999999999999999999999999987532211 1
Q ss_pred ccccCCCCCCCCCccccccCC-CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc-----------
Q 005536 482 ISTAPQGTPGYLDPQYHQYFH-LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC----------- 549 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 549 (692)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||....... ......+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhHHH
Confidence 223345788999999876544 6889999999999999999999986433211 1111111111000
Q ss_pred -----ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 -----VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 -----~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
........+ .........++.+++.+||+.||++||+++|++
T Consensus 233 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 233 DYKPSFPKWARQDF----SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred HHHhhcccccccCH----HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 000000000 000011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.16 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=197.9
Q ss_pred hhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----ee
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-----EP 395 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-----~~ 395 (692)
.+-.|...+++|.|+||.||+|++.. +..||||+.-....- --+|+++|++++|||||+|+-++.... ..
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 44567788999999999999999655 689999998654321 126999999999999999999987532 34
Q ss_pred EEEEEeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CceEEeeecCC
Q 005536 396 ILVYEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLS 472 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla 472 (692)
.||||||| .+|.+.++.. .+..++...+.-+..|+.+||+|||+. +|+||||||+|+|+|.+ +.+||+|||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 58999996 4999888742 234577777888999999999999995 99999999999999976 89999999999
Q ss_pred ccCCCCCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc-
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV- 550 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 550 (692)
+...... ......-|..|.|||.+.+. .|+.+.||||.|+|+.||+-|++.|......++ .....+.++.-..
T Consensus 174 K~L~~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---L~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 174 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---LVEIIKVLGTPTRE 248 (364)
T ss_pred eeeccCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---HHHHHHHhCCCCHH
Confidence 9754332 22445678899999987655 899999999999999999999999976443333 2233333332111
Q ss_pred ---------cccccccCCcCC--CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 551 ---------DEIIDPYLEPHR--DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 551 ---------~ei~d~~l~~~~--~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.-.+.+.... .-+......+.++|+.++|+.+|.+|.++.|++
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 122223222211 112334456889999999999999999999987
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.03 Aligned_cols=264 Identities=24% Similarity=0.337 Sum_probs=201.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|+||.||+|+.. +++.|++|++.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999864 68899999998654 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987653 5699999999999999999999994 9999999999999999999999999999864433222
Q ss_pred ccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc------cccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV------DEII 554 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ei~ 554 (692)
......++..|+|||.+.+. .++.++||||||+++|||++|++++...... .........+..... .++.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 23445689999999988654 4688999999999999999997777533221 111112221111100 0000
Q ss_pred c------ccCCc-CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 555 D------PYLEP-HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 555 d------~~l~~-~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+ +.... .......+....+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 00000 000000123468899999999999999999998873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.39 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=201.0
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|+||.||+|+.. +++.|++|.++.... ...+++.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 678999999986644 3677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... ..+++..+..|+.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999764 348899999999999999999999 49999999999999999999999999998764333222
Q ss_pred cc---ccCCCCCCCCCccccccCC---CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 482 IS---TAPQGTPGYLDPQYHQYFH---LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 482 ~~---~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.. ....++..|++||++.+.. ++.++||||||+++|||++|+.||...... ... ...+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~-~~~~~~~~~~~--- 226 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQI-MFHVGAGHKPP--- 226 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHH-HHHHhcCCCCC---
Confidence 21 1356889999999988766 889999999999999999999998633211 111 11111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+.. .......+.+++.+||+.+|++||++.|++
T Consensus 227 --~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 227 --IPD-----SLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred --CCc-----ccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 110 011245678999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=311.67 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=201.3
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..+.||+|+||.||+++.. +++.|++|+++.. .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999875 4789999998754 23345789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++++.|..++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9988777655543 2458999999999999999999999 4999999999999999999999999999987544333
Q ss_pred cccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc------------
Q 005536 481 HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR------------ 547 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 547 (692)
.......++..|+|||++.+. .++.++||||||+++|||++|+.|+......+.. ......+..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHhhhcccC
Confidence 233445688999999999888 8899999999999999999999988643221111 000010000
Q ss_pred Cccc--ccccccCCc-CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 548 GCVD--EIIDPYLEP-HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 548 ~~~~--ei~d~~l~~-~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.... +..+..... .....+.....++.+|+.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000000 000011122567899999999999999999998873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.80 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=194.2
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-----chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--Cee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-----TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEP 395 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~ 395 (692)
.+|+..+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999864 57899999986432 23346788999999999999999999998763 568
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++++||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999764 348999999999999999999998 49999999999999999999999999998753
Q ss_pred CCCC--CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 476 MTES--SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 476 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||..... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~---- 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT---- 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC----
Confidence 2211 1111234589999999999988899999999999999999999999863221 111111111111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.+ +......+.+++ +||..+|++||+|+||+
T Consensus 227 -~~~~-------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 227 -NPQL-------PSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred -CCCC-------chhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 1111 112234556666 78889999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.05 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=201.7
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC-----
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEG----- 393 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~----- 393 (692)
..+++|+..+.||+|+||+||+|+.. +++.+++|.+.... ...++|.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46789999999999999999999975 46789999987653 3457899999999999 6999999999997644
Q ss_pred -eeEEEEEeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeec
Q 005536 394 -EPILVYEFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470 (692)
Q Consensus 394 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 470 (692)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999987644 4569999999999999999999998 499999999999999999999999999
Q ss_pred CCccCCCCCCcccccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHh
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI 545 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~ 545 (692)
++...... ........|+..|+|||++.. ..++.++||||||+++|||++|+.||....+. .....+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~ 230 (275)
T cd06608 159 VSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKI 230 (275)
T ss_pred cceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHHh
Confidence 98753222 222334568999999998753 34678999999999999999999998632211 111122
Q ss_pred ccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 546 GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 546 ~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.++....+.. +......+.+|+.+||..||++|||+.|+++
T Consensus 231 ~~~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTLKS----------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCCCc----------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2221111111 1123457889999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.29 Aligned_cols=195 Identities=25% Similarity=0.382 Sum_probs=159.4
Q ss_pred ceeecccccEEEEEEEEeC---CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCeeEEEEEeCC
Q 005536 329 KHRLGTGAYGTVYAGKLHN---DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE--EGEPILVYEFMP 403 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 403 (692)
..+||+|+||+||+++..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999998654 4689999886432 33567899999999999999999999864 457889999985
Q ss_pred CCCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCceEEeeecCC
Q 005536 404 NGTLCQHLQRER-------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLS 472 (692)
Q Consensus 404 ~gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla 472 (692)
++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 58888775321 2348899999999999999999999 499999999999999 56779999999999
Q ss_pred ccCCCCCC--cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCC
Q 005536 473 RLGMTESS--HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFS 529 (692)
Q Consensus 473 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~ 529 (692)
+....... .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86432211 12234568999999999876 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.53 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=196.8
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|+..+.||+|++|+||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999865 578999999875432 2235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
++ ++|.+++.... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-SK 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC-Cc
Confidence 97 59999887653 368999999999999999999999 49999999999999999999999999998753211 11
Q ss_pred ccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc---cc----
Q 005536 482 ISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD---EI---- 553 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---ei---- 553 (692)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .......+.+...... .+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1223356889999998865 468899999999999999999999986433111 1111111111110000 00
Q ss_pred --c--------cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 554 --I--------DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 554 --~--------d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
. ...+..... .......+.+++.+||+.+|++||++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAP--RLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred ccccccccccCChhHHHhCc--CCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 0 000000000 011125678999999999999999999887
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.84 Aligned_cols=269 Identities=24% Similarity=0.312 Sum_probs=201.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCch-----hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTD-----SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
+|+..+.||+|+||.||+|... +++.||||+++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999864 5889999999765322 344577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+ +++|.+++.... ..+++..++.++.|+++||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997653 3699999999999999999999994 9999999999999999999999999999764332
Q ss_pred CCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC---------
Q 005536 479 SSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------- 548 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 548 (692)
. .......+++.|+|||.+.+ ..++.++||||||+++|||++|..++....+... .......+...
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 N-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred C-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhcc
Confidence 1 22233456889999998754 4678899999999999999999777754332111 11111111100
Q ss_pred cccccccccCCcC--CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 549 CVDEIIDPYLEPH--RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 549 ~~~ei~d~~l~~~--~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
............. ...........+.+++.+||+.+|++|||+.||++ ++|..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~-------~~~~~~ 287 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE-------HPYFSN 287 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh-------CccccC
Confidence 0000000000000 00011123467889999999999999999999984 666553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.55 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=206.4
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|+..+.||+|++|.||+++..+ ++.|+||++..... ...+++.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999765 88999999986644 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS-AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~-~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
+++++|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~- 154 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL- 154 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC-
Confidence 9999999999765 558999999999999999999998 5 99999999999999999999999999987643322
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... ....+.......+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~-~~~~~~~~~~~~~------- 223 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFE-LMQAICDGPPPSL------- 223 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHH-HHHHHhcCCCCCC-------
Confidence 22234568899999999998899999999999999999999999986543211 111 1222222111111
Q ss_pred CCCccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLS-SIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~-~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+.. ....+.+++.+||..+|++||++.|+++
T Consensus 224 -----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 -----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred -----CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 3457889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.67 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=202.4
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE--EGEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~--~~~~~lV~ 399 (692)
+|+..+.||.|+||.||++.. .+++.||+|.++... ....+++.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999985 457889999987542 3455678999999999999999999998764 34678999
Q ss_pred EeCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 400 EFMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAM--NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
||+++++|.+++.... ...+++..++.++.|++.||+|||... ..+|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999997642 346999999999999999999999321 259999999999999999999999999999864
Q ss_pred CCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 476 MTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 476 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.... .......+++.|++||.+.+..++.++||||||+++|+|++|+.|+..... ....+.+..+....+
T Consensus 161 ~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-- 230 (265)
T cd08217 161 GHDS-SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKFRRI-- 230 (265)
T ss_pred cCCc-ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCCCC--
Confidence 3322 112345689999999999988899999999999999999999999874321 122233333322111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||+.+|++||++.+|++
T Consensus 231 ----------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 231 ----------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----------ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=307.93 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=202.3
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
+|+..+.||+|+||.||++... +++.|++|.+.... ....+++.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677889999999999999876 57889999987653 345677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.... ..+++..+.+++.|++.||+|||+. .+++|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999998653 5689999999999999999999982 3999999999999999999999999999875322211
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....++..|+|||++.+..++.++||||||+++|||++|+.|+.......+ ... ...+.+..+....+ ..
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~-----~~-- 226 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIF-ELLQYIVNEPPPRL-----PS-- 226 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHH-HHHHHHhcCCCCCC-----Ch--
Confidence 126788999999999988999999999999999999999999864321111 111 11222222111110 00
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.....++.+++.+||..+|++|||+.|++
T Consensus 227 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 227 ----GKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred ----hhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 01345688999999999999999998887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.49 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=198.7
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333457999999999999864 5789999998766666677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... ....
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 176 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK 176 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence 999998854 3489999999999999999999994 99999999999999999999999999987533222 1223
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...|+..|+|||++.+..++.++||||||+++|||++|+.||....+.. ....+... +.+.+..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~-----~~~~~~~---- 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRDN-----LPPRVKD---- 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhc-----CCCcccc----
Confidence 3468999999999988889999999999999999999999986432211 11112111 1111110
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.......+.+++.+||+.+|.+|||++|+++
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112346788999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.86 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=198.5
Q ss_pred cceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCC
Q 005536 328 EKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGT 406 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 406 (692)
...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999864 588999999976655566788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccC
Q 005536 407 LCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAP 486 (692)
Q Consensus 407 L~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 486 (692)
|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ......
T Consensus 105 L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 9988754 348999999999999999999998 499999999999999999999999999987533222 222345
Q ss_pred CCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccC
Q 005536 487 QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWT 566 (692)
Q Consensus 487 ~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~ 566 (692)
.|+..|+|||++.+..++.++||||||+++|||++|+.||....+.. ....+........ . . .
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-----~-~----~ 240 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPKL-----K-N----A 240 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCCCc-----c-c----c
Confidence 68999999999998899999999999999999999999986432211 1122221111100 0 0 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 567 LSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 567 ~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
......+.+++.+||+.+|++||++.||++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 112346789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=304.77 Aligned_cols=259 Identities=26% Similarity=0.312 Sum_probs=201.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~lV~ 399 (692)
++|...++||.|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++++.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999974 47889999987543 34567799999999999999999999998654 4689999
Q ss_pred EeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 400 EFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 400 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||+++++|.+++... ....+++.....|+.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987643 23458999999999999999999999 4999999999999999999999999999875322
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|++....... .... ....+.......+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIE-LLSYIVNMPNPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHH-HHHHHhcCCchhhccC-
Confidence 11 1234578899999999988999999999999999999999999975432111 1111 1122221111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.. ........+.+++.+||+.+|.+|||+.||++
T Consensus 232 ~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PG-----NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC-----CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 00123467899999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.57 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=195.3
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-----chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--Cee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-----TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEP 395 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~ 395 (692)
.+|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999864 47899999886432 22356788999999999999999999998764 467
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+++++|.+++... ..+++...++++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998754 348889999999999999999998 49999999999999999999999999998753
Q ss_pred CCCC--CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 476 MTES--SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 476 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
.... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~--- 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP-T--- 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC-C---
Confidence 2211 11123345889999999998888999999999999999999999998632111 1111111111 0
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. ...+......+.+++.+|+. +|++||+++||++
T Consensus 227 -~-------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 -N-------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -C-------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 11122334567889999985 8999999988873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.77 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=201.0
Q ss_pred eecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHH
Q 005536 331 RLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQ 409 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 409 (692)
.||+|.||+||.|+..+ ...+|||.+...+....+-+..|+.+-++|+|+|||+++|++.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999655 45699999988888888889999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCceEEeeecCCccCCCCCCcccccC
Q 005536 410 HLQRERGSGL--PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKVADFGLSRLGMTESSHISTAP 486 (692)
Q Consensus 410 ~l~~~~~~~l--~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~ 486 (692)
+|...-+ ++ .+.+.-....||++||.|||+ +.|+|||||-.|||++ ..|.+||+|||-++.... -.......
T Consensus 662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHhccC-CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 9987643 45 677777888999999999999 5999999999999995 678999999999986332 23344556
Q ss_pred CCCCCCCCccccccC--CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 487 QGTPGYLDPQYHQYF--HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 487 ~gt~~Y~aPE~~~~~--~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
-||..|||||++..+ .|..++|||||||++.||.||++||..-.. ++.++-+++--. .-.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkVGmyK-----------vHP~ 799 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKVGMYK-----------VHPP 799 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhhccee-----------cCCC
Confidence 799999999998765 588899999999999999999999952211 111121222111 1123
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+.+...+...++.+|+.++|.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 44567788899999999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.51 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=198.0
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc----------hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT----------DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG 393 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~ 393 (692)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999854 588999998864211 12346788999999999999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 458999999999999999999998 499999999999999999999999999997
Q ss_pred cCCCCCC-cccccCCCCCCCCCccccccCC--CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 474 LGMTESS-HISTAPQGTPGYLDPQYHQYFH--LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 474 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
....... .......|+..|+|||.+.... ++.++||||||+++|||++|..|+...... ....+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNK-RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhcc-cc
Confidence 5332211 1223456899999999987654 889999999999999999999998532211 111111111 11
Q ss_pred cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
...+... ........+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPD-------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCcc-------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 11123467889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.14 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=202.1
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|+||.||++.... +..||+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999654 7889999987542 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-ceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~ 480 (692)
+++++|.+++.......+++..++.++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+..... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~-~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC-Cc
Confidence 999999999987655568999999999999999999998 4999999999999999885 569999999876432 22
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......|++.|+|||++.+..++.++||||||+++|||++|+.|+.... ......+ ...+...++.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~-~~~~~~~~~~------ 223 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLK-ICQGYFAPIS------ 223 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcccCCCCC------
Confidence 22234568999999999988889999999999999999999999985322 1222222 2222221110
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
......+.+++.+||+.+|++|||+.||++
T Consensus 224 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 ------PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112346889999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.60 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=199.2
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..++||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 478999999865432 235678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.++.... ..+++..++.++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999888776543 348999999999999999999999 499999999999999999999999999987643322
Q ss_pred cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC--cc------c
Q 005536 481 HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--CV------D 551 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------~ 551 (692)
.......++..|+|||++.+ ..++.++||||||+++|||++|++|+......+ ...........- .. .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccc
Confidence 22334567899999998865 457889999999999999999998886433211 111111110000 00 0
Q ss_pred ccccccCCcCCC------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 552 EIIDPYLEPHRD------AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 552 ei~d~~l~~~~~------~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+.+....+... .........+.+|+.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 001123467899999999999999999998873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=303.37 Aligned_cols=251 Identities=25% Similarity=0.446 Sum_probs=199.3
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC------chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD------TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
+|+..+.||+|+||.||+++. .+++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 568899999987432 1235678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-ceEEeeecCCccCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLGM 476 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~ 476 (692)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999754 458999999999999999999999 4999999999999998775 69999999987643
Q ss_pred CCCC---cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 477 TESS---HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 477 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ... ...+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~-~~~~~~~~~--- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LAL-IFKIASATT--- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHH-HHHHhccCC---
Confidence 3211 112234688999999999888899999999999999999999999864332111 111 111111000
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
. ...+.....++.+++.+||+.+|++||++.|++
T Consensus 229 -~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 229 -A-------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred -C-------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 0 011123345788999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.78 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=201.1
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999998654 6789999987553 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999764 458999999999999999999998 499999999999999999999999999987421100
Q ss_pred --------------CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHh
Q 005536 480 --------------SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI 545 (692)
Q Consensus 480 --------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~ 545 (692)
........++..|+|||++....++.++||||||+++|||++|+.||....+ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 0011224578899999999888899999999999999999999999863321 1112222
Q ss_pred ccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 546 GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 546 ~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
..+... .+... ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~---~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDIE---WPEGD-------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HhcccC---CCCcc-------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 221111 11110 0133567899999999999999997666655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.90 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred HHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
...+++|+..+.||+|+||.||++... +++.|++|.+..... ..+++.+|++++++++|+|++++++++...+..++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346677888899999999999999976 578899999986544 567889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999998753 469999999999999999999999 59999999999999999999999999988653222
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
. .......++..|++||++.+..++.++||||||+++|||++|+.|+....+... ...+.........+
T Consensus 170 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~--- 238 (286)
T cd06614 170 K-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LFLITTKGIPPLKN--- 238 (286)
T ss_pred h-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCCCCcc---
Confidence 1 122344578999999999888899999999999999999999999864322111 11111111111100
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.......+.+++.+||+.+|.+||++.+|++
T Consensus 239 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 -------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0113357889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.21 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=197.0
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++++|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++.+++.+.+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 588999999875532 23346789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+. ++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP- 156 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC-
Confidence 9995 78877776543 4578888999999999999999994 9999999999999999999999999998753221
Q ss_pred CcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC----------
Q 005536 480 SHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG---------- 548 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 548 (692)
........+++.|+|||++.+. .++.++||||||+++|||++|+.||+......+ .....+..+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhh
Confidence 1222334578999999998754 578899999999999999999999864332111 111111111100
Q ss_pred ---cccccccccCCcCCCc--cCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 549 ---CVDEIIDPYLEPHRDA--WTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 549 ---~~~ei~d~~l~~~~~~--~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
...+............ ........+.+++.+|++.+|.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0000000000000000 0001235678999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.18 Aligned_cols=264 Identities=23% Similarity=0.265 Sum_probs=196.5
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|+||.||+++.. +++.||+|+++... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999864 58899999987542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
++ ++|.+++.... ..+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VR 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-CC
Confidence 96 68888887543 458999999999999999999999 49999999999999999999999999999753221 12
Q ss_pred ccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc------ccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC------VDEII 554 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~ei~ 554 (692)
......++..|+|||++.+. .++.++||||||+++|||+||+.|+.......+ ........+.... ..++.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcc
Confidence 22344678999999988664 478999999999999999999988643222111 1111111111000 00000
Q ss_pred cccCCcCC------CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 555 DPYLEPHR------DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 555 d~~l~~~~------~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+....... .........++.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 0011123467889999999999999999998873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.67 Aligned_cols=243 Identities=26% Similarity=0.450 Sum_probs=200.1
Q ss_pred ceeecccccEEEEEEEEeC-CCEEEEEEeec----CCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe--eEEEEEe
Q 005536 329 KHRLGTGAYGTVYAGKLHN-DDWVAIKRFRY----RDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE--PILVYEF 401 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~----~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~--~~lV~E~ 401 (692)
..+||+|+|-+||||.... |-.||=-.++. ..+...++|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 3479999999999998643 55555322221 235567899999999999999999999999987655 7899999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~~ 480 (692)
+..|+|..|+.+.+ .++.+....|+.||++||.|||+. .|+|||||||..||+|+. -|.|||+|+|||.+... .
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--S 199 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--c
Confidence 99999999998764 488889999999999999999996 689999999999999975 58999999999986322 2
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
+. ..+.|||.|||||.+. ..|++..||||||+.++||+|+..|+. +..-++.+.+++-.|...+-+.+.-.
T Consensus 200 ~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs------EC~n~AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 200 HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS------ECTNPAQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh------hhCCHHHHHHHHHcCCCHHHhhccCC-
Confidence 22 3378999999999988 789999999999999999999998874 44456667788877766655554322
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.++.++|.+||.. ..+|||+.|+++
T Consensus 271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3688999999999 999999999973
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.74 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=200.7
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344567999999999999985 4678999999876655666778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccc
Confidence 9999999876 3489999999999999999999994 99999999999999999999999999887533222 222
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||....+. .....+..+....+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~-------- 237 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDNLPPKLKN-------- 237 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhcCCCCCcc--------
Confidence 3346899999999998888999999999999999999999998643221 1122222221111100
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 564 ~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.......+.+++.+||+.+|++||++.+++
T Consensus 238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred --cccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 011235789999999999999999998887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.67 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=198.4
Q ss_pred HhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE----- 392 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~----- 392 (692)
.+.++|...+.||+|+||+||++.. .+++.||||++.... ....+++.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999985 457889999987542 23456688999999999999999999987543
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 393 -GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999998 7899887753 359999999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .......... ..
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~-~~ 236 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGT-PS 236 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCC-CC
Confidence 9863221 234468999999999876 5788999999999999999999999864322111 1111111100 00
Q ss_pred cccccc-----------cCCcCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 551 DEIIDP-----------YLEPHRD----AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 551 ~ei~d~-----------~l~~~~~----~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.+.... .+..... .........+.+|+.+||+.||.+|||+.|++ .++|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell-------~hp~~~~ 303 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL-------AHPYFSQ 303 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh-------cCcchhc
Confidence 000000 0000000 00001123567999999999999999999887 4677653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.86 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=197.3
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
|+..++||.|++|.||+|... ++..||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 68999999987543 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
+++|.+++.......+++..++.++.|++.||+|||+ ++++||||+|+||++++++.+||+|||+++..... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~ 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VRT 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-ccc
Confidence 5799999987654569999999999999999999999 49999999999999999999999999999753221 112
Q ss_pred cccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc---------ccc
Q 005536 483 STAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC---------VDE 552 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~e 552 (692)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||.......+ +.. ..+...... ..+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhchh
Confidence 2333568899999987654 578899999999999999999999864332111 000 111100000 000
Q ss_pred ccccc---CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 553 IIDPY---LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 553 i~d~~---l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..... ...............+.+++.+||+.+|++||+++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00000 00000001112235788999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.83 Aligned_cols=273 Identities=22% Similarity=0.283 Sum_probs=211.4
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCC-C-----CCeeeeEEEEEeCCe
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-H-----PNLLRLLGCCIEEGE 394 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H-----~niv~l~g~~~~~~~ 394 (692)
+.-+|.+.+.||+|.||.|-++... +++.||||+++.. +.-..+-..|+.+|..|+ | -|+|++++++...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3348899999999999999999854 5899999999854 556677889999999997 5 389999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC--CceEEeeecCC
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN--YRSKVADFGLS 472 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~--~~~kl~DFGla 472 (692)
.+||+|.+ .-+|+++|+.++...++...+..|+.||+.||.+||+. +|||.||||+||||.+- ..+||+|||.|
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 67999999999888899999999999999999999985 99999999999999654 37999999999
Q ss_pred ccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHH--------HH
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI--------DR 544 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~--------~~ 544 (692)
.... .... ....+..|.|||++.+.+|+.+.|+||||||++||++|.+.|......++......+. +.
T Consensus 339 c~~~---q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFES---QRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccC---Ccce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8622 2222 4456789999999999999999999999999999999988887655544433222111 11
Q ss_pred hcc---------Cccc-----c----------------cccccCCc-CCCc----cCHHHHHHHHHHHHHhcccCCCCCC
Q 005536 545 IGR---------GCVD-----E----------------IIDPYLEP-HRDA----WTLSSIHNVAELAFRCLAFHRDMRP 589 (692)
Q Consensus 545 ~~~---------~~~~-----e----------------i~d~~l~~-~~~~----~~~~~~~~l~~L~~~Cl~~~p~~RP 589 (692)
-.+ +... + ..+....+ .... .....-..+++++.+||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 100 0000 0 00111111 1111 1112335789999999999999999
Q ss_pred CHHHHHHHHHhhhhccccccc
Q 005536 590 TMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 590 sm~eVl~~L~~i~~~~~~~~~ 610 (692)
|..|.+ .++|....
T Consensus 495 tp~qal-------~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQAL-------NHPFLTGT 508 (586)
T ss_pred CHHHHh-------cCcccccc
Confidence 999987 67777633
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=307.60 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=202.8
Q ss_pred hccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|...+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788899999999999999985 45788999998766556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++.+. .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~ 170 (293)
T cd06647 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (293)
T ss_pred CCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-c
Confidence 9999999998653 48899999999999999999998 499999999999999999999999999886533222 2
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......+++.|++||.+....++.++||||||+++|||++|+.||....+..... .+..+.....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~~-------- 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPEL-------- 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCCCCCC--------
Confidence 2233468899999999988889999999999999999999999997543322111 0000100000
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
. ........+.+++.+||+.+|++||++.+++
T Consensus 236 -~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 236 -Q-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred -C-CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0 0112345688999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.25 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=204.1
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
|+..+.||+|++|.||+++.. +++.+++|++........+++.+|++++++++|+|++++++++...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 677889999999999999975 5788999999876555778899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||.+........ ..
T Consensus 82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999987653 469999999999999999999999 4999999999999999999999999999876433221 34
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...++..|++||++....++.++||||||+++|||++|+.|+........ .............+.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~-------- 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIATNGPPGLRNP-------- 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhcCCCCcCcc--------
Confidence 45789999999999888899999999999999999999999864322111 111111111111111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
......+.+++.+||+.+|++|||+.|+++
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111356889999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.81 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=193.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHH-HHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKL-LSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..+.||+|+||.||+++.. +++.||+|+++... .....++..|+.+ ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999865 58899999997653 2334566667765 566789999999999999999999999
Q ss_pred eCCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 401 FMPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|++ |+|.+++.... ...+++..++.++.|++.||+|||+. .+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 995 78988886532 24689999999999999999999983 38999999999999999999999999999764321
Q ss_pred CCcccccCCCCCCCCCcccccc----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQY----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~ 554 (692)
...+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... . ......+ .+....+.
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~-~~~~~~~~ 229 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVV-EEPSPQLP 229 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHH-hcCCCCCC
Confidence 12233468899999998754 45688999999999999999999998532111 1 1111111 11111110
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. .....++.+++.+||+.+|++||++.+|++
T Consensus 230 ~-----------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 A-----------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c-----------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 012356889999999999999999988863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.64 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=204.2
Q ss_pred ceeecccccEEEEEEEEeC--CC--EEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 329 KHRLGTGAYGTVYAGKLHN--DD--WVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
.++||+|.||.|++|.+.. |+ .||||.++..... ..++|++|+.+|-+|+|+|+++|+|+..+ ....+|+|+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 5689999999999998754 43 5899999876543 67899999999999999999999999988 67889999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc-c
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH-I 482 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~ 482 (692)
.|+|.+.|++.....|........+.|||.||+||.+ +++|||||..+|+||-....+||+||||.|.......+ .
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999998655678888999999999999999999 59999999999999999999999999999965443322 2
Q ss_pred c-ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 483 S-TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 483 ~-~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
+ ....-...|.|||.+....++.+||||+|||+||||+| |+.||-.-.. ..+++.+.+ .
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL~~iD~------------~ 331 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQILKNIDA------------G 331 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHHHhccc------------c
Confidence 2 22234678999999999999999999999999999999 6677753322 122333332 2
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
++-..+..+.+++++++++||..+|.+|||+..|.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22334556889999999999999999999999997544
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.64 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=199.8
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
-|+..++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999864 57899999986543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~~~ 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIK 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc-hhh
Confidence 99999999864 358999999999999999999998 59999999999999999999999999998753322 122
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
.....++..|++||++.+..++.++||||||+++|||++|..|+....+. .....+..+.... +
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~-----~---- 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKNNPPT-----L---- 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcCCCCC-----C----
Confidence 23346889999999998888999999999999999999999998632211 1111222211111 1
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.......+.+++.+||+.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1123356889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.98 Aligned_cols=266 Identities=24% Similarity=0.275 Sum_probs=210.7
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
+.|+..++||+|.-|+||++.+.+ +..+|+|++.+.. .....+.+.|-+||+.++||.++.|++.+..++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345557789999999999999876 4889999997653 344567788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC--
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT-- 477 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~-- 477 (692)
|||+||+|...++++.+..+++..+...|.+++-||+|||-. |||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999998888899999999999999999999996 999999999999999999999999998743110
Q ss_pred -------------------------------CCC----------------------cccccCCCCCCCCCccccccCCCC
Q 005536 478 -------------------------------ESS----------------------HISTAPQGTPGYLDPQYHQYFHLS 504 (692)
Q Consensus 478 -------------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~s 504 (692)
... ..+...+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011234699999999999999999
Q ss_pred CccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccC
Q 005536 505 DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFH 584 (692)
Q Consensus 505 ~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~ 584 (692)
.++|.|+|||+||||+.|.-||......+- + .. ++-+.+.. ... ......+.+||++.|.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l----~N---------Iv~~~l~F--p~~-~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET--L----RN---------IVGQPLKF--PEE-PEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh--H----HH---------HhcCCCcC--CCC-CcchhHHHHHHHHHhccC
Confidence 999999999999999999999975543221 1 11 12211111 111 134567889999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhcccccccccC
Q 005536 585 RDMRPTMMEVAEELEHIRVSSWASNIYMG 613 (692)
Q Consensus 585 p~~RPsm~eVl~~L~~i~~~~~~~~~~~~ 613 (692)
|.+|.-...=+ .+|+.++.+.++.|+
T Consensus 376 P~kRlg~~rGA---~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 376 PSKRLGSKRGA---AEIKRHPFFEGVNWA 401 (459)
T ss_pred hhhhhccccch---HHhhcCccccCCChh
Confidence 99998622221 234567766666554
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=299.84 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=204.5
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
+|+..+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999875 48899999997542 2456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 468999999999999999999998 499999999999999999999999999987643321
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ............ ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~--~~~------- 220 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA--DVL------- 220 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc--ccc-------
Confidence 224456889999999998888999999999999999999999998754432 112222222110 000
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
.+......+.+++.+||+.+|++||++. ++++..++|
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~-----~~~l~~~~~ 257 (258)
T cd05578 221 ----YPATWSTEAIDAINKLLERDPQKRLGDN-----LKDLKNHPY 257 (258)
T ss_pred ----CcccCcHHHHHHHHHHccCChhHcCCcc-----HHHHhcCCC
Confidence 1112236788999999999999999984 344445554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.38 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=196.3
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.+.|+..+.||+|+||+||+|+.. +++.||+|.+.... ....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999865 58899999986442 23446788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||++ |+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99996 68877776443 459999999999999999999998 49999999999999999999999999998753221
Q ss_pred CCcccccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+....... . ...+..+....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~-~~~~~~~~~~~--- 233 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A-LYHIAQNDSPT--- 233 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------H-HHHHhcCCCCC---
Confidence 2346788999999874 4568899999999999999999999985332111 1 11111111110
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+. .......+.+++.+||+.+|++||++.+|+.
T Consensus 234 --~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 234 --LS------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred --CC------chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 10 1123457899999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=288.76 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=206.0
Q ss_pred HHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCc--------hhHHHHHHHHHHHHhCC-CCCeeeeEEEE
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDT--------DSIDQVMNEIKLLSSVS-HPNLLRLLGCC 389 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~-H~niv~l~g~~ 389 (692)
+..-++|...+.||.|..++|-+... ..+...|+|++..... .-.+.-.+|+.||+++. ||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34556788889999999999987764 4578899999864321 12344568999999995 99999999999
Q ss_pred EeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeee
Q 005536 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 390 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 469 (692)
......++|+|.|+.|.|+|+|... -.++++...+|+.|+.+|+.|||. +.|+||||||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999999864 459999999999999999999999 59999999999999999999999999
Q ss_pred cCCccCCCCCCcccccCCCCCCCCCcccccc------CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHH
Q 005536 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQY------FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 470 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~ 543 (692)
|+|.... .........|||+|+|||.+.. ..|+...|.|+.||++|.|+.|.+||-.. .....+.
T Consensus 168 GFa~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlMLR 238 (411)
T KOG0599|consen 168 GFACQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLMLR 238 (411)
T ss_pred ceeeccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHHH
Confidence 9998643 3344567789999999998653 25778899999999999999999998521 2234455
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.+|... + ...+| .+....+.+|+.+||+.||.+|.|.+|++
T Consensus 239 ~ImeGkyq-F-------~speW-adis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 239 MIMEGKYQ-F-------RSPEW-ADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred HHHhcccc-c-------CCcch-hhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 66666432 1 11122 24556789999999999999999999998
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=306.19 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=195.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCe-----
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGE----- 394 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~----- 394 (692)
++|+..+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 58899999986542 223467889999999995 6999999999987665
Q ss_pred eEEEEEeCCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeec
Q 005536 395 PILVYEFMPNGTLCQHLQRER---GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFG 470 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFG 470 (692)
.++||||+++ +|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988887543 2358999999999999999999999 49999999999999998 8999999999
Q ss_pred CCccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
+++..... ........+++.|+|||++.+ ..++.++||||||+++|||++|..||....+... .......+....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIP-VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPT 232 (295)
T ss_pred cceecCCC-ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 98753222 112233357889999998764 4678999999999999999999999864332211 111111111100
Q ss_pred cc---cccc-------ccCC-cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 VD---EIID-------PYLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 ~~---ei~d-------~~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.. ...+ +... ............++.+++.+||+.+|.+||++.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00 0000 0000 000000112345788999999999999999998887
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.43 Aligned_cols=244 Identities=28% Similarity=0.416 Sum_probs=202.4
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.|...+.||.|+||.||.++. .+.+.||||++....+ ..+.++++|+..|.+++|||++.+-||+..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678899999999999984 5578899999986644 346678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|| -|+-.|+|.-. .++|.+..+..|..+.+.||+|||++ +.||||||+.||||.+.+.|||+|||.|.+...
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 67888888655 36799999999999999999999996 899999999999999999999999999876322
Q ss_pred cccccCCCCCCCCCcccc---ccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 481 HISTAPQGTPGYLDPQYH---QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
....+|||.|||||++ ..++|+-|+||||||++-.||.-+++|....+ +..++..|..+...-+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-------AMSALYHIAQNesPtL---- 245 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTL---- 245 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-------HHHHHHHHHhcCCCCC----
Confidence 2445899999999985 46789999999999999999999998874221 3344455554432221
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. ..+..+.+..++..||+.-|.+|||..++++
T Consensus 246 -q------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 -Q------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -C------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1 2345678899999999999999999887653
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=306.07 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=197.8
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~lV 398 (692)
++|+..+.||+|+||.||+|+.. +++.+++|.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888889999999999999975 478899999975532 2234677899999999999999999999877 889999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999887643 368999999999999999999998 49999999999999999999999999998764332
Q ss_pred CCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc-----------
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG----------- 546 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 546 (692)
. .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||......... ......+.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHhh
Confidence 1 222334578899999988654 4688999999999999999999998744322111 11111100
Q ss_pred ------cCcccccccccCCcCCCccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 547 ------RGCVDEIIDPYLEPHRDAWTLS-SIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 547 ------~~~~~ei~d~~l~~~~~~~~~~-~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.....+.....+. ...+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLR---KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhh---ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000000 011111 2456889999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=302.34 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=198.6
Q ss_pred cCccceeecccccEEEEEEEE-eCCCEEEEEEeecC-CchhHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVS---HPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~---H~niv~l~g~~~~~~~~~lV~ 399 (692)
.|+..+.||+|+||.||+|+. .+++.||+|.++.. .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 46889999998754 3445677889999999997 999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++... .+++...+.++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998643 58999999999999999999998 499999999999999999999999999987643322
Q ss_pred CcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
.......|+..|+|||++.+. .++.++||||||+++|||++|+.||........ ...+..... +.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~~~~~~-----~~~ 222 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLIPKSKP-----PRL 222 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hhccccCCC-----CCC
Confidence 222344689999999988654 578899999999999999999999864322111 111111111 111
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.. .....++.+++.+||+.+|++||++.|+++
T Consensus 223 ~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ED------NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Cc------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 10 013357889999999999999999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.78 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|+..+.||+|+||.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999865 57899999987532 234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999765 458999999999999999999999 59999999999999999999999999999864332
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||..... ....+.+..+... +.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~------~~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKVR------FP 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcc------CC
Confidence 2344689999999999888899999999999999999999999864331 1112222222111 00
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
......+.+++.+||+.+|.+||+. +...++++..++|..
T Consensus 219 -------~~~~~~l~~li~~~l~~~p~~R~~~--~~~~~~~l~~~~~~~ 258 (290)
T cd05580 219 -------SFFSPDAKDLIRNLLQVDLTKRLGN--LKNGVNDIKNHPWFA 258 (290)
T ss_pred -------ccCCHHHHHHHHHHccCCHHHccCc--ccCCHHHHHcCcccc
Confidence 1123567899999999999999822 112233333566654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=304.70 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=198.5
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEEEEE
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPILVYE 400 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~lV~E 400 (692)
|+..++||+|+||.||+|+..+ ++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999998664 7899999998663 33456788999999999999999999999988 88999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 58988886542 4689999999999999999999994 999999999999999999999999999986443332
Q ss_pred cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc---cccccc-
Q 005536 481 HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC---VDEIID- 555 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ei~d- 555 (692)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|++....... .....+....-. ...+.+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccc
Confidence 22344567889999997764 4678999999999999999999999864432211 111111111000 000000
Q ss_pred -------cc--CCcCC-CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 -------PY--LEPHR-DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 -------~~--l~~~~-~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+. ..... +.........+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 00000 0000012467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.79 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=197.5
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..+.||+|++|+||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999865 578999999865432 334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeecCCccCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~ 479 (692)
|++ ++|.+++.......+++.....++.|++.||+|||+ ++|+||||+|+||++++ +..+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 995 688888866544457888889999999999999998 49999999999999985 567999999999753222
Q ss_pred CcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccc----
Q 005536 480 SHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII---- 554 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~---- 554 (692)
........+++.|+|||++.+ ..++.++||||||+++|||+||+.||......+.. ......+... ..+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~ 232 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL---FKIFRILGTP-NEETWPGVT 232 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC-Chhhccccc
Confidence 122234467899999998865 45789999999999999999999998654322111 1111111110 00000
Q ss_pred ---cc-----cCC-cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 555 ---DP-----YLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 555 ---d~-----~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+. ... ............++.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 0000001122356889999999999999999999984
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=293.32 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=204.2
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPILVY 399 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~lV~ 399 (692)
+|+..+.||+|++|.||+|+.. +++.|++|.+..... ...+.+.+|++++++++|+||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 588999999976542 5678899999999999999999999999988 8899999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998653 69999999999999999999999 499999999999999999999999999987643322
Q ss_pred Cc-ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc-Cccccccccc
Q 005536 480 SH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR-GCVDEIIDPY 557 (692)
Q Consensus 480 ~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ei~d~~ 557 (692)
.. ......++..|++||.+.....+.++||||||++++||++|+.|+.... ..... ...+.. .....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~-~~~~~~~~~~~~----- 224 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAA-LYKIGSSGEPPE----- 224 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHH-HHhccccCCCcC-----
Confidence 11 1344568999999999988889999999999999999999999987443 11111 111111 11111
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 225 -------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 -------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11123467899999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=304.11 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=193.2
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|...++||+|+||.||+++.. +++.||+|.+.... .....++.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999864 47899999987543 345667899999999996 99999999999999999999999
Q ss_pred CCCCCHHHH---HhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 402 MPNGTLCQH---LQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 402 ~~~gsL~~~---l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
+. ++|.++ +.......+++.....++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 455543 3333345699999999999999999999974 48999999999999999999999999998753322
Q ss_pred CCcccccCCCCCCCCCccccccC---CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYF---HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.......|+..|+|||++.+. .++.++||||||+++|||++|+.||.... ..... ...+..+....
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~-~~~~~~~~~~~--- 230 (288)
T cd06616 162 --IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQ-LTQVVKGDPPI--- 230 (288)
T ss_pred --CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHH-HhhhcCCCCCc---
Confidence 122334688999999998766 68999999999999999999999986332 11111 11111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+... .......++.+|+.+||+.+|++||++.||+
T Consensus 231 --~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 231 --LSNS---EEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred --CCCc---CCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1110 0122445789999999999999999998887
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.14 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=201.2
Q ss_pred ecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||.|+||.||+++... ++.|++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999754 7899999987542 23456799999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 487 (692)
.+++.+. ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999764 348999999999999999999999 599999999999999999999999999998643322 223346
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
++..|++||.+....++.++|+||||+++|||++|..|+...... ... ....+..+... ...+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~-----------~~~~~ 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PME-IYNDILKGNGK-----------LEFPN 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHH-HHHHHhccCCC-----------CCCCc
Confidence 889999999998888999999999999999999999998754321 111 11112111000 00111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
....++.+++.+||+.+|++||++.+.. ++++..++|..+
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~--~~~l~~~~~~~~ 257 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGG--IKDIKKHKWFNG 257 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccC--HHHHhcChhhhC
Confidence 1245789999999999999999954432 555667888654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.93 Aligned_cols=269 Identities=25% Similarity=0.300 Sum_probs=200.3
Q ss_pred HHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC---
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG--- 393 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~--- 393 (692)
+...++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999975 47899999997543 233456788999999999999999999987654
Q ss_pred -------eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEE
Q 005536 394 -------EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV 466 (692)
Q Consensus 394 -------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl 466 (692)
..++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777777654 3468999999999999999999999 49999999999999999999999
Q ss_pred eeecCCccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHh
Q 005536 467 ADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI 545 (692)
Q Consensus 467 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~ 545 (692)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......+..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998644333222233456889999998764 45788999999999999999999998643321 1111122211
Q ss_pred ccCcc---cccc--------cccCC--cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 546 GRGCV---DEII--------DPYLE--PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 546 ~~~~~---~ei~--------d~~l~--~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..... .++. ++... .............+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11100 0000 00000 0000000123467899999999999999999988873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=290.23 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=207.0
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.+++|+..+.||+|.|+.||+.. ...|+.+|+|.++.. ...+.+++.+|+.|-+.|+||||++|.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45677778899999999999876 345888888887643 344678889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCceEEeeecCCccC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD---YNYRSKVADFGLSRLG 475 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~ 475 (692)
+|+|.|++|..-+... ...++...-....||+++|.|.|. ++|||||+||+|+||- ..--+||+|||+|...
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999998766543 236677777889999999999999 5999999999999994 4456999999999864
Q ss_pred CCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 476 MTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 476 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
. ....-....|||+|||||+++..+|+..+|||+-||+||-|+.|..||.... .....+++..|..+- +
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-------~~rlye~I~~g~yd~--~ 232 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYEQIKAGAYDY--P 232 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHhccccCC--C
Confidence 4 3334456689999999999999999999999999999999999999996422 223456666654321 1
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
+ ..|+ ...++..+|+.+||..||.+|.|+.|.+ .++|..
T Consensus 233 ~------~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL-------~HpWi~ 271 (355)
T KOG0033|consen 233 S------PEWD-TVTPEAKSLIRRMLTVNPKKRITADEAL-------KHPWIC 271 (355)
T ss_pred C------cccC-cCCHHHHHHHHHHhccChhhhccHHHHh-------CCchhc
Confidence 1 1121 2345678999999999999999999887 566653
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.19 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=198.0
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
+|+..++||+|++|+||+|+.. +++.||||.++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999975 578899999976533 34567789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 403 PNGTLCQHLQRER-GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 403 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+ ++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~-~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-VN 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC-cc
Confidence 7 58988887543 2458999999999999999999998 49999999999999999999999999999753221 12
Q ss_pred ccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC---------ccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG---------CVD 551 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 551 (692)
......++..|++||.+.+. .++.++||||||+++|||++|+.||......... ....+..... ...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL---LKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCChhhHHHHhcCc
Confidence 22334578899999987654 5788999999999999999999998754322111 1111111000 000
Q ss_pred ccccccC---CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 552 EIIDPYL---EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 552 ei~d~~l---~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
....... ..............+.+++.+||+.+|.+||++.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 0000000 0000000112245678999999999999999998887
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.17 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=207.8
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
-|++..+||+|+||.|||+..+ .|+.||||++.. ..+.++..+|+.|+.+.+.|++|+++|.+.....+++|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3677889999999999999854 589999999865 4567899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
-|++.+.+... .++|++.++-.|+...++||+|||.. .-||||||+.||||+.+|.+||+|||.|-.. .+.....
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL-TDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL-TDTMAKR 186 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh-hhhHHhh
Confidence 99999988765 57899999999999999999999997 7899999999999999999999999999763 2334445
Q ss_pred ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCC
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
..+.||+.|||||+++.-.|..++||||||++..||.-|++|+..-.|-..+. ++... .+..-
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIPT~----------PPPTF 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIPTK----------PPPTF 249 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------eccCC----------CCCCC
Confidence 66789999999999999999999999999999999999999986433321110 11111 11111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 564 ~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+.....++.+++++||-.+|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 223456678999999999999999999888764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.15 Aligned_cols=260 Identities=23% Similarity=0.275 Sum_probs=193.4
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeC--CeeEEEEE
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEE--GEPILVYE 400 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~--~~~~lV~E 400 (692)
|+..++||+|+||.||+++.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999854 57899999987542 223334568999999985 99999999999987 88999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++ ++|.+++.... ..++|..++.++.|++.||+|||+ .+|+||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 68888887543 468999999999999999999999 49999999999999999 999999999997643221
Q ss_pred cccccCCCCCCCCCccccc-cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHh-----------ccC
Q 005536 481 HISTAPQGTPGYLDPQYHQ-YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI-----------GRG 548 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 548 (692)
......++..|+|||++. +..++.++||||||+++|||++|..||....+.+. .....+.. ...
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhccc
Confidence 122345789999999764 45678899999999999999999999965433221 11111111 111
Q ss_pred cccccccccCC-cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 549 CVDEIIDPYLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 549 ~~~ei~d~~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.......+... .............+.+|+.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 10000000000 0000011134578999999999999999999999873
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.20 Aligned_cols=268 Identities=25% Similarity=0.338 Sum_probs=198.3
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC--Cee
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE--GEP 395 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~--~~~ 395 (692)
+.++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4577888999999999999999865 5788999988643 334456788899999999 999999999998654 368
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||++ ++|.+++... .++|..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 6999888653 58899999999999999999999 49999999999999999999999999999764
Q ss_pred CCCCC----cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHH--------H
Q 005536 476 MTESS----HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALA--------I 542 (692)
Q Consensus 476 ~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~--------~ 542 (692)
..... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||....+.......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 33221 12234468999999998754 46788999999999999999999998643322111000000 0
Q ss_pred HHhccCcccccccccCCcC---CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 543 DRIGRGCVDEIIDPYLEPH---RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 543 ~~~~~~~~~ei~d~~l~~~---~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+......++++...... ..........++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0000000111111000000 00001113467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.56 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=205.0
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||.|+||.||++... +++.|++|++..... ...+++.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 478999999976533 5667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 402 MPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 402 ~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
+++++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998753 35699999999999999999999994 99999999999999999999999999997643322
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......|++.|+|||.+....++.++||||||+++++|++|+.|++.... .. ......+.....+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~~------ 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LE-LALKILKGQYPPI------ 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HH-HHHHHhcCCCCCC------
Confidence 223345688999999999888899999999999999999999999864321 11 1222222211111
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+......+.+++.+||..+|++||++.|+++
T Consensus 224 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=313.14 Aligned_cols=272 Identities=23% Similarity=0.306 Sum_probs=199.4
Q ss_pred hhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----e
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-----E 394 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-----~ 394 (692)
++++|+..++||+|+||.||+|+. .+++.||||.+.... ......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999985 458899999986432 334567889999999999999999999876543 5
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 799999996 588877754 3589999999999999999999994 999999999999999999999999999876
Q ss_pred CCCCCCc--ccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc-
Q 005536 475 GMTESSH--ISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV- 550 (692)
Q Consensus 475 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 550 (692)
....... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 3322211 1233468999999998654 468899999999999999999999986432111 11111111111100
Q ss_pred --ccccccc-------CC-cCCCc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 551 --DEIIDPY-------LE-PHRDA---WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 551 --~ei~d~~-------l~-~~~~~---~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
..+.+.. .. ..... .......++.+++.+||+.+|++||++.|++ .++|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l-------~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL-------AHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh-------cCcccccc
Confidence 0000000 00 00000 0011245688999999999999999998887 45665533
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.74 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=199.6
Q ss_pred ecccccEEEEEEEEeC-CCEEEEEEeecCCc---hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||+|+||.||+++..+ ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999765 88999999875433 4567789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC-------
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS------- 480 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~------- 480 (692)
.+++.+.. .+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997653 68999999999999999999998 4999999999999999999999999999875332211
Q ss_pred cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.......++..|++||.+.....+.++||||||+++|||++|+.|+....+. ...+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~------- 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILNGKIEWP------- 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCcCCC-------
Confidence 1223446788999999998888999999999999999999999998643321 11222222211100
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.. ......+.+++.+||+.+|++|||+.++.+.| .++|..
T Consensus 222 ~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l----~~~~~~ 261 (265)
T cd05579 222 ED----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK----NHPFFK 261 (265)
T ss_pred cc----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh----cCcccc
Confidence 00 01245788999999999999999996665544 355554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.01 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=196.9
Q ss_pred ecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||+|+||+||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 58899999987532 23355678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 487 (692)
.+++.......+++..++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 999987655569999999999999999999999 4999999999999999999999999999875332 12223446
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
++..|++||++.+..++.++||||||+++|||++|+.||......... ......... . . ...+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~----~--~-------~~~~~ 219 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLE----M--A-------VEYPD 219 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhcccc----c--c-------ccCCc
Confidence 788999999998888999999999999999999999998643321110 111111110 0 0 00111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHhhhhccccc
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMME-VAEELEHIRVSSWAS 608 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~e-Vl~~L~~i~~~~~~~ 608 (692)
.....+.+++.+||+.+|++||+..| .++.| ..++|..
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l---l~h~~~~ 258 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEV---REHPLFK 258 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHH---HhChhhh
Confidence 22457889999999999999996555 33222 3466654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.66 Aligned_cols=268 Identities=22% Similarity=0.281 Sum_probs=196.5
Q ss_pred cCccceeecccccEEEEEEEEeC---CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN---DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPI 396 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~ 396 (692)
+|+..++||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999654 7899999998642 34456788999999999999999999999988 7899
Q ss_pred EEEEeCCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC----CCceEEeee
Q 005536 397 LVYEFMPNGTLCQHLQRER---GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY----NYRSKVADF 469 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~DF 469 (692)
+||||++ ++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777765432 2358999999999999999999999 49999999999999999 999999999
Q ss_pred cCCccCCCCCC--cccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCccccc------HHHH
Q 005536 470 GLSRLGMTESS--HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN------LAAL 540 (692)
Q Consensus 470 Gla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~------~~~~ 540 (692)
|+++....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986432221 122334678999999987654 57899999999999999999999997543322100 0001
Q ss_pred HHHHhccCc---------cccccc---ccCCcCCCccC--------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 541 AIDRIGRGC---------VDEIID---PYLEPHRDAWT--------LSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 541 ~~~~~~~~~---------~~ei~d---~~l~~~~~~~~--------~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
....+.... ..+... ........... .....++.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111000 000000 00000000000 022346889999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.62 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=193.3
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-------
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG------- 393 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~------- 393 (692)
++|+..++||+|+||.||+++.. +++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999864 58899999986542 222345678999999999999999999987654
Q ss_pred -eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 394 -EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 394 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3499999995 5888887654 24589999999999999999999994 9999999999999999999999999999
Q ss_pred ccCCCCCC---cccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC
Q 005536 473 RLGMTESS---HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 473 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
........ .......++..|+|||++.+. .++.++||||||+++|||++|+.|+....+...... ...+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~----~~~~~~~ 242 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL----ISQLCGS 242 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHHhCC
Confidence 76432211 112334578899999987654 478899999999999999999998865433211111 1111110
Q ss_pred cccccc---------ccc-CCcCCC-c-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 549 CVDEII---------DPY-LEPHRD-A-----WTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 549 ~~~ei~---------d~~-l~~~~~-~-----~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
...++. +.. ...... . ........+.+|+.+||+.+|.+|||++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 000000 000 000000 0 0001124567899999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.04 Aligned_cols=256 Identities=23% Similarity=0.264 Sum_probs=201.4
Q ss_pred cCccceeecccccEEEEEEEE----eCCCEEEEEEeecCC----chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCee
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL----HNDDWVAIKRFRYRD----TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~ 395 (692)
+|+..+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999874 346789999987532 23346788999999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998754 458999999999999999999998 59999999999999999999999999998764
Q ss_pred CCCCCcccccCCCCCCCCCccccccCC--CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 476 MTESSHISTAPQGTPGYLDPQYHQYFH--LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 476 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
............|+..|++||.+.+.. .+.++||||||+++|||++|..|+....... ......+.+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~---- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKSK---- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHccC----
Confidence 433322233456899999999987654 7889999999999999999999986332211 1111111111110
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+. .+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 229 --~~-------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PP-------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC-------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 0111234678999999999999999999998877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=292.37 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=201.7
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999865 578899999986643 4667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999998765 469999999999999999999998 4999999999999999999999999999986433222
Q ss_pred ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcC
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......++..|+|||...+..++.++|||+||+++|||++|+.|+....+ ... ...........+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~--~~~~~~~~~~~~-------- 219 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAA--LFRIVQDDHPPL-------- 219 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHH--HHHHhccCCCCC--------
Confidence 12345689999999999888889999999999999999999999863321 111 111111111111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 562 ~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+......+.+++.+||..+|++||++.|++
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 112235788999999999999999999987
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.60 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=196.9
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc-hhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
|+..+.||+|+||+||+|+..+ ++.|+||++..... .......+|+..+.+++ |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667899999999999999764 78899999875422 23334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
+|+|.+++.......+++..++.++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++...... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PP 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CC
Confidence 8899999987654578999999999999999999999 49999999999999999999999999999753322 12
Q ss_pred cccCCCCCCCCCccccc-cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH---------HHHHhc-cCccc
Q 005536 483 STAPQGTPGYLDPQYHQ-YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL---------AIDRIG-RGCVD 551 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~---------~~~~~~-~~~~~ 551 (692)
.....++..|+|||.+. ...++.++||||||++++||++|+.||.............. ..+... .....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23346788999999874 45688999999999999999999998865433221100000 000000 00000
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
..+..................+.+++.+||+.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000000111357889999999999999999998873
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.27 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=196.3
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc--hhHHHHHHHHHHHHhC---CCCCeeeeEEEEEeCCe-----
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT--DSIDQVMNEIKLLSSV---SHPNLLRLLGCCIEEGE----- 394 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~H~niv~l~g~~~~~~~----- 394 (692)
|+..+.||+|+||.||+|+... ++.||+|+++.... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999764 88999999975422 2234566788877666 59999999999988776
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.+++|||++ ++|.+++.......+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 5899998775545699999999999999999999994 999999999999999999999999999876
Q ss_pred CCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc-
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI- 553 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei- 553 (692)
..... ......++..|+|||++.+..++.++||||||+++|||++|+.|+......+ ......+..........
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcC
Confidence 43221 1123357889999999998899999999999999999999988886433211 11112221111000000
Q ss_pred ---------ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 554 ---------IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 554 ---------~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
...................+.+++.+||+.+|++||++.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 000000000111123346778999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=302.49 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=196.9
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
.|+..+.||+|+||.||+++.. ++..||+|++.... ....+++.+|++++++++|+|++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667788999999999999864 57899999987542 2344678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++ |+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 996 5888877654 3559999999999999999999998 4999999999999999999999999999875322
Q ss_pred cccccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 481 HISTAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.....|++.|+|||++. ...++.++||||||+++|||++|+.|+...... .....+..+.....
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~---- 244 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPTL---- 244 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhccCCCC----
Confidence 12346889999999873 457889999999999999999999987532111 11111211111100
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
. .......+.+|+.+||+.+|.+||++.+|++.+..+
T Consensus 245 -~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 245 -Q------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -C------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0 112335688999999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.55 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=203.2
Q ss_pred cCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..++||+|+||.||+++.. +++.+++|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999754 57889999987542 34466788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 402 MPNGTLCQHLQRER--GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 402 ~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 2458999999999999999999998 49999999999999999999999999999864332
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
......+++.|++||++.+..++.++|+||||+++|||++|+.|+...... .....+..+....+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~------ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQRGKYPPI------ 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCCC------
Confidence 223346889999999999889999999999999999999999998643221 11222222222211
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+.....++.+++.+||+.+|++||++.|+++
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 ------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1234467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.75 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=198.0
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE----- 392 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~----- 392 (692)
...++|+..+.||+|+||.||+++.. +++.||||.+... +....+++.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35578999999999999999999854 6889999998643 334456788999999999999999999998643
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 393 -GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 6888887643 8899999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc-----
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG----- 546 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~----- 546 (692)
++..... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......++
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 9863222 122334688999999999999999999999999999999999999864332111 000000000
Q ss_pred --------------cC------cccccccccCCcC-CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 547 --------------RG------CVDEIIDPYLEPH-RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 547 --------------~~------~~~ei~d~~l~~~-~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+. ...+++...+... ...........+.+++.+||+.||++|||+.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00 0001111110000 0000112355788999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.23 Aligned_cols=270 Identities=20% Similarity=0.276 Sum_probs=189.2
Q ss_pred HHhhccCccceeecccccEEEEEEEEeCC--CEEEEE------------------EeecCCchhHHHHHHHHHHHHhCCC
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHND--DWVAIK------------------RFRYRDTDSIDQVMNEIKLLSSVSH 379 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~--~~vavK------------------~~~~~~~~~~~~~~~E~~il~~l~H 379 (692)
....++|+..++||+|+||+||++.+... ..+++| +++ .......++.+|+.+|++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 34557899999999999999999875432 122222 111 112345678899999999999
Q ss_pred CCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 005536 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG---SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456 (692)
Q Consensus 380 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NI 456 (692)
+||+++++++.+.+..++|+|++ .++|.+++..... ..........|+.|++.||+|||+ .+|+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHE
Confidence 99999999999999999999999 5678887764321 123455677899999999999999 4999999999999
Q ss_pred EEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcc-cCCCCCcccc
Q 005536 457 LLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKV-VDFSRPHSEV 535 (692)
Q Consensus 457 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p-~~~~~~~~~~ 535 (692)
||+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999986443333333445799999999999999999999999999999999998754 3322111111
Q ss_pred cHHHHHHHHhccCcccccccc-----------cCCcCCCcc-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 536 NLAALAIDRIGRGCVDEIIDP-----------YLEPHRDAW-----TLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 536 ~~~~~~~~~~~~~~~~ei~d~-----------~l~~~~~~~-----~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+ ......+.. ...++.+. .+....... .......+.+++.+||+.||.+|||+.|+++
T Consensus 379 ~~-~~~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QL-LKIIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HH-HHHHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11 111111110 00011000 000000000 0011235678899999999999999999973
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=299.96 Aligned_cols=257 Identities=16% Similarity=0.202 Sum_probs=186.8
Q ss_pred hccCccceeecccccEEEEEEEEeCC----CEEEEEEeecCCchhH-----------HHHHHHHHHHHhCCCCCeeeeEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHND----DWVAIKRFRYRDTDSI-----------DQVMNEIKLLSSVSHPNLLRLLG 387 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~H~niv~l~g 387 (692)
.++|...++||+|+||+||+|...++ ..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999987554 4566665433221111 11233445566778999999999
Q ss_pred EEEeCC----eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 005536 388 CCIEEG----EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR 463 (692)
Q Consensus 388 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~ 463 (692)
++.... ..++++|++. .++.+.+... ...++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 876544 3467788763 4666666543 236788899999999999999999 49999999999999999999
Q ss_pred eEEeeecCCccCCCCCCc------ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccH
Q 005536 464 SKVADFGLSRLGMTESSH------ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNL 537 (692)
Q Consensus 464 ~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~ 537 (692)
+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999764322111 11234699999999999999999999999999999999999999975432221110
Q ss_pred --HHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 538 --AALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 538 --~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
...+..++.++... .......+.+++..|++.+|++||++.++.+.|+
T Consensus 245 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK--------------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhhhhc--------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 01122333222110 0112357889999999999999999999998763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.91 Aligned_cols=269 Identities=24% Similarity=0.283 Sum_probs=199.9
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CeeEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEPIL 397 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~~l 397 (692)
.++|+..+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457889999999999999999964 488999999975432 2234567899999999999999999998765 46899
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58988887643 5689999999999999999999994 999999999999999999999999999976432
Q ss_pred CCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccc--
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII-- 554 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~-- 554 (692)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+... .....+..+... ..+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~-~~~~~~ 235 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPN-ESIWPG 235 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC-hhhchh
Confidence 21 22233346888999998865 4678999999999999999999999874432211 111111111100 0000
Q ss_pred -------cc-cCCcC-C---CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 555 -------DP-YLEPH-R---DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 555 -------d~-~l~~~-~---~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.. .+... . ..........+.+++.+||+.||++|||+.|++ .++|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il-------~h~~f~ 294 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL-------ESSYFK 294 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh-------cChhhc
Confidence 00 00000 0 000011245678999999999999999998887 467764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.53 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=200.6
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
|+..+.||+|++|.||+++.. +++.+++|+++.... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999864 578899999875532 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
+ ++|.+++.... ..+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||.+....... ..
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 6 48888887643 569999999999999999999999 499999999999999999999999999987643332 22
Q ss_pred cccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc---cccccc---
Q 005536 483 STAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC---VDEIID--- 555 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ei~d--- 555 (692)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. .......+.... ...+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 2334688899999998776 789999999999999999999998864433221 111111111110 000000
Q ss_pred c---cC----CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 556 P---YL----EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~---~l----~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
. .. .............++.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00 00000111234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=300.49 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=193.8
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCC
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGT 406 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 406 (692)
.+.+|.|+++.||+++. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33455666666666654 6889999999764 34566789999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC------
Q 005536 407 LCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS------ 480 (692)
Q Consensus 407 L~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~------ 480 (692)
|.+++.......+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999876556689999999999999999999994 999999999999999999999999998864322111
Q ss_pred cccccCCCCCCCCCcccccc--CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc---
Q 005536 481 HISTAPQGTPGYLDPQYHQY--FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID--- 555 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d--- 555 (692)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... ...+.+. +....+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~~-~~~~~~~~~~~ 235 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKVR-GTVPCLLDKST 235 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-ccCccccccCc
Confidence 11233457889999999865 358899999999999999999999986432211 1111111 11111111
Q ss_pred -----------------ccCC-cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 556 -----------------PYLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 556 -----------------~~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+... ............++.+|+.+||+.+|++|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 0000 000111223346788999999999999999999887
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.95 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=200.4
Q ss_pred ccCccceeecccccEEEEEEEEeCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E 400 (692)
..|+..++||.||.+.||++...+.+.+|+|++... +.+..+-|.+|+.+|.+|+ |.+||+|++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 468888999999999999999988899999988643 5667888999999999996 9999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|= +.+|..+|.+.......| .+..+..|++.++.++|.+ +|||-||||.|+|+-. |.+||+|||+|.....+.+
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 97 679999998876555556 6678899999999999996 9999999999999965 5899999999987666655
Q ss_pred ccc-ccCCCCCCCCCccccccC-----------CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC
Q 005536 481 HIS-TAPQGTPGYLDPQYHQYF-----------HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 481 ~~~-~~~~gt~~Y~aPE~~~~~-----------~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
.+. ....||+.||+||.+... +.+.+|||||+|||||+|+.|+.||..- .+ .+.+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n----~~aK---- 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----IN----QIAK---- 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HH----HHHH----
Confidence 443 456799999999976433 2567999999999999999999998621 11 1111
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+..+.||.-.-.+...+ ...++.++++.||+.||++||+..|++
T Consensus 582 -l~aI~~P~~~Iefp~~~--~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 582 -LHAITDPNHEIEFPDIP--ENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred -HHhhcCCCccccccCCC--CchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 22334442211122111 112388999999999999999999987
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.28 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=197.4
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----C
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-----G 393 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~-----~ 393 (692)
+.++|...+.||+|+||+||+++.. +++.||||.++.. ......++.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467899999999999999999854 5789999998753 233456778999999999999999999988654 3
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 4799999995 7898888654 459999999999999999999998 499999999999999999999999999998
Q ss_pred cCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc-----
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR----- 547 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 547 (692)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .....+.+..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHH
Confidence 643221 22234467899999998764 4688999999999999999999999864322111 1111111110
Q ss_pred ------Ccccccccc---cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 548 ------GCVDEIIDP---YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 548 ------~~~~ei~d~---~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
....+.+.. ...............++.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000000000 0000000011123467889999999999999999988873
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.49 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=196.0
Q ss_pred ceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 329 KHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
..+||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 46889999998765555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 487 (692)
.+++.. ..+++.....++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++....... .......
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 998754 348999999999999999999999 499999999999999999999999999987533222 2223446
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
|++.|++||++.+..++.++||||||+++|||++|..|+....... ....+..+.. +.+.. ..
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~~~~-----~~~~~-~~---- 240 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLP-----PKLKN-LH---- 240 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhhCC-----cccCC-cc----
Confidence 8899999999988889999999999999999999999986432211 1111111111 10100 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.....+.+++.+||+.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 12345788999999999999999998873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=296.20 Aligned_cols=247 Identities=20% Similarity=0.235 Sum_probs=187.9
Q ss_pred eecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHH---hCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 331 RLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLS---SVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~---~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++. ..+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 57899999986542 122233445554443 3479999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++...... ..
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Cc
Confidence 99999998754 459999999999999999999999 49999999999999999999999999998753221 12
Q ss_pred ccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....||..|+|||.+.. ..++.++||||||+++|||++|+.||.......... ....... .+..+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~~~---- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNVEL---- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCcCC----
Confidence 33468999999998864 568899999999999999999999996443221111 1111100 01111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhhhcccccc
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl~~L~~i~~~~~~~~ 609 (692)
+.....++.+++.+||+.+|++|| +++|++ .++|...
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~-------~h~~~~~ 260 (279)
T cd05633 219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVK-------EHVFFKG 260 (279)
T ss_pred ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH-------hCccccC
Confidence 112345788999999999999999 577665 5566544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=299.42 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=194.7
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC-chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E 400 (692)
++|+..+.||+|+||.||+++..+ ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999999765 8899999997643 334556777888777775 9999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. ++|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 984 57777665533 4699999999999999999999973 489999999999999999999999999987533221
Q ss_pred cccccCCCCCCCCCccccccCC----CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 481 HISTAPQGTPGYLDPQYHQYFH----LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ......+.......+..
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~- 241 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEPPSLPP- 241 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCCCCCCCC-
Confidence 223345788999999987553 788999999999999999999998632111 01111111111111100
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
......++.+|+.+||+.+|++||++.++++
T Consensus 242 ---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 242 ---------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred ---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0013357899999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.10 Aligned_cols=273 Identities=19% Similarity=0.270 Sum_probs=201.1
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CCee
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE----EGEP 395 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~----~~~~ 395 (692)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478899999999999999999854 58899999987542 2345678899999999999999999998763 3468
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6899988654 349999999999999999999999 49999999999999999999999999999753
Q ss_pred CCCCC---cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH--------HHH
Q 005536 476 MTESS---HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL--------AID 543 (692)
Q Consensus 476 ~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~--------~~~ 543 (692)
..... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.............. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32221 11234478999999998765 4688999999999999999999999964432211110000 000
Q ss_pred HhccCcccccccccCCcCC---CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 544 RIGRGCVDEIIDPYLEPHR---DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~---~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.+......+..+..-.... .........++.+++.+||+.+|++||++.+++ .++|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l-------~~~~~~ 298 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL-------QHPFLA 298 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH-------hChhhh
Confidence 0111111111110000000 000112356789999999999999999998877 456654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=291.37 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=188.5
Q ss_pred HHHHhhccCccceee--cccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005536 318 EIEKATSFFSEKHRL--GTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEG 393 (692)
Q Consensus 318 el~~~~~~f~~~~~L--G~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~ 393 (692)
+.....++|+..+.+ |+|+||.||++.. .++..+|+|.+........ |+.+...+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445566666665 9999999999985 4578899999875422211 22222222 6999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-ceEEeeecCC
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLS 472 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla 472 (692)
..++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 699999999999999999999994 899999999999999998 9999999998
Q ss_pred ccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e 552 (692)
+..... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... .......+ .... ... ..
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~-~~~~-~~~-~~ 228 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESL-LKRQ-QKK-LP 228 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHH-HHhh-ccc-CC
Confidence 753221 234689999999999988999999999999999999999999973322 22222111 1111 100 00
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT-MMEVA 595 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPs-m~eVl 595 (692)
. .......+.+++.+||+.+|.+||+ ++|++
T Consensus 229 ~------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 229 F------------IKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred c------------ccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 0 0123356889999999999999996 56665
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.31 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=192.1
Q ss_pred cCccceeecccccEEEEEEEE----eCCCEEEEEEeecCC----chhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCee
Q 005536 325 FFSEKHRLGTGAYGTVYAGKL----HNDDWVAIKRFRYRD----TDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~ 395 (692)
+|+..+.||+|+||.||+++. .+++.||+|+++... ....+++.+|++++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999986 367899999997532 23346788999999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++||||+++++|.+++... ..+++.....++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999764 458899999999999999999999 49999999999999999999999999999764
Q ss_pred CCCCCcccccCCCCCCCCCccccccC--CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 476 MTESSHISTAPQGTPGYLDPQYHQYF--HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 476 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
............|+..|+|||.+... .++.++||||||+++|||++|+.|+........ ... ..+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~-~~~~~~~~~~--- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAE-ISRRILKSEP--- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHH-HHHHhhccCC---
Confidence 33222222345689999999998653 467899999999999999999999864322111 111 1111111100
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP 589 (692)
..+......+.+++.+||+.+|++||
T Consensus 230 ----------~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 230 ----------PYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred ----------CCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 01112234678999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.29 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=196.5
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC-----CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--Cee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR-----DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--GEP 395 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--~~~ 395 (692)
.+|+..+.||+|+||.||+++.. ++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999864 5889999987532 123456788999999999999999999998764 468
Q ss_pred EEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccC
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 475 (692)
++|+||+++++|.+++... ..+++...++++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998754 348899999999999999999998 49999999999999999999999999999753
Q ss_pred CCCC--CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccc
Q 005536 476 MTES--SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 476 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei 553 (692)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||..... .....+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~ 229 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTKP-M 229 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCCC-C
Confidence 2211 1112334689999999999888899999999999999999999999863221 11111211111111 1
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+....+.+.+++.+||+ +|.+||+..+++.
T Consensus 230 -----------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 -----------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 112334678899999999 5799999987763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=326.26 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=214.8
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEeC--------CCEEEEEEeecC-CchhHHHHHHHHHHHHhC-CCCCeeeeEE
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHN--------DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLG 387 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~H~niv~l~g 387 (692)
.++...++....+.||+|.||.|++|.... ...||||.++.. +..+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 556666666777799999999999998542 346999999865 345678899999999999 6999999999
Q ss_pred EEEeCCeeEEEEEeCCCCCHHHHHhhcc------C--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 005536 388 CCIEEGEPILVYEFMPNGTLCQHLQRER------G--------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKS 453 (692)
Q Consensus 388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~ 453 (692)
+|...+..++|+||++.|+|.++|...+ . ..|+....+.++.|||.|++||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998876 0 1388899999999999999999994 899999999
Q ss_pred CceEEcCCCceEEeeecCCccCCCCCCcccccCCC--CCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCC
Q 005536 454 SNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG--TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSR 530 (692)
Q Consensus 454 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~ 530 (692)
+|||+.++..+||+|||+|+..............| ...|||||.+....++.|||||||||+||||+| |..|+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999999655444443232233 446999999999999999999999999999999 5566642
Q ss_pred CcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005536 531 PHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i 601 (692)
+.....+.+.+++|...+ .+..+.+++.+++..||+.+|++||++.|+.+.|+..
T Consensus 525 ----~~~~~~l~~~l~~G~r~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 ----IPPTEELLEFLKEGNRME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----CCcHHHHHHHHhcCCCCC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 221222345666654332 2233457889999999999999999999999999984
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.83 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=206.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
+.|..-++||+||||.||..+.. .|+.+|.|++.+. ........++|-.+|.+++.+.||.+-..+...+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888899999999999988754 4888999988643 2344556789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
..|.||+|.-||.......+++...+..|.+|+.||++||.. +||.|||||+|||||+.|+++|+|+|||..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999999888767799999999999999999999994 99999999999999999999999999998654433
Q ss_pred CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
. ....+||.+|||||++++..|+...|.||||++||||+.|+.||....... -.|-+|.+..
T Consensus 342 ~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----------------k~eEvdrr~~ 403 (591)
T KOG0986|consen 342 P--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----------------KREEVDRRTL 403 (591)
T ss_pred c--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------------hHHHHHHHHh
Confidence 3 344589999999999999999999999999999999999999996332111 1112233333
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM 592 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~ 592 (692)
.....++....++...|....|+.||.+|.--.
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 333444556667888999999999999997544
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.71 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=203.2
Q ss_pred CccceeecccccEEEEEEEEeCCC-EEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~~~-~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
|.+...||.|+||.|||+...+.. .-|.|.+........++|+-|++||...+||+||+|++.|..++.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 444567999999999999876543 4567888777788899999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|.+...+... +..|+..++.-++.|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+.... ..-....
T Consensus 114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRD 188 (1187)
T ss_pred chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch-hHHhhhc
Confidence 9998887765 5679999999999999999999999 599999999999999999999999999975421 1122234
Q ss_pred cCCCCCCCCCcccc-----ccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCC
Q 005536 485 APQGTPGYLDPQYH-----QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~-----~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
...|||.|||||+. ...+|+.++||||||++|.||..+.+|-. +.+. ..++-++.+.....++.|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnp-MRVllKiaKSePPTLlqP--- 258 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNP-MRVLLKIAKSEPPTLLQP--- 258 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccch-HHHHHHHhhcCCCcccCc---
Confidence 56799999999974 56689999999999999999999987753 3332 233334444444433333
Q ss_pred cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
-.....+.+++.+||..||+.||++.++++
T Consensus 259 -------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 -------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 123356889999999999999999998874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.97 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=192.2
Q ss_pred eeecccccEEEEEEEEe-CCCEEEEEEeecCCc---hhHHHHHHHHHHH-HhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT---DSIDQVMNEIKLL-SSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.||+|+||.||+++.. +++.||+|.++.... .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 578999999875432 2233445555544 455899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999999764 458999999999999999999999 4999999999999999999999999999875322 23
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...++..|++||.+.+..++.++||||||+++|||++|..|+...... .....+..+.... ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~--~~~~------ 216 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRINW--PEEV------ 216 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccCC--CCcc------
Confidence 346889999999998888899999999999999999999998643221 1122222221110 0000
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.......+.+++.+||+.+|++||++.++.+. ..++|..
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~----l~~~~~~ 255 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEI----KSHPFFK 255 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHH----HcChHhh
Confidence 01234578899999999999999987766543 3445554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.80 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=193.8
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
+.|+..+.||+|+||+||+|+.. +++.+++|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999964 5788999998643 2234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 479 (692)
||+. |+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9996 6888877654 3458999999999999999999998 4999999999999999999999999999875322
Q ss_pred CcccccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 480 SHISTAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.....+++.|+|||++. ...++.++||||||+++|||++|+.|+...... .....+.++......
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~-- 235 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQ-- 235 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHHhhcCCCCcC--
Confidence 12346789999999874 356788999999999999999999987532211 111112221111110
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.......+.+|+.+||+.+|++||++.+|++
T Consensus 236 ---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 236 ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred ---------cccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1123356889999999999999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.45 Aligned_cols=265 Identities=22% Similarity=0.244 Sum_probs=194.4
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCch--hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC------
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG------ 393 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~g~~~~~~------ 393 (692)
.++|+..++||+|+||.||+++.. +++.||||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 5789999998754322 2346789999999999999999999876543
Q ss_pred --eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 394 --EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 394 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
..++|+||+. ++|...+... ...+++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 4699999995 5777777654 3469999999999999999999999 4999999999999999999999999999
Q ss_pred CccCCCCCC----------cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH
Q 005536 472 SRLGMTESS----------HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 472 a~~~~~~~~----------~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~ 540 (692)
++....... ...+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 975332111 11233457889999998765 458899999999999999999999986433321 1111
Q ss_pred HHHHhccCc---------ccccc----cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 541 AIDRIGRGC---------VDEII----DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 541 ~~~~~~~~~---------~~ei~----d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.......-. ..... ..................+.+++.+||+.+|++|||+.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 111111100 00000 00000000000011225688999999999999999998887
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=293.03 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=194.4
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecC-----CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR-----DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
+|...++||+|+||+||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999998644 344566665432 123345677899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 399 YEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988753 23569999999999999999999999 49999999999999986 469999999987643
Q ss_pred CCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.. ........|++.|+|||++.+..++.++|+||||+++|+|++|+.|+.... .... ...+..+....
T Consensus 157 ~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~-~~~~~~~~~~~---- 224 (260)
T cd08222 157 GS-CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSV-VLRIVEGPTPS---- 224 (260)
T ss_pred CC-cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHH-HHHHHcCCCCC----
Confidence 22 222334568899999999988889999999999999999999999985322 1111 11121121111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+.....++.+++.+||+.+|++||++.|+++
T Consensus 225 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 --------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11234457889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=297.25 Aligned_cols=253 Identities=17% Similarity=0.224 Sum_probs=191.5
Q ss_pred eeccc--ccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 331 RLGTG--AYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 331 ~LG~G--~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
.||+| +||+||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 56666 99999999864 68999999987543 234577889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc---
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI--- 482 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~--- 482 (692)
+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999987655568999999999999999999998 599999999999999999999999998653321111100
Q ss_pred ---cccCCCCCCCCCccccccC--CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc--------
Q 005536 483 ---STAPQGTPGYLDPQYHQYF--HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC-------- 549 (692)
Q Consensus 483 ---~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 549 (692)
.....++..|++||++.+. .++.++||||||+++|||++|+.||....... .....+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCccccc
Confidence 1112356779999998763 57899999999999999999999986432111 1111111000
Q ss_pred ----------------------------ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 ----------------------------VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 ----------------------------~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
...+.+..+. ..........+.+|+.+||+.||++|||+.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR---TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc---chhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000011110 111223556789999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.62 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=199.5
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----eeE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-----EPI 396 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~-----~~~ 396 (692)
+|+..+.||+|+||.||+++..+ ++.||||++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999754 8899999987643 445678999999999999999999999988775 789
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+||||++ ++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 5898888654 369999999999999999999999 499999999999999999999999999998643
Q ss_pred CCCC--cccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc----
Q 005536 477 TESS--HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC---- 549 (692)
Q Consensus 477 ~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 549 (692)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.. .........-.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 3221 122344678999999999887 8899999999999999999999998654322111 11111110000
Q ss_pred -------ccccccc---cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 -------VDEIIDP---YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 -------~~ei~d~---~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..+.+.. ................+.+++.+||+.+|++||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 0000000 000000000112345788999999999999999999887
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.21 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=198.2
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
|+..+.||+|+||.||+|+..+ ++.||+|.++... ....+.+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566789999999999999764 8899999998653 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
+ ++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++...... ..
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RT 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cc
Confidence 7 69999998653 459999999999999999999999 499999999999999999999999999997643222 12
Q ss_pred cccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc------------
Q 005536 483 STAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC------------ 549 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 549 (692)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .....+......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccc
Confidence 2334567889999998766 889999999999999999999988864332111 111111111000
Q ss_pred ccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.......................+.+++.+||+.+|++||++.+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 0000000000000000011245789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.10 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=191.2
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC------
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG------ 393 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~------ 393 (692)
.++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999854 58899999987532 233456889999999999999999999987543
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4689999995 47766542 3589999999999999999999994 99999999999999999999999999987
Q ss_pred cCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHH---------
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAID--------- 543 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~--------- 543 (692)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 166 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 238 (342)
T cd07879 166 HADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEF 238 (342)
T ss_pred CCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHH
Confidence 5321 1233467889999998865 4688999999999999999999999974332111 111111
Q ss_pred --HhccCcccccccc---cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 544 --RIGRGCVDEIIDP---YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 544 --~~~~~~~~ei~d~---~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+........... ...............++.+|+.+||+.+|++||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0000000000000 000000000001234678999999999999999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=293.02 Aligned_cols=242 Identities=27% Similarity=0.398 Sum_probs=192.4
Q ss_pred CccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 326 FSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
|...++||+|+||+||+|+.. +++.|++|++.... ....+++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 57889999987542 23446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+. ++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 95 6888877654 3468999999999999999999998 499999999999999999999999999986421
Q ss_pred ccccCCCCCCCCCccccc---cCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 482 ISTAPQGTPGYLDPQYHQ---YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
......|+..|+|||++. ...++.++||||||+++|||++|..|+........ . ..+..........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~~--- 242 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNDSPTLQS--- 242 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------H-HHHHhcCCCCCCc---
Confidence 123446889999999874 45688899999999999999999999864322111 1 1111111111111
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
......+.+|+.+||+.+|.+||++.+++
T Consensus 243 --------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 243 --------NEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred --------cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11224578999999999999999999887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.26 Aligned_cols=269 Identities=20% Similarity=0.219 Sum_probs=198.3
Q ss_pred ccCcc-ceeecccccEEEEEEEEe-CCCEEEEEEeecCCchh--------------HHHHHHHHHHHHhCCCCCeeeeEE
Q 005536 324 SFFSE-KHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDS--------------IDQVMNEIKLLSSVSHPNLLRLLG 387 (692)
Q Consensus 324 ~~f~~-~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~H~niv~l~g 387 (692)
++|.. .+.||+|+||+||++... +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999864 58899999987542221 125789999999999999999999
Q ss_pred EEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEe
Q 005536 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVA 467 (692)
Q Consensus 388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 467 (692)
++...+..++||||++ |+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6999988653 458999999999999999999998 499999999999999999999999
Q ss_pred eecCCccCCCC-------------CCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcc
Q 005536 468 DFGLSRLGMTE-------------SSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHS 533 (692)
Q Consensus 468 DFGla~~~~~~-------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~ 533 (692)
|||+++..... .........++..|+|||++.+. .++.++||||||+++|||++|+.||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99998753310 01111233468899999998764 46889999999999999999999987543321
Q ss_pred cccHHHHHHHHhccCcccccc-----------cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 534 EVNLAALAIDRIGRGCVDEII-----------DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~ei~-----------d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.........+......+. .+...............++.+++.+||+.+|++||++.|++
T Consensus 242 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l------- 311 (335)
T PTZ00024 242 ---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL------- 311 (335)
T ss_pred ---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh-------
Confidence 112222222211100000 00000000000012245688999999999999999999887
Q ss_pred hccccc
Q 005536 603 VSSWAS 608 (692)
Q Consensus 603 ~~~~~~ 608 (692)
.++|..
T Consensus 312 ~~~~~~ 317 (335)
T PTZ00024 312 KHEYFK 317 (335)
T ss_pred cCcccC
Confidence 467764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.82 Aligned_cols=267 Identities=21% Similarity=0.270 Sum_probs=197.9
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CC
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE-EG 393 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~-~~ 393 (692)
++..++++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999854 6889999988643 22345678899999999999999999999876 46
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..++|+||+ +++|.+++.. ..+++.....++.|++.||+|||+ .+|+||||+|+|||+++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 6789888764 347888889999999999999999 499999999999999999999999999987
Q ss_pred cCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHH--------HHHHH
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA--------LAIDR 544 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~--------~~~~~ 544 (692)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||............. .+.+.
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5321 1123457889999998765 578999999999999999999999986443211110000 00111
Q ss_pred hccCcccccccccCCcCC---CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 545 IGRGCVDEIIDPYLEPHR---DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 545 ~~~~~~~ei~d~~l~~~~---~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+..+...+++........ ..........+.+++.+||+.+|++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111111111100000000 000011236788999999999999999988876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=288.53 Aligned_cols=240 Identities=20% Similarity=0.222 Sum_probs=185.1
Q ss_pred eecccccEEEEEEEEe-CCCEEEEEEeecCCc---hhHHHHHHHHH---HHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 331 RLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT---DSIDQVMNEIK---LLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
.||+|+||.||+++.. +++.||+|.+..... .....+..|.. +++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999864 478999999875421 22223444544 4445679999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CC
Confidence 99999988653 459999999999999999999999 49999999999999999999999999998753221 12
Q ss_pred ccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 484 TAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
....|+..|+|||.+.+. .++.++||||||+++|||++|+.||.......... ........ +..+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~------~~~~---- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM------AVEL---- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc------CCCC----
Confidence 234689999999998754 68999999999999999999999997543221111 11111110 1111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRP-----TMMEVA 595 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RP-----sm~eVl 595 (692)
+.....++.+++.+||..+|.+|| ++.|++
T Consensus 219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 111235788999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.88 Aligned_cols=266 Identities=22% Similarity=0.283 Sum_probs=198.3
Q ss_pred ChHHHHHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005536 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391 (692)
Q Consensus 315 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~ 391 (692)
...++..++++|...+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 468899999987532 2335678899999999999999999998864
Q ss_pred C------CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceE
Q 005536 392 E------GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSK 465 (692)
Q Consensus 392 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~k 465 (692)
. ...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEE
Confidence 3 3467888887 7899888764 348999999999999999999999 4999999999999999999999
Q ss_pred EeeecCCccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Q 005536 466 VADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDR 544 (692)
Q Consensus 466 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~ 544 (692)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......
T Consensus 161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~ 233 (345)
T cd07877 161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRL 233 (345)
T ss_pred Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHH
Confidence 999999875321 2234467899999998766 56888999999999999999999998643321111 111110
Q ss_pred hccCcccccc---------------cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 545 IGRGCVDEII---------------DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 545 ~~~~~~~ei~---------------d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.. ....++. +................++.+++.+||+.+|.+||++.+++
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 234 VG-TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred hC-CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 00 0000000 00000000000001234678999999999999999988887
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.53 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=198.4
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV 398 (692)
++|...+.||+|+||.||+++.. +++.|++|.+... .....+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999865 6889999998753 2334567889999999998 99999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+++++|.+++... ..+++..++.|+.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999765 3699999999999999999999984 9999999999999999999999999998753322
Q ss_pred CC-------------------cccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHH
Q 005536 479 SS-------------------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA 539 (692)
Q Consensus 479 ~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~ 539 (692)
.. .......++..|++||.+....++.++||||||++++||++|+.|+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~ 229 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------L 229 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------H
Confidence 21 1122345789999999998888999999999999999999999998743311 1
Q ss_pred HHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005536 540 LAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMME 593 (692)
Q Consensus 540 ~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~e 593 (692)
..+.+..... ..+......+.+++.+||+.+|++||++.+
T Consensus 230 -~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 230 -TFQKILKLEY-------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred -HHHHHHhcCC-------------CCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1111111100 011122456889999999999999999933
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.70 Aligned_cols=267 Identities=20% Similarity=0.265 Sum_probs=197.0
Q ss_pred HHHHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG- 393 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~- 393 (692)
.+....++|+..+.||+|+||+||++.. .++..||||++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3455678899999999999999999985 468899999986432 233457889999999999999999999987543
Q ss_pred -----eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEee
Q 005536 394 -----EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVAD 468 (692)
Q Consensus 394 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 468 (692)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEee
Confidence 458999999 7799888764 358999999999999999999999 4999999999999999999999999
Q ss_pred ecCCccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccH--------HH
Q 005536 469 FGLSRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNL--------AA 539 (692)
Q Consensus 469 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~--------~~ 539 (692)
||+++.... ......+++.|++||.+.+ ..++.++||||||+++|+|++|+.||........... ..
T Consensus 162 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999975322 1223467899999998875 4688999999999999999999999864322110000 00
Q ss_pred HHHHHhccCcccccccc--cCC-cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 540 LAIDRIGRGCVDEIIDP--YLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 540 ~~~~~~~~~~~~ei~d~--~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.+.+........... ... .............+.+++.+||+.+|++|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 01111111100000000 000 000000012234678999999999999999999887
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.09 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=202.3
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
.-...|...+.||+|.|++|.+++.. .+..||||.+.+. +....+.+.+|+++|+.|+|||||+++.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567888999999999999999854 4889999998765 33444568999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
||||+.+|.+++||.+.. .+.......+..|+.+|++|||+ +.|+|||||++|||||.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999998764 35558888999999999999999 599999999999999999999999999998643
Q ss_pred CCCcccccCCCCCCCCCccccccCCC-CCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHL-SDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.........|++.|.|||++.+..| .++.|+||+|++||-|+.|..||+...-.+- .++...|+..
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~r----- 273 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKYR----- 273 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeeec-----
Confidence 4455567789999999999988876 4689999999999999999999985432111 1111111110
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.+.-...+.-+|++++|-.+|.+|++++++.
T Consensus 274 --------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 274 --------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred --------ccceeechhHHHHHHhhccCccccCCHHHhh
Confidence 0111223566899999999999999987775
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=282.28 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=198.7
Q ss_pred ecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 332 LGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
||+|+||.||+++.. +++.+++|.++... ....+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 47899999987543 23566889999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCC
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 487 (692)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 9999765 358999999999999999999999 599999999999999999999999999997643221 2234556
Q ss_pred CCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 488 GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 488 gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
++..|++||...+...+.++|+||||+++|||++|+.||..... ....+.+.++.. ..+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-------------~~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPL-------------RFPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCC-------------CCCC
Confidence 89999999999888889999999999999999999999864321 111222222111 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
.....+.+++.+||..+|++||++.+ +++++.++|
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~----~~~l~~~~~ 249 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG----AEEIKAHPF 249 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc----HHHHHhCCC
Confidence 12357789999999999999999966 455556665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.02 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=209.5
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
+..-|+..+.||+|.|..|-+++ .-.|..||||++.+.. .....++.+|+.-|+.++|||||+|+.+......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 44567777889999999999887 4579999999997653 33456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCceEEeeecCCccCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~~~~ 477 (692)
+|+-.+|+|++||-+.. ..+.+....+.+.||..|+.|+|+. .++||||||+||.+- .-|-+||.|||++-.+.
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 99999999999998764 5599999999999999999999996 899999999999875 56789999999986532
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCC-ccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSD-KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
.....+...|...|-|||.+.+..|+. +.||||||||||-|++|+.||...+..+-. .-|+|=
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC 234 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC 234 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence 234456678999999999999988874 789999999999999999999754432221 122222
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.-..+.....+..+||..||..||++|.+.+|| ...+|....
T Consensus 235 -----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI-------~s~~Wlq~~ 276 (864)
T KOG4717|consen 235 -----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEI-------VSTSWLQAG 276 (864)
T ss_pred -----cccCchhhhHHHHHHHHHHHhcCchhhccHHHH-------hccccccCC
Confidence 112234556788999999999999999995554 578887543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.34 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=190.4
Q ss_pred cCccceeecccccEEEEEEEEeC---CCEEEEEEeecC--CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC----Ce
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN---DDWVAIKRFRYR--DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE----GE 394 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~----~~ 394 (692)
+|+..+.||+|+||.||+++... +..||+|++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788899999999999998643 678999998643 223356788999999999 599999999976543 35
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788889885 7899988653 458999999999999999999998 4999999999999999999999999999975
Q ss_pred CCCCCC---cccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc----
Q 005536 475 GMTESS---HISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG---- 546 (692)
Q Consensus 475 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~---- 546 (692)
...... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........+.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 332111 11233468999999998765 468899999999999999999999986433211 1111111110
Q ss_pred -------cCccccccc---ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 547 -------RGCVDEIID---PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 547 -------~~~~~ei~d---~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
......... .................+.+++.+||+.+|++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000 0000000000011235788999999999999999998876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=276.33 Aligned_cols=246 Identities=23% Similarity=0.375 Sum_probs=194.9
Q ss_pred ceeecccccEEEEEEEEe-CCCEEEEEEeecC-CchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 329 KHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
...||.|..|.|++.+.. .|...|||.+... +.++.++.+..+.++..-+ .|.||+.+|+|..+...++.||.| .-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 457999999999999865 4789999999765 4566778888888877664 899999999999999999999998 33
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
-++.+|... ..++++...-++...+.+||.||.+. .+|||||+||+|||+|+.|++|++|||++-...+ +...+.
T Consensus 176 C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAhtr 250 (391)
T KOG0983|consen 176 CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAHTR 250 (391)
T ss_pred HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec--cccccc
Confidence 455555544 45699999999999999999999986 7999999999999999999999999999865433 334466
Q ss_pred CCCCCCCCCcccccc---CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 486 PQGTPGYLDPQYHQY---FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~---~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
..|.+.|||||.+.- ..|+.++||||||+.|+||.||+.|+.....+-+ .+..+.+.. -|.+.++
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~e-----PP~L~~~- 318 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEE-----PPLLPGH- 318 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcC-----CCCCCcc-
Confidence 689999999998853 4688899999999999999999999975432211 122222211 1333322
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
+.....+.+++..||+.|+.+||...++++
T Consensus 319 ----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 ----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ----cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 124567899999999999999999999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.64 Aligned_cols=269 Identities=21% Similarity=0.297 Sum_probs=197.6
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC---------
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--------- 392 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--------- 392 (692)
..+|...+.||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468899999999999999999864 5789999999877666778899999999999999999999876543
Q ss_pred -----CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCceEE
Q 005536 393 -----GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKV 466 (692)
Q Consensus 393 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl 466 (692)
...++||||++ ++|.+++.. ..+++...+.++.|++.||.|||+. +|+||||||+||+++ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 689888754 3489999999999999999999984 999999999999997 4567899
Q ss_pred eeecCCccCCCCCCc--ccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHH
Q 005536 467 ADFGLSRLGMTESSH--ISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 467 ~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~ 543 (692)
+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....+..... ...+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LILE 233 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHH
Confidence 999999753221111 1123457889999997644 568889999999999999999999996443321110 0010
Q ss_pred Hhcc-----------CcccccccccCCcC--CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 544 RIGR-----------GCVDEIIDPYLEPH--RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 544 ~~~~-----------~~~~ei~d~~l~~~--~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.... .............. ..........++.+++.+||+.+|++||++.|++ .++|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell-------~h~~~~ 304 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL-------MHPYMS 304 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh-------CCCccc
Confidence 0000 00000000000000 0000012335688999999999999999988887 567765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=305.18 Aligned_cols=272 Identities=22% Similarity=0.291 Sum_probs=201.2
Q ss_pred HhhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCe---
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE--- 394 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~--- 394 (692)
.+.++|+..+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999975 4788999998653 23345677889999999999999999998776554
Q ss_pred ---eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 395 ---PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 395 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6799998865 3589999999999999999999994 999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHH--------HHH
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA--------LAI 542 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~--------~~~ 542 (692)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9753221 234467889999998765 367899999999999999999999986443221110000 000
Q ss_pred HHhccCcccccccccCC---cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 543 DRIGRGCVDEIIDPYLE---PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 543 ~~~~~~~~~ei~d~~l~---~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
.++........+..... ............++.+++.+||+.+|++|||+.||+ .++|....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell-------~h~~~~~~ 304 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL-------AHPYLAEY 304 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh-------cCCCcccc
Confidence 11110000000000000 000000011245788999999999999999998886 56776543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.21 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=192.4
Q ss_pred HHhhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC-chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE----- 392 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~----- 392 (692)
-+....|++.+.||+||||.|||++. -||+.||||++.... ........+|+++|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567788899999999999999984 479999999998653 33455678999999999999999998321100
Q ss_pred --------------------------------------------------------------------------------
Q 005536 393 -------------------------------------------------------------------------------- 392 (692)
Q Consensus 393 -------------------------------------------------------------------------------- 392 (692)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Q 005536 393 ----------------------------------GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438 (692)
Q Consensus 393 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yL 438 (692)
..+||-||||+.-+|.+++..+.... .....++++.+|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 12467889998888888777654221 4667789999999999999
Q ss_pred HhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC------C-----------CCCcccccCCCCCCCCCccccccC
Q 005536 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM------T-----------ESSHISTAPQGTPGYLDPQYHQYF 501 (692)
Q Consensus 439 H~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~aPE~~~~~ 501 (692)
|+. +||||||||.||+||++..+||+|||+|.... . ......+...||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 995 99999999999999999999999999997611 0 011133556799999999998765
Q ss_pred C---CCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHH
Q 005536 502 H---LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAF 578 (692)
Q Consensus 502 ~---~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~ 578 (692)
. |+.|+|+||+||||+||+.- |...- -....+..++++.+.+--| + ..+....=+.++.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM------ERa~iL~~LR~g~iP~~~~--f-------~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLYP---FGTSM------ERASILTNLRKGSIPEPAD--F-------FDPEHPEEASLIR 852 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhcc---CCchH------HHHHHHHhcccCCCCCCcc--c-------ccccchHHHHHHH
Confidence 4 99999999999999999873 43111 1223455666665554311 1 1122233468999
Q ss_pred HhcccCCCCCCCHHHHH
Q 005536 579 RCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 579 ~Cl~~~p~~RPsm~eVl 595 (692)
++++.||.+|||+.|++
T Consensus 853 ~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELL 869 (1351)
T ss_pred HHhcCCCccCCCHHHHh
Confidence 99999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.87 Aligned_cols=271 Identities=25% Similarity=0.347 Sum_probs=202.2
Q ss_pred CccceeecccccEEEEEEE-EeCCCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------CeeEE
Q 005536 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE------GEPIL 397 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~------~~~~l 397 (692)
+...+.||+|+||.||+|+ ...|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+. +.+.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556789999999999999 456999999999864 345667788999999999999999999986543 46899
Q ss_pred EEEeCCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--C--CCceEEeeecCC
Q 005536 398 VYEFMPNGTLCQHLQRERG-SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD--Y--NYRSKVADFGLS 472 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld--~--~~~~kl~DFGla 472 (692)
||||+.+|+|...|.+... ..|++...+.+..+++.||.|||+ ++|+||||||.||++- + .-..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999987543 469999999999999999999998 5999999999999993 2 335799999999
Q ss_pred ccCCCCCCcccccCCCCCCCCCcccccc-CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc-
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV- 550 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 550 (692)
|....+ ...+...||..|++||.+.. ..|+...|.|||||++||.+||..||....... +.....+..+.+..-
T Consensus 172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCCc
Confidence 964333 35677899999999999885 789999999999999999999999996433221 111111221111110
Q ss_pred ------cccccccCC----cCCCccCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhhh
Q 005536 551 ------DEIIDPYLE----PHRDAWTLSSIHNVAELAFRCLAFHRDMRP--TMMEVAEELEHIRV 603 (692)
Q Consensus 551 ------~ei~d~~l~----~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP--sm~eVl~~L~~i~~ 603 (692)
.+.-+|... +............+-.....+|..+|++|- ...+...++..|..
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111111000 001112233445566777778888999997 66666666666543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.84 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=200.8
Q ss_pred HHhhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeE
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~ 396 (692)
..++-++....+||.|.||.||-+. +.+|...|+|-++..+ ....+...+|+.++..|+|||+|+.+|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3455677778899999999999998 5568889999987654 334567789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
|.||||++|+|.+.+... +.+++........|++.|++|||++ +||||||||+|||||.+|.+|++|||.|....
T Consensus 1311 IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999999754 4466666677889999999999995 99999999999999999999999999998643
Q ss_pred CCCC---cccccCCCCCCCCCccccccC---CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 477 TESS---HISTAPQGTPGYLDPQYHQYF---HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 477 ~~~~---~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
.... .......||+-|||||++.+. ....+.||||+|||++||+||++||..-.. +++ .+-.+..|..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~a--IMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWA--IMYHVAAGHK 1459 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhH--HHhHHhccCC
Confidence 3211 112345799999999998654 345689999999999999999999963221 111 2233344433
Q ss_pred cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
.. .+.....+-.+++.+||+.||++|-++.|++
T Consensus 1460 Pq------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1460 PQ------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred CC------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 32 3334555678899999999999997776554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=282.75 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=210.0
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEeC------CCEEEEEEeecC-CchhHHHHHHHHHHHHhCCCCCeeeeEEEEE
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~H~niv~l~g~~~ 390 (692)
|+..-..+++..-.+-+|.||.||.|.+.+ .+.|.+|.++.. .+-+...|+.|...+..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 444445667777789999999999997654 345778887654 3445678899999999999999999999997
Q ss_pred eC-CeeEEEEEeCCCCCHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 005536 391 EE-GEPILVYEFMPNGTLCQHLQRER------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR 463 (692)
Q Consensus 391 ~~-~~~~lV~E~~~~gsL~~~l~~~~------~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~ 463 (692)
++ +.++++|.++.-|+|..+|...+ .+.++..+...+|.|++.|++|||++ +|||.||.++|.+||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence 65 67899999999999999998433 23477788899999999999999995 9999999999999999999
Q ss_pred eEEeeecCCccCCCCCCccc-ccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHH
Q 005536 464 SKVADFGLSRLGMTESSHIS-TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALA 541 (692)
Q Consensus 464 ~kl~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~ 541 (692)
+||+|=.++|.....+.+-. ........||+||.+++..|+.++|||||||+||||+| |+.|+..-+|++ .
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m 507 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------M 507 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------H
Confidence 99999999997554444432 33345679999999999999999999999999999999 666654222211 1
Q ss_pred HHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 542 IDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 542 ~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
...+++| .+-..+.++++++..++.-||+..|++||+++|++.-|.+.-
T Consensus 508 ~~ylkdG------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 508 EHYLKDG------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHhcc------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2222222 222345578899999999999999999999999999887753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.31 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=197.9
Q ss_pred hccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV 398 (692)
.++|+..+.||+|.||+|-+.+- ..++.+|+|++++.. .++...-+.|-++|...+||.+..|-..+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36788899999999999999874 458899999998763 44555667899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||..||.|+-||.+. +.+++......-.+|..||.|||+ ++||.||||.+|+|||.+|.+||+|||+++.....
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999999875 448888888888999999999999 59999999999999999999999999999864332
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
........|||.|+|||++....|....|.|.+||++|||++|+.||.......-. +.+-. .++
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-------eLIl~---ed~----- 385 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-------ELILM---EDL----- 385 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-------HHHHh---hhc-----
Confidence 33445678999999999999999999999999999999999999999743321111 11110 111
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP 589 (692)
..+.....+...|+...|..||.+|.
T Consensus 386 -----kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 -----KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11222334667889999999999995
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=272.47 Aligned_cols=268 Identities=23% Similarity=0.325 Sum_probs=211.5
Q ss_pred ChHHHHHhhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeC
Q 005536 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEE 392 (692)
Q Consensus 315 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~ 392 (692)
+++++-+.|+ +.||+|+|+.|--.+ +.++..+|||++.+.......+..+|++++.+.+ |+||++|+++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566666664 479999999998776 6789999999998887778889999999999996 99999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---ceEEeee
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY---RSKVADF 469 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DF 469 (692)
...|||||-|.||.|..+|++. ..+++.++-++..+||.||.|||. ++|.||||||+|||-.+.. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999875 458999999999999999999999 5999999999999996554 4899999
Q ss_pred cCCccCC--C----CCCcccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhCCcccCCCCC-------
Q 005536 470 GLSRLGM--T----ESSHISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRP------- 531 (692)
Q Consensus 470 Gla~~~~--~----~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~------- 531 (692)
.|+.-.. . ........+.|...|||||+.. ...|+.+.|.||||||||-|++|.+||.....
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 9874311 1 1122234567999999999742 23578899999999999999999999964322
Q ss_pred -cccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 532 -HSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 532 -~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
..-..-.....+.|++|.. |+.|+ +| .....+..+|+...|..++.+|.++.+++ .++|..
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-eFPdk-------dW-ahIS~eakdlisnLlvrda~~rlsa~~vl-------nhPw~~ 365 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-EFPDK-------DW-AHISSEAKDLISNLLVRDAKQRLSAAQVL-------NHPWVQ 365 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-cCChh-------hh-HHhhHHHHHHHHHHHhccHHhhhhhhhcc-------CCcccc
Confidence 1112223455666776643 22222 22 23456778899999999999999988887 566654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=298.03 Aligned_cols=266 Identities=19% Similarity=0.214 Sum_probs=185.0
Q ss_pred hhccCccceeecccccEEEEEEEE-----------------eCCCEEEEEEeecCCchhHHHH--------------HHH
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL-----------------HNDDWVAIKRFRYRDTDSIDQV--------------MNE 370 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 370 (692)
..++|+..++||+|+||+||+|.+ .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2346799999975543333333 346
Q ss_pred HHHHHhCCCCCe-----eeeEEEEEe--------CCeeEEEEEeCCCCCHHHHHhhccC---------------------
Q 005536 371 IKLLSSVSHPNL-----LRLLGCCIE--------EGEPILVYEFMPNGTLCQHLQRERG--------------------- 416 (692)
Q Consensus 371 ~~il~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 416 (692)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+...+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677887753 3568999999999999999975321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCCCc
Q 005536 417 -SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP 495 (692)
Q Consensus 417 -~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aP 495 (692)
..++|..+..|+.|++.+|+|||+ .+|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 125678899999999999999999 4999999999999999999999999999975332222122223458999999
Q ss_pred cccccCC----------------------CCCccceeehhHHHHHHHhCCc-ccCCCCCccc-c---cHHHHHHHHhccC
Q 005536 496 QYHQYFH----------------------LSDKSDVYSFGVVLIEIITALK-VVDFSRPHSE-V---NLAALAIDRIGRG 548 (692)
Q Consensus 496 E~~~~~~----------------------~s~ksDV~SfGvll~eLltg~~-p~~~~~~~~~-~---~~~~~~~~~~~~~ 548 (692)
|.+.... ...+.||||+||++|||+++.. |+........ . ......+..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875332 1235799999999999999875 5532111110 0 0000111111111
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHhhhhccccc
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHR---DMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p---~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.. +. ..+ ........+|+.++|..+| .+|+|++|++ .|+|..
T Consensus 460 ~~----~~------~~~-d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL-------~Hp~f~ 504 (507)
T PLN03224 460 KY----DF------SLL-DRNKEAGWDLACKLITKRDQANRGRLSVGQAL-------SHRFFL 504 (507)
T ss_pred CC----Cc------ccc-cccChHHHHHHHHHhccCCCCcccCCCHHHHh-------CCCCcC
Confidence 11 10 000 1123567899999999765 6899999988 677764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=312.61 Aligned_cols=273 Identities=23% Similarity=0.258 Sum_probs=216.9
Q ss_pred hHHHHHhhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE 391 (692)
Q Consensus 316 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~ 391 (692)
..++..-.+.|.+.+.||+|+||.|...+... ++.||+|++++- ......-|..|-.+|..-+.+-|+.|...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 35556667889999999999999999998654 788999999763 23455678999999999999999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
+.++|+|||||+||+|-.+|.+.. .+++..+...+.+|..||.-||+. |+|||||||.|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998764 699999999999999999999996 999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~ 546 (692)
+-....+..-.+...+|||.|++||+++. +.|+...|.||+||++|||+.|..||.... +... ..+|.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveT-Y~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVET-YGKIM 294 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHH-HHHHh
Confidence 87655566666778899999999998752 568899999999999999999999996321 2221 22222
Q ss_pred cCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccccccCC
Q 005536 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYMGS 614 (692)
Q Consensus 547 ~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~~~~s 614 (692)
.- .+. +. ++ ...+.+.+..+||.+.+. +|+.|..-.. +++|+.++|+.++.|.+
T Consensus 295 ~h--k~~----l~--FP-~~~~VSeeakdLI~~ll~-~~e~RLgrng----iedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 295 NH--KES----LS--FP-DETDVSEEAKDLIEALLC-DREVRLGRNG----IEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred ch--hhh----cC--CC-cccccCHHHHHHHHHHhc-Chhhhccccc----HHHHHhCccccCCChhh
Confidence 11 000 10 00 012345677889988886 6777765222 46778999998887644
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=277.13 Aligned_cols=232 Identities=19% Similarity=0.197 Sum_probs=183.5
Q ss_pred cccEEEEEEEEe-CCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhh
Q 005536 335 GAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR 413 (692)
Q Consensus 335 G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 413 (692)
|.+|.||+++.. +++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999854 57899999997542 234555666667799999999999999999999999999999999976
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCC
Q 005536 414 ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493 (692)
Q Consensus 414 ~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 493 (692)
. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+..... ......++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----SCDGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccc----ccccCCcCcccc
Confidence 4 348999999999999999999999 5999999999999999999999999998764322 122335677899
Q ss_pred CccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHH
Q 005536 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNV 573 (692)
Q Consensus 494 aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l 573 (692)
|||.+.+..++.++||||+|+++|||++|+.|+...... +.. .....+ +......+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~-----~~~~~~-------~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INT-----HTTLNI-------PEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccc-----ccccCC-------cccCCHHH
Confidence 999998888999999999999999999998876422110 000 000000 11123567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 005536 574 AELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606 (692)
Q Consensus 574 ~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~ 606 (692)
.+++.+||+.||++||++.+. .++++..++|
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~--~~~~~~~h~~ 236 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVA--GVEDIKSHPF 236 (237)
T ss_pred HHHHHHHccCCHHHhcCCCcc--chHHHHcCCC
Confidence 899999999999999998655 3566667776
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=308.28 Aligned_cols=145 Identities=28% Similarity=0.415 Sum_probs=131.1
Q ss_pred ccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...++||+|+||+||+|... +++.||||+++... ....+++.+|+.++..++|+||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999876 57899999997542 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
||+++++|.+++... ..+++..++.|+.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999764 358899999999999999999999 499999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=286.48 Aligned_cols=243 Identities=25% Similarity=0.358 Sum_probs=196.4
Q ss_pred ceeecccccEEEEEEEE-eCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 329 KHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
.+.||+|.||+||-|+. ++|+.||||.+.+. ......++.+|+.||.+++||.||.|..-|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 46899999999999985 56999999998654 2445588999999999999999999999999999999999999 56
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CceEEeeecCCccCCCCCCcc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN---YRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla~~~~~~~~~~ 482 (692)
+..+.+.......|++..-..++.||+.||.|||. ++|+|.||||+||||... -.+||+|||+||++.... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 66666655555679999999999999999999999 599999999999999543 479999999999854433 3
Q ss_pred cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
...++||+.|+|||++++..|...-|+||.||++|--++|..||..... + .++++. .......
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---I------ndQIQN--------AaFMyPp 785 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---I------NDQIQN--------AAFMYPP 785 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---h------hHHhhc--------cccccCC
Confidence 3567899999999999999999999999999999999999999963322 1 122222 1111122
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..|. +...+..+||...|+..-++|-+..+-+
T Consensus 786 ~PW~-eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 NPWS-EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred Cchh-hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 3332 4456778999999999999999866543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=280.68 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=197.0
Q ss_pred HhhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCC--ch-----hHHHHHHHHHHHHhCCCCCeeeeEEEEE-e
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD--TD-----SIDQVMNEIKLLSSVSHPNLLRLLGCCI-E 391 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~-----~~~~~~~E~~il~~l~H~niv~l~g~~~-~ 391 (692)
...++|-..++||+|||+.|||+. +...+.||||+-.... .+ -.+...+|..|-+.|.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345677788899999999999998 5567889999875431 11 1234678999999999999999999986 5
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCceEEee
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY---NYRSKVAD 468 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~D 468 (692)
.+.++-|+||++|.+|.-||... +.+++.++..|+.||+.||.||.+. +++|||-||||.||||.+ -|.+||.|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 67889999999999999999875 4589999999999999999999985 689999999999999954 47899999
Q ss_pred ecCCccCCCCCCc------ccccCCCCCCCCCccccccC----CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHH
Q 005536 469 FGLSRLGMTESSH------ISTAPQGTPGYLDPQYHQYF----HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538 (692)
Q Consensus 469 FGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~ 538 (692)
|||++....+... ......||.+|++||.+.-+ +.+.|.||||.|||+|..+.|++||.......++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--- 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--- 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---
Confidence 9999985443322 23345799999999976433 5788999999999999999999999754332221
Q ss_pred HHHHHHhccCcc---cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 539 ALAIDRIGRGCV---DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 539 ~~~~~~~~~~~~---~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+.++.+ .|+--| .. .....+...+|++||++..++|.+..+++
T Consensus 694 ------LqeNTIlkAtEVqFP----~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 ------LQENTILKATEVQFP----PK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------HhhhchhcceeccCC----CC----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111 111101 01 11234567899999999999999877665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=273.17 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=196.5
Q ss_pred ceeecccccEEEEEEEE-eCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 329 KHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
...||.|+||+|+|-.. +.|+..|||+++..+. .+.++++.|.+...+- +.||||+++|.+..++..++-||+| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 55799999999999875 4589999999987644 6678899998876655 6999999999999999999999999 56
Q ss_pred CHHHH---HhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcc
Q 005536 406 TLCQH---LQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 406 sL~~~---l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 482 (692)
+|..+ +.......+++...-.|+.-+..||.||.+. -.||||||||+|||||..|.+||+|||++-.. ..+..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL--v~SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL--VDSIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH--HHHHH
Confidence 66443 3333445699999999999999999999986 68999999999999999999999999998642 22334
Q ss_pred cccCCCCCCCCCccccccC--CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCc
Q 005536 483 STAPQGTPGYLDPQYHQYF--HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~ 560 (692)
.+.-.|...|||||.+... .|+-+|||||||++|||+.||+.|+..... ....+..+..|....+..+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l~~~---- 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPILLFD---- 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCeecCc----
Confidence 4566799999999988543 488899999999999999999999864322 1122333444444333222
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 561 ~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.........+..++.-||..|...||...++.+
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111234567889999999999999999988864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=267.78 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=205.0
Q ss_pred hhccCccc-eeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC----Ce
Q 005536 322 ATSFFSEK-HRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEE----GE 394 (692)
Q Consensus 322 ~~~~f~~~-~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~----~~ 394 (692)
+++.|.+. ++||-|-.|.|-.... ..++.+|+|++... ....+|+++-=.. .|||||.+++++... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45555543 5799999999988764 45788999998643 4456788876555 499999999998643 46
Q ss_pred eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCceEEeeecC
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY---NYRSKVADFGL 471 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGl 471 (692)
+++|||.|+||.|+..++......+++.++-.|..||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999998877899999999999999999999996 9999999999999964 55799999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
|+.. ........+.-|+.|.|||++...+|+...|+||+||++|-|++|.+||..... ....--...+|+.|..
T Consensus 211 AK~t--~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy- 284 (400)
T KOG0604|consen 211 AKET--QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQY- 284 (400)
T ss_pred cccc--CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCc-
Confidence 9862 223344667889999999999999999999999999999999999999974322 1222233444544422
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
++ ...+|+ ...+...++++.+|+.+|.+|.|+.|++ .++|..+.
T Consensus 285 ~F-------P~pEWs-~VSe~aKdlIR~LLkt~PteRlTI~~~m-------~hpwi~~~ 328 (400)
T KOG0604|consen 285 EF-------PEPEWS-CVSEAAKDLIRKLLKTEPTERLTIEEVM-------DHPWINQY 328 (400)
T ss_pred cC-------CChhHh-HHHHHHHHHHHHHhcCCchhheeHHHhh-------cCchhccc
Confidence 11 112332 4567788999999999999999977765 78887544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=265.75 Aligned_cols=238 Identities=28% Similarity=0.371 Sum_probs=194.4
Q ss_pred ccEEEEEEEEeC-CCEEEEEEeecCCchh-HHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhh
Q 005536 336 AYGTVYAGKLHN-DDWVAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR 413 (692)
Q Consensus 336 ~fG~Vy~g~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 413 (692)
+||.||+++..+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999998665444 78999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCC
Q 005536 414 ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493 (692)
Q Consensus 414 ~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 493 (692)
... +++..++.++.+++.+|+|||+. +|+|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 533 89999999999999999999994 99999999999999999999999999998643321 234456889999
Q ss_pred CccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHH
Q 005536 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNV 573 (692)
Q Consensus 494 aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l 573 (692)
+||.+....++.++||||||++++||++|..|++.... .....+.+.++........ .....++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~----------~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ------LLELFKKIGKPKPPFPPPE----------WKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhccCCCCcccc----------ccCCHHH
Confidence 99999888899999999999999999999998864211 1122233332221110000 0033578
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 005536 574 AELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 574 ~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+++.+||..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=300.77 Aligned_cols=265 Identities=22% Similarity=0.232 Sum_probs=172.2
Q ss_pred hhccCccceeecccccEEEEEEEEeC-----CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEE------EE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN-----DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC------CI 390 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~------~~ 390 (692)
..++|+..++||+|+||+||+|++.+ +..||||++..... .+.+.+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999999754 57899999864321 1222222 1222223333222221 24
Q ss_pred eCCeeEEEEEeCCCCCHHHHHhhccCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 005536 391 EEGEPILVYEFMPNGTLCQHLQRERGS------------------GLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIK 452 (692)
Q Consensus 391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik 452 (692)
+....+|||||+++++|.++++..... ......+..|+.|++.||+|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 556899999999999999998754210 01233456799999999999999 599999999
Q ss_pred CCceEEcC-CCceEEeeecCCccCCCCCCcccccCCCCCCCCCccccccC----------------------CCCCccce
Q 005536 453 SSNILLDY-NYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF----------------------HLSDKSDV 509 (692)
Q Consensus 453 ~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksDV 509 (692)
|+|||+++ ++.+||+|||+|+..............+|+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986433333344556789999999965322 24456799
Q ss_pred eehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc-----cccccccCCcC----CCccCHHHHHHHHHHHHHh
Q 005536 510 YSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV-----DEIIDPYLEPH----RDAWTLSSIHNVAELAFRC 580 (692)
Q Consensus 510 ~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~ei~d~~l~~~----~~~~~~~~~~~l~~L~~~C 580 (692)
|||||+||||+++..+.+.. + ..+...+..... ...+.+..... .+.. ........+|+.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~dLi~~m 433 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------L-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVL-DLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------H-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhc-cccchHHHHHHHHH
Confidence 99999999999976543311 0 011111111000 00111100000 0000 00112456899999
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 581 LAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 581 l~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
|+.||++|||++|++ .++|...
T Consensus 434 L~~dP~kR~ta~e~L-------~Hpff~~ 455 (566)
T PLN03225 434 MRFKGRQRISAKAAL-------AHPYFDR 455 (566)
T ss_pred ccCCcccCCCHHHHh-------CCcCcCC
Confidence 999999999999887 5777653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=267.92 Aligned_cols=202 Identities=26% Similarity=0.385 Sum_probs=167.2
Q ss_pred ccCccceeecccccEEEEEEEEeC-----CCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCee
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-----DDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIE-EGEP 395 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~-~~~~ 395 (692)
..|+....||+|.||.|||+.-.+ ...+|||+++.... .-.....+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457888899999999999996433 23689999986522 223457799999999999999999999988 6789
Q ss_pred EEEEEeCCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC----CceEEee
Q 005536 396 ILVYEFMPNGTLCQHLQRER---GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN----YRSKVAD 468 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~D 468 (692)
+|++||.+. +|.+.++-.+ ...++......|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 8888887543 2459999999999999999999999 489999999999999777 8999999
Q ss_pred ecCCccCCCCCC--cccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCC
Q 005536 469 FGLSRLGMTESS--HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFS 529 (692)
Q Consensus 469 FGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~ 529 (692)
||++|++...-. .....++-|..|.|||.+.+. +||.+.|||+.|||+.||+|.++.|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999998543221 223455679999999987765 7999999999999999999998887643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.75 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=198.3
Q ss_pred hhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~ 399 (692)
.+..|.....+|.|+|+.|-+... .+++..+||++... ..+-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356777788899999999988874 45788999999755 23344677777666 6999999999999999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-cCCCceEEeeecCCccCCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL-DYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILl-d~~~~~kl~DFGla~~~~~~ 478 (692)
|.+.++-|.+.+.... .....+..|+.+++.|+.|||+ ++++||||||+|||+ ++.++++|+|||.++....+
T Consensus 396 e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998888776643 2236777899999999999999 499999999999999 58899999999999864333
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
.....-|..|.|||+.....|++++|+||||++||||++|+.|+...... .....+++.+...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc-------
Confidence 33446688999999999999999999999999999999999999754332 2334555544332
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWA 607 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~ 607 (692)
....+...+|+.+||+.||.+||+|.++. .++|.
T Consensus 533 --------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~-------~h~w~ 566 (612)
T KOG0603|consen 533 --------ECVSDEAKDLLQQLLQVDPALRLGADEIG-------AHPWF 566 (612)
T ss_pred --------cccCHHHHHHHHHhccCChhhCcChhhhc-------cCcch
Confidence 23445778999999999999999987765 78887
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=275.87 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=196.6
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV 398 (692)
..|.....||+|+||.|.++..+. .+.+|||++++. ..++.+--+.|-++|... +-|.++++..++...+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 457788899999999999997544 567999999865 234455566788888776 578999999999999999999
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
|||+.+|+|--+++.. ..+.+..+...|.+||-||-+||+ ++||.||||..|||||.+|.+||+|||+++....+
T Consensus 429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999875 347777888999999999999999 59999999999999999999999999999863332
Q ss_pred CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l 558 (692)
. .......|||.|+|||.+...+|+...|.|||||+||||+.|++||+.....+ + .+.|.+
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l----F~aI~e----------- 564 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L----FQAIME----------- 564 (683)
T ss_pred C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H----HHHHHH-----------
Confidence 2 23355689999999999999999999999999999999999999998543221 1 122211
Q ss_pred CcCCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP 589 (692)
+.-.++.....+..++....|..+|.+|.
T Consensus 565 --hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 --HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11223445667888999999999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=287.58 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=212.1
Q ss_pred CCChHHHHHhhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEE
Q 005536 313 FYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCI 390 (692)
Q Consensus 313 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~ 390 (692)
...++.+...++-|++.+.||.|.+|.||+++ .++++.+|||++... .+..++...|..+|+.+ .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34555666677889999999999999999998 567888999988754 44556777899999988 5999999999986
Q ss_pred e-----CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceE
Q 005536 391 E-----EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSK 465 (692)
Q Consensus 391 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~k 465 (692)
- +++++||||||.+|+..|+++...+..+.|..+.-|+.+++.||.+||. ..++|||||-.||||+.++.+|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEE
Confidence 3 5789999999999999999998878889999999999999999999999 4899999999999999999999
Q ss_pred EeeecCCccCCCCCCcccccCCCCCCCCCccccccC-----CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHH
Q 005536 466 VADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF-----HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540 (692)
Q Consensus 466 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~ 540 (692)
|.|||++.... ..........||+.|||||++... .|+.++|+||||++..||--|.+|+-...| ..
T Consensus 164 LvDFGvSaQld-sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mr 235 (953)
T KOG0587|consen 164 LVDFGVSAQLD-STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MR 235 (953)
T ss_pred Eeeeeeeeeee-cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hh
Confidence 99999997633 233344556899999999997543 477789999999999999999998753332 11
Q ss_pred HHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 541 ~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
++=.+.++....+ ..+....+++.++|..||..|.++||++.++++
T Consensus 236 aLF~IpRNPPPkL----------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ALFLIPRNPPPKL----------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhccCCCCCCccc----------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1222222222111 123455678999999999999999999998874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=270.20 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=201.3
Q ss_pred HHhhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCC-C-C----CeeeeEEEEEeC
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-H-P----NLLRLLGCCIEE 392 (692)
Q Consensus 320 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H-~----niv~l~g~~~~~ 392 (692)
...+++|.+...+|+|.||.|-....+. +..||||+++.. ..-.+..+-|+++|.++. + | -+|++.+|+.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3447889999999999999999886543 688999999754 334456678999999994 3 2 378889999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC------------
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY------------ 460 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~------------ 460 (692)
++.+||+|.+ |-+++++|..+...+++...+..|+.|++++++|||+. +++|-||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 67999999998778899999999999999999999995 9999999999999932
Q ss_pred --------CCceEEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCc
Q 005536 461 --------NYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPH 532 (692)
Q Consensus 461 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~ 532 (692)
+..+||+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||+||.||...|......
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3468999999998632222 5567899999999999999999999999999999999999988755422
Q ss_pred ccccHHHHHH--------HHh------ccCccc--c---------cccccCC-cCCCccCHHHHHHHHHHHHHhcccCCC
Q 005536 533 SEVNLAALAI--------DRI------GRGCVD--E---------IIDPYLE-PHRDAWTLSSIHNVAELAFRCLAFHRD 586 (692)
Q Consensus 533 ~~~~~~~~~~--------~~~------~~~~~~--e---------i~d~~l~-~~~~~~~~~~~~~l~~L~~~Cl~~~p~ 586 (692)
+.....+.+. .+. .+|+++ + +.++-.. .........+..++.+|+.+||.+||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 2111111111 000 011111 0 0000000 000001123455799999999999999
Q ss_pred CCCCHHHHH
Q 005536 587 MRPTMMEVA 595 (692)
Q Consensus 587 ~RPsm~eVl 595 (692)
+|+|+.|++
T Consensus 396 ~RiTl~EAL 404 (415)
T KOG0671|consen 396 RRITLREAL 404 (415)
T ss_pred ccccHHHHh
Confidence 999999887
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=236.54 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=194.8
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCch--hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+|+..++||+|.||+||||+..+ ++.||+|+++..+.+ --....+|+-+|+.++|+|||++++....+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667789999999999999554 788999999866432 235678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 481 (692)
+ ..+|..+..... ..++......++.|+++||.+.|++ .+.|||+||+|.|++.+|+.|++|||+++.+... ..
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VR 156 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eE
Confidence 9 568888877654 4589999999999999999999995 8999999999999999999999999999864322 22
Q ss_pred ccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHHHhccCcc---cccccc
Q 005536 482 ISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCV---DEIIDP 556 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ei~d~ 556 (692)
.....+-|..|.+|.++.+. -|+...|+||-|+++.||.. |++.|......++.....+......+... ..+.|-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 33445679999999988766 57888999999999999997 44445433322222222222222222211 122222
Q ss_pred cCCcCCC---ccC---HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 557 YLEPHRD---AWT---LSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 557 ~l~~~~~---~~~---~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
...+.+. .|+ ......=.+|..+.|.-+|.+|.++++.+
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 2211111 111 11112345788888888999999988776
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-31 Score=276.45 Aligned_cols=258 Identities=20% Similarity=0.258 Sum_probs=209.2
Q ss_pred ceeecccccEEEEEEEEeCCC-EEEEEEeecC---CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 329 KHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
...||-||||.|=+.+..... .+|+|.+++. +..+.+....|-.||-..+.|.||+++-.+.+....|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 457999999999998876544 3788877654 566777888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|.|+..|.+. ..++......++..+.+|++|||+ ++||.|||||+|.|||.+|.+||.|||+|+... .....-
T Consensus 505 GElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~KTw 577 (732)
T KOG0614|consen 505 GELWTILRDR--GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRKTW 577 (732)
T ss_pred chhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc--cCCcee
Confidence 9999999875 458888888999999999999999 499999999999999999999999999998643 333445
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...|||.|.|||.+.+...+..+|.||||+++|||++|.+||....+-.. .+.+-+|- | .-+
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkGi-----d------~i~ 639 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKGI-----D------KIE 639 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhhh-----h------hhh
Confidence 66899999999999999999999999999999999999999986554322 22232221 0 012
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccccccC
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYMG 613 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~~~~ 613 (692)
++........+|+++..+.+|.+|.-. .-.-+.+|+++.|+.+..+.
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~--~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGY--QKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhcc--ccCChHHHHhhhhhhcCChh
Confidence 233344567889999999999999752 12234678899999876543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=254.18 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=208.5
Q ss_pred hccCccceeecccccEEEEEEEEe-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~l 397 (692)
.+.|+..+.||+|+|.+|..+++. ..+.+|+|++++. +.++++..+.|-.+..+. +||.+|-|..|+..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999865 4678999999864 456778888999998877 69999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
|.||+++|+|.-++++. +.|+++.+.....+|..||.|||+ ++||.||||..|+|||..+.+||.|+|+.+....
T Consensus 329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999999888875 459999999999999999999999 5999999999999999999999999999987443
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcc-cccHHHHHHHHhccCcccccccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHS-EVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ei~d~ 556 (692)
. ........|||.|+|||.+.+..|....|.|++||+++||+.|+.||+.-.... +.+...+..+.+-+.
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-------- 474 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-------- 474 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--------
Confidence 3 344456789999999999999999999999999999999999999998543221 222223333333221
Q ss_pred cCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~ 608 (692)
.+. .+....-+...+++.-|+.||.+|..-.--. -+..|+.++...
T Consensus 475 qir-----iprslsvkas~vlkgflnkdp~erlgc~~~~-g~~dik~h~ffr 520 (593)
T KOG0695|consen 475 QIR-----IPRSLSVKASHVLKGFLNKDPKERLGCRPQT-GFSDIKSHAFFR 520 (593)
T ss_pred ccc-----ccceeehhhHHHHHHhhcCCcHHhcCCCccc-chhhhhcchhhh
Confidence 111 0111223456788899999999985321100 344555554443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=239.29 Aligned_cols=202 Identities=27% Similarity=0.438 Sum_probs=167.5
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecC-CchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEE
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E 400 (692)
+.......||+|++|.|-+-++ .+|+..|+|+++.. +.+..++.++|+.+..+- ..|.+|.++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444466799999999988774 56899999999865 455667888999987665 69999999999999999999999
Q ss_pred eCCCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 401 FMPNGTLCQHLQR--ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 401 ~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
.| .-+|..+-.+ .++..+++...-+||..+.+||.|||+. -.+||||+||+|||++.+|++|++|||++-...
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-- 200 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV-- 200 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence 99 5677665543 2356799999999999999999999997 589999999999999999999999999986532
Q ss_pred CCcccccCCCCCCCCCcccccc----CCCCCccceeehhHHHHHHHhCCcccCCCC
Q 005536 479 SSHISTAPQGTPGYLDPQYHQY----FHLSDKSDVYSFGVVLIEIITALKVVDFSR 530 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SfGvll~eLltg~~p~~~~~ 530 (692)
++-..+...|...|||||.+.. ..|+-||||||||+.+.||.+++.|++...
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2222344578899999998643 368899999999999999999999997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-31 Score=254.39 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=193.2
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc--hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--------C
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE--------G 393 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~g~~~~~--------~ 393 (692)
.|....+||+|.||.||+++..+ ++.||+|+.-..++ .--...++|+++|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 34556789999999999998554 67789887654322 2234567999999999999999999988532 2
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 473 (692)
..+||+.+++. +|.-.|... ...++..++.+++.++..||.|+|.. .|+|||+|++|+||+.++.+||+|||+++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 48999999964 787777543 34589999999999999999999995 99999999999999999999999999997
Q ss_pred cCCCCC---CcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc
Q 005536 474 LGMTES---SHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 474 ~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 549 (692)
.+.... ....+..+-|..|.+||.+.+. .|+++.|||.-||++.||.|+.+.+..........+.......+....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 643221 1223455679999999987654 799999999999999999999887765544333333333222222221
Q ss_pred ccccccccCCcCC--C-------ccCHHHH------HHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 VDEIIDPYLEPHR--D-------AWTLSSI------HNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 ~~ei~d~~l~~~~--~-------~~~~~~~------~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..++..-.+.... + ..-.+.. ++.++|+.+++..||.+|+++.+++
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 1111110000000 0 0001111 2678999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.33 Aligned_cols=207 Identities=26% Similarity=0.382 Sum_probs=175.6
Q ss_pred hhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
-...|...+.||-|+||.|.++...| ...+|.|.+++.+ .........|-+||...+.+-||+|+..|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34678889999999999999987444 5679999998764 3455667889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC-
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM- 476 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~- 476 (692)
||||++||++-.+|.+. ..+.+..+...+.++..|+++.|.. |+|||||||.|||||.+|.+||.||||+.=+.
T Consensus 707 VMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999999875 4478888888889999999999996 99999999999999999999999999973100
Q ss_pred -------CCCCc---------------------------------ccccCCCCCCCCCccccccCCCCCccceeehhHHH
Q 005536 477 -------TESSH---------------------------------ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516 (692)
Q Consensus 477 -------~~~~~---------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll 516 (692)
....| .....+||+.|+|||++....++.-.|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00000 00123599999999999999999999999999999
Q ss_pred HHHHhCCcccCCCCCcc
Q 005536 517 IEIITALKVVDFSRPHS 533 (692)
Q Consensus 517 ~eLltg~~p~~~~~~~~ 533 (692)
|||+.|+.||....+.+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999998766644
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=281.85 Aligned_cols=245 Identities=28% Similarity=0.376 Sum_probs=185.8
Q ss_pred ccCccceeecccccEE-EEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 324 SFFSEKHRLGTGAYGT-VYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~-Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.-|...+.+|.|.-|+ ||+|.. +++.||||++-. +-.+-..+|+..|..- +|||||++++.-.+.+..||..|.
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 3466667899999986 799987 678999999863 3334567899999887 599999999988888999999999
Q ss_pred CCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-----CCceEEeeecCCcc
Q 005536 402 MPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-----NYRSKVADFGLSRL 474 (692)
Q Consensus 402 ~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DFGla~~ 474 (692)
| ..+|.+++... ......-...+.+..|+++||++||+. +||||||||.||||+- ..+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 67999999874 111122134567889999999999996 9999999999999975 35899999999987
Q ss_pred CCCCCCcc--cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhC-CcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 475 GMTESSHI--STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA-LKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 475 ~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
...+.... .....||.||+|||.+....-+.+.||||+|+|+|..++| ..||...-.. +. .|..+...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~--------NIl~~~~~ 731 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QA--------NILTGNYT 731 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hh--------hhhcCccc
Confidence 54433322 3456799999999999998888899999999999999986 7888632110 00 01111110
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
++ .+.+. .++ +..+||.+|+.++|..||++.+|+
T Consensus 732 --L~-~L~~~-----~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 732 --LV-HLEPL-----PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred --ee-eeccC-----chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 00 01110 011 678999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=239.26 Aligned_cols=210 Identities=35% Similarity=0.569 Sum_probs=183.5
Q ss_pred ecccccEEEEEEEEeC-CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHH
Q 005536 332 LGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQ 409 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 409 (692)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999765 889999999865432 45789999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeecCCccCCCCCCcccccCCC
Q 005536 410 HLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRLGMTESSHISTAPQG 488 (692)
Q Consensus 410 ~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 488 (692)
++.... ..+++..++.++.+++++|+|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987642 4589999999999999999999994 9999999999999999 89999999999976332211 2334568
Q ss_pred CCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCH
Q 005536 489 TPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567 (692)
Q Consensus 489 t~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~ 567 (692)
...|++||.+... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999998877 888999999999999999
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005536 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597 (692)
Q Consensus 568 ~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~ 597 (692)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=237.93 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=173.5
Q ss_pred CccceeecccccEEEEEEEEeC-CCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCC
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
|...+.||+|++|+||+++..+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999876 789999999866544 67889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCccc
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 483 (692)
+++|.+++..... .+++..+..++.+++.+|.|||+. +++|+||+++||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999986532 289999999999999999999994 999999999999999999999999999986443321122
Q ss_pred ccCCCCCCCCCcccc-ccCCCCCccceeehhHHHHHHHhCCcccCC
Q 005536 484 TAPQGTPGYLDPQYH-QYFHLSDKSDVYSFGVVLIEIITALKVVDF 528 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~-~~~~~s~ksDV~SfGvll~eLltg~~p~~~ 528 (692)
....++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 344678899999998 667788899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=245.40 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=198.1
Q ss_pred ccceeecccccEEEEEEEE-eCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----CeeEEE
Q 005536 327 SEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-----GEPILV 398 (692)
Q Consensus 327 ~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~-----~~~~lV 398 (692)
+..+.||-|+||.||..+. ++|+.||.|++... +-...+.+.+|+++|..++|.|++..++..... .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3467899999999998875 46899999998643 234567889999999999999999999876543 357788
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 478 (692)
+|.| ..+|...+.. ...|+-+...-+..||++||+|||+. +|.||||||.|.|++.|-.+||+|||++|.-..+
T Consensus 136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 8888 4577666654 35688888889999999999999995 9999999999999999999999999999975445
Q ss_pred CCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHH-----HHhc---cCc
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI-----DRIG---RGC 549 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~-----~~~~---~~~ 549 (692)
....++..+-|..|.|||.+++. +|+.+.||||.|+++.||+.++..|....|..+..+....+ +.++ +|.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 55555666678999999998765 79999999999999999999999988777766554442221 1111 221
Q ss_pred ccccccccCC-cCCC-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005536 550 VDEIIDPYLE-PHRD-----AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598 (692)
Q Consensus 550 ~~ei~d~~l~-~~~~-----~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L 598 (692)
...++....+ +... .-+...-.+...+..+++.++|++|.+..+.+.-+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1112111111 0000 00012224556788899999999999988776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=245.99 Aligned_cols=272 Identities=22% Similarity=0.337 Sum_probs=200.8
Q ss_pred ccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC-----C---CCeeeeEEEEEeC--
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-----H---PNLLRLLGCCIEE-- 392 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----H---~niv~l~g~~~~~-- 392 (692)
.+|.+.++||-|.|+|||++.. .+.+.||+|+.+.. ..-.+..+.||++|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6789999999999999999974 45678999998743 344566789999999984 2 4799999999754
Q ss_pred --CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---------
Q 005536 393 --GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN--------- 461 (692)
Q Consensus 393 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~--------- 461 (692)
.+.++|+|++ |-+|..+|....-+.++.....+|+.||+.||.|||..| +|||-||||+||||-.+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 5899999999 889999999887788999999999999999999999986 99999999999998210
Q ss_pred --C-----------------------------------------------------------------------------
Q 005536 462 --Y----------------------------------------------------------------------------- 462 (692)
Q Consensus 462 --~----------------------------------------------------------------------------- 462 (692)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------ce
Q 005536 463 ------------------------------------------------------------------------------RS 464 (692)
Q Consensus 463 ------------------------------------------------------------------------------~~ 464 (692)
.+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 01
Q ss_pred EEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCc---ccccHHHHH
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPH---SEVNLAALA 541 (692)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~---~~~~~~~~~ 541 (692)
||+|||-|.... +..+.-..|..|.|||++.+..|+..+|||||+|++|||+||-..|+...-. .+.+..+.+
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 222222222100 1112223577899999999999999999999999999999999988632211 112222223
Q ss_pred HHHhc--------cCc-cccccccc--------CC--------cCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 542 IDRIG--------RGC-VDEIIDPY--------LE--------PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 542 ~~~~~--------~~~-~~ei~d~~--------l~--------~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
++.++ .|+ ..++++.. |+ -..-.|+.+...++.+++.-||+.+|++|||+.+.+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl- 548 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL- 548 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh-
Confidence 33222 121 12232221 00 012346678889999999999999999999999887
Q ss_pred HHHhhhhccccccc
Q 005536 597 ELEHIRVSSWASNI 610 (692)
Q Consensus 597 ~L~~i~~~~~~~~~ 610 (692)
.++|....
T Consensus 549 ------~hPwLn~~ 556 (590)
T KOG1290|consen 549 ------KHPWLNPV 556 (590)
T ss_pred ------cCccccCC
Confidence 68887644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=226.99 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=189.8
Q ss_pred hccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeC--CeeEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEE--GEPILV 398 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~--~~~~lV 398 (692)
.++|+..+++|+|.|+.||.|. ..+++.++||.+++ -..+...+|++||..|+ ||||++|++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999998 45678899999984 45567889999999998 99999999998765 468899
Q ss_pred EEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CceEEeeecCCccCCC
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLSRLGMT 477 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~ 477 (692)
+||+.|.+...+. ..|+...+.....|++.||.|+|+. ||+|||+||.|+++|.. ..++|+|+|+|.+...
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999887776544 2367777888899999999999995 99999999999999965 5799999999987433
Q ss_pred CCCcccccCCCCCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCc-------
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC------- 549 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 549 (692)
.. .....+.+..|--||.+-.. .|+..-|+||||++|.+|+..+.||-......+ .+. .....++...
T Consensus 186 ~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLV-kIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLV-KIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHH-HHHHHhChHHHHHHHHH
Confidence 22 12333456677899987554 577889999999999999999999864433221 111 1111111000
Q ss_pred ccccccccCCcC-----CCccC--------HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 550 VDEIIDPYLEPH-----RDAWT--------LSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 550 ~~ei~d~~l~~~-----~~~~~--------~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
..-.+|+..... +..|. .-...+..+|+.+.|..|-.+|||++|.+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 000122222110 00110 01125788999999999999999999886
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=237.53 Aligned_cols=262 Identities=24% Similarity=0.289 Sum_probs=193.3
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecC--CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE------ 392 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~------ 392 (692)
...+|...+.+|.|.- .|-.+. .-.++.||+|++... +....++..+|..++..++|+|+++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777788899988 444443 234788999998644 344567788999999999999999999998643
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
...++||||| ..+|.+.++.. ++-.+...|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 3689999999 67999888733 77888899999999999999995 9999999999999999999999999999
Q ss_pred ccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHH--------HHHHHH
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA--------ALAIDR 544 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~--------~~~~~~ 544 (692)
+.. +.....+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|......++.... ..+.++
T Consensus 166 r~e--~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTE--DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccc--CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 852 2224567778899999999998888999999999999999999999888633221111110 011111
Q ss_pred hc-------c-------Ccccccc-cccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 545 IG-------R-------GCVDEII-DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 545 ~~-------~-------~~~~ei~-d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+. + -...+.+ |....... +.+.-......+|+.+||..+|++|-+.++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~-e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVL-EGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccc-cCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 11 0 0111111 11111111 11112234678899999999999999988876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=255.44 Aligned_cols=195 Identities=25% Similarity=0.294 Sum_probs=166.0
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCc--------hhHHHHHHHHHHHHhCC---CCCeeeeEEEEEeC
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDT--------DSIDQVMNEIKLLSSVS---HPNLLRLLGCCIEE 392 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~---H~niv~l~g~~~~~ 392 (692)
.|...+.||+|+||.|+.+..+. ...|+||.+.+..- ...-..-.|++||..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47888999999999999998655 56789998875421 11112446999999997 99999999999999
Q ss_pred CeeEEEEEeC-CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecC
Q 005536 393 GEPILVYEFM-PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 393 ~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 471 (692)
+.+||+||-. ++.+|++++..+ ..+++.+...|..|++.|+++||+ ++|||||||-+|+.+|.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 9999999986 456899999764 459999999999999999999999 5999999999999999999999999999
Q ss_pred CccCCCCCCcccccCCCCCCCCCccccccCCCCC-ccceeehhHHHHHHHhCCcccC
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD-KSDVYSFGVVLIEIITALKVVD 527 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDV~SfGvll~eLltg~~p~~ 527 (692)
|.+. .+......+||.+|.|||++.+.+|-- .-|||++|++||.++....|+.
T Consensus 717 aa~~---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYT---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhh---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8652 233445678999999999999988754 5899999999999999888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=222.10 Aligned_cols=255 Identities=17% Similarity=0.246 Sum_probs=189.5
Q ss_pred hccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEE-EEeCCeeEEEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGC-CIEEGEPILVY 399 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~-~~~~~~~~lV~ 399 (692)
.+.|.+.+.||+|.||.+-++..+. .+.+++|.+... ....++|.+|...--.| .|.||+.-++. |...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678889999999999999998654 567888888654 45678899998876666 49999998875 45667888999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCceEEeeecCCccCCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD--YNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DFGla~~~~~ 477 (692)
||+|.|+|..-+.. ..+.+..-.+++.|+++||.|||+ +.++|||||.+|||+- +..++||+|||+.+....
T Consensus 102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999887765 348888889999999999999999 5999999999999992 345899999999874211
Q ss_pred CCCcccccCCCCCCCCCcccccc-----CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQY-----FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~e 552 (692)
.......+..|.+||.... ....+.+|||.||++++.++||..||... ...+.... -+.++..+....
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~--~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYW--EWEQWLKRKNPA 248 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHH--HHHHHhcccCcc
Confidence 1122335678999997532 24567899999999999999999999732 22223333 333444443332
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~ 600 (692)
+.+. .. ...+.+.++.++-|..++++|-...++.++-..
T Consensus 249 ~P~~-----F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 249 LPKK-----FN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred Cchh-----hc----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 2221 11 123467788999999999999666666555433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=248.24 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=200.1
Q ss_pred hhccCccceeecccccEEEEEEEE-eCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E 400 (692)
..+.|+..+++|.|.||.|||++. ..++..|||.++....+...-.++|+-+++.-+|+|||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345678889999999999999984 4588999999998877788888899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
|+.+|+|.+.-+-. .++++.++-...++..+||+|||+. +=+|||||-.|||+++.+.+|++|||.+-.+.. .-
T Consensus 93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TI 166 (829)
T ss_pred ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hh
Confidence 99999998866543 5688889999999999999999994 889999999999999999999999999865322 22
Q ss_pred cccccCCCCCCCCCcccc---ccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccccc
Q 005536 481 HISTAPQGTPGYLDPQYH---QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~ 557 (692)
.......||+.|||||+. +.+.|..++|||+.|+...||---++|...-. ...+...+.+. .+++-
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTkS----~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTKS----GFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhcc----CCCCC
Confidence 233456799999999974 45678999999999999999987766643211 11122222221 11221
Q ss_pred CCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
-..+... ..+.+-++++.+|-.+|++||+++.++
T Consensus 236 ~lkDk~k----ws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 236 TLKDKTK----WSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cccCCcc----chHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1112222 335678899999999999999988654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=239.07 Aligned_cols=274 Identities=21% Similarity=0.213 Sum_probs=206.9
Q ss_pred CChHHHHHhhccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCC------CCCeeeeE
Q 005536 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS------HPNLLRLL 386 (692)
Q Consensus 314 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------H~niv~l~ 386 (692)
|.+.-.+....+|.+....|+|-|++|..|.... ++.||||+++.. +.-.+.=+.|++||++|+ .-|.++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4445556677889999999999999999998543 779999999854 233345578999999996 35899999
Q ss_pred EEEEeCCeeEEEEEeCCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-Cce
Q 005536 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERG-SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRS 464 (692)
Q Consensus 387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-~~~ 464 (692)
-.|...++++||+|.+ ..+|.+.|.+... -.|........+.|+.-||..|... +|+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 9999999999999998 6799999987643 3488888999999999999999985 99999999999999876 568
Q ss_pred EEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHH--
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI-- 542 (692)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~-- 542 (692)
||+|||.|...... ..+...-...|.|||++.+.+|+..-|+||.||.||||.||+..|..........+.+...
T Consensus 577 KLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 577 KLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99999998653222 2233344568999999999999999999999999999999999997654433332222211
Q ss_pred ---HHhccCcc-cccccccC----------------------Cc------------CCCccCHHHHHHHHHHHHHhcccC
Q 005536 543 ---DRIGRGCV-DEIIDPYL----------------------EP------------HRDAWTLSSIHNVAELAFRCLAFH 584 (692)
Q Consensus 543 ---~~~~~~~~-~ei~d~~l----------------------~~------------~~~~~~~~~~~~l~~L~~~Cl~~~ 584 (692)
.++++|.+ +.-+|..+ .+ ......+..+..+.+|+.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 11222211 11111110 11 011223456778999999999999
Q ss_pred CCCCCCHHHHH
Q 005536 585 RDMRPTMMEVA 595 (692)
Q Consensus 585 p~~RPsm~eVl 595 (692)
|++|.|..+.+
T Consensus 734 P~KRit~nqAL 744 (752)
T KOG0670|consen 734 PEKRITVNQAL 744 (752)
T ss_pred hhhcCCHHHHh
Confidence 99999988876
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=272.04 Aligned_cols=195 Identities=19% Similarity=0.241 Sum_probs=139.7
Q ss_pred hCCC-CCeeeeEEEE-------EeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 005536 376 SVSH-PNLLRLLGCC-------IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447 (692)
Q Consensus 376 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~ii 447 (692)
.++| +||+++++++ .+.+.+++++||+ +++|.++|... ...+++..++.++.||++||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4556 6888888887 3335678889988 67999999754 3459999999999999999999998 5999
Q ss_pred ecCCCCCceEEcC-------------------CCceEEeeecCCccCCCCCC---------------cccccCCCCCCCC
Q 005536 448 HRDIKSSNILLDY-------------------NYRSKVADFGLSRLGMTESS---------------HISTAPQGTPGYL 493 (692)
Q Consensus 448 HrDik~~NILld~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~Y~ 493 (692)
||||||+||||+. ++.+||+|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566667776653110000 0011235889999
Q ss_pred CccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHH
Q 005536 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNV 573 (692)
Q Consensus 494 aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l 573 (692)
|||++.+..++.++|||||||+||||++|..|+.... .....+... .+.+.. .....+.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~----~~~~~~--------~~~~~~~ 241 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHR----VLPPQI--------LLNWPKE 241 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHh----hcChhh--------hhcCHHH
Confidence 9999999999999999999999999999877754110 011111111 011100 0112345
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 005536 574 AELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 574 ~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
.+++.+||+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=225.70 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=193.7
Q ss_pred HHHhhccCccceeecccccEEEEEEEEeC----CCEEEEEEeecCCchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCC
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEG 393 (692)
Q Consensus 319 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~ 393 (692)
+....+.|...++||+|.|++||++++.. ++.||+|.+... ..-....+|++.|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33455678889999999999999998543 578999999764 33456889999999996 999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCceEEeeecCC
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLS 472 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla 472 (692)
+..+|+||++...-.+++.. ++...+......+..||+++|+ +|||||||||+|+|.+. .+.-.|.|||+|
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 99999999999888887754 6678888899999999999999 59999999999999975 467889999998
Q ss_pred ccCCC-------CC--------------------------C----------cccccCCCCCCCCCccccc-cCCCCCccc
Q 005536 473 RLGMT-------ES--------------------------S----------HISTAPQGTPGYLDPQYHQ-YFHLSDKSD 508 (692)
Q Consensus 473 ~~~~~-------~~--------------------------~----------~~~~~~~gt~~Y~aPE~~~-~~~~s~ksD 508 (692)
..... .. . ......+||+||.|||++. ....+++.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 61000 00 0 0011235999999999865 456788999
Q ss_pred eeehhHHHHHHHhCCcccCCCCCcccccHHHHHH----HHh-----ccCc--c---------ccccc-------ccCCc-
Q 005536 509 VYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI----DRI-----GRGC--V---------DEIID-------PYLEP- 560 (692)
Q Consensus 509 V~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~----~~~-----~~~~--~---------~ei~d-------~~l~~- 560 (692)
|||-|||++-+++++.||-.....-+ .+.+.+. ..+ -.|+ + .+... ..+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999964332211 1111000 000 0111 0 00000 00000
Q ss_pred -----CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 561 -----HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 561 -----~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
....+.......+.+|..+|+..||.+|-|++|.+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 11112222234688999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=208.96 Aligned_cols=171 Identities=20% Similarity=0.214 Sum_probs=128.3
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|+|.+++... +..++|..++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999764 35699999999999999999999994 3 999999999999999 9998763221
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
...||+.|+|||++.+..++.++||||||+++|||+||+.|+....... .........+... ++.. ..
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~----~~ 130 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRD----RS 130 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Cccc----cc
Confidence 1268999999999999999999999999999999999999986432211 1111111111110 0000 00
Q ss_pred cCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 005536 565 WTLSSIH--NVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 565 ~~~~~~~--~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~ 605 (692)
....... ++.+++.+||+.+|++||++.|+++.+..+....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 0112222 6899999999999999999999999888775543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=218.49 Aligned_cols=261 Identities=19% Similarity=0.194 Sum_probs=197.5
Q ss_pred cCccceeecccccEEEEEEEEeCC--CEEEEEEeecCCchhHHHHHHHHHHHHhCCC----CCeeeeEEEE-EeCCeeEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHND--DWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH----PNLLRLLGCC-IEEGEPIL 397 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~H----~niv~l~g~~-~~~~~~~l 397 (692)
+|...++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986553 4788888776533333378889999998873 6899999998 47778999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-----CceEEeeecCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-----YRSKVADFGLS 472 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-----~~~kl~DFGla 472 (692)
||+.+ +.+|.++........++..+.++|+.|++.+|.+||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 88999987665556799999999999999999999995 99999999999999865 46999999999
Q ss_pred c--cCCCCCCc--c-----cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHH
Q 005536 473 R--LGMTESSH--I-----STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 473 ~--~~~~~~~~--~-----~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~ 543 (692)
+ ........ . .....||..|.++..+.+...+.+.|+||++.++.|++.|..||..........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~------- 247 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS------- 247 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH-------
Confidence 8 32222211 1 123459999999999999999999999999999999999999985433222211
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
.+.+......... .. .....++.++...+-..+..++|....+...|++....
T Consensus 248 ~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR-----FG---DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHhhhhcccc-----cc---CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111111111111 00 11223455555556668999999999999998887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=223.37 Aligned_cols=171 Identities=19% Similarity=0.126 Sum_probs=131.8
Q ss_pred hHHHHHhhccCccceeecccccEEEEEEEEe--CCCEEEEEEeecC-----CchhHHHHHHHHHHHHhCCCCCeeeeEEE
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLH--NDDWVAIKRFRYR-----DTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388 (692)
Q Consensus 316 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~H~niv~l~g~ 388 (692)
-.......++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|++..+..
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 3444556678999999999999999999864 4677899987533 12235678999999999999999853332
Q ss_pred EEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEEcCCCceEEe
Q 005536 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDI-KSSNILLDYNYRSKVA 467 (692)
Q Consensus 389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDi-k~~NILld~~~~~kl~ 467 (692)
.+..+|||||+++++|.. +... . ...++.+++++|+|||+ ++|+|||| ||+|||++.++.+||+
T Consensus 90 ---~~~~~LVmE~~~G~~L~~-~~~~-----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHL-ARPH-----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred ---cCCcEEEEEccCCCCHHH-hCcc-----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEE
Confidence 246799999999999963 2111 1 14678899999999999 49999999 9999999999999999
Q ss_pred eecCCccCCCCCCc-------ccccCCCCCCCCCccccccC
Q 005536 468 DFGLSRLGMTESSH-------ISTAPQGTPGYLDPQYHQYF 501 (692)
Q Consensus 468 DFGla~~~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~ 501 (692)
|||+|+........ ..+...+++.|++||++...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999864332211 11355788999999987544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-24 Score=206.94 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=190.7
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCC--chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCC
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGT 406 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 406 (692)
..+|.+...|..|+|++..+. +++|+++..+ ....++|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346888999999999997654 6777776542 3345679999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec-CCCCCceEEcCCCceEEeeecCCccCCCCCCccccc
Q 005536 407 LCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR-DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTA 485 (692)
Q Consensus 407 L~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHr-Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 485 (692)
|+..|+...+-.++..+..++|.++|+|++|||+. .+++-| -|.+..+++|++.+++|+= +-.++ +.....
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~g 345 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEVG 345 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheec-cccee-----eeeccc
Confidence 99999987666688889999999999999999997 355544 6899999999999988751 11111 111122
Q ss_pred CCCCCCCCCccccccCCCC---CccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCC
Q 005536 486 PQGTPGYLDPQYHQYFHLS---DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562 (692)
Q Consensus 486 ~~gt~~Y~aPE~~~~~~~s---~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~ 562 (692)
..-.|.||+||.++..+-+ ...|+|||+++||||.|+..||..-.+-+-- ++ + .+.+.+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mk-i-----------aleglr 407 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MK-I-----------ALEGLR 407 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hh-h-----------hhcccc
Confidence 3457889999998876544 3689999999999999999999644332110 00 0 011122
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 563 ~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
...+......+.+|+.-|...||.+||.+..|+-.||+++
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2233445567889999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-21 Score=200.27 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=197.7
Q ss_pred CccceeecccccEEEEEEEEeCCCEEEEEEeecCCch---hHHHHHHHHHHHHhCCCC-CeeeeEEEEEeCCeeEEEEEe
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD---SIDQVMNEIKLLSSVSHP-NLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~H~-niv~l~g~~~~~~~~~lV~E~ 401 (692)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 78999999765332 477899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-ceEEeeecCCccCCCCC
Q 005536 402 MPNGTLCQHLQRERG-SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLGMTES 479 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~ 479 (692)
+.+++|.+++..... ..+.......+..|++.++.|+|+. +++|||+||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976665421 2588999999999999999999995 899999999999999998 79999999997533322
Q ss_pred Cc-----ccccCCCCCCCCCcccccc---CCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 480 SH-----ISTAPQGTPGYLDPQYHQY---FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 480 ~~-----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
.. ......||..|++||.+.+ ...+...|+||+|++++++++|..|+...... .......+.+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 21 2456689999999999987 57888999999999999999999996543321 0111122222221111
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~ 597 (692)
.. ..... ..........+.+++..++..+|..|.++.+....
T Consensus 234 ~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SL-ASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc-ccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 00000 00001223567889999999999999998887754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=193.31 Aligned_cols=263 Identities=17% Similarity=0.201 Sum_probs=204.8
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~ 399 (692)
.--+|.+.++||+|.||..+.|+ +-+++.||||.-.. ..+..++..|....+.|. .++|...+.+..++.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34579999999999999999998 67899999998654 344567888988888885 799999999989988999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-----CceEEeeecCCcc
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-----YRSKVADFGLSRL 474 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-----~~~kl~DFGla~~ 474 (692)
|++ |-+|+|++.-. ++.++..+...||.|++.-++|+|+. .+|.|||||+|+||..- ..+.|.|||+|+.
T Consensus 104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 999 88999877654 57799999999999999999999994 99999999999999643 4689999999987
Q ss_pred CCCCCCcc------cccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccC
Q 005536 475 GMTESSHI------STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 475 ~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
..+..+.. ....-||.+||+-..+.+...+.+.|.-|+|-+++..|-|..||..-..... ..-.++|++.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn----K~kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN----KEKYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch----HHHHHHhccc
Confidence 55433322 2345699999999999999999999999999999999999999974332211 1223444432
Q ss_pred cccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005536 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 549 ~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~ 603 (692)
.-.- ...+.....+++++.-+.-.-..+-++-|+.+-+...+..+-.
T Consensus 255 Kr~T--------~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 255 KRST--------PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred cccC--------CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2111 1112223345666676666677788889999888777766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=182.92 Aligned_cols=262 Identities=18% Similarity=0.236 Sum_probs=203.0
Q ss_pred hhccCccceeecccccEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCeeEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-~niv~l~g~~~~~~~~~lV~ 399 (692)
...+|...++||.|+||.+|.|. ..+|..||||.-... ....++.-|.++...|+| ..|..+..+..+.+.-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999998 667999999986543 344567889999999975 78888888889999999999
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CceEEeeecCCccCC
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN---YRSKVADFGLSRLGM 476 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla~~~~ 476 (692)
|.+ +.+|++++.-. .+.++..+.+.+|-|++.-++|+|. +++|||||||+|+|..-+ ..+.++|||+|+...
T Consensus 91 dLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 88999988754 3558999999999999999999999 599999999999999644 468999999998644
Q ss_pred CCCC--c----ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcc
Q 005536 477 TESS--H----ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 477 ~~~~--~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (692)
+..+ | ......||.+|.+-..+.+...+.+.|+-|+|.+|..+.-|..||..-........ .+++.+...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK----yEkI~EkK~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK----YEKISEKKM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH----HHHHHHhhc
Confidence 3222 2 23455699999998888888889999999999999999999999975544333222 223322222
Q ss_pred cccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.-.+ +......+.++.-.+.-|-...-++-|+..-+-+.++-+.
T Consensus 242 s~~i--------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 242 STPI--------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred CCCH--------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111 1122234457777888898888899999887777666554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=187.57 Aligned_cols=172 Identities=13% Similarity=0.081 Sum_probs=134.0
Q ss_pred hhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHH---H------HHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSID---Q------VMNEIKLLSSVSHPNLLRLLGCCIEE 392 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~il~~l~H~niv~l~g~~~~~ 392 (692)
..++|...+.||.|+||.||.... ++..+|||.++........ . |.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 568899999999999999999655 5778999999765332222 2 67999999999999999999986643
Q ss_pred --------CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 393 --------GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 393 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
...+|||||++|.+|.++.. ++. ....+++.+|..||+. +++|||+||+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35789999999999988732 222 3456999999999994 999999999999999988 9
Q ss_pred EEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHh
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521 (692)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLlt 521 (692)
+|+|||.......+... ..+.....+..++|+|+||+.+.-+..
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988653221111 013334456679999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=182.98 Aligned_cols=138 Identities=17% Similarity=0.150 Sum_probs=108.1
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCch--h-------HHH-----------------HHHHHHHHHhCCCCCe
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD--S-------IDQ-----------------VMNEIKLLSSVSHPNL 382 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~il~~l~H~ni 382 (692)
...||+|+||.||+|...+|+.||||+++..... . ... ..+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 112 2349999999988877
Q ss_pred eeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceEEcCC
Q 005536 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL-HSAMNPPIYHRDIKSSNILLDYN 461 (692)
Q Consensus 383 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yL-H~~~~~~iiHrDik~~NILld~~ 461 (692)
........ ...+|||||++++++...+.. ...+++.....++.|++.+|.|| |+ .+|+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 54433322 234899999988877654332 24588999999999999999999 56 4999999999999998 4
Q ss_pred CceEEeeecCCcc
Q 005536 462 YRSKVADFGLSRL 474 (692)
Q Consensus 462 ~~~kl~DFGla~~ 474 (692)
+.++|+|||+|..
T Consensus 154 ~~v~LiDFG~a~~ 166 (190)
T cd05147 154 GKLYIIDVSQSVE 166 (190)
T ss_pred CcEEEEEcccccc
Confidence 7899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=218.79 Aligned_cols=260 Identities=22% Similarity=0.246 Sum_probs=189.1
Q ss_pred ccceeecccccEEEEEEEEe-CCCEEEEEEeec---CC--ch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 327 SEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRY---RD--TD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 327 ~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~---~~--~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
...+.+|.|++|.|+..... .....+.|.++. .. .. ....+..|+.+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34668999999977766533 333344444331 11 11 1122667888888999999988887777666555669
Q ss_pred EeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC-
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE- 478 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~- 478 (692)
||+++ +|+.++... ..++...+..+..|+..|++|||+. +|.|||||++|++++.++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999998764 3588888899999999999999995 9999999999999999999999999998764322
Q ss_pred --CCcccccCCCCCCCCCccccccCCCCCc-cceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccccccc
Q 005536 479 --SSHISTAPQGTPGYLDPQYHQYFHLSDK-SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 479 --~~~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d 555 (692)
.........|...|+|||.+.+..|.+. .||||.|+++..|++|+.||.......... .+....+....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~--- 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNI--- 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccc---
Confidence 2255567789999999999999999875 899999999999999999997554433221 00000000000
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccc
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~~ 610 (692)
...........+.+...++.++|+.+|.+|-||++|+ ...|...+
T Consensus 547 ---~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~-------~d~W~~~i 591 (601)
T KOG0590|consen 547 ---FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL-------NDEWIRSI 591 (601)
T ss_pred ---ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh-------hChHhhhc
Confidence 0011111234456778899999999999999988877 56676533
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=175.90 Aligned_cols=140 Identities=14% Similarity=0.159 Sum_probs=111.0
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCch--h------------------------HHHHHHHHHHHHhCCCCCe
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD--S------------------------IDQVMNEIKLLSSVSHPNL 382 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~il~~l~H~ni 382 (692)
...||+|+||.||+|+..+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999878999999999865211 0 1224578999999999988
Q ss_pred eeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 383 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
.....+... ..+|||||++++++....... ..++.....+++.|++.+|.+||+. .+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CC
Confidence 555444333 348999999888654432222 3477888999999999999999983 3999999999999999 88
Q ss_pred ceEEeeecCCccC
Q 005536 463 RSKVADFGLSRLG 475 (692)
Q Consensus 463 ~~kl~DFGla~~~ 475 (692)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=198.29 Aligned_cols=219 Identities=25% Similarity=0.410 Sum_probs=166.6
Q ss_pred HHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 005536 374 LSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKS 453 (692)
Q Consensus 374 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~ 453 (692)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+... ...++|.....+..+++.||+|||+. +-.+|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 35688999999999999999999999999999999999873 46699999999999999999999995 3339999999
Q ss_pred CceEEcCCCceEEeeecCCccCCC-CCCcccccCCCCCCCCCccccccC-------CCCCccceeehhHHHHHHHhCCcc
Q 005536 454 SNILLDYNYRSKVADFGLSRLGMT-ESSHISTAPQGTPGYLDPQYHQYF-------HLSDKSDVYSFGVVLIEIITALKV 525 (692)
Q Consensus 454 ~NILld~~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDV~SfGvll~eLltg~~p 525 (692)
+|.++|..+.+||+|||+..+... ..........-..-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999876432 111111222245679999987663 246789999999999999999999
Q ss_pred cCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 005536 526 VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~ 604 (692)
|+......+. .....+++++ ....+-|.+... . +..+++..++.+||..+|.+||++++|-..++.+...
T Consensus 158 ~~~~~~~~~~---~eii~~~~~~-~~~~~rP~i~~~----~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDP---DEIILRVKKG-GSNPFRPSIELL----N-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCCh---HHHHHHHHhc-CCCCcCcchhhh----h-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9864443332 2222223331 112222222211 0 3334788999999999999999999999988887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-20 Score=213.03 Aligned_cols=252 Identities=19% Similarity=0.204 Sum_probs=185.5
Q ss_pred cCccceeecccccEEEEEEEEeCCCEEEEEEeecCC-chhHHHHHHHHHH--HHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD-TDSIDQVMNEIKL--LSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-~~~~~~~~~E~~i--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++...+.||.+.|=+|.+++.++|. |+||++-+.+ .-..+.|.++++- ...++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677788999999999999988887 9999987665 3345555544433 4556899999998887777788999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc--CCCCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTES 479 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~--~~~~~ 479 (692)
+. -+|+|.|... ..|...+...||.|++.||...|.. +|+|||||.+||||+.-.-+.|+||..-+. .+.++
T Consensus 103 vk-hnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 84 5898888643 4478888899999999999999995 999999999999999999999999987654 22222
Q ss_pred Ccc----cccCCCCCCCCCcccccc----------CC-CCCccceeehhHHHHHHHh-CCcccCCCCCcccccHHHHHHH
Q 005536 480 SHI----STAPQGTPGYLDPQYHQY----------FH-LSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 480 ~~~----~~~~~gt~~Y~aPE~~~~----------~~-~s~ksDV~SfGvll~eLlt-g~~p~~~~~~~~~~~~~~~~~~ 543 (692)
... .........|+|||.+.. .. ++++.||||+||+++||++ |+++|+ +.+.+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLAY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHhH
Confidence 221 222334568999997643 12 7789999999999999998 577775 3333222
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
++|. .......+....+ ..+.+|+..|++.||++|.++++.++.-+++.
T Consensus 248 --r~~~-~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 --RSGN-ADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred --hccC-ccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 2221 1100111111111 14678999999999999999999998866554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=170.39 Aligned_cols=184 Identities=16% Similarity=0.148 Sum_probs=138.3
Q ss_pred ccceeecccccEEEEEEEEeCCCEEEEEEeecCCch----hHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEEe
Q 005536 327 SEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD----SIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 327 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.+...|++|+||+||.+.. ++..++.+.+.....- ....|.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997655 6777888877654221 1225889999999995 5889999886 346999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEEcCCCceEEeeecCCccCCCCCC
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDI-KSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDi-k~~NILld~~~~~kl~DFGla~~~~~~~~ 480 (692)
+++.+|.+.+.. ....++.|++.+|+++|+. +|+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 1135778999999999994 9999999 79999999999999999999985332221
Q ss_pred c----c--------cccCCCCCCCCCccccccC-CCC-CccceeehhHHHHHHHhCCcccC
Q 005536 481 H----I--------STAPQGTPGYLDPQYHQYF-HLS-DKSDVYSFGVVLIEIITALKVVD 527 (692)
Q Consensus 481 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~s-~ksDV~SfGvll~eLltg~~p~~ 527 (692)
. . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 1122378899999854322 223 46789999999999999987653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=170.12 Aligned_cols=137 Identities=21% Similarity=0.225 Sum_probs=107.7
Q ss_pred CccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-----CCCCeeeeEEEEEeCC---e-eE
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-----SHPNLLRLLGCCIEEG---E-PI 396 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~H~niv~l~g~~~~~~---~-~~ 396 (692)
....+.||+|+||.||. ..+....+||+.........+++.+|+.+++.+ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 333333479988766555667899999999999 5799999999998873 3 34
Q ss_pred EEEEe--CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceEEcC----CCceEEeee
Q 005536 397 LVYEF--MPNGTLCQHLQRERGSGLPWTIRITIATETAQAI-AYLHSAMNPPIYHRDIKSSNILLDY----NYRSKVADF 469 (692)
Q Consensus 397 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL-~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~DF 469 (692)
+|+|| .++++|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999653 25555 35677888777 999994 9999999999999974 348999995
Q ss_pred cCC
Q 005536 470 GLS 472 (692)
Q Consensus 470 Gla 472 (692)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=178.11 Aligned_cols=232 Identities=18% Similarity=0.207 Sum_probs=152.0
Q ss_pred cCccceeecccccEEEEEEEEeC-CCEEEEEEeecCC---chhHHHHHHHHHHHHhCCC----------CCeeeeEEEEE
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSH----------PNLLRLLGCCI 390 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H----------~niv~l~g~~~ 390 (692)
.+...+.||.|+++.||.++..+ ++.+|||.+.... ....+++.+|.-.+..+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 44557789999999999999765 7899999987553 2356777777766655433 12222222221
Q ss_pred ---------eC---C-----eeEEEEEeCCCCCHHHHHhh---ccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 005536 391 ---------EE---G-----EPILVYEFMPNGTLCQHLQR---ERG--SGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448 (692)
Q Consensus 391 ---------~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~--~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiH 448 (692)
.. . ..+++|+-+ .++|.+.+.. ... ..+....++.+..|+++.+++||+. +++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 235677777 6788887543 211 1245666788889999999999995 9999
Q ss_pred cCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCCCcccccc--------CCCCCccceeehhHHHHHHH
Q 005536 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY--------FHLSDKSDVYSFGVVLIEII 520 (692)
Q Consensus 449 rDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDV~SfGvll~eLl 520 (692)
+||||+|+|++++|.++|+||+....... .... ...+..|.+||.... -.++.+.|.|++|++||.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654211 1111 345678999997533 35788999999999999999
Q ss_pred hCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCC
Q 005536 521 TALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMR 588 (692)
Q Consensus 521 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~R 588 (692)
+++.|++...+...... ....+. +.++.+.+|+..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~-----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999985543222111 222334 677889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.5e-19 Score=191.63 Aligned_cols=231 Identities=25% Similarity=0.266 Sum_probs=178.8
Q ss_pred ecccccEEEEEEE----EeCCCEEEEEEeecCCch--hHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 332 LGTGAYGTVYAGK----LHNDDWVAIKRFRYRDTD--SIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 332 LG~G~fG~Vy~g~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+|+|.||.|+..+ ...+..+|.|.+++.... .......|..++...+ ||.+|++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999998653 344677898888754211 1125567888898887 99999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccc
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 484 (692)
|.|...+... ...+.........++|-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++........
T Consensus 82 g~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 82 GDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred chhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 9999888764 3456666666778999999999996 9999999999999999999999999999874433221
Q ss_pred cCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCc
Q 005536 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564 (692)
Q Consensus 485 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~ 564 (692)
.||..|||||++. .....+|.||||++.+||+||-.||.. ....+|.+. .-.
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~-------------~~~ 205 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA-------------ELE 205 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh-------------ccC
Confidence 7999999999998 567799999999999999999988863 112222110 112
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHH
Q 005536 565 WTLSSIHNVAELAFRCLAFHRDMRPTM--MEVAEEL 598 (692)
Q Consensus 565 ~~~~~~~~l~~L~~~Cl~~~p~~RPsm--~eVl~~L 598 (692)
.+.+.......++..++..+|..|.-. ..+.+.+
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 234555667788889999999999654 3444433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=196.37 Aligned_cols=202 Identities=19% Similarity=0.239 Sum_probs=162.5
Q ss_pred ChHHHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC---CCCeeeeEEEEEe
Q 005536 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS---HPNLLRLLGCCIE 391 (692)
Q Consensus 315 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---H~niv~l~g~~~~ 391 (692)
+..+.+.-...|.+.+.||+|+||+||+|...+++.||+|+-+..+. -+|.-=.+++.+|+ -+-|..+..++.-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 33455556678899999999999999999988899999999876532 22333334444454 3445555555666
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-------CCCce
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-------YNYRS 464 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld-------~~~~~ 464 (692)
.+.-+||+||.+.|||.+++.. .+.++|...+.++.|++..+.+||.. +|||+||||.|.||. ++..+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 7778999999999999999984 35699999999999999999999995 999999999999993 34569
Q ss_pred EEeeecCCccCCC-CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCc
Q 005536 465 KVADFGLSRLGMT-ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALK 524 (692)
Q Consensus 465 kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~ 524 (692)
+|+|||.+..+.. .........++|.++--+|...+..++.+.|.|.|+.+++-||.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999864221 22345567789999999999999999999999999999999999954
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-17 Score=163.96 Aligned_cols=134 Identities=20% Similarity=0.294 Sum_probs=114.3
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCch--------hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD--------SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
+.||+|++|.||+|.. ++..|++|+....... ...++.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 234678999999999999998888888788889999999
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
+++++|.+++.... + .+..++.+++.+|++||+. +++|||++|.|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 7889999999999999994 999999999999999 78999999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.6e-17 Score=185.18 Aligned_cols=139 Identities=22% Similarity=0.291 Sum_probs=113.7
Q ss_pred HhhccCccceeecccccEEEEEEEEeCCCEEEEEEe-ecC-C------chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005536 321 KATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRF-RYR-D------TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE 392 (692)
Q Consensus 321 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~ 392 (692)
.....|...++||+|+||+||+|.+.+.. +++|+. ... . ....+++.+|++++.+++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 34455667889999999999999876554 444432 211 1 11235688999999999999999988888887
Q ss_pred CeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
...++||||+++++|.+++. .+..++.+++.+|+|||+ .+|+||||||+|||+ +++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 78899999999999999885 346799999999999999 499999999999999 6779999999999
Q ss_pred cc
Q 005536 473 RL 474 (692)
Q Consensus 473 ~~ 474 (692)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-17 Score=165.23 Aligned_cols=140 Identities=16% Similarity=0.138 Sum_probs=110.5
Q ss_pred cCccceeecccccEEEEEEE--EeCCCEEEEEEeecCCch------------------------hHHHHHHHHHHHHhCC
Q 005536 325 FFSEKHRLGTGAYGTVYAGK--LHNDDWVAIKRFRYRDTD------------------------SIDQVMNEIKLLSSVS 378 (692)
Q Consensus 325 ~f~~~~~LG~G~fG~Vy~g~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~il~~l~ 378 (692)
.|+..+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 567999999999754210 0123568999999997
Q ss_pred CC--CeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCc
Q 005536 379 HP--NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP-IYHRDIKSSN 455 (692)
Q Consensus 379 H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~-iiHrDik~~N 455 (692)
+. .+.+++++ ...++||||+++.+|...+... ..+.......++.|++.+|++||+. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 34455543 2358999999998887655332 2355666789999999999999995 8 9999999999
Q ss_pred eEEcCCCceEEeeecCCcc
Q 005536 456 ILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 456 ILld~~~~~kl~DFGla~~ 474 (692)
|+++ ++.++|+|||.+..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.6e-17 Score=159.04 Aligned_cols=130 Identities=22% Similarity=0.307 Sum_probs=107.8
Q ss_pred eecccccEEEEEEEEeCCCEEEEEEeecCCc--------hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT--------DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.||+|+||+||+|.+ ++..|++|....... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 677899998654311 12356789999999999887766666666777789999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
++++|.+++.... . .++.+++.+|++||+. +++|||++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875431 0 7899999999999994 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=158.32 Aligned_cols=142 Identities=19% Similarity=0.147 Sum_probs=111.4
Q ss_pred HHHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCch----------------------hHHHHHHHHHHHH
Q 005536 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD----------------------SIDQVMNEIKLLS 375 (692)
Q Consensus 318 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~ 375 (692)
++......|...+.||+|+||.||++...+++.||||+++..... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444447778899999999999999888999999987643210 1123677899999
Q ss_pred hCCCC--CeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 005536 376 SVSHP--NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKS 453 (692)
Q Consensus 376 ~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~ 453 (692)
.+.|+ .+++.++ ....++||||+++++|.+.... .....++.+++.++.++|+ .+|+||||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence 99887 4555544 2456899999999998765431 2346788999999999999 4999999999
Q ss_pred CceEEcCCCceEEeeecCCcc
Q 005536 454 SNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 454 ~NILld~~~~~kl~DFGla~~ 474 (692)
+||++++++.++|+|||++..
T Consensus 154 ~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred ccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-18 Score=180.45 Aligned_cols=174 Identities=24% Similarity=0.366 Sum_probs=131.3
Q ss_pred eeEEEEEeCCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 394 EPILVYEFMPNGTLCQHLQRER-GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
.+++.|+++...+|.+||.+.+ ....+|...+.++.|++.|+.| ++.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997443 4468899999999999999999 38999999999999999999999999998
Q ss_pred ccCCCCC-----CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc
Q 005536 473 RLGMTES-----SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 473 ~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
....... ....+...||..||+||.+.+.+|+.|+||||||++|+||++- |. ... ....+..-++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~--T~~----er~~t~~d~r~ 474 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FS--TQF----ERIATLTDIRD 474 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hc--cHH----HHHHhhhhhhc
Confidence 6533332 2234666799999999999999999999999999999999982 11 100 11122333444
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eV 594 (692)
|.+++.+- .+++ +=..|+.+++.+.|.+||++.++
T Consensus 475 g~ip~~~~-------~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 GIIPPEFL-------QDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CCCChHHh-------hcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 43331110 1111 22578999999999999955444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=162.72 Aligned_cols=181 Identities=21% Similarity=0.179 Sum_probs=124.9
Q ss_pred eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE--cCCC--ceEEeee
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL--DYNY--RSKVADF 469 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILl--d~~~--~~kl~DF 469 (692)
.+|+||... .-+|.++|..+. .+...+.-|..|+++|..|||.+ +|.|||+|+.|||| |+|. .+.|+||
T Consensus 317 tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 317 TLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred eEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEccc
Confidence 568899887 459999997643 56667778888999999999995 99999999999999 4444 5789999
Q ss_pred cCCccCCC-----CCCcccccCCCCCCCCCccccccCC------CCCccceeehhHHHHHHHhCCcccCCCCCcccccHH
Q 005536 470 GLSRLGMT-----ESSHISTAPQGTPGYLDPQYHQYFH------LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538 (692)
Q Consensus 470 Gla~~~~~-----~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~ 538 (692)
|.+--... ..........|...-||||+....+ --.|+|.|+.|.+.||+++...||..... .-.+..
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r 468 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTR 468 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechh
Confidence 97642111 0001112234777889999875432 12489999999999999999999974211 111111
Q ss_pred HHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005536 539 ALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599 (692)
Q Consensus 539 ~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~ 599 (692)
. +++..+ ...+...+..+.+|+...|+.||.+|++..-.+..|.
T Consensus 469 ~-----Yqe~qL------------Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 469 T-----YQESQL------------PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred h-----hhhhhC------------CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1 111111 1222334457889999999999999998776555443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=141.59 Aligned_cols=135 Identities=20% Similarity=0.198 Sum_probs=115.6
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH--PNLLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
+.+.||+|.++.||+++..+ ..+++|....... ..++.+|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999755 7799999865433 5678999999999976 59999999888888899999999887
Q ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 406 TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 406 sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.+..+ +......++.+++.+|++||.....+++|+|++|+|||+++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5567788999999999999986445799999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=137.07 Aligned_cols=86 Identities=31% Similarity=0.677 Sum_probs=65.5
Q ss_pred CccccccCCCCCCCceeeccCCCCCCCC----ceEeecCC--Cc--ce--ecEEEEEeec--cEEEEeeC--CCccCCCC
Q 005536 22 ADLCDRTCRNGKSTKRVPYPFGFSPGCA----IRLTCANA--TV--KI--GEFEVQNVTA--DSIFVNLP--TKCHRQIT 87 (692)
Q Consensus 22 ~~~C~~~CG~~~~~~~ipYPFg~~~~C~----f~l~C~~~--~~--~~--~~~~v~~i~~--~~~~v~~~--~~C~~~~~ 87 (692)
+++|+++|| |++||||||++++|+ |+|+|+++ .+ ++ ++|+|++|++ .+++|..+ ..|+....
T Consensus 1 ~~~C~~~CG----nv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~~ 76 (106)
T PF13947_consen 1 KPGCPSSCG----NVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSSS 76 (106)
T ss_pred CCCCCCccC----CEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCCC
Confidence 478999999 999999999999998 89999876 33 33 4899999997 46777655 55654431
Q ss_pred -----CccCCCCCCcccc-CCceEEEECCCC
Q 005536 88 -----SLHPLFGPNYGMT-RQNSLLLQNCTT 112 (692)
Q Consensus 88 -----~~~~~~~~~f~~s-~~n~~~~~gC~~ 112 (692)
...++.+ +|.++ .+|.|+++||++
T Consensus 77 ~~~~~~~~~~~~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 77 SNSSNSNLSLNG-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred CcccccEEeecC-CceEccCCcEEEEECCCC
Confidence 1123333 77776 899999999985
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=145.88 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=98.9
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCch--hHHHH----------------------HHHHHHHHhCCCC--Ce
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD--SIDQV----------------------MNEIKLLSSVSHP--NL 382 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~il~~l~H~--ni 382 (692)
.+.||+|+||+||++...+++.||||+++..... ....+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4579999999999999888999999998754211 11111 3566666666543 34
Q ss_pred eeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 383 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
.+.+++ ...++||||++++++......... .. .....++.+++.++.++|.. .+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CC
Confidence 555543 346899999998554321111100 11 56788999999999999983 4999999999999999 89
Q ss_pred ceEEeeecCCcc
Q 005536 463 RSKVADFGLSRL 474 (692)
Q Consensus 463 ~~kl~DFGla~~ 474 (692)
.++|+|||.+..
T Consensus 152 ~~~liDfg~a~~ 163 (187)
T cd05119 152 KVYIIDVPQAVE 163 (187)
T ss_pred cEEEEECccccc
Confidence 999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.9e-16 Score=175.77 Aligned_cols=208 Identities=25% Similarity=0.355 Sum_probs=141.9
Q ss_pred hccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEe
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~ 401 (692)
...|+.++.|..|+||.||..+... .+.+|+| +++.+. -..+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee------------------
Confidence 4678999999999999999998654 4567773 332210 0000 22222233332
Q ss_pred CCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCC--
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES-- 479 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~-- 479 (692)
|+-.+.+... .+++.. ++.+++|||+. +|+|||+||.|.||+.-|.+|+.|||+++.+....
T Consensus 136 ---gDc~tllk~~--g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNI--GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccC--CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444444432 223332 27899999995 99999999999999999999999999987632210
Q ss_pred ----------Cc--ccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc
Q 005536 480 ----------SH--ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 480 ----------~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
.+ ....+.||+.|+|||++....|....|.|++|+|+||.+-|..||....+++-.... +..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------isd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------ISD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------hhh
Confidence 01 123356999999999999999999999999999999999999999877664322111 110
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RP 589 (692)
++. -++. ......++++++.+.|+.+|..|-
T Consensus 274 ----~i~----wpE~---dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 ----DIE----WPEE---DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----hcc----cccc---CcCCCHHHHHHHHHHHHhChHhhc
Confidence 000 0011 112345788999999999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=146.64 Aligned_cols=135 Identities=21% Similarity=0.262 Sum_probs=106.3
Q ss_pred ceeec-ccccEEEEEEEEeCCCEEEEEEeecCC-------------chhHHHHHHHHHHHHhCCCCCe--eeeEEEEEeC
Q 005536 329 KHRLG-TGAYGTVYAGKLHNDDWVAIKRFRYRD-------------TDSIDQVMNEIKLLSSVSHPNL--LRLLGCCIEE 392 (692)
Q Consensus 329 ~~~LG-~G~fG~Vy~g~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~H~ni--v~l~g~~~~~ 392 (692)
...|| .||.|+||+.... +..++||+++... ......+.+|+.++.+|+|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999874 6679999886421 1233568899999999998875 7777775443
Q ss_pred C----eeEEEEEeCCC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEe
Q 005536 393 G----EPILVYEFMPN-GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVA 467 (692)
Q Consensus 393 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 467 (692)
. ..++|+||+++ .+|.+++... .++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6898888642 34443 35689999999999 499999999999999999999999
Q ss_pred eecCCcc
Q 005536 468 DFGLSRL 474 (692)
Q Consensus 468 DFGla~~ 474 (692)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-15 Score=171.93 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=189.8
Q ss_pred hccCccceeecccccEEEEEEEEeC--CCEEEEEEeecCC--chhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEE
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHN--DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 323 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~l 397 (692)
...|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456677789999999998776543 3456666665443 233444556888888887 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceEEcCCC-ceEEeeecCCccC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH-SAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLG 475 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH-~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~ 475 (692)
+.||..++++.+.+........+....-....|+..++.|+| . .++.||||||+|.+++..+ ..|++|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999998883222223555666788899999999999 5 5999999999999999999 9999999999865
Q ss_pred CC--CCCcccccCCC-CCCCCCccccccC-CCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhccCccc
Q 005536 476 MT--ESSHISTAPQG-TPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 476 ~~--~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (692)
.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......... .
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--------------~ 241 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--------------S 241 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------------e
Confidence 44 22233345567 9999999998774 45668999999999999999999987654433211 1
Q ss_pred ccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~~~~~~~~ 609 (692)
.+...........| ........++..+++..+|..|.+. +.+...+|...
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~-------~~~~~d~~~~~ 291 (601)
T KOG0590|consen 242 SWKSNKGRFTQLPW-NSISDQAHDLLHKILKENPSNRLSI-------EELKLDNWLSS 291 (601)
T ss_pred eecccccccccCcc-ccCChhhhhcccccccCCchhcccc-------ccccccccccc
Confidence 11111000000111 1223456778889999999999994 44456666554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.5e-13 Score=149.93 Aligned_cols=138 Identities=19% Similarity=0.210 Sum_probs=100.2
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCchhH----------------------------------------HHHHH
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSI----------------------------------------DQVMN 369 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 369 (692)
+.||.|++|.||+|++.+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999875421110 02455
Q ss_pred HHHHHHhCC----CCCeeeeEEEE-EeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 005536 370 EIKLLSSVS----HPNLLRLLGCC-IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ-AIAYLHSAMN 443 (692)
Q Consensus 370 E~~il~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~-aL~yLH~~~~ 443 (692)
|...+.+++ |.+-+.+-..+ ......+|||||++|++|.+.+..... .+ .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh---
Confidence 666565552 33333333333 234567999999999999887654221 12 24567777766 4678887
Q ss_pred CCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 444 ~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.+++|+|+||.||++++++.+++.|||++..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 4999999999999999999999999999865
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-13 Score=136.94 Aligned_cols=203 Identities=22% Similarity=0.304 Sum_probs=140.5
Q ss_pred HHHHHhCCCCCeeeeEEEEEeC-----CeeEEEEEeCCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005536 371 IKLLSSVSHPNLLRLLGCCIEE-----GEPILVYEFMPNGTLCQHLQRERG--SGLPWTIRITIATETAQAIAYLHSAMN 443 (692)
Q Consensus 371 ~~il~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~aL~yLH~~~~ 443 (692)
..-|-++-|.|||++..++.+. .+..++.|||+.|+|.++|++.+. ..+......+|+.||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445566799999999998654 357899999999999999987542 347777778999999999999998 57
Q ss_pred CCeEecCCCCCceEEcCCCceEEeeecCCccCCCC---CCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHH
Q 005536 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE---SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEII 520 (692)
Q Consensus 444 ~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLl 520 (692)
++|+|+++..+.|++..++-+|+.----....... .........+-++|.+||+=...+.+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999998887532111110000 001112234678999999987778888999999999999998
Q ss_pred hCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005536 521 TALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 521 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~ 596 (692)
-+..-...+....+. +...... .. .+....+ ++++.+|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~~---ee~ia~~----i~-----~len~lq----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEV---EENIANV----II-----GLENGLQ----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeeh---hhhhhhh----ee-----eccCccc----------cCcCcccccCCCCCCcchhhhhc
Confidence 875432211111000 0000000 00 0111111 35788999999999999998864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=118.13 Aligned_cols=131 Identities=17% Similarity=0.139 Sum_probs=96.9
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCee-eeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLL-RLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
.+.|+.|.++.||+.+.. +..|++|....... ....+.+|++++..+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 457899999999999864 67899998764422 233567899999998755544 455443 3345899999999887
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM--NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.+.. . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 1 11345679999999999852 12369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.3e-12 Score=138.46 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=174.8
Q ss_pred cCccceeecc--cccEEEEEEEE---eCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeE
Q 005536 325 FFSEKHRLGT--GAYGTVYAGKL---HNDDWVAIKRFRYRDT--DSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 325 ~f~~~~~LG~--G~fG~Vy~g~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~ 396 (692)
.|...+.+|. |.+|.||++.. .++..+|+|+-+..-. .....=.+|+.-..+++ |+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455677999 99999999986 4577899998554322 22233345666666674 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceEEcCC-CceEEeeecC
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ----AIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGL 471 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~----aL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGl 471 (692)
+-+|++ +.+|.++.+... ..++....+.+..+... ||.++|+ +.|+|-|+||.||++..+ ...++.|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 999998 578888877542 33566666666666667 9999999 599999999999999999 8999999999
Q ss_pred CccCCCCC----CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHHHhcc
Q 005536 472 SRLGMTES----SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 472 a~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~ 547 (692)
...+.... ........|...|++||..++ -++.++|+|++|.+++|-.++......... . .+..++.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~--~W~~~r~ 340 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------S--SWSQLRQ 340 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------C--Ccccccc
Confidence 87643322 122233468889999998875 578899999999999999998655432200 0 0111111
Q ss_pred CcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 548 ~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+. +-+... .....++..++..+++.+|..|++.+.+.
T Consensus 341 ~~---ip~e~~--------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 GY---IPLEFC--------EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc---Cchhhh--------cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 111111 11223455588999999999999877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.7e-11 Score=135.48 Aligned_cols=144 Identities=18% Similarity=0.223 Sum_probs=95.1
Q ss_pred ccCccceeecccccEEEEEEEEeC-CCEEEEEEeecCCchh------------------------------H--------
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDS------------------------------I-------- 364 (692)
Q Consensus 324 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~------------------------------~-------- 364 (692)
..|+. +.||.|++|.||++++.+ |+.||||+.++.-... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 689999999999999988 9999999997542110 0
Q ss_pred --HHHHHHHHHHHhCC----CCCeeeeEEEEEe-CCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHH-HH
Q 005536 365 --DQVMNEIKLLSSVS----HPNLLRLLGCCIE-EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQA-IA 436 (692)
Q Consensus 365 --~~~~~E~~il~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~a-L~ 436 (692)
-+|.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.+.-.-. ....+ +..++...+.. +.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d---~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTD---MKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCC---HHHHHHHHHHHHHH
Confidence 12445555555553 4444444444433 45678999999999998742211 11122 12233222221 22
Q ss_pred HHHhcCCCCeEecCCCCCceEEcCCC----ceEEeeecCCccC
Q 005536 437 YLHSAMNPPIYHRDIKSSNILLDYNY----RSKVADFGLSRLG 475 (692)
Q Consensus 437 yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DFGla~~~ 475 (692)
.++. .+++|+|+||.||+++.++ .+++.|||+....
T Consensus 275 Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 2333 4999999999999999888 9999999998653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.9e-10 Score=124.34 Aligned_cols=166 Identities=16% Similarity=0.167 Sum_probs=126.0
Q ss_pred EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHH
Q 005536 345 LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR 424 (692)
Q Consensus 345 ~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 424 (692)
..++.+|.|...+..+....+...+-++.|+.++||||++++....+.+..|||+|-+ --|..++.... -...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHH
Confidence 4567888888888766544556778899999999999999999999999999999998 45777776542 3445
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCCCccccccCCCC
Q 005536 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504 (692)
Q Consensus 425 ~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 504 (692)
--.+.||+.||.|||+. .+++|++|....|++++.|..||++|.+....... ........--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~-~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF-NAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC-CcccccchhhhcccChhhcCccc--
Confidence 56678999999999976 58999999999999999999999999887542111 11111111223456676554322
Q ss_pred CccceeehhHHHHHHHhC
Q 005536 505 DKSDVYSFGVVLIEIITA 522 (692)
Q Consensus 505 ~ksDV~SfGvll~eLltg 522 (692)
-.-|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 235999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-10 Score=115.30 Aligned_cols=143 Identities=23% Similarity=0.291 Sum_probs=112.2
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCC---eeEEEEEeC
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSH--PNLLRLLGCCIEEG---EPILVYEFM 402 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H--~niv~l~g~~~~~~---~~~lV~E~~ 402 (692)
.+.|+.|..+.||++...+|+.+++|....... ....++.+|+++++.+++ .++.+++.+..+.. ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999887768899999765422 245678899999999976 44677888776542 568999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM---------------------------------------- 442 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~---------------------------------------- 442 (692)
++.++.+.+.. ..++...+..++.+++++|++||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888775532 24677778888889999998888531
Q ss_pred -------------CCCeEecCCCCCceEEcC--CCceEEeeecCCcc
Q 005536 443 -------------NPPIYHRDIKSSNILLDY--NYRSKVADFGLSRL 474 (692)
Q Consensus 443 -------------~~~iiHrDik~~NILld~--~~~~kl~DFGla~~ 474 (692)
...++|+|+++.|||++. +..+.|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-11 Score=132.18 Aligned_cols=258 Identities=18% Similarity=0.181 Sum_probs=183.5
Q ss_pred CCChHH-HHHhhccCccceeecccccEEEEEEEE--eCCCEEEEEEeecCCchhHHH--HHHHHHHHHhC-CCCCeeeeE
Q 005536 313 FYPYKE-IEKATSFFSEKHRLGTGAYGTVYAGKL--HNDDWVAIKRFRYRDTDSIDQ--VMNEIKLLSSV-SHPNLLRLL 386 (692)
Q Consensus 313 ~~~~~e-l~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l-~H~niv~l~ 386 (692)
+|.-.+ ....+..|.....||.|.|+.|++... .++..+++|.+...-....++ -..|+.+...+ .|.+++...
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 334556788999999999999998763 457789999887553322222 24566666666 499999988
Q ss_pred EEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CceE
Q 005536 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSK 465 (692)
Q Consensus 387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~-~~~k 465 (692)
..+...+..++--||++++++...+.- ...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..+
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhh
Confidence 888888888899999999998776622 2457888899999999999999998 599999999999999886 8899
Q ss_pred EeeecCCccCCCCCCcccccCCCCCCCC--CccccccCCCCCccceeehhHHHHHHHhCCcccCCCCCcccccHHHHHHH
Q 005536 466 VADFGLSRLGMTESSHISTAPQGTPGYL--DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 466 l~DFGla~~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~~~~~~~~~~~~~~~~~ 543 (692)
+.|||.+..... . .....++.++. +|+......+-.+.|+||||.-+.|.+++......... +.
T Consensus 408 ~~~~~~~t~~~~---~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~ 473 (524)
T KOG0601|consen 408 LGDFGCWTRLAF---S-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SL 473 (524)
T ss_pred ccccccccccce---e-cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ce
Confidence 999999863111 1 11122333344 56666777888999999999999999998653321100 11
Q ss_pred HhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl~~L~~i~ 602 (692)
.++++...- .+ ...+.+..++..+...++..||.+.++....+.++
T Consensus 474 ~i~~~~~p~------------~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 474 TIRSGDTPN------------LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred eeecccccC------------CC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 122221111 01 12256778899999999999999988876665544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.5e-10 Score=108.53 Aligned_cols=134 Identities=16% Similarity=0.099 Sum_probs=98.6
Q ss_pred eeecccccEEEEEEEEeC-------CCEEEEEEeecCC------------c----------hhHHHHH----HHHHHHHh
Q 005536 330 HRLGTGAYGTVYAGKLHN-------DDWVAIKRFRYRD------------T----------DSIDQVM----NEIKLLSS 376 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~E~~il~~ 376 (692)
..||.|--+.||.|...+ +..+|||..+... . ...+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998553 4789999986421 0 1122333 89999999
Q ss_pred CC--CCCeeeeEEEEEeCCeeEEEEEeCCCCCHHH-HHhhccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCC
Q 005536 377 VS--HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQ-HLQRERGSGLPWTIRITIATETAQAIAYL-HSAMNPPIYHRDIK 452 (692)
Q Consensus 377 l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~ia~~ia~aL~yL-H~~~~~~iiHrDik 452 (692)
+. .-++.+++++ ..-+|||||+.+..+.. .|.. ..++......+..+++.+|..| |. .+|+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 95 3577777765 45689999997654422 2221 2245556677889999999999 66 499999999
Q ss_pred CCceEEcCCCceEEeeecCCcc
Q 005536 453 SSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 453 ~~NILld~~~~~kl~DFGla~~ 474 (692)
+.|||+++ +.+.|+|||.+..
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHHEEEEC-CcEEEEECCCcee
Confidence 99999974 6799999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=103.02 Aligned_cols=130 Identities=20% Similarity=0.290 Sum_probs=100.3
Q ss_pred eecccccEEEEEEEEeCCCEEEEEEeecCC---c-----hhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeC
Q 005536 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRD---T-----DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.+++|+-+.+|.+.+.+.. +++|.=.... + -..++-.+|+.++.+++--.|.-..=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999765444 5555432221 1 12345678999999997656655555566777889999999
Q ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
++-.|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998998888754 356778888889999995 999999999999998775 99999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-09 Score=100.36 Aligned_cols=143 Identities=22% Similarity=0.207 Sum_probs=106.1
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEe-ecC-------CchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEE
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRF-RYR-------DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~ 399 (692)
....|-||+-+.|+++.+. |+...||.- .+. ..-..++..+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568899999999999874 555555543 221 1123456788999999987656655555566666678999
Q ss_pred EeCCC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---ceEEeeecCCcc
Q 005536 400 EFMPN-GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY---RSKVADFGLSRL 474 (692)
Q Consensus 400 E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFGla~~ 474 (692)
||+++ .++.+++...-...........++..+-+.+.-||. .+|+|+||..+||+|..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 488888887544333333447889999999999999 5999999999999996554 458999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.3e-08 Score=107.25 Aligned_cols=168 Identities=15% Similarity=0.254 Sum_probs=126.7
Q ss_pred cEEEEEEE-EeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CCeeEEEEEeCCC-CCHHHH
Q 005536 337 YGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE----EGEPILVYEFMPN-GTLCQH 410 (692)
Q Consensus 337 fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~-gsL~~~ 410 (692)
-.+.||+. ..||..|++|+++.......-.-..-++.++++.|.|+|++..++.. +..++|||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789987 45789999999943322222223356888999999999999998873 3468999999986 578775
Q ss_pred Hhhc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCC
Q 005536 411 LQRE-------------RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 411 l~~~-------------~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 477 (692)
-... .+..+++...|.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|...+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4421 123478899999999999999999995 999999999999999999999999988765433
Q ss_pred CCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcc
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKV 525 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p 525 (692)
+.. |-+.. -.+-|.=.||.+|+.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 11111 1256888899999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.1e-08 Score=101.19 Aligned_cols=133 Identities=13% Similarity=0.079 Sum_probs=97.8
Q ss_pred EEEEEEEEeCCCEEEEEEeecCCch-hH----------HHHHHHHHHHHhCCC--CCeeeeEEEEEe-----CCeeEEEE
Q 005536 338 GTVYAGKLHNDDWVAIKRFRYRDTD-SI----------DQVMNEIKLLSSVSH--PNLLRLLGCCIE-----EGEPILVY 399 (692)
Q Consensus 338 G~Vy~g~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~il~~l~H--~niv~l~g~~~~-----~~~~~lV~ 399 (692)
..|++..+ +|+.|.||+....... .. ..+.+|...+.++.. -..+.++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666655 6778999987543211 11 137799999988853 344555666543 23578999
Q ss_pred EeCCCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-------CCceEEeeecC
Q 005536 400 EFMPNG-TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-------NYRSKVADFGL 471 (692)
Q Consensus 400 E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~-------~~~~kl~DFGl 471 (692)
|++++- +|.+++........+...+..++.+++..++-||.. +|+|+|++++|||++. +..+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999876 899988643223456667789999999999999995 9999999999999985 56899999998
Q ss_pred Ccc
Q 005536 472 SRL 474 (692)
Q Consensus 472 a~~ 474 (692)
++.
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.8e-10 Score=129.26 Aligned_cols=249 Identities=19% Similarity=0.229 Sum_probs=165.9
Q ss_pred hhccCccceeecccccEEEEEEEEe-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~l 397 (692)
..+.|...+-+-+|.++.++..+-. .+...++|...... ..+.+....+-.++-..+||-++....-+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666677888999999876522 23333444333221 1222223333333333445666665555555678899
Q ss_pred EEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCc-cCC
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGM 476 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~-~~~ 476 (692)
+++|..+++|...|+... .++..........+..+++|||.. .+.|+|++|.|+|...++..+++|||... ...
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998753 244444445556778899999994 59999999999999999999999998332 110
Q ss_pred C----CC-------------------------CcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCcccC
Q 005536 477 T----ES-------------------------SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVD 527 (692)
Q Consensus 477 ~----~~-------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~~ 527 (692)
. +. ........||+.|++||...+......+|.|++|++++|.++|..||+
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 011233468999999999999999999999999999999999999998
Q ss_pred CCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005536 528 FSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM 592 (692)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~ 592 (692)
...+... .+.+..+.... ...+.....+..+++.+.+..+|.+|-.|.
T Consensus 1037 a~tpq~~-------f~ni~~~~~~~----------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-------FENILNRDIPW----------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh-------hhccccCCCCC----------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6554221 12222211111 111223345677899999999999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-08 Score=98.56 Aligned_cols=124 Identities=20% Similarity=0.231 Sum_probs=83.2
Q ss_pred EEEEEEEeCCCEEEEEEeecCC-------------ch-------------hHHHHHHHHHHHHhCCCC--CeeeeEEEEE
Q 005536 339 TVYAGKLHNDDWVAIKRFRYRD-------------TD-------------SIDQVMNEIKLLSSVSHP--NLLRLLGCCI 390 (692)
Q Consensus 339 ~Vy~g~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~il~~l~H~--niv~l~g~~~ 390 (692)
-||.|...++..+|||..+... .. ......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999986431 00 123467899999999865 567776552
Q ss_pred eCCeeEEEEEeCC--CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceEEcCCCceEEe
Q 005536 391 EEGEPILVYEFMP--NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL-HSAMNPPIYHRDIKSSNILLDYNYRSKVA 467 (692)
Q Consensus 391 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yL-H~~~~~~iiHrDik~~NILld~~~~~kl~ 467 (692)
.-.|||||++ +..+..+.... ++......++.+++..+..+ |. .+|+|+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 54554433221 22345567788888866664 56 499999999999999988 99999
Q ss_pred eecCCcc
Q 005536 468 DFGLSRL 474 (692)
Q Consensus 468 DFGla~~ 474 (692)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-07 Score=99.63 Aligned_cols=266 Identities=15% Similarity=0.152 Sum_probs=163.0
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhC-CCCCeeeeEEEE-------EeCCeeEEEE
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCC-------IEEGEPILVY 399 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~g~~-------~~~~~~~lV~ 399 (692)
..+.||+|+.+.+|.-- .-..-+.|++.........+. +..|... .||-+-.-+.|= ......-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 46689999999999532 111234566654433332222 2223333 455433322221 1122355677
Q ss_pred EeCCCCC-HHHHHhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 400 EFMPNGT-LCQHLQR----ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 400 E~~~~gs-L~~~l~~----~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
..+++.- +.+++.. ..-....|...++.+..+|.+.+-||.+ |..-+|+.++|+|+.+++.+.|.|=..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 7776542 2233321 1123488999999999999999999996 999999999999999999999998654433
Q ss_pred CCCCCCcccccCCCCCCCCCccccc-----cCCCCCccceeehhHHHHHHHhC-CcccCCCCCcccccHHHHHHHHhccC
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITA-LKVVDFSRPHSEVNLAALAIDRIGRG 548 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SfGvll~eLltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 548 (692)
. .........+|...|.+||... +..-+..+|-|.|||++++|+.| +.||..-....... .-....|..|
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap--~p~E~~Ia~g 242 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP--NPLETDIAHG 242 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC--Ccchhhhhcc
Confidence 2 3334455678999999999743 44567789999999999999986 88885321111000 0001122233
Q ss_pred ccccccccc--CCcCCCccCHHH-HHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhhhcc
Q 005536 549 CVDEIIDPY--LEPHRDAWTLSS-IHNVAELAFRCLAF--HRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 549 ~~~ei~d~~--l~~~~~~~~~~~-~~~l~~L~~~Cl~~--~p~~RPsm~eVl~~L~~i~~~~ 605 (692)
....--|.. +.+.-..++... ...+..|..+|+.. ++.-||+++-++..|..++...
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 222222211 111112233332 34677788888864 3678999999999998887653
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.4e-08 Score=84.57 Aligned_cols=64 Identities=16% Similarity=0.278 Sum_probs=43.9
Q ss_pred CCCCCCCCCcceeecccCCCC-C---ccccccc--ccccCccceEEEeeeccCCCCC-----CCCccceeEEEEEecCC
Q 005536 131 KTCGVGSDNITCFSWPYNENK-S---ASFMSFN--DLSRTGCNYLFSSLAFNSGGNS-----AGSLEFQLLELGWGLNG 198 (692)
Q Consensus 131 ~~C~~~~~g~~Cc~~~~~~~~-~---~~~~~~~--~~~~~~C~~~~~~~~~~~~~~~-----~~~~~~~~~~L~W~i~~ 198 (692)
..| +|++|||+.||+++ + ..+...+ .....+|++||++...++..+. ....+++||+|||.|+.
T Consensus 2 ~~C----sG~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~i~t 76 (103)
T PF08488_consen 2 SSC----SGIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWFIDT 76 (103)
T ss_pred Ccc----CCcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEEEec
Confidence 579 79999999999863 2 2222222 2345799999999876653321 12456799999999964
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.4e-08 Score=109.68 Aligned_cols=149 Identities=19% Similarity=0.236 Sum_probs=103.1
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCC--------CCcccccCCCCCCCCCcccccc
Q 005536 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE--------SSHISTAPQGTPGYLDPQYHQY 500 (692)
Q Consensus 429 ~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~--------~~~~~~~~~gt~~Y~aPE~~~~ 500 (692)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+...... +.....-.+-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3556999999997 79999999999999999999999999987542221 1111122345678999999999
Q ss_pred CCCCCccceeehhHHHHHHHhCCcc-cCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHH
Q 005536 501 FHLSDKSDVYSFGVVLIEIITALKV-VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFR 579 (692)
Q Consensus 501 ~~~s~ksDV~SfGvll~eLltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~ 579 (692)
...+.++|+||+|+++|.+..|.++ +......... ..... . .+. ....++.+.+.++.+=+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~~~-~------~~~----~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFSRN-L------LNA----GAFGYSNNLPSELRESLKK 247 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhhhc-c------ccc----ccccccccCcHHHHHHHHH
Confidence 8899999999999999999954443 3322111100 00000 0 000 0111223456788888999
Q ss_pred hcccCCCCCCCHHHHH
Q 005536 580 CLAFHRDMRPTMMEVA 595 (692)
Q Consensus 580 Cl~~~p~~RPsm~eVl 595 (692)
++..++..||++.++.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999877765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=6.8e-07 Score=88.91 Aligned_cols=106 Identities=26% Similarity=0.271 Sum_probs=85.6
Q ss_pred HHHHHHHHHHHHhCC--CCCeeeeEEEEEeCC----eeEEEEEeCCCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Q 005536 364 IDQVMNEIKLLSSVS--HPNLLRLLGCCIEEG----EPILVYEFMPNG-TLCQHLQRERGSGLPWTIRITIATETAQAIA 436 (692)
Q Consensus 364 ~~~~~~E~~il~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~ 436 (692)
...+.+|...+..+. .-.+++.+++..... ..+||+|++++. +|.+++..... ++...+..++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 446788888888885 445667777766532 458999999874 79998876422 566677899999999999
Q ss_pred HHHhcCCCCeEecCCCCCceEEcCCC---ceEEeeecCCcc
Q 005536 437 YLHSAMNPPIYHRDIKSSNILLDYNY---RSKVADFGLSRL 474 (692)
Q Consensus 437 yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFGla~~ 474 (692)
-||+. +|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99994 999999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.3e-07 Score=90.43 Aligned_cols=134 Identities=19% Similarity=0.139 Sum_probs=95.1
Q ss_pred CccceeecccccEEEEEEEEeCCCEEEEEEeecCCc----------------------hhHHHHHHHHHHHHhCCCC--C
Q 005536 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT----------------------DSIDQVMNEIKLLSSVSHP--N 381 (692)
Q Consensus 326 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~il~~l~H~--n 381 (692)
.....+||-|.-+.||.|...+|.++|||.-+.... -......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445678999999999999999999999997653210 0123457899999999755 7
Q ss_pred eeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 005536 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN 461 (692)
Q Consensus 382 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~ 461 (692)
+.+.+++ +.-.+||||+++--|...- ++....-.|+..|+.-+.-+-. .||||+|+++-|||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 8887765 3457999999886554321 1122222333344443333333 399999999999999999
Q ss_pred CceEEeeecCCc
Q 005536 462 YRSKVADFGLSR 473 (692)
Q Consensus 462 ~~~kl~DFGla~ 473 (692)
+.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999997654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-06 Score=85.78 Aligned_cols=139 Identities=14% Similarity=0.085 Sum_probs=105.0
Q ss_pred ecccccEEEEEEEEeCCCEEEEEEeecCC------chhHHHHHHHHHHHHhCCC--CCeeeeEEEEEe----CCeeEEEE
Q 005536 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRD------TDSIDQVMNEIKLLSSVSH--PNLLRLLGCCIE----EGEPILVY 399 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~H--~niv~l~g~~~~----~~~~~lV~ 399 (692)
-|.||-+.|+.-.+. |..+-+|+-...- +-....|.+|+..|.+|.. -.+.+++.+... ....+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999987664 4468888865221 3356789999999999963 335555532222 12468999
Q ss_pred EeCCC-CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc--eEEeeecCCcc
Q 005536 400 EFMPN-GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYR--SKVADFGLSRL 474 (692)
Q Consensus 400 E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DFGla~~ 474 (692)
|-+++ -+|.+++....-.+.+...+..+..+++..|+-||+. ++.|+|+-+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 5898888664334567788889999999999999995 9999999999999986666 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=9.5e-07 Score=98.56 Aligned_cols=157 Identities=20% Similarity=0.248 Sum_probs=102.5
Q ss_pred CCCCCChHHHHHh------------hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchh--------------
Q 005536 310 SVPFYPYKEIEKA------------TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDS-------------- 363 (692)
Q Consensus 310 ~~~~~~~~el~~~------------~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~-------------- 363 (692)
.++.+++++.++. -..|+. +.|+.++-|.||+|++++|+.||||+.++.-...
T Consensus 100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~ 178 (517)
T COG0661 100 RVPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL 178 (517)
T ss_pred CCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence 4566777655432 234443 4799999999999999999999999987542111
Q ss_pred ----------------HH----------HHHHHHHHHHhCC-----CCCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHh
Q 005536 364 ----------------ID----------QVMNEIKLLSSVS-----HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ 412 (692)
Q Consensus 364 ----------------~~----------~~~~E~~il~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 412 (692)
.+ ++.+|..-+.+++ .+++.-.-=++.-.....|+|||++|-.+.+...
T Consensus 179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~ 258 (517)
T COG0661 179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA 258 (517)
T ss_pred HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence 11 1344555555542 2333332233334567899999999988888743
Q ss_pred hccCCCCCHHHHHHHHHHHHHH-HHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 413 RERGSGLPWTIRITIATETAQA-IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 413 ~~~~~~l~~~~~~~ia~~ia~a-L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
... ..++. ..|+..++++ +..+-. .+++|.|.+|.||+++.++++.+.|||+...
T Consensus 259 l~~-~g~d~---k~ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 259 LKS-AGIDR---KELAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred HHh-cCCCH---HHHHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceec
Confidence 322 33553 3344444433 222222 3899999999999999999999999999764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.4e-06 Score=83.06 Aligned_cols=139 Identities=14% Similarity=0.160 Sum_probs=86.8
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCC--CeeeeEEEEEeCCeeEEEEEeCCCCC-
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP--NLLRLLGCCIEEGEPILVYEFMPNGT- 406 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gs- 406 (692)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 24457788876432 334568899999998643 35777888877778889999998863
Q ss_pred HHHH---------------------HhhccCCCCCHHHHHH-HHH----------HHH-HHHHHHHhc-CCCCeEecCCC
Q 005536 407 LCQH---------------------LQRERGSGLPWTIRIT-IAT----------ETA-QAIAYLHSA-MNPPIYHRDIK 452 (692)
Q Consensus 407 L~~~---------------------l~~~~~~~l~~~~~~~-ia~----------~ia-~aL~yLH~~-~~~~iiHrDik 452 (692)
+... ||.......+...+.. +.. .+. ....+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1111001111111100 000 011 112233222 12467899999
Q ss_pred CCceEEcCCCceEEeeecCCcc
Q 005536 453 SSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 453 ~~NILld~~~~~kl~DFGla~~ 474 (692)
|.||++++++ +.|.||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.8e-05 Score=80.73 Aligned_cols=140 Identities=16% Similarity=0.125 Sum_probs=86.9
Q ss_pred eeccccc-EEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCeeEEEEEeCCCCCHH
Q 005536 331 RLGTGAY-GTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEFMPNGTLC 408 (692)
Q Consensus 331 ~LG~G~f-G~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 408 (692)
.|-.|.. ..||+.... +..++||+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 788998754 4678888876432 345678999988884 455678888877767789999999987776
Q ss_pred HHH-------------------hhccC--CCCC--HHHHHHHHH--------------------HHHHHHHHHHhc----
Q 005536 409 QHL-------------------QRERG--SGLP--WTIRITIAT--------------------ETAQAIAYLHSA---- 441 (692)
Q Consensus 409 ~~l-------------------~~~~~--~~l~--~~~~~~ia~--------------------~ia~aL~yLH~~---- 441 (692)
+.. |.... .+.. +..++.... .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11100 0111 001110000 011122222111
Q ss_pred CCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 442 ~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
..+.++|+|+.|.|||++++..+.|.||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124589999999999999988889999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-05 Score=78.93 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=92.9
Q ss_pred hhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHH---------HHHHHHHHhCCC---CCeeeeEEEE
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQV---------MNEIKLLSSVSH---PNLLRLLGCC 389 (692)
Q Consensus 322 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~il~~l~H---~niv~l~g~~ 389 (692)
..++|...+.+-......|.+-.. ++..+++|..+.......+.| .+++..+.+++. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456777777887777777776655 567899999876654433332 234444444432 2233333322
Q ss_pred E-----eCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCce
Q 005536 390 I-----EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 390 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
. -....+|+|||++|..|.++.. ++. .++..+++++.-||+. |++|+|..|.|+++++++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-E
Confidence 2 1235578999999988866542 222 3556777889999996 999999999999998655 9
Q ss_pred EEeeecCCcc
Q 005536 465 KVADFGLSRL 474 (692)
Q Consensus 465 kl~DFGla~~ 474 (692)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.4e-05 Score=80.32 Aligned_cols=143 Identities=22% Similarity=0.288 Sum_probs=86.9
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCC--CeeeeEEEEEeC---CeeEEEEEeCC
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP--NLLRLLGCCIEE---GEPILVYEFMP 403 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~ 403 (692)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999998877 68999997543 4567788899998888533 456777755333 35689999999
Q ss_pred CCCHHH----------------HH---hhcc--CCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 005536 404 NGTLCQ----------------HL---QRER--GSGLPWTIR---------ITI------------ATETAQ-AIAYLHS 440 (692)
Q Consensus 404 ~gsL~~----------------~l---~~~~--~~~l~~~~~---------~~i------------a~~ia~-aL~yLH~ 440 (692)
+..+.. .+ +... ...+.+... ... ...+.. .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887776 11 1110 111111110 000 112222 3444443
Q ss_pred c----CCCCeEecCCCCCceEEc-CCCceEEeeecCCcc
Q 005536 441 A----MNPPIYHRDIKSSNILLD-YNYRSKVADFGLSRL 474 (692)
Q Consensus 441 ~----~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~ 474 (692)
. ....++|+|+.+.|||++ +++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 235799999999999999 666668999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-05 Score=88.53 Aligned_cols=159 Identities=19% Similarity=0.230 Sum_probs=100.8
Q ss_pred CCCCCChHHHHHh------------hccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchh--------------
Q 005536 310 SVPFYPYKEIEKA------------TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDS-------------- 363 (692)
Q Consensus 310 ~~~~~~~~el~~~------------~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~-------------- 363 (692)
..|.+|++|+.++ -..|+. +.||.-+.|.||++++++|+.||||+-++.-+..
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~ 214 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKV 214 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence 4566777776443 234443 4799999999999999999999999976542111
Q ss_pred -------------HH----------HHHHHHHHHHhC----CCCC---eeeeEEEEE-eCCeeEEEEEeCCCCCHHHHHh
Q 005536 364 -------------ID----------QVMNEIKLLSSV----SHPN---LLRLLGCCI-EEGEPILVYEFMPNGTLCQHLQ 412 (692)
Q Consensus 364 -------------~~----------~~~~E~~il~~l----~H~n---iv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~ 412 (692)
.+ +|.+|.+-..+. .|-+ -|.+=.++. -.....|+||||+|..+.|.-.
T Consensus 215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~ 294 (538)
T KOG1235|consen 215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA 294 (538)
T ss_pred HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH
Confidence 01 244555544433 3555 111222222 2356799999999987765432
Q ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC----CCceEEeeecCCccC
Q 005536 413 RERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY----NYRSKVADFGLSRLG 475 (692)
Q Consensus 413 ~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~DFGla~~~ 475 (692)
-. ...++.. .|+..+.++ |++.....|++|.|-+|.||+++. ++++.+-|||+....
T Consensus 295 i~-~~gi~~~---~i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 295 ID-KRGISPH---DILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HH-HcCCCHH---HHHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 21 2235544 344344333 222222348999999999999983 678999999998653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2e-05 Score=78.46 Aligned_cols=151 Identities=17% Similarity=0.203 Sum_probs=102.1
Q ss_pred CChHHHHHhhccCcccee---ecccccEEEEEEEEeCCCEEEEEEeecCCchh------------------------HHH
Q 005536 314 YPYKEIEKATSFFSEKHR---LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDS------------------------IDQ 366 (692)
Q Consensus 314 ~~~~el~~~~~~f~~~~~---LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~------------------------~~~ 366 (692)
.+.+.+..+.++...... |.+|.-+.||+|...++..+|||+++...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345566666665555554 55677788999988889999999997542110 112
Q ss_pred HHHHHHHHHhCC--CCCeeeeEEEEEeCCeeEEEEEeCCCCCH-HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005536 367 VMNEIKLLSSVS--HPNLLRLLGCCIEEGEPILVYEFMPNGTL-CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443 (692)
Q Consensus 367 ~~~E~~il~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~ 443 (692)
..+|+.-|.++. +-.+.+.+++. .-.|||||+....+ .-.|. .-++.......+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~-- 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKE-- 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHh--
Confidence 356888888874 55666666654 34799999954311 11111 11233334666777777777777663
Q ss_pred CCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 444 ~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.+++|+||+.=|||+. ++.+.|+|||-|..
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccc
Confidence 4999999999999999 88999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.4e-07 Score=98.08 Aligned_cols=192 Identities=20% Similarity=0.152 Sum_probs=133.4
Q ss_pred HHHhhccCccceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCeeEE
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN-LLRLLGCCIEEGEPIL 397 (692)
Q Consensus 319 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n-iv~l~g~~~~~~~~~l 397 (692)
++..++-+...+.+++++++++||.+-.-.+...++.+... ....-++++|.+++||| .+..++-+..++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 33444444555668999999999987433333334444322 34456899999999999 7777777777888999
Q ss_pred EEEeCCCC-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCC
Q 005536 398 VYEFMPNG-TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 398 V~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 476 (692)
+++++..+ +-..-.... .-.+...+...+...-+++|+|||+. .=+|+| ||+..+ ...|..||+.+....
T Consensus 312 ~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccC
Confidence 99999776 211111100 01133334445666777899999984 458998 777766 688999999887533
Q ss_pred CCCCcccccCCCCCCCCCccccccCCCCCccceeehhHHHHHHHhCCccc
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVV 526 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SfGvll~eLltg~~p~ 526 (692)
... ......+|+.++|||+.+...+..+-|+|++|+--.++--|-.|-
T Consensus 383 ~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 222 345567999999999999999999999999998777777665554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.1e-05 Score=76.88 Aligned_cols=103 Identities=23% Similarity=0.274 Sum_probs=82.0
Q ss_pred HHHHHHHHhCCC-CCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005536 368 MNEIKLLSSVSH-PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-ERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445 (692)
Q Consensus 368 ~~E~~il~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~ 445 (692)
.+|.-++..+.+ +++++++|.|- .++|.||...+++...-.. ..-..-+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 69999999993 3789999987765421000 00123689999999999999999999865556
Q ss_pred eEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 446 IYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 446 iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
+.-.|++++|+-+++++++|+.|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00012 Score=71.97 Aligned_cols=129 Identities=22% Similarity=0.253 Sum_probs=93.1
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEeecCC----------------chhHHHHHHHHHHHHhCC------CCCeeee
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD----------------TDSIDQVMNEIKLLSSVS------HPNLLRL 385 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------H~niv~l 385 (692)
....||+|+.-.||. ++++....||+.+... ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456799999999996 5566778899887654 223566777777666665 8899999
Q ss_pred EEEEEeCCeeEEEEEeCCC------CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 005536 386 LGCCIEEGEPILVYEFMPN------GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD 459 (692)
Q Consensus 386 ~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld 459 (692)
+|+..++..+-+|+|.+.+ -||.+++... .++. . +...+-+-..||-+. .|+.+|++|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 9999999999999999753 3688888543 2554 2 233333445566663 899999999999995
Q ss_pred CCC----ceEEee
Q 005536 460 YNY----RSKVAD 468 (692)
Q Consensus 460 ~~~----~~kl~D 468 (692)
... .+.|.|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.5e-05 Score=90.19 Aligned_cols=147 Identities=17% Similarity=0.295 Sum_probs=92.9
Q ss_pred ceeecccccEEEEEEEEeCC---CEEEEEEeecCC-chhHHHHHHHHHHHHhCC-CCCe--eeeEEEEEeC---CeeEEE
Q 005536 329 KHRLGTGAYGTVYAGKLHND---DWVAIKRFRYRD-TDSIDQVMNEIKLLSSVS-HPNL--LRLLGCCIEE---GEPILV 398 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~ni--v~l~g~~~~~---~~~~lV 398 (692)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876654 367777765432 123457889999999995 6655 7888887664 468999
Q ss_pred EEeCCCCCHHH--------------------H---HhhccC---------CCCCHH--HHHHHH---------------H
Q 005536 399 YEFMPNGTLCQ--------------------H---LQRERG---------SGLPWT--IRITIA---------------T 429 (692)
Q Consensus 399 ~E~~~~gsL~~--------------------~---l~~~~~---------~~l~~~--~~~~ia---------------~ 429 (692)
|||+++..+.+ . ||.... .+..+. +..++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998754321 1 121110 011111 111110 1
Q ss_pred HHHHHHHHHHhcCC--------CCeEecCCCCCceEEcCC-Cc-eEEeeecCCccC
Q 005536 430 ETAQAIAYLHSAMN--------PPIYHRDIKSSNILLDYN-YR-SKVADFGLSRLG 475 (692)
Q Consensus 430 ~ia~aL~yLH~~~~--------~~iiHrDik~~NILld~~-~~-~kl~DFGla~~~ 475 (692)
.+...+.+|..... +.++|+|+++.|||++.+ .. .-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667754321 349999999999999853 33 579999998663
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00017 Score=73.14 Aligned_cols=139 Identities=20% Similarity=0.214 Sum_probs=78.4
Q ss_pred eeecccccE-EEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCC---CeeeeEEEEEeC---CeeEEEEEeC
Q 005536 330 HRLGTGAYG-TVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP---NLLRLLGCCIEE---GEPILVYEFM 402 (692)
Q Consensus 330 ~~LG~G~fG-~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~---niv~l~g~~~~~---~~~~lV~E~~ 402 (692)
+.|+.|+.. .||+. +..+++|..+. .....++.+|.+++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 58874 23477776543 22345788999999888532 345555544332 2458899999
Q ss_pred CCCCHHHH------------------HhhccCCC--C-------------CHHHHH--HHH-------HHHHH-HHHHHH
Q 005536 403 PNGTLCQH------------------LQRERGSG--L-------------PWTIRI--TIA-------TETAQ-AIAYLH 439 (692)
Q Consensus 403 ~~gsL~~~------------------l~~~~~~~--l-------------~~~~~~--~ia-------~~ia~-aL~yLH 439 (692)
+|.++.+. ||...... . .|.... .+. .+.+. .++.++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98766321 11110000 0 011110 000 01111 111111
Q ss_pred hc---CCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 440 SA---MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 440 ~~---~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
.. ..+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 124589999999999999876677999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00039 Score=73.23 Aligned_cols=77 Identities=13% Similarity=0.107 Sum_probs=58.0
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCC---CCeeeeEEEEEe---CCeeEEEEEe
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH---PNLLRLLGCCIE---EGEPILVYEF 401 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H---~niv~l~g~~~~---~~~~~lV~E~ 401 (692)
..+.||.|..+.||+-...+++ +++|..+. ......|.+|.+.|+.|.. -.+.++++++.. .+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3567999999999998765564 66677432 1133578899999999853 478899988764 3668999999
Q ss_pred CCCCCH
Q 005536 402 MPNGTL 407 (692)
Q Consensus 402 ~~~gsL 407 (692)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00044 Score=69.99 Aligned_cols=141 Identities=18% Similarity=0.240 Sum_probs=81.4
Q ss_pred ceeecccccEEEEEEEEeC--CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCeeEEEEEeCCCC
Q 005536 329 KHRLGTGAYGTVYAGKLHN--DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN-LLRLLGCCIEEGEPILVYEFMPNG 405 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g 405 (692)
.+.|..|-...+|+....+ +..|++|........ ...-.+|+.+++.+...+ .+++++... -.+||||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567778888999987664 578889977543221 122347888888885333 444544332 24899999887
Q ss_pred CHHHH-----------------HhhccCC---------CC-CHHHHHHHHH----------------------HHHHHHH
Q 005536 406 TLCQH-----------------LQRERGS---------GL-PWTIRITIAT----------------------ETAQAIA 436 (692)
Q Consensus 406 sL~~~-----------------l~~~~~~---------~l-~~~~~~~ia~----------------------~ia~aL~ 436 (692)
++... +|..... .. .|..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65311 1111100 11 1222111111 1111112
Q ss_pred HH----Hhc-CCCCeEecCCCCCceEEcC-CCceEEeeecCCcc
Q 005536 437 YL----HSA-MNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRL 474 (692)
Q Consensus 437 yL----H~~-~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 474 (692)
.| ... ....++|+|+.+.|||+++ +..+.|.||..|..
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 22 111 1246999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0007 Score=66.16 Aligned_cols=125 Identities=23% Similarity=0.338 Sum_probs=90.9
Q ss_pred ccCccceeeccccc-EEEEEEEEeCCCEEEEEEeecC---Cc------------------hhHHHHHHHHHHHHhCC---
Q 005536 324 SFFSEKHRLGTGAY-GTVYAGKLHNDDWVAIKRFRYR---DT------------------DSIDQVMNEIKLLSSVS--- 378 (692)
Q Consensus 324 ~~f~~~~~LG~G~f-G~Vy~g~~~~~~~vavK~~~~~---~~------------------~~~~~~~~E~~il~~l~--- 378 (692)
..++..+.||.|.. |.|||.++ +|+.+|+|.++.- .. ...+-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999988 5668999994321 00 11235788998888885
Q ss_pred CCCe--eeeEEEEEeCC------------------eeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Q 005536 379 HPNL--LRLLGCCIEEG------------------EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438 (692)
Q Consensus 379 H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yL 438 (692)
+.++ |+.+||..-.. ...||.||++... .+ ..+-+.++.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 4566 99999974331 2357888876533 11 223445777788889
Q ss_pred HhcCCCCeEecCCCCCceEEcCCCceEEeeecCC
Q 005536 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 439 H~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 472 (692)
|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 995 9999999999986 4589999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00031 Score=73.89 Aligned_cols=142 Identities=20% Similarity=0.248 Sum_probs=86.8
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCC--CeeeeEEE------EEeCCeeEEEEE
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP--NLLRLLGC------CIEEGEPILVYE 400 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~--niv~l~g~------~~~~~~~~lV~E 400 (692)
.+.|..|....+|+....+ ..+++|+... ...++...|++++..+.+. .+.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987644 4688888764 2345566788888877533 34555442 123456789999
Q ss_pred eCCCCCHHH--------------HHhhcc-C--------CCCCHHHHHH----------HHHHHHHHHHHHHh----cCC
Q 005536 401 FMPNGTLCQ--------------HLQRER-G--------SGLPWTIRIT----------IATETAQAIAYLHS----AMN 443 (692)
Q Consensus 401 ~~~~gsL~~--------------~l~~~~-~--------~~l~~~~~~~----------ia~~ia~aL~yLH~----~~~ 443 (692)
|++|..+.. .||... . ....|..... ....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866421 111110 0 0123322211 11223344555543 123
Q ss_pred CCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 444 ~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0012 Score=71.75 Aligned_cols=76 Identities=14% Similarity=0.147 Sum_probs=56.2
Q ss_pred ceeecccccEEEEEEEEeCC-CEEEEEEeecC-----C--chhHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCeeEE
Q 005536 329 KHRLGTGAYGTVYAGKLHND-DWVAIKRFRYR-----D--TDSIDQVMNEIKLLSSVS---HPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~il~~l~---H~niv~l~g~~~~~~~~~l 397 (692)
.+.||.|.+..||+....+| +.|+||.-... . +...+++..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998877 48999985422 1 234567788888888763 3467778777 4456789
Q ss_pred EEEeCCCCC
Q 005536 398 VYEFMPNGT 406 (692)
Q Consensus 398 V~E~~~~gs 406 (692)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00036 Score=71.83 Aligned_cols=137 Identities=16% Similarity=0.101 Sum_probs=78.4
Q ss_pred ecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCeeEEEEEeCCCCCHHH-
Q 005536 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL-LRLLGCCIEEGEPILVYEFMPNGTLCQ- 409 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~- 409 (692)
+..|-...+|+.. .++..+++|........-.-...+|.++++.+....+ .++++... -.+||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4567778899887 4566788887654322211235789999988864333 44444432 368999998866532
Q ss_pred -------------H---Hhhcc--CCCCCHHHHH-HHH---------HHHHHHHHHHHhc-----CCCCeEecCCCCCce
Q 005536 410 -------------H---LQRER--GSGLPWTIRI-TIA---------TETAQAIAYLHSA-----MNPPIYHRDIKSSNI 456 (692)
Q Consensus 410 -------------~---l~~~~--~~~l~~~~~~-~ia---------~~ia~aL~yLH~~-----~~~~iiHrDik~~NI 456 (692)
. ||... +.+++...++ ... ..+...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 12111 1112222111 111 0111112222211 123589999999999
Q ss_pred EEcCCCceEEeeecCCcc
Q 005536 457 LLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 457 Lld~~~~~kl~DFGla~~ 474 (692)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00072 Score=64.07 Aligned_cols=129 Identities=16% Similarity=0.149 Sum_probs=85.7
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
..+.|++|.+|.||+|.+.++ .+|+|+-+. +.....+..|+++|..+.-.++.+=+-.+- .-.+.|||+.|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcch
Confidence 356799999999999988654 788888654 345577899999999998776654333222 22345999988788
Q ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceEEcCCCceEEeeecCCcc
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIK-SSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik-~~NILld~~~~~kl~DFGla~~ 474 (692)
.+.-... +-...+ .+++.---|.. .+|-|+.|. |..++|..+..+.|+||.-|+.
T Consensus 100 ~~~~~~~-----~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG-----DRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc-----cHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6654321 222222 33444222333 388888886 4444444555999999998874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0028 Score=67.43 Aligned_cols=141 Identities=16% Similarity=0.204 Sum_probs=78.4
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCC--CCeeeeEE------EEEeCCeeEEEEEe
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH--PNLLRLLG------CCIEEGEPILVYEF 401 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H--~niv~l~g------~~~~~~~~~lV~E~ 401 (692)
+.|+.|...++|+....++ .+++|++.... .++...|+.++..|.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999876555 58889876222 2333345555555532 12334442 12235568999999
Q ss_pred CCCCCHH-----------H---HHhhccC---------CCCCH-HHHHH-------------HHHHHHHHHHHHHhc---
Q 005536 402 MPNGTLC-----------Q---HLQRERG---------SGLPW-TIRIT-------------IATETAQAIAYLHSA--- 441 (692)
Q Consensus 402 ~~~gsL~-----------~---~l~~~~~---------~~l~~-~~~~~-------------ia~~ia~aL~yLH~~--- 441 (692)
++|..+. + .||.... ..+.| ..... +...+...++.+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9886431 1 1121110 01222 11111 111111222333311
Q ss_pred -CCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 442 -MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 442 -~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
...+++|+|+.+.|||++++...-|.||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 245899999999999999776668999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0014 Score=69.03 Aligned_cols=140 Identities=19% Similarity=0.252 Sum_probs=83.6
Q ss_pred eeecccccEEEEEEEEeC-------CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCeeEEEEEe
Q 005536 330 HRLGTGAYGTVYAGKLHN-------DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN-LLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n-iv~l~g~~~~~~~~~lV~E~ 401 (692)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667677899987655 4788899876432 23345568888888885333 3455555432 368999
Q ss_pred CCCCCHHHH-----------------HhhccCC-------CC--CHHHHHH--------------------------HHH
Q 005536 402 MPNGTLCQH-----------------LQRERGS-------GL--PWTIRIT--------------------------IAT 429 (692)
Q Consensus 402 ~~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------ia~ 429 (692)
++|.++... ||..... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765421 1111111 00 0111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCceEEcCC----CceEEeeecCCcc
Q 005536 430 ETAQAIAYLHS------AMNPPIYHRDIKSSNILLDYN----YRSKVADFGLSRL 474 (692)
Q Consensus 430 ~ia~aL~yLH~------~~~~~iiHrDik~~NILld~~----~~~kl~DFGla~~ 474 (692)
++...+.+|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134578999999999999985 8899999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.007 Score=64.06 Aligned_cols=143 Identities=15% Similarity=0.218 Sum_probs=83.3
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCC--CeeeeEEEE------EeCCeeEEEEE
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP--NLLRLLGCC------IEEGEPILVYE 400 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~--niv~l~g~~------~~~~~~~lV~E 400 (692)
.+.++.|....+|+....++ .+++|+.+... ..++...|++++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34566776789998876555 57788775431 234455677777776422 244544421 22456789999
Q ss_pred eCCCCCHH-----------H---HHhhccCC----------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005536 401 FMPNGTLC-----------Q---HLQRERGS----------GLPWTIRI------------TIATETAQAIAYLHS---- 440 (692)
Q Consensus 401 ~~~~gsL~-----------~---~l~~~~~~----------~l~~~~~~------------~ia~~ia~aL~yLH~---- 440 (692)
|++|..+. . .+|..... .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99875431 1 12211100 01121111 011123345555543
Q ss_pred cCCCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 441 ~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
....+++|+|+++.||+++++....|.||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2346899999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0014 Score=77.64 Aligned_cols=195 Identities=17% Similarity=0.162 Sum_probs=131.8
Q ss_pred HHHHHHHHHhCCCCCeeeeEEEEEeCCe----eEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005536 367 VMNEIKLLSSVSHPNLLRLLGCCIEEGE----PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442 (692)
Q Consensus 367 ~~~E~~il~~l~H~niv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~ 442 (692)
...|...+.++.|+|++.++++..+... ..+..|++..-++...++.. ..++....+.+..+..+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 3456777788899999999999876543 23456788888888888764 4578888889999999999999995
Q ss_pred CCCeEecCCCCC---ceEEcCCCceEEe--eecCCccCCCCCCcccccCCCCCCCCCccccccCCCCC--ccceeehhHH
Q 005536 443 NPPIYHRDIKSS---NILLDYNYRSKVA--DFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD--KSDVYSFGVV 515 (692)
Q Consensus 443 ~~~iiHrDik~~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDV~SfGvl 515 (692)
...|.-+..+ +.-.+..+.+.++ ||+.++....... .....-+..|.+||......++. ..|+|.+|.+
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 4444444444 4444566677777 8888875433221 12223455677888776555444 4799999999
Q ss_pred HHHHHhCCcccCCCCCcccccHHHHHHHHhccCcccccccccCCcCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005536 516 LIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 516 l~eLltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~L~~~Cl~~~p~~RPsm~eVl 595 (692)
+..+..+..+...... ...+++. .......+...+|+..++++|+...+++
T Consensus 382 ~~~~~~~~~i~~~~~~------------------~~~~l~~-----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------------PVSLLDV-----------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HhhhhhcCcccccccc------------------hhhhhcc-----------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999998654331110 0111111 0111456788899999999999999887
Q ss_pred HH
Q 005536 596 EE 597 (692)
Q Consensus 596 ~~ 597 (692)
..
T Consensus 433 ~~ 434 (1351)
T KOG1035|consen 433 TH 434 (1351)
T ss_pred hc
Confidence 53
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0097 Score=62.66 Aligned_cols=127 Identities=20% Similarity=0.317 Sum_probs=76.4
Q ss_pred CCEEEEEEee--cCCchhHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCC--eeEEEEEeCCCCCHHHHHhhc-------
Q 005536 348 DDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSH--PNLLRLLGCCIEEG--EPILVYEFMPNGTLCQHLQRE------- 414 (692)
Q Consensus 348 ~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~------- 414 (692)
++.+++. .. ...........+|..+|+.+.- --+...++.|.++. .++.||+|+++..+.+.+...
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6677777 32 1233455666788888888753 44556677777665 779999999874332211110
Q ss_pred -----------cC-----------------CC-CCHHHHHHHHH--------HHHHHHHHHHhcC-----CCCeEecCCC
Q 005536 415 -----------RG-----------------SG-LPWTIRITIAT--------ETAQAIAYLHSAM-----NPPIYHRDIK 452 (692)
Q Consensus 415 -----------~~-----------------~~-l~~~~~~~ia~--------~ia~aL~yLH~~~-----~~~iiHrDik 452 (692)
+. .. -.|...++.+. ....-..||+... .+.++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 00 00 11222221110 1122344554432 2469999999
Q ss_pred CCceEEcCCCceEEeeecCCccC
Q 005536 453 SSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 453 ~~NILld~~~~~kl~DFGla~~~ 475 (692)
+.||+++++.-+-|.||+++.+.
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999988999999999763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.01 Score=61.79 Aligned_cols=31 Identities=23% Similarity=0.474 Sum_probs=26.0
Q ss_pred CCeEecCCCCCceEEcCCCc-eEEeeecCCcc
Q 005536 444 PPIYHRDIKSSNILLDYNYR-SKVADFGLSRL 474 (692)
Q Consensus 444 ~~iiHrDik~~NILld~~~~-~kl~DFGla~~ 474 (692)
+.++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.015 Score=62.58 Aligned_cols=140 Identities=21% Similarity=0.241 Sum_probs=80.7
Q ss_pred eeecccccEEEEEEEEeC-----CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCeeEEEEEeCC
Q 005536 330 HRLGTGAYGTVYAGKLHN-----DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL-LRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~ 403 (692)
+.|-.|-.-.+|+....+ ++.|++|..........+ -.+|..++..+...++ .++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345457777889876533 357888887654332222 2678888888864433 455665533 2 5899998
Q ss_pred CCCHHHH-----------------Hhhcc--CC--CCCHHHHHHHHHH-----------------HHHHHHHHHh-----
Q 005536 404 NGTLCQH-----------------LQRER--GS--GLPWTIRITIATE-----------------TAQAIAYLHS----- 440 (692)
Q Consensus 404 ~gsL~~~-----------------l~~~~--~~--~l~~~~~~~ia~~-----------------ia~aL~yLH~----- 440 (692)
+.+|... +|... .. ...|.....+..+ +...+..|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666321 12111 00 1123322222211 1112222221
Q ss_pred cCCCCeEecCCCCCceEEcC-CCceEEeeecCCcc
Q 005536 441 AMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRL 474 (692)
Q Consensus 441 ~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 474 (692)
.....++|+|+++.|||+++ +..+.+.||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11246899999999999986 46899999988754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.003 Score=65.34 Aligned_cols=144 Identities=17% Similarity=0.195 Sum_probs=96.8
Q ss_pred CChHHHHHhhc---cCccceeecccccEEEEEEEEeCCCEEEEEEeecCC-----------------ch-----hHHHHH
Q 005536 314 YPYKEIEKATS---FFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD-----------------TD-----SIDQVM 368 (692)
Q Consensus 314 ~~~~el~~~~~---~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~ 368 (692)
|.|-.|+...+ -++..++||-|.-+-||.+-..+|++.++|.-+... .. +.-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44555555444 356788999999999999999999999988654220 00 111245
Q ss_pred HHHHHHHhCC-C-CCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005536 369 NEIKLLSSVS-H-PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446 (692)
Q Consensus 369 ~E~~il~~l~-H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~i 446 (692)
+|+..|+.|. | =-+.+.+++ ..-++|||++.+-.|.+.-+-. +.. .+...+..-+.-|.. .|+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~---~ly~~lm~~Iv~la~---~Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPP---TLYDDLMGLIVRLAN---HGL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChH---HHHHHHHHHHHHHHH---cCc
Confidence 7888888885 3 345555554 3458899999887775533221 222 222233333444444 499
Q ss_pred EecCCCCCceEEcCCCceEEeeecCC
Q 005536 447 YHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 447 iHrDik~~NILld~~~~~kl~DFGla 472 (692)
||+|..-=||+++++..++++||--.
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred eecccchheeEEecCCCEEEeechHh
Confidence 99999999999999999999999654
|
|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.00098 Score=45.96 Aligned_cols=29 Identities=45% Similarity=1.035 Sum_probs=21.8
Q ss_pred cCCCCCcccccccccCCCCceeeecCCCCCCCCcc
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFV 235 (692)
Q Consensus 201 ~C~~~~~C~~~~~~~~~~~g~~C~C~~G~~Gnpy~ 235 (692)
.|+.|+.|.+. ...|.|.|..||.||||.
T Consensus 7 ~C~~nA~C~~~------~~~~~C~C~~Gy~GdG~~ 35 (36)
T PF12947_consen 7 GCHPNATCTNT------GGSYTCTCKPGYEGDGFF 35 (36)
T ss_dssp GS-TTCEEEE-------TTSEEEEE-CEEECCSTC
T ss_pred CCCCCcEeecC------CCCEEeECCCCCccCCcC
Confidence 47889999865 238999999999999873
|
; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A. |
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0033 Score=38.92 Aligned_cols=24 Identities=21% Similarity=0.675 Sum_probs=18.7
Q ss_pred ceeeecCCCCCCCCccCCCCCccccc
Q 005536 220 GHRCRCQEGFEGDGFVAGDGCRRTSD 245 (692)
Q Consensus 220 g~~C~C~~G~~Gnpy~~~~gC~~i~e 245 (692)
+|+|.|..||.=++ .+..|.||||
T Consensus 1 sy~C~C~~Gy~l~~--d~~~C~DIdE 24 (24)
T PF12662_consen 1 SYTCSCPPGYQLSP--DGRSCEDIDE 24 (24)
T ss_pred CEEeeCCCCCcCCC--CCCccccCCC
Confidence 58999999998544 2347999987
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.093 Score=55.40 Aligned_cols=31 Identities=29% Similarity=0.331 Sum_probs=26.5
Q ss_pred CCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 443 ~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 358999999999999998 5789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.084 Score=57.52 Aligned_cols=73 Identities=11% Similarity=0.048 Sum_probs=50.7
Q ss_pred ceeecccccEEEEEEEEeCCCEEEEEEeecCC-------chhHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCeeEEE
Q 005536 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD-------TDSIDQVMNEIKLLSSVS---HPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 329 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~---H~niv~l~g~~~~~~~~~lV 398 (692)
.+.||.|..-.||+.... +..++||+-.... +...++-..|...|..+. ..++.+++.++.+ .-+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 567899999999998764 4569999875221 123344445666666553 3588889988774 45788
Q ss_pred EEeCCC
Q 005536 399 YEFMPN 404 (692)
Q Consensus 399 ~E~~~~ 404 (692)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.062 Score=57.50 Aligned_cols=73 Identities=15% Similarity=0.110 Sum_probs=49.4
Q ss_pred eecccccEEEEEEEEeCC-CEEEEEEeecC-------CchhHHHHHHHHHHHHhCC--CC-CeeeeEEEEEeCCeeEEEE
Q 005536 331 RLGTGAYGTVYAGKLHND-DWVAIKRFRYR-------DTDSIDQVMNEIKLLSSVS--HP-NLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~il~~l~--H~-niv~l~g~~~~~~~~~lV~ 399 (692)
.||.|....||++...++ +.|+||.-... -+-..++..-|...|.... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 57999986421 1334455566777776653 23 45555543 455667999
Q ss_pred EeCCCC
Q 005536 400 EFMPNG 405 (692)
Q Consensus 400 E~~~~g 405 (692)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.023 Score=59.36 Aligned_cols=74 Identities=14% Similarity=0.174 Sum_probs=49.9
Q ss_pred cceeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCeeEEEEEeCCC
Q 005536 328 EKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS---HPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 328 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
..+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+++++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35678989999999877 667889999876 334467888888888883 45688999998888888999999987
Q ss_pred C
Q 005536 405 G 405 (692)
Q Consensus 405 g 405 (692)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.0014 Score=79.20 Aligned_cols=175 Identities=12% Similarity=0.048 Sum_probs=119.9
Q ss_pred EEEEEeecCCchhH-----HHHHHHHHHHHhCCCCCeeeeEEEEE--eCCeeEEEEEeCCCCCHHHHHhhccC--CCCCH
Q 005536 351 VAIKRFRYRDTDSI-----DQVMNEIKLLSSVSHPNLLRLLGCCI--EEGEPILVYEFMPNGTLCQHLQRERG--SGLPW 421 (692)
Q Consensus 351 vavK~~~~~~~~~~-----~~~~~E~~il~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~ 421 (692)
..+|+.+..+-+.. +....|..-++...|+++.....-.. +..+.+.+++|+..|.+++.|.+... ..++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45666554433332 23344555555668988877655433 23467889999999999998876432 23444
Q ss_pred HHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCCCccccc
Q 005536 422 TIRITIATETAQAIAYLHSAM--NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQ 499 (692)
Q Consensus 422 ~~~~~ia~~ia~aL~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 499 (692)
.-....-.+...+..-.|+.. ..--+|+++|+-|.+|+.+.++|++++|+.+..... ........+++-|+.|+...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHH
Confidence 333333334355555555542 234689999999999999999999999999842222 22234456788899999998
Q ss_pred cCCCCCccceeehhHHHHHHHhCCccc
Q 005536 500 YFHLSDKSDVYSFGVVLIEIITALKVV 526 (692)
Q Consensus 500 ~~~~s~ksDV~SfGvll~eLltg~~p~ 526 (692)
.-.++.++|+|..|..+|++--|..++
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 888999999999999999998876654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.067 Score=56.60 Aligned_cols=136 Identities=18% Similarity=0.222 Sum_probs=93.8
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecC-----Cch---------------------hHHHHHHHHHHHHhCCCCCee
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYR-----DTD---------------------SIDQVMNEIKLLSSVSHPNLL 383 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~---------------------~~~~~~~E~~il~~l~H~niv 383 (692)
..|..|--+-||.+.-.+|..+|||+++.. +.+ -.-...+|+.-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357889999999999999999999998643 111 012345688888888765543
Q ss_pred eeEEEEEeCCeeEEEEEeCCCCC-HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 005536 384 RLLGCCIEEGEPILVYEFMPNGT-LCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY 462 (692)
Q Consensus 384 ~l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~ 462 (692)
-.--..+. .-.|||+|+.... -.-.|. ...++...+..+-.+++.-+.-|-+.| ++||.||.--|+|+- +|
T Consensus 230 ~PePIlLk--~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCceeee--cceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CC
Confidence 32222222 2369999984211 111121 234677777788888888888887764 899999999999985 45
Q ss_pred ceEEeeecCCc
Q 005536 463 RSKVADFGLSR 473 (692)
Q Consensus 463 ~~kl~DFGla~ 473 (692)
.+.|+|.+-+.
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 78999998775
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.13 Score=54.32 Aligned_cols=32 Identities=16% Similarity=0.226 Sum_probs=28.8
Q ss_pred CCCeEecCCCCCceEEcCCCceEEeeecCCcc
Q 005536 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 443 ~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 474 (692)
..+++|+|+.+.|||+++++.+.|.||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 35799999999999999999999999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.08 Score=56.33 Aligned_cols=139 Identities=22% Similarity=0.338 Sum_probs=83.2
Q ss_pred ecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCC------eeeeEEEEE--eCC--eeEEEEEe
Q 005536 332 LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN------LLRLLGCCI--EEG--EPILVYEF 401 (692)
Q Consensus 332 LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n------iv~l~g~~~--~~~--~~~lV~E~ 401 (692)
|.+ .-..||+....+++. ++|..+.. ....+...|...+..|.-.. +..+=|-.. -.. ..+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988877775 88888764 34455566777776663211 222222211 123 77889999
Q ss_pred CCCCCHHH---------------HHhhc-------c---CCCCCHHH-------------HHHHHHHHHHHHHHHHhcC-
Q 005536 402 MPNGTLCQ---------------HLQRE-------R---GSGLPWTI-------------RITIATETAQAIAYLHSAM- 442 (692)
Q Consensus 402 ~~~gsL~~---------------~l~~~-------~---~~~l~~~~-------------~~~ia~~ia~aL~yLH~~~- 442 (692)
++|..+.. .||.. + .....|.. ......++...+..+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99877762 11110 0 01244541 0123344444555554422
Q ss_pred ---CCC---eEecCCCCCceEEcCCCc-eEEeeecCCcc
Q 005536 443 ---NPP---IYHRDIKSSNILLDYNYR-SKVADFGLSRL 474 (692)
Q Consensus 443 ---~~~---iiHrDik~~NILld~~~~-~kl~DFGla~~ 474 (692)
... +||+|+.+.|||+|.+.. ..+.||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 223 999999999999999885 99999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.11 Score=55.64 Aligned_cols=140 Identities=17% Similarity=0.238 Sum_probs=78.4
Q ss_pred eeecccccEEEEEEEEeC----CCEEEEEEeecCCchhHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCeeEEEEEeCCC
Q 005536 330 HRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL-LRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~ 404 (692)
+.|..|=.-.+|+....+ +..|++|....... ..-.-.+|..+++.+..-++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345556667788876543 23788888765432 22223578888888865544 45566552 22 58999977
Q ss_pred CCHHH-----------------HHhhccC---C-CCCHHHHHHHHHH----------------------HHHHHHHHHhc
Q 005536 405 GTLCQ-----------------HLQRERG---S-GLPWTIRITIATE----------------------TAQAIAYLHSA 441 (692)
Q Consensus 405 gsL~~-----------------~l~~~~~---~-~l~~~~~~~ia~~----------------------ia~aL~yLH~~ 441 (692)
.+|.. .||.... . .-.|....++..+ +..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 1121110 0 1123332222211 11112222211
Q ss_pred -----CCCCeEecCCCCCceEEcC-CCceEEeeecCCcc
Q 005536 442 -----MNPPIYHRDIKSSNILLDY-NYRSKVADFGLSRL 474 (692)
Q Consensus 442 -----~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 474 (692)
...-+.|+|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1124789999999999975 57899999988753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.13 Score=63.30 Aligned_cols=141 Identities=18% Similarity=0.290 Sum_probs=79.2
Q ss_pred eeecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC--CCC--eeeeEE--------EEEe-CC--e
Q 005536 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS--HPN--LLRLLG--------CCIE-EG--E 394 (692)
Q Consensus 330 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--H~n--iv~l~g--------~~~~-~~--~ 394 (692)
+.|+ |..-.+|+....+++.+++|+.+.... ......|.+.|..|. ++. +.+++- .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 456778988887888899999986432 233334555555442 122 223221 1111 22 4
Q ss_pred eEEEEEeCCCCCHHHH-----------------Hhhc--------cCCCCCHHHH-----------------HHHHHHHH
Q 005536 395 PILVYEFMPNGTLCQH-----------------LQRE--------RGSGLPWTIR-----------------ITIATETA 432 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~-----------------l~~~--------~~~~l~~~~~-----------------~~ia~~ia 432 (692)
.+-+++|++|..|.+. |+.. ....+.|..+ ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999998777541 1110 0112344321 12222222
Q ss_pred HHHH-----HHHhcCCCCeEecCCCCCceEEcCCC--ceE-EeeecCCcc
Q 005536 433 QAIA-----YLHSAMNPPIYHRDIKSSNILLDYNY--RSK-VADFGLSRL 474 (692)
Q Consensus 433 ~aL~-----yLH~~~~~~iiHrDik~~NILld~~~--~~k-l~DFGla~~ 474 (692)
..+. .|.+ ....+||+|+.+.|||++.+. ++. |.|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 2222 345799999999999999875 454 999998754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.51 Score=50.35 Aligned_cols=71 Identities=15% Similarity=0.102 Sum_probs=44.6
Q ss_pred cccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCCCC--CeeeeE---E--EEEeCCeeEEEEEeCCCCC
Q 005536 335 GAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHP--NLLRLL---G--CCIEEGEPILVYEFMPNGT 406 (692)
Q Consensus 335 G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~--niv~l~---g--~~~~~~~~~lV~E~~~~gs 406 (692)
+.-..||+....++..+++|..+.. .....+...|++.+..|... .++..+ | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4556799988878888999987633 23445666777777766321 122211 1 1223456788999998754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.054 Score=53.82 Aligned_cols=122 Identities=17% Similarity=0.109 Sum_probs=60.2
Q ss_pred CCEEEEEEeecCCchhHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCeeEEEEEeCCCCCHHH-------H---------
Q 005536 348 DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCIEEGEPILVYEFMPNGTLCQ-------H--------- 410 (692)
Q Consensus 348 ~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-------~--------- 410 (692)
++.|+||+.... ....-.-.+|..+++.+.. -.-.++++.+.+ ..|+||+++.+|.. .
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 456888888755 3444555678888888864 444556665433 26779997655421 1
Q ss_pred -HhhccC-----CCCCHHHHHHH----------------------HHHHHHHHHHHHh---c--CCCCeEecCCCCCceE
Q 005536 411 -LQRERG-----SGLPWTIRITI----------------------ATETAQAIAYLHS---A--MNPPIYHRDIKSSNIL 457 (692)
Q Consensus 411 -l~~~~~-----~~l~~~~~~~i----------------------a~~ia~aL~yLH~---~--~~~~iiHrDik~~NIL 457 (692)
+|.... ..--|.....+ ...+..-+..+.+ . ....+.|+|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 111100 00112222111 1111222222221 1 1135789999999999
Q ss_pred E-cCCCceEEeeecCCcc
Q 005536 458 L-DYNYRSKVADFGLSRL 474 (692)
Q Consensus 458 l-d~~~~~kl~DFGla~~ 474 (692)
+ +.++.++++||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.13 Score=50.81 Aligned_cols=152 Identities=16% Similarity=0.127 Sum_probs=92.0
Q ss_pred cccEEEEEEEEeCCCEEEEEEeecCCch-hHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCeeEEEEEeCCCCCHHHHHhh
Q 005536 335 GAYGTVYAGKLHNDDWVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR 413 (692)
Q Consensus 335 G~fG~Vy~g~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 413 (692)
++-.|.-+|+-.-| ...+|+++...-. ...-|.++..++.+++ .|++|..- .....-++.|++-....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 33444445543333 3566776644333 4456788899988875 46666621 33456788898832111
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCceEEeeecCCccCCCCCCcccccCCCCCCCC
Q 005536 414 ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493 (692)
Q Consensus 414 ~~~~~l~~~~~~~ia~~ia~aL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 493 (692)
.. ..++.-=+.+|.-.|+. +++.+|+|-.|+||+-|..|.+||.|=+.--. . +.-|.
T Consensus 142 -----~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---~----------~V~~v 198 (308)
T PF07387_consen 142 -----NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---N----------QVNMV 198 (308)
T ss_pred -----ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh---h----------eeeEE
Confidence 11 11222224677888964 47899999999999999999999999653210 0 11122
Q ss_pred CccccccCCCCCccceeehhHHHHHHHhCC
Q 005536 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITAL 523 (692)
Q Consensus 494 aPE~~~~~~~s~ksDV~SfGvll~eLltg~ 523 (692)
--| ....|.++.+=+|=.-++++....
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 211 234567788878877777777643
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.053 Score=59.61 Aligned_cols=51 Identities=24% Similarity=0.281 Sum_probs=40.5
Q ss_pred hHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-CeeEEEEEeCCCCCHHHHHhhc
Q 005536 363 SIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-GEPILVYEFMPNGTLCQHLQRE 414 (692)
Q Consensus 363 ~~~~~~~E~~il~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~ 414 (692)
...+..-....++.+.|+|+-..+.+-... ....+|+|++ +.+|++.+...
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 345667778899999999999999887654 3477899998 78999988654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.27 Score=48.93 Aligned_cols=74 Identities=15% Similarity=0.252 Sum_probs=51.0
Q ss_pred eecccccEEEEEEEEeCCCEEEEEEeecCCchhHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCeeEEEEEeCCCCCH
Q 005536 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS---HPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 331 ~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
.+.-|.--.-|... .+...+.||+=. ......|..|+.-|..|. .-++.+++.+-.+.+..+||+||++-+.+
T Consensus 23 ~v~gG~inea~~v~-dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLR-DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEee-cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 44444444444432 234568888743 344567888888777764 46688889888899999999999988665
Q ss_pred H
Q 005536 408 C 408 (692)
Q Consensus 408 ~ 408 (692)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 4
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 692 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-44 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-116
Identities = 112/291 (38%), Positives = 164/291 (56%), Gaps = 9/291 (3%)
Query: 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKL 373
P ++E+AT+ F K +G G +G VY G L + VA+KR + I++ EI+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 374 LSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG--LPWTIRITIATET 431
LS HP+L+ L+G C E E IL+Y++M NG L +HL + W R+ I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES-SHISTAPQGTP 490
A+ + YLH I HRD+KS NILLD N+ K+ DFG+S+ G +H+ST +GT
Sbjct: 149 ARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550
GY+DP+Y L++KSDVYSFGVVL E++ A + S P VNLA A++ G +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
++I+DP L D S+ + A +CLA + RP+M +V +LE+
Sbjct: 266 EQIVDPNLA---DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-100
Identities = 98/291 (33%), Positives = 161/291 (55%), Gaps = 8/291 (2%)
Query: 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSID-QVMNEIK 372
+ +E++ A+ FS K+ LG G +G VY G+L + VA+KR + T + Q E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLP--WTIRITIATE 430
++S H NLLRL G C+ E +LVY +M NG++ L+ S P W R IA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
+A+ +AYLH +P I HRD+K++NILLD + + V DFGL++L + +H++TA +GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 491 GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSE--VNLAALAIDRIGRG 548
G++ P+Y S+K+DV+ +GV+L+E+IT + D +R ++ V L +
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599
++ ++D L+ + + + ++A C RP M EV LE
Sbjct: 260 KLEALVDVDLQGNYKD---EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = 2e-99
Identities = 93/310 (30%), Positives = 159/310 (51%), Gaps = 24/310 (7%)
Query: 308 NSSVPFYPYKEIEKATSFFSEK------HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT 361
++ + + E++ T+ F E+ +++G G +G VY G + N+ VA+K+
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 362 DSIDQV----MNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS 417
+ +++ EIK+++ H NL+ LLG + + LVY +MPNG+L L G+
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 418 G-LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
L W +R IA A I +LH HRDIKS+NILLD + +K++DFGL+R
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 477 TES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
+ + +++ GT Y+ P+ ++ KSD+YSFGVVL+EIIT L VD R
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQ 241
Query: 536 NLAALAIDRIG-RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594
L + + +++ ID + +S+ + +A +CL ++ RP + +V
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 595 AEELEHIRVS 604
+ L+ + S
Sbjct: 298 QQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 5e-76
Identities = 74/320 (23%), Positives = 123/320 (38%), Gaps = 38/320 (11%)
Query: 308 NSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQV 367
+S V + + + G +G V+ +L N+ VA+K F +D S Q
Sbjct: 9 SSGVDL-GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQS-WQN 65
Query: 368 MNEIKLLSSVSHPNLLRLLGCCIE----EGEPILVYEFMPNGTLCQHLQRERGSGLPWTI 423
E+ L + H N+L+ +G + + L+ F G+L L+ + W
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNE 122
Query: 424 RITIATETAQAIAYLHS-------AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
IA A+ +AYLH P I HRDIKS N+LL N + +ADFGL+
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 477 TESSHISTAPQ-GTPGYLDPQY--------HQYFHLSDKSDVYSFGVVLIEIITALKVVD 527
S T Q GT Y+ P+ F + D+Y+ G+VL E+ + D
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL---RIDMYAMGLVLWELASRCTAAD 239
Query: 528 FSRPHSEVNLAAL-----AIDRIGRGCVDEIIDPYLEPHRDAWTLSS-IHNVAELAFRCL 581
+ +++ + V + P L + W + + + E C
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECW 296
Query: 582 AFHRDMRPTMMEVAEELEHI 601
+ R + V E + +
Sbjct: 297 DHDAEARLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-68
Identities = 78/297 (26%), Positives = 139/297 (46%), Gaps = 37/297 (12%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD--TDSIDQVMNEIK 372
P+ ++ K ++G G++GTV+ + H D VA+K +D + +++ + E+
Sbjct: 35 PWCDLN-------IKEKIGAGSFGTVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVA 86
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-ERGSGLPWTIRITIATET 431
++ + HPN++ +G + +V E++ G+L + L + L R+++A +
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+ + YLH+ NPPI HR++KS N+L+D Y KV DFGLSRL + S + GTP
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPE 204
Query: 492 YLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548
++ P + ++KSDVYSFGV+L E+ T +P +N A + +G
Sbjct: 205 WMAPEVLRDEPS---NEKSDVYSFGVILWELATL------QQPWGNLNPAQ-VVAAVGFK 254
Query: 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
+ A + C RP+ + + L + S+
Sbjct: 255 --------CKRLEIPRNLNPQV---AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-67
Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 36/294 (12%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFR--YRDTDSIDQVMNEIK 372
P +I R+G+G++GTVY GK H D VA+K + NE+
Sbjct: 22 PDGQIT-------VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
+L H N+L +G + +V ++ +L HL I IA +T
Sbjct: 73 VLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQT 129
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL-GMTESSHISTAPQGTP 490
A+ + YLH+ I HRD+KS+NI L + K+ DFGL+ SH G+
Sbjct: 130 ARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 491 GYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547
++ P + S +SDVY+FG+VL E++T P+S +N I+ +GR
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIEMVGR 240
Query: 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
G L P + + L CL RD RP+ + E+E +
Sbjct: 241 G--------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-64
Identities = 57/298 (19%), Positives = 115/298 (38%), Gaps = 46/298 (15%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD--TDSIDQVMNEIK 372
+K++ +L G ++ G+ +D + +K + RD T E
Sbjct: 8 DFKQLN-------FLTKLNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECP 59
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPIL--VYEFMPNGTLCQHLQRERGSGLPWTIRITIATE 430
L SHPN+L +LG C P + +MP G+L L + + + A +
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
A+ +A+LH+ + P I + S ++++D + ++++ + S S P
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAP 172
Query: 491 GYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547
++ P Q +D++SF V+L E++T P ++++ + +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR------EVPFADLSNMEIGMKVALE 226
Query: 548 GCVDEI---IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
G I I P++ ++L C+ RP + LE ++
Sbjct: 227 GLRPTIPPGISPHV---------------SKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-63
Identities = 75/318 (23%), Positives = 135/318 (42%), Gaps = 53/318 (16%)
Query: 305 AAGNSSVPFYPYKEIEKATSFFSE---KHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD 360
A G S P + +E + ++G G +G V+ G+ + + VAIK D
Sbjct: 2 AMGGSEFPKSRLPTLA-----DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 361 TDS-------IDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR 413
++ + E+ ++S+++HPN+++L G P +V EF+P G L L
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 414 ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-----YNYRSKVAD 468
+ + W++++ + + A I Y+ + NPPI HRD++S NI L +KVAD
Sbjct: 115 KAHP-IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 469 FGLSRLGMTESSHISTAPQGTPGY-----LDPQYHQYFHLSDKSDVYSFGVVLIEIITAL 523
FGLS+ +S H + G + + + Y ++K+D YSF ++L I+T
Sbjct: 173 FGLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESY---TEKADTYSFAMILYTILTG- 224
Query: 524 KVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAF 583
P E + + ++ I + L P + + C +
Sbjct: 225 -----EGPFDEYSYGKIKF-------INMIREEGLRPTIPEDCPPRL---RNVIELCWSG 269
Query: 584 HRDMRPTMMEVAEELEHI 601
RP + +EL +
Sbjct: 270 DPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 37/293 (12%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLL 374
YKEIE + +G GA+G V K D VAIK+ + E++ L
Sbjct: 6 DYKEIE-------VEEVVGRGAFGVVCKAKWRAKD-VAIKQIE--SESERKAFIVELRQL 55
Query: 375 SSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQ-RERGSGLPWTIRITIATETAQ 433
S V+HPN+++L G C+ LV E+ G+L L E ++ + +Q
Sbjct: 56 SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSRLGMTESSHISTAPQGTPGY 492
+AYLHS + HRD+K N+LL K+ DFG + + T +G+ +
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAW 169
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI-DRIGRGCVD 551
+ P+ + + S+K DV+S+G++L E+IT +P E+ A I + G
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITR------RKPFDEIGGPAFRIMWAVHNGTRP 223
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
+I +P + L RC + RP+M E+ + + H+
Sbjct: 224 PLIKNLPKP------------IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-62
Identities = 60/302 (19%), Positives = 109/302 (36%), Gaps = 47/302 (15%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDS--IDQVMNEIK 372
P++++E +G G +G VY G+ H + VAI+ + + E+
Sbjct: 31 PFEQLE-------IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVM 81
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
H N++ +G C+ ++ TL ++ + L IA E
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIV 140
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHISTAPQG 488
+ + YLH+ I H+D+KS N+ D N + + DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 489 TPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA 539
+L P S SDV++ G + E+ P A
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR------EWPFKTQPAEA 250
Query: 540 LAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELE 599
I ++G G + + ++++ C AF ++ RPT ++ + LE
Sbjct: 251 -IIWQMGTGMKPNLSQIGMGKE-----------ISDILLFCWAFEQEERPTFTKLMDMLE 298
Query: 600 HI 601
+
Sbjct: 299 KL 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-59
Identities = 80/299 (26%), Positives = 127/299 (42%), Gaps = 44/299 (14%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD----TDSIDQVMNE 370
+ E+ + +G G +G VY D+ VA+K R+ + +I+ V E
Sbjct: 5 DFAELT-------LEEIIGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQE 56
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE 430
KL + + HPN++ L G C++E LV EF G L + L +R +P I + A +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQ 113
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS--------KVADFGLSRLGMTESSHI 482
A+ + YLH PI HRD+KSSNIL+ + K+ DFGL+R
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTT 170
Query: 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
+ G ++ P+ + S SDV+S+GV+L E++T P ++ A+A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAY 224
Query: 543 DRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
I EP A+L C RP+ + ++L I
Sbjct: 225 GVAMNKLALPIPSTCPEP------------FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 69/323 (21%), Positives = 116/323 (35%), Gaps = 46/323 (14%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNE--IK 372
E +G G YG VY G L VA+K F + + + +NE I
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSFANRQNF---INEKNIY 59
Query: 373 LLSSVSHPNLLRLLGCCIE-----EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI 427
+ + H N+ R + E +LV E+ PNG+L ++L W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRL 116
Query: 428 ATETAQAIAYLHSAM------NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL------- 474
A + +AYLH+ + P I HRD+ S N+L+ + ++DFGLS
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 475 GMTESSHISTAPQGTPGYLDP-------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVD 527
E + + + GT Y+ P + D+Y+ G++ EI +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 528 FSRPHSEVNLA-------ALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSI--HNVAELAF 578
E +A + + E P +AW +S+ ++ E
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF---PEAWKENSLAVRSLKETIE 293
Query: 579 RCLAFHRDMRPTMMEVAEELEHI 601
C + R T E + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAEL 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 66/298 (22%), Positives = 124/298 (41%), Gaps = 31/298 (10%)
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
++G G YG V+ GK + VA+K F + S EI + H N+L +
Sbjct: 43 KQIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAAD 100
Query: 390 IEEGEPI----LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM--- 442
I+ L+ ++ NG+L +L+ L + +A + + +LH+ +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 443 --NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI---STAPQGTPGYLDP-- 495
P I HRD+KS NIL+ N +AD GL+ +++++ + GT Y+ P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 496 ----QYHQYFHLSDKSDVYSFGVVLIEIIT----ALKVVDFSRPHSEVNLAALAIDRIGR 547
+F +D+YSFG++L E+ V ++ P+ ++ + + + +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 548 GCVDEIIDPYLEPHRDAWTLSSIH-NVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
+ + P W+ + +L C A + R T + V + L + S
Sbjct: 278 IVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-58
Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW-VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G + +K D ++ + E+K++ + HPN+L+ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ + E++ GTL + + S PW+ R++ A + A +AYLHS MN I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHS-MN--II 130
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH-------------ISTAPQGTPGYLD 494
HRD+ S N L+ N VADFGL+RL + E + G P ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 495 P---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551
P Y +K DV+SFG+VL EII + P + L +
Sbjct: 191 PEMINGRSY---DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--FGLNVRGFLDRYCP 245
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
P + RC + RP+ +++ LE +R+
Sbjct: 246 PNCPPSF---------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-58
Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 31/295 (10%)
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+G G YG V+ G ++ VA+K F RD S E+ + H N+L +
Sbjct: 14 ECVGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKS-WFRETELYNTVMLRHENILGFIASD 71
Query: 390 I----EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM--- 442
+ + L+ + G+L +LQ L + I A +A+LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 443 --NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL---GMTESSHISTAPQGTPGYLDP-- 495
P I HRD+KS NIL+ N + +AD GL+ + + + GT Y+ P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 496 ----QYHQYFHLSDKSDVYSFGVVLIEIIT----ALKVVDFSRPHSEVNLAALAIDRIGR 547
F + D+++FG+VL E+ V D+ P +V + + + +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 548 GCVDEIIDPYLEPHRDAWTLSSIH-NVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ P + W ++A+L C + R T + + + L I
Sbjct: 249 VVCVDQQRPNIPNR---WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-57
Identities = 69/321 (21%), Positives = 136/321 (42%), Gaps = 38/321 (11%)
Query: 309 SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVM 368
S +P + I + + +G G +G V+ GK ++ VA+K F R+ S
Sbjct: 30 SGLPLLVQRTIARTIVL---QESIGKGRFGEVWRGKWRGEE-VAVKIFSSREERS-WFRE 84
Query: 369 NEIKLLSSVSHPNLLRLLGCCIEEGEPI----LVYEFMPNGTLCQHLQRERGSGLPWTIR 424
EI + H N+L + ++ LV ++ +G+L +L R +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM 141
Query: 425 ITIATETAQAIAYLHSAM-----NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479
I +A TA +A+LH + P I HRD+KS NIL+ N +AD GL+ + +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 480 SHISTAP---QGTPGY---------LDPQYHQYFHLSDKSDVYSFGVVLIEIIT----AL 523
I AP GT Y ++ ++ + F ++D+Y+ G+V EI
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK---RADIYAMGLVFWEIARRCSIGG 258
Query: 524 KVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAF 583
D+ P+ ++ + +++ + + ++ + P + + ++ +A++ C
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYA 316
Query: 584 HRDMRPTMMEVAEELEHIRVS 604
+ R T + + + L +
Sbjct: 317 NGAARLTALRIKKTLSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 72/311 (23%), Positives = 128/311 (41%), Gaps = 39/311 (12%)
Query: 302 LCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW-VAIKRFRYRD 360
L + +G P + ++G G +G V++G+L D+ VA+K R
Sbjct: 92 LTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL 151
Query: 361 TDS-IDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSG 418
+ + E ++L SHPN++RL+G C ++ +PI +V E + G L R G+
Sbjct: 152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFL-RTEGAR 209
Query: 419 LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478
L + + + A + YL S HRD+ + N L+ K++DFG+SR +
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLES-KC--CIHRDLAARNCLVTEKNVLKISDFGMSRE-EAD 265
Query: 479 SSHISTAPQG------TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPH 532
+ ++ T P+ Y S +SDV+SFG++L E + + +
Sbjct: 266 GVYAASGGLRQVPVKWTA----PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
Query: 533 SEVNLAALAIDRIGRGCVDEIIDPY-LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTM 591
+ + + +G L V L +C A+ RP+
Sbjct: 322 QQT------REFVEKG--------GRLPCPELC-----PDAVFRLMEQCWAYEPGQRPSF 362
Query: 592 MEVAEELEHIR 602
+ +EL+ IR
Sbjct: 363 STIYQELQSIR 373
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 69/374 (18%), Positives = 138/374 (36%), Gaps = 50/374 (13%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR--DTDSIDQVMNEI 371
++ +EK + ++G G++G K + IK + ++ E+
Sbjct: 19 YFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV 74
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
+L+++ HPN+++ E G +V ++ G L + + ++G + +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+ ++H I HRDIKS NI L + ++ DFG++R+ + GTP
Sbjct: 135 CLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPY 190
Query: 492 YLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548
YL P + Y ++KSD+++ G VL E+ T ++ L + +I G
Sbjct: 191 YLSPEICENKPY---NNKSDIWALGCVLYELCT------LKHAFEAGSMKNL-VLKIISG 240
Query: 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608
+ Y S ++ L + + RP++ + LE ++
Sbjct: 241 SFPPVSLHY----------SY--DLRSLVSQLFKRNPRDRPSVNSI---LEKGFIAKRIE 285
Query: 609 NIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVPPKSGDCLTTLDEVKDSSPV 668
LS T K G + P + ++ + K + P
Sbjct: 286 KF-----------LSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPA 334
Query: 669 SVQDPWLSEQSSPS 682
+ L+ +
Sbjct: 335 AKYGIPLAYKKYGD 348
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 39/280 (13%)
Query: 331 RLGTGAYGTVYAGKLHNDD--WVAIKRFRYRDT--DSIDQVMNEIKLLSSVSHPNLLRLL 386
+G G++ TVY G L + VA + R + E ++L + HPN++R
Sbjct: 33 EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 387 GCCIEEGEP----ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ +LV E M +GTL +L+R + + + + + + + +LH+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-R 148
Query: 443 NPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
PPI HRD+K NI + K+ D GL+ L + + + A GTP ++ P+ ++
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEEK 205
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561
+ + DVY+FG+ ++E+ T P+SE AA R+ G D P
Sbjct: 206 Y-DESVDVYAFGMCMLEMAT------SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP- 257
Query: 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL-EH 600
V E+ C+ ++D R + ++L H
Sbjct: 258 ----------EVKEIIEGCIRQNKDERYS----IKDLLNH 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 5e-40
Identities = 81/286 (28%), Positives = 130/286 (45%), Gaps = 41/286 (14%)
Query: 330 HRLGTGAYGTVYAGKLHNDDW-VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
H+LG G YG VY G VA+K + DT +++ + E ++ + HPNL++LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
C E ++ EFM G L +L+ + + + +AT+ + A+ YL N H
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KN--FIH 341
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLSDKS 507
R++ + N L+ N+ KVADFGLSRL MT ++ + A P + P+ Y S KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CVDEIIDPYLE 559
DV++FGV+L EI T S+V + + + C +++ Y
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEGCPEKV---Y-- 449
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
EL C ++ RP+ E+ + E + S
Sbjct: 450 ---------------ELMRACWQWNPSDRPSFAEIHQAFETMFQES 480
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-40
Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+LG G +G V+ G + VAIK + T S + + E +++ + H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 390 IEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
EE PI +V E+M G+L L+ E G L + +A + A +AY+ MN H
Sbjct: 249 SEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MN--YVH 303
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLSDKS 507
RD++++NIL+ N KVADFGL+RL + ++ + + P + P+ Y + KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567
DV+SFG++L E+ T +V + EV +D++ RG P P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPC--PPECPES----- 409
Query: 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
+ +L +C + RPT + LE S+
Sbjct: 410 -----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 58/326 (17%), Positives = 113/326 (34%), Gaps = 40/326 (12%)
Query: 296 LSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIK 354
+ + + ++ + + +LG G + V + LH+ + A+K
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 355 RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEP----ILVYEFMPNGTLCQH 410
R + ++ E + +HPN+LRL+ C+ E L+ F GTL
Sbjct: 61 RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE 120
Query: 411 LQRERGSGLPWT---IRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVA 467
++R + G T I + + + +H+ HRD+K +NILL + +
Sbjct: 121 IERLKDKGNFLTEDQIL-WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLM 176
Query: 468 DFGLSRLGMTESSHISTAPQ--------GTPGYLDP---QYHQYFHLSDKSDVYSFGVVL 516
D G A T Y P + + +++DV+S G VL
Sbjct: 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
Query: 517 IEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAEL 576
++ P+ V ++ + + P SS + +L
Sbjct: 237 YAMMF------GEGPYDMVFQKGDSVALA-------VQNQLSIPQSP--RHSS--ALWQL 279
Query: 577 AFRCLAFHRDMRPTMMEVAEELEHIR 602
+ RP + + +LE ++
Sbjct: 280 LNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 84/297 (28%), Positives = 134/297 (45%), Gaps = 61/297 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW-VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
KH+LG G YG VY G VA+K + DT +++ + E ++ + HPNL++LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 388 CCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C E P ++ EFM G L +L+ + + + +AT+ + A+ YL N
Sbjct: 77 VCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKN--F 132
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGYLDPQ 496
HRD+ + N L+ N+ KVADFGLSRL MT ++ + TAP+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESL------A 185
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG-------- 548
Y+++ S KSDV++FGV+L EI T S+V + + +
Sbjct: 186 YNKF---SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDYRMERPEG 236
Query: 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
C +++ Y EL C ++ RP+ E+ + E + S
Sbjct: 237 CPEKV---Y-----------------ELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-39
Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
+LG G +G V+ G + VAIK + T S + + E +++ + H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 390 IEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
EE PI +V E+M G+L L+ E G L + +A + A +AY+ MN H
Sbjct: 332 SEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MN--YVH 386
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP-GYLDPQYHQYFHLSDKS 507
RD++++NIL+ N KVADFGL+RL + ++ + + P + P+ Y + KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567
DV+SFG++L E+ T +V + EV +D++ RG P P
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPC--PPECPES----- 492
Query: 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
+ +L +C + RPT + LE S+
Sbjct: 493 -----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 79/306 (25%), Positives = 132/306 (43%), Gaps = 63/306 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
RLG G +G V+ G + VA+K + + + S D + E L+ + H L+RL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 389 CIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+E PI + E+M NG+L L+ G L + +A + A+ +A++ N
Sbjct: 77 VTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERN--YI 131
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGYLDPQY 497
HRD++++NIL+ K+ADFGL+RL + ++ + + TAP+ Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI------NY 184
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------C 549
+ + KSDV+SFG++L EI+T ++ + EV I + RG C
Sbjct: 185 GTF---TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNC 235
Query: 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609
+E+ Y +L C + RPT + LE ++
Sbjct: 236 PEEL---Y-----------------QLMRLCWKERPEDRPTFDYLRSVLEDFFTAT--EG 273
Query: 610 IYMGSP 615
Y P
Sbjct: 274 QYQPQP 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 71/291 (24%), Positives = 129/291 (44%), Gaps = 57/291 (19%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G G +G V G + VA+K + + + + E +++ + H NL++LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNK-VAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 389 CIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+EE + +V E+M G+L +L+ S L + + + +A+ YL N
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 139
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS------TAPQGTPGYLDPQYHQYF 501
HRD+ + N+L+ + +KV+DFGL++ + + TAP+ + ++
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTAPEAL------REKKF- 191
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CVDEI 553
S KSDV+SFG++L EI + +V P +V + R+ +G C +
Sbjct: 192 --STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPAV 243
Query: 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
Y E+ C MRP+ +++ E+LEHI+
Sbjct: 244 ---Y-----------------EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 61/292 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G+G +G V+ G N D VAIK R S + + E +++ +SHP L++L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 389 CIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
C+E+ PI LV EFM +G L +L+ +RG + + + + +AYL +
Sbjct: 72 CLEQ-APICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL-EEAC--VI 126
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGYLDPQY 497
HRD+ + N L+ N KV+DFG++R + + + S +P+ +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVF------SF 179
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------C 549
+Y S KSDV+SFGV++ E+ + K+ +R +SEV ++ I G
Sbjct: 180 SRY---SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTGFRLYKPRLA 230
Query: 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ Y ++ C + RP + +L I
Sbjct: 231 STHV---Y-----------------QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 31/272 (11%)
Query: 294 NQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVA 352
+ + + P Y + F + ++G G + VY L + VA
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVA 61
Query: 353 IKR---FRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQ 409
+K+ F D + + EI LL ++HPN+++ IE+ E +V E G L +
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 410 HLQRERGSGLPW---TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV 466
++ + T+ + A+ ++HS + HRDIK +N+ + K+
Sbjct: 122 MIKHFKKQKRLIPERTVWK-YFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL 177
Query: 467 ADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITAL 523
D GL R ++++ + GTP Y+ P + Y + KSD++S G +L E+
Sbjct: 178 GDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAA-- 231
Query: 524 KVVDFSRP--HSEVNLAALAIDRIGRGCVDEI 553
P ++NL +L +I + +
Sbjct: 232 ----LQSPFYGDKMNLYSL-CKKIEQCDYPPL 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-38
Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 59/290 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+G G +G V G + VA+K + + + + E +++ + H NL++LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK-VAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 389 CIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+EE + +V E+M G+L +L+ S L + + + +A+ YL N
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN--FV 311
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG-------TPGYLDPQYHQY 500
HRD+ + N+L+ + +KV+DFGL++ S+ T P+ +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----PEALRE 360
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CVDE 552
S KSDV+SFG++L EI + +V P +V + R+ +G C
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA 414
Query: 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
+ Y ++ C RPT +++ E+LEHIR
Sbjct: 415 V---Y-----------------DVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 61/293 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
LG+G +G V GK VA+K + + S D+ E + + +SHP L++ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 389 CIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
C +E PI V E++ NG L +L R G GL + + + + + +A+L +
Sbjct: 72 CSKE-YPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--FI 126
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGYLDPQY 497
HRD+ + N L+D + KV+DFG++R + + ++S +AP+ Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF------HY 179
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------C 549
+Y S KSDV++FG+++ E+ + K+ +SEV + ++ +G
Sbjct: 180 FKY---SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVSQGHRLYRPHLA 230
Query: 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
D I Y ++ + C + RPT ++ +E +R
Sbjct: 231 SDTI---Y-----------------QIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 72/322 (22%), Positives = 135/322 (41%), Gaps = 63/322 (19%)
Query: 303 CQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD 362
C ++ EI + + +LG G +G V+ + VA+K +
Sbjct: 169 CMSSKPQKPWEKDAWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS 226
Query: 363 SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPW 421
+ E ++ ++ H L++L +E PI ++ EFM G+L L+ + GS P
Sbjct: 227 VEA-FLAEANVMKTLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481
I + + A+ +A++ N HRD++++NIL+ + K+ADFGL+R+ + ++ +
Sbjct: 284 PKLIDFSAQIAEGMAFI-EQRN--YIHRDLRAANILVSASLVCKIADFGLARV-IEDNEY 339
Query: 482 IS----------TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP 531
+ TAP+ + + KSDV+SFG++L+EI+T ++
Sbjct: 340 TAREGAKFPIKWTAPEA---------INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390
Query: 532 HSEVNLAALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAF 583
+ EV I + RG C +E+ Y + RC
Sbjct: 391 NPEV------IRALERGYRMPRPENCPEEL---Y-----------------NIMMRCWKN 424
Query: 584 HRDMRPTMMEVAEELEHIRVSS 605
+ RPT + L+ ++
Sbjct: 425 RPEERPTFEYIQSVLDDFYTAT 446
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 65/283 (22%), Positives = 110/283 (38%), Gaps = 40/283 (14%)
Query: 331 RLGTGAYGTVYAGKLHNDD--WVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+GTG+YG + D + K Y +++E+ LL + HPN++R
Sbjct: 13 TIGTGSYGRCQKIR-RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 387 GCCIEEGEPIL--VYEFMPNGTLCQHLQRERGSGLPWTIR--ITIATETAQAIAYLHS-- 440
I+ L V E+ G L + + + + T+ A+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QY 497
+ HRD+K +N+ LD K+ DFGL+R+ + + + GTP Y+ P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557
Y ++KSD++S G +L E+ P + + L +I G I Y
Sbjct: 191 MSY---NEKSDIWSLGCLLYELCA------LMPPFTAFSQKEL-AGKIREGKFRRIPYRY 240
Query: 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
S + E+ R L RP++ E+ LE+
Sbjct: 241 ----------SD--ELNEIITRMLNLKDYHRPSVEEI---LEN 268
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 68/298 (22%)
Query: 330 HRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLL 383
LG+GA+GTVY G + VAIK R + + ++++E +++SV +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 384 RLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
RLLG C+ + L+ + MP G L +++ + + + + + A+ + YL
Sbjct: 81 RLLGICLTS--TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLED-R 136
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGY 492
+ HRD+ + N+L+ K+ DFGL++L E A +
Sbjct: 137 R--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--- 191
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLAALAIDRIGRG--- 548
+ Y + +SDV+S+GV + E++T F S+P+ + + + + +G
Sbjct: 192 ---LHRIY---THQSDVWSYGVTVWELMT------FGSKPYDGIPASEI-SSILEKGERL 238
Query: 549 -----CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
C ++ Y + +C D RP E+ E +
Sbjct: 239 PQPPICTIDV---Y-----------------MIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 61/292 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
LGTG +G V GK VAIK + + S D+ + E K++ ++SH L++L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 389 CIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
C ++ PI ++ E+M NG L +L+ R + + + +A+ YL +
Sbjct: 88 CTKQ-RPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL-ESKQ--FL 142
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGYLDPQY 497
HRD+ + N L++ KV+DFGLSR + + + S + P+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL-------- 193
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------C 549
Y S KSD+++FGV++ EI + K+ +SE + I +G
Sbjct: 194 -MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLRLYRPHLA 246
Query: 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+++ Y + + C D RPT + + +
Sbjct: 247 SEKV---Y-----------------TIMYSCWHEKADERPTFKILLSNILDV 278
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 71/320 (22%), Positives = 131/320 (40%), Gaps = 72/320 (22%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTD-SIDQVMNEI 371
EK F LG G +G V + + VA+K + I + EI
Sbjct: 17 HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 372 KLLSSVSHPNLLRLLGCCIEEG-EPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
++L ++ H N+++ G C E+G I L+ EF+P+G+L ++L + + + ++ A
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAV 133
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS------ 483
+ + + YL S HRD+ + N+L++ ++ K+ DFGL++ T+ + +
Sbjct: 134 QICKGMDYLGS-RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 484 -----TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT---------ALKVVDFS 529
AP+ ++ SDV+SFGV L E++T AL +
Sbjct: 191 SPVFWYAPECL------MQSKF---YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 530 RPHSEVNLAALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCL 581
H ++ + L ++ + G C DE+ Y +L +C
Sbjct: 242 PTHGQMTVTRL-VNTLKEGKRLPCPPNCPDEV---Y-----------------QLMRKCW 280
Query: 582 AFHRDMRPTMMEVAEELEHI 601
F R + + E E +
Sbjct: 281 EFQPSNRTSFQNLIEGFEAL 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 71/346 (20%), Positives = 138/346 (39%), Gaps = 68/346 (19%)
Query: 330 HRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLL 383
LG+GA+GTVY G + VAIK R + + ++++E +++SV +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 384 RLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
RLLG C+ + L+ + MP G L +++ + + + + + A+ + YL
Sbjct: 81 RLLGICLTS--TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLED-R 136
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGY 492
+ HRD+ + N+L+ K+ DFGL++L E A +
Sbjct: 137 R--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--- 191
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLAALAIDRIGRG--- 548
+ Y + +SDV+S+GV + E++T F S+P+ + + + + +G
Sbjct: 192 ---LHRIY---THQSDVWSYGVTVWELMT------FGSKPYDGIPASEI-SSILEKGERL 238
Query: 549 -----CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603
C ++ Y + +C D RP E+ E +
Sbjct: 239 PQPPICTIDV---Y-----------------MIMVKCWMIDADSRPKFRELIIEFSKMAR 278
Query: 604 SSWASNIYMGSPAVSCCSLSECGSERSLSGLTVKKAGVKSQRLIVP 649
+ G + S ++ R+L V + ++P
Sbjct: 279 DPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIP 324
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 63/296 (21%), Positives = 109/296 (36%), Gaps = 61/296 (20%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDW--VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLL 383
F E +G+G +G V+ K H D IKR +Y + ++ E+K L+ + H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAK-HRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 384 RLLGCCIEEGEPI----------------LVYEFMPNGTLCQHLQRERGSGLPWTIRITI 427
GC + EF GTL Q +++ RG L + + +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
+ + + Y+HS + +RD+K SNI L + K+ DFGL + +
Sbjct: 128 FEQITKGVDYIHS-KK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 488 GTPGYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDR 544
GT Y+ P Y + D+Y+ G++L E++
Sbjct: 183 GTLRYMSPEQISSQDY---GKEVDLYALGLILAELLHVCD-----TAFETSKF----FTD 230
Query: 545 IGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ G + +I D L + L+ + RP E+ L
Sbjct: 231 LRDGIISDIFDKKE---------------KTLLQKLLSKKPEDRPNTSEI---LRT 268
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 69/351 (19%), Positives = 135/351 (38%), Gaps = 64/351 (18%)
Query: 284 CFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAG 343
+ + + + L Q A S+ + E+ +LG G +G+V
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEE--RHLKFLQQLGKGNFGSVEMC 60
Query: 344 KLHNDDW-----VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG-EPI- 396
+ VA+K+ ++ + + EI++L S+ H N+++ G C G +
Sbjct: 61 RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120
Query: 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNI 456
L+ E++P G+L +LQ+ + + + ++ + + YL + HRD+ + NI
Sbjct: 121 LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT-KR--YIHRDLATRNI 176
Query: 457 LLDYNYRSKVADFGLSRLGMTESSHISTAPQGT--------PGYLDPQYHQYFHLSDKSD 508
L++ R K+ DFGL+++ + + + P L ++ S SD
Sbjct: 177 LVENENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPESL--TESKF---SVASD 230
Query: 509 VYSFGVVLIEIITALKVVDFSRPHSEVNLAAL---------AIDRIGRG--------CVD 551
V+SFGVVL E+ T ++ + I+ + C D
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD 290
Query: 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
EI Y + C + + RP+ ++A ++ IR
Sbjct: 291 EI---Y-----------------MIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 29/244 (11%)
Query: 295 QLSAKRLLCQAAGNSSVPFYPYKEIEKATSF---FSEKHRLGTGAYGTVYAGKLHNDD-- 349
QL +R+ + + ++ Y + F F RLG G+YG V+ + +D
Sbjct: 25 QLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVR-SKEDGR 83
Query: 350 WVAIKRFRYRDTDSID--QVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILVYEFMPNGT 406
A+KR D + + E+ V HP +RL E G L E +
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142
Query: 407 LCQHLQRERGSGLP-WTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSK 465
L QH + G+ LP + +T A+A+LHS + H D+K +NI L R K
Sbjct: 143 LQQHCEAW-GASLPEAQVW-GYLRDTLLALAHLHS-QG--LVHLDVKPANIFLGPRGRCK 197
Query: 466 VADFGLSRLGMTESSHISTAPQGTPGYLDP-----QYHQYFHLSDKSDVYSFGVVLIEII 520
+ DFGL + + +G P Y+ P Y +DV+S G+ ++E+
Sbjct: 198 LGDFGLLVE-LGTAGAGEVQ-EGDPRYMAPELLQGSY------GTAADVFSLGLTILEVA 249
Query: 521 TALK 524
++
Sbjct: 250 CNME 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 58/307 (18%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW---VAIKRFRYRDTD-SIDQVMNEIKL 373
+++ + LG G +G+V G VAIK + +++M E ++
Sbjct: 5 FLKR-DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 374 LSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
+ + +P ++RL+G C + E + LV E G L + L +R +P + + + +
Sbjct: 64 MHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 120
Query: 433 QAIAYLHSAMNPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG--- 488
+ YL N + HRD+ + N+LL + +K++DFGLS+ + S+ + G
Sbjct: 121 MGMKYL-EEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 489 ---TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI 545
P+ + S +SDV+S+GV + E ++ + EV + I
Sbjct: 177 LKWYA----PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFI 226
Query: 546 GRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 597
+G C E+ Y L C + + RP + V +
Sbjct: 227 EQGKRMECPPECPPEL---Y-----------------ALMSDCWIYKWEDRPDFLTVEQR 266
Query: 598 LEHIRVS 604
+ S
Sbjct: 267 MRACYYS 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 66/318 (20%), Positives = 129/318 (40%), Gaps = 66/318 (20%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTDSIDQVMNEIK 372
+ E+ +LG G +G+V + VA+K+ ++ + + EI+
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 373 LLSSVSHPNLLRLLGCCIEEG-EPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE 430
+L S+ H N+++ G C G + L+ E++P G+L +LQ+ + + + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQ 122
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGT- 489
+ + YL + HRD+ + NIL++ R K+ DFGL+++ + + +
Sbjct: 123 ICKGMEYLGT-KR--YIHRDLATRNILVENENRVKIGDFGLTKV-LPQDKEFFKVKEPGE 178
Query: 490 -------PGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT----------ALKVVDFSRPH 532
P L ++ S SDV+SFGVVL E+ T + +
Sbjct: 179 SPIFWYAPESL--TESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 533 SEVNLAALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFH 584
++ + L I+ + C DEI Y + C +
Sbjct: 234 GQMIVFHL-IELLKNNGRLPRPDGCPDEI---Y-----------------MIMTECWNNN 272
Query: 585 RDMRPTMMEVAEELEHIR 602
+ RP+ ++A ++ IR
Sbjct: 273 VNQRPSFRDLALRVDQIR 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 61/304 (20%), Positives = 105/304 (34%), Gaps = 59/304 (19%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLL 383
F LG G +G V+ K DD AIKR R + ++VM E+K L+ + HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 384 RLLGCCIEEGEPI------------LVYEFMPNGTLCQHLQRERGSGLP-WTIRITIATE 430
R +E+ + + L + ++ + I +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ--- 487
A+A+ +LHS + HRD+K SNI + KV DFGL + +
Sbjct: 127 IAEAVEFLHS-KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 488 --------GTPGYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
GT Y+ P + Y S K D++S G++L E++ P S
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSY---SHKVDIFSLGLILFELLY---------PFSTQM 231
Query: 537 LAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596
+ + + + L+ RP + +
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYV------------MVQDMLSPSPMERPEAINI-- 277
Query: 597 ELEH 600
+E+
Sbjct: 278 -IEN 280
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 68/323 (21%), Positives = 126/323 (39%), Gaps = 69/323 (21%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTDSIDQVMNEI 371
E+ +LG G +G+V + VA+K+ ++ D EI
Sbjct: 18 TIFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 372 KLLSSVSHPNLLRLLGCCIEEG-EPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
++L ++ +++ G G + + LV E++P+G L LQR R L + + ++
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSS 134
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS------ 483
+ + + YL S HRD+ + NIL++ K+ADFGL++L + +
Sbjct: 135 QICKGMEYLGS-RR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 484 -----TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT--------ALKVVDFSR 530
AP+ + + S +SDV+SFGVVL E+ T + + +
Sbjct: 192 SPIFWYAPESL------SDNIF---SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 531 PHSEVNLAALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLA 582
+V + ++ + G C E+ + EL C A
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEV---H-----------------ELMKLCWA 282
Query: 583 FHRDMRPTMMEVAEELEHIRVSS 605
RP+ + +L+ + S
Sbjct: 283 PSPQDRPSFSALGPQLDMLWSGS 305
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 70/321 (21%), Positives = 124/321 (38%), Gaps = 60/321 (18%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTD-SIDQVMNEIK 372
I +G G +G VY G+ + AIK ++ + E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
L+ ++HPN+L L+G + + +M +G L Q ++ + + I+ +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQV 133
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+ + YL + HRD+ + N +LD ++ KVADFGL+R + Q
Sbjct: 134 ARGMEYL-AEQK--FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHA 188
Query: 492 YLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
L P Q +++ + KSDV+SFGV+L E++T ++
Sbjct: 189 RL-PVKWTALESLQTYRF---TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL------T 238
Query: 543 DRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594
+ +G C D + Y ++ +C +RPT +
Sbjct: 239 HFLAQGRRLPQPEYCPDSL---Y-----------------QVMQQCWEADPAVRPTFRVL 278
Query: 595 AEELEHIRVSSWASNIYMGSP 615
E+E I VS+ + Y+ P
Sbjct: 279 VGEVEQI-VSALLGDHYVQLP 298
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 51/302 (16%), Positives = 101/302 (33%), Gaps = 56/302 (18%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW--------VAIKRFRYRDTDSIDQVMNEIKLLSSVSHP 380
LG G + ++ G V +K + + ++S +SH
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
+L+ G C+ E ILV EF+ G+L +L++ + + ++ +A + A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFL-E 130
Query: 441 AMNPPIY-HRDIKSSNILLDYNYRS--------KVADFGLSRLGMTESSHIS-----TAP 486
H ++ + NILL K++D G+S + + P
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-VLPKDILQERIPWVPP 186
Query: 487 QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546
+ + + + +D +SFG L EI + + +
Sbjct: 187 ECI------ENPKNL--NLATDKWSFGTTLWEICSGGDKPLSALDSQRK------LQFYE 232
Query: 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSW 606
L + A +A L C+ + D RP+ + +L +
Sbjct: 233 DRHQ-------LPAPKAA-------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
Query: 607 AS 608
Sbjct: 279 VP 280
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 66/297 (22%), Positives = 110/297 (37%), Gaps = 59/297 (19%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPN 381
+LG G++G V G+ VA+K + + + + E+ + S+ H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 382 LLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L+RL G + P+ +V E P G+L L++ +G A + A+ + YL
Sbjct: 83 LIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYL-E 138
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG------TPGYLD 494
+ HRD+ + N+LL K+ DFGL R H
Sbjct: 139 SKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA---- 192
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLA--ALAIDRIG----- 546
P+ + S SD + FGV L E+ T + P +N + ID+ G
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT------YGQEPWIGLNGSQILHKIDKEGERLPR 246
Query: 547 -RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
C +I Y + +C A + RPT + + + L +
Sbjct: 247 PEDCPQDI---Y-----------------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 67/299 (22%), Positives = 129/299 (43%), Gaps = 68/299 (22%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNL 382
LG+G +GTV+ G + V IK + S V + + + S+ H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 383 LRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+RLLG C + LV +++P G+L H+++ RG+ L + + + A+ + YL
Sbjct: 78 VRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYL-EE 133
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPG 491
+ HR++ + N+LL + +VADFG++ L + + A +
Sbjct: 134 HG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-- 189
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLAALAIDRIGRG-- 548
+ +Y + +SDV+S+GV + E++T F + P++ + LA + D + +G
Sbjct: 190 ----HFGKY---THQSDVWSYGVTVWELMT------FGAEPYAGLRLAEV-PDLLEKGER 235
Query: 549 ------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
C ++ Y + +C ++RPT E+A E +
Sbjct: 236 LAQPQICTIDV---Y-----------------MVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 66/310 (21%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNL 382
LG G +G V + VA+K + EI +L ++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 383 LRLLGCCIEEG-EPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
++ GCC + G + LV E++P G+L +L R + + A + + +AYLH+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA 152
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGT--------PGY 492
+ HRD+ + N+LLD + K+ DFGL++ + E + P
Sbjct: 153 -QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIIT---------ALKVVDFSRPHSEVNLAALAID 543
L + +++ SDV+SFGV L E++T + ++ + L +
Sbjct: 209 L--KEYKF---YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL-TE 262
Query: 544 RIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595
+ RG C E+ Y L C RPT +
Sbjct: 263 LLERGERLPRPDKCPAEV---Y-----------------HLMKNCWETEASFRPTFENLI 302
Query: 596 EELEHIRVSS 605
L+ +
Sbjct: 303 PILKTVHEKY 312
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD--WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLL 383
F E LG GA+G V + + D + AIK+ R+ + + + +++E+ LL+S++H ++
Sbjct: 8 FEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVV 65
Query: 384 RLLGCCIEEGEPI-------------LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE 430
R +E + + E+ NGTL + E + + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQ 124
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ--- 487
+A++Y+HS I HRD+K NI +D + K+ DFGL++ + Q
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 488 ----------GTPGYLDP-QYHQYFHLSDKSDVYSFGVVLIE 518
GT Y+ H ++K D+YS G++ E
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 74/307 (24%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDS-IDQVMNEIK 372
I ++ +G G +G VY G L ++D A+K + Q + E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
++ SHPN+L LLG C+ L V +M +G L ++ E + I +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+ + YL ++ HRD+ + N +LD + KVADFGL+R + + + G
Sbjct: 138 AKGMKYL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTG 191
Query: 492 YLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
P Q ++ + KSDV+SFGV+L E++T P+ +VN +
Sbjct: 192 AKLPVKWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDI-T 242
Query: 543 DRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594
+ +G C D + Y E+ +C +MRP+ E+
Sbjct: 243 VYLLQGRRLLQPEYCPDPL---Y-----------------EVMLKCWHPKAEMRPSFSEL 282
Query: 595 AEELEHI 601
+ I
Sbjct: 283 VSRISAI 289
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW-----VAIKRFRYRDTDSIDQV--MN 369
EI + + +G G +G VY G L VAIK + +V +
Sbjct: 39 TEIHPSCVTRQKV--IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLG 95
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIA 428
E ++ SH N++RL G + +P+ ++ E+M NG L + L+ + G + +
Sbjct: 96 EAGIMGQFSHHNIIRLEGVIS-KYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGML 153
Query: 429 TETAQAIAYLHSAMNPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
A + YL + MN Y HRD+ + NIL++ N KV+DFGLSR+ + T
Sbjct: 154 RGIAAGMKYL-ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 488 G------TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
G T P+ Y + SDV+SFG+V+ E++T
Sbjct: 210 GKIPIRWTA----PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSIDQV--MNE 370
+EIE + + +G+G G V G+L VAIK + + ++E
Sbjct: 44 REIEASRIHIEKI--IGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSE 100
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
++ HPN++RL G G + V E+M NG+L L+ G + +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVT-RGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLR 158
Query: 430 ETAQAIAYLHSAMNPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG 488
+ YL S + Y HRD+ + N+L+D N KV+DFGLSR+ + + + G
Sbjct: 159 GVGAGMRYL-SDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV-LEDDPDAAYTTTG 213
Query: 489 -------TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
T P+ + S SDV+SFGVV+ E++
Sbjct: 214 GKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW---VAIKRFR--YRDTDSIDQVMNEIK 372
+++ +K LG+G +GTV G VA+K + D D+++ E
Sbjct: 12 YLDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
++ + +P ++R++G C E E LV E G L ++LQ+ + I + +
Sbjct: 71 VMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQV 126
Query: 432 AQAIAYLHSAMNPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG-- 488
+ + YL N + HRD+ + N+LL + +K++DFGLS+ + ++ G
Sbjct: 127 SMGMKYL-EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 489 ----TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ Y+ S KSDV+SFGV++ E +
Sbjct: 183 PVKWYA----PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 70/298 (23%), Positives = 122/298 (40%), Gaps = 68/298 (22%)
Query: 329 KHRLGTGAYGTVYAGKLHNDD----WVAIKRFRYRDTD-SIDQVMNEIKLLSSVSHPNLL 383
LG G +G VY G N VA+K + T + ++ M+E ++ ++ HP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 384 RLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+L+G E EP ++ E P G L +L+R + S T+ + + + +A+AYL ++
Sbjct: 77 KLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYL-ESI 132
Query: 443 NPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPG 491
N HRDI NIL+ K+ DFGLSR + + + +P+
Sbjct: 133 N---CVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESI-- 186
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--- 548
+ ++ + SDV+ F V + EI++ K F + +V I + +G
Sbjct: 187 ----NFRRF---TTASDVWMFAVCMWEILSFGKQPFFWLENKDV------IGVLEKGDRL 233
Query: 549 -----CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
C + Y L RC + RP E+ L +
Sbjct: 234 PKPDLCPPVL---Y-----------------TLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 25/227 (11%)
Query: 332 LGTGAYGTVYAGKLHND--DWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
LG G YG VYAG +AIK RD+ + EI L + H N+++ LG
Sbjct: 30 LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPW--TIRITIATETAQAIAYLHSAMNPPIY 447
E G + E +P G+L L+ + G TI + + + YLH I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ---IV 144
Query: 448 HRDIKSSNILLD-YNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-----QYHQYF 501
HRDIK N+L++ Y+ K++DFG S+ + T GT Y+ P Y
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGY- 202
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548
+D++S G +IE+ T P E+ A+ ++G
Sbjct: 203 --GKAADIWSLGCTIIEMATG------KPPFYELGEPQAAMFKVGMF 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 77/305 (25%), Positives = 120/305 (39%), Gaps = 69/305 (22%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSIDQV--MNEIKLLSSVSHPNL 382
LG G +G+V G L +D VA+K + ++ + ++E + SHPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 383 LRLLGCCIEEG-----EPILVYEFMPNGTLCQHLQRERGSGLPWTIR----ITIATETAQ 433
+RLLG CIE +P+++ FM G L +L R P I + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
+ YL S N HRD+ + N +L + VADFGLS+ + + QG +
Sbjct: 159 GMEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKM 211
Query: 494 DP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDR 544
P Y + KSDV++FGV + EI T + E+ D
Sbjct: 212 -PVKWIAIESLADRVY---TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM------YDY 261
Query: 545 IGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596
+ G C+DE+ Y E+ + C RPT +
Sbjct: 262 LLHGHRLKQPEDCLDEL---Y-----------------EIMYSCWRTDPLDRPTFSVLRL 301
Query: 597 ELEHI 601
+LE +
Sbjct: 302 QLEKL 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 69/307 (22%), Positives = 122/307 (39%), Gaps = 72/307 (23%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPN 381
LG G +G+V +L +D VA+K + D + + + E + HP+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK-ADIIASSDIEEFLREAACMKEFDHPH 86
Query: 382 LLRLLGCCIEEG------EPILVYEFMPNGTLCQHLQRERGSGLPWTIR----ITIATET 431
+ +L+G + P+++ FM +G L L R P+ + + +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A + YL S+ N HRD+ + N +L + VADFGLSR + + QG
Sbjct: 147 ACGMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 492 YLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
L P + Y + SDV++FGV + EI+T + ++E+
Sbjct: 200 KL-PVKWLALESLADNLY---TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------Y 249
Query: 543 DRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594
+ + G C++E+ Y +L ++C + RP+ +
Sbjct: 250 NYLIGGNRLKQPPECMEEV---Y-----------------DLMYQCWSADPKQRPSFTCL 289
Query: 595 AEELEHI 601
ELE+I
Sbjct: 290 RMELENI 296
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 46/216 (21%), Positives = 87/216 (40%), Gaps = 33/216 (15%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIK-----------------RFRYRDTDSIDQVMNEIKLL 374
L G + + + ++ + A+K + D NE++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 375 SSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTL------CQHLQRERGSGLPWTIRITIA 428
+ + + L G E ++YE+M N ++ L + +P + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG 488
+ +Y+H+ N I HRD+K SNIL+D N R K++DFG S I + +G
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGS-RG 212
Query: 489 TPGYLDP---QYHQYFHLSDKSDVYSFGVVLIEIIT 521
T ++ P ++ K D++S G+ L +
Sbjct: 213 TYEFMPPEFFSNESSYN-GAKVDIWSLGICLYVMFY 247
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 72/297 (24%), Positives = 120/297 (40%), Gaps = 68/297 (22%)
Query: 330 HRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPNLLR 384
+G G +G V+ G + + VAIK + +DS ++ + E + HP++++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 385 LLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
L+G E P+ ++ E G L LQ + S L I A + + A+AYL +
Sbjct: 81 LIGVITEN--PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL-ESKR 136
Query: 444 PPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----------TAPQGTPGY 492
+ HRDI + N+L+ N K+ DFGLSR M +S++ AP+
Sbjct: 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESI--- 189
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG---- 548
+ ++ + SDV+ FGV + EI+ +++V I RI G
Sbjct: 190 ---NFRRF---TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLP 237
Query: 549 ----CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
C + Y L +C A+ RP E+ +L I
Sbjct: 238 MPPNCPPTL---Y-----------------SLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 47/227 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQV--MNEIKLLSSV-SH 379
LG GA+G V D VA+K + + M+E+K+L + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 380 PNLLRLLGCCIEEGEPILV-YEFMPNGTLCQHLQRERGSGLPWTIR-------------- 424
N++ LLG C + G P++V EF G L +L+ +R +P+ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS- 483
I + + A+ + +L ++ HRD+ + NILL K+ DFGL+R + ++
Sbjct: 151 ICYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 484 ---------TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
AP+ Y + +SDV+SFGV+L EI +
Sbjct: 208 GDARLPLKWMAPETI------FDRVY---TIQSDVWSFGVLLWEIFS 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSIDQV--MNE 370
KE++ + +G G +G V +G+L VAIK + + + E
Sbjct: 40 KELDATNISIDKV--VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGE 96
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
++ HPN++RL G + +P++ V E+M NG+L L++ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLR 154
Query: 430 ETAQAIAYLHSAMNPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG 488
A + YL S M Y HRD+ + NIL++ N KV+DFGL R+ + T G
Sbjct: 155 GIASGMKYL-SDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 489 ------TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
T P+ Y + SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTS----PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 74/311 (23%), Positives = 124/311 (39%), Gaps = 59/311 (18%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDS-IDQVMNEIK 372
I ++ +G G +G VY G L ++D A+K + Q + E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPIL-VYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
++ SHPN+L LLG C+ L V +M +G L ++ E + I +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 201
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+ + +L ++ HRD+ + N +LD + KVADFGL+R + T
Sbjct: 202 AKGMKFL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGA 256
Query: 492 YLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAI 542
L P Q ++ + KSDV+SFGV+L E++T P+ +VN +
Sbjct: 257 KL-PVKWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDI-T 306
Query: 543 DRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594
+ +G C D + Y E+ +C +MRP+ E+
Sbjct: 307 VYLLQGRRLLQPEYCPDPL---Y-----------------EVMLKCWHPKAEMRPSFSEL 346
Query: 595 AEELEHIRVSS 605
+ I +
Sbjct: 347 VSRISAIFSTF 357
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 77/311 (24%), Positives = 122/311 (39%), Gaps = 80/311 (25%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW---VAIKRFR--YRDTDSIDQVMNEIKLLSSV-SHPNL 382
+ +G G +G V ++ D AIKR + D D E+++L + HPN+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNI 88
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------ITIA 428
+ LLG C G L E+ P+G L L++ R + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG 488
+ A+ + YL S HRD+ + NIL+ NY +K+ADFGLSR +
Sbjct: 149 ADVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198
Query: 489 TPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLA 538
T G L P Y Y + SDV+S+GV+L EI++ P+ + A
Sbjct: 199 TMGRL-PVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIVS------LGGTPYCGMTCA 248
Query: 539 ALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT 590
L +++ +G C DE+ Y +L +C RP+
Sbjct: 249 EL-YEKLPQGYRLEKPLNCDDEV---Y-----------------DLMRQCWREKPYERPS 287
Query: 591 MMEVAEELEHI 601
++ L +
Sbjct: 288 FAQILVSLNRM 298
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-33
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 40/287 (13%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLR 384
F K LG GA GT+ + ++ VA+KR + E++LL HPN++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
+ + E TL +++++ + IT+ +T +A+LHS
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLN-- 138
Query: 445 PIYHRDIKSSNILL-----DYNYRSKVADFGLSRL--GMTESSHISTAPQGTPGYLDP-- 495
I HRD+K NIL+ ++ ++DFGL + S + GT G++ P
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 496 -QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554
+ + D++S G V +I+ + S P + I +G +D +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVIS-----EGSHPFGKSLQRQANI-LLGACSLDCLH 251
Query: 555 DPYLEPHRDAWTLSSIHNVA-ELAFRCLAFHRDMRPTMMEVAEELEH 600
+A EL + +A RP+ V L+H
Sbjct: 252 PE-----------KHEDVIARELIEKMIAMDPQKRPSAKHV---LKH 284
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 9e-33
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW---VAIKRFRYRDTD-SIDQVMNEIK 372
K K + LG G +G+V G VAIK + +++M E +
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
++ + +P ++RL+G C + E + LV E G L + L +R +P + + +
Sbjct: 389 IMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 445
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG--- 488
+ + YL N HR++ + N+LL + +K++DFGLS+ + S+ + G
Sbjct: 446 SMGMKYL-EEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 489 ---TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ + S +SDV+S+GV + E ++
Sbjct: 503 LKWYA----PECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 54/215 (25%), Positives = 84/215 (39%), Gaps = 24/215 (11%)
Query: 325 FFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRF-RYRDTDSIDQVMNEIKLLSSVSHPNL 382
+ LG GA V+ G+ D AIK F +D M E ++L ++H N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 383 LRLLGCCIEEGEPILVY---EFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIAYL 438
++L EE EF P G+L L + GLP + + + + + +L
Sbjct: 70 VKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 439 HSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
I HR+IK NI+ D K+ DFG +R + + + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSL-YGTEEYLH 183
Query: 495 PQYHQYFHLSD--------KSDVYSFGVVLIEIIT 521
P ++ L D++S GV T
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G VY A + + +A+K + + Q+ E+++ S + HPN+LRL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ L+ E+ P GT+ + LQ+ T TE A A++Y HS +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR---VI 131
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
HRDIK N+LL K+ADFG S SS + GT YL P + +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLC-GTLDYLPPEMIEGRMH---D 185
Query: 505 DKSDVYSFGVVLIEIIT 521
+K D++S GV+ E +
Sbjct: 186 EKVDLWSLGVLCYEFLV 202
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 51/232 (21%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQV--MNEIKLLSSVSHP 380
LG G +G V + VA+K + + + ++E +L V+HP
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVNHP 86
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR---------------- 424
++++L G C ++G +L+ E+ G+L L+ R G +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 425 ------ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478
I+ A + +Q + YL + M + HRD+ + NIL+ + K++DFGLSR E
Sbjct: 147 LTMGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 479 SSHISTAPQGTPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIIT 521
S++ + + G + P H Y + +SDV+SFGV+L EI+T
Sbjct: 204 DSYV----KRSQGRI-PVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW--------VAIKRFRYRDTDSIDQV--MNEIKLLSSV- 377
LG GA+G V + D VA+K + D D ++E++++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIG 132
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR------------- 424
H N++ LLG C ++G ++ E+ G L ++LQ R GL ++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 425 -ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483
++ A + A+ + YL ++ HRD+ + N+L+ + K+ADFGL+R +
Sbjct: 193 LVSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248
Query: 484 TAPQGTPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ T G L P Y + +SDV+SFGV+L EI T
Sbjct: 249 ---KTTNGRL-PVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFT 288
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 68/315 (21%), Positives = 125/315 (39%), Gaps = 76/315 (24%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
K LG GA+G V+ + +N VA+K + + E +LL+++ H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------ITIA 428
++ G C + I+V+E+M +G L + L+ + + IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS----- 483
++ A + YL ++ + HRD+ + N L+ N K+ DFG+SR + +
Sbjct: 140 SQIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 484 -----TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA 538
P+ Y ++ + +SDV+SFGV+L EI T K F ++EV
Sbjct: 197 LPIRWMPPESI------MYRKF---TTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--- 244
Query: 539 ALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT 590
I+ I +G C E+ Y ++ C R
Sbjct: 245 ---IECITQGRVLERPRVCPKEV---Y-----------------DVMLGCWQREPQQRLN 281
Query: 591 MMEVAEELEHIRVSS 605
+ E+ + L + ++
Sbjct: 282 IKEIYKILHALGKAT 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDS-IDQVMNEIKLLSSVSHPN 381
LG G++G VY G VAIK + + +NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------ITIATETAQ 433
++RLLG + +++ E M G L +L+ R + + I +A E A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
+AYL +A HRD+ + N ++ ++ K+ DFG++R + +G G L
Sbjct: 150 GMAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLL 202
Query: 494 DP---------QYHQYFHLSDKSDVYSFGVVLIEIIT 521
P + + + SDV+SFGVVL EI T
Sbjct: 203 -PVRWMSPESLKDGVF---TTYSDVWSFGVVLWEIAT 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 69/315 (21%), Positives = 122/315 (38%), Gaps = 80/315 (25%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW--------VAIKRFRYRDTDSIDQV--MNEIKLLSSV- 377
LG G +G V + D VA+K + D D ++E++++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIG 144
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR------------- 424
H N++ LLG C ++G ++ E+ G L ++L+ R G+ ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 425 -ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483
++ + A+ + YL ++ HRD+ + N+L+ N K+ADFGL+R +
Sbjct: 205 LVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260
Query: 484 TAPQGTPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSE 534
+ T G L P Y + +SDV+SFGV++ EI T P E
Sbjct: 261 ---KTTNGRL-PVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 535 VNLAALAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRD 586
+ + G C +E+ Y + C
Sbjct: 314 L------FKLLKEGHRMDKPANCTNEL---Y-----------------MMMRDCWHAVPS 347
Query: 587 MRPTMMEVAEELEHI 601
RPT ++ E+L+ I
Sbjct: 348 QRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 46/227 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW--------VAIKRFRYRDTDSIDQV--MNEIKLLSSV- 377
LG GA+G V + D VA+K + D D ++E++++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIG 98
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR------------- 424
H N++ LLG C ++G ++ E+ G L ++L+ R G+ ++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 425 -ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483
++ + A+ + YL ++ HRD+ + N+L+ N K+ADFGL+R +
Sbjct: 159 LVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 214
Query: 484 TAPQGTPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ T G L P Y + +SDV+SFGV++ EI T
Sbjct: 215 ---KTTNGRL-PVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFT 254
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 75/312 (24%), Positives = 128/312 (41%), Gaps = 52/312 (16%)
Query: 310 SVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDS-I 364
++P EI++ +G G +G V+ G + + VAIK + +DS
Sbjct: 378 TMPSTRDYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 365 DQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTI 423
++ + E + HP++++L+G E P+ ++ E G L LQ + S L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKFS-LDLAS 492
Query: 424 RITIATETAQAIAYLHSAMNPPIY-HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482
I A + + A+AYL + + HRDI + N+L+ N K+ DFGLSR M +S++
Sbjct: 493 LILYAYQLSTALAYL-ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYY 547
Query: 483 STAPQGTP-GYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALA 541
+ P ++ P+ + + SDV+ FGV + EI+ +++V
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------ 601
Query: 542 IDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMME 593
I RI G C + Y L +C A+ RP E
Sbjct: 602 IGRIENGERLPMPPNCPPTL---Y-----------------SLMTKCWAYDPSRRPRFTE 641
Query: 594 VAEELEHIRVSS 605
+ +L I
Sbjct: 642 LKAQLSTILEEE 653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 69/314 (21%), Positives = 123/314 (39%), Gaps = 75/314 (23%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL 382
K LG GA+G V+ + HN VA+K + + E +LL+ + H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR-------------ITIAT 429
+R G C E ++V+E+M +G L + L+ + +A+
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGT 489
+ A + YL + ++ HRD+ + N L+ K+ DFG+SR + + + G
Sbjct: 166 QVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRD-IYSTDYYRV---GG 218
Query: 490 PGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDF-SRPHSEVNLAA 539
L P Y ++ + +SDV+SFGVVL EI T + +P +++
Sbjct: 219 RTML-PIRWMPPESILYRKF---TTESDVWSFGVVLWEIFT------YGKQPWYQLSNTE 268
Query: 540 LAIDRIGRG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTM 591
ID I +G C E+ Y + C R ++
Sbjct: 269 A-IDCITQGRELERPRACPPEV---Y-----------------AIMRGCWQREPQQRHSI 307
Query: 592 MEVAEELEHIRVSS 605
+V L+ + +
Sbjct: 308 KDVHARLQALAQAP 321
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 59/197 (29%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G VY A + N +A+K + + Q+ EI++ S + HPN+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ L+ EF P G L + LQ+ T E A A+ Y H +
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERK---VI 136
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
HRDIK N+L+ Y K+ADFG S S T GT YL P + +
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTMC-GTLDYLPPEMIEGKTH---D 190
Query: 505 DKSDVYSFGVVLIEIIT 521
+K D++ GV+ E +
Sbjct: 191 EKVDLWCAGVLCYEFLV 207
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 56/288 (19%), Positives = 103/288 (35%), Gaps = 49/288 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKR--FRYRDTDSIDQVMNEIKLLSSVSHPNL--LRLLG 387
+G+G V+ AIK D ++D NEI L+ + + +RL
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
I + +V E N L L++ + S + R + +A+ +H I
Sbjct: 96 YEITDQYIYMVMECG-NIDLNSWLKK-KKS-IDPWERKSYWKNMLEAVHTIHQHG---IV 149
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGYLDPQ---------- 496
H D+K +N L+ + K+ DFG++ +++ + Q GT Y+ P+
Sbjct: 150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 497 -YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP---HSEVNLAALAIDRIGRGCVDE 552
+S KSDV+S G +L + + ++ L I +
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTY-------GKTPFQQIINQISKLH--AIIDPNHEI 259
Query: 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
E ++ ++ CL R ++ E+ L H
Sbjct: 260 EFPDIPEK-----------DLQDVLKCCLKRDPKQRISIPEL---LAH 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 54/215 (25%), Positives = 84/215 (39%), Gaps = 24/215 (11%)
Query: 325 FFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRF-RYRDTDSIDQVMNEIKLLSSVSHPNL 382
+ LG GA V+ G+ D AIK F +D M E ++L ++H N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 383 LRLLGCCIEEGEPILVY---EFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIAYL 438
++L EE EF P G+L L + GLP + + + + + +L
Sbjct: 70 VKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 439 HSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
I HR+IK NI+ D K+ DFG +R + + + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSL-YGTEEYLH 183
Query: 495 PQYHQYFHLSD--------KSDVYSFGVVLIEIIT 521
P ++ L D++S GV T
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 44/224 (19%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQV--MNEIKLLSSV-SH 379
LG GA+G V VA+K + + ++ M+E+K++S + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLGQH 109
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER----------GSGLPWTIR--ITI 427
N++ LLG C G +++ E+ G L L+R+ + + R +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS---- 483
+++ AQ +A+L ++ N HRD+ + N+LL + +K+ DFGL+R M +S++I
Sbjct: 170 SSQVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 484 ------TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
AP+ Y + +SDV+S+G++L EI +
Sbjct: 227 RLPVKWMAPESI------FDCVY---TVQSDVWSYGILLWEIFS 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 56/288 (19%), Positives = 103/288 (35%), Gaps = 49/288 (17%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKR--FRYRDTDSIDQVMNEIKLLSSVSHPNL--LRLLG 387
+G+G V+ AIK D ++D NEI L+ + + +RL
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
I + +V E N L L++ + S + R + +A+ +H I
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKK-KKS-IDPWERKSYWKNMLEAVHTIHQHG---IV 130
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGYLDPQ---------- 496
H D+K +N L+ + K+ DFG++ +++ + Q GT Y+ P+
Sbjct: 131 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 497 -YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP---HSEVNLAALAIDRIGRGCVDE 552
+S KSDV+S G +L + + ++ L I +
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTY-------GKTPFQQIINQISKLH--AIIDPNHEI 240
Query: 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
E ++ ++ CL R ++ E+ L H
Sbjct: 241 EFPDIPEK-----------DLQDVLKCCLKRDPKQRISIPEL---LAH 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 48/228 (21%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQV--MNEIKLLSSV-SH 379
LG GA+G V + VA+K + ++ M+E+K+LS + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNH 86
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------- 424
N++ LLG C G +++ E+ G L L+R+R S +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 425 -ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483
++ + + A+ +A+L ++ N HRD+ + NILL + +K+ DFGL+R +S+++
Sbjct: 147 LLSFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 484 ----------TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
AP+ Y + +SDV+S+G+ L E+ +
Sbjct: 204 KGNARLPVKWMAPESI------FNCVY---TFESDVWSYGIFLWELFS 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 57/306 (18%), Positives = 106/306 (34%), Gaps = 63/306 (20%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFR--YRDTDSIDQVMNEIKLLSSVSHP 380
LG +G VY G L VAIK + + +E L + + HP
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHP 72
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------IT 426
N++ LLG ++ +++ + +G L + L + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 427 IATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS--- 483
+ + A + YL S+ + + H+D+ + N+L+ K++D GL R +
Sbjct: 133 LVAQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 484 -------TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
AP+ Y ++ S SD++S+GVVL E+ + + +V
Sbjct: 190 SLLPIRWMAPEAI------MYGKF---SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV- 239
Query: 537 LAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596
++ I V L D + ++ L C RP ++
Sbjct: 240 -----VEMIRNRQV-------LPCPDD--CPAWVYA---LMIECWNEFPSRRPRFKDIHS 282
Query: 597 ELEHIR 602
L
Sbjct: 283 RLRAWG 288
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDSIDQV--MNEIKLLSSV-SH 379
LG+GA+G V + VA+K + DS ++ M+E+K+++ + SH
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSH 108
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--------------- 424
N++ LLG C G L++E+ G L +L+ +R I
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 425 ------ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478
+ A + A+ + +L + HRD+ + N+L+ + K+ DFGL+R M++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 479 SSHISTAPQGTPGYLDP---------QYHQYFHLSDKSDVYSFGVVLIEIIT 521
S+++ L P Y + KSDV+S+G++L EI +
Sbjct: 226 SNYVVR----GNARL-PVKWMAPESLFEGIY---TIKSDVWSYGILLWEIFS 269
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 68/349 (19%), Positives = 122/349 (34%), Gaps = 73/349 (20%)
Query: 295 QLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSE--------KHRLGTGAYGTVYAGKLH 346
+ +L P Y + + S E LG GA+G VY G++
Sbjct: 34 EYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 93
Query: 347 NDDW------VAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398
VA+K + D +D + E ++S +H N++R +G ++ ++
Sbjct: 94 GMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 399 YEFMPNGTLCQHLQRER---GSGLPWTIR--ITIATETAQAIAYLHSAMNPPIYHRDIKS 453
E M G L L+ R + + +A + A YL + HRDI +
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-EENH--FIHRDIAA 209
Query: 454 SNILLDY---NYRSKVADFGLSRLGMTESSHISTAPQG------TPGYLDPQYHQYFHLS 504
N LL +K+ DFG++R + + + P P+ +
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMAR-DIYRAGYYRKGGCAMLPVKWMP----PEAFMEGIFT 264
Query: 505 DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--------CVDEIIDP 556
K+D +SFGV+L EI + + S+ + EV ++ + G C +
Sbjct: 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------LEFVTSGGRMDPPKNCPGPV--- 315
Query: 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
Y + +C + RP + E +E+
Sbjct: 316 Y-----------------RIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-30
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 329 KHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLL 386
K RLGTG +G V + VAIK+ R + ++ EI+++ ++HPN++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 387 GCCIEEGE-------PILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQAIAYL 438
+ + P+L E+ G L ++L Q E GL T+ ++ + A+ YL
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRS---KVADFGLSRLGMTESSHISTAPQGTPGYLDP 495
H I HRD+K NI+L + K+ D G ++ + + + GT YL P
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEF-VGTLQYLAP 192
Query: 496 ---QYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ +Y + D +SFG + E IT
Sbjct: 193 ELLEQKKY---TVTVDYWSFGTLAFECIT 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 43/285 (15%)
Query: 332 LGTGAYGTVYAGKLHNDDWVAIKR--FRYRDTDSIDQVMNEIKLLSSVSHPNL--LRLLG 387
+G+G V+ AIK D ++D NEI L+ + + +RL
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
I + +V E N L L++ + S + R + +A+ +H I
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKK-KKS-IDPWERKSYWKNMLEAVHTIHQHG---IV 177
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGYLDPQ---------- 496
H D+K +N L+ + K+ DFG++ +++ + Q G Y+ P+
Sbjct: 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 497 -YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555
+S KSDV+S G +L + P ++ + I +
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYG------KTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
E ++ ++ CL R ++ E+ L H
Sbjct: 291 DIPEK-----------DLQDVLKCCLKRDPKQRISIPEL---LAH 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 65/307 (21%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDW------VAIKRFR--YRDTDSIDQVMNEIKLLSSVSHP 380
LG GA+G VY G++ VA+K + D +D + E ++S +H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQ 93
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER-----GSGLPWTIRITIATETAQAI 435
N++R +G ++ ++ E M G L L+ R S L + +A + A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 436 AYLHSAMNPPIYHRDIKSSNILLDY---NYRSKVADFGLSRLGMTESSHISTAPQG---- 488
YL + HRDI + N LL +K+ DFG++R + +S+
Sbjct: 154 QYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRASYYRKGGCAMLPV 209
Query: 489 --TPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546
P P+ + K+D +SFGV+L EI + + S+ + EV ++ +
Sbjct: 210 KWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------LEFVT 259
Query: 547 RG--------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEEL 598
G C + Y + +C + RP + E +
Sbjct: 260 SGGRMDPPKNCPGPV---Y-----------------RIMTQCWQHQPEDRPNFAIILERI 299
Query: 599 EHIRVSS 605
E+
Sbjct: 300 EYCTQDP 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G++ VY + +H VAIK + + +V NE+K+ + HP++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 388 CCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
E+ + LV E NG + ++L+ R + + YLHS I
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSHG---I 133
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-----QYHQYF 501
HRD+ SN+LL N K+ADFGL+ T GTP Y+ P H
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAH--- 189
Query: 502 HLSDKSDVYSFGVVL 516
+SDV+S G +
Sbjct: 190 --GLESDVWSLGCMF 202
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 49/297 (16%), Positives = 102/297 (34%), Gaps = 50/297 (16%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHND--DWVAIKRFRYRDTDSIDQVMNEIKLL 374
E + + + + R+G G++G V+ A+K+ R + E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAVKKVRLEVFR-----VEELVAC 104
Query: 375 SSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQA 434
+ +S P ++ L G E + E + G+L Q +++ LP + + +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEG 162
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLSRLGMTESSHISTAP----QGT 489
+ YLH+ I H D+K+ N+LL + R+ + DFG + + S GT
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 490 PGYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546
++ P K D++S +++ ++ P ++ +I
Sbjct: 220 ETHMAPEVVMGKPC---DAKVDIWSSCCMMLHMLNG------CHPWTQYFRGP-LCLKIA 269
Query: 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRD--MRPTMMEVAEEL-EH 600
P + + + ++ R + A EL
Sbjct: 270 SE------PPPIREIPPSCAPLTAQ------AIQEGLRKEPVHRAS----AMELRRK 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 46/212 (21%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 329 KHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+ L G + VY + + + A+KR + + ++ E+ + +S HPN+++
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 387 GCCIEEGEP-------ILVYEFMPNGTLCQHLQRERGSGLPWTIRI-TIATETAQAIAYL 438
E L+ + G L + L++ G + I +T +A+ ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ----------- 487
H PPI HRD+K N+LL K+ DFG + + +A +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 488 GTPGYLDP---QYHQYFHLSDKSDVYSFGVVL 516
TP Y P + F + +K D+++ G +L
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 64/275 (23%), Positives = 106/275 (38%), Gaps = 57/275 (20%)
Query: 290 TSLRNQLSAKRL----LCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKL 345
T+L ++L RL + Q P E + + +G GA+G V+ +
Sbjct: 11 TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRD--IGEGAFGRVFQARA 68
Query: 346 HNDDW------VAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397
VA+K + D E L++ +PN+++LLG C L
Sbjct: 69 PGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127
Query: 398 VYEFMPNGTLCQHLQRERGSGLPWTIR----------------------ITIATETAQAI 435
++E+M G L + L+ + + IA + A +
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187
Query: 436 AYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP 495
AYL S HRD+ + N L+ N K+ADFGLSR + + + P
Sbjct: 188 AYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK----ADGNDAI-P 239
Query: 496 ---------QYHQYFHLSDKSDVYSFGVVLIEIIT 521
Y++Y + +SDV+++GVVL EI +
Sbjct: 240 IRWMPPESIFYNRY---TTESDVWAYGVVLWEIFS 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 39/228 (17%), Positives = 71/228 (31%), Gaps = 24/228 (10%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGK------LHNDDWVAIKRFRYRDTDSIDQVM 368
P E + + H LG GA+ VY N +K + +
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 369 NEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRER---GSGLPWTIRI 425
++ L ++ + + +LV E GTL + + +P + I
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 426 TIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-----------KVADFGLSR- 473
+ A I +H I H DIK N +L + + D G S
Sbjct: 176 SFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 474 LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ + I TA T G+ + + + D + + ++
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLL 383
+ + +G+GA V A + VAIKR + S+D+++ EI+ +S HPN++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT---IAT---ETAQAIAY 437
+ + E LV + + G++ ++ G + + IAT E + + Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-----GTPGY 492
LH N I HRD+K+ NILL + ++ADFG+S + I+ GTP +
Sbjct: 137 LHK--NGQI-HRDVKAGNILLGEDGSVQIADFGVSAF-LATGGDITRNKVRKTFVGTPCW 192
Query: 493 LDP----QYHQYFHLSDKSDVYSFGVVLIEIIT 521
+ P Q Y K+D++SFG+ IE+ T
Sbjct: 193 MAPEVMEQVRGYDF---KADIWSFGITAIELAT 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 41/228 (17%), Positives = 86/228 (37%), Gaps = 44/228 (19%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD--WVAIKRFRYRDTDSID--QVMNEIKLLSSVS-HP 380
F E ++G+G +G+V+ D AIKR + S+D + E+ + + H
Sbjct: 13 FHELEKIGSGEFGSVFKCV-KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWT---IRITIATETAQAIAY 437
+++R E+ ++ E+ G+L + + ++ + + + + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD-LLLQVGRGLRY 130
Query: 438 LHSAMNPPIYHRDIKSSNILLDYN-------------------YRSKVADFGLSRLGMTE 478
+HS M+ + H DIK SNI + K+ D G T
Sbjct: 131 IHS-MS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----TR 183
Query: 479 SSHISTAPQGTPGYLDP----QYHQYFHLSDKSDVYSFGVVLIEIITA 522
S +G +L + + + K+D+++ + ++ A
Sbjct: 184 ISSPQVE-EGDSRFLANEVLQENYTH---LPKADIFALALTVVCAAGA 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 326 FSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLL 383
F + LG G G V+ + +A K +Q++ E+++L + P ++
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
G +GE + E M G+L Q L++ +P I ++ + + YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHL 503
I HRD+K SNIL++ K+ DFG+S G S ++ GT Y+ P+ Q H
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSF-VGTRSYMSPERLQGTHY 207
Query: 504 SDKSDVYSFGVVLIEIIT 521
S +SD++S G+ L+E+
Sbjct: 208 SVQSDIWSMGLSLVEMAV 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
++ ++G GA GTVY + VAI++ + + ++NEI ++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
++ L + E +V E++ G+L + + + E QA+ +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN 135
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDP---QY 497
+ HRDIKS NILL + K+ DFG ++ +S + GTP ++ P
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTR 190
Query: 498 HQYFHLSDKSDVYSFGVVLIEII 520
Y K D++S G++ IE+I
Sbjct: 191 KAY---GPKVDIWSLGIMAIEMI 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 57/298 (19%), Positives = 107/298 (35%), Gaps = 51/298 (17%)
Query: 331 RLGTGAYGTVYAGKLH--NDDWVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLLRLL- 386
+ G G +Y N V +K + D ++ M E + L+ V HP+++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 387 ----GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ +V E++ +L + ++ LP I E A++YLHS
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-QYHQYF 501
+ + D+K NI+L + K+ D G + ++ GTPG+ P
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPEIVRT-- 251
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561
+ +D+Y+ G L + L + + L D DP L+ +
Sbjct: 252 GPTVATDIYTVGRTLAALTLDL------PTRNGRYVDGLPED-----------DPVLKTY 294
Query: 562 RDAWTLSSIHNVAELAFRCLAFHRDMRP-TMMEVAEELEHIRVSSWASNIYMGSPAVS 618
L R + R T E++ +L + A + + P +S
Sbjct: 295 DS---------YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 42/195 (21%), Positives = 78/195 (40%), Gaps = 22/195 (11%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G + + + A K + +++ EI + S++H +++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 388 CCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
E+ + + +V E +L + +R R + R + YLH +
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEAR-YYLRQIVLGCQYLHRNR---V 162
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-----QYHQYF 501
HRD+K N+ L+ + K+ DFGL+ + GTP Y+ P + H
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH--- 218
Query: 502 HLSDKSDVYSFGVVL 516
S + DV+S G ++
Sbjct: 219 --SFEVDVWSIGCIM 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 49/289 (16%)
Query: 331 RLGTGAYGTVYAGK---LHNDDWVAIKRFRY---RDTDSIDQVMNEIKLLSSVSHPNLLR 384
+LG G TVY + L+ VAIK +++ + E+ S +SH N++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIK--VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
++ E+ LV E++ TL +++ G L I + I + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP-LSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHISTAPQGTPGYLDPQYHQY 500
I HRDIK NIL+D N K+ DFG+++ +T+++H+ GT Y P+ +
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV----LGTVQYFSPEQAKG 186
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
+ +D+YS G+VL E++ P + ++AI I
Sbjct: 187 EATDECTDIYSIGIVLYEMLVG------EPPFNGETAVSIAIKHI--------------- 225
Query: 561 HRDAWTLSSIHN------VAELAFRCLAFHRDMRP-TMMEVAEELEHIR 602
+++ ++ + R + R T+ E+ ++L +
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 42/195 (21%), Positives = 78/195 (40%), Gaps = 22/195 (11%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G + + + A K + +++ EI + S++H +++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 388 CCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
E+ + + +V E +L + +R R + R + YLH +
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEAR-YYLRQIVLGCQYLHRNR---V 136
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-----QYHQYF 501
HRD+K N+ L+ + K+ DFGL+ + GTP Y+ P + H
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH--- 192
Query: 502 HLSDKSDVYSFGVVL 516
S + DV+S G ++
Sbjct: 193 --SFEVDVWSIGCIM 205
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 33/356 (9%), Positives = 78/356 (21%), Gaps = 67/356 (18%)
Query: 286 RKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVY-AGK 344
R +L+ + + + + + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 345 LHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCC---------IEE 392
+ + A+K F ++++ + + + +
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 393 GEPI-----------------LVYEFMPNGTLCQHLQR-----ERGSGLPWTIRITIATE 430
+P L+ + L + +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
+ A L S + H N+ + + R + D + A
Sbjct: 203 LIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPV 255
Query: 491 GYLDPQY--HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548
Y ++ + + + G+ + + P V +
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCL------FLPFGLVTPGIKGSWKRPS- 308
Query: 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAF----RCLAFHRDMRPTMMEVAEELEH 600
P D+ S + + R L F R R +E +E
Sbjct: 309 --------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA---MET 353
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
+ LG GA+G VY K A K + + ++ + EI++L++ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+++LLG +G+ ++ EF P G + E GL + + +A+ +LHS
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGA-VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTP--------GY 492
I HRD+K+ N+L+ ++ADFG+S + T S GTP
Sbjct: 137 R---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMC 191
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVN 536
+ Y + K+D++S G IT +++ PH E+N
Sbjct: 192 ETMKDTPYDY---KADIWSLG------ITLIEMAQIEPPHHELN 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 37/203 (18%), Positives = 73/203 (35%), Gaps = 20/203 (9%)
Query: 333 GTGAYGTVYAGK-LHNDDWVAIKRF--RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
G TV + ++V ++R + + + E+ + +HPN++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
I + E +V FM G+ + G+ I +A+ Y+H + HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYV-HR 152
Query: 450 DIKSSNILLDYNYRSKVADFG----LSRLGMTESSHISTAPQ--GTPGYLDP-----QYH 498
+K+S+IL+ + + ++ + G + +L P
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 499 QYFHLSDKSDVYSFGVVLIEIIT 521
Y KSD+YS G+ E+
Sbjct: 213 GY---DAKSDIYSVGITACELAN 232
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVMNEIK-LLSSVSHPNLLRLLG 387
LG GAYG V + + + +A+KR R ++ +++ ++ + +V P + G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
EG+ + E M + +L + ++ ++G +P I IA +A+ +LHS ++
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-------QYH 498
+ HRD+K SN+L++ + K+ DFG+S + + G Y+ P
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCKPYMAPERINPELNQK 188
Query: 499 QYFHLSDKSDVYSFGVVLIEIIT 521
Y S KSD++S G+ +IE+
Sbjct: 189 GY---SVKSDIWSLGITMIELAI 208
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHP 380
F++ ++G G++G V+ G VAIK D I+ + EI +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
+ + G +++ + ++ E++ G+ L L T TI E + + YLHS
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP--LDETQIATILREILKGLDYLHS 137
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDP---Q 496
HRDIK++N+LL + K+ADFG++ +L T+ + GTP ++ P +
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIK 192
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIIT 521
Y K+D++S G+ IE+
Sbjct: 193 QSAYDS---KADIWSLGITAIELAR 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
++G G+ G V + H+ VA+K R + + NE+ ++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
++ + + E ++ EF+ G L + + R L T+ QA+AYLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHA- 159
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDP---QY 497
+ HRDIKS +ILL + R K++DFG ++ S GTP ++ P
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISR 215
Query: 498 HQYFHLSDKSDVYSFGVVLIEII 520
Y + + D++S G+++IE++
Sbjct: 216 SLY---ATEVDIWSLGIMVIEMV 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVMNEIK-LLSSVSHPNLLRLLG 387
+G GAYG+V + +A+KR R D Q++ ++ ++ S P +++ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 388 CCIEEGEPILVYEFMPNG--TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
EG+ + E M +++ +P I I T +A+ +L +
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-------QYH 498
I HRDIK SNILLD + K+ DFG+S G S T G Y+ P
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 499 QYFHLSDKSDVYSFGVVLIEIIT 521
Y +SDV+S G+ L E+ T
Sbjct: 205 GY---DVRSDVWSLGITLYELAT 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVMNEIK-LLSSVSHPNL 382
+G+G G V+ + +A+K+ R + + +++ ++ +L S P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
++ G I + + E M GT + L++ +P I + +A+ YL
Sbjct: 87 VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
+ HRD+K SNILLD + K+ DFG+S G G Y+ P+
Sbjct: 145 G--VIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 503 LSD-----KSDVYSFGVVLIEIIT 521
+ ++DV+S G+ L+E+ T
Sbjct: 201 PTKPDYDIRADVWSLGISLVELAT 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 74/307 (24%), Positives = 115/307 (37%), Gaps = 55/307 (17%)
Query: 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLS-SVSHPNL 382
+ + LG G+ GTV VA+KR D D + EIKLL+ S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR-----ITIATETAQAIAY 437
+R + + E N L ++ + S ++ I++ + A +A+
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 438 LHSAMNPPIYHRDIKSSNILLD-------------YNYRSKVADFGLSRL---GMTESSH 481
LHS I HRD+K NIL+ N R ++DFGL + G +
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 482 ISTAPQGTPGYLDP-------QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSE 534
P GT G+ P L+ D++S G V I++ P +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-----KGKHPFGD 242
Query: 535 VNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVA-ELAFRCLAFHRDMRPTMME 593
I R G +DE+ + S+ A +L + + RPT M+
Sbjct: 243 KYSRESNIIR-GIFSLDEMKCLHDR---------SLIAEATDLISQMIDHDPLKRPTAMK 292
Query: 594 VAEELEH 600
V L H
Sbjct: 293 V---LRH 296
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN 381
F +LG G+YG+VY VAIK+ + +++ EI ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+++ G + + +V E+ G+ + R R L TI T + + YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGS-VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLS-RLGMTESSHISTAPQGTPGYLDP---QY 497
HRDIK+ NILL+ +K+ADFG++ +L T + + GTP ++ P Q
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPEVIQE 199
Query: 498 HQYFHLSDKSDVYSFGVVLIEII 520
Y +D++S G+ IE+
Sbjct: 200 IGYNC---VADIWSLGITAIEMA 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMN--EIK 372
Y++I K +G G+YG V+ + VAIK+F + D + + + EI+
Sbjct: 5 YEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR 54
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
+L + HPNL+ LL + LV+E+ + T+ L R + ++ +I +T
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTL 112
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
QA+ + H HRD+K NIL+ + K+ DFG +R
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVS 378
FS+ +G G++G VY + + N + VAIK+ Y + ++ E++ L +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
HPN ++ GC + E LV E+ L L + Q +AYL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST----APQGTPGYLD 494
HS + HRD+K+ NILL K+ DFG + + +S + T AP+ +
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDE 227
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIIT 521
QY K DV+S G+ IE+
Sbjct: 228 GQYDG------KVDVWSLGITCIELAE 248
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 30/205 (14%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G++ TV A +L AIK R + + V E ++S + HP ++L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI------ATETAQAIAYLHSA 441
++ + + NG L +++++ E A+ YLH
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIG--------SFDETCTRFYTAEIVSALEYLHG- 148
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ-GTPGYLDP---QY 497
I HRD+K NILL+ + ++ DFG +++ ES GT Y+ P
Sbjct: 149 KG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 498 HQYFHLSDKS-DVYSFGVVLIEIIT 521
KS D+++ G ++ +++
Sbjct: 207 KSA----CKSSDLWALGCIIYQLVA 227
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HP 380
F +G G YG VY G+ + AIK D +++ EI +L S H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 381 NLLRLLGCCIEEGEPI------LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQA 434
N+ G I++ P LV EF G++ ++ +G+ L I E +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTPGYL 493
+++LH + HRDIK N+LL N K+ DFG+S L T + GTP ++
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWM 196
Query: 494 DPQYHQYFHLSD-----KSDVYSFGVVLIEIIT 521
P+ D KSD++S G+ IE+
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/291 (23%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 331 RLGTGAYGTVYAGK---LHNDDWVAIK--RFRY-RDTDSIDQVMNEIKLLSSVSHPNLLR 384
LG G V+ + H D VA+K R RD + E + ++++HP ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRD--VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 385 LL--GCCIEEGEPI--LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
+ G P+ +V E++ TL + G + I + + QA+ + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP-MTPKRAIEVIADACQALNFSHQ 134
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ---GTPGYLDPQY 497
I HRD+K +NI++ KV DFG++R + +S + T GT YL P+
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557
+ + +SDVYS G VL E++T P + + ++A + ++ I P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVAYQHVR----EDPIPP- 239
Query: 558 LEPHRDAWTLSSIH-----NVAELAFRCLAFHRDMRP-TMMEVAEELEHIR 602
S+ H ++ + + LA + + R T E+ +L +
Sbjct: 240 ----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 18/161 (11%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMN--EIK 372
Y+ + +G G+YG V + VAIK+F D D + + + EIK
Sbjct: 27 YENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK 76
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
LL + H NL+ LL C ++ LV+EF+ + T+ L+ ++ +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQII 134
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
I + HS I HRDIK NIL+ + K+ DFG +R
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 35/209 (16%)
Query: 329 KHRLGTGAYGTVY-AGKLHNDDWVAIKRF--------RYRDTDSIDQVMNEIKLLSSVSH 379
LG+GA G V A + VAI+ R+ D V EI++L ++H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTL------CQHLQRERGSGLPWTIRITIATETAQ 433
P ++++ + + +V E M G L + L+ + +
Sbjct: 200 PCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--------LL 250
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
A+ YLH I HRD+K N+LL + + K+ DFG S++ + E+S + T GTP
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTL-CGTP 305
Query: 491 GYLDP---QYHQYFHLSDKSDVYSFGVVL 516
YL P + D +S GV+L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 45/360 (12%), Positives = 98/360 (27%), Gaps = 83/360 (23%)
Query: 288 RSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LH 346
R+TS Q +A L+ + N+ PF E+ + LG
Sbjct: 37 RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQE 96
Query: 347 NDDWVAIK---RFRYRDTDSIDQVMNEIK-------------------------LLSSVS 378
+ + +++I Q+ E+ L+
Sbjct: 97 TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156
Query: 379 HPNLLRLLGCCIEEGEPILVYEFM-PNGTLCQ------HLQRERGSGLPWTIRITIATET 431
++R+ + + + L S L R+ + +
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQV 215
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
+ +A LH + H ++ +I+LD + F + G
Sbjct: 216 IRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRG 267
Query: 492 YLDPQY-----------HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540
+ P+ + ++ D ++ G+V+ I A P ++
Sbjct: 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA------DLPITKDAALGG 321
Query: 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ I R C + + V L L + ++ R ++ +E
Sbjct: 322 -SEWIFRSCKN---------------IPQ--PVRALLEGFLRYPKEDRLLPLQA---MET 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 47/371 (12%), Positives = 106/371 (28%), Gaps = 69/371 (18%)
Query: 267 GLIAGASIVAVVALLCYCFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFF 326
G G ++ + R+TS Q +A L+ + N+ PF E+ +
Sbjct: 21 GTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTL 80
Query: 327 SEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQV------MNEIKLLSSVSH 379
LG A + + + + + + + ++LL + +
Sbjct: 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140
Query: 380 P-------------NLLRLLGCC------IEEGEPILVYEFM----PNGTLCQHLQ---- 412
+L++ ++E + ++ F L +
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 413 --RERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470
S L R+ + + + +A LH + H ++ +I+LD + F
Sbjct: 201 HSSTHKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 471 LSRLGMTESSHISTAPQGTPGYLDP-----QYHQYFHLSDKSDVYSFGVVLIEIITALKV 525
+ P H ++ D ++ G+ + I A
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA--- 313
Query: 526 VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHR 585
P+++ + I R C + I + L L + +
Sbjct: 314 ---DLPNTDDAALGG-SEWIFRSCKN--IPQPVRA---------------LLEGFLRYPK 352
Query: 586 DMRPTMMEVAE 596
+ R ++ E
Sbjct: 353 EDRLLPLQAME 363
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 44/203 (21%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 320 EKATSFFSEKHRLGTGAYGTVYAG--KLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV 377
+ + LGTGA+G V+ + +++ A K + V EI+ +S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVL 211
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--ITIATETAQAI 435
HP L+ L ++ E +++YEFM G L + + E + + + + +
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGL 268
Query: 436 AYLHSAMNPPIYHRDIKSSNILLDYNYRS--KVADFGLSRLGMTESSHISTAPQGTPGYL 493
++H N H D+K NI+ + K+ DFGL+ + + GT +
Sbjct: 269 CHMHE-NN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVT-TGTAEFA 323
Query: 494 DPQYHQYFHLSDKSDVYSFGVVL 516
P+ + + +D++S GV+
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLS 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 55/267 (20%), Positives = 89/267 (33%), Gaps = 60/267 (22%)
Query: 304 QAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIK-----RFR 357
+ ++ + + + K +G G+YG V AIK + R
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 358 YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS 417
+ ++++ E++L+ + HPN+ RL +E LV E G L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 418 GLPWTIRITIATETA--------------------------------------QAIAYLH 439
+ T+ A+ YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 440 SAMNPPIYHRDIKSSNILL--DYNYRSKVADFGLSRL---GMTESSHISTAPQGTPGY-- 492
+ I HRDIK N L + ++ K+ DFGLS+ + T GTP +
Sbjct: 186 N-QG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 493 ---LDPQYHQYFHLSDKSDVYSFGVVL 516
L+ Y K D +S GV+L
Sbjct: 243 PEVLNTTNESY---GPKCDAWSAGVLL 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V + + A+K + D + + E ++L + HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
V E+ G L HL RER R A E A+ YLHS N +
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGA-EIVSALDYLHSEKN--VV 271
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
+RD+K N++LD + K+ DFGL + G+ + + + T GTP YL P + + Y
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDY---- 326
Query: 505 DKS-DVYSFGVVLIEIIT 521
++ D + GVV+ E++
Sbjct: 327 GRAVDWWGLGVVMYEMMC 344
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 35/206 (16%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRF--------RYRDTDSIDQVMNEIKLLSSVSHPNL 382
LG+GA G V A + VAIK R+ D V EI++L ++HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTL------CQHLQRERGSGLPWTIRITIATETAQAIA 436
+++ + + +V E M G L + L+ + + A+
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--------LLAVQ 128
Query: 437 YLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
YLH I HRD+K N+LL + + K+ DFG S++ + E+S + T GTP YL
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTL-CGTPTYL 183
Query: 494 DP---QYHQYFHLSDKSDVYSFGVVL 516
P + D +S GV+L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 43/199 (21%), Positives = 82/199 (41%), Gaps = 17/199 (8%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIK--RFRY-RDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
+G G G VY + + VA+K D ++ E + + P+++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+G+ + + L L R +G L + I + A+ H+A
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGP-LAPPRAVAIVRQIGSALDAAHAAG---A 155
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRL----GMTESSHISTAPQGTPGYLDPQYHQYFH 502
HRD+K NIL+ + + + DFG++ +T+ + GT Y+ P+ H
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT----VGTLYYMAPERFSESH 211
Query: 503 LSDKSDVYSFGVVLIEIIT 521
+ ++D+Y+ VL E +T
Sbjct: 212 ATYRADIYALTCVLYECLT 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 28/229 (12%)
Query: 305 AAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIK-----RFRY 358
+ G + ++ + +G G + V A+K +F
Sbjct: 6 SGGGGGILDMADDDVL-FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS 64
Query: 359 RDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG 418
S + + E + + HP+++ LL +G +V+EFM LC + +R
Sbjct: 65 SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADA 123
Query: 419 LPW--------TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS---KVA 467
+R I +A+ Y H N I HRD+K +LL S K+
Sbjct: 124 GFVYSEAVASHYMR-QI----LEALRYCHD-NN--IIHRDVKPHCVLLASKENSAPVKLG 175
Query: 468 DFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
FG++ + ES ++ GTP ++ P+ + DV+ GV+L
Sbjct: 176 GFGVAIQ-LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 32/225 (14%)
Query: 306 AGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDT 361
A + + + LG G++G V K A+K + + +
Sbjct: 11 ATPGMFVQHSTAIFSD---RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67
Query: 362 DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-----ERG 416
+ ++ E++LL + HPN+++L ++G LV E G L + E
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 417 SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSR 473
+ I + I Y+H I HRD+K N+LL + ++ DFGLS
Sbjct: 128 AA-------RIIRQVLSGITYMHK-NK--IVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 474 LGMTESSHISTAPQGTPGYLDPQ--YHQYFHLSDKSDVYSFGVVL 516
E+S GT Y+ P+ + Y +K DV+S GV+L
Sbjct: 178 --HFEASKKMKDKIGTAYYIAPEVLHGTY---DEKCDVWSTGVIL 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 41/202 (20%), Positives = 77/202 (38%), Gaps = 13/202 (6%)
Query: 320 EKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS 378
++ LG+GA+G V+ + K V NEI +++ +
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATETAQAIA 436
HP L+ L ++ E +L+ EF+ G L R + I + + +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 437 YLHSAMNPPIYHRDIKSSNILL--DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
++H + I H DIK NI+ K+ DFGL+ + + T +
Sbjct: 164 HMHE-HS--IVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVT-TATAEFAA 218
Query: 495 PQYHQYFHLSDKSDVYSFGVVL 516
P+ + +D+++ GV+
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 326 FSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
S+ LG G +G V+ + +A K + R ++V NEI +++ + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATETAQAIAYLHSAM 442
L + + +LV E++ G L R + L I + + I ++H M
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTELDTILFMKQICEGIRHMHQ-M 206
Query: 443 NPPIYHRDIKSSNILLDYNYRS--KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
I H D+K NIL K+ DFGL+R + GTP +L P+ Y
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVN-FGTPEFLAPEVVNY 262
Query: 501 FHLSDKSDVYSFGVVL 516
+S +D++S GV+
Sbjct: 263 DFVSFPTDMWSVGVIA 278
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSID-QVMNEIKLLSSVSHPNLLRLLG 387
++G G YG VY + + VA+K+ R +T+ + + EI LL ++HPN+++LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
E + LV+EF+ L + + +G+P + + + Q +A+ HS +
Sbjct: 70 VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VL 125
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSR 473
HRD+K N+L++ K+ADFGL+R
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 67/231 (29%)
Query: 332 LGTGAYGTVYAGKLHNDD--WVAIK--------------------------RFRYRDTDS 363
+G G+YG V + +D + A+K +
Sbjct: 21 IGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 364 IDQVMNEIKLLSSVSHPNLLRLLGCCIE------EGEPILVYEFMPNGTLCQHLQRERGS 417
I+QV EI +L + HPN+++L +E E +V+E + G + + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-- 133
Query: 418 GLPWTIRITIATETAQ--------AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469
++ + A+ I YLH I HRDIK SN+L+ + K+ADF
Sbjct: 134 ---------LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 470 GLSRLGMTESSHISTAPQGTPGYLDP----QYHQYFHLSDKSDVYSFGVVL 516
G+S + +S GTP ++ P + + F DV++ GV L
Sbjct: 182 GVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTL 230
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 32/211 (15%)
Query: 320 EKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS 378
++ + LG G +G V+ + + K + + TD V EI +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATETA---- 432
H N+L L E ++++EF+ + +R L E
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDI---FERINTSAFEL---------NEREIVSY 107
Query: 433 -----QAIAYLHSAMNPPIYHRDIKSSNILL--DYNYRSKVADFGLSRLGMTESSHISTA 485
+A+ +LHS N I H DI+ NI+ + K+ +FG +R + +
Sbjct: 108 VHQVCEALQFLHS-HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLL 163
Query: 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
P Y P+ HQ+ +S +D++S G ++
Sbjct: 164 -FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 8/148 (5%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLLRLLGC 388
+LG G Y TVY G +VA+K + + + EI L+ + H N++RL
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 389 CIEEGEPILVYEFMPN---GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
E + LV+EFM N + GL + + Q +A+ H
Sbjct: 72 IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSR 473
I HRD+K N+L++ + K+ DFGL+R
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V + + A+K R D + + E ++L + HP L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
V E+ G L HL RER R A E A+ YLHS +
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGA-EIVSALEYLHSR---DVV 127
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
+RDIK N++LD + K+ DFGL + G+++ + + T GTP YL P + + Y
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY---- 182
Query: 505 DKS-DVYSFGVVLIEIIT 521
++ D + GVV+ E++
Sbjct: 183 GRAVDWWGLGVVMYEMMC 200
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRD--TDSIDQVMNEIKL 373
+ + + +LG+GAYG V + AIK R T S +++ E+ +
Sbjct: 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV 89
Query: 374 LSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-----ERGSGLPWTIRITIA 428
L + HPN+++L ++ LV E G L + E + I
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VII 142
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTA 485
+ + YLH N I HRD+K N+LL + + K+ DFGLS + E+
Sbjct: 143 KQVLSGVTYLHK-HN--IVHRDLKPENLLLESKEKDALIKIVDFGLSA--VFENQKKMKE 197
Query: 486 PQGTPGYLDPQ--YHQYFHLSDKSDVYSFGVVL 516
GT Y+ P+ +Y +K DV+S GV+L
Sbjct: 198 RLGTAYYIAPEVLRKKY---DEKCDVWSIGVIL 227
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRY-RDTDSID-QVMNEIKLLSSVSHPNLLRLLGC 388
++G G YG VY + + + A+K+ R ++ + I + EI +L + H N+++L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
+ +LV+E + L + L G T + + + IAY H + H
Sbjct: 69 IHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDRR---VLH 123
Query: 449 RDIKSSNILLDYNYRSKVADFGLSR 473
RD+K N+L++ K+ADFGL+R
Sbjct: 124 RDLKPQNLLINREGELKIADFGLAR 148
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRY-RDTDSID-QVMNEIKLLSSVSHPNLLRLLGC 388
++G G YG VY K VA+KR R + + I + EI LL + HPN++ L+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
E LV+EFM L + L + I+ + + +A+ H I H
Sbjct: 88 IHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIK-IYLYQLLRGVAHCHQHR---ILH 142
Query: 449 RDIKSSNILLDYNYRSKVADFGLSR 473
RD+K N+L++ + K+ADFGL+R
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLAR 167
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 51/208 (24%), Positives = 79/208 (37%), Gaps = 40/208 (19%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK-----RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
LG G+YG V A+K + R R + V EI+LL + H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 386 LGCCIEEGEP--ILVYEFMPNGT--LCQHLQRERGSGLPWTIRITIATETAQ-------- 433
+ E + +V E+ G + + +R P A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FP--------VCQAHGYFCQLID 120
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTPG 491
+ YLHS I H+DIK N+LL K++ G++ T+ QG+P
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPA 176
Query: 492 YLDP---QYHQYFHLSDKSDVYSFGVVL 516
+ P F K D++S GV L
Sbjct: 177 FQPPEIANGLDTFS-GFKVDIWSAGVTL 203
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 55/259 (21%), Positives = 93/259 (35%), Gaps = 41/259 (15%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPNLLRLLG 387
+G GA+G V + D A+K + + E +L + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ LV ++ G L L + R +A E AI +H ++
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQ-LH--YV 197
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
HRDIK NIL+D N ++ADFG M + + S+ GTP Y+ P+ Q
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 508 -----DVYSFGVVLIEIITAL-----------------KVVDFSRPHSEVNLAALAID-- 543
D +S GV + E++ F P +++ A D
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317
Query: 544 ---------RIGRGCVDEI 553
R+G+ +++
Sbjct: 318 RRLICSREHRLGQNGIEDF 336
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 30/198 (15%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
LG+GA+ V+ + A+K + + NEI +L + H N++ L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 391 EEGEPILVYEFMPNGTLCQHLQR--ERG-------SGLPWTIRITIATETAQAIAYLHSA 441
LV + + G L R ERG S + + A+ YLH
Sbjct: 77 STTHYYLVMQLVSGGEL---FDRILERGVYTEKDASLVIQQV--------LSAVKYLHE- 124
Query: 442 MNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
I HRD+K N+L + N + + DFGLS+ M ++ +STA GTPGY+ P+
Sbjct: 125 NG--IVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTA-CGTPGYVAPEVL 179
Query: 499 QYFHLSDKSDVYSFGVVL 516
S D +S GV+
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 313 FYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDT-DSIDQVMNE 370
Y I+ F K +LG+GA+G V+ + + IK + ++Q+ E
Sbjct: 14 LYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE 70
Query: 371 IKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR--ITIA 428
I++L S+ HPN++++ + +V E G L + + + G + +
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTA 485
+ A+AY HS + + H+D+K NIL + K+ DFGL+ L H + A
Sbjct: 131 KQMMNALAYFHS-QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNA 186
Query: 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
GT Y+ P+ + ++ K D++S GVV+
Sbjct: 187 -AGTALYMAPEVFKR-DVTFKCDIWSAGVVM 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID-QVMNEIKLLSSVSHPNLL 383
+ + +LG G Y TVY GK D+ VA+K R + + E+ LL + H N++
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
L E LV+E++ L Q+L ++ + + +AY H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-LFLFQLLRGLAYCHRQK- 120
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ HRD+K N+L++ K+ADFGL+R
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 62/232 (26%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIK------RFRYRDTDSIDQVMN 369
Y + +G G++G V+ KL D VAIK RF+ R
Sbjct: 42 YTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR---------- 81
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEPI------LVYEFMPNGTLCQHLQRERGSGLPWTI 423
E++++ V HPN++ L G+ LV E++P T+ + + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 424 RITIATETAQ---AIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSRL---GM 476
+ I Q ++AY+HS I HRDIK N+LLD K+ DFG +++ G
Sbjct: 141 -LLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 477 TESSHIST----APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
S+I + AP+ G Y + D++S G V+ E++
Sbjct: 197 PNVSYICSRYYRAPELIFGATNY-----------TTNIDIWSTGCVMAELMQ 237
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 31/203 (15%)
Query: 329 KHRLGTGAYGTVY-AGKLHNDDWVAIKRF--RYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
K LG GA+ V A K + ++ E ++ + HPN++RL
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 386 LGCCIEEGEPILVYEFMPNGTLC------QHLQRERGSGLPWTIRITIATETAQAIAYLH 439
EE LV++ + G L + S I ++IAY H
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--------LESIAYCH 122
Query: 440 SAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP- 495
S I HR++K N+LL K+ADFGL+ + +S GTPGYL P
Sbjct: 123 S-NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF-AGTPGYLSPE 177
Query: 496 --QYHQYFHLSDKSDVYSFGVVL 516
+ Y S D+++ GV+L
Sbjct: 178 VLKKDPY---SKPVDIWACGVIL 197
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G G++G V K A+K + + + + V E++++ + HP L+ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+E + +V + + G L HLQ+ T+++ I E A+ YL + I
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFIC-ELVMALDYLQN-QR--II 137
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ--YHQYFHLSD 505
HRD+K NILLD + + DF ++ + E+ + A GT Y+ P+ +
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGAGYS 195
Query: 506 KS-DVYSFGVVLIEIIT 521
+ D +S GV E++
Sbjct: 196 FAVDWWSLGVTAYELLR 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSID-QVMNEIKLLSSVSHPNLLRLLG 387
++G G YGTV+ K + VA+KR R D + + + EI LL + H N++RL
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ + LV+EF L ++ G P ++ + + + + + HS +
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGFCHSRN---VL 123
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSR 473
HRD+K N+L++ N K+A+FGL+R
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 313 FYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRF--RYRDTDSIDQVMN 369
Y + ++ LG G++G V K A+K ++
Sbjct: 14 LYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 370 EIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR-----ERGSGLPWTIR 424
E++LL + HPN+++L + +V E G L + + E +
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------ 124
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSH 481
I + I Y+H N I HRD+K NILL + + K+ DFGLS +++
Sbjct: 125 -RIIKQVFSGITYMHK-HN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTK 179
Query: 482 ISTAPQGTPGYLDP-----QYHQYFHLSDKSDVYSFGVVL 516
+ GT Y+ P Y +K DV+S GV+L
Sbjct: 180 MKDRI-GTAYYIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 28/197 (14%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+G G++G V A K+ + +D+ EI+++ S+ HPN++RL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 391 EEGEPILVYEFMPNGTL------CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
+ + LV E G L + + + + + A+AY H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV--------LSAVAYCHKLN-- 126
Query: 445 PIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ--YHQ 499
+ HRD+K N L + K+ DFGL+ + T GTP Y+ PQ
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTK-VGTPYYVSPQVLEGL 183
Query: 500 YFHLSDKSDVYSFGVVL 516
Y + D +S GV++
Sbjct: 184 Y---GPECDEWSAGVMM 197
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 39/204 (19%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRF-RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
LG GAYG V ++ VA+K R D + + EI + ++H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 390 IEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ--------AIAYLHS 440
EG L E+ G L + E G+P AQ + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--EPDIGMP--------EPDAQRFFHQLMAGVVYLHG 123
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTPGYLDP--- 495
I HRDIK N+LLD K++DFGL+ + ++ GT Y+ P
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 496 ---QYHQYFHLSDKSDVYSFGVVL 516
++H ++ DV+S G+VL
Sbjct: 180 KRREFH-----AEPVDVWSCGIVL 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 16/228 (7%)
Query: 297 SAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAG--KLHNDDWVAIK 354
G ++ F + S++ LG G + V K ++ A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKE--LGRGKFAVVRQCISKSTGQEY-AAK 60
Query: 355 --RFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHL 411
+ R R D ++++EI +L P ++ L E IL+ E+ G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 412 QRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVAD 468
E + I + + + + YLH N I H D+K NILL K+ D
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQ-NN--IVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 469 FGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
FG+SR + + + GTP YL P+ Y ++ +D+++ G++
Sbjct: 178 FGMSRK-IGHACELREI-MGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LGTG++G V + + A+K + I+ +NE ++L +V+ P L++L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ +V E++ G + HL+R P R A + YLHS ++ +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAA-QIVLTFEYLHS-LD--LI 163
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
+RD+K N+L+D +V DFG ++ + GTP L P Y
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGY---- 215
Query: 505 DKS-DVYSFGVVLIEIIT 521
+K+ D ++ GV++ E+
Sbjct: 216 NKAVDWWALGVLIYEMAA 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 5e-22
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 332 LGTGAYGTVY-----AGKLHNDDWVAIKRFR----YRDTDSIDQVMNEIKLLSSVSHPNL 382
LG G YG V+ G + A+K + R+ E +L V HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ L+ G+ L+ E++ G L L+RE +A E + A+ +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLA-EISMALGHLHQ-K 140
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQ 499
I +RD+K NI+L++ K+ DFGL + + + + T GT Y+ P
Sbjct: 141 G--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRSG 197
Query: 500 YFHLSDKS-DVYSFGVVLIEIIT 521
+ +++ D +S G ++ +++T
Sbjct: 198 H----NRAVDWWSLGALMYDMLT 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 32/200 (16%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V G+ VA+K R + R D + ++ EI+ L HP++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 388 CCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQ----AIAYLHSAM 442
+ +V E++ G L ++ + R + A Q A+ Y H M
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGR-------VEEMEARRLFQQILSAVDYCHRHM 131
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP------Q 496
+ HRD+K N+LLD + +K+ADFGLS + M++ + T+ G+P Y P
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISGRL 186
Query: 497 YHQYFHLSDKSDVYSFGVVL 516
Y + D++S GV+L
Sbjct: 187 YA-----GPEVDIWSCGVIL 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 36/202 (17%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRF--RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
LG G++G V K A+K ++ E++LL + HPN+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQR--ERG-------SGLPWTIRITIATETAQAIAYLH 439
+ +V E G L +R + + + I Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQV--------FSGITYMH 138
Query: 440 SAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
N I HRD+K NILL + + K+ DFGLS +++ + GT Y+ P+
Sbjct: 139 K-HN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDR-IGTAYYIAPE 193
Query: 497 --YHQYFHLSDKSDVYSFGVVL 516
Y +K DV+S GV+L
Sbjct: 194 VLRGTY---DEKCDVWSAGVIL 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 39/223 (17%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAG--KLHNDDWVAIKRFRYR------DTDSIDQ 366
P+K+ +K F+ LG+G + V K ++ A K + R S ++
Sbjct: 4 PFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEY-AAKFIKKRQSRASRRGVSREE 61
Query: 367 VMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT 426
+ E+ +L V H N++ L + +L+ E + G L L ++ S
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKES--------- 111
Query: 427 IATETA---------QAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSR 473
+E + YLH+ I H D+K NI+L K+ DFGL+
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHT-KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 474 LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
+ + GTP ++ P+ Y L ++D++S GV+
Sbjct: 168 E-IEDGVEFKNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 23/195 (11%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G G + V + + VAIK + + T + ++ E++++ ++HPN+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFREVRIMKILNHPNIVKLFE 81
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
E L+ E+ G + +L G + + + A+ Y H I
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLV-AHG-RMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGY------LDPQYHQYF 501
HRD+K+ N+LLD + K+ADFG S T + G P Y +Y
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAFC-GAPPYAAPELFQGKKYD--- 191
Query: 502 HLSDKSDVYSFGVVL 516
+ DV+S GV+L
Sbjct: 192 --GPEVDVWSLGVIL 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-22
Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 32/201 (15%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRF--RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
LG GA+ V K+ A + ++ E ++ + HPN++RL
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERG-------SGLPWTIRITIATETAQAIAYLHSA 441
EEG L+++ + G L + + R S I +A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADASHCIQQI--------LEAVLHCHQ- 128
Query: 442 MNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP--- 495
M + HR++K N+LL K+ADFGL+ E GTPGYL P
Sbjct: 129 MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPEVL 185
Query: 496 QYHQYFHLSDKSDVYSFGVVL 516
+ Y D+++ GV+L
Sbjct: 186 RKDPY---GKPVDLWACGVIL 203
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMN-----EIKLLSSVSHPNLLR 384
LG G + TVY + + + VAIK+ + +N EIKLL +SHPN++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
LL + LV++FM L ++ P I+ T Q + YLH
Sbjct: 77 LLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIK-AYMLMTLQGLEYLHQHW-- 132
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSR 473
I HRD+K +N+LLD N K+ADFGL++
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 33/204 (16%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPNLLRLLG 387
LGTG++G V+ HN + A+K + + QV +E +LS V+HP ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI------ATETAQAIAYLHSA 441
+ + ++ +++ G L L++ + R A E A+ YLHS
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEVCLALEYLHS- 124
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYH 498
+ I +RD+K NILLD N K+ DFG ++ ++ GTP Y+ P
Sbjct: 125 KD--IIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 499 QYFHLSDKS-DVYSFGVVLIEIIT 521
Y +KS D +SFG+++ E++
Sbjct: 179 PY----NKSIDWWSFGILIYEMLA 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 49/198 (24%), Positives = 77/198 (38%), Gaps = 14/198 (7%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQV---MNEIKLLSSVSHPNLLRLLG 387
+G GA+G V A+K + E +++ + P +++L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
++ +V E+MP G L + W R A E A+ +HS M
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWA-RFYTA-EVVLALDAIHS-MG--FI 190
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
HRD+K N+LLD + K+ADFG E GTP Y+ P +
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 505 DKS-DVYSFGVVLIEIIT 521
+ D +S GV L E++
Sbjct: 251 GRECDWWSVGVFLYEMLV 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 39/204 (19%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRF-RYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
LG GAYG V ++ VA+K R D + + EI + ++H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 390 IEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ--------AIAYLHS 440
EG L E+ G L + E G+P AQ + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--EPDIGMP--------EPDAQRFFHQLMAGVVYLHG 123
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTPGYLDP--- 495
I HRDIK N+LLD K++DFGL+ + ++ GT Y+ P
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 496 ---QYHQYFHLSDKSDVYSFGVVL 516
++H ++ DV+S G+VL
Sbjct: 180 KRREFH-----AEPVDVWSCGIVL 198
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 317 KEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIK-------------RFRYRDTD 362
K+ K + + +LG+GAYG V K + AIK
Sbjct: 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 363 SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWT 422
+++ NEI LL S+ HPN+++L ++ LV EF G L + + R +
Sbjct: 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHK---FD 144
Query: 423 IR--ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMT 477
I + I YLH N I HRDIK NILL + K+ DFGLS
Sbjct: 145 ECDAANIMKQILSGICYLHK-HN--IVHRDIKPENILLENKNSLLNIKIVDFGLSS--FF 199
Query: 478 ESSHISTAPQGTPGYLDP-----QYHQYFHLSDKSDVYSFGVVL 516
+ GT Y+ P +Y ++K DV+S GV++
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKKKY------NEKCDVWSCGVIM 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 24/201 (11%)
Query: 281 LCYCFRKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTV 340
+ + +L Q + +A S+ Y+ I K LG G YG V
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITK----------LGEGTYGEV 50
Query: 341 YAGK-LHNDDWVAIKRFRY-RDTDSIDQ-VMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397
Y ++ VAIKR R + + + + E+ LL + H N++ L L
Sbjct: 51 YKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110
Query: 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNIL 457
++E+ N L +++ ++ + + + + + + HS HRD+K N+L
Sbjct: 111 IFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLL 164
Query: 458 LDYNYRS-----KVADFGLSR 473
L + S K+ DFGL+R
Sbjct: 165 LSVSDASETPVLKIGDFGLAR 185
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMN-----EIKLL---SSVSHPN 381
+G GAYGTVY + H+ +VA+K R + + E+ LL + HPN
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 382 LLRLLGCCIEEGEPI-----LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
++RL+ C LV+E + L +L + GLP + + + +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+LH+ I HRD+K NIL+ K+ADFGL+R
Sbjct: 135 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 31/209 (14%)
Query: 323 TSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSH 379
+ + K LG GA+ V A K + ++ E ++ + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLC------QHLQRERGSGLPWTIRITIATETAQ 433
PN++RL EE LV++ + G L + S I +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--------LE 139
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTESSHISTAPQGTP 490
+IAY HS I HR++K N+LL K+ADFGL+ + +S GTP
Sbjct: 140 SIAYCHS-NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF-AGTP 194
Query: 491 GYLDP---QYHQYFHLSDKSDVYSFGVVL 516
GYL P + Y S D+++ GV+L
Sbjct: 195 GYLSPEVLKKDPY---SKPVDIWACGVIL 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 51/211 (24%), Positives = 77/211 (36%), Gaps = 36/211 (17%)
Query: 329 KHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSI---------DQVMNEIKLLSSVS 378
K LG G V A+K S + + E+ +L VS
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 379 -HPNLLRLLGCCIEEGEPILVYEFMPNGTL------CQHLQRERGSGLPWTIRITIATET 431
HPN+++L LV++ M G L L + + +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL-------- 133
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
+ I LH +N I HRD+K NILLD + K+ DFG S + + GTP
Sbjct: 134 LEVICALHK-LN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV-CGTPS 188
Query: 492 YLDP------QYHQYFHLSDKSDVYSFGVVL 516
YL P + + D++S GV++
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLL 386
LG G++G V A D A+K + D ++ M E ++LS +HP L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C V EF+ G L H+Q+ R R A E A+ +LH I
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-RFYAA-EIISALMFLHDKG---I 145
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K N+LLD+ K+ADFG+ + G+ +T GTP Y+ P Q Y
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEMLY--- 201
Query: 504 SDKS-DVYSFGVVLIEIIT 521
+ D ++ GV+L E++
Sbjct: 202 -GPAVDWWAMGVLLYEMLC 219
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 51/222 (22%)
Query: 326 FSEKHRLGTGAYGTVYAGKL-HNDDWVAIK------RFRYRDTDSIDQVMNEIKLLSSVS 378
+++ +G G++G VY KL + + VAIK RF+ R E++++ +
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----------ELQIMRKLD 105
Query: 379 HPNLLRLLGCCIEEGEPI------LVYEFMPNGTLCQHLQRERGSGLPWTIRIT--IATE 430
H N++RL GE LV +++P T+ + + + + +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSR-LGMTES--SHIST-- 484
+++AY+HS I HRDIK N+LLD + K+ DFG ++ L E S+I +
Sbjct: 165 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 485 --APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
AP+ G Y + DV+S G VL E++
Sbjct: 222 YRAPELIFGATDY-----------TSSIDVWSAGCVLAELLL 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLL 386
+G G+Y V D A+K + D + ID V E + +HP L+ L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C E V E++ G L H+QR+R R A E + A+ YLH I
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSA-EISLALNYLHER---GI 131
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P + Y
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDY--- 187
Query: 504 SDKS-DVYSFGVVLIEIIT 521
S D ++ GV++ E++
Sbjct: 188 -GFSVDWWALGVLMFEMMA 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 59/263 (22%), Positives = 86/263 (32%), Gaps = 47/263 (17%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDT---DSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G GA+ V A+K D + E +L + + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLP--WTIRITIATETAQAIAYLHSAMNPP 445
+E LV E+ G L L + G +P R +A E AI +H +
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMA-RFYLA-EIVMAIDSVHR-LG-- 182
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
HRDIK NILLD ++ADFG + + S GTP YL P+ Q
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 506 KSDVY-------SFGVVLIEIITAL-----------------KVVDFSRPHSEVNLAALA 541
+ Y + GV E+ S P + + A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 542 ID-----------RIGRGCVDEI 553
D R+GRG +
Sbjct: 303 RDFIQRLLCPPETRLGRGGAGDF 325
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 308 NSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQ 366
+ + + SE LG GA VY + A+K +
Sbjct: 40 DYWIDGSNRDALSDFFEVESE---LGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKI 94
Query: 367 VMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG-------SGL 419
V EI +L +SHPN+++L E LV E + G L + E+G +
Sbjct: 95 VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADA 153
Query: 420 PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGM 476
I +A+AYLH I HRD+K N+L + K+ADFGLS++ +
Sbjct: 154 VKQI--------LEAVAYLHE-NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-V 201
Query: 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
+ T GTPGY P+ + + D++S G++
Sbjct: 202 EHQVLMKTV-CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 332 LGTGAYGTVYAGKLHNDD--WVAIKR------FRYRDTDSIDQVMNEIKLLSSVSH--PN 381
LG+G +G+VY+G D VAIK + + + +V E+ LL VS
Sbjct: 51 LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 382 LLRLLGCCIEEGEPILVYEF-MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
++RLL +L+ E P L + ERG+ L + + + +A+ + H+
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGA-LQEELARSFFWQVLEAVRHCHN 167
Query: 441 AMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSRLGMTESSHISTAPQGTPGYLDP---Q 496
+ HRDIK NIL+D N K+ DFG L + + + GT Y P +
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDF-DGTRVYSPPEWIR 221
Query: 497 YHQYFHLSDKSDVYSFGVVL 516
YH+Y + V+S G++L
Sbjct: 222 YHRYH--GRSAAVWSLGILL 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-21
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYR---DTDSIDQVMNEIK-LLSSVSHPNLLRLL 386
+G G++G V A + + A+K + + +M+E LL +V HP L+ L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ V +++ G L HLQRER P R A E A A+ YLHS +N I
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAA-EIASALGYLHS-LN--I 160
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K NILLD + DFGL + + +S ST GTP YL P Y
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQPY--- 216
Query: 504 SDKS-DVYSFGVVLIEIIT 521
D++ D + G VL E++
Sbjct: 217 -DRTVDWWCLGAVLYEMLY 234
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 320 EKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYR------DTDSIDQVMNEIK 372
+K F+ LG+G + V + A K + R +++ E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA 432
+L V HPN++ L + +L+ E + G L L ++ S +E
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKES----------LSEEE 116
Query: 433 ---------QAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMTES 479
+ YLH+ I H D+K NI+L K+ DFGL+ + +
Sbjct: 117 ATSFIKQILDGVNYLHT-KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDG 172
Query: 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
GTP ++ P+ Y L ++D++S GV+
Sbjct: 173 VEFKNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 38/215 (17%)
Query: 323 TSFFSEKHRLGTGAYGTVYAG--KLHNDDWVAIKRFRYR------DTDSIDQVMNEIKLL 374
+ LG+G + V K ++ A K + R S +++ E+ +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEY-AAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 375 SSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETA-- 432
+ HPN++ L + + +L+ E + G L L E+ S TE
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA-EKES----------LTEDEAT 111
Query: 433 -------QAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMTESSH 481
+ YLHS I H D+K NI+L N R K+ DFG++ + +
Sbjct: 112 QFLKQILDGVHYLHS-KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNE 167
Query: 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
GTP ++ P+ Y L ++D++S GV+
Sbjct: 168 FKNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSV-SHPNLLRLL 386
+G G+Y V D A++ + D + ID V E + +HP L+ L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C E V E++ G L H+QR+R R A E + A+ YLH I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSA-EISLALNYLHER---GI 174
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P + Y
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDY--- 230
Query: 504 SDKS-DVYSFGVVLIEIIT 521
S D ++ GV++ E++
Sbjct: 231 -GFSVDWWALGVLMFEMMA 248
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 332 LGTGAYGTVY-AGKLHNDD---WVAIKRFRYRDTDSIDQV--MNEIKLLSSVSHPNLLRL 385
LG G++G V+ K+ D A+K + D+V E +L V+HP +++L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
EG+ L+ +F+ G L L +E + +A E A A+ +LHS +
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLA-ELALALDHLHS-LG-- 146
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFH 502
I +RD+K NILLD K+ DFGLS+ + + GT Y+ P +
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGH-- 203
Query: 503 LSDKS-DVYSFGVVLIEIIT 521
+S D +SFGV++ E++T
Sbjct: 204 --TQSADWWSFGVLMFEMLT 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 46/256 (17%), Positives = 82/256 (32%), Gaps = 45/256 (17%)
Query: 360 DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGL 419
+D +I+ + S N + L + + + L + R
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 420 PWTIRIT-IATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478
I + A+A+ +LHS + HRD+K SNI + KV DFGL +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS-KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 479 SSHISTAPQ-----------GTPGYLDP---QYHQYFHLSDKSDVYSFGVVLIEIITALK 524
+ GT Y+ P + Y S K D++S G++L E++ +
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY---SHKVDIFSLGLILFELLYS-- 272
Query: 525 VVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFH 584
FS V + I + + + L+
Sbjct: 273 ---FSTQMERVRI----ITDVRNLKFPLLFTQKYP------------QEHMMVQDMLSPS 313
Query: 585 RDMRPTMMEVAEELEH 600
RP ++ +E+
Sbjct: 314 PTERPEATDI---IEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 2/69 (2%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRY-RDTDSIDQVMNEIKLLSSVSHPNLL 383
F +G G +G V+ K DD AIKR R + ++VM E+K L+ + HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 384 RLLGCCIEE 392
R +E
Sbjct: 68 RYFNAWLET 76
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 52/254 (20%), Positives = 93/254 (36%), Gaps = 40/254 (15%)
Query: 286 RKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKL 345
+K + + + + KE + + K +G G V
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ---KYDPKDVIGRGVSSVVRRCV- 114
Query: 346 HND--DWVAIKRFRYR--------DTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGE 394
H A+K + + E +L V+ HP+++ L+
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 395 PILVYEFMPNGTL------CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
LV++ M G L L + + ++ +A+++LH+ N I H
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL--------LEAVSFLHA-NN--IVH 223
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP------QYHQYFH 502
RD+K NILLD N + +++DFG S + + GTPGYL P +
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCH-LEPGEKLREL-CGTPGYLAPEILKCSMDETHPG 281
Query: 503 LSDKSDVYSFGVVL 516
+ D+++ GV+L
Sbjct: 282 YGKEVDLWACGVIL 295
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 32/200 (16%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V GK VA+K R + R D + ++ EI+ L HP++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 388 CCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQ----AIAYLHSAM 442
+ +V E++ G L ++ + R + + Q + Y H M
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGR-------LDEKESRRLFQQILSGVDYCHRHM 136
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP------Q 496
+ HRD+K N+LLD + +K+ADFGLS + M++ + T+ G+P Y P
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISGRL 191
Query: 497 YHQYFHLSDKSDVYSFGVVL 516
Y + D++S GV+L
Sbjct: 192 YA-----GPEVDIWSSGVIL 206
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLS-SVSHPNLLRLL 386
LG G++G V+ A + + AIK + D ++ M E ++LS + HP L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ V E++ G L H+Q L A E + +LHS I
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-TFYAA-EIILGLQFLHS-KG--I 139
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K NILLD + K+ADFG+ + M + +T GTP Y+ P +Y
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKY--- 195
Query: 504 SDKS-DVYSFGVVLIEIIT 521
+ S D +SFGV+L E++
Sbjct: 196 -NHSVDWWSFGVLLYEMLI 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 332 LGTGAYGTVY-----AGKLHNDDWVAIKRFR----YRDTDSIDQVMNEIKLLSSVSH-PN 381
LGTGAYG V+ +G A+K + + + + E ++L + P
Sbjct: 62 LGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
L+ L E + L+ +++ G L HL + +I + E A+ +LH
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVG-EIVLALEHLHK- 177
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYH 498
+ I +RDIK NILLD N + DFGLS+ + + + + GT Y+ P +
Sbjct: 178 LG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 499 QYFHLSDKS-DVYSFGVVLIEIIT 521
H DK+ D +S GV++ E++T
Sbjct: 236 DSGH--DKAVDWWSLGVLMYELLT 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 320 EKATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS 378
K F + G G +GTV GK VAIK+ ++ ++ L+ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 379 HPNLLRLLGCCIEEGEP-------ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
HPN+++L GE +V E++P+ TL + + + I I
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPP-ILIKVFL 135
Query: 432 AQ---AIAYLHSAMNPPIYHRDIKSSNILLDY-NYRSKVADFGLSR-LGMTES--SHIST 484
Q +I LH + + HRDIK N+L++ + K+ DFG ++ L +E ++I +
Sbjct: 136 FQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 485 ----APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
AP+ G Y + D++S G + E++
Sbjct: 195 RYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMML 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-20
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 18/202 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V+A ++ + A K+ + M E K+L+ V ++ L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITI--ATETAQAIAYLHSAMNPP 445
+ + LV M G + H+ + I + + +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFH 502
I +RD+K N+LLD + +++D GL+ + GTPG++ P +Y
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY-- 366
Query: 503 LSDKS-DVYSFGVVLIEIITAL 523
D S D ++ GV L E+I A
Sbjct: 367 --DFSVDYFALGVTLYEMIAAR 386
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 40/219 (18%)
Query: 320 EKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYR------DTDSIDQVMNEIK 372
E ++ LG+G + V + A K + R S + + E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR--ERGSGLPWTIRITIATE 430
+L + HPN++ L + + IL+ E + G L E+ S TE
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKES----------LTE 113
Query: 431 TA---------QAIAYLHSAMNPPIYHRDIKSSNILL----DYNYRSKVADFGLSRLGMT 477
+ YLHS + I H D+K NI+L R K+ DFGL+ +
Sbjct: 114 EEATEFLKQILNGVYYLHS-LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-ID 169
Query: 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
+ GTP ++ P+ Y L ++D++S GV+
Sbjct: 170 FGNEFKNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 34/280 (12%), Positives = 69/280 (24%), Gaps = 57/280 (20%)
Query: 331 RLGTGAYGTVYAG---KLHNDDWVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLLR 384
G + L VA+ D + + ++ LS + P + R
Sbjct: 38 FHGGVPPLQFWQALDTALDRQ--VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
+L ++V E++ G+L + I A A H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
+ S + + + +A T P P
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA-------------TMPDANP-------------- 181
Query: 505 DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564
+ D+ G L ++ LA + +EP
Sbjct: 182 -QDDIRGIGASLYALLVN--RWPLPEAGVRSGLAPA---------ERDTAGQPIEPADID 229
Query: 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
+ ++ +A R + +R + ++
Sbjct: 230 RDIPF--QISAVAARSVQGDGGIRSA-STLLNLMQQATAV 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 36/205 (17%)
Query: 332 LGTGAYGTVYAGKLHNDD--WVAIK--------RFRYRDTDSIDQVMNEIKLLSSVSHPN 381
LG+GA+G V+ + V +K + + + +V EI +LS V H N
Sbjct: 32 LGSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGT-----LCQH--LQRERGSGLPWTIRITIATETAQA 434
++++L +G LV E +G + +H L S + + A
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL--------VSA 142
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
+ YL I HRDIK NI++ ++ K+ DFG + + T GT Y
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC-GTIEYCA 197
Query: 495 P---QYHQYFHLSDKSDVYSFGVVL 516
P + Y + +++S GV L
Sbjct: 198 PEVLMGNPY--RGPELEMWSLGVTL 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 17/200 (8%)
Query: 332 LGTGAYGTVYAGKLHNDDWV-AIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G +G V A ++ + A K+ + +NE ++L V+ ++ L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ LV M G L H+ +G P + A E + LH I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIV 308
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHLS 504
+RD+K NILLD + +++D GL+ + E I GT GY+ P + +Y
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRV-GTVGYMAPEVVKNERY---- 362
Query: 505 DKS-DVYSFGVVLIEIITAL 523
S D ++ G +L E+I
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSV-SHPNLLRLL 386
LG G++G V + + D+ A+K + D ++ M E ++L+ P L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C V E++ G L H+Q+ P A E A + +L S I
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAA-EIAIGLFFLQSK---GI 142
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K N++LD K+ADFG+ + + + T GTP Y+ P Y Y
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQPY--- 198
Query: 504 SDKS-DVYSFGVVLIEIIT 521
KS D ++FGV+L E++
Sbjct: 199 -GKSVDWWAFGVLLYEMLA 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 33/200 (16%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIK---RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
LG G++G V VA+K R + +D +V EI L + HP++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 388 CCIEEGEPILVYEFMPNGTLCQHL-QRERGSGLPWTIRITIATETAQ----AIAYLHSAM 442
+ ++V E+ G L ++ +++R + Q AI Y H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKR-------MTEDEGRRFFQQIICAIEYCHRHK 128
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP------Q 496
I HRD+K N+LLD N K+ADFGLS + MT+ + + T+ G+P Y P
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTSC-GSPNYAAPEVINGKL 183
Query: 497 YHQYFHLSDKSDVYSFGVVL 516
Y + DV+S G+VL
Sbjct: 184 YA-----GPEVDVWSCGIVL 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 56/207 (27%), Positives = 77/207 (37%), Gaps = 38/207 (18%)
Query: 332 LGTGAYGTVYAGKLHNDD--WVAIKR------FRYRDTDSIDQVMNEIKLLSSVS----H 379
LG G +GTV+AG D VAIK + E+ LL V H
Sbjct: 39 LGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRIT------IATETAQ 433
P ++RLL + +LV E E+G + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-------PLGEGPSRCFFGQVVA 150
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRS-KVADFGLSRLGMTESSHISTAPQGTPGY 492
AI + HS + HRDIK NIL+D K+ DFG L + GT Y
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDF-DGTRVY 204
Query: 493 LDP---QYHQYFHLSDKSDVYSFGVVL 516
P HQY + + V+S G++L
Sbjct: 205 SPPEWISRHQYH--ALPATVWSLGILL 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 39/207 (18%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGC 388
+LG G Y V+ + N++ V +K + I EIK+L ++ PN++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPNIITLADI 99
Query: 389 CIEEGE--PILVYEFMPNGTLCQHLQRERGSGLP-WTIRITIATETAQAIAYLHSAMNPP 445
+ P LV+E + N Q Q L + IR + E +A+ Y HS
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-YEILKALDYCHSMG--- 150
Query: 446 IYHRDIKSSNILLDYNYRS-KVADFGLSRLG-----MTESSHIST----APQGTPGYLDP 495
I HRD+K N+++D+ +R ++ D+GL+ +++ P+ L
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPE-----LLV 203
Query: 496 QYHQYFHLSDKS-DVYSFGVVLIEIIT 521
Y Y D S D++S G +L +I
Sbjct: 204 DYQMY----DYSLDMWSLGCMLASMIF 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 45/209 (21%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 319 IEKATSFFSEKHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV 377
+ + LG G++ ++ A+K EI L
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLC 62
Query: 378 S-HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRI--TIATETAQA 434
HPN+++L ++ LV E + G L + ++ ++ ++ I + A
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-KKKH---FSETEASYIMRKLVSA 118
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRS---KVADFGLSRLGMTESSHISTAPQGTPG 491
++++H + + HRD+K N+L + K+ DFG +RL ++ + T P T
Sbjct: 119 VSHMHD-VG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLH 174
Query: 492 YLDPQ---YHQYFHLSDKS-DVYSFGVVL 516
Y P+ + Y D+S D++S GV+L
Sbjct: 175 YAAPELLNQNGY----DESCDLWSLGVIL 199
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 20/162 (12%)
Query: 328 EKHRLGTGAYGTVYAGK---LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
E ++G G YG VY K +D A+K+ EI LL + HPN++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM--SACREIALLRELKHPNVIS 82
Query: 385 LLGCCIEEGEPI--LVYEFMPN---GTLCQHLQRERGSGLPWTIRITIATETAQ---AIA 436
L + + L++++ + + H + R + + Q I
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRS----KVADFGLSRL 474
YLH+ + HRD+K +NIL+ K+AD G +RL
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 326 FSEKHRLGTGAYGTVYAGK--LHNDDWVAIKRFRYRDTD------SIDQVMNEIKLL--- 374
+ +G GAYG V+ + + +VA+KR R + + +I E+ +L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRHL 68
Query: 375 SSVSHPNLLRLLGCCIEEGEPI-----LVYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
+ HPN++RL C LV+E + L +L + G+P +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ + + +LHS + HRD+K NIL+ + + K+ADFGL+R
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 19/174 (10%)
Query: 312 PFYPYKEIEKATSFFSEK-HRLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQV- 367
++ + + EK ++G G +G V+ + VA+K+ + +
Sbjct: 6 DSVECPFCDEVSKY--EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA 63
Query: 368 MNEIKLLSSVSHPNLLRLLGCCIEEGEPI--------LVYEFMPNGTLCQHLQRERGSGL 419
+ EIK+L + H N++ L+ C + P LV++F + L L
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 122
Query: 420 PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
I+ + + Y+H I HRD+K++N+L+ + K+ADFGL+R
Sbjct: 123 LSEIK-RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 9e-19
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSV-SHPNLLRLL 386
LG G++G V + + D+ A+K + D ++ M E ++L+ P L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
C V E++ G L H+Q+ P A E A + +L S I
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAA-EIAIGLFFLQSK---GI 463
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP---QYHQYFHL 503
+RD+K N++LD K+ADFG+ + + + T GTP Y+ P Y Y
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQPY--- 519
Query: 504 SDKS-DVYSFGVVLIEIIT 521
KS D ++FGV+L E++
Sbjct: 520 -GKSVDWWAFGVLLYEMLA 537
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 49/202 (24%), Positives = 80/202 (39%), Gaps = 38/202 (18%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCI 390
+G+G +G + + VA+K + R + V EI S+ HPN++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 391 EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ--------AIAYLHSAM 442
++ E+ G L + + + + A+ ++Y HS
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGR----------FSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 443 NPPIYHRDIKSSNILLDYNYRS--KVADFGLSRLGMTESSHISTAPQGTPGYLDP----- 495
I HRD+K N LLD + K+ DFG S+ S + GTP Y+ P
Sbjct: 137 ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPAYIAPEVLLR 191
Query: 496 -QYHQYFHLSDKSDVYSFGVVL 516
+Y +DV+S GV L
Sbjct: 192 QEYD-----GKIADVWSCGVTL 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 35/211 (16%)
Query: 329 KHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
+ LG GA+ V L A+K + +V E+++L H N+L L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERG-------SGLPWTIRITIATETAQAIAYLH 439
EE LV+E M G++ H+ +R S + + A A+ +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDV--------ASALDFLH 128
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRS---KVADFGLSRL------GMTESSHISTAPQGTP 490
+ I HRD+K NIL ++ + K+ DF L S+ P G+
Sbjct: 129 N-KG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 491 GY-----LDPQYHQYFHLSDKSDVYSFGVVL 516
Y ++ + + D++S GV+L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 76/324 (23%), Positives = 114/324 (35%), Gaps = 79/324 (24%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR-YRDTDSIDQVMNEIKLLSSVSHPNLL 383
F K LG GAYG V + + VAIK+ + + + EIK+L H N++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 384 RLLGC----CIEEGEPI-LVYEFMPNGT-LCQHLQRERGSGLPWTIRITIATE------- 430
+ E + ++ E M T L + I + ++
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELM--QTDLHR------------VISTQMLSDDHIQYFI 118
Query: 431 --TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQG 488
T +A+ LH + + HRD+K SN+L++ N KV DFGL+R+ ++ S
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 489 TPG---------YLDP----QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP---- 531
G Y P +Y S DV+S G +L E+ RP
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKY---SRAMDVWSCGCILAELFL-------RRPIFPG 225
Query: 532 HSEVNLAALAIDRIGRGCVDEIIDP--------YLE--PHRDAWTLSSI-HNVAELAF-- 578
+ L IG D + Y++ P A L + V
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL 285
Query: 579 --RCLAFHRDMRPTMMEVAEELEH 600
R L F R T E LEH
Sbjct: 286 LQRMLVFDPAKRIT---AKEALEH 306
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-18
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 16/200 (8%)
Query: 332 LGTGAYGTVYAG-KLHNDDWVAIKRF---RYRDTDSIDQVMNEIKLLSSVS---HPNLLR 384
+G G +G VY K A+K R + +NE +LS VS P ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 385 LLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
+ + + + M G L HL + R A E + ++H+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAA-EIILGLEHMHNR--- 311
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
+ +RD+K +NILLD + +++D GL+ + H S GT GY+ P+ Q
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 368
Query: 505 DKS-DVYSFGVVLIEIITAL 523
D S D +S G +L +++
Sbjct: 369 DSSADWFSLGCMLFKLLRGH 388
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 70/316 (22%), Positives = 122/316 (38%), Gaps = 64/316 (20%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNL 382
+ +G+GA G V A + VAIK+ +++ + E+ L+ V+H N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 383 LRLL-----GCCIEEGEPI-LVYEFMP---NGTLCQHLQRERGSGLPWTIRITIATETAQ 433
+ LL +EE + + +V E M + L ER S L + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM--------LC 138
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
I +LHSA I HRD+K SNI++ + K+ DFGL+R +S + T T Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP----HSEVNLAALAIDRIGRGC 549
P+ + D++S G ++ E+I ++ I+++G C
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIK-------GGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 550 VDEI--IDP----YLE--PHRDAWTLSSIHNVAE-----------------LAFRCLAFH 584
+ + + P Y+E P ++ + L + L
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 585 RDMRPTMMEVAEELEH 600
R + V E L+H
Sbjct: 307 ASKRIS---VDEALQH 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 35/203 (17%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNL 382
+ +H +GTG+YG V VAIK+ D ID +++ EI +L+ ++H ++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 383 LRLLGCCIEEG-----EPILVYEFMP---------NGTLC-QHLQRERGSGLPWTIRITI 427
+++L I + E +V E L H++ T+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-------------TL 161
Query: 428 ATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ 487
+ Y+HSA I HRD+K +N L++ + KV DFGL+R + + ++
Sbjct: 162 LYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR-TVDYPENGNSQLP 217
Query: 488 GTPGYLDPQYHQYFHLSDKSDVY 510
+P D + H +
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQL 240
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 61/317 (19%), Positives = 116/317 (36%), Gaps = 78/317 (24%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNL 382
+ +G+GAYG+V + + + VAIK+ ++ + E+ LL + H N+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 383 LRLL-----GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ--- 433
+ LL + LV FM L + + + + E Q
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQK------------IMGLKFSEEKIQYLV 132
Query: 434 -----AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL---GMTESSHIST- 484
+ Y+HSA + HRD+K N+ ++ + K+ DFGL+R MT ++ T
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVVTR 187
Query: 485 ---APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP----HSEVNL 537
AP+ + + Y + D++S G ++ E++T + ++
Sbjct: 188 WYRAPE-----VILSWMHY---NQTVDIWSVGCIMAEMLT-------GKTLFKGKDYLDQ 232
Query: 538 AALAIDRIGRGCVDEI-------IDPYLE--PHRDAWTLSSIH-NVAELAF----RCLAF 583
+ G + + Y++ P + + + A + L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292
Query: 584 HRDMRPTMMEVAEELEH 600
D R T A+ L H
Sbjct: 293 DVDKRLT---AAQALTH 306
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 52/261 (19%), Positives = 97/261 (37%), Gaps = 85/261 (32%)
Query: 320 EKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIK------RFRYRDTDSIDQVMNEIK 372
E ++ +S LGTG++G V + + A+K R++ R E+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----------ELD 52
Query: 373 LLSSVSHPNLLRLLGCCIEEGEPI------------------------------------ 396
++ + H N+++L+ G+
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 397 --LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ---AIAYLHSAMNPPIYHRDI 451
++ E++P+ TL + L+ SG + I+ Q A+ ++HS I HRDI
Sbjct: 113 LNVIMEYVPD-TLHKVLKSFIRSGRSIPM-NLISIYIYQLFRAVGFIHSLG---ICHRDI 167
Query: 452 KSSNILLDYN-YRSKVADFGLSRL---GMTESSHIST----APQ---GTPGYLDPQYHQY 500
K N+L++ K+ DFG ++ ++I + AP+ G Y
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY-------- 219
Query: 501 FHLSDKSDVYSFGVVLIEIIT 521
+ D++S G V E+I
Sbjct: 220 ---TPSIDLWSIGCVFGELIL 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 317 KEIEKATSFFSE----KHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEI 371
+++ + + F++ K +G G+Y + A+K D +++ EI
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EI 68
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG-------SGLPWTIR 424
LL HPN++ L + +V E M G L + + S + +TI
Sbjct: 69 -LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTI- 125
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRS-KVADFGLSRLGMTESS 480
+ + YLH+ + HRD+K SNIL N S ++ DFG ++ E+
Sbjct: 126 -------TKTVEYLHA-QG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 481 HISTAPQGTPGYLDP---QYHQYFHLSDKS-DVYSFGVVL 516
+ T P T ++ P + Y D + D++S GV+L
Sbjct: 176 LLMT-PCYTANFVAPEVLERQGY----DAACDIWSLGVLL 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 46/193 (23%), Positives = 74/193 (38%), Gaps = 42/193 (21%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKR----FRYRDTDSID--QVMNEIKLLSSVS 378
+ KH +G G+YG VY + + VAIK+ F D ID +++ EI +L+ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE----DLIDCKRILREITILNRLK 83
Query: 379 HPNLLRLLGCCIEEGEPI-----LVYEFMP---------NGTLC-QHLQRERGSGLPWTI 423
++RL I + +V E L +H++
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK----------- 132
Query: 424 RITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483
TI ++H + I HRD+K +N LL+ + KV DFGL+R +E
Sbjct: 133 --TILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 484 TAPQGTPGYLDPQ 496
P
Sbjct: 188 VNDLEENEEPGPH 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 71/316 (22%), Positives = 121/316 (38%), Gaps = 64/316 (20%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNL 382
+ +G+GA G V A D VAIK+ + + E+ L+ V+H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 383 LRLL-----GCCIEEGEPI-LVYEFMP---NGTLCQHLQRERGSGLPWTIRITIATETAQ 433
+ LL +EE + + LV E M + L ER S L + +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM--------LC 175
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
I +LHSA I HRD+K SNI++ + K+ DFGL+R +S + T T Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 230
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP----HSEVNLAALAIDRIGRGC 549
P+ + D++S G ++ E++ + ++ I+++G C
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR-------HKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 550 VDEI--IDP----YLE--PHRDAWTLSSI-----------------HNVAELAFRCLAFH 584
+ + + P Y+E P T + +L + L
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 585 RDMRPTMMEVAEELEH 600
R + V + L+H
Sbjct: 344 PAKRIS---VDDALQH 356
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 32/203 (15%)
Query: 329 KHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLL 386
K LG G G V A+K DS E+ S P+++ +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPK-ARQEVDHHWQASGGPHIVCIL 88
Query: 387 GCCIEEGEPI----LVYEFMPNGTLCQHLQRERGSGLPWTIRI--TIATETAQAIAYLHS 440
++ E M G L +Q ERG +T R I + AI +LHS
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQ-AFTEREAAEIMRDIGTAIQFLHS 146
Query: 441 AMNPPIYHRDIKSSNILLDYNYRS---KVADFGLSRLGMTESSHISTAPQGTPGYLDPQ- 496
N I HRD+K N+L + K+ DFG ++ T + + T P TP Y+ P+
Sbjct: 147 -HN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQT-PCYTPYYVAPEV 200
Query: 497 --YHQYFHLSDKS-DVYSFGVVL 516
+Y DKS D++S GV++
Sbjct: 201 LGPEKY----DKSCDMWSLGVIM 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 63/324 (19%), Positives = 116/324 (35%), Gaps = 79/324 (24%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
+ + LG G G V++ D VAIK+ D S+ + EIK++ + H N+++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 385 LL-------------GCCIEEGEPI-LVYEFMPNGT-LCQHLQRERGSGLPWTIRITIAT 429
+ + E + +V E+M T L +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLAN------------VLEQGPLL 118
Query: 430 E---------TAQAIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKVADFGLSRLGMTES 479
E + + Y+HSA + HRD+K +N+ ++ + K+ DFGL+R+
Sbjct: 119 EEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 480 SHIS--TAPQGTPGYLDP----QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP-- 531
SH + T Y P + Y + D+++ G + E++T +
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEMLT-------GKTLF 225
Query: 532 --HSEVNLAALAIDRIGR------GCVDEIIDPYLE--PHRDAWTLSSI-HNVAELAF-- 578
E+ L ++ I + +I Y+ L+ + ++ A
Sbjct: 226 AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285
Query: 579 --RCLAFHRDMRPTMMEVAEELEH 600
+ L F R T E L H
Sbjct: 286 LEQILTFSPMDRLT---AEEALSH 306
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 39/199 (19%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKR----FRYRDTDSID--QVMNEIKLLSSVS 378
+ +LG GAYG V+ + VA+K+ F+ +S D + EI +L+ +S
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ----NSTDAQRTFREIMILTELS 66
Query: 379 -HPNLLRLLGCCIEEG--EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE----- 430
H N++ LL + + LV+++M + L IR I
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-------------ETDLHAVIRANILEPVHKQY 113
Query: 431 ----TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAP 486
+ I YLHS + HRD+K SNILL+ KVADFGLSR + + P
Sbjct: 114 VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 487 QGTPGYLDPQYHQYFHLSD 505
+ L+D
Sbjct: 171 LSINENTENFDDDQPILTD 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 54/264 (20%), Positives = 94/264 (35%), Gaps = 71/264 (26%)
Query: 329 KHRLGTGAYGTVYAGKLHNDD------WVAIKRFRYRDTDS-IDQVMNEIKLLSSV-SHP 380
LG GA+G V D VA+K + T S +M+E+K+L + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 381 NLLRLLGCCIEEGEPILV-YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
N++ LLG C + G P++V EF G L +L+ +R +P+ + + + +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 440 SAM-------------------------------NPPIYHRDIKSSNILLDY-------- 460
+ P ++D + L+ Y
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 461 ----------------------NYRSKVADFGLSRLGMTESSHISTAPQGTPG-YLDPQY 497
K+ DFGL+R + ++ P ++ P+
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 498 HQYFHLSDKSDVYSFGVVLIEIIT 521
+ +SDV+SFGV+L EI +
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 66/313 (21%), Positives = 119/313 (38%), Gaps = 79/313 (25%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLL- 386
+G+GAYG V + VAIK+ ++ + E++LL + H N++ LL
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 387 ----GCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE---------TA 432
+++ LV FM G+ L ++ E
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM-------------GTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 433 QAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL---GMTESSHIST----A 485
+ + Y+H+A I HRD+K N+ ++ + K+ DFGL+R MT ++ T A
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVVTRWYRA 193
Query: 486 PQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP----HSEVNLAALA 541
P+ + + +Y + D++S G ++ E+IT + ++
Sbjct: 194 PE-----VILNWMRY---TQTVDIWSVGCIMAEMIT-------GKTLFKGSDHLDQLKEI 238
Query: 542 IDRIG---RGCVDEIIDP----YLE--PHRDAWTLSSIH-NVAELAF----RCLAFHRDM 587
+ G V + Y++ P + +SI N + LA + L +
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298
Query: 588 RPTMMEVAEELEH 600
R T E L H
Sbjct: 299 RVT---AGEALAH 308
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 40/221 (18%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQ-----------VMNEIKLL 374
++ + + +G+YG V AG VAIKR +D V+ EI+LL
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 375 SSVSHPNLLRLLGCCIEEGEPI-----LVYEFMPNGTLCQHLQRERGSGLPWTIRITIAT 429
+ HPN+L L + EP LV E M L Q + +R P I+
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-FMY 141
Query: 430 ETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG-----MTESSHIST 484
+ LH A + HRD+ NILL N + DF L+R T +++
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH--YVTH 196
Query: 485 ----APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
AP+ L Q+ + + D++S G V+ E+
Sbjct: 197 RWYRAPE-----LVMQFKGF---TKLVDMWSAGCVMAEMFN 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 321 KATSFFSE----KHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSID---QVMNEIK 372
K + + LG G G V + A+K + + E++
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVE 106
Query: 373 LLSSVS-HPNLLRLLGCCIEEGEPI----LVYEFMPNGTLCQHLQRERGSGLPWTIRI-- 425
L S P+++R++ +V E + G L +Q +RG +T R
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQ-AFTEREAS 164
Query: 426 TIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS---KVADFGLSRLGMTESSHI 482
I +AI YLHS +N I HRD+K N+L + K+ DFG ++ T S +
Sbjct: 165 EIMKSIGEAIQYLHS-IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNS 219
Query: 483 STAPQGTPGYLDPQ---YHQYFHLSDKS-DVYSFGVVL 516
T P TP Y+ P+ +Y DKS D++S GV++
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKY----DKSCDMWSLGVIM 253
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 74/336 (22%), Positives = 131/336 (38%), Gaps = 75/336 (22%)
Query: 308 NSSVPFYPYKEIEKATSF-----FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDT 361
+ P + +E+ K T + + +G+GAYG+V A VA+K+
Sbjct: 9 SQERPTFYRQELNK-TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 362 DSID--QVMNEIKLLSSVSHPNLLRLL-----GCCIEEGEPI-LVYEFMP----NGTLCQ 409
I + E++LL + H N++ LL +EE + LV M N CQ
Sbjct: 68 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 410 HLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469
L + L + I + + Y+HSA I HRD+K SN+ ++ + K+ DF
Sbjct: 128 KLTDDHVQFLIYQI--------LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176
Query: 470 GLSRLG---MTESSHIST----APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA 522
GL+R MT +++T AP+ + + Y + D++S G ++ E++T
Sbjct: 177 GLARHTADEMTG--YVATRWYRAPE-----IMLNWMHY---NQTVDIWSVGCIMAELLT- 225
Query: 523 LKVVDFSRP----HSEVNLAALAIDRIGRGCVDEI-------IDPYLE--PHRDAWTLSS 569
R ++ L + +G + + Y++ ++
Sbjct: 226 ------GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 279
Query: 570 IH-NVAELAF----RCLAFHRDMRPTMMEVAEELEH 600
+ LA + L D R T A+ L H
Sbjct: 280 VFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 312
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 71/310 (22%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR-YRDTDSIDQVMNEIKLLSSVSHPNLL 383
++ +G GAYG V + N VAIK+ + + + EIK+L H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 384 RLLGC----CIEEGEPI-LVYEFMP----NGTLCQHLQRERGSGLPWTIRITIATETAQA 434
+ IE+ + + +V + M QHL + + I +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--------LRG 140
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS--TAPQGTPGY 492
+ Y+HSA + HRD+K SN+LL+ K+ DFGL+R+ + H T T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 493 LDP----QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRP----HSEVNLAALAIDR 544
P Y + D++S G +L E+++ +RP ++ +
Sbjct: 198 RAPEIMLNSKGY---TKSIDIWSVGCILAEMLS-------NRPIFPGKHYLDQLNHILGI 247
Query: 545 IG---RGCVDEIIDP----YLE--PHRDAWTLSSI-HNVAELAF----RCLAFHRDMRPT 590
+G + ++ II+ YL PH++ + + N A + L F+ R
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 591 MMEVAEELEH 600
V + L H
Sbjct: 308 ---VEQALAH 314
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 4e-12
Identities = 30/213 (14%), Positives = 62/213 (29%), Gaps = 63/213 (29%)
Query: 308 NSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTD----- 362
+ +P + EK +G G +G V+ + VAIK D
Sbjct: 14 SHCLPTEKLQRCEK----------IGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGS 62
Query: 363 ---SIDQVMNEIKLLSSV---------SHPNLLRLLGCCIEEGE---------------- 394
+ ++++ EI + + + L +G
Sbjct: 63 HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 395 --------------PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
+V EF G + ++ + S +I + ++A +
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEA 179
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
++ HRD+ N+LL K+ +
Sbjct: 180 SLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-----------H 379
LG G + TV+ A + N+ VA+K R + + +EIKLL V+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 380 PNLLRLLGC---CIEEGEPI-LVYEFM-PNGTLCQHLQRERGSGLPWTIRITIATETAQA 434
++L+LL G + +V+E + N L +++ G+P I+ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRS------KVADFGLSRLGMTE-SSHIST--- 484
+ Y+H I H DIK N+L++ K+AD G + ++ I T
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 201
Query: 485 -APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+P+ G + +D++S ++ E+IT
Sbjct: 202 RSPEVLLG------APW---GCGADIWSTACLIFELIT 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 47/218 (21%), Positives = 77/218 (35%), Gaps = 62/218 (28%)
Query: 321 KATSFFSE----KHRLGTGAYGTVY-AGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLS 375
K + + LG G G V + A+K + E++L
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHW 65
Query: 376 SVS-HPNLLRLLGCCIEEGEPI-----LVYEFMPNGTLCQHLQR--ERGSGL------PW 421
S P+++R++ E +V E + G L R +RG
Sbjct: 66 RASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASE 121
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILL---DYNYRSKVADFGLSRLGMTE 478
++ +I +AI YLHS +N I HRD+K N+L N K+ DFG
Sbjct: 122 IMK-SIG----EAIQYLHS-IN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------- 166
Query: 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVL 516
A + +Y + D++S GV++
Sbjct: 167 ------AKE----TTGEKYDK------SCDMWSLGVIM 188
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 39/267 (14%), Positives = 79/267 (29%), Gaps = 60/267 (22%)
Query: 286 RKRSTSLRNQLSAKRLLCQAAGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK- 344
+ T+ L +L +G +K G +Y
Sbjct: 20 FQSMTTSLEALPTGTVLTDKSGRQ------WKLKSF----------QTRDNQGILYEAAP 63
Query: 345 --------LHNDDWVAIK-----------RFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
++K + ++ QV KL S +
Sbjct: 64 TSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKL-YSTPLLAIPTC 122
Query: 386 LGCCIEEGEPILVYEFM------PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
+G + + + Y F+ + L L L + +A A+ +LH
Sbjct: 123 MGFGVHQDK----YRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVACRLLDALEFLH 176
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKV--ADFGLSRLGMTESSHISTAPQ------GTPG 491
H ++ + NI +D +S+V A +G + H++ G
Sbjct: 177 EN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLE 233
Query: 492 YLDPQYHQYFHLSDKSDVYSFGVVLIE 518
++ H+ S +SD+ S G +++
Sbjct: 234 FISMDLHKGCGPSRRSDLQSLGYCMLK 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 53/279 (18%), Positives = 91/279 (32%), Gaps = 86/279 (30%)
Query: 313 FYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEI 371
++ K + + +LG G + TV+ + +VA+K + + ++EI
Sbjct: 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEI 84
Query: 372 KLLSSV-----SHPN---LLRLLGC-----------CIEEGEPILVYEFMPNG-TLCQHL 411
+LL SV + PN +++LL C +V+E + G L + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL--GHHLLKWI 135
Query: 412 QRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN---------- 461
+ GLP I + Q + YLH+ I H DIK NILL N
Sbjct: 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAE 193
Query: 462 ---------------------------------------YRSKVADFGLSRLGMTESSHI 482
+ K+AD G +
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKH 249
Query: 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
T T Y + + +D++S + E+ T
Sbjct: 250 FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 51/215 (23%), Positives = 80/215 (37%), Gaps = 50/215 (23%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIK----RFRYRDTDSIDQVMNEIKLLSSVSH------P 380
+G G++G V A VA+K R+ Q EI++L +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR-----QAAEEIRILEHLRKQDKDNTM 159
Query: 381 NLLRLLGCCIEEGEPILVYEFM-PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
N++ +L + +E + N L + +++ + G + A Q + LH
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRS--KVADFGLSRLGMTESSHIST--------APQ-- 487
I H D+K NILL RS KV DFG S E + T AP+
Sbjct: 218 KN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRFYRAPEVI 271
Query: 488 -GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
G Y D++S G +L E++T
Sbjct: 272 LGAR-Y-----------GMPIDMWSLGCILAELLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 50/216 (23%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIK----RFRYRDTDSIDQVMNEIKLLSSVSHP------ 380
+G G++G V A +WVAIK + + + Q E++LL ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 116
Query: 381 NLLRLLGCCIEEGEPILVYEFM-PNGTLCQHLQRERGSGLPWT-IRITIATETAQAIAYL 438
++ L + LV+E + N L L+ G+ R A + A+ +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFL 173
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRS--KVADFGLSRLGMTESSHIST--------APQ- 487
+ I H D+K NILL RS K+ DFG S I +P+
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQSRFYRSPEV 229
Query: 488 --GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
G P Y D++S G +L+E+ T
Sbjct: 230 LLGMP-Y-----------DLAIDMWSLGCILVEMHT 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 45/200 (22%), Positives = 78/200 (39%), Gaps = 18/200 (9%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLG 387
++G+G++G +Y G + + VAIK + Q+ E K+ + + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRW 72
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
C E ++V E + G + L + +A + I Y+HS
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 127
Query: 448 HRDIKSSNILLDYNYRSK---VADFGLSRLGMTESS--HI----STAPQGTPGYLDPQYH 498
HRD+K N L+ + + DFGL++ + HI + GT Y H
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 499 QYFHLSDKSDVYSFGVVLIE 518
S + D+ S G VL+
Sbjct: 188 LGIEQSRRDDLESLGYVLMY 207
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 42/202 (20%), Positives = 73/202 (36%), Gaps = 20/202 (9%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLG 387
R+G G++G ++ G L N+ VAIK R Q+ +E + ++ + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYY 73
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
E +LV + + G + L G A + + +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 128
Query: 448 HRDIKSSNILLDYNYRSK-----VADFGLSRLGMTESS--HI----STAPQGTPGYLDPQ 496
+RDIK N L+ V DFG+ + + HI GT Y+
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188
Query: 497 YHQYFHLSDKSDVYSFGVVLIE 518
H S + D+ + G V +
Sbjct: 189 THLGREQSRRDDLEALGHVFMY 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 22/203 (10%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLG 387
++G G +G + GK L+ +++VAIK + + Q+ E + + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA-PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 388 CCIEEGEPILVYEFM-PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+V E + P+ L + L + IA + + Y+HS +
Sbjct: 73 FGPCGKYNAMVLELLGPS--L-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NL 126
Query: 447 YHRDIKSSNILLDYNYRSK-----VADFGLSRLGMTESS--HI----STAPQGTPGYLDP 495
+RD+K N L+ + DF L++ + + HI + GT Y+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 496 QYHQYFHLSDKSDVYSFGVVLIE 518
H S + D+ + G + +
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMY 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLG 387
++G+G++G +Y G + ++ VAIK + Q++ E K+ + + +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRW 70
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+E +LV + + G + L L + +A + + ++HS
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 448 HRDIKSSNILLDYNYRSK---VADFGLSRLGMTESS--HI----STAPQGTPGYLDPQYH 498
HRDIK N L+ R+ + DFGL++ S+ HI + GT Y H
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185
Query: 499 QYFHLSDKSDVYSFGVVLIE 518
S + D+ S G VL+
Sbjct: 186 LGIEQSRRDDLESLGYVLMY 205
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 54/375 (14%), Positives = 102/375 (27%), Gaps = 98/375 (26%)
Query: 315 PYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIK-- 372
P K ++ S + T Y +L+ND+ V K R Q +++
Sbjct: 97 PIKTEQRQPS-------MMTRMYIE-QRDRLYNDNQVFAKYNVSR-----LQPYLKLRQA 143
Query: 373 LLSSVSHPNLLR--LLGCCIEEGEPILVYE---------FMPNG---------------- 405
LL N+L +LG G+ + + M
Sbjct: 144 LLELRPAKNVLIDGVLGS----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 406 ----TLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR------DIKSSN 455
L + S + I + + Q A L + Y +++++
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--AELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 456 ILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVV 515
+N K+ L T ++ L + L S + V
Sbjct: 258 AWNAFNLSCKI-------LLTTRFKQVTDF-------LSAATTTHISLDHHSMTLTPDEV 303
Query: 516 LIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI--IDPYLEPHRDAWTLSSIHNV 573
++ L P + + I D + D + H + L++I
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK--HVNCDKLTTI--- 358
Query: 574 AELAFRCLAFHRDMRPTMMEVAEEL----EHIRVSS------WASNIYMGSPAV--SCC- 620
E + L + R ++ + L + + W I V
Sbjct: 359 IESSLNVLEPA-EYR----KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 621 -SLSECGSERSLSGL 634
SL E + S +
Sbjct: 414 YSLVEKQPKESTISI 428
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 36/218 (16%), Positives = 73/218 (33%), Gaps = 34/218 (15%)
Query: 330 HRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNLL---- 383
+G G +G +Y +++ + V + D + E+K + P +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 384 -----------RLLGCCIEEGEP----ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIA 428
+ G + + ++ + G+ Q + + ++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLS 158
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV--ADFGLSRLGMTESS--HIST 484
+ Y+H H DIK+SN+LL+Y +V D+GL+ E +
Sbjct: 159 LRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 485 AP----QGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIE 518
P GT + H S + D+ G +I+
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 41/216 (18%), Positives = 77/216 (35%), Gaps = 35/216 (16%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKL---LSSVSHPNLLRLL 386
++G+G +G +Y + + A + ++ + +E+K ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102
Query: 387 GCCIEEGEP----------------ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATE 430
G P +V E + G Q + + G+ T+ + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTV-LQLGIR 159
Query: 431 TAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV--ADFGLSRLGMTESSHI------ 482
+ Y+H H DIK++N+LL Y +V AD+GLS +H
Sbjct: 160 MLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIE 518
GT + H+ LS +SDV G ++
Sbjct: 217 RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 48/238 (20%), Positives = 83/238 (34%), Gaps = 74/238 (31%)
Query: 332 LGTGAYGTVY-AGKLHNDDWVAIK----RFRYRDTDSIDQVMNEIKLLSSVSH-----PN 381
+G G +G V + N + A+K +Y E +L + + N
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR-----SAKIEADILKKIQNDDINNNN 97
Query: 382 LLRLLGCCIEEGEPILVYEFM-PNGTLCQHLQRERGSGLPWT-IRITIATETAQAIAYLH 439
+++ G + L++E + P+ L + + R +G I+ E +A+ YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPS--LYEIITRNNYNGFHIEDIK-LYCIEILKALNYLR 154
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRS-------------------------KVADFGLSRL 474
+ H D+K NILLD Y K+ DFG +
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209
Query: 475 GMTESSHIST--------APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
+S + + AP+ + SD++SFG VL E+ T
Sbjct: 210 -TFKSDYHGSIINTRQYRAPEVILNLG-W-----------DVSSDMWSFGCVLAELYT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 64/231 (27%)
Query: 332 LGTGAYGTVYAGKLH--NDDWVAIK----RFRYRDTDSIDQVMNEIKLLSSVSHP----- 380
LG GA+G V H VA+K RY + +EI++L ++
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE-----AARSEIQVLEHLNTTDPNST 76
Query: 381 -NLLRLLGCCIEEGEPILVYEFM-PNGTLCQHLQRERGSGLPWT-IRITIATETAQAIAY 437
+++L G +V+E + + ++ IR +A + +++ +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIR-KMAYQICKSVNF 133
Query: 438 LHSAMNPPIYHRDIKSSNILL-DYNYRS------------------KVADFGLS-RLGMT 477
LHS + H D+K NIL +Y KV DFG +
Sbjct: 134 LHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 478 ESSHIST----APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
S+ +ST AP+ + S DV+S G +LIE
Sbjct: 191 HSTLVSTRHYRAPEVILALG-W-----------SQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 44/234 (18%), Positives = 74/234 (31%), Gaps = 70/234 (29%)
Query: 332 LGTGAYGTVYAGKLH--NDDWVAIK----RFRYRDTDSIDQVMNEIKLLSSVSHP----- 380
LG G +G V H VA+K +YR+ EI +L +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE-----AARLEINVLKKIKEKDKENK 81
Query: 381 -NLLRLLGCCIEEGEPILVYEFM-PNGTLCQHLQRERGSGLPWT-IRITIATETAQAIAY 437
+ + G + +E + N + L+ P +R +A + A+ +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKN--TFEFLKENNFQPYPLPHVR-HMAYQLCHALRF 138
Query: 438 LHSAMNPPIYHRDIKSSNILLDYNYRS-------------------KVADFGLSRLGMTE 478
LH + H D+K NIL + +VADFG + +
Sbjct: 139 LHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFD 192
Query: 479 SSHIST--------APQ---GTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
H +T P+ + + DV+S G +L E
Sbjct: 193 HEHHTTIVATRHYRPPEVILELG-W-----------AQPCDVWSIGCILFEYYR 234
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 692 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1gl4a2 | 40 | g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-69
Identities = 81/283 (28%), Positives = 124/283 (43%), Gaps = 27/283 (9%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLL 383
+ R+G+G++GTVY GK H D VA+K + NE+ +L H N+L
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
+G + +V ++ +L HL I IA +TAQ + YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---A 122
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRL-GMTESSHISTAPQGTPGYLDPQYHQYF- 501
I HRD+KS+NI L + K+ DFGL+ + SH G+ ++ P+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 502 --HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
S +SDVY+FG+VL E++T P+S +N I +GRG YL
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRG--------YLS 228
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
P + + L CL RD RP ++ +E +
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 9e-68
Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 23/280 (8%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
RLG G +G V+ G + VA+K + + + S D + E L+ + H L+RL
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
+E ++ E+M NG+L L+ G L + +A + A+ +A++
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
HRD++++NIL+ K+ADFGL+RL + + P+ Y +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 506 KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565
KSDV+SFG++L EI+T ++ + EV I + RG D E
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEE----- 238
Query: 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
+ +L C + RPT + LE ++
Sbjct: 239 -------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 7e-64
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 23/277 (8%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+ +G+G +G V+ G N D VAIK R S + + E +++ +SHP L++L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
G C+E+ LV+EFM +G L R + + + + + +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEAC 121
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
+ HRD+ + N L+ N KV+DFG++R + + ST + + P+ + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 506 KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565
KSDV+SFGV++ E+ + K+ +R +SEV ++ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLASTH--- 230
Query: 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
V ++ C + RP + +L I
Sbjct: 231 -------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-63
Identities = 70/278 (25%), Positives = 127/278 (45%), Gaps = 29/278 (10%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+G G +G V G + VA+K + + + + E +++ + H NL++L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 386 LGCCIEEGEPI-LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNP 444
LG +EE + +V E+M G+L +L+ S L + + + +A+ YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 445 PIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLS 504
HRD+ + N+L+ + +KV+DFGL++ E+S + + P+ + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 505 DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564
KSDV+SFG++L EI + +V P +V + R+ +G + D
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA---- 228
Query: 565 WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
V E+ C MRP+ +++ E+LEHI+
Sbjct: 229 --------VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 3e-63
Identities = 86/305 (28%), Positives = 141/305 (46%), Gaps = 25/305 (8%)
Query: 306 AGNSSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSI 364
A + S P Y E+E+ + + KH+LG G YG VY G VA+K + DT +
Sbjct: 1 AMDPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV 57
Query: 365 DQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIR 424
++ + E ++ + HPNL++LLG C E ++ EFM G L +L+ + +
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 425 ITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIST 484
+ +AT+ + A+ YL HRD+ + N L+ N+ KVADFGLSRL ++
Sbjct: 118 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 485 APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDR 544
+ + P+ Y S KSDV++FGV+L EI T P+ ++L+ +
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM-----SPYPGIDLSQVY--- 226
Query: 545 IGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
E+++ R V EL C ++ RP+ E+ + E +
Sbjct: 227 -------ELLEKDYRMERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
Query: 605 SWASN 609
S S+
Sbjct: 277 SSISD 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-63
Identities = 67/296 (22%), Positives = 132/296 (44%), Gaps = 29/296 (9%)
Query: 329 KHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+ +G G +G V+ GK ++ VA+K F R+ S + EI + H N+L +
Sbjct: 8 QESIGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 65
Query: 389 CIEEG----EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS---- 440
++ + LV ++ +G+L +L R + I +A TA +A+LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 441 -AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ---GTPGYLDPQ 496
P I HRD+KS NIL+ N +AD GL+ + + I AP GT Y+ P+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 497 Y------HQYFHLSDKSDVYSFGVVLIEIITALKV----VDFSRPHSEVNLAALAIDRIG 546
++F ++D+Y+ G+V EI + D+ P+ ++ + +++ +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
+ ++ + P + + ++ +A++ C + R T + + + L +
Sbjct: 243 KVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-62
Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 23/276 (8%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+ LGTG +G V GK VAIK + + S D+ + E K++ ++SH L++L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
G C ++ ++ E+M NG L +L+ R + + + +A+ YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
HRD+ + N L++ KV+DFGLSR + + S + + P+ Y S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 506 KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565
KSD+++FGV++ EI + K+ +SE + I +G + P+L +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASEK--- 229
Query: 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
V + + C D RPT + + +
Sbjct: 230 -------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 8e-62
Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 23/280 (8%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRL 385
+ +LG G +G V+ G + VAIK + T S + + E +++ + H L++L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
E +V E+M G+L L+ E G L + +A + A +AY+
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 133
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
HRD++++NIL+ N KVADFGL+RL + + P+ Y +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 506 KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565
KSDV+SFG++L E+ T +V + EV +D++ RG E
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPES----- 242
Query: 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605
+ +L +C + RPT + LE S+
Sbjct: 243 -------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (512), Expect = 7e-60
Identities = 66/312 (21%), Positives = 135/312 (43%), Gaps = 40/312 (12%)
Query: 314 YPYKEIEKATSFFSEK---------HRLGTGAYGTVYAGKLHNDD----WVAIKRFRYRD 360
+ +++ +A F+++ +G G +G V +G L +VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 361 TDS-IDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGL 419
T+ ++E ++ HPN++ L G + +++ EFM NG+L L++ G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 420 PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479
+ + A + YL + HRD+ + NIL++ N KV+DFGLSR ++
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 480 SHI----STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
S + + + P+ QY + SDV+S+G+V+ E+++ + RP+ ++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDM 237
Query: 536 NLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595
++I+ + +R + + +L C R+ RP ++
Sbjct: 238 TN-------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 596 EELEHIRVSSWA 607
L+ + + +
Sbjct: 285 NTLDKMIRNPNS 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-60
Identities = 60/290 (20%), Positives = 119/290 (41%), Gaps = 29/290 (10%)
Query: 321 KATSFFSEKHRLGTGAYGTVYAGKLHNDDW---VAIKRFR-YRDTDSIDQVMNEIKLLSS 376
K + LG G +G+V G VAIK + + +++M E +++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 377 VSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
+ +P ++RL+G C + +LV E G L + L +R +P + + + + +
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMK 123
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGTPGYLD 494
YL HRD+ + N+LL + +K++DFGLS+ +A + +
Sbjct: 124 YLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 495 PQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554
P+ + S +SDV+S+GV + E ++ + +P+ ++ + + I +G E
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEV-MAFIEQGKRMECP 234
Query: 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604
+ L C + + RP + V + + S
Sbjct: 235 PECPPE------------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 64/325 (19%), Positives = 121/325 (37%), Gaps = 40/325 (12%)
Query: 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYR-DTDSIDQVMNEIKLLSS 376
+E F + LG G G V+ +A K +Q++ E+++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 377 VSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIA 436
+ P ++ G +GE + E M G+L Q L++ +P I ++ + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 437 YLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
YL I HRD+K SNIL++ K+ DFG+S ++ + GT Y+ P+
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFVGTRSYMSPE 173
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIIT-----------------------ALKVVDFSRPHS 533
Q H S +SD++S G+ L+E+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 534 EVNLAALAIDRIGRGCVDEIIDPYL-EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM 592
L++ +D + E++D + EP + + +CL + R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 593 EVAE-------ELEHIRVSSWASNI 610
++ + E + + W +
Sbjct: 294 QLMVHAFIKRSDAEEVDFAGWLCST 318
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 4e-58
Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 34/294 (11%)
Query: 316 YKEIEK---ATSFFSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSIDQVMNEI 371
Y+ + + F+ LG GA+G VY + A K + + ++ M EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
+L+S HPN+++LL E ++ EF G + + L + + +T
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQT 119
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPG 491
A+ YLH I HRD+K+ NIL + K+ADFG+S + GTP
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPY 175
Query: 492 YLDPQYHQYFHLSD-----KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546
++ P+ D K+DV+S G+ LIE+ PH E+N + + +I
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE------IEPPHHELNPMRV-LLKIA 228
Query: 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ + P N + +CL + D R T ++ L+H
Sbjct: 229 KSEPPTLAQPSRWS----------SNFKDFLKKCLEKNVDARWTTSQL---LQH 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-58
Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 33/286 (11%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD----WVAIKRF-RYRDTDSIDQVMNEIKLLSSVSHP 380
F+E +G G +G VY G L ++D A+K R D + Q + E ++ SHP
Sbjct: 31 FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 381 NLLRLLGCCIE-EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
N+L LLG C+ EG P++V +M +G L ++ R I + A+ +
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKG---MK 144
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL---GMTESSHISTAPQGTPGYLDPQ 496
+ HRD+ + N +LD + KVADFGL+R +S H T + ++ +
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556
Q + KSDV+SFGV+L E++T P+ +VN + + +G ++ P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDI-TVYLLQG--RRLLQP 256
Query: 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
P + E+ +C +MRP+ E+ + I
Sbjct: 257 EYCPDP----------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 3e-57
Identities = 66/316 (20%), Positives = 115/316 (36%), Gaps = 51/316 (16%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYR-DTDSIDQVM 368
+E + +G GA+G V+ + VA+K + D
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 369 NEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG---------- 418
E L++ +PN+++LLG C L++E+M G L + L+
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 419 ------------LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV 466
L ++ IA + A +AYL HRD+ + N L+ N K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 467 ADFGLSR-LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKV 525
ADFGLSR + + ++ P+ Y + +SDV+++GVVL EI +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 526 VDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHR 585
+ H EV + + D + + L + L C +
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACPENCPLE----LYNLMRLCWSKLP 283
Query: 586 DMRPTMMEVAEELEHI 601
RP+ + L+ +
Sbjct: 284 ADRPSFCSIHRILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 328 EKHRLGTGAYGTVYAGKLHNDDW---VAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNL 382
E LG+G +GTV G VA+K + D D+++ E ++ + +P +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+R++G C E +LV E G L ++LQ+ R + I + + + + YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ--GTPGYLDPQYHQY 500
HRD+ + N+LL + +K++DFGLS+ + ++ + P+ Y
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
+ S KSDV+SFGV++ E + + +P+ + + + + +G
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEV-TAMLEKGERMGCPAGCPRE 238
Query: 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ +L C + + RP V L +
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 4e-57
Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 38/285 (13%)
Query: 323 TSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY---RDTDSIDQVMNEIKLLSSVS 378
FS+ +G G++G VY + + N + VAIK+ Y + + ++ E++ L +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
HPN ++ GC + E LV E+ ++ L + Q +AYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQY- 497
HS + HRD+K+ NILL K+ DFG + + +S + GTP ++ P+
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183
Query: 498 --HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555
K DV+S G+ IE+ P +N + + I + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSA-LYHIAQNESPALQS 236
Query: 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ CL RPT + L+H
Sbjct: 237 GHWSE-----------YFRNFVDSCLQKIPQDRPTSEVL---LKH 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 32/284 (11%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSID--QVMNEIKLLSSVSHPNL 382
+ + +GTG+YG + +D + K Y + +++E+ LL + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 383 LRLLGCCIEE--GEPILVYEFMPNGTLCQHLQRERGSG--LPWTIRITIATETAQAIAYL 438
+R I+ +V E+ G L + + L + + T+ A+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 439 H--SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
H S + HRD+K +N+ LD K+ DFGL+R+ + + + A GTP Y+ P+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPE 184
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556
++KSD++S G +L E+ P + + L +I G I
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCA------LMPPFTAFSQKEL-AGKIREGKFRRIPYR 237
Query: 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
Y + + + R L RP++ E+ LE+
Sbjct: 238 YSDELNE------------IITRMLNLKDYHRPSVEEI---LEN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 32/292 (10%)
Query: 318 EIEKATSFFSEKHRLGTGAYGTVYAGKLHNDD-----WVAIKRFRYRDTDS-IDQVMNEI 371
EI S + + +G G +G VY G L VAIK + T+ + E
Sbjct: 3 EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 372 KLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATET 431
++ SH N++RL G + +++ E+M NG RE+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGI 119
Query: 432 AQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL--GMTESSHISTAPQGT 489
A + YL N HRD+ + NIL++ N KV+DFGLSR+ E+++ ++ +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 490 PGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549
+ P+ Y + SDV+SFG+V+ E++T + + + E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
V + I+ S+ + +L +C R RP ++ L+ +
Sbjct: 222 VMKAINDGFRLPTPMDCPSA---IYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-56
Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 35/284 (12%)
Query: 325 FFSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPN 381
F +G G++ TVY G VA + R + E ++L + HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 382 LLRLLGCCIE----EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAY 437
++R + +LV E M +GTL +L+R + + + + + + + +
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQF 127
Query: 438 LHSAMNPPIYHRDIKSSNILL-DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
LH+ PPI HRD+K NI + K+ D GL+ L + + + A GTP ++ P+
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE 183
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556
++ + DVY+FG+ ++E+ T+ P+SE AA R+ G D
Sbjct: 184 MYEE-KYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
P V E+ C+ ++D R ++ ++ L H
Sbjct: 237 VAIP-----------EVKEIIEGCIRQNKDERYSIKDL---LNH 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-56
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 49/313 (15%)
Query: 309 SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW---VAIKRFR-YRDTDSI 364
+ P + +I+ F + +G G +G V ++ D AIKR + Y D
Sbjct: 2 TIYPVLDWNDIK-----FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH 54
Query: 365 DQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQR---------- 413
E+++L + HPN++ LLG C G L E+ P+G L L++
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 414 ----ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469
S L + A + A+ + YL HRD+ + NIL+ NY +K+ADF
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 171
Query: 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFS 529
GLSR ++ + Y + SDV+S+GV+L EI++
Sbjct: 172 GLSRGQEVYVKKTMGR--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG----- 224
Query: 530 RPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589
P+ + A L +++ +G E + V +L +C RP
Sbjct: 225 TPYCGMTCAEL-YEKLPQGYRLEKPLNCDDE------------VYDLMRQCWREKPYERP 271
Query: 590 TMMEVAEELEHIR 602
+ ++ L +
Sbjct: 272 SFAQILVSLNRML 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 9e-55
Identities = 64/305 (20%), Positives = 122/305 (40%), Gaps = 45/305 (14%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDDW------VAIKRFR-YRDTDSIDQVMNEIKLLSSVS 378
S LG GA+G V + VA+K + + +M+E+K+LS +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 379 -HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGS----------------GLPW 421
H N++ LLG C G +++ E+ G L L+R+R S L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481
++ + + A+ +A+L S HRD+ + NILL + +K+ DFGL+R +S++
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 482 -ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540
+ + ++ P+ + +SDV+S+G+ L E+ + P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256
Query: 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
++I + ++++ + C RPT ++ + +E
Sbjct: 257 ---------FYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEK 304
Query: 601 IRVSS 605
S
Sbjct: 305 QISES 309
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-54
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 31/281 (11%)
Query: 331 RLGTGAYGTVYAGKLHNDD----WVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLL 383
+LG G++G V G+ VA+K + +++D + E+ + S+ H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMN 443
RL G +V E P G+L L++ +G A + A+ + YL S
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES--- 129
Query: 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH--ISTAPQGTPGYLDPQYHQYF 501
HRD+ + N+LL K+ DFGL R H + + + P+ +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561
S SD + FGV L E+ T + S++ + +I +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERLPRPEDCPQ- 242
Query: 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602
++ + +C A + RPT + + + L +
Sbjct: 243 ----------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 64/304 (21%), Positives = 128/304 (42%), Gaps = 50/304 (16%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD------WVAIKRFRYR-DTDSIDQVMNEIKLLSSV- 377
LG+GA+G V + VA+K + + D+ + +M+E+K+++ +
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG--------------------- 416
SH N++ LLG C G L++E+ G L +L+ +R
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 417 SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476
+ L + + A + A+ + +L HRD+ + N+L+ + K+ DFGL+R M
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 477 TESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEV 535
++S++ + + ++ P+ + KSDV+S+G++L EI + P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPGI 270
Query: 536 NLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595
+ A ++I + + + I+ + C AF RP+ +
Sbjct: 271 PVDAN---------FYKLIQNGFKMDQPFYATEEIYI---IMQSCWAFDSRKRPSFPNLT 318
Query: 596 EELE 599
L
Sbjct: 319 SFLG 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 64/271 (23%), Positives = 107/271 (39%), Gaps = 28/271 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
++G GA GTVY + VAI++ + + ++NEI ++ +PN++ L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+ E +V E++ G+L + + E QA+ +LHS + HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 450 DIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDV 509
DIKS NILL + K+ DFG +T + GTP ++ P+ K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 510 YSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSS 569
+S G++ IE+I P+ N G + L
Sbjct: 200 WSLGIMAIEMIEG------EPPYLNENPLRALYLIATNGTPELQNPEKLSA--------- 244
Query: 570 IHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ RCL + R + E+ L+H
Sbjct: 245 --IFRDFLNRCLDMDVEKRGSAKEL---LQH 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 66/314 (21%), Positives = 131/314 (41%), Gaps = 30/314 (9%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-----WVAIKRFR-YRDTDSIDQVMNEIKLLSSVSH 379
F + LG+GA+GTVY G + VAIK R + ++++E +++SV +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
P++ RLLG C L+ + MP G L +++ + + + + A+ + YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQGTPGYLDPQYH 498
+ + HRD+ + N+L+ K+ DFGL++ LG E + + + ++ +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
+ + +SDV+S+GV + E++T +P+ + + + + +G
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEI-SSILEKGERLPQPPICT 239
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYMGSPAVS 618
V + +C D RP E+ E + + G +
Sbjct: 240 ID------------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 619 CCSLSECGSERSLS 632
S ++ R+L
Sbjct: 288 LPSPTDSNFYRALM 301
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-52
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 331 RLGTGAYGTVYAGKLHNDDW----VAIKRFRYRDTDSI-DQVMNEIKLLSSVSHPNLLRL 385
+G G +G V+ G + + VAIK + +DS+ ++ + E + HP++++L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
+G E ++ E G L LQ + S L I A + + A+AYL S
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KR 128
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
HRDI + N+L+ N K+ DFGLSR + + ++ + ++ P+ + +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 506 KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAW 565
SDV+ FGV + EI+ +++V I RI G +
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPPT----- 237
Query: 566 TLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ L +C A+ RP E+ +L I
Sbjct: 238 -------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 73/279 (26%), Positives = 107/279 (38%), Gaps = 35/279 (12%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPN 381
F LG G +G VY + +A+K Q+ E+++ S + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
+LRL G + L+ E+ P GT+ + LQ+ T TE A A++Y HS
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK 125
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
+ HRDIK N+LL K+ADFG S + GT YL P+ +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGR 179
Query: 502 HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561
+K D++S GV+ E + P RI R ++
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVG------KPPFEANTYQET-YKRISRVEFT--FPDFVTE- 229
Query: 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+L R L + RP + EV LEH
Sbjct: 230 ----------GARDLISRLLKHNPSQRPMLREV---LEH 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-52
Identities = 62/294 (21%), Positives = 102/294 (34%), Gaps = 38/294 (12%)
Query: 311 VPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRY-RDTDSIDQVM 368
VPF +E + LG GAYG V ++ VA+K R D + +
Sbjct: 1 VPF-----VED----WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK 51
Query: 369 NEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIA 428
EI + ++H N+++ G E L E+ G L ++ + G+P
Sbjct: 52 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFF 109
Query: 429 TETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR-LGMTESSHISTAPQ 487
+ + YLH I HRDIK N+LLD K++DFGL+ +
Sbjct: 110 HQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 488 GTPGYLDPQYHQYFHLSD-KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG 546
GT Y+ P+ + DV+S G+VL ++ D + D
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKE 221
Query: 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ L + L + R T+ ++ +
Sbjct: 222 KKTYLNPWKKIDSAPLA------------LLHKILVENPSARITIPDI---KKD 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 68/307 (22%), Positives = 126/307 (41%), Gaps = 37/307 (12%)
Query: 309 SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYR-DT 361
S+ Y E E A + LG G++G VY G + VAIK
Sbjct: 5 SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64
Query: 362 DSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG--- 418
+ +NE ++ + +++RLLG + +++ E M G L +L+ R +
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124
Query: 419 -----LPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
+ I +A E A +AYL++ HRD+ + N ++ ++ K+ DFG++R
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181
Query: 474 -LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPH 532
+ T+ ++ P+ + + SDV+SFGVVL EI T + +
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM 592
+V + + G + + D + + EL C ++ MRP+ +
Sbjct: 242 EQV------LRFVMEGGLLDKPDNCPDM------------LFELMRMCWQYNPKMRPSFL 283
Query: 593 EVAEELE 599
E+ ++
Sbjct: 284 EIISSIK 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (444), Expect = 1e-49
Identities = 55/273 (20%), Positives = 104/273 (38%), Gaps = 28/273 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
LGTGA+G V+ + A K + V EI+ +S + HP L+ L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
++ E +++YEFM G L + + E + + + + + ++H H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHEN---NYVHL 148
Query: 450 DIKSSNILL--DYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
D+K NI+ + K+ DFGL+ + S T GT + P+ + + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567
D++S GV+ +++ P N + + A++
Sbjct: 207 DMWSVGVLSYILLSG------LSPFGGENDDET---------LRNVKSCDWNMDDSAFSG 251
Query: 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
S + + + L + R T+ + LEH
Sbjct: 252 IS-EDGKDFIRKLLLADPNTRMTIHQA---LEH 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 2e-48
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 25/287 (8%)
Query: 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQ-VMNEIKL 373
+K+ E + + LGTGA+ V + VAIK + + + + NEI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 374 LSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQ 433
L + HPN++ L G L+ + + G L + + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 434 AIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
A+ YLH + LD + + ++DFGLS++ + + + GTPGY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYV 176
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553
P+ S D +S GV+ ++ P + N A L ++I +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYDENDAKL-FEQILKAEY--- 226
Query: 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ P+ D + + + + + R T + L+H
Sbjct: 227 --EFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQA---LQH 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-48
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD--------WVAIKRFRYRDTDS-IDQVMNEIKLLSS 376
LG GA+G V + D VA+K + T+ + +++E++++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 377 VS-HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSG--------------LPW 421
+ H N++ LLG C ++G ++ E+ G L ++LQ R G L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 422 TIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481
++ A + A+ + YL S HRD+ + N+L+ + K+ADFGL+R +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 482 IST-APQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL 540
T + ++ P+ + +SDV+SFGV+L EI T P+ V + L
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEEL 246
Query: 541 AIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ G + + + C RPT ++ E+L+
Sbjct: 247 -FKLLKEGHRMDKPSNCTNE------------LYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 601 I 601
I
Sbjct: 294 I 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 3e-47
Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 28/273 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
LG+GA+G V+ K V NEI +++ + HP L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
++ E +L+ EF+ G L + + I + + + ++H I H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 151
Query: 450 DIKSSNILLDYNYRS--KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
DIK NI+ + S K+ DFGL+ I T + P+ + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567
D+++ GV+ +++ P + + + + E DA++
Sbjct: 210 DMWAIGVLGYVLLSG------LSPFAGEDDLET---------LQNVKRCDWEFDEDAFSS 254
Query: 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
S + L R T+ + LEH
Sbjct: 255 VS-PEAKDFIKNLLQKEPRKRLTVHDA---LEH 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-47
Identities = 57/283 (20%), Positives = 103/283 (36%), Gaps = 33/283 (11%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPN 381
F LG G++ TV + L AIK R + + V E ++S + HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
++L ++ + + NG L +++++ T E A+ YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG- 126
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQY 500
I HRD+K NILL+ + ++ DFG +++ ES + + GT Y+ P+
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
SD+++ G ++ +++ P N + +I + D P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAG------LPPFRAGNEYLI-FQKIIKLEYD--FPEKFFP 235
Query: 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV---AEELEH 600
+L + L R E+ H
Sbjct: 236 K-----------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-47
Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 29/273 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
LG G +G V+ + K + + TD + V EI +L+ H N+L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
E ++++EF+ + + + L ++ + +A+ +LHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 450 DIKSSNILLDY--NYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
DI+ NI+ + K+ +FG +R + P Y P+ HQ+ +S +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567
D++S G ++ +++ P + I+ I Y +
Sbjct: 185 DMWSLGTLVYVLLSG------INPFLAETNQQI-IENIMNA-------EYTFDEEAFKEI 230
Query: 568 SSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
S + R L R R T E L+H
Sbjct: 231 SI--EAMDFVDRLLVKERKSRMTASEA---LQH 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 73/312 (23%), Positives = 121/312 (38%), Gaps = 44/312 (14%)
Query: 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDW------VAIKRFRYRDTDS-IDQ 366
Y + E LG GA+G V D VA+K + T S
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 367 VMNEIKLLSSVSH-PNLLRLLGCCIEEGEPI-LVYEFMPNGTLCQHLQRERG-------- 416
+M+E+K+L + H N++ LLG C + G P+ ++ EF G L +L+ +R
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 417 ------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFG 470
L I + + A+ + +L S HRD+ + NILL K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 471 LSRLGMTESSHI-STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFS 529
L+R + ++ + ++ P+ + +SDV+SFGV+L EI + +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GA 234
Query: 530 RPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP 589
P+ V + R+ G D + + C RP
Sbjct: 235 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE------------MYQTMLDCWHGEPSQRP 282
Query: 590 TMMEVAEELEHI 601
T E+ E L ++
Sbjct: 283 TFSELVEHLGNL 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 7e-46
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 32/283 (11%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
LG G V+ + L VA+K R RD + E + ++++HP ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 387 GCCIEEGE----PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
E P +V E++ TL + E + I + + QA+ + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN- 130
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI--STAPQGTPGYLDPQYHQY 500
I HRD+K +NI++ KV DFG++R + + + A GT YL P+ +
Sbjct: 131 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
+ +SDVYS G VL E++T P + + ++A + + P
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVAYQHVRED--------PIPP 234
Query: 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRP-TMMEVAEELEHIR 602
LS+ ++ + + LA + + R T E+ +L +
Sbjct: 235 SARHEGLSA--DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 1e-44
Identities = 66/292 (22%), Positives = 98/292 (33%), Gaps = 43/292 (14%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSID---------QVMNEIKLLS 375
+ K LG G V A+K S + E+ +L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 376 SVS-HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQA 434
VS HPN+++L LV++ M G L +L + L I +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEV 122
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLD 494
I LH I HRD+K NILLD + K+ DFG S + GTP YL
Sbjct: 123 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLA 177
Query: 495 PQYHQ------YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG 548
P+ + + + D++S GV++ ++ S P +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG------SPPFWHRKQMLM-------- 223
Query: 549 CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ I+ + W S V +L R L R T E L H
Sbjct: 224 -LRMIMSGNYQFGSPEWDDYS-DTVKDLVSRFLVVQPQKRYTAEEA---LAH 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 34/292 (11%)
Query: 331 RLGTGAYGTVYAGKLHNDD--WVAIKRFR--YRDTDSIDQVMNEI---KLLSSVSHPNLL 383
+G GAYG V+ + + +VA+KR R + + E+ + L + HPN++
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 384 RLLGCCI-----EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
RL C E + LV+E + +L + G+P + + + + +L
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYH 498
HS + HRD+K NIL+ + + K+ADFGL+R+ + + S T Y P+
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
+ D++S G + E+ R S+V+ +D IG ++
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 559 EPHRDAWTLSS------IHNVAELAF----RCLAFHRDMRPTMMEVAEELEH 600
P + + S+ + ++ EL +CL F+ R + L H
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSH 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 62/287 (21%), Positives = 104/287 (36%), Gaps = 30/287 (10%)
Query: 332 LGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSIDQ-----VMNEIKLLSSVSHPNLLRL 385
LG G + TVY + N + VAIK+ + + EIKLL +SHPN++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 386 LGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
L + LV++FM + + L
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML-----MTLQGLEYLHQHW 120
Query: 446 IYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDP-QYHQYFHLS 504
I HRD+K +N+LLD N K+ADFGL++ + T T Y P
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKS-FGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 505 DKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564
D+++ G +L E++ + F S+++ + +G ++ D P
Sbjct: 180 VGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 565 WT----------LSSIHNVA-ELAFRCLAFHRDMRPTMMEVAEELEH 600
+ S+ + +L F+ R T + L+
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 59/287 (20%), Positives = 108/287 (37%), Gaps = 19/287 (6%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNL 382
F + ++G G YG VY + + VA+K+ R + EI LL ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 383 LRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
++LL E + LV+EF+ L + + +G+P + + + Q +A+ HS
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
+ HRD+K N+L++ K+ADFGL+R + +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSE----VNLAALAIDRIGRGCVDEIIDPYL 558
S D++S G + E++T + + + + G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 559 EPHRDAWTLSSI-----HNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
P S + + L + L + + R + L H
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA---LAH 283
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 2e-40
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 35/285 (12%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRF---RYRDTDSIDQVMNE---IKLLSSVS 378
FS +G G +G VY + + A+K R + +NE + L+S+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 379 HPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYL 438
P ++ + + + + M G L HL + E + ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--EIILGLEHM 123
Query: 439 HSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL-DPQY 497
H+ + +RD+K +NILLD + +++D GL+ + H S GT GY+
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 177
Query: 498 HQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557
+ +D +S G +L +++ + + IDR+ E+ D +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELPDSF 232
Query: 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV-AEE-LEH 600
R L L + R + A+E E
Sbjct: 233 SPELRS------------LLEGLLQRDVNRRLGCLGRGAQEVKES 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 2e-40
Identities = 57/276 (20%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLLRLL 386
LGTG++G V+ + HN + A+K + ++ +E +LS V+HP ++R+
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 387 GCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
G + + ++ +++ G L L++ + P A+ L + I
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA-----AEVCLALEYLHSKDI 125
Query: 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDK 506
+RD+K NILLD N K+ DFG ++ ++ GTP Y+ P+ +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 507 SDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWT 566
D +SFG+++ E++ P + N ++I + P+
Sbjct: 182 IDWWSFGILIYEMLA------GYTPFYDSNTMKT-YEKILNAELR--FPPFFNE------ 226
Query: 567 LSSIHNVAELAFRCLAFHRDMRPTMME--VAEELEH 600
+V +L R + R ++ + H
Sbjct: 227 -----DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 59/278 (21%), Positives = 97/278 (34%), Gaps = 34/278 (12%)
Query: 332 LGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCC 389
LG G G V + A+K + + E++L S P+++R++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 390 ----IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPP 445
++V E + G L +Q I +AI YLHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 131
Query: 446 IYHRDIKSSNILLD---YNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFH 502
I HRD+K N+L N K+ DFG ++ + +S + TP Y+ P+
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGPEK 189
Query: 503 LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHR 562
D++S GV++ ++ P + A++ G I E
Sbjct: 190 YDKSCDMWSLGVIMYILLC------GYPPFYSNHGLAIS-----PGMKTRIRMGQYEFPN 238
Query: 563 DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
W+ S V L L R T+ E + H
Sbjct: 239 PEWSEVS-EEVKMLIRNLLKTEPTQRMTITEF---MNH 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 3e-40
Identities = 53/282 (18%), Positives = 95/282 (33%), Gaps = 30/282 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
++G+G++G +Y G + + VAIK + Q+ E K+ + + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 390 IEEGEP-ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
EG+ ++V E + R + +A + I Y+HS H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKN---FIH 126
Query: 449 RDIKSSNIL---LDYNYRSKVADFGLSRLGMTESSHI------STAPQGTPGYLDPQYHQ 499
RD+K N L + DFGL++ +H + GT Y H
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 500 YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
S + D+ S G VL+ + AA + R ++ P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLG-------SLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ S A C + D +P + + ++
Sbjct: 240 LCKG---YPS--EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (369), Expect = 4e-40
Identities = 54/281 (19%), Positives = 97/281 (34%), Gaps = 19/281 (6%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
++G G YG VY + + + A+K+ R D + EI +L + H N+++L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYH 448
+ +LV+E + E G L + + IAY H + H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 449 RDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSD 508
RD+K N+L++ K+ADFGL+R + S D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 509 VYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID--------PYLEP 560
++S G + E++ + ++ + + + EP
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 561 HRDAWTLSSIHNVA-ELAFRCLAFHRDMRPTMMEVAEELEH 600
L + +L + L + R T + LEH
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA---LEH 281
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 64/280 (22%), Positives = 107/280 (38%), Gaps = 33/280 (11%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFR---YRDTDSIDQVMNEIKLLS-SVSHP 380
F LG G++G V+ + + + AIK + D ++ M E ++LS + HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L + + V E++ G L H+Q + A E + +LHS
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS 121
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
I +RD+K NILLD + K+ADFG+ + M + +T GTP Y+ P+
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 501 FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEP 560
+ D +SFGV+L E++ P + L I +LE
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIG------QSPFHGQDEEEL-FHSIRMDNPF--YPRWLEK 228
Query: 561 HRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+L + + R + + +H
Sbjct: 229 -----------EAKDLLVKLFVREPEKRLGVR--GDIRQH 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 37/287 (12%)
Query: 325 FFSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDS------IDQVMNEIKLLSSV 377
++ LG+G + V + A K + R T S + + E+ +L +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 378 SHPNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAY 437
HPN++ L + + IL+ E + G L L + Q +
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNG 125
Query: 438 LHSAMNPPIYHRDIKSSNILLDYN----YRSKVADFGLSRLGMTESSHISTAPQGTPGYL 493
++ + I H D+K NI+L R K+ DFGL+ + + GTP ++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFV 183
Query: 494 DPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553
P+ Y L ++D++S GV+ +++ + + +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFE 236
Query: 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ + A + R L R T+ + L+H
Sbjct: 237 DEYFSNTSALA---------KDFIRRLLVKDPKKRMTIQDS---LQH 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 62/293 (21%), Positives = 106/293 (36%), Gaps = 29/293 (9%)
Query: 326 FSEKHRLGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR 384
+++ +G G++G VY KL + VAIK+ E++++ + H N++R
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGCCIEEGEP------ILVYEFMPNGTLCQHLQRERGSG-LPWTIRITIATETAQAIAY 437
L GE LV +++P R LP + +++AY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 438 LHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 496
+HS I HRDIK N+LLD + K+ DFG ++ + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPEL 193
Query: 497 YHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556
+ DV+S G VL E++ + ++ + R + E+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 557 YLE---PHRDAWTLSSIHNVA------ELAFRCLAFHRDMRPTMMEVAEELEH 600
Y E P A + + L R L + R T +E H
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA---CAH 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 56/285 (19%), Positives = 94/285 (32%), Gaps = 25/285 (8%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDS--IDQVMNEIKLLSSVSHPNLLRLLG 387
++G G YGTV+ K + VA+KR R D D + EI LL + H N++RL
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 388 CCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIY 447
+ + LV+EF Q + L + +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-----FQLLKGLGFCHSRNVL 123
Query: 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKS 507
HRD+K N+L++ N K+A+FGL+R S S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 508 DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTL 567
D++S G + E+ A + + + +G ++ P + +
Sbjct: 184 DMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 568 SSIHN------------VAELAFRCLAFHRDMRPTMMEVAEELEH 600
+L L + R + E L+H
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA---LQH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 57/294 (19%), Positives = 109/294 (37%), Gaps = 27/294 (9%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFR-YRDTDSIDQVMNEIKLLSSVSHPNLL 383
++ +G GAYG V + N VAIK+ + + + EIK+L H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 384 RLLGCCIEEGEPILVYEFMPNGTL-CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM 442
+ + ++ + + + L + + + Y+HSA
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 128
Query: 443 NPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQ--GTPGYLDPQYHQY 500
+ HRD+K SN+LL+ K+ DFGL+R+ + H + T Y P+
Sbjct: 129 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 501 FHLSDKS-DVYSFGVVLIEIIT-------------ALKVVDFSRPHSEVNLAALAIDRIG 546
KS D++S G +L E+++ ++ S+ +L + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 547 RGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600
+ + +R S +L + L F+ R + + L H
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADS--KALDLLDKMLTFNPHKRIEVEQA---LAH 295
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 10/200 (5%)
Query: 326 FSEKHRLGTGAYGTVYAGK-LHNDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPN 381
F LG G +G V + + A+K R D + + E ++L + HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
L L V E+ G L HL RER A+ ++ L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG-----AEIVSALEYL 121
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
+ + +RDIK N++LD + K+ DFGL + G+++ + GTP YL P+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDN 180
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
D + GVV+ E++
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 51/293 (17%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFR------YRDTDSIDQVMNEIKLLSSVS--HPN 381
LG+G +G+VY+G + ++ VAIK + + + +V E+ LL VS
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
++RLL +L+ E ERG L + + + +A+ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC 129
Query: 442 MNPPIYHRDIKSSNILLDYN-YRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQY 500
+ HRDIK NIL+D N K+ DFG L + T GT Y P++ +Y
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFDGTRVYSPPEWIRY 183
Query: 501 FHLSDKS-DVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
+S V+S G++L +++ E + +EII +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVC-------GDIPFEHD--------------EEIIRGQVF 222
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYM 612
+ +SS L CLA RPT E+ H W ++ +
Sbjct: 223 FRQR---VSS--ECQHLIRWCLALRPSDRPTFEEI---QNH----PWMQDVLL 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (349), Expect = 3e-37
Identities = 44/283 (15%), Positives = 84/283 (29%), Gaps = 30/283 (10%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389
R+G G++G ++ G L N+ VAIK R Q+ +E + ++ + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 390 IEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHR 449
+EG ++ + G + L G A + + +H + +R
Sbjct: 70 GQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 450 DIKSSNILLD-----YNYRSKVADFGLSRLGMTESSHISTAPQ------GTPGYLDPQYH 498
DIK N L+ V DFG+ + + + GT Y+ H
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 499 QYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558
S + D+ + G V + + + + +RIG
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----KQKYERIGEK--------KQ 233
Query: 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601
+ D P + +
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 52/297 (17%), Positives = 100/297 (33%), Gaps = 35/297 (11%)
Query: 331 RLGTGAYGTVYAGKLHNDD-WVAIKRFRYRDTDS--IDQVMNEIKLLSSVSHPNLLRLLG 387
++G G +G V+ + VA+K+ + + EIK+L + H N++ L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 388 CCIE--------EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLH 439
C +G LV++F + L R+ + L+
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM-----QMLLNGLY 131
Query: 440 SAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR---LGMTESSHISTAPQGTPGYL-DP 495
I HRD+K++N+L+ + K+ADFGL+R L + T T Y
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 496 QYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALA--------IDRIGR 547
D++ G ++ E+ T ++ + ++ L + +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 548 GCVDEIIDPYLEPHRDAWTLSSIHNVAELAF----RCLAFHRDMRPTMMEVAEELEH 600
+ E ++ R + A + L R + L H
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA---LNH 305
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 40/313 (12%)
Query: 313 FYPYKEIEKATSFFSEKHR----LGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSID 365
FY E+ K +R +G+GAYG V + VAIK+ ++
Sbjct: 4 FYRQ-EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62
Query: 366 QVMNEIKLLSSVSHPNLLRLLGCCIEEG------EPILVYEFMPNGTLCQHLQRERGSGL 419
+ E++LL + H N++ LL + + LV FM GT L + L
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KL 118
Query: 420 PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479
+ + + + Y+H+A HRD+K N+ ++ + K+ DFGL+R
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR---QAD 172
Query: 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITA--------LKVVDFSRP 531
S ++ + + D++S G ++ E+IT
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 532 HSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAF----RCLAFHRDM 587
A + R+ + E + + S + N + LA + L +
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQ 291
Query: 588 RPTMMEVAEELEH 600
R T E L H
Sbjct: 292 RVTAGEA---LAH 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 4e-34
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 44/296 (14%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGC 388
+LG G Y V+ + N++ V +K + ++ EIK+L ++ PN++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 389 CIEEGE--PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPI 446
+ P LV+E + N Q Q L E +A+ Y HS I
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---I 150
Query: 447 YHRDIKSSNILLDY-NYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSD 505
HRD+K N+++D+ + + ++ D+GL+ + + + P+ + + D
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYD 208
Query: 506 -KSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDA 564
D++S G +L +I + F H + +G + + ID Y
Sbjct: 209 YSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 565 WT----------------LSSIHNVAELAF----RCLAFHRDMRPTMMEVAEELEH 600
+ + H V+ A + L + R T E +EH
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA---MEH 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 1e-33
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 21/235 (8%)
Query: 295 QLSAKRLLCQAAGN----SSVPFYPYKEIEKATSFFSEKHRLGTGAYGTVYAGK-LHNDD 349
Q S K L +A + P ++++ F LGTG++G V K + +
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 350 WVAIKRFR---YRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPNGT 406
A+K I+ +NE ++L +V+ P L++L + +V E++ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 407 LCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKV 466
+ HL+R A + YLHS + +RD+K N+L+D +V
Sbjct: 128 MFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182
Query: 467 ADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
DFG ++ + + GTP L P+ + D ++ GV++ E+
Sbjct: 183 TDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 61/283 (21%), Positives = 99/283 (34%), Gaps = 34/283 (12%)
Query: 331 RLGTGAYGTVYAGKLHNDDW----VAIKRFR----YRDTDSIDQVMNEIKLLSSVSH-PN 381
LGTGAYG V+ + + A+K + + + + E ++L + P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 382 LLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
L+ L E + L+ +++ G L HL + + + L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV-----GEIVLALEHL 145
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYL--DPQYHQ 499
I +RDIK NILLD N + DFGLS+ + + + + GT Y+ D
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 500 YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559
D +S GV++ E++T + P + EI L+
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTG------ASPFTVDGEKNS---------QAEISRRILK 250
Query: 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMM-EVAEE-LEH 600
S +L R L R A+E EH
Sbjct: 251 SEPPYPQEMS-ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-31
Identities = 58/315 (18%), Positives = 120/315 (38%), Gaps = 41/315 (13%)
Query: 312 PFYPYKEIEKATSFFSEKHR----LGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSI 364
P + +E+ K E+++ +G+GAYG+V A VA+K+ ++
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 365 DQVMNEIKLLSSVSHPNLLRLLGCC-----IEEGEPILVYEFMPNGTLCQHLQRERGSGL 419
+ E++LL + H N++ LL +EE + + + G ++ + + L
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQK--L 118
Query: 420 PWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479
+ + + + Y+HSA HRD+K SN+ ++ + K+ DFGL+
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLA---RHTD 172
Query: 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA 539
++ + H + D++S G ++ E++T ++
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLK 229
Query: 540 LAIDRIG-------RGCVDEIIDPYLE--PHRDAWTLSSIHNVA-----ELAFRCLAFHR 585
L + +G + E Y++ +++ A +L + L
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 586 DMRPTMMEVAEELEH 600
D R T + L H
Sbjct: 290 DKRITAAQA---LAH 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 19/200 (9%)
Query: 331 RLGTGAYGTVYAGK-LHNDDWVAIKRFR--YRDTDSIDQVMNEIKLLSSVSHPNLLRLLG 387
+G+GA G V A D VAIK+ +++ + E+ L+ V+H N++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 388 CCI------EEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSA 441
E + LV E M + + I +LHSA
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138
Query: 442 MNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYF 501
HRD+K SNI++ + K+ DFGL+R T S + T T Y P+
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 502 HLSDKSDVYSFGVVLIEIIT 521
+ D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMVR 213
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 8e-26
Identities = 44/209 (21%), Positives = 78/209 (37%), Gaps = 20/209 (9%)
Query: 330 HRLGTGAYGTVYAGK-LHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGC 388
+LG G + TV+ K + N+ VA+K R D + +EIKLL V+ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 389 CIEEGEPILVY--EFMPNGTLC------------QHLQRERGSGLPWTIRITIATETAQA 434
+L + PNG +++ G+P I+ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 435 IAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGLSRLGMTESSHISTAP-QGTPGY 492
+ Y+H I H DIK N+L++ + ++ LG T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 493 LDPQYHQYFHLSDKSDVYSFGVVLIEIIT 521
P+ +D++S ++ E+IT
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 3e-20
Identities = 21/153 (13%), Positives = 42/153 (27%), Gaps = 19/153 (12%)
Query: 331 RLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVM----------NEIKLLSSVSHP 380
+G G V+ +K + T +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 381 NLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHS 440
L +L G + + VY + N L + + + + + + +A +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 441 AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473
I H D+ N+L+ + DF S
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.9 bits (88), Expect = 1e-04
Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 6/39 (15%)
Query: 197 NGSCNCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFV 235
N CS +A+C + +G CRC + G+G
Sbjct: 4 NNRHQCSVHAECR------DYATGFCCRCVANYTGNGRQ 36
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 692 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.6 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 95.07 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 90.6 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 89.98 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.01 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 86.6 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 86.31 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 86.13 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.08 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 84.62 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.42 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 84.06 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.78 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 82.67 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.35 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 80.82 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.63 Aligned_cols=263 Identities=26% Similarity=0.379 Sum_probs=216.6
Q ss_pred HHHHHHHCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 88987513675540531146199999999189899999912289300899999999998189997001679998489008
Q 005536 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 317 ~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 396 (692)
+++|...++|...+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++|||||+++|++. .+..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEE
T ss_conf 7700388993886798107982899999999999999998647-688899999999998679998857873104-59769
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99970899988899742059999988899999999999999873389992853778996688399965994214774587
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~ 476 (692)
+||||+++|+|.+++.......++|..++.|+.|+|.||.|||+ ++|+||||||+||||++++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECC
T ss_conf 99995789828888751478988788999999999999999974---895467564225156202440423410147735
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 78875323677999999921001277898462542358899988379545788995410079999999515854413466
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~ 556 (692)
...........||+.|+|||++.+..++.++||||||++||||+|+..|+...... ......+..+.....
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~~~~~--- 231 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGYRMVR--- 231 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCCC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHHCCCCCC---
T ss_conf 88644203567744445828983799982456452579999999689888888899------999999970688889---
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 6886777339889999999999801469999999999999998422
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~ 602 (692)
+...+..+.+|+.+||+.+|++||||.+|++.|+.+-
T Consensus 232 ---------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 ---------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ---------6557199999999975889768939999999861132
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=383.82 Aligned_cols=269 Identities=29% Similarity=0.405 Sum_probs=223.3
Q ss_pred CCHHHHHHHHCCCCCCEEECCCCCEEEEEEEEEC-CCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
Q ss_conf 8968898751367554053114619999999918-989999991228930089999999999818999700167999848
Q 005536 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE 392 (692)
Q Consensus 314 ~~~~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 392 (692)
..++++|...++|...++||+|+||+||+|++.. ++.||||+++.. ....++|.+|+.++++++||||++++|++.+.
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCCCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEEC
T ss_conf 99765174579939865982088808999999999969999997776-10399999999999867999882677527457
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 90089997089998889974205999998889999999999999987338999285377899668839996599421477
Q 005536 393 GEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla 472 (692)
+..++||||+++|+|.+++.......+++..++.|+.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf 854787631467606777530355415799999999999997888987---89305760457689989992898324454
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 45877887532367799999992100127789846254235889998837954578899541007999999951585441
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~e 552 (692)
+..............|++.|+|||++.+..++.++||||||+++|||+++..|+....... ...+.+..+...+
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~~~~ 236 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRME 236 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCCC
T ss_pred EECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCCCC
T ss_conf 6537887221035566546669278727999810430217899999986799887742599------9999985588888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 3466688677733988999999999980146999999999999999842201
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
. +......+.+|+.+||+.+|++||||.+|++.|+.+...
T Consensus 237 ~------------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 R------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred C------------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 8------------743309999999997577976893999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=384.02 Aligned_cols=269 Identities=23% Similarity=0.382 Sum_probs=215.3
Q ss_pred CCHHHHHHHHCC---------CCCCEEECCCCCEEEEEEEEEC-C---CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCC
Q ss_conf 896889875136---------7554053114619999999918-9---89999991228-93008999999999981899
Q 005536 314 YPYKEIEKATSF---------FSEKHRLGTGAYGTVYAGKLHN-D---DWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSH 379 (692)
Q Consensus 314 ~~~~el~~~t~~---------f~~~~~LG~G~~g~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h 379 (692)
++|+++++++.+ |...+.||+|+||+||+|++.. + ..||||++... .....++|.+|+.++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCEEEEEEEEEECCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 97001679998489008999708999888997420599999888999999999999998733899928537789966883
Q 005536 380 PNLLRLLGCCIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD 459 (692)
Q Consensus 380 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld 459 (692)
||||+++|++.+.+..++||||+++|+|.+++.... ..++|..++.|+.|+|.||+|||+ ++|+||||||+||||+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEC
T ss_conf 888618999962887799997227985300210456-799999999999999998898852---7983576150448988
Q ss_pred CCCCEEEEEECCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf 9996599421477458778875----3236779999999210012778984625423588999883-7954578899541
Q 005536 460 YNYRSKVADFGLSRLGMTESSH----ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSE 534 (692)
Q Consensus 460 ~~~~~ki~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~ 534 (692)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||+| |+.||.....
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--- 239 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--- 239 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred CCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---
T ss_conf 99919988844315756777765365025666883003878883699786121445357899998679999999999---
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 00799999995158544134666886777339889999999999801469999999999999998422013
Q 005536 535 VNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 535 ~~l~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~ 605 (692)
......+.++.... .+...+..+.+|+.+||+.+|++||||.+|++.|+++...+
T Consensus 240 ----~~~~~~i~~~~~~~------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 240 ----QDVINAIEQDYRLP------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ----HHHHHHHHTTCCCC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----HHHHHHHHCCCCCC------------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf ----99999997378899------------97422699999999975879768929999999999984186
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.47 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=214.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 36755405311461999999991898999999122893008999999999981899970016799984890089997089
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMP 403 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 403 (692)
++|...+.||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889999999998788-6768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf 99888997420599999888999999999999998733899928537789966883999659942147745877887532
Q 005536 404 NGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHIS 483 (692)
Q Consensus 404 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~~~ 483 (692)
+|+|.+++... ...+++..++.|+.|+|.||+|||+ ++|+||||||+|||+|.++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEE
T ss_conf 99189975201-3478899999999999998776531---6431044315326666887768655321002368873350
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 36779999999210012778984625423588999883795457889954100799999995158544134666886777
Q 005536 484 TAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRD 563 (692)
Q Consensus 484 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~~~ 563 (692)
....||+.|+|||++.+..++.++||||||+++|||+|+..|+...... ....+.+..+.... .+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~~--~p------- 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFRLY--KP------- 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHHHTCCCC--CC-------
T ss_pred CCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHHCCCCC--CC-------
T ss_conf 4300176667857860799984033210599999998789888778999------99999998068889--95-------
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 33988999999999980146999999999999999842201
Q 005536 564 AWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 564 ~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
.....++.+|+.+||+.+|++||||++|++.|++|+.+
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---43679999999997657976891999999999999857
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.34 Aligned_cols=265 Identities=29% Similarity=0.446 Sum_probs=212.6
Q ss_pred HHHHHCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 98751367554053114619999999918989999991228--9300899999999998189997001679998489008
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 319 l~~~t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 396 (692)
+|...++|...+.||+|+||+||+|++. ..||||+++.. +....+.|.+|+.++++++||||++++|++. ....+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf 1315451899889830788589999999--98999999734699899999999999998479987864567971-55899
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99970899988899742059999988899999999999999873389992853778996688399965994214774587
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~ 476 (692)
+||||+++|+|.++++... ..+++..++.|+.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 80 lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 9996589988899985235-789999999999999999888750---999516147899798189978875002213335
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 78-8753236779999999210012---7789846254235889998837954578899541007999999951585441
Q 005536 477 TE-SSHISTAPQGTPGYLDPQYHQY---FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 477 ~~-~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~e 552 (692)
.. .........||+.|+|||++.+ ..++.++||||||++||||+||+.||....+... ....+.++...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~- 228 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLS- 228 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCC-
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCC-
T ss_conf 56776312566557431799999505689999531516359999999978899899896999------99999658889-
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 3466688677733988999999999980146999999999999999842201
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
+.+ .......++.+.+|+.+||+.+|++||||.+|++.|+.++..
T Consensus 229 ---p~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 ---PDL----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---CCG----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCC----HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---860----003655549999999997588976892999999999999970
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.44 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=213.2
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEECC-----CEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf 513675540531146199999999189-----899999912289-30089999999999818999700167999848900
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHND-----DWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 395 (692)
..+.|...+.||+|+||+||+|++... ..||||+++... .....+|.+|+.++++++|||||+++|++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 88996861598117790999999968998787999999988445968999999999999856898783236778338803
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 89997089998889974205999998889999999999999987338999285377899668839996599421477458
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~ 475 (692)
++|+||+.++++.+++... ...++|..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEECCCCCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 8999721357402221023-4542089999999999985412121---23425765644278889984998455103003
Q ss_pred CCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 7788--75323677999999921001277898462542358899988379545788995410079999999515854413
Q 005536 476 MTES--SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 476 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei 553 (692)
.... ........||+.|+|||++.+..++.++||||||+++|||+++..|+....... .....+..+....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~~~- 233 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFRLP- 233 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCCC-
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH------HHHHHHHCCCCCC-
T ss_conf 578765267426777734348888704999973556344898999996798865568999------9999986357899-
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 4666886777339889999999999801469999999999999998422013
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~ 605 (692)
.+...+..+.+|+.+||+.+|++||+|.+|+++|+++...+
T Consensus 234 -----------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 234 -----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----------CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf -----------85045799999999977679768939999999999986695
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.45 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=210.4
Q ss_pred HHHHCCCCCCEEECCCCCEEEEEEEEECC------CEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE
Q ss_conf 87513675540531146199999999189------89999991228-930089999999999818-99970016799984
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHND------DWVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIE 391 (692)
Q Consensus 320 ~~~t~~f~~~~~LG~G~~g~Vykg~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 391 (692)
|...++|...+.||+|+||+||+|+.... ..||+|.+... +......+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 57789939701983078819999998578855420499999966335878999999999999971589968687788862
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 8900899970899988899742059---------------------9999888999999999999998733899928537
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERG---------------------SGLPWTIRITIATETAQAIAYLHSAMNPPIYHRD 450 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrD 450 (692)
.+..++||||+++|+|.++|+..+. ..+++..++.|+.|++.||+|||+ ++|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECC
T ss_conf 9958999972799959999986257775102210000122200125778999999999999999999973---9905052
Q ss_pred CCCCCEEECCCCCEEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCC
Q ss_conf 7899668839996599421477458778875-3236779999999210012778984625423588999883-7954578
Q 005536 451 IKSSNILLDYNYRSKVADFGLSRLGMTESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDF 528 (692)
Q Consensus 451 ik~~NILld~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~ 528 (692)
|||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||+||||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCC
T ss_conf 70321443459828985142222045778615623435787657838872799996330300039999998389999999
Q ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 899541007999999951585441346668867773398899999999998014699999999999999984
Q 005536 529 SRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEH 600 (692)
Q Consensus 529 ~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~ 600 (692)
...... ....+..+...+ .+......+.+|+.+||+.+|++||||+||++.|..
T Consensus 270 ~~~~~~------~~~~~~~~~~~~------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 270 IPVDAN------FYKLIQNGFKMD------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCSHH------HHHHHHTTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH------HHHHHHCCCCCC------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 898999------999985699899------------887678999999999758896689399999999748
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.74 Aligned_cols=264 Identities=27% Similarity=0.376 Sum_probs=216.8
Q ss_pred HHHHHHHCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 88987513675540531146199999999189899999912289300899999999998189997001679998489008
Q 005536 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 317 ~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 396 (692)
.+++...++|...+.||+|+||.||+|++.+++.||||+++.. ....+.|.+|+.++++++|+|||+++|++. .+..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred CCEECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEE
T ss_conf 5607477997984699307980999999999999999998804-488899999999998666678868999982-39759
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99970899988899742059999988899999999999999873389992853778996688399965994214774587
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~ 476 (692)
+||||+++|+|..++.......++|..++.|+.|+|.||+|||+ ++|+||||||+|||+|.++.+||+|||+++...
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCC
T ss_conf 99994479943542000035530599999999999999998754---114335312307999899929984425554256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 78875323677999999921001277898462542358899988379545788995410079999999515854413466
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDP 556 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~ 556 (692)
...........||+.|+|||++....++.++||||||++||||++|..|+...... ......+.++...++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~~~~~--- 235 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRMPC--- 235 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCCC---
T ss_pred CCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH------HHHHHHHHHCCCCCC---
T ss_conf 88733524545566545808983799891774132358999998689999988889------999999982689999---
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 68867773398899999999998014699999999999999984220
Q 005536 557 YLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 557 ~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~ 603 (692)
+....+++.+++.+||+.+|++||+|++|+++|+....
T Consensus 236 ---------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 ---------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ---------83237999999999756697589199999998766623
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.87 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=214.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 13675540531146199999999189899999912289300899999999998189997001679998489008999708
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.++|...++||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|++.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 6997996898207883999999889989999998747-577899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 99988899742059999988899999999999999873389992853778996688399965994214774587788753
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~~ 482 (692)
++|+|.+++.... ..+++..+++|+.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEE
T ss_conf 8993888641024-677689999999999999998754---684346654135887699847988614420235787225
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 236779999999210012778984625423588999883-7954578899541007999999951585441346668867
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....||+.|+|||++.+..++.++||||||+++|||+| |+.||..... ......+.++.... .+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~--~p----- 223 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRLY--RP----- 223 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCCC--CC-----
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH-------HHHHHHHHHCCCCC--CC-----
T ss_conf 24657887757807863799885210336432467397559999889999-------99999998079789--96-----
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 7733988999999999980146999999999999999842
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHI 601 (692)
Q Consensus 562 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i 601 (692)
......+.+|+.+||+.+|++|||+.++++.|.+|
T Consensus 224 -----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -----54659999999997668976893999999874188
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.36 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=207.7
Q ss_pred CCCCCCE-EECCCCCEEEEEEEEEC---CCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 3675540-53114619999999918---989999991228-930089999999999818999700167999848900899
Q 005536 324 SFFSEKH-RLGTGAYGTVYAGKLHN---DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~-~LG~G~~g~Vykg~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 398 (692)
++|...+ +||+|+||+||+|.+.. +..||||.++.. +....++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 97089998889974205999998889999999999999987338999285377899668839996599421477458778
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~ 478 (692)
|||+++|+|.+++...+ ..+++..++.|+.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 98078996899752125-699999999999999998789986---88105767646604546885420331342115543
Q ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 875--3236779999999210012778984625423588999883-7954578899541007999999951585441346
Q 005536 479 SSH--ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 479 ~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d 555 (692)
... ......||+.|+|||++....++.++||||||+++|||+| |+.||...... .....+.++...++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~-- 233 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRMEC-- 233 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCCCCC--
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHCCCCCCC--
T ss_conf 432113562113743358688727999954123220178999993899999997999-------99999981899999--
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 668867773398899999999998014699999999999999984220
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~ 603 (692)
+...+.++.+|+.+||+.+|++||+|.+|++.|+.+..
T Consensus 234 ----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 ----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----------97678999999999757797689099999999999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.84 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=209.1
Q ss_pred HCCCCCCEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 13675540531146199999999-18989999991228930089999999999818999700167999848900899970
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 401 (692)
.++|...++||+|+||+||+++. .+++.||+|+++..+....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779889998999970
Q ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 89998889974205999998889999999999999987338999285377899668839996599421477458778875
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~ 481 (692)
+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 99 ~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS 171 (293)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TC
T ss_pred CCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC-CC
T ss_conf 3798089886415---99999999999999999999998---79722677688868878996864251564132136-66
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 32367799999992100127789846254235889998837954578899541007999999951585441346668867
Q 005536 482 ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........+. ..+..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~-~~~~~------ 238 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PELQN------ 238 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS-CCCSS------
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCC-CCCCC------
T ss_conf 4444444777368266447998801203137299999804889989979999------9999985799-98888------
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 77339889999999999801469999999999999998422013334
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 562 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~ 608 (692)
+......+.+|+.+||+.+|++|||+.|++ .++|..
T Consensus 239 ----~~~~s~~~~~li~~~L~~dP~~R~s~~eil-------~Hp~~~ 274 (293)
T d1yhwa1 239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELL-------QHQFLK 274 (293)
T ss_dssp ----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHT-------TCGGGG
T ss_pred ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHC
T ss_conf ----553799999999998669966890999996-------499657
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=364.92 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=217.5
Q ss_pred HHHHHHHHCCCCCCEEECCCCCEEEEEEEEEC------CCEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 68898751367554053114619999999918------98999999122893-008999999999981899970016799
Q 005536 316 YKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRDT-DSIDQVMNEIKLLSSVSHPNLLRLLGC 388 (692)
Q Consensus 316 ~~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~ 388 (692)
+.++|...++|...+.||+|+||+||+|+..+ ++.||||+++.... ...++|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHHCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 984890089997089998889974205----------------------9999988899999999999999873389992
Q 005536 389 CIEEGEPILVYEFMPNGTLCQHLQRER----------------------GSGLPWTIRITIATETAQAIAYLHSAMNPPI 446 (692)
Q Consensus 389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~i 446 (692)
+.+.+..++|+||+++|+|.++++... ...+++..++.|+.|+|.||+|||+ ++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCE
T ss_conf 60598038999815899299999852755421000011100121034678898999999999999998554135---786
Q ss_pred EECCCCCCCEEECCCCCEEEEEECCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCC-
Q ss_conf 85377899668839996599421477458778-8753236779999999210012778984625423588999883795-
Q 005536 447 YHRDIKSSNILLDYNYRSKVADFGLSRLGMTE-SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALK- 524 (692)
Q Consensus 447 iHrDik~~NILld~~~~~ki~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~- 524 (692)
+||||||+|||+|.++.+||+|||+++..... .....+...||+.|+|||++.+..++.++||||||+++|||+++..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 457889954100799999995158544134666886777339889999999999801469999999999999998422
Q 005536 525 VVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 525 p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~ 602 (692)
|+..... ......+.++...++ +...+..+.+|+.+||+.+|++||||.||+++|++|.
T Consensus 242 p~~~~~~-------~e~~~~v~~~~~~~~------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAH-------EEVIYYVRDGNILAC------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCH-------HHHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCH-------HHHHHHHHCCCCCCC------------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999899-------999999973997888------------7325299999999974889657939999999999842
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.19 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=203.2
Q ss_pred EEECCCCCEEEEEEEEEC---CCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 053114619999999918---989999991228--930089999999999818999700167999848900899970899
Q 005536 330 HRLGTGAYGTVYAGKLHN---DDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFMPN 404 (692)
Q Consensus 330 ~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 404 (692)
++||+|+||+||+|.+.+ ++.||||+++.. +....++|.+|+.++++++||||++++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC--C
Q ss_conf 98889974205999998889999999999999987338999285377899668839996599421477458778875--3
Q 005536 405 GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH--I 482 (692)
Q Consensus 405 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~--~ 482 (692)
|+|.+++... ..+++..++.|+.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 9689997522--578999999999999999766874---79556777611310235675123413453313432344322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 236779999999210012778984625423588999883-7954578899541007999999951585441346668867
Q 005536 483 STAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPH 561 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~ 561 (692)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.++...+.
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~~~-------- 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERMGC-------- 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCC--------
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHCCCCCCC--------
T ss_conf 44567784203916653799984344303403132896589999999899-------999999982899999--------
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 773398899999999998014699999999999999984220
Q 005536 562 RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 562 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~ 603 (692)
+...+..+.+|+.+||+.+|++||||.+|++.|+..-.
T Consensus 232 ----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 232 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf ----86567999999999758897689098999998528875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.38 Aligned_cols=270 Identities=21% Similarity=0.301 Sum_probs=206.5
Q ss_pred HHHHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 875136755405311461999999991-89899999912289-3008999999999981899970016799984890089
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 320 ~~~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 397 (692)
|...++|...++||+|+||+||+++.. +++.||+|+++... ....+++.+|+.++++++||||+++++++.+.+..++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 78756888978971277809999999899969999998754097899999999999986799999949999998999999
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99708999888997420599999888999999999999998733899928537789966883999659942147745877
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~ 477 (692)
||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 99767998689987424--9999999999999999999999985--9997144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCH-HHHHHHHHCC---------
Q ss_conf 887532367799999992100127789846254235889998837954578899541007-9999999515---------
Q 005536 478 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNL-AALAIDRIGR--------- 547 (692)
Q Consensus 478 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l-~~~~~~~~~~--------- 547 (692)
.......||+.|+|||++.+.+++.++||||+||++|||++|+.||........... ..........
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf ---86211137714119468758998948889989999999998889989988789999998875177545774212333
Q ss_pred -------------CCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf -------------85441346668867773-39889999999999801469999999999999
Q 005536 548 -------------GCVDEIIDPYLEPHRDA-WTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 548 -------------~~~~ei~d~~l~~~~~~-~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
....+..+......... .......++.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 221111222354134778876650268766764448999999999986899467908999960
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.52 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=208.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 36755405311461999999991-89899999912289300899999999998189997001679998489008999708
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
+.|...+.||+|+||+||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 99988899742059999988899999999999999873389992853778996688399965994214774587788753
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~~ 482 (692)
++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-CCC
T ss_conf 998188999862-8999999999999999999999998---89887140700314878999899716123035778-641
Q ss_pred CCCCCCCCCCCCCCCCC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 23677999999921001-----2778984625423588999883795457889954100799999995158544134666
Q 005536 483 STAPQGTPGYLDPQYHQ-----YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY 557 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~ 557 (692)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||....+.+. ...+..+....+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~~~i~~~~~~~~~~-- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPTLAQ-- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHHSCCCCCSS--
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHCCCCCCCCC--
T ss_conf 001025626479999832025788888066578789999998208899999899999-------99997079987776--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 886777339889999999999801469999999999999998422013334
Q 005536 558 LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 558 l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~ 608 (692)
+......+.+|+.+||+.||++|||+.|++ .++|..
T Consensus 238 --------~~~~s~~~~~li~~~L~~dp~~R~t~~ell-------~hp~~~ 273 (288)
T d2jfla1 238 --------PSRWSSNFKDFLKKCLEKNVDARWTTSQLL-------QHPFVT 273 (288)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-------TSGGGC
T ss_pred --------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCCCCC
T ss_conf --------566999999999997669966891999996-------292318
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=349.88 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=210.3
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 5136755405311461999999991-898999999122893008999999999981899970016799984890089997
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 400 (692)
.-++|.+.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 86575898898407681999999889998999999845243169999999999986799799929999998999999998
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCC
Q ss_conf 08999888997420599999888999999999999998733899928537789966883--9996599421477458778
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD--YNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld--~~~~~ki~DFGla~~~~~~ 478 (692)
|+++|+|.+++.... ..+++..+..|+.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 104 ~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 579988999997623-789999999999999999999975---6976000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 87532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.... ..
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~--~~-- 246 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNM--DD-- 246 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCS--CC--
T ss_pred --CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCC--CC--
T ss_conf --432000686242188997589987267655465999999859899899799-------99999998478898--94--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 867773398899999999998014699999999999999984220133345
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~ 609 (692)
.........+.+|+.+||+.||++|||+.|+++ ++|...
T Consensus 247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~-------hp~~~~ 285 (350)
T d1koaa2 247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE-------HPWLTP 285 (350)
T ss_dssp -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH-------STTTSC
T ss_pred -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC-------CCCCCC
T ss_conf -----223589999999999975689667908999862-------913288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.97 Aligned_cols=257 Identities=22% Similarity=0.290 Sum_probs=206.8
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 136755405311461999999991-89899999912289-3008999999999981899970016799984890089997
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 400 (692)
.++|...+.||+|+||+||+++.. +++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC-
Q ss_conf 0899988899742059999988899999999999999873389992853778996688399965994214774587788-
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES- 479 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~- 479 (692)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 45898089997537--999999999999999999999997---5983575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 753236779999999210012778-9846254235889998837954578899541007999999951585441346668
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHL-SDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
........||+.|+|||++.+..+ +.++||||||++||||++|+.||+........ .. ..........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~-~~~~~~~~~~----- 227 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YS-DWKEKKTYLN----- 227 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HH-HHHTTCTTST-----
T ss_pred CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH-----HH-HHHCCCCCCC-----
T ss_conf 531113255747428728618999997101617379999998299788889859999-----99-9863888788-----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 86777339889999999999801469999999999999998422013334
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~ 608 (692)
........+.+|+.+||+.+|++|||++|++ .++|..
T Consensus 228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil-------~hpwf~ 264 (271)
T d1nvra_ 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIK-------KDRWYN 264 (271)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-------TCTTTT
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHC
T ss_conf ------6446999999999997679966890999996-------198458
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.77 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=206.9
Q ss_pred CEEECCCCCEEEEEEEEECC----CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CEEEEEEEEC
Q ss_conf 40531146199999999189----89999991228-930089999999999818999700167999848-9008999708
Q 005536 329 KHRLGTGAYGTVYAGKLHND----DWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-GEPILVYEFM 402 (692)
Q Consensus 329 ~~~LG~G~~g~Vykg~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~ 402 (692)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|++++++++||||++++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC--
Q ss_conf 999888997420599999888999999999999998733899928537789966883999659942147745877887--
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS-- 480 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~-- 480 (692)
++|+|.+++... ...+++..+++++.|+|.||.|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ECCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf 067414421013-4540489999999998876520033---676257766875767799988991065232255665553
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf -5323677999999921001277898462542358899988379545788995410079999999515854413466688
Q 005536 481 -HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.......||+.|+|||.+....++.++||||||+++|||+|++.|+.......+ ....+..+.... .+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i~~g~~~~--~p--- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLL--QP--- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCC--CC---
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCC--CC---
T ss_conf 1002565556455676887437999745746619999999978999988899999------999998089889--96---
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 6777339889999999999801469999999999999998422013
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~ 605 (692)
......+.+|+.+||+.+|++||+|.||++.|+.+...-
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf -------447599999999976889768939999999999999752
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.12 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=206.0
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEEE
Q ss_conf 36755405311461999999991-89899999912289--3008999999999981899970016799984--8900899
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE--EGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 398 (692)
++|...+.||+|+||+||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 9708999888997420--5999998889999999999999987338--99928537789966883999659942147745
Q 005536 399 YEFMPNGTLCQHLQRE--RGSGLPWTIRITIATETAQAIAYLHSAM--NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 87788753236779999999210012778984625423588999883795457889954100799999995158544134
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~ 554 (692)
.... ........||+.|+|||++.+..++.++||||||+++|||+||+.||..... ......+.++....+.
T Consensus 164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~~~ 235 (269)
T d2java1 164 LNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRRIP 235 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCCC
T ss_pred CCCC-CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCCCC
T ss_conf 2457-7755667788232799998399999389887527899998018899899899-------9999999718998897
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 666886777339889999999999801469999999999999
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 236 ------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 ------------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ------------435999999999976799557918999972
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.19 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=208.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEEC-CC----EEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 367554053114619999999918-98----9999991228-93008999999999981899970016799984890089
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHN-DD----WVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 397 (692)
..|+..+.||+|+||+||+|++.. ++ .||+|+++.. +....++|.+|+.++++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99708999888997420599999888999999999999998733899928537789966883999659942147745877
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~ 477 (692)
++||+.+|+|.+++... ...+++..+++|+.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 99842687401011133-4579999999999999999999987---6950476212031167998758602552223354
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 8875-3236779999999210012778984625423588999883-7954578899541007999999951585441346
Q 005536 478 ESSH-ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 478 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d 555 (692)
.... ......||+.|+|||++.+..++.++||||||++||||+| |+.||+..... + ....+..+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~------~~~~i~~~~~~~--- 233 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E------ISSILEKGERLP--- 233 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-G------HHHHHHHTCCCC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-H------HHHHHHCCCCCC---
T ss_conf 445322365105864467088746999835654407999999997799999999989-9------999997599899---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 66886777339889999999999801469999999999999998422013
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~ 605 (692)
.+......+.+|+.+||+.+|.+||||.++++.|+.+...+
T Consensus 234 ---------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 234 ---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp ---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred ---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCH
T ss_conf ---------98556899999999847899346919999999999987586
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.10 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=216.1
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 36755405311461999999991-8989999991228---9300899999999998189997001679998489008999
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||+||+++.. +++.||||.+... +....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 70899988899742059999988899999999999999873389992853778996688399965994214774587788
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 704898777765315--999999999999999999976216---508847677412366888538860321024225677
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf -7532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 480 -SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 480 -~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+.++... +
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~-~----- 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYD-F----- 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCC-C-----
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC-C-----
T ss_conf 64333555677552584400268989666230456999998038899899599-------9999999718999-9-----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 867773398899999999998014699999999999999984220133345335
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIYM 612 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~~~ 612 (692)
+......+.+|+.+||+.||++|||++|++.. ..++.++|..++.+
T Consensus 230 -------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 230 -------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPLKAHPFFESVTW 275 (288)
T ss_dssp -------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HHHHTSGGGTTCCC
T ss_pred -------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC-HHHHCCCCCCCCCH
T ss_conf -------85479999999999855797689197897377-89876976478998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.51 Aligned_cols=245 Identities=29% Similarity=0.384 Sum_probs=204.4
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 36755405311461999999991-8989999991228---9300899999999998189997001679998489008999
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||+||+++.. +++.||+|.+... +....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 70899988899742059999988899999999999999873389992853778996688399965994214774587788
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~ 479 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC-
T ss_conf 504798589887504--899999999999999999999998---89465220234414668998711555633544888-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 75323677999999921001277898462542358899988379545788995410079999999515854413466688
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
......||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+.++...
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~-------- 222 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEFT-------- 222 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCC--------
T ss_pred --CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHCCCCC--------
T ss_conf --52355788763499997589989314404675999998329999888999-------9999999718999--------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 6777339889999999999801469999999999999
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
.+....+.+.+|+.+||+.||++|||+.|+++
T Consensus 223 -----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----98668999999999976479768909999971
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.76 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=196.3
Q ss_pred CCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCEEEEEE
Q ss_conf 55405311461999999991-8989999991228--93008999999999981899970016799984----89008999
Q 005536 327 SEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE----EGEPILVY 399 (692)
Q Consensus 327 ~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 399 (692)
...++||+|+||+||+++.. ++..||+|++... .....+.|.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEEECCCCCCCCC
Q ss_conf 708999888997420599999888999999999999998733899928537789966883-9996599421477458778
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD-YNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld-~~~~~ki~DFGla~~~~~~ 478 (692)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC-
T ss_conf 578989489997513--5546999999999999999999978-997996876743511667999889800576542368-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 87532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
.......||+.|+|||++.+ +++.++||||||+++|||++|+.||...... ......+..+......+.
T Consensus 168 --~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~~-- 236 (270)
T d1t4ha_ 168 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDK-- 236 (270)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGG--
T ss_pred --CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHCCCCCCCCCC--
T ss_conf --76677553813008988478-9998671100799999998788999876559------999999973899865675--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 86777339889999999999801469999999999999
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
....++.+|+.+||+.+|++|||+.|+++
T Consensus 237 ---------~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 ---------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---------57899999999976379758929999967
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.13 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=209.0
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECC-C--EEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCEEEEE
Q ss_conf 3675540531146199999999189-8--9999991228-930089999999999818-999700167999848900899
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHND-D--WVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~~~-~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 398 (692)
++|...+.||+|+||+||+|++.++ . .||||+++.. .....+.|.+|+++++++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 9708999888997420--------------59999988899999999999999873389992853778996688399965
Q 005536 399 YEFMPNGTLCQHLQRE--------------RGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRS 464 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 464 (692)
+||+++|+|.++|+.. ....+++..+++++.|+|.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCCE
T ss_conf 98028986999986403555551231012345789999999999999999876630---895455505204898688763
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCCCCHHHHHHH
Q ss_conf 994214774587788753236779999999210012778984625423588999883795-4578899541007999999
Q 005536 465 KVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALK-VVDFSRPHSEVNLAALAID 543 (692)
Q Consensus 465 ki~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~-p~~~~~~~~~~~l~~~~~~ 543 (692)
||+|||+++..... .......||..|+|||.+....++.++||||||+++|||++|.. |+... . ......
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~------~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T------CAELYE 237 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-C------HHHHHH
T ss_pred EECCCCCCCCCCCC--CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC-C------HHHHHH
T ss_conf 87434432244422--34553013775555387526999962215313889999983689999999-9------999999
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 9515854413466688677733988999999999980146999999999999999842201
Q 005536 544 RIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 544 ~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
.+.++...+ .+......+.+|+.+||+.+|++||||.+|++.|+++...
T Consensus 238 ~i~~~~~~~------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQGYRLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGTCCCC------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHCCCCC------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 998268888------------8766789999999997678966894999999999999861
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=347.63 Aligned_cols=259 Identities=19% Similarity=0.257 Sum_probs=210.7
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 5136755405311461999999991-898999999122893008999999999981899970016799984890089997
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 400 (692)
..+.|...+.||+|+||+||+++.. +++.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 54035998999317782999999989997999999887264679999999999986799798919999998999999998
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCC
Q ss_conf 08999888997420599999888999999999999998733899928537789966883--9996599421477458778
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD--YNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld--~~~~~ki~DFGla~~~~~~ 478 (692)
|+++|+|.+++... ...+++..++.|+.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 28998088889863-8998999999999999999999997---7926513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 87532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
.......||+.|+|||++.+..++.++||||+|++||||+||+.||...... .....+.++... . ...
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~-~-~~~- 250 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWE-F-DED- 250 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCCC-C-CSS-
T ss_pred --CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHCCCC-C-CCC-
T ss_conf --7201004764534899974799897633389899999999688998997999-------999999847889-8-930-
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 867773398899999999998014699999999999999984220133345
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~ 609 (692)
........+.+|+.+||+.+|.+|||+.|++ .++|...
T Consensus 251 ------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil-------~Hp~~~~ 288 (352)
T d1koba_ 251 ------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL-------EHPWLKG 288 (352)
T ss_dssp ------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-------TSTTTSS
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCC
T ss_conf ------0247999999999997569966891899996-------0973488
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.30 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=209.5
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CEEEEEEE
Q ss_conf 51367554053114619999999918989999991228930089999999999818999700167999848-90089997
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-GEPILVYE 400 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E 400 (692)
..++|...+.||+|+||.||+|++ .++.||||+++.. ...+.|.+|++++++++||||++++|++.+. +..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 789948857982079808999999-9909999998857--7799999999999867898985498788723892899996
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 08999888997420599999888999999999999998733899928537789966883999659942147745877887
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~ 480 (692)
|+++|+|.++|.......++|..+++|+.|++.||.|||+ ++|+||||||+|||++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCC---
T ss_conf 3699989999874578888999999999999852321133---7655366656760146899776324560034478---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 53236779999999210012778984625423588999883-79545788995410079999999515854413466688
Q 005536 481 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
......+|..|+|||++.+..++.++||||||+++|||+| |+.|+..... .+ ....+.++...++
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~------~~~~i~~~~~~~~------ 221 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD------VVPRVEKGYKMDA------ 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GG------HHHHHTTTCCCCC------
T ss_pred -CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-HH------HHHHHHCCCCCCC------
T ss_conf -776556664677817872798885887775799999999789999999999-99------9999980899999------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 6777339889999999999801469999999999999998422013
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSS 605 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~ 605 (692)
+......+.+|+.+||+.||.+||||.+++++|++++.+.
T Consensus 222 ------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 222 ------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ------7657999999999975669768939999999999998677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.72 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=213.0
Q ss_pred HHHHCCCCCCEEECCCCCEEEEEEEEEC----CCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
Q ss_conf 8751367554053114619999999918----9899999912289-3008999999999981899970016799984890
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLHN----DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE 394 (692)
Q Consensus 320 ~~~t~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 394 (692)
|...++|...+.||+|+||.||+|++.. +..||||.++... ....+.|.+|+.++++++||||++++|++. .+.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCE
T ss_conf 7688996987799307882999999936996449999999365668799999999999998689999856988995-374
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 08999708999888997420599999888999999999999998733899928537789966883999659942147745
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 799998406980776542247-899999999999999877523022---6744141026553206789678765034213
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 87788753236779999999210012778984625423588999883-79545788995410079999999515854413
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIGRGCVDEI 553 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei 553 (692)
.............||+.|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ....+.++....+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~~~ 230 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM 230 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCCC
T ss_pred CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCCCCC
T ss_conf 367762330540058310326675169988745244424789999826999988899999-------9999981899989
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 466688677733988999999999980146999999999999999842201
Q 005536 554 IDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 554 ~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
+...+..+.+|+.+||..+|++|||+.+|++.|+.+...
T Consensus 231 ------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 ------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ------------877799999999997687976892999999999999778
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.12 Aligned_cols=270 Identities=22% Similarity=0.319 Sum_probs=203.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EEEEEE
Q ss_conf 3675540531146199999999189899999912289300899999999998189997001679998489----008999
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG----EPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 399 (692)
+.|...++||+|+||+||+|++ +++.||||+++... .....+..|+..+.+++||||++++|++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-99899999987200-467999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 7089998889974205999998889999999999999987338-----99928537789966883999659942147745
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM-----NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
||+++|+|.++|++. .++|..+++++.|+|.||+|||+.. .++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
T ss_conf 646698989998658---99989999999999999999887665204689866153173135786887768876386623
Q ss_pred CCCCCCC---CCCCCCCCCCCCCCCCCCCC------CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCC----CC----CH
Q ss_conf 8778875---32367799999992100127------78984625423588999883795457889954----10----07
Q 005536 475 GMTESSH---ISTAPQGTPGYLDPQYHQYF------HLSDKSDVYSFGVVLIEIITALKVVDFSRPHS----EV----NL 537 (692)
Q Consensus 475 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGviL~Elltg~~p~~~~~~~~----~~----~l 537 (692)
....... ......||+.|+|||++.+. .++.++||||||++||||+||..|+....... +. ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred CCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCH
T ss_conf 46777620013552503547678221056545467776750122015999999962899887663112410122556430
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 9999999515854413466688677733988999999999980146999999999999999842201
Q 005536 538 AALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 538 ~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
.......... +..+|.+.. .....+....+.+|+.+||+.+|++||||.||++.|+++...
T Consensus 238 ~~~~~~~~~~----~~~~p~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCE----QKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTT----SCCCCCCCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHC----CCCCCCCCC--CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 9999998750----246888776--557768999999999997606985895999999999988886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=350.66 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=199.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 136755405311461999999991-89899999912289---30089999999999818999700167999848900899
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 398 (692)
.+.|+..+.||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 78567627970188809999999899939999998444435889999999999999977899982389999989988999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 97089998889974205999998889999999999999987338999285377899668839996599421477458778
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~ 478 (692)
|||+++|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 9806999457899737--999999999999999999999986---8976667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 8753236779999999210012---7789846254235889998837954578899541007999999951585441346
Q 005536 479 SSHISTAPQGTPGYLDPQYHQY---FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d 555 (692)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... . ....+..+.......
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~-~~~~i~~~~~~~~~~ 236 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------S-ALYHIAQNESPALQS 236 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSCCCCCSC
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHHCCCCCCCC
T ss_conf ----87313476636889983467888672145455899999998788999997999------9-999998289998887
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 66886777339889999999999801469999999999999
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
. ...+.+.+|+.+||+.||.+|||+.|+++
T Consensus 237 -------~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 -------G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------C----CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -------8----88999999999977379657918999971
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=351.29 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=208.6
Q ss_pred HHHHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 875136755405311461999999991-89899999912289-3008999999999981899970016799984890089
Q 005536 320 EKATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 320 ~~~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 397 (692)
+...+.|...+.||+|+||+||+++.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 87766669988994065839999999999989999998157731289999999999986799899919899998998889
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCC
Q ss_conf 99708999888997420599999888999999999999998733899928537789966883---999659942147745
Q 005536 398 VYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD---YNYRSKVADFGLSRL 474 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~ki~DFGla~~ 474 (692)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+. +++.+||+|||+++.
T Consensus 85 vmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 88526898488865303--678878999999999999875241---3055687046300110468882499831543587
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 87788753236779999999210012778984625423588999883795457889954100799999995158544134
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII 554 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~ 554 (692)
... ........||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+.++... ..
T Consensus 160 ~~~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~-~~ 229 (307)
T d1a06a_ 160 EDP--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFEQILKAEYE-FD 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHTTCCC-CC
T ss_pred CCC--CCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC-CC
T ss_conf 258--9704400328422591887379998078734515999999859799999899-------9999998616877-78
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 666886777339889999999999801469999999999999998422013334
Q 005536 555 DPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 555 d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~ 608 (692)
.+ ........+.+|+.+||+.+|++|||+.|++ .++|..
T Consensus 230 ~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil-------~hp~~~ 268 (307)
T d1a06a_ 230 SP--------YWDDISDSAKDFIRHLMEKDPEKRFTCEQAL-------QHPWIA 268 (307)
T ss_dssp TT--------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH-------HSTTTT
T ss_pred CC--------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHC
T ss_conf 76--------6667899999999997608975791899986-------298447
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.45 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=209.2
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
Q ss_conf 5136755405311461999999991-89899999912289------3008999999999981899970016799984890
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD------TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGE 394 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 394 (692)
..+.|...+.||+|+||+||+++.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEEC
Q ss_conf 08999708999888997420599999888999999999999998733899928537789966883999----65994214
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY----RSKVADFG 470 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~----~~ki~DFG 470 (692)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEECCCCCCCCCHHCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99999867786431001035--642155789999999999876662---5422113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 77458778875323677999999921001277898462542358899988379545788995410079999999515854
Q 005536 471 LSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 471 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 550 (692)
+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+..
T Consensus 163 ~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY 233 (293)
T ss_dssp TCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCC
T ss_pred HHHHCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHHCCC
T ss_conf 42105777--6312247777430999981899997665221409999997088998899999-------99999981688
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 4134666886777339889999999999801469999999999999998422013334533
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~~ 611 (692)
.- . ..........+.+|+.+||+.||++|||+.|++ .++|.....
T Consensus 234 ~~-~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil-------~hp~~~~~~ 278 (293)
T d1jksa_ 234 EF-E--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL-------QHPWIKPKD 278 (293)
T ss_dssp CC-C--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH-------HSTTTCC--
T ss_pred CC-C--------CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCCCCCCCC
T ss_conf 88-7--------010478899999999998638966891999996-------190418887
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.13 Aligned_cols=270 Identities=24% Similarity=0.313 Sum_probs=213.9
Q ss_pred CCHHHHHHHHCCCCCCEEECCCCCEEEEEEEEEC------CCEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 8968898751367554053114619999999918------989999991228-930089999999999818-99970016
Q 005536 314 YPYKEIEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYR-DTDSIDQVMNEIKLLSSV-SHPNLLRL 385 (692)
Q Consensus 314 ~~~~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 385 (692)
+...+++...++|...++||+|+||.||+|+... ++.||||+++.. .....+.+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEE
T ss_conf 89825261679979844984167839999998677755578399999986001717899999999998861499849974
Q ss_pred EEEEEEC-CEEEEEEEECCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 7999848-90089997089998889974205--------------99999888999999999999998733899928537
Q 005536 386 LGCCIEE-GEPILVYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRD 450 (692)
Q Consensus 386 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrD 450 (692)
++++.+. ...++||||+++|+|.++++... ...+++..++.++.|++.||+|||+ ++|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCC
T ss_conf 1154047975799998458992999998536666653222023321468999999999999999998873---7971786
Q ss_pred CCCCCEEECCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCC
Q ss_conf 789966883999659942147745877887-5323677999999921001277898462542358899988379-54578
Q 005536 451 IKSSNILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITAL-KVVDF 528 (692)
Q Consensus 451 ik~~NILld~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~-~p~~~ 528 (692)
|||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+..++.++||||||+++|||+|+. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCC
T ss_conf 77310657799828984575200113566522247516672102036864688996632213678999998688999989
Q ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 8995410079999999515854413466688677733988999999999980146999999999999999842201
Q 005536 529 SRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 529 ~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
..... .....+.++...++. ......+.+++.+||+.+|++||||.|++++|+.+..+
T Consensus 240 ~~~~~------~~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDE------EFCRRLKEGTRMRAP------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSH------HHHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHCCCCCCCC------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99899------999999638988888------------65789999999997677966791999999999799867
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.32 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=208.5
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 136755405311461999999991-8989999991228---930089999999999818999700167999848900899
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 398 (692)
.++|...+.||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 97089998889974205999998889999999999999987338999285377899668839996599421477458778
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~ 478 (692)
|||+++|+|.+++.... .+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 00357986055553256--77599999999999652113431---59622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 87532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+..+...
T Consensus 159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~~~~------- 223 (337)
T d1o6la_ 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEIR------- 223 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC-------
T ss_pred -CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC-------
T ss_conf -8620551008899666650489888333102230678899878999999699-------9999998528998-------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 8677733988999999999980146999999999999999842201333453
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
.+.....++.+|+.+||+.||.+||+.... .++++..++|..++
T Consensus 224 ------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~--~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 224 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPS--DAKEVMEHRFFLSI 267 (337)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTT--THHHHHTSGGGTTC
T ss_pred ------CCCCCCHHHHHHHHHHCCCCCHHHCCCCCC--CHHHHHCCCCCCCC
T ss_conf ------986689999999986663893442256523--49999729150369
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.82 Aligned_cols=271 Identities=24% Similarity=0.333 Sum_probs=214.8
Q ss_pred CCCH-HHHHHHHCCCCCCEEECCCCCEEEEEEEEEC------CCEEEEEEEECCC-CHHHHHHHHHHHHHHHC-CCCCEE
Q ss_conf 8896-8898751367554053114619999999918------9899999912289-30089999999999818-999700
Q 005536 313 FYPY-KEIEKATSFFSEKHRLGTGAYGTVYAGKLHN------DDWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLL 383 (692)
Q Consensus 313 ~~~~-~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv 383 (692)
.+++ .+++...++|...+.||+|+||.||+|++.. +..||||+++... .....+|.+|+.++.++ +||||+
T Consensus 11 ~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp TSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEE
T ss_conf 48984026377899698549820688299999980664477886999999874248779999999999987626999887
Q ss_pred EEEEEEEECCEEEEEEEECCCCCHHHHHHHCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 167999848900899970899988899742059----------------9999888999999999999998733899928
Q 005536 384 RLLGCCIEEGEPILVYEFMPNGTLCQHLQRERG----------------SGLPWTIRITIATETAQAIAYLHSAMNPPIY 447 (692)
Q Consensus 384 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ii 447 (692)
+++|++.+.+..++||||+++|+|.++++.... ..+++..++.++.|++.||+|||+ ++++
T Consensus 91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~iv 167 (311)
T d1t46a_ 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI 167 (311)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred EEEEEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEE
T ss_conf 8998983199789999737998799999853566544444533222334588999999999999999998875---7926
Q ss_pred ECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCC
Q ss_conf 537789966883999659942147745877887-5323677999999921001277898462542358899988379545
Q 005536 448 HRDIKSSNILLDYNYRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVV 526 (692)
Q Consensus 448 HrDik~~NILld~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~ 526 (692)
||||||+|||++.++.+|++|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+|+..|+
T Consensus 168 HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ECCCCCCCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 66241021000025752102340102336788615862013596876778861799997400102589999998589988
Q ss_pred CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78899541007999999951585441346668867773398899999999998014699999999999999984220
Q 005536 527 DFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 527 ~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~ 603 (692)
.......+. +...+..+..... +......+.+|+.+||+.+|++||||.+|+++|+++..
T Consensus 248 ~~~~~~~~~-----~~~~i~~~~~~~~------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 248 YPGMPVDSK-----FYKMIKEGFRMLS------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp STTCCSSHH-----HHHHHHHTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHH-----HHHHHHCCCCCCC------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 778998999-----9999866898898------------54365999999999757796579299999999987653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.13 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=214.2
Q ss_pred HHHHHHHCCCCCCEEECCCCCEEEEEEEEE------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEE
Q ss_conf 889875136755405311461999999991------8989999991228-930089999999999818999700167999
Q 005536 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLH------NDDWVAIKRFRYR-DTDSIDQVMNEIKLLSSVSHPNLLRLLGCC 389 (692)
Q Consensus 317 ~el~~~t~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 389 (692)
++++...++|...++||+|+||+||+|.+. +++.||||+++.. .......|.+|+.++++++||||++++|++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 10042689918835982078818999998786447789689999987012868999999999999976999884125478
Q ss_pred EECCEEEEEEEECCCCCHHHHHHHCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 84890089997089998889974205--------9999988899999999999999873389992853778996688399
Q 005536 390 IEEGEPILVYEFMPNGTLCQHLQRER--------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN 461 (692)
Q Consensus 390 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~ 461 (692)
......++||||+++|+|.+++...+ ...+++..+++++.|+|.||.|||+ ++|+||||||+|||+|.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCC
T ss_conf 42881067776048998899987503321134446887999999999999999998764---796543286775403599
Q ss_pred CCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCCCCHHH
Q ss_conf 9659942147745877887-5323677999999921001277898462542358899988379-5457889954100799
Q 005536 462 YRSKVADFGLSRLGMTESS-HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITAL-KVVDFSRPHSEVNLAA 539 (692)
Q Consensus 462 ~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~-~p~~~~~~~~~~~l~~ 539 (692)
+++||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|++ .|+.... ...
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~ 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQ 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHH
T ss_pred CEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC------HHH
T ss_conf 64999424542023577630313402316323788887369988333444378999999968999999989------999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9999951585441346668867773398899999999998014699999999999999984220
Q 005536 540 LAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 540 ~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~ 603 (692)
....+.++...++. ......+.+|+.+||+.+|++||||.+|+++|++...
T Consensus 244 -~~~~i~~~~~~~~p------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 -VLRFVMEGGLLDKP------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -HHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHHHCCCCCCC------------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf -99999808888886------------3353999999999757796589399999999787617
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=342.63 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=206.4
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 36755405311461999999991-8989999991228---9300899999999998189997001679998489008999
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 70899988899742059999988899999999999999873389992853778996688399965994214774587788
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~ 479 (692)
||+++|+|..++... ..+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC-
T ss_conf 503786322343222--211100799999999876554124---76770556810503868998898317521671245-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 75323677999999921001277898462542358899988379545788995410079999999515854413466688
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
.....||+.|+|||++.+..++.++||||+|++||||++|+.||..... .....++..+...
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~-------- 219 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAELR-------- 219 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCCC--------
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC--------
T ss_conf ---6434576343599998389998043046533368999759899999699-------9999999708988--------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 677733988999999999980146999999-----9999999998422013334533
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----sm~ev~~~L~~i~~~~~~~~~~ 611 (692)
.+......+.+++.+||..+|.+|+ ++++++ .++|..++.
T Consensus 220 -----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il-------~Hp~f~~i~ 264 (316)
T d1fota_ 220 -----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK-------NHPWFKEVV 264 (316)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH-------TSGGGSSCC
T ss_pred -----CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHH-------CCCCCCCCC
T ss_conf -----997789999999999954499766643102199998-------193514679
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=340.40 Aligned_cols=260 Identities=18% Similarity=0.219 Sum_probs=200.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC---CHHHHHHH---HHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 36755405311461999999991-89899999912289---30089999---9999998189997001679998489008
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVM---NEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~~ 396 (692)
++|...+.||+|+||.||+++.. +++.||+|.+.... ......+. .++.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99970899988899742059999988899999999999999873389992853778996688399965994214774587
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~ 476 (692)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 999914898389998732--553278999999999999999997---796220444221678588967982201023337
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 788753236779999999210012-7789846254235889998837954578899541007999999951585441346
Q 005536 477 TESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIID 555 (692)
Q Consensus 477 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d 555 (692)
.. ......||+.|+|||++.. ..++.++|||||||+||||+||+.||......... ...........
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~~~~----- 226 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAV----- 226 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSSSCCC-----
T ss_pred CC---CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHCCCCCC-----
T ss_conf 88---6433113455421687603899984410467789999998599988889989999----99986046888-----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 6688677733988999999999980146999999999999999842201333453
Q 005536 556 PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 556 ~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
..+......+.+|+.+||+.||.+||++.+. ..+++..++|..++
T Consensus 227 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~--~a~eil~Hp~f~~i 271 (364)
T d1omwa3 227 --------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGR--GAQEVKESPFFRSL 271 (364)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSS--THHHHHTSGGGTTC
T ss_pred --------CCCCCCCHHHHHHHHHHCCCCHHHHCCCCCC--CHHHHHCCCCCCCC
T ss_conf --------7887789999999999856698880887435--79999749102378
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=339.59 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=206.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 36755405311461999999991-8989999991228---9300899999999998189997001679998489008999
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 399 (692)
++|...+.||+|+||.||+++.. +++.||||++... +....+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 70899988899742059999988899999999999999873389992853778996688399965994214774587788
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTES 479 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~ 479 (692)
||+.+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred CCCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC--
T ss_conf 2334662266675158--989999999999999989999859---986176799993607789788610103332256--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 75323677999999921001277898462542358899988379545788995410079999999515854413466688
Q 005536 480 SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYLE 559 (692)
Q Consensus 480 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l~ 559 (692)
......||+.|+|||++.+..++.++|||||||+||||+||+.||....+ ......+..+....
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~~------- 257 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKVRF------- 257 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCC-------
T ss_pred --CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCC-------
T ss_conf --66433676356788997179988533114500789999758899899599-------99999986179889-------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHHHHCCCCCCC
Q ss_conf 677733988999999999980146999999-----999999999842201333453
Q 005536 560 PHRDAWTLSSIHNVAELAFRCLAFHRDMRP-----TMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 560 ~~~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----sm~ev~~~L~~i~~~~~~~~~ 610 (692)
+......+.+|+.+||+.||.+|+ ++++++ .++|...+
T Consensus 258 ------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell-------~Hp~f~~~ 300 (350)
T d1rdqe_ 258 ------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK-------NHKWFATT 300 (350)
T ss_dssp ------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH-------TSGGGTTC
T ss_pred ------CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHH-------CCCCCCCC
T ss_conf ------76689999999999834099860655345499997-------19051589
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.63 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=213.1
Q ss_pred HHHHHCCCCCCEEECCCCCEEEEEEEEECC--------CEEEEEEEECCC-CHHHHHHHHHHHHHHHC-CCCCEEEEEEE
Q ss_conf 987513675540531146199999999189--------899999912289-30089999999999818-99970016799
Q 005536 319 IEKATSFFSEKHRLGTGAYGTVYAGKLHND--------DWVAIKRFRYRD-TDSIDQVMNEIKLLSSV-SHPNLLRLLGC 388 (692)
Q Consensus 319 l~~~t~~f~~~~~LG~G~~g~Vykg~~~~~--------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~ 388 (692)
++...++|...+.||+|+||.||+++.... ..||||+++... .....++.+|+..+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCC
T ss_conf 72258996970098516782899999857875556675499999988112868899999999999981399969734652
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCC
Q ss_conf 984890089997089998889974205--------------999998889999999999999987338999285377899
Q 005536 389 CIEEGEPILVYEFMPNGTLCQHLQRER--------------GSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSS 454 (692)
Q Consensus 389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~ 454 (692)
+.+.+..++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+ ++|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred CCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCC
T ss_conf 201886899997369990999998606776432223345743467999999999999999987663---79786302210
Q ss_pred CEEECCCCCEEEEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCC
Q ss_conf 6688399965994214774587788-753236779999999210012778984625423588999883-79545788995
Q 005536 455 NILLDYNYRSKVADFGLSRLGMTES-SHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPH 532 (692)
Q Consensus 455 NILld~~~~~ki~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~ 532 (692)
|||++.++.+||+|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred CEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH-
T ss_conf 2245478976762211101135555543146678884663266751798882555477588888740179898999999-
Q ss_pred CCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 41007999999951585441346668867773398899999999998014699999999999999984220
Q 005536 533 SEVNLAALAIDRIGRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRV 603 (692)
Q Consensus 533 ~~~~l~~~~~~~~~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~ 603 (692)
....+.+..+...+. +......+.+|+.+||+.+|.+|||+.||++.|++|..
T Consensus 244 ------~~~~~~i~~~~~~~~------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ------EELFKLLKEGHRMDK------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ------HHHHHHHHTTCCCCC------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHCCCCCCC------------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------999999972888898------------74352999999999766797679399999999988860
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.02 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=205.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECC----CEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 3675540531146199999999189----89999991228---9300899999999998189997001679998489008
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHND----DWVAIKRFRYR---DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPI 396 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 396 (692)
++|...+.||+|+||.||+|++... ..||||+++.. +....++|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99970899988899742059999988899999999999999873389992853778996688399965994214774587
Q 005536 397 LVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGM 476 (692)
Q Consensus 397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~ 476 (692)
+|+||+++|+|.+++.... ..+++..++.++.|+|.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 1465423861254442126-899999999999999999987521---787520566888156556543325611555303
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHC-CCCCCC
Q ss_conf 78875--3236779999999210012778984625423588999883-7954578899541007999999951-585441
Q 005536 477 TESSH--ISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIIT-ALKVVDFSRPHSEVNLAALAIDRIG-RGCVDE 552 (692)
Q Consensus 477 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~e 552 (692)
..... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.... ... ....+. .+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~-~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQ-ILHKIDKEGERLP 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHH-HHHHHHTSCCCCC
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC------HHH-HHHHHHHCCCCCC
T ss_conf 588752654763257310799998379999421566148999999968999999969------999-9999984799999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 34666886777339889999999999801469999999999999998422
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIR 602 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~ 602 (692)
. +...+..+.+|+.+||+.+|++||||.+|.+.|++.+
T Consensus 236 ~------------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 236 R------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf 8------------5445399999999976889667929999999999649
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=336.14 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=210.9
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----
Q ss_conf 5136755405311461999999991-89899999912289---300899999999998189997001679998489----
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD---TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG---- 393 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 393 (692)
..++|...+.||+|+||+||+++.. +++.||||.++... ....+.|.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf 06206986899608992999999999998999999855664698999999999999985699988731143543268876
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 00899970899988899742059999988899999999999999873389992853778996688399965994214774
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~ 473 (692)
..++||||+++++|.+++... ..+++..++.|+.|++.||+|||+ ++|+||||||+|||++.+...+++|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEEECCCCCEEHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 699999778898710112035--899999999999999999999985---795276346755665754320100344432
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 58778--8753236779999999210012778984625423588999883795457889954100799999995158544
Q 005536 474 LGMTE--SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 474 ~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 551 (692)
..... .........||+.|+|||++.+..++.++||||||+++|||+||+.||....+ .......+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH------HHHHHHHHHCCCCC
T ss_conf 212354433334642576243699998399999663202652899999769799899699------99999998469999
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 13466688677733988999999999980146999999-99999999984220
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRP-TMMEVAEELEHIRV 603 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RP-sm~ev~~~L~~i~~ 603 (692)
.. . ........+.+++.+||+.||++|| +++++++.|.+++.
T Consensus 234 ~~---~-------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 PS---A-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp GG---G-------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CC---H-------HCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 71---0-------0347899999999998667976777399999999999758
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.73 Aligned_cols=253 Identities=22% Similarity=0.241 Sum_probs=197.4
Q ss_pred HHCCCCCCE-EECCCCCEEEEEEEE-ECCCEEEEEEEECCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCE
Q ss_conf 513675540-531146199999999-18989999991228930089999999999818-99970016799984----890
Q 005536 322 ATSFFSEKH-RLGTGAYGTVYAGKL-HNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSV-SHPNLLRLLGCCIE----EGE 394 (692)
Q Consensus 322 ~t~~f~~~~-~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~ 394 (692)
..++|.+.. .||+|+||+||+++. .+++.||||+++.. ..+.+|+.++.++ +||||+++++++.+ ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCE
T ss_conf 0148798107965454869999998899989999998974-----77999999999866999978298999503468978
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECC
Q ss_conf 089997089998889974205999998889999999999999987338999285377899668839---99659942147
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY---NYRSKVADFGL 471 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~ki~DFGl 471 (692)
.++||||+++|+|.+++.......+++..+..|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999977899849999986278775799999999999999999997---6986444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 74587788753236779999999210012778984625423588999883795457889954100799999995158544
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 551 (692)
++..... .......||+.|+|||++.+..++.++||||||++||||+||+.||......... ......+..+..
T Consensus 161 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~- 234 (335)
T d2ozaa1 161 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQY- 234 (335)
T ss_dssp CEECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred EEECCCC--CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH---HHHHHHHHCCCC-
T ss_conf 2333688--8643226775637927774898888888876451677886588998898877889---999999853888-
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 134666886777339889999999999801469999999999999
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
... .........++.+|+.+||+.+|++|||+.|+++
T Consensus 235 -------~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 -------EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------SCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------CCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -------889-8543469999999999975699657909999970
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.69 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=205.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 36755405311461999999991-8989999991228---9300899999999998-18999700167999848900899
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR---DTDSIDQVMNEIKLLS-SVSHPNLLRLLGCCIEEGEPILV 398 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV 398 (692)
++|...+.||+|+||+||+++.. +++.||||+++.. .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 97089998889974205999998889999999999999987338999285377899668839996599421477458778
Q 005536 399 YEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~ 478 (692)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEECCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 7503798089986404--7899999999999999999999868---9340347654044448996301555302323566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 87532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
....+...||+.|+|||++.+..++.++||||||+++|||++|+.||....+ ......+..+... .
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~------~ 222 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNPF------Y 222 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC------C
T ss_pred -CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC------C
T ss_conf -5334545787776899998279988323201122789898738899999899-------9999999718998------9
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 8677733988999999999980146999999999999999842201333453
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
+......+.+|+.+||..+|.+||++.. +++.++|...+
T Consensus 223 -------p~~~s~~~~dli~~~L~~dP~~R~s~~~------~l~~hpff~~~ 261 (320)
T d1xjda_ 223 -------PRWLEKEAKDLLVKLFVREPEKRLGVRG------DIRQHPLFREI 261 (320)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSBTTBS------CGGGSGGGTTC
T ss_pred -------CCCCCHHHHHHHHHHCCCCCCCCCCHHH------HHHHCCHHCCC
T ss_conf -------7567999999999965448987838899------99809013158
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.36 Aligned_cols=270 Identities=23% Similarity=0.357 Sum_probs=205.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 36755405311461999999991-89899999912289--3008999999999981899970016799984890089997
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 400 (692)
++|...++||+|+||+||+++.. +++.||+|+++... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 08999888997420599999888999999999999998733899928537789966883999659942147745877887
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~ 480 (692)
|+. +.+.+++.......+++..+..++.|++.||+|||+ ++|+||||||+|||++.+..+||+|||+|+.... ..
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-~~ 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PV 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-CS
T ss_pred ECC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCC-CC
T ss_conf 237-744555442025688889999999999999998652---8899213571140113467621035786134368-86
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC--
Q ss_conf 5323677999999921001277-8984625423588999883795457889954100799999995158544134666--
Q 005536 481 HISTAPQGTPGYLDPQYHQYFH-LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPY-- 557 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~-- 557 (692)
.......||+.|+|||...... ++.++||||+|+++|||++|+.||........ ........... .+...+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~--~~~~~~~~~ 231 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTP--DEVVWPGVT 231 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC--CTTTSTTGG
T ss_pred CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH---HHHHHHHCCCC--CHHHCCCCC
T ss_conf 4100103652154112213665777422103333134279668799898899999---99999832898--333144422
Q ss_pred ----CCCCC--------CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf ----88677--------733988999999999980146999999999999999842201333453
Q 005536 558 ----LEPHR--------DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 558 ----l~~~~--------~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
..... ..........+.+|+.+||+.||++|||+.|++ .++|..++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell-------~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL-------AHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH-------TSGGGTTC
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf 24212434543222204441667899999999997639955791899996-------78701469
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.39 Aligned_cols=266 Identities=24% Similarity=0.256 Sum_probs=199.6
Q ss_pred CEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 405311461999999991-8989999991228930-----0899999999998189997001679998489008999708
Q 005536 329 KHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTD-----SIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEFM 402 (692)
Q Consensus 329 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 402 (692)
.++||+|+||+||+++.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 99988899742059999988899999999999999873389992853778996688399965994214774587788753
Q 005536 403 PNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSHI 482 (692)
Q Consensus 403 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~~ 482 (692)
+++++..+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRA 156 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCC
T ss_pred CCHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC-CCC
T ss_conf 45077655412--6677899999999999999988631---63550357762588537784114657610005787-554
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC---
Q ss_conf 2367799999992100127-789846254235889998837954578899541007999999951585441346668---
Q 005536 483 STAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL--- 558 (692)
Q Consensus 483 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l--- 558 (692)
.....||+.|+|||++... .++.++||||||+++|||++|+.||......+ ......+.+.........+..-
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH---HHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf 3302047333639997267788805643630428999985969999999999---9999998518997254521000213
Q ss_pred ---CCCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf ---86777339-----88999999999980146999999999999999842201333453
Q 005536 559 ---EPHRDAWT-----LSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 559 ---~~~~~~~~-----~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
.......+ ......+.+|+.+||+.||++|||+.|++ .++|..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L-------~Hp~f~~~ 286 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL-------KMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH-------TSGGGTSS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf 443034789886785656899999999997638945690899996-------79965789
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.93 Aligned_cols=252 Identities=20% Similarity=0.237 Sum_probs=204.1
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 5136755405311461999999991-898999999122893008999999999981899970016799984890089997
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 400 (692)
..++|...+.||+|+||+||+++.. +++.||+|.++.. ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578-6659999999999985799798909899988998899995
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCCCCCCC
Q ss_conf 089998889974205999998889999999999999987338999285377899668839--996599421477458778
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY--NYRSKVADFGLSRLGMTE 478 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~--~~~~ki~DFGla~~~~~~ 478 (692)
|+++|+|.+++... +..+++..+..|+.|++.||.|||+ .+|+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred CCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC-
T ss_conf 38998088998753-8999999999999999999999987---699751355444344378851899764411100346-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 87532367799999992100127789846254235889998837954578899541007999999951585441346668
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEIIDPYL 558 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~d~~l 558 (692)
........+|+.|+|||...+..++.++||||+|+++|||++|+.||..... ......+.++... . +.
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~-~-~~-- 224 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYT-F-DE-- 224 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCC-C-CH--
T ss_pred -CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCC-C-CH--
T ss_conf -7753212233222340210487778401130279999999828999999899-------9999999838999-8-80--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 86777339889999999999801469999999999999
Q 005536 559 EPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAE 596 (692)
Q Consensus 559 ~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~ 596 (692)
.........+.+|+.+||..||++|||+.|+++
T Consensus 225 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 -----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----223678999999999986699668909999963
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=328.69 Aligned_cols=256 Identities=24% Similarity=0.280 Sum_probs=205.5
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCH---------HHHHHHHHHHHHHHCC-CCCEEEEEEEEEE
Q ss_conf 136755405311461999999991-8989999991228930---------0899999999998189-9970016799984
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTD---------SIDQVMNEIKLLSSVS-HPNLLRLLGCCIE 391 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 391 (692)
.++|...+.||+|+||+||+++.. +++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf 89008999708999888997420599999888999999999999998733899928537789966883999659942147
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGl 471 (692)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 76059999768986689999865--999999999999999999999987---5994323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 74587788753236779999999210012------778984625423588999883795457889954100799999995
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQY------FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRI 545 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 545 (692)
++..... .......||+.|+|||++.+ ..++.++||||+|++||||++|+.||....+ ......+
T Consensus 157 a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i 227 (277)
T d1phka_ 157 SCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMI 227 (277)
T ss_dssp CEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH
T ss_pred EEECCCC--CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCH-------HHHHHHH
T ss_conf 1672688--721345246788898886053445678899233185656023103228889889999-------9999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 158544134666886777339889999999999801469999999999999998422013334
Q 005536 546 GRGCVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 546 ~~~~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~ 608 (692)
.++... ...+ .......++.+|+.+||+.+|++||++.||+ .++|..
T Consensus 228 ~~~~~~-~~~~--------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil-------~h~~~~ 274 (277)
T d1phka_ 228 MSGNYQ-FGSP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL-------AHPFFQ 274 (277)
T ss_dssp HHTCCC-CCTT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT-------TSGGGC
T ss_pred HHCCCC-CCCC--------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHH
T ss_conf 818988-8985--------4346899999999997658966891999997-------397879
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.49 Aligned_cols=273 Identities=22% Similarity=0.322 Sum_probs=199.4
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-C-CCEEEEEEEECCC--CHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEE---
Q ss_conf 5136755405311461999999991-8-9899999912289--30089999999999818---99970016799984---
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-N-DDWVAIKRFRYRD--TDSIDQVMNEIKLLSSV---SHPNLLRLLGCCIE--- 391 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~--- 391 (692)
..++|...++||+|+||+||+++.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEE
Q ss_conf --890089997089998889974205999998889999999999999987338999285377899668839996599421
Q 005536 392 --EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADF 469 (692)
Q Consensus 392 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DF 469 (692)
....++++||++++.+..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCCEEEEEEEECCCCCHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECCH
T ss_conf 66746999997405871444443-037899989999999999999999975---88983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 47745877887532367799999992100127789846254235889998837954578899541007999999951585
Q 005536 470 GLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 470 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 549 (692)
|+++.... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||....+.+. ............
T Consensus 161 g~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred HHHHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHHCCCC
T ss_conf 01011002--3457776548511483100179888111000328999999878799899898999---999998407996
Q ss_pred CCCCCC----------CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 441346----------6688677733988999999999980146999999999999999842201333453
Q 005536 550 VDEIID----------PYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 550 ~~ei~d----------~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
...... ...............+.+.+|+.+||+.||++|||+.|++ .++|..++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L-------~Hpff~~i 299 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL-------SHPYFQDL 299 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH-------TSGGGTTC
T ss_pred HHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf 11053211110333022345645440445899999999998748966791899996-------69634075
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=327.49 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=201.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 3675540531146199999999189899999912289--30089999999999818999700167999848900899970
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYEF 401 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 401 (692)
++|...++||+|+||+||+++..+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 89998889974205999998889999999999999987338999285377899668839996599421477458778875
Q 005536 402 MPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESSH 481 (692)
Q Consensus 402 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~~ 481 (692)
+.++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+..... ...
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~-~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVR 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EHHHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCC-CCC
T ss_conf 0045678998604--7751445689999999999986057---488267877505686899787323664301146-765
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC------
Q ss_conf 32367799999992100127-78984625423588999883795457889954100799999995158544134------
Q 005536 482 ISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDEII------ 554 (692)
Q Consensus 482 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ei~------ 554 (692)
......+++.|+|||.+... .++.++||||||+++|||++|+.||......+. .................
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGST
T ss_pred CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH---HHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 410102431101378871788888410021117589999779799898898999---99999863899711042123332
Q ss_pred --CCCCC----CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf --66688----677733988999999999980146999999999999
Q 005536 555 --DPYLE----PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVA 595 (692)
Q Consensus 555 --d~~l~----~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~ 595 (692)
+.... .............+.+|+.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 21433333567646665125899999999998668966890999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.32 Aligned_cols=270 Identities=22% Similarity=0.297 Sum_probs=193.8
Q ss_pred CCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------EEEE
Q ss_conf 6755405311461999999991-89899999912289300899999999998189997001679998489------0089
Q 005536 325 FFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG------EPIL 397 (692)
Q Consensus 325 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 397 (692)
.|...++||+|+||+||+++.. +++.||||++...... +.+|+.++++++|+||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCCCC
Q ss_conf 9970899988899742-0599999888999999999999998733899928537789966883999-6599421477458
Q 005536 398 VYEFMPNGTLCQHLQR-ERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLG 475 (692)
Q Consensus 398 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~ki~DFGla~~~ 475 (692)
||||++++.+....+. .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 98416886078888631036899999999999999999999986---687645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHH--------HHHHHC
Q ss_conf 7788753236779999999210012-7789846254235889998837954578899541007999--------999951
Q 005536 476 MTESSHISTAPQGTPGYLDPQYHQY-FHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAAL--------AIDRIG 546 (692)
Q Consensus 476 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~--------~~~~~~ 546 (692)
... .......||..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....... .+....
T Consensus 174 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCC--CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf 477--653200255555682776404688821000246527785502879989879999999999974898177654306
Q ss_pred CCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 5854413466688--6777339889999999999801469999999999999998422013334533
Q 005536 547 RGCVDEIIDPYLE--PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNIY 611 (692)
Q Consensus 547 ~~~~~ei~d~~l~--~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~~ 611 (692)
... .+..-+... .............+.+|+.+||+.||++|||+.|++ .++|..+..
T Consensus 252 ~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L-------~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNY-TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC-------AHSFFDELR 310 (350)
T ss_dssp C----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH-------TSGGGGGGG
T ss_pred CCH-HHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCCC
T ss_conf 210-11035544567444431568999999999997658955792999996-------698452466
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.96 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=200.9
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-----
Q ss_conf 5136755405311461999999991-8989999991228--9300899999999998189997001679998489-----
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG----- 393 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 393 (692)
..++|...++||+|+||+||+++.. +++.||||+++.. +....+.+.+|+.++++++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf -0089997089998889974205999998889999999999999987338999285377899668839996599421477
Q 005536 394 -EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLS 472 (692)
Q Consensus 394 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla 472 (692)
..++||||+ +.+|...+.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 1599998405-5218999874---022699999999999999999873---78764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCC---
Q ss_conf 45877887532367799999992100127-78984625423588999883795457889954100799999995158---
Q 005536 473 RLGMTESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRG--- 548 (692)
Q Consensus 473 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 548 (692)
+.... ..+...||+.|+|||.+.+. .++.++||||+|+++|||++|+.||........... ........
T Consensus 169 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE---IMKVTGTPPAE 241 (346)
T ss_dssp EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCHH
T ss_pred ECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHH---HHHCCCCCCHH
T ss_conf 20687----631024553335889981787899650103003899999978699888976899999---98503788488
Q ss_pred ---------------CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf ---------------54413466688677733988999999999980146999999999999999842201333453
Q 005536 549 ---------------CVDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 549 ---------------~~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
...+.....+ ..........+.+|+.+||..||++|||+.|+++ ++|....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~-------Hp~f~~~ 307 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF----ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA-------HPYFESL 307 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG----GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH-------SGGGTTT
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCH----HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC-------CHHHCCC
T ss_conf 8865300034433115786665566----7755689999999999977299557929999963-------9623758
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.86 Aligned_cols=271 Identities=20% Similarity=0.240 Sum_probs=200.2
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------
Q ss_conf 136755405311461999999991-8989999991228--93008999999999981899970016799984--------
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIE-------- 391 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 391 (692)
-++|...++||+|+||+||+|+.. +++.||||++... .....+++.+|+.++++++|+|++++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf 89008999708999888997420599999888999999999999998733899928537789966883999659942147
Q 005536 392 EGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGL 471 (692)
Q Consensus 392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGl 471 (692)
.+..++|+||++++.+...... ...++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 7638999853578741012220--3443308999999999999988522---9988567672220366899687631350
Q ss_pred CCCCCCCCC---CCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 745877887---532367799999992100127-7898462542358899988379545788995410079999999515
Q 005536 472 SRLGMTESS---HISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGR 547 (692)
Q Consensus 472 a~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 547 (692)
++....... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHH---HHHHHHHCCC
T ss_conf 0223554443211356602497874289970799989178700678646617448799899899999---9999984189
Q ss_pred CCCCCCCCC----C----CC-CCCCCCCHH-------HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 854413466----6----88-677733988-------99999999998014699999999999999984220133345
Q 005536 548 GCVDEIIDP----Y----LE-PHRDAWTLS-------SIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASN 609 (692)
Q Consensus 548 ~~~~ei~d~----~----l~-~~~~~~~~~-------~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~ 609 (692)
. ..+.... . .. ......... ....+.+|+.+||+.||++|||++|++ .++|..+
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL-------~Hpff~~ 310 (318)
T d3blha1 241 I-TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL-------NHDFFWS 310 (318)
T ss_dssp C-CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH-------HSGGGSS
T ss_pred C-CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCC
T ss_conf 9-82553443203444332013344555033404445998999999998738965890999997-------4950156
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.50 Aligned_cols=272 Identities=20% Similarity=0.274 Sum_probs=201.3
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EE
Q ss_conf 513675540531146199999999-189899999912289-300899999999998189997001679998489----00
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKL-HNDDWVAIKRFRYRD-TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEG----EP 395 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~ 395 (692)
.+.+|...++||+|+||+||+++. .+++.||||++...+ ....+++++|+.++++++|||++++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 89997089998889974205999998889999999999999987338999285377899668839996599421477458
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLG 475 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~ 475 (692)
+++++++.+|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 9999962598656644058---99999999999999999999997---89867778764378879997787545705650
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 77887--5323677999999921001-27789846254235889998837954578899541007999999951585441
Q 005536 476 MTESS--HISTAPQGTPGYLDPQYHQ-YFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 476 ~~~~~--~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~e 552 (692)
..... .......||+.|+|||.+. ...++.++||||+|+++|||++|+.||......+.... ......... .+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~-~~ 235 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPS-QE 235 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCC-HH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHH---HHHHCCCCC-HH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998---765206997-56
Q ss_pred CC--------------CCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 34--------------66688-677733988999999999980146999999999999999842201333453
Q 005536 553 II--------------DPYLE-PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 553 i~--------------d~~l~-~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
.. .+... .............+.+|+.+||+.||.+|||+.|++ .++|....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L-------~hpf~~~~ 301 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL-------AHPYLEQY 301 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH-------TSGGGTTT
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf 6423433222202446775577877783789999999999997648956790899986-------19865558
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=312.85 Aligned_cols=263 Identities=17% Similarity=0.202 Sum_probs=201.0
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEE-EEEEEEECCEEEEEEE
Q ss_conf 136755405311461999999991-89899999912289300899999999998189997001-6799984890089997
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNLLR-LLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~E 400 (692)
-++|...+.||+|+||.||+|+.. +++.||||.+.... ..+++..|+++++.++|+|++. +.++..+.+..++|+|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 888999689850788099999998899899999972100--588899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCCCCC
Q ss_conf 08999888997420599999888999999999999998733899928537789966883---999659942147745877
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLD---YNYRSKVADFGLSRLGMT 477 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~ki~DFGla~~~~~ 477 (692)
|+ +++|.+.+... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+....
T Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EC-CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 73-87133324430-6887689999999999999999997---9944266787660643357776156504675134255
Q ss_pred CCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 887------53236779999999210012778984625423588999883795457889954100799999995158544
Q 005536 478 ESS------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD 551 (692)
Q Consensus 478 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 551 (692)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 13466688677733988999999999980146999999999999999842201
Q 005536 552 EIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 552 ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
+. ....+.++.+++.+||+.+|++||++.++.+.|+++...
T Consensus 239 ~~------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 239 VL------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HH------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 75------------347889999999998439955791999999999999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.57 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=197.0
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCC------HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf 136755405311461999999991-898999999122893------00899999999998189--997001679998489
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDT------DSIDQVMNEIKLLSSVS--HPNLLRLLGCCIEEG 393 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 393 (692)
.++|...+.||+|+||+||+++.. +++.||||+++.... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEEECC
Q ss_conf 00899970899-988899742059999988899999999999999873389992853778996688399-9659942147
Q 005536 394 EPILVYEFMPN-GTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYN-YRSKVADFGL 471 (692)
Q Consensus 394 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~ki~DFGl 471 (692)
..++|+||+.+ +++.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 6899998336862289998615--899999999999999999999987---79755667611147744788489775465
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 74587788753236779999999210012778-98462542358899988379545788995410079999999515854
Q 005536 472 SRLGMTESSHISTAPQGTPGYLDPQYHQYFHL-SDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCV 550 (692)
Q Consensus 472 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 550 (692)
++.... ...+...||+.|+|||++.+..+ +.++||||+|+++|||++|+.||.... .+.++..
T Consensus 158 a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~ 221 (273)
T d1xwsa_ 158 GALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV 221 (273)
T ss_dssp CEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC
T ss_pred CEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-------------HHHHCCC
T ss_conf 353244---455665658774799998489978865332554034536756889988736-------------7761544
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 413466688677733988999999999980146999999999999999842201333453
Q 005536 551 DEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 551 ~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
... . ....++.+|+.+||+.||++|||++|++ .++|..++
T Consensus 222 --~~~-------~----~~s~~~~~li~~~L~~dp~~R~s~~eil-------~hp~~~~~ 261 (273)
T d1xwsa_ 222 --FFR-------Q----RVSSECQHLIRWCLALRPSDRPTFEEIQ-------NHPWMQDV 261 (273)
T ss_dssp --CCS-------S----CCCHHHHHHHHHHTCSSGGGSCCHHHHH-------TSGGGSSC
T ss_pred --CCC-------C----CCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf --778-------7----7999999999997608975893999985-------39866788
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=310.63 Aligned_cols=263 Identities=16% Similarity=0.174 Sum_probs=207.3
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCEEEEEEE
Q ss_conf 136755405311461999999991-898999999122893008999999999981899-970016799984890089997
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E 400 (692)
.++|.+.+.||+|+||+||+|+.. +++.||||.+.... ..+.+.+|++.+..++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEEECCCCCC
Q ss_conf 089998889974205999998889999999999999987338999285377899668839-----996599421477458
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDY-----NYRSKVADFGLSRLG 475 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~-----~~~~ki~DFGla~~~ 475 (692)
|+ +++|.+++... +..+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EC-CCCHHHHHHHH-CCCHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 64-88879999752-0311068999999999999999997---7966266771315234754344795687236605771
Q ss_pred CCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 77887------532367799999992100127789846254235889998837954578899541007999999951585
Q 005536 476 MTESS------HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGC 549 (692)
Q Consensus 476 ~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 549 (692)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 46766541110246762775102679896488888699989831999999869876788530219999999970567999
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 4413466688677733988999999999980146999999999999999842201
Q 005536 550 VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVS 604 (692)
Q Consensus 550 ~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~ 604 (692)
..++. ...++++.+++..|+..+|++||+++.+.+.|+++...
T Consensus 237 ~~~l~------------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 237 LRELC------------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHT------------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHC------------CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 58965------------79989999999998439930085999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.89 Aligned_cols=272 Identities=22% Similarity=0.238 Sum_probs=206.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 36755405311461999999991-89899999912289--3008999999999981899970016799984890089997
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEEGEPILVYE 400 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 400 (692)
++|...++||+|+||+||+++.. +++.||||+++... ....+++.+|+.+++.++|+||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 08999888997420599999888999999999999998733899928537789966883999659942147745877887
Q 005536 401 FMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMTESS 480 (692)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~~~~~~~ 480 (692)
++.+++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.+..+||+|||.++..... .
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-C
T ss_pred ECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC-C
T ss_conf 02332221121235--654036789999999999877433---99860014676121133782665204601104688-7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC------CC
Q ss_conf 5323677999999921001277-8984625423588999883795457889954100799999995158544------13
Q 005536 481 HISTAPQGTPGYLDPQYHQYFH-LSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVD------EI 553 (692)
Q Consensus 481 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ei 553 (692)
.......++..|+|||.+.... ++.++||||||+++|||++|+.|+.......+ ............... ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 5100103443101466750698888044402654188998518999988999999--99999861189973551344322
Q ss_pred CCCC------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 4666------88677733988999999999980146999999999999999842201333453
Q 005536 554 IDPY------LEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 554 ~d~~------l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
.+.. ...............+.+|+.+||+.||.+|||++|++ .++|..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L-------~Hp~f~~~ 289 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL-------QHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT-------TSGGGSSC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf 211334445443104330656899999999998649966890999996-------49534079
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.23 Aligned_cols=259 Identities=23% Similarity=0.262 Sum_probs=205.0
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE----CCCEEEEEEEECC----CCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCE
Q ss_conf 36755405311461999999991----8989999991228----93008999999999981899-970016799984890
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH----NDDWVAIKRFRYR----DTDSIDQVMNEIKLLSSVSH-PNLLRLLGCCIEEGE 394 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 394 (692)
++|...+.||+|+||+||+++.. +++.||+|.++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 08999708999888997420599999888999999999999998733899928537789966883999659942147745
Q 005536 395 PILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
.++++||+.+|+|.+++.... .++......++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf 001231234117999987304--54378888889999999988514---9989654773201246999888741320222
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 877887532367799999992100127--789846254235889998837954578899541007999999951585441
Q 005536 475 GMTESSHISTAPQGTPGYLDPQYHQYF--HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 475 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~e 552 (692)
.............|++.|++||.+.+. .++.++||||||++||||++|+.||.......... ...........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~~~-- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSEP-- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHCCC--
T ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHCCCCCC--
T ss_conf 0344443221222333331068760577688713251777799999976899988887777999---99983356899--
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCC
Q ss_conf 34666886777339889999999999801469999999-----99999999842201333453
Q 005536 553 IIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPT-----MMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 553 i~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPs-----m~ev~~~L~~i~~~~~~~~~ 610 (692)
..+.....++.+++.+||+.+|++||+ ++|++ .++|...+
T Consensus 254 -----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil-------~Hpff~~i 298 (322)
T d1vzoa_ 254 -----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK-------EHLFFQKI 298 (322)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH-------TSGGGTTC
T ss_pred -----------CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHH-------CCHHHCCC
T ss_conf -----------8865479999999999744589881999745099997-------49723489
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.19 Aligned_cols=267 Identities=24% Similarity=0.291 Sum_probs=203.3
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------C
Q ss_conf 136755405311461999999991-8989999991228--930089999999999818999700167999848------9
Q 005536 323 TSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYR--DTDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE------G 393 (692)
Q Consensus 323 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 393 (692)
.++|.+.++||+|+||+||+|+.. +++.||||++... +....+++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 00899970899988899742059999988899999999999999873389992853778996688399965994214774
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~ 473 (692)
..++|+||+.+ ++.+.++ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEEECCCH-HHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 26999841446-7787650----3899999999999999999886522---11245677632113654431320102321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHC-------
Q ss_conf 5877887532367799999992100127789846254235889998837954578899541007999999951-------
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIG------- 546 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~------- 546 (692)
.... ....+...+|+.|+|||.+.+..++.++||||+|++++||++|+.||....... ..........
T Consensus 168 ~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 168 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred CCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH---HHHHHHHHCCCCCHHHH
T ss_conf 1466--655332214655558133147777877433356625789865989988897788---99999972058987999
Q ss_pred -----------CCC-------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf -----------585-------44134666886777339889999999999801469999999999999998422013334
Q 005536 547 -----------RGC-------VDEIIDPYLEPHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWAS 608 (692)
Q Consensus 547 -----------~~~-------~~ei~d~~l~~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~ 608 (692)
... .......................+.+|+.+||..||++|||++|++ .++|..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL-------~Hpw~~ 315 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL-------QHPYIN 315 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH-------TSTTTG
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCCCCC
T ss_conf 8765667777641754356664212643335432101333799999999998769945790899996-------694208
Q ss_pred C
Q ss_conf 5
Q 005536 609 N 609 (692)
Q Consensus 609 ~ 609 (692)
.
T Consensus 316 ~ 316 (355)
T d2b1pa1 316 V 316 (355)
T ss_dssp G
T ss_pred C
T ss_conf 7
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=306.25 Aligned_cols=267 Identities=19% Similarity=0.243 Sum_probs=197.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CEEEEEE
Q ss_conf 36755405311461999999991-89899999912289300899999999998189-99700167999848--9008999
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEE--GEPILVY 399 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~ 399 (692)
++|...++||+|+||+||+++.. +++.||||+++.. ..+++.+|+.++.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCCCCCCC
Q ss_conf 708999888997420599999888999999999999998733899928537789966883999-6599421477458778
Q 005536 400 EFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY-RSKVADFGLSRLGMTE 478 (692)
Q Consensus 400 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~ki~DFGla~~~~~~ 478 (692)
||+++++|..+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+. .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC
T ss_conf 631798589974-----6899999999999999999887643---34434564412377489983664156542664688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHH----------HHHHHHHCC
Q ss_conf 87532367799999992100127-7898462542358899988379545788995410079----------999999515
Q 005536 479 SSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLA----------ALAIDRIGR 547 (692)
Q Consensus 479 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~----------~~~~~~~~~ 547 (692)
.......+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||.......+.... .........
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf --744432248642476102688888845232335455587604889998876018999999998788415555542254
Q ss_pred CCC---CCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 854---41346668867-----7733988999999999980146999999999999999842201333453
Q 005536 548 GCV---DEIIDPYLEPH-----RDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 548 ~~~---~ei~d~~l~~~-----~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
... ........... ..........++.+|+.+||..||.+|||++|++ .++|...+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L-------~Hp~F~~v 325 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM-------EHPYFYTV 325 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH-------TSGGGTTS
T ss_pred CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCCCCCCC
T ss_conf 44743000003334331121155211244899999999998669956890899996-------49355887
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.35 Aligned_cols=268 Identities=20% Similarity=0.272 Sum_probs=200.7
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-----C
Q ss_conf 5136755405311461999999991-89899999912289--30089999999999818999700167999848-----9
Q 005536 322 ATSFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRD--TDSIDQVMNEIKLLSSVSHPNLLRLLGCCIEE-----G 393 (692)
Q Consensus 322 ~t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 393 (692)
.+++|...++||+|+||+||+++.. +++.||||++.... ....+++.+|+.++++++|+|++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 00899970899988899742059999988899999999999999873389992853778996688399965994214774
Q 005536 394 EPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSR 473 (692)
Q Consensus 394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~DFGla~ 473 (692)
..+++++|+.+|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||++.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEECCCCHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 649999962588623200224---53099999999999999999973---887651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 5877887532367799999992100127-789846254235889998837954578899541007999999951585441
Q 005536 474 LGMTESSHISTAPQGTPGYLDPQYHQYF-HLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAALAIDRIGRGCVDE 552 (692)
Q Consensus 474 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~e 552 (692)
... .......|++.|+|||...+. .++.++||||+|+++|||++|+.||....... ............. .+
T Consensus 170 ~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~-~~ 241 (348)
T d2gfsa1 170 HTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG-AE 241 (348)
T ss_dssp CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC-HH
T ss_pred CCC----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHCCCCC-HH
T ss_conf 257----544443454355583553377567855124320589999976889978898899---9999997307997-57
Q ss_pred CC------------CCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 34------------66688---677733988999999999980146999999999999999842201333453
Q 005536 553 II------------DPYLE---PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEELEHIRVSSWASNI 610 (692)
Q Consensus 553 i~------------d~~l~---~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev~~~L~~i~~~~~~~~~ 610 (692)
+. ..... .............+.+|+.+||+.||.+|||+.|++ .++|....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL-------~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL-------AHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH-------TSGGGTTT
T ss_pred HHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH-------CCHHHCCC
T ss_conf 7320010244544430355787555662678999999999997758834593899985-------59954879
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-44 Score=276.81 Aligned_cols=273 Identities=20% Similarity=0.252 Sum_probs=195.4
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEE
Q ss_conf 36755405311461999999991-89899999912289300899999999998189-----------9970016799984
Q 005536 324 SFFSEKHRLGTGAYGTVYAGKLH-NDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-----------HPNLLRLLGCCIE 391 (692)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 391 (692)
.+|...++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEEECCCCCH-HHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC------
Q ss_conf 8--900899970899988-8997420599999888999999999999998733899928537789966883999------
Q 005536 392 E--GEPILVYEFMPNGTL-CQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNY------ 462 (692)
Q Consensus 392 ~--~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~------ 462 (692)
. ...++++++...+.. ...........+++..+..++.|++.||+|||+. .+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCCCCC
T ss_conf 25652023432000354200000122346786899999999999998887640--5864656770570563057656443
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHH---
Q ss_conf 65994214774587788753236779999999210012778984625423588999883795457889954100799---
Q 005536 463 RSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLIEIITALKVVDFSRPHSEVNLAA--- 539 (692)
Q Consensus 463 ~~ki~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGviL~Elltg~~p~~~~~~~~~~~l~~--- 539 (692)
.++++|||.+..... ......||+.|+|||.+....++.++||||+|++++||++|+.||.............
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEEEECCCCCCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 056753144212344----5422366521057132146677764320123789999987889989875543210268999
Q ss_pred HHHHHHCCCC---------CCCCCCC-----CCC-----------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 9999951585---------4413466-----688-----------67773398899999999998014699999999999
Q 005536 540 LAIDRIGRGC---------VDEIIDP-----YLE-----------PHRDAWTLSSIHNVAELAFRCLAFHRDMRPTMMEV 594 (692)
Q Consensus 540 ~~~~~~~~~~---------~~ei~d~-----~l~-----------~~~~~~~~~~~~~l~~li~~Cl~~~p~~RPsm~ev 594 (692)
.....++... .....+. ... .............+.+|+.+||..||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 99998379987886245322000132012202432357764442100015674358999999999877994579089999
Q ss_pred HHHHHHHHHCCCCCCC
Q ss_conf 9999842201333453
Q 005536 595 AEELEHIRVSSWASNI 610 (692)
Q Consensus 595 ~~~L~~i~~~~~~~~~ 610 (692)
+ .++|..+.
T Consensus 326 L-------~Hp~f~~~ 334 (362)
T d1q8ya_ 326 V-------NHPWLKDT 334 (362)
T ss_dssp H-------TCGGGTTC
T ss_pred H-------CCCCCCCC
T ss_conf 6-------69340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.4e-25 Score=163.45 Aligned_cols=164 Identities=15% Similarity=0.114 Sum_probs=119.4
Q ss_pred CCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCC------------------HHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 55405311461999999991898999999122893------------------008999999999981899970016799
Q 005536 327 SEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDT------------------DSIDQVMNEIKLLSSVSHPNLLRLLGC 388 (692)
Q Consensus 327 ~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~ 388 (692)
.+.++||+|+||+||+|+..+++.||||.++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 98489008999708999888997420599999888999999999999998733899928537789966883999659942
Q 005536 389 CIEEGEPILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVAD 468 (692)
Q Consensus 389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ki~D 468 (692)
. ..+++|||+++..+.+ ++......++.|++.+|+|||+. +|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CCEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEEE
T ss_conf 2----8889999504565420---------01578999999999999998268---88983689036114289-899987
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCEEEHHHHHH
Q ss_conf 147745877887532367799999992------1001277898462542358899
Q 005536 469 FGLSRLGMTESSHISTAPQGTPGYLDP------QYHQYFHLSDKSDVYSFGVVLI 517 (692)
Q Consensus 469 FGla~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~s~ksDVySfGviL~ 517 (692)
||+|......... .|+.. ++ ....|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCH---------HHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 7884308998709---------9998779999999-7578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.07 E-value=1.2e-09 Score=72.21 Aligned_cols=150 Identities=17% Similarity=0.098 Sum_probs=103.6
Q ss_pred HHHHHHHCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEE
Q ss_conf 88987513675540531146199999999189899999912289300899999999998189-99700167999848900
Q 005536 317 KEIEKATSFFSEKHRLGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEP 395 (692)
Q Consensus 317 ~el~~~t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 395 (692)
.|+++.-..|...+..+.+....||+... ++..+++|+...........+..|...+..+. +-.+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990-89869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q ss_conf 89997089998889974205999998889999999999999987338---------------------------------
Q 005536 396 ILVYEFMPNGTLCQHLQRERGSGLPWTIRITIATETAQAIAYLHSAM--------------------------------- 442 (692)
Q Consensus 396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--------------------------------- 442 (692)
++||+++++.++.+..... .....++.+++..|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEECCCCCCCCCCCCC-------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 9999860433435433440-------269999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf -----------------------99928537789966883999659942147745
Q 005536 443 -----------------------NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 443 -----------------------~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
...++|+|+.+.|||++++...-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.59 E-value=2.1e-07 Score=58.79 Aligned_cols=131 Identities=19% Similarity=0.176 Sum_probs=83.5
Q ss_pred EECCCCC-EEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCEEEEEEEECCCCCH
Q ss_conf 5311461-99999999189899999912289300899999999998189--99700167999848900899970899988
Q 005536 331 RLGTGAY-GTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVS--HPNLLRLLGCCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 331 ~LG~G~~-g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~E~~~~gsL 407 (692)
.+..|.. ..||+....++..+++|....... ..+..|...++.+. .-.+.+++++..+.+..++|++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred HHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf 899742059999988899999999999999873-----------------------------------------------
Q 005536 408 CQHLQRERGSGLPWTIRITIATETAQAIAYLHS----------------------------------------------- 440 (692)
Q Consensus 408 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~----------------------------------------------- 440 (692)
.+.. +. ...++.+++..|+.||+
T Consensus 94 ~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCCC-------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 3221-------26---8999999999999873688544887554124688999999875411011340112137999999
Q ss_pred ----CC----CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf ----38----99928537789966883999659942147745
Q 005536 441 ----AM----NPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 441 ----~~----~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
.. ...++|+|+.+.|||++++..+-|.||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.39 E-value=4e-06 Score=51.22 Aligned_cols=77 Identities=18% Similarity=0.116 Sum_probs=50.2
Q ss_pred CEEECCCCCEEEEEEEEEC-CCEEEEEEEECC-------CCHHHHHHHHHHHHHHHCC-C--CCEEEEEEEEEECCEEEE
Q ss_conf 4053114619999999918-989999991228-------9300899999999998189-9--970016799984890089
Q 005536 329 KHRLGTGAYGTVYAGKLHN-DDWVAIKRFRYR-------DTDSIDQVMNEIKLLSSVS-H--PNLLRLLGCCIEEGEPIL 397 (692)
Q Consensus 329 ~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~l 397 (692)
.+.||.|....||+....+ ++.+++|.-... -....++...|...+..+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9970899988
Q 005536 398 VYEFMPNGTL 407 (692)
Q Consensus 398 V~E~~~~gsL 407 (692)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.79 E-value=6.6e-05 Score=43.99 Aligned_cols=73 Identities=15% Similarity=0.227 Sum_probs=48.0
Q ss_pred CEEECCCCCEEEEEEEEECC--------CEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEEEEEE
Q ss_conf 40531146199999999189--------899999912289300899999999998189-997001679998489008999
Q 005536 329 KHRLGTGAYGTVYAGKLHND--------DWVAIKRFRYRDTDSIDQVMNEIKLLSSVS-HPNLLRLLGCCIEEGEPILVY 399 (692)
Q Consensus 329 ~~~LG~G~~g~Vykg~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 399 (692)
.+.|+.|-.-.+|+....++ ..|.++... . ........+|..+++.+. +.-..++++++. -.+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECC----CCEEE
T ss_conf 9991785334348999688775445789817999659-9-6116589999999999975799980899818----95699
Q ss_pred EECCCCCH
Q ss_conf 70899988
Q 005536 400 EFMPNGTL 407 (692)
Q Consensus 400 E~~~~gsL 407 (692)
||+++.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEECCCCC
T ss_conf 97345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.78 E-value=9.2e-05 Score=43.11 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=76.8
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCE--EEEEE-----EEEECCEEEEEEEECCCCCH
Q ss_conf 461999999991898999999122893008999999999981899970--01679-----99848900899970899988
Q 005536 335 GAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPNL--LRLLG-----CCIEEGEPILVYEFMPNGTL 407 (692)
Q Consensus 335 G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL 407 (692)
+.--.||+....+|+.+++|..+.. ....+++..|...+..|....+ +..+. .....+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 6120269998389997999984787-788999999999999998559987875206898056653479999865277688
Q ss_pred H-----H---------HHHHCC-------CCCCCHH-------------------HHHHHHHHHHHHHHHHH----HCCC
Q ss_conf 8-----9---------974205-------9999988-------------------89999999999999987----3389
Q 005536 408 C-----Q---------HLQRER-------GSGLPWT-------------------IRITIATETAQAIAYLH----SAMN 443 (692)
Q Consensus 408 ~-----~---------~l~~~~-------~~~l~~~-------------------~~~~ia~~ia~~L~yLH----~~~~ 443 (692)
. . .+|... ...+++. .+-.+...+...+..+. +...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 9928537789966883999659942147745
Q 005536 444 PPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 444 ~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
.+++|+|+.+.|||++++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.60 E-value=0.0014 Score=36.09 Aligned_cols=158 Identities=12% Similarity=0.088 Sum_probs=83.6
Q ss_pred CCHHHHHHHHCCCCCCEE-----ECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCC--EEEEE
Q ss_conf 896889875136755405-----31146199999999189899999912289300899999999998189997--00167
Q 005536 314 YPYKEIEKATSFFSEKHR-----LGTGAYGTVYAGKLHNDDWVAIKRFRYRDTDSIDQVMNEIKLLSSVSHPN--LLRLL 386 (692)
Q Consensus 314 ~~~~el~~~t~~f~~~~~-----LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 386 (692)
.+.+|++...++|...+. |..|---+.|+.+..+++ +++|...... ..++...|+.++..|...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 89999999998679998568523788852673899978972-8999807899--98899999999875430255545564
Q ss_pred E------EEEECCEEEEEEEECCCCCHHH--------------HHHHCC-C---C---CCC------------------H
Q ss_conf 9------9984890089997089998889--------------974205-9---9---999------------------8
Q 005536 387 G------CCIEEGEPILVYEFMPNGTLCQ--------------HLQRER-G---S---GLP------------------W 421 (692)
Q Consensus 387 g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~-~---~---~l~------------------~ 421 (692)
- ..........++.+..+..... .++... . . ... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 8899999999999999873-3899928537789966883999659942147745
Q 005536 422 TIRITIATETAQAIAYLHS-AMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRL 474 (692)
Q Consensus 422 ~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDik~~NILld~~~~~ki~DFGla~~ 474 (692)
......+......+...+. ....++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 127999999987642048554545033378636564020454126742221236
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.07 E-value=0.003 Score=34.13 Aligned_cols=28 Identities=36% Similarity=0.921 Sum_probs=23.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 6899974356644458988214416999977776
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGF 234 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~ 234 (692)
.|+.|+.|.|. ..+|+|.|.+||.|||+
T Consensus 8 ~C~~~A~C~Nt------~Gsy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 8 QCSVHAECRDY------ATGFCCRCVANYTGNGR 35 (40)
T ss_dssp GSCTTEEEEEC------SSCEEEEECTTEEECSS
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCCCC
T ss_conf 88999896658------99928589999747989
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.60 E-value=0.088 Score=25.39 Aligned_cols=32 Identities=25% Similarity=0.752 Sum_probs=25.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 689997435664445898821441699997777668999744
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRR 242 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~~~g~gC~~ 242 (692)
-|.++++|.+. .+..+|.|.|..||.| .-|+.
T Consensus 13 ~C~NgG~C~~~----~~~~~~~C~C~~gy~G------~~Ce~ 44 (53)
T d3egfa_ 13 YCLNGGVCMHI----ESLDSYTCNCVIGYSG------DRCQT 44 (53)
T ss_dssp CSCSSCEEEEE----SSSSCEEEECCTTCCS------SSSCC
T ss_pred CCCCCCEEECC----CCCCCEEEECCCCCCC------CCCCC
T ss_conf 78999496335----8989848689899838------98760
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.98 E-value=0.082 Score=25.55 Aligned_cols=28 Identities=32% Similarity=0.788 Sum_probs=23.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ....+|+|.|..||.|.
T Consensus 5 PC~ngG~C~~~----~~~~~y~C~C~~g~~G~ 32 (41)
T d1tpga1 5 RCFNGGTCQQA----LYFSDFVCQCPEGFAGK 32 (41)
T ss_dssp CSCTTCEEEEE----SSSSCEEEECCTTCBSS
T ss_pred CCCCCCEEECC----CCCCCEEECCCCCCCCC
T ss_conf 78999897447----88788477898988798
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.01 E-value=0.093 Score=25.23 Aligned_cols=26 Identities=23% Similarity=0.894 Sum_probs=21.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|..+++|.+. ..+|+|.|..||.|.
T Consensus 12 pC~n~g~C~n~------~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 12 PCEHAGKCINT------LGSFECQCLQGYTGP 37 (42)
T ss_dssp SSSTTCEEEEC------SSSEEEECCTTEEST
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 88999386889------999786899988188
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.60 E-value=0.21 Score=23.19 Aligned_cols=26 Identities=35% Similarity=0.888 Sum_probs=21.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ..+|.|.|..||.|.
T Consensus 10 PC~ngg~C~~~------~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 10 PCLNGGSCKDD------INSYECWCPFGFEGK 35 (39)
T ss_dssp CCCTTCEEEEE------TTEEEEECCTTCCST
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 88999488739------999787899999878
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.31 E-value=0.087 Score=25.42 Aligned_cols=31 Identities=35% Similarity=0.880 Sum_probs=23.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 6899974356644458988214416999977776689997446
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRRT 243 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~~~g~gC~~i 243 (692)
-|.++++|.+. ..+|+|.|..||.| ..|+.+
T Consensus 8 pC~ngg~C~~~------~~~y~C~C~~g~~G------~~Ce~~ 38 (40)
T d1g1sa2 8 SCSKQGECLET------IGNYTCSCYPGFYG------PECEYV 38 (40)
T ss_dssp GGGGSEEEEEC------SSSEEEEECTTEES------TTSCEE
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCC------CCCCCC
T ss_conf 48999598789------99868838999658------987888
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.13 E-value=0.18 Score=23.61 Aligned_cols=35 Identities=29% Similarity=0.624 Sum_probs=25.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 689997435664445898821441699997777668999744
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRR 242 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~~~g~gC~~ 242 (692)
-|.++++|... .......+|.|.|..||.| .-|+.
T Consensus 13 ~C~NgG~C~~~-~~~~~~~~y~C~C~~gy~G------~~Ce~ 47 (63)
T d1haea_ 13 FCVNGGECFMV-KDLSNPSRYLCKCQPGFTG------ARCTE 47 (63)
T ss_dssp TSCTTCEEEEE-ESSSSSCCEEEECCTTEES------TTSCE
T ss_pred CCCCCCEEEEC-CCCCCCCCEEEECCCCCCC------CCCCC
T ss_conf 69898988144-6205899978578999878------78587
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.08 E-value=0.16 Score=23.88 Aligned_cols=26 Identities=35% Similarity=0.896 Sum_probs=21.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ..+|+|.|..||.|.
T Consensus 8 PC~n~g~C~~~------~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 8 PCQNDATCLDQ------IGEFQCICMPGYEGV 33 (39)
T ss_dssp CCCSSCEEEEC------SSCEEEECCTTEESS
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 78999998779------999887699998548
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.62 E-value=0.21 Score=23.16 Aligned_cols=26 Identities=35% Similarity=0.949 Sum_probs=21.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ..+|.|.|..||.|.
T Consensus 7 PC~ngg~C~~~------~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 7 PCQNQGKCKDG------LGEYTCTCLEGFEGK 32 (39)
T ss_dssp CCCSSCEECCC------SSSCCEECCTTEETT
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 78999488789------999897799999869
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.42 E-value=0.21 Score=23.17 Aligned_cols=29 Identities=28% Similarity=0.665 Sum_probs=20.7
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 997435664445898821441699997777668999744
Q 005536 204 KNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRR 242 (692)
Q Consensus 204 ~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~~~g~gC~~ 242 (692)
.++.|.|. .++|+|.|..||..++ ..|+|
T Consensus 15 ~~~~C~Nt------~Gsy~C~C~~Gy~~~g----~~C~D 43 (43)
T d1emoa1 15 KHGQCINT------DGSYRCECPFGYILAG----NECVD 43 (43)
T ss_dssp SSSCCCCC------SSCCCCCCCTTEEESS----SCEEE
T ss_pred CCCEEECC------CCCEEEECCCCCCCCC----CCCCC
T ss_conf 88886888------9994867999952689----84309
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.06 E-value=0.17 Score=23.73 Aligned_cols=32 Identities=22% Similarity=0.666 Sum_probs=24.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 689997435664445898821441699997777668999744
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGDGFVAGDGCRR 242 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~~~g~gC~~ 242 (692)
-|.++++|.+. ....+|.|.|..||.| .-|+.
T Consensus 11 ~C~ngG~C~~~----~~~~~~~C~C~~gy~G------~~Ce~ 42 (48)
T d1nqlb_ 11 YCLHDGVCMYI----EALDKYACNCVVGYIG------ERCQY 42 (48)
T ss_dssp EECTTCEEEEE----TTTTEEEEEECTTEES------TTSCE
T ss_pred CCCCCCEEEEE----CCCCCEEEECCCCCCC------CCCCC
T ss_conf 78999097420----7979968709898646------98785
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.78 E-value=0.29 Score=22.31 Aligned_cols=25 Identities=40% Similarity=0.906 Sum_probs=19.0
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 9974356644458988214416999977776
Q 005536 204 KNADCTRNFTFANGISGHRCRCQEGFEGDGF 234 (692)
Q Consensus 204 ~n~~C~~~~~~~~~~~g~~C~C~~G~~g~~~ 234 (692)
.|++|.|+ -.||.|.|.+||+-.|.
T Consensus 11 GnGTCtNv------iGgFec~C~~GFepgpm 35 (39)
T d1emoa2 11 GNGTCKNV------IGGFECTCEEGFEPGPM 35 (39)
T ss_dssp SSSCEEEC------SSSEEECCSSSSCCCSS
T ss_pred CCCEEEEC------CCCEEEEECCCCCCCCC
T ss_conf 78625403------45268750377678764
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=82.67 E-value=0.25 Score=22.69 Aligned_cols=26 Identities=27% Similarity=0.755 Sum_probs=21.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ..+|.|.|..||.|.
T Consensus 9 PC~ngg~C~~~------~~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 9 PCQNGGSCKDQ------LQSYICFCLPAFEGR 34 (37)
T ss_dssp CCCTTCEEEEE------TTEEEEECCTTEEST
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 78999888789------999687799998678
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.35 E-value=0.29 Score=22.27 Aligned_cols=26 Identities=35% Similarity=0.934 Sum_probs=21.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ..+|.|.|..||.|.
T Consensus 7 PC~ngg~C~~~------~~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 7 PCLHNGRCLDK------INEFQCECPTGFTGH 32 (35)
T ss_dssp CSTTTCEEEEC------SSCEEEECCTTEESS
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 78999387779------999587799988778
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.82 E-value=0.17 Score=23.72 Aligned_cols=26 Identities=35% Similarity=0.970 Sum_probs=20.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 68999743566444589882144169999777
Q 005536 201 NCSKNADCTRNFTFANGISGHRCRCQEGFEGD 232 (692)
Q Consensus 201 ~C~~n~~C~~~~~~~~~~~g~~C~C~~G~~g~ 232 (692)
-|.++++|.+. ..+|.|.|..||.|.
T Consensus 8 pC~ngg~C~~~------~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 8 SCSGHGECVET------INNYTCKCDPGFSGL 33 (39)
T ss_dssp GGGGSEEEEEE------TTEEEEEECTTEEST
T ss_pred CCCCCCEEECC------CCCEEEECCCCCCCC
T ss_conf 68999198788------999788489997285
|